title,url,time_published,summary,ticker,relevance_score,ticker_sentiment_score,ticker_sentiment_label
Johnson & Johnson  ( JNJ )  Stock Sinks As Market Gains: What You Should Know,https://www.zacks.com/stock/news/2037568/johnson-johnson-jnj-stock-sinks-as-market-gains-what-you-should-know,2023-01-10 22:45:23,"In the latest trading session, Johnson & Johnson (JNJ) closed at $175.16, marking a -0.24% move from the previous day.",JNJ,0.636698,0.303915,Somewhat-Bullish
"Healthcare Stocks, a Star Last Year, Are Stumbling Out of the Gate",https://www.barrons.com/articles/healthcare-stocks-performance-2023-51673386289,2023-01-10 21:32:00,"Healthcare Stocks, a Standout in 2022, Are Going Nowhere in ...",JNJ,0.159569,-0.129209,Neutral
Is The 60/40 Portfolio A Thing Of The Past? Not So Fastâ€¦,https://www.forbes.com/sites/greatspeculations/2023/01/10/is-the-6040-portfolio-a-thing-of-the-past-not-so-fast/,2023-01-10 19:47:29,"Investors who use a 60/40 portfolio had a rough year. In the past, putting 60% in stocks and 40% in bonds has often helped investors hedge against losses in either asset class. But 2022 had other ideas.",JNJ,0.048327,-0.007979,Neutral
"If You Invested $1,000 In Inovio Stock At Its COVID-19 Pandemic Low, Here's How Much You'd Have Now - Inovio Pharmaceuticals  ( NASDAQ:INO ) ",https://www.benzinga.com/news/23/01/30315163/if-you-invested-1-000-in-inovio-stock-at-its-covid-19-pandemic-low-heres-how-much-youd-have-now,2023-01-10 17:48:18,Investors who bought stocks during the COVID-19 market crash in 2020 have generally experienced some big gains in the past two and a half years. But there was no question some big-name stocks performed better than others since the pandemic bottom.,JNJ,0.129866,0.0,Neutral
"Jim Cramer's Investing Club meeting Tuesday: Microsoft, health care, Emerson Electric",https://www.cnbc.com/2023/01/10/jim-cramers-investing-club-meeting-tuesday-microsoft-health-care.html,2023-01-10 16:32:15,"The Investing Club holds its ""Morning Meeting"" every weekday at 10:20 a.m. ET.",JNJ,0.260189,0.155282,Somewhat-Bullish
Best Stocks To Buy In 2023? 2 Health Care Stocks To Know,https://stockmarket.com/featured/best-stocks-to-buy-in-2023-2-health-care-stocks-to-know-2023-01-10,2023-01-10 15:59:15,"To get the ball rolling, healthcare stocks refer to investments in companies that operate within the healthcare industry. This industry encompasses a wide range of sectors such as pharmaceuticals, medical devices, biotechnology, and healthcare services.",JNJ,0.537213,0.387804,Bullish
How To Choose Recession-Proof Stocks To Fortify Your Portfolio In 2023,https://www.forbes.com/sites/qai/2023/01/10/how-to-choose-recession-proof-stocks-to-fortify-your-portfolio-in-2023/,2023-01-10 15:45:57,"Chances are, the best recession stocks are companies you've never heard of. They're the 'unsexy' businesses that keep the world turning. This is where their strength lies: providing steady, consistent returns.",JNJ,0.033562,-0.022847,Neutral
JNJ: 3 Stocks to Help Stabilize Your Portfolio in 2023,https://stocknews.com/news/jnj-pg-atr-3-stocks-to-help-stabilize-your-portfolio-in-2023/,2023-01-10 14:49:43,JNJ: 3 Stocks to Help Stabilize Your Portfolio in ...,JNJ,0.251866,0.187417,Somewhat-Bullish
Bayer flags new blood thinner as $5 bln-plus opportunity,https://www.reuters.com/business/healthcare-pharmaceuticals/bayer-flags-new-blood-thinner-5-bln-plus-opportunity-2023-01-10/,2023-01-10 13:06:14,"FRANKFURT, Jan 10 ( Reuters ) - Bayer predicted on Tuesday its experimental drug against dangerous blood clots could make more than 5 billion euros ( $5.4 billion ) in peak annual sales, as the company seeks to revive a share price that has drawn interest from activist investors.",JNJ,0.077845,0.101351,Neutral
3 Top Dividend Kings to Buy for the Long Haul,https://www.fool.com/investing/2023/01/10/3-top-dividend-kings-to-buy-for-the-long-haul/,2023-01-10 10:52:00,It's the underlying businesses that fund their dividends that make these stocks especially attractive.,JNJ,0.397697,0.323028,Somewhat-Bullish
Should Investors Worry About AbbVie's Dividend?,https://www.fool.com/investing/2023/01/10/should-investors-worry-about-abbvie-dividend/,2023-01-10 10:31:00,"The risks are real, but they're decreasing over time.",JNJ,0.056674,0.023096,Neutral
Nyxoah Appoints Mr. Daniel Wildman to its Board of Directors,https://www.globenewswire.com/news-release/2023/01/09/2585684/0/en/Nyxoah-Appoints-Mr-Daniel-Wildman-to-its-Board-of-Directors.html,2023-01-09 21:30:00,Nyxoah Appoints Mr. Daniel Wildman to its Board of Directors,JNJ,0.040969,0.079614,Neutral
Nyxoah Appoints Mr. Daniel Wildman to its Board of Directors - Nyxoah  ( NASDAQ:NYXH ) ,https://www.benzinga.com/pressreleases/23/01/g30341181/nyxoah-appoints-mr-daniel-wildman-to-its-board-of-directors,2023-01-09 21:30:00,"Mont-Saint-Guibert, Belgium - January 9, 2023, 10:30pm CET / 4:30pm ET - Nyxoah SA NYXH ( ""Nyxoah"" or the ""Company"" ) , a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea ( OSA ) , today announced that it has ...",JNJ,0.04028,0.075528,Neutral
US Stocks End Mixed As Markets Ponder 'Soft Landing' Odds,https://www.barrons.com/news/us-stocks-end-mixed-as-markets-ponder-soft-landing-odds-01673299508,2023-01-09 21:28:03,"Wall Street stocks ended mixed on Monday despite a strong start, with markets looking ahead to critical inflation data and bank earnings later in the week. Major indices looked poised for another solid run after Friday's rally, which came on the back of jobs data that raised hopes for a ""soft ...",JNJ,0.143415,-0.160968,Somewhat-Bearish
"Stock Market Today: Nasdaq Pops as Tesla, Coinbase Stocks Soar",https://www.kiplinger.com/investing/stocks/stock-market-today-010923-nasdaq-pops-as-tesla-coinbase-stocks-soar,2023-01-09 21:20:45,A busy week started with a bang for at least one of the three major market indexes. While today was quiet on the economic and earnings fronts - both heat up later this week with the December consumer price index ( CPI ) on Thursday and big banks reporting Q4 results on Friday - there was plenty ...,JNJ,0.135347,-0.194665,Somewhat-Bearish
"J&J may eye deals that boost eye care, surgical robots businesses - CEO",https://www.reuters.com/markets/deals/jj-may-eye-deals-that-boost-eye-care-surgical-robots-businesses-ceo-2023-01-09/,2023-01-09 19:35:00,"J&J may eye deals that boost eye care, surgical robots businesses ... ...",JNJ,0.19117,0.26366,Somewhat-Bullish
Dividend Kings: List and Definition,https://www.fool.com/investing/stock-market/types-of-stocks/dividend-stocks/dividend-kings/,2023-01-09 17:32:52,Get a list of current -- and potential future -- Dividend Kings and also learn how to leverage these strong companies to build wealth.,JNJ,0.082677,0.063775,Neutral
Johnson & Johnson Unusual Options Activity - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/01/30336949/johnson-johnson-unusual-options-activity,2023-01-09 17:10:35,"Someone with a lot of money to spend has taken a bullish stance on Johnson & Johnson JNJ. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",JNJ,0.805739,0.395371,Bullish
"Atreca Appoints Philippe Bishop, MD as Chief Medical Officer - Atreca  ( NASDAQ:BCEL ) ",https://www.benzinga.com/pressreleases/23/01/g30331959/atreca-appoints-philippe-bishop-md-as-chief-medical-officer,2023-01-09 13:30:54,"SAN CARLOS, Calif., Jan. 09, 2023 ( GLOBE NEWSWIRE ) -- Atreca, Inc. ( Atreca ) BCEL, a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active human immune response, today announced the ...",JNJ,0.041975,-0.070877,Neutral
"Atreca Appoints Philippe Bishop, MD as Chief Medical Officer",https://www.globenewswire.com/news-release/2023/01/09/2585273/0/en/Atreca-Appoints-Philippe-Bishop-MD-as-Chief-Medical-Officer.html,2023-01-09 13:30:00,"SAN CARLOS, Calif., Jan. 09, 2023 ( GLOBE NEWSWIRE ) -- Atreca, Inc. ( Atreca ) ( NASDAQ: BCEL ) , a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active human immune response, today ...",JNJ,0.042571,-0.070973,Neutral
Emergent BioSolutions to reduce workforce by about 5%,https://www.reuters.com/business/healthcare-pharmaceuticals/emergent-biosolutions-reduce-workforce-by-about-5-2023-01-09/,2023-01-09 12:32:00,Emergent BioSolutions to reduce workforce by about ...,JNJ,0.318897,0.0,Neutral
Tata Motors starts delivery of EV version of mini truck Ace at Rs 9.99 lakh,https://www.business-standard.com/article/automobile/tata-motors-starts-delivery-of-ev-version-of-mini-truck-ace-at-rs-9-99-lakh-123010900629_1.html,2023-01-09 12:03:00,Tata Motors starts delivery of EV version of mini truck Ace at Rs 9.99 ... Business Standard ...,JNJ,0.092927,0.039534,Neutral
MedTech Expert Joins KMM Group as Healthcare Industry Advisor,https://www.prnewswire.com/news-releases/medtech-expert-joins-kmm-group-as-healthcare-industry-advisor-301716175.html,2023-01-09 12:00:00,"HATBORO, Pa., Jan. 9, 2023 /PRNewswire/ -- KMM Group has engaged with long time healthcare executive J. Mark King as their new Non-Executive/Non-Owner Chairman of the Board and Healthcare Industry Advisor.",JNJ,0.113062,0.050695,Neutral
Should Invesco S&P 500 Low Volatility ETF  ( SPLV )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2036580/should-invesco-sp-500-low-volatility-etf-splv-be-on-your-investing-radar,2023-01-09 11:20:05,Style Box ETF report for ...,JNJ,0.129168,0.070052,Neutral
2 Warren Buffett Stocks That Are No-Brainer Buys and 1 to Avoid Like the Plague,https://www.fool.com/investing/2023/01/09/2-warren-buffett-stocks-buy-1-to-avoid-like-plague/,2023-01-09 10:06:00,"Two Buffett stocks stand out as clear-cut buys in the new year, while another top holding has lost much of its luster.",JNJ,0.181819,0.027729,Neutral
Functional chewing gum market to grow by 5.0% Y-O-Y in 2023; Increasing demand for nicotine in smoking cessation therapy will drive growth - Technavio,https://www.prnewswire.com/news-releases/functional-chewing-gum-market-to-grow-by-5-0-y-o-y-in-2023-increasing-demand-for-nicotine-in-smoking-cessation-therapy-will-drive-growth---technavio-301714219.html,2023-01-09 07:30:00,Functional chewing gum market to grow by 5.0% Y-O-Y in 2023 ... PR ...,JNJ,0.039548,0.067547,Neutral
2 Healthcare Stocks That Could Make You Richer,https://www.fool.com/investing/2023/01/08/2-healthcare-stocks-that-could-make-you-richer/,2023-01-08 14:45:00,The healthcare industry presents opportunities for both growth and value investors.,JNJ,0.333257,0.091682,Neutral
GE's Spinoff Deserves Healthy Skepticism,https://www.wsj.com/articles/ges-spinoff-deserves-healthy-skepticism-11673061196,2023-01-07 14:00:00,"While GE HealthCare will deliver better growth as a stand-alone, the new company's valuation looks stretched and its leverage is high.",JNJ,0.388879,0.242817,Somewhat-Bullish
This Unstoppable Stock Is Approaching a Once-in-a-Decade Buying Opportunity,https://www.fool.com/investing/2023/01/07/this-unstoppable-stock-is-approaching-a-once-in-a/,2023-01-07 12:20:00,"Johnson & Johnson's upcoming spinoff could lead to better returns, and it'll happen before 2024.",JNJ,0.236742,0.076697,Neutral
3 No-Brainer Dividend Stocks to Buy in 2023,https://www.fool.com/investing/2023/01/07/3-no-brainer-dividend-stocks-to-buy-in-2023/,2023-01-07 11:10:00,These stocks have what it takes to win over the long run.,JNJ,0.27432,0.043835,Neutral
The 3 Best Warren Buffett Dividend Stocks to Buy Now,https://www.fool.com/investing/2023/01/07/3-best-warren-buffett-dividend-stocks-to-buy-now/,2023-01-07 10:52:00,All three were winners for Buffett in 2022.,JNJ,0.183895,0.232422,Somewhat-Bullish
"Dow Jumps 700 Points; S&P 500 Rises Over 2% - Aehr Test Systems  ( NASDAQ:AEHR ) , ATAI Life Sciences  ( NASDAQ:ATAI ) ",https://www.benzinga.com/news/earnings/23/01/30316154/dow-jumps-700-points-s-p-500-rises-over-2,2023-01-06 19:43:24,"U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 700 points on Friday. The Dow traded up 2.14% to 33,634.19 while the NASDAQ rose 2.54% to 10,566.63. The S&P 500 also rose, gaining, 2.30% to 3,895.60.",JNJ,0.05257,0.031033,Neutral
FATE To End Janssen Deal and Prioritize Pipeline Development,https://www.zacks.com/stock/news/2036413/fate-to-end-janssen-deal-and-prioritize-pipeline-development,2023-01-06 18:55:00,FATE decides not to continue its collaboration and option agreement with Janssen. The company also conducts a strategic review.,JNJ,0.105604,0.006707,Neutral
"Nasdaq Gains 1.5%; Fate Therapeutics Shares Plunge - Aehr Test Systems  ( NASDAQ:AEHR ) , ATAI Life Sciences  ( NASDAQ:ATAI ) ",https://www.benzinga.com/news/earnings/23/01/30313745/nasdaq-gains-1-5-fate-therapeutics-shares-plunge,2023-01-06 17:01:06,"U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 550 points on Friday. The Dow traded up 1.69% to 33,488.01 while the NASDAQ rose 1.52% to 10,461.92. The S&P 500 also rose, gaining, 1.67% to 3,871.65. Check This Out: 5 Tech Stocks That Are Flying - And May ...",JNJ,0.053153,0.031041,Neutral
"Tesla Falls Again, but This Nasdaq Stock Is Truly Plunging",https://www.fool.com/investing/2023/01/06/tesla-falls-again-but-this-nasdaq-stock-is-truly-p/,2023-01-06 15:54:00,The Nasdaq Composite once again is underperforming the rest of the market.,JNJ,0.133841,0.089218,Neutral
Why Fate Therapeutics  ( FATE )  Shares Are Plunging Today - Fate Therapeutics  ( NASDAQ:FATE ) ,https://www.benzinga.com/general/biotech/23/01/30310640/fate-therapeutics-ends-collaboration-deal-with-janssen-cuts-staff,2023-01-06 15:27:18,"Fate Therapeutics Inc FATE has decided to terminate the collaboration and option agreement with Janssen Biotech Inc, a Johnson & Johnson unit JNJ, on revised terms and conditions. The agreement has been terminated, and all collaboration activities will be wound down in the first quarter of 2023.",JNJ,0.414559,0.325335,Somewhat-Bullish
"Moral Rating Agency slams Western companies, including Microsoft and NestlÃ©, over alleged supply of products to Russia",https://www.marketwatch.com/story/moral-rating-agency-slams-western-companies-including-microsoft-and-nestle-over-alleged-supply-of-products-to-russia-11673016382,2023-01-06 14:46:00,New research claims consumer giants are still selling products into the country.,JNJ,0.192081,0.082969,Neutral
Injectable Nanomedicines Market will surpass USD 1257.7 million by 2030 at a CAGR of 7.6% till 2030 : GreyViews,https://www.benzinga.com/pressreleases/23/01/g30310044/injectable-nanomedicines-market-will-surpass-usd-1257-7-million-by-2030-at-a-cagr-of-7-6-till-2030,2023-01-06 14:00:00,"Pune India, Jan. 06, 2023 ( GLOBE NEWSWIRE ) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa. These are the key regions where the injectable nanomedicines market is operating ...",JNJ,0.02607,0.09518,Neutral
JNJ: 1 Dividend Stock to Buy Now and Retire on Later,https://stocknews.com/news/jnj-nvo-pfe-bmy-1-dividend-stock-to-buy-now-and-retire-on-later/,2023-01-06 13:03:07,"Record-high inflation, the Fed's hawkish stance, geopolitical turbulence, and growing recession fears kept the stock market highly volatile last year. However, Johnson & Johnson ( JNJ ) has been able to survive the market turmoil due to the defensive nature of its business and solid fundamentals.",JNJ,0.71174,0.430685,Bullish
"Insights on the Allergic Conjunctivitis Global Market to 2031 - by Drug Class, Disease Type, Distribution Channel and Region",https://www.prnewswire.com/news-releases/insights-on-the-allergic-conjunctivitis-global-market-to-2031---by-drug-class-disease-type-distribution-channel-and-region-301714458.html,2023-01-05 19:15:00,Insights on the Allergic Conjunctivitis Global Market to 2031 - by ... PR ...,JNJ,0.032871,0.020154,Neutral
Johnson & Johnson sets up mega-IPO for consumer health unit,https://www.axios.com/2023/01/05/johnson-and-johnson-ipo-consumer-health-tylenol-band-aid,2023-01-05 15:11:41,"Johnson & Johnson on Wednesday IPO registration papers for its consumer health products business, which is being spun out under the name Kenvue. Why it matters: This could be the largest U.S. IPO since Rivian went public in late 2021, with Renaissance Capital estimating that Kenvue could raise up ...",JNJ,0.269776,0.0,Neutral
Here is What to Know Beyond Why Johnson & Johnson  ( JNJ )  is a Trending Stock,https://www.zacks.com/stock/news/2035619/here-is-what-to-know-beyond-why-johnson-johnson-jnj-is-a-trending-stock,2023-01-05 14:00:13,"Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",JNJ,0.474958,0.141861,Neutral
3D Systems Announces Appointment of Bert Bruce to Medical Advisory Board,https://www.globenewswire.com/news-release/2023/01/05/2583729/8852/en/3D-Systems-Announces-Appointment-of-Bert-Bruce-to-Medical-Advisory-Board.html,2023-01-05 13:30:00,"ROCK HILL, S.C., Jan. 05, 2023 ( GLOBE NEWSWIRE ) -- 3D Systems ( NYSE:DDD ) today announced the appointment of Mr. Bert Bruce to the company's Medical Advisory Board. Mr. Bruce will join the five other members of the advisory board who have been named since the Board's establishment in May ...",JNJ,0.0312,0.081172,Neutral
"Stock Market Live: Stocks Edge Lower On Hawkish Fed Minutes, Jobs Data In Focus",https://www.thestreet.com/markets/stock-market-live-stocks-edge-lower-after-hawkish-fed-minutes,2023-01-05 13:10:00,Hawkish Fed minutes and a worrying rise in job cuts have stocks edging lower in early Thursday trading.,JNJ,0.160277,0.104442,Neutral
Jennifer Convery Joins Wilbur-Ellis Board of Directors,https://www.prnewswire.com/news-releases/jennifer-convery-joins-wilbur-ellis-board-of-directors-301714033.html,2023-01-05 13:00:00,"SAN FRANCISCO, Jan. 5, 2023 /PRNewswire/ -- Wilbur-Ellis announced today that Jennifer Convery has joined the Company's board of directors. As a commercial and operational leader in the food industry, Ms. Convery has extensive experience executing a purpose-driven strategy, while exceeding ...",JNJ,0.075874,0.087331,Neutral
Jennifer Convery Joins Wilbur-Ellis Board of Directors,https://www.newswire.ca/news-releases/jennifer-convery-joins-wilbur-ellis-board-of-directors-889926164.html,2023-01-05 13:00:00,"SAN FRANCISCO, Jan. 5, 2023 /CNW/ -- Wilbur-Ellis announced today that Jennifer Convery has joined the Company's board of directors. As a commercial and operational leader in the food industry, Ms. Convery has extensive experience executing a purpose-driven strategy, while exceeding financial ...",JNJ,0.075874,0.087331,Neutral
Silvergate Stock Plunges As FTX Collapse Triggers $8.1 Billion In Customer Withdrawals,https://www.thestreet.com/markets/silvergate-stock-plunges-as-ftx-saga-triggers-8-billion-withdrawals,2023-01-05 12:36:00,"""The digital asset industry has undergone a transformational shift, with significant over-leverage in the industry leading to several high-profile bankruptcies,"" Silvergate said.",JNJ,0.092213,0.047755,Neutral
Walgreens Stock Slides As $6.5 Billion Opioid Charge Clouds Earnings Beat,https://www.thestreet.com/markets/walgreens-stock-falls-6-5-billion-opioid-charge-clouds-earnings,2023-01-05 12:15:00,Walgreens booked a $6.5 billion charge to its first quarter earnings linked to its role in the U.S. opioid crisis.,JNJ,0.112532,0.04822,Neutral
Johnson & Johnson Files For IPO of Consumer Health Division Kenvue,https://www.thestreet.com/markets/johnson-johnson-files-to-ipo-of-consumer-health-division-kenvue,2023-01-05 11:43:00,"Johnson & Johnson's consumer health care division, named Kenvue, will have annual sales of around $15 billion.",JNJ,0.668563,0.309507,Somewhat-Bullish
Should Vanguard High Dividend Yield ETF  ( VYM )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2035495/should-vanguard-high-dividend-yield-etf-vym-be-on-your-investing-radar,2023-01-05 11:20:07,Style Box ETF report for ...,JNJ,0.125789,0.069184,Neutral
Should iShares Russell Top 200 Value ETF  ( IWX )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2035498/should-ishares-russell-top-200-value-etf-iwx-be-on-your-investing-radar,2023-01-05 11:20:06,Style Box ETF report for ...,JNJ,0.122269,-0.025788,Neutral
"Amazon Stock Leaps As CEO Andy Jassy Confirms Plans To Cut 18,000 Jobs",https://www.thestreet.com/markets/amazon-stock-leaps-as-ceo-jassy-confirms-plans-to-cut-18000-jobs,2023-01-05 11:14:00,"""Amazon has weathered uncertain and difficult economies in the past, and we will continue to do so,"" said CEO Andy Jassy.",JNJ,0.06623,-0.043188,Neutral
"Stocks Edge Higher, Jobs Data, Amazon, Johnson & Johnson, Walgreen - Five Things To Know",https://www.thestreet.com/markets/stocks-flat-amazon-johnson-johnson-walgreen-5-things-to-know,2023-01-05 10:42:00,"Stock futures flat as Fed minutes challenge rate bets. Jobs data in focus as Fed highlights wage growth. Johnson & Johnson plans IPO for consumer health care division. Amazon confirms 18,000 layoffs as big tech sheds more jobs and Walgreens earnings on deck with pharmacy sales in focus.",JNJ,0.162583,0.0924,Neutral
5 Top Stocks to Buy to Start the New Year Right,https://www.fool.com/investing/2023/01/05/5-top-stocks-to-buy-to-start-the-new-year-right/,2023-01-05 10:30:00,This may be the easiest of your New Year's resolutions. And it could pay off big.,JNJ,0.076236,0.131574,Neutral
"Twitter Whistleblower Joins Rapid7, a Cybersecurity Company",https://www.wsj.com/articles/twitter-whistleblower-joins-rapid7-a-cybersecurity-company-11672870454,2023-01-04 22:14:00,"Peiter Zatko will start a new role advising executives on cybersecurity investments, months after he filed a whistleblower complaint alleging security flaws at Twitter.",JNJ,0.084423,0.026564,Neutral
Celularity Appoints Paul Graves as Chief Communications Officer,https://www.globenewswire.com/news-release/2023/01/04/2583280/0/en/Celularity-Appoints-Paul-Graves-as-Chief-Communications-Officer.html,2023-01-04 21:10:00,Veteran executive brings more than 30 years of biopharmaceutical public relations and public affairs experience Veteran executive brings more than 30 years of biopharmaceutical public relations and public affairs experience ...,JNJ,0.064104,-0.053348,Neutral
Celularity Appoints Paul Graves as Chief Communications Officer - Celularity  ( NASDAQ:CELU ) ,https://www.benzinga.com/pressreleases/23/01/g30282751/celularity-appoints-paul-graves-as-chief-communications-officer,2023-01-04 21:10:00,"FLORHAM PARK, N.J., Jan. 04, 2023 ( GLOBE NEWSWIRE ) -- Celularity Inc. CELU ( ""Celularity"" ) , a biotechnology company developing placental-derived allogeneic cell and biomaterial therapies, today announced that Paul Graves has been appointed Senior Vice President, Chief Communications Officer, ...",JNJ,0.060541,-0.05317,Neutral
"""Motley Fool Money"" 2023 Investing Preview",https://www.fool.com/investing/2023/01/04/motley-fool-money-2023-investing-preview/,2023-01-04 19:12:57,"Stocks to watch, stocks to avoid, CEOs on the hot seat, and a few reckless predictions.",JNJ,0.011439,-0.008665,Neutral
AstraZeneca Stock Scores Relative Strength Rating Upgrade,https://www.investors.com/news/astrazeneca-stock-scores-relative-strength-rating-upgrade/,2023-01-04 19:03:00,"On Wednesday, AstraZeneca ( AZN ) stock reached a noteworthy performance benchmark, with its Relative Strength ( RS ) Rating moving into the 90-plus percentile with an upgrade to 92, a rise from 89 the day before. When looking for the best stocks to buy and watch, one factor to watch closely ...",JNJ,0.33628,0.0,Neutral
Two Female Scientists Win this year's King Faisal Prize,https://www.benzinga.com/pressreleases/23/01/g30280267/two-female-scientists-win-this-years-king-faisal-prize,2023-01-04 18:57:02,"Jeddah, Saudi Arabia, Jan. 04, 2023 ( GLOBE NEWSWIRE ) -- Two women scientists were announced King Faisal Prize for Medicine and Science laureates for 2023: a Covid-19 vaccine developer and a nanotechnology scientist.",JNJ,0.030524,-0.037629,Neutral
Oklahoma AG announces 4 new opioid settlements worth $226M,https://apnews.com/article/health-business-oklahoma-state-government-opioids-f8ba29f914a56f612aceb1f5c561c49a,2023-01-04 17:32:54,"OKLAHOMA CITY ( AP ) - Oklahoma entered settlement agreements with three major pharmacy chains and an opioid manufacturer totaling more than $226 million, Attorney General John O'Connor announced Wednesday.",JNJ,0.090134,-0.168831,Somewhat-Bearish
Worried About 2023? Here's a Safer Way to Invest in Stocks This Year,https://www.fool.com/investing/2023/01/04/worried-about-2023-heres-a-safer-way-to-invest/,2023-01-04 14:37:00,"By holding a broad range of stocks and spreading out your investment over the year, you can minimize your overall risk.",JNJ,0.066784,0.003016,Neutral
"Johnson & Johnson, Chubb And This Big US Bank On CNBC's 'Final Trades' - Goldman Sachs Group  ( NYSE:GS ) , Chubb  ( NYSE:CB ) ",https://www.benzinga.com/news/23/01/30269300/johnson-johnson-chubb-and-this-big-us-bank-on-cnbcs-final-trades,2023-01-04 13:16:16,"On CNBC's ""Halftime Report Final Trades,"" Joseph Terranova of Virtus Investment Partners named The Goldman Sachs Group, Inc. GS as his final trade. Analysts have a consensus Outperform rating on GS, according to Benzinga data.",JNJ,0.570165,0.590232,Bullish
JNJ: 3 Warren Buffett Stocks to Buy in 2023 and 1 to Sell,https://stocknews.com/news/jnj-ko-deo-ally-3-warren-buffett-stocks-to-buy-in-2023-and-1/,2023-01-04 12:48:17,"Warren Edward Buffett is undoubtedly one of the most successful investors of all time. According to Forbes, Buffett has compounded his wealth at such a high rate that he is currently the world's fifth-wealthiest person with a net worth of over $107 billion.",JNJ,0.265509,0.243172,Somewhat-Bullish
"Over-the-Counter  ( OTC )  Analgesics Market Size to Worth Around USD 38.45 Billion by 2029, Says Brandessence Market Research",https://www.prnewswire.com/news-releases/over-the-counter-otc-analgesics-market-size-to-worth-around-usd-38-45-billion-by-2029--says-brandessence-market-research-301713314.html,2023-01-04 12:40:00,Over-the-Counter ( OTC ) Analgesics Market Size to Worth Around ... PR ...,JNJ,0.032871,0.10793,Neutral
5 Dow Stocks That Make for No-Brainer Buys in 2023,https://www.fool.com/investing/2023/01/04/5-dow-stocks-that-make-for-no-brainer-buys-in-2023/,2023-01-04 10:21:00,"Among the Dow Jones Industrial Average's 30 components, there are five incredible deals just begging to be bought in the new year.",JNJ,0.114001,0.023862,Neutral
AstraZeneca ADR Scores Relative Strength Rating Upgrade,https://www.investors.com/ibd-data-stories/astrazeneca-adr-scores-relative-strength-rating-upgrade/,2023-01-04 08:00:00,"On Wednesday, AstraZeneca ADR ( AZN ) reached a noteworthy performance benchmark, with its Relative Strength ( RS ) Rating moving into the 90-plus percentile with an upgrade to 92, a rise from 89 the day before. When looking for the best stocks to buy and watch, one factor to watch closely is ...",JNJ,0.345674,0.0,Neutral
"Hair loss treatment products market size to grow by USD 2,216.5 million, growth opportunities led by Church & Dwight Co Inc, Cipla Ltd, Costco Wholesale Corp - Technavio",https://www.prnewswire.com/news-releases/hair-loss-treatment-products-market-size-to-grow-by-usd-2-216-5-million-growth-opportunities-led-by-church--dwight-co-inc-cipla-ltd-costco-wholesale-corp---technavio-301711812.html,2023-01-04 08:00:00,Hair loss treatment products market size to grow by USD 2216.5 ... PR ...,JNJ,0.033703,0.0,Neutral
Johnson & Johnson  ( JNJ )  Gains As Market Dips: What You Should Know,https://www.zacks.com/stock/news/2034825/johnson-johnson-jnj-gains-as-market-dips-what-you-should-know,2023-01-03 22:45:22,"In the latest trading session, Johnson & Johnson (JNJ) closed at $178.19, marking a +0.87% move from the previous day.",JNJ,0.749619,0.277471,Somewhat-Bullish
Bone Graft and Substitutes Market will reach to USD 5.78 billion by 2030 : GreyViews,https://www.benzinga.com/pressreleases/23/01/g30263402/bone-graft-and-substitutes-market-will-reach-to-usd-5-78-billion-by-2030-greyviews,2023-01-03 20:00:00,"Pune India, Jan. 03, 2023 ( GLOBE NEWSWIRE ) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa. These are the key regions where bone graft and substitute market is operating and ...",JNJ,0.023327,0.04716,Neutral
Orthopedic Trauma Fixation Devices Market is expected to grow from USD 8.9 billion in 2022 to USD 16.4 billion by 2030 : GreyViews,https://www.benzinga.com/pressreleases/23/01/g30262608/orthopedic-trauma-fixation-devices-market-is-expected-to-grow-from-usd-8-9-billion-in-2022-to-usd-,2023-01-03 19:00:00,"Pune India, Jan. 03, 2023 ( GLOBE NEWSWIRE ) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa.",JNJ,0.024878,0.068438,Neutral
PFE: 1 Stock That Would Be an Excellent Addition to Your Portfolio for Years to Come,https://stocknews.com/news/pfe-jnj-nvo-bmy-1-stock-that-would-be-an-excellent-addition-to-your/,2023-01-03 13:56:39,PFE: 1 Stock That Would Be an Excellent Addition to Your Portfolio ... ...,JNJ,0.08282,0.078603,Neutral
Addverb and Velociti Alliance Partner to Bring Innovative Futuristic Automation to Convenience and Grocery Intralogistics,https://www.prnewswire.com/news-releases/addverb-and-velociti-alliance-partner-to-bring-innovative-futuristic-automation-to-convenience-and-grocery-intralogistics-301711884.html,2023-01-03 13:38:00,Addverb and Velociti Alliance Partner to Bring Innovative Futuristic ... PR ...,JNJ,0.056943,0.0,Neutral
Human Insulin Drugs and Delivery Devices Market is expected to grow from USD 46.40 billion in 2022 to USD 87.82 billion by 2030 : GreyViews,https://www.benzinga.com/pressreleases/23/01/g30255655/human-insulin-drugs-and-delivery-devices-market-is-expected-to-grow-from-usd-46-40-billion-in-2022,2023-01-03 13:00:00,"Pune India, Jan. 03, 2023 ( GLOBE NEWSWIRE ) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa.",JNJ,0.023013,0.070803,Neutral
"The Zacks Analyst Blog Highlights Apple, Johnson & Johnson, CSX, American International Group and CenterPoint Energy",https://www.zacks.com/stock/news/2034406/the-zacks-analyst-blog-highlights-apple-johnson-johnson-csx-american-international-group-and-centerpoint-energy,2023-01-03 11:15:00,"Apple, Johnson & Johnson, CSX, American International Group and CenterPoint Energy are included in this Analyst Blog.",JNJ,0.156123,0.133969,Neutral
23 Top Dividend Stocks to Buy and Hold in 2023,https://www.fool.com/investing/2023/01/03/23-top-dividend-stocks-to-buy-and-hold-in-2023/,2023-01-03 10:55:00,These dividend stocks could reward investors in the new year and beyond.,JNJ,0.067727,0.115334,Neutral
4 Warren Buffett Stocks That Are Screaming Buys in 2023,https://www.fool.com/investing/2023/01/03/4-warren-buffett-stocks-are-screaming-buys-in-2023/,2023-01-03 10:21:00,These tried-and-true Buffett stocks are amazing values hiding in plain sight.,JNJ,0.126119,0.071767,Neutral
Should You Invest in the Vanguard Health Care ETF  ( VHT ) ?,https://www.zacks.com/stock/news/2034286/should-you-invest-in-the-vanguard-health-care-etf-vht,2023-01-02 11:20:07,Sector ETF report for ...,JNJ,0.134968,0.071604,Neutral
Investing Action Plan: Brace For A Blue Wave Of Earnings,https://www.investors.com/research/investing-action-plan/stock-market-investing-action-plan-tesla-chevron-microsoft-and-a-blue-wave-of-earnings/,2023-01-20 23:40:00,"A mixed week for the stock market is no surprise after a strong start to January. Tech stocks staged a nice show, leaving the Nasdaq composite comfortably above its 50-day line, while the Dow turned and undercut its 50-day average and the S&P 500 ended clinging to support.",JNJ,0.035929,-0.056054,Neutral
"Business Highlights: Musk testifies; Google lays off 12,000",https://apnews.com/article/business-highlights-4ccb80c6b7b5da9d1a4efc80772b9735,2023-01-20 23:00:27,Business Highlights: Musk testifies. Google lays off 12000 The Associated Press - en ...,JNJ,0.043818,0.071512,Neutral
J&J subsidiary to pay $9.75M to resolve kickback allegations,https://apnews.com/article/health-medical-technology-johnson-and-massachusetts-devices-d29503fac3b8c64294e9b4460ea654f8,2023-01-20 21:57:25,"BOSTON ( AP ) - A subsidiary of health care company Johnson & Johnson has agreed to pay nearly $10 million to settle allegations that it violated federal and state law by providing free products to a surgeon to induce him to use its products in procedures, prosecutors said Friday.",JNJ,0.228073,0.066177,Neutral
Making Sense of the Early Q4 Results: Is An Earnings Cliff Coming?,https://www.zacks.com/commentary/2042184/making-sense-of-the-early-q4-results-is-an-earnings-cliff-coming,2023-01-20 19:36:00,"By the end of this week, we will have seen quarterly results from about 28% of all S&P 500 members and will have a very good sense of whether the earnings-cliff narrative has started unfolding or been further pushed out.",JNJ,0.101797,-0.044714,Neutral
VHT: 3 Top Health Care ETFs to Buy and Hold for the Long Haul,https://stocknews.com/news/vht-ryh-pph-3-top-health-care-etfs-to-buy-and-hold-for/,2023-01-20 19:21:38,"Despite macro headwinds, the healthcare industry continues to witness stable growth, thanks to its relatively inelastic demand. Moreover, an aging population and increasing prevalence of chronic diseases are expected to boost the healthcare industry.",JNJ,0.19231,0.013724,Neutral
Could Alphabet Cuts Spell a Potentially Tough Year Ahead for Tech?,https://www.benzinga.com/markets/23/01/30504478/could-alphabet-cuts-spell-a-potentially-tough-year-ahead-for-tech,2023-01-20 15:36:03,"( Friday Market Open ) The weekend probably can't come soon enough for the info tech world with Friday's latest round of layoffs. This time, it's Alphabet GOOGL announcing 12,000 job cuts. That follows Microsoft MSFT earlier this week and other major mega-cap tech companies slicing their ...",JNJ,0.07238,0.016078,Neutral
Draganfly To Rally Around 87%? Here Are 10 Other Analyst Forecasts For Friday,https://www.benzinga.com/news/23/01/30501127/draganfly-to-rally-around-87-here-are-10-other-analyst-forecasts-for-friday,2023-01-20 13:30:47,"SVB Leerink raised the price target for BeiGene, Ltd. BGNE from $236 to $300. SVB Leerink analyst Andrew Berens maintained an Outperform rating. BeiGene shares rose 2% to $279.90 in pre-market trading. Raymond James cut the price target for Wintrust Financial Corporation WTFC from $118 to $110.",JNJ,0.279015,0.125162,Neutral
J&J  ( JNJ )  to Begin Q4 Earnings Season for Pharma Sector,https://www.zacks.com/stock/news/2041827/jj-jnj-to-begin-q4-earnings-season-for-pharma-sector,2023-01-20 13:05:00,"Growth in J&J's (JNJ) Pharma unit is expected to have been driven by drugs like Darzalex and Stelara. In the MedTech segment, continued recovery in worldwide procedure volume should drive sales.",JNJ,0.18967,0.081589,Neutral
3 No-Brainer Warren Buffett Stocks to Load Up On for 2023,https://www.fool.com/investing/2023/01/20/3-no-brainer-warren-buffett-stocks-buy-for-2023/,2023-01-20 12:18:00,These top-notch Buffett stocks are no-brainer buys right now.,JNJ,0.244109,0.199931,Somewhat-Bullish
Is Vanguard High Dividend Yield ETF  ( VYM )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2041762/is-vanguard-high-dividend-yield-etf-vym-a-strong-etf-right-now,2023-01-20 11:20:06,Smart Beta ETF report for ...,JNJ,0.115787,0.061204,Neutral
Avoid Meta Platforms' Stock Until It Makes This Move,https://www.fool.com/investing/2023/01/20/avoid-meta-stock-until-it-makes-this-move/,2023-01-20 10:19:00,Meta needs to resolve a developing identity crisis.,JNJ,0.053035,-0.025027,Neutral
"Clearmind Teams With Yissum, University of Jerusalem On 2 Psychedelic R&D Projects",https://www.benzinga.com/markets/cannabis/23/01/30490764/clearmind-teams-with-yissum-university-of-jerusalem-on-2-psychedelic-r-d-projects,2023-01-19 19:57:03,Psychedelics biotech Clearmind Medicine Inc. CMND has successfully completed two drug discovery projects with leading scientists at the Hebrew University of Jerusalem.,JNJ,0.244109,0.202019,Somewhat-Bullish
Koch gets $2.5 bln in dividends from unit that offloaded asbestos liability,https://www.reuters.com/business/koch-gets-25-bln-dividends-unit-that-offloaded-asbestos-liability-2023-01-19/,2023-01-19 19:55:00,Koch gets $2.5 bln in dividends from unit that offloaded asbestos ... ...,JNJ,0.079392,-0.17013,Somewhat-Bearish
3 Top Passive-Income Stocks to Own in 2023,https://www.fool.com/investing/2023/01/19/3-top-passive-income-stocks-to-own-in-2023/,2023-01-19 19:00:00,These stocks can add safety and growth to your portfolio.,JNJ,0.1172,0.0,Neutral
4 Big Pharma Stocks Could Soon Deliver An RSV Vaccine,https://www.investors.com/news/technology/4-pharmaceutical-stocks-are-close-to-cracking-multibillion-dollar-rsv-vaccine-market/,2023-01-19 18:41:00,4 Pharmaceutical Stocks Are Close To Cracking Multibillion-Dollar ... Investor's Business Daily ...,JNJ,0.06203,-0.028139,Neutral
"Climbing the Wall: As Wall Street Considers Fresh Worrisome Economic Data, Stocks Head Lower",https://www.benzinga.com/markets/23/01/30486260/climbing-the-wall-as-wall-street-considers-fresh-worrisome-economic-data-stocks-head-lower,2023-01-19 15:57:23,"( Thursday Market Open ) Yesterday's steep sell-off looked like it might be a wake-up call as earnings season accelerated. This morning's trading picked up where Wednesday left off, with stock index futures losing more ground amid bubbling recession concerns.",JNJ,0.03463,0.0,Neutral
Self-Tanning Products Market Share  ( $1.51 Billion by 2028 )  Growth Forecasts at 5.9% of CAGR during 2022 to 2028 - Global Analysis by The Insight Partners,https://www.benzinga.com/pressreleases/23/01/g30484604/self-tanning-products-market-share-1-51-billion-by-2028-growth-forecasts-at-5-9-of-cagr-during-202,2023-01-19 14:53:30,"New York, Jan. 19, 2023 ( GLOBE NEWSWIRE ) -- According to The Insight Partners' new research study on ""Self-Tanning Products Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Product Type ( Cream & Lotion, Serum, Mist, and Others ) , Category ( Natural & Organic and Conventional ...",JNJ,0.027476,0.191853,Somewhat-Bullish
Warren Buffett Says 90% of People Who Buy Stocks Make This Mistake,https://www.fool.com/investing/2023/01/19/warren-buffett-says-90-of-people-make-this-mistake/,2023-01-19 14:00:00,Investors should focus on the long game.,JNJ,0.269033,0.32523,Somewhat-Bullish
J&J  ( JNJ )  Discontinues HIV Vaccine Phase III Mosaico Study,https://www.zacks.com/stock/news/2041151/jj-jnj-discontinues-hiv-vaccine-phase-iii-mosaico-study,2023-01-19 12:41:00,"J&J (JNJ) discontinues phase III study on its investigational HIV vaccine regimen, which shows that the candidate lacks efficacy in preventing HIV.",JNJ,0.18967,0.103918,Neutral
Should Vanguard Russell 1000 Value ETF  ( VONV )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2041113/should-vanguard-russell-1000-value-etf-vonv-be-on-your-investing-radar,2023-01-19 11:20:06,Style Box ETF report for ...,JNJ,0.127456,0.069608,Neutral
Skincare Market Size to Hit $145.82 Billion by 2028 | At 5.52% CAGR,https://www.benzinga.com/pressreleases/23/01/g30477950/skincare-market-size-to-hit-145-82-billion-by-2028-at-5-52-cagr,2023-01-19 10:35:45,"Pune, India, Jan. 19, 2023 ( GLOBE NEWSWIRE ) -- As per a report published by Fortune Business Insights, the global skincare market size is set to rise at a 5.52% CAGR and is anticipated to generate a revenue of $145.82 billion by 2028 from $100.13 billion in 2021.",JNJ,0.037098,0.0,Neutral
Global Neurovascular Devices Market Size worth $3.8 billion by 2026 - Exclusive Report by MarketsandMarketsâ„¢,https://www.benzinga.com/pressreleases/23/01/g30477899/global-neurovascular-devices-market-size-worth-3-8-billion-by-2026-exclusive-report-by-marketsandm,2023-01-19 10:30:00,"Chicago, Jan. 19, 2023 ( GLOBE NEWSWIRE ) -- According to the new market research report ""Neurovascular Devices Market Size, Growth by Product ( Embolization ( Coil, Flow Diverter ) , Stents, Balloon Occlusion Devices, Clot Retrievers, Microcatheters ) , Pathology ( Stroke, Aneurysm, CAS, AVM ) ...",JNJ,0.069697,0.045145,Neutral
"Budget wishlist: Pharma, healthcare industries seek simplified regulations",https://www.business-standard.com/budget/article/budget-wishlist-pharma-healthcare-industries-seek-simplified-regulations-123011900709_1.html,2023-01-19 10:14:00,"Budget wishlist: Pharma, healthcare industries seek simplified ... Business Standard ...",JNJ,0.053035,0.0,Neutral
"Budget 2023 wishlist: Pharma, healthcare industry seek simplified regulations, research-based incentives",https://www.moneycontrol.com/news/business/budget/budget-2023-wishlist-pharma-healthcare-industry-seek-simplified-regulations-research-based-incentives-9894621.html,2023-01-19 09:24:44,"Budget 2023: Outlining the wishlist for the sector in the upcoming Union Budget, Indian Pharmaceutical Alliance ( IPA ) Secretary General Sudarshan Jain said the domestic pharma industry is currently around USD 50 billion in size and aspires to grow to around USD 130 billion by 2030 and USD 450 ...",JNJ,0.053035,0.0,Neutral
Addex Provides Corporate Update and Financial Guidance,https://www.globenewswire.com/news-release/2023/01/19/2591425/0/en/Addex-Provides-Corporate-Update-and-Financial-Guidance.html,2023-01-19 06:00:00,Ad Hoc Announcement Pursuant to Art. 53 LR ...,JNJ,0.04111,0.046289,Neutral
Johnson & Johnson  ( JNJ )  Stock Moves -1.51%: What You Should Know,https://www.zacks.com/stock/news/2040979/johnson-johnson-jnj-stock-moves--151-what-you-should-know,2023-01-18 22:45:20,"In the latest trading session, Johnson & Johnson (JNJ) closed at $169.76, marking a -1.51% move from the previous day.",JNJ,0.742397,0.298598,Somewhat-Bullish
Johnson & Johnson to Participate in the SVB Securities Global Biopharma Conference,https://investingnews.com/johnson-johnson-to-participate-in-the-svb-securities-global-biopharma-conference/,2023-01-18 21:49:40,"Johnson & Johnson ( NYSE: JNJ ) will participate in the SVB Securities Global Biopharma Conference on Wednesday, February 15 th . Biljana Naumovic, Worldwide Vice President, Oncology and Peter Lebowitz, Global Therapeutic Head, Oncology will represent the Company in a virtual session scheduled at ...",JNJ,0.891977,0.356352,Bullish
"Johnson & Johnson's HIV Vaccine Regimen Does Not Prevent Infection, Phase 3 Study Shows",https://www.benzinga.com/general/biotech/23/01/30467711/johnson-johnsons-hiv-vaccine-regimen-does-not-prevent-infection-phase-3-study-shows,2023-01-18 19:37:18,"The Janssen Pharmaceutical Companies of Johnson & Johnson JNJ announced the results of an independent, scheduled data review of the Phase 3 Mosaico study of the investigational HIV vaccine regimen.",JNJ,0.448842,0.147037,Neutral
Dow Jones Falls Despite Cooling Inflation Signs; Tesla Falls As Trial Begins On Musk's 2018 Tweet,https://www.investors.com/market-trend/stock-market-today/dow-jones-falls-after-cooling-inflation-signs-fed-bullards-target-rate-for-soft-landing-slb-netflix-on-tap/,2023-01-18 18:55:00,Dow Jones Falls Despite Cooling Inflation Signs. Tesla Falls As Trial ... Investor's Business Daily ...,JNJ,0.134968,-0.202229,Somewhat-Bearish
"Sharply Lower PPI, Retail Sales Data Further Signs of a Slowing Economy",https://www.benzinga.com/markets/23/01/30469653/sharply-lower-ppi-retail-sales-data-further-signs-of-a-slowing-economy,2023-01-18 18:50:47,( Wednesday Market Open ) Just checking. Is bad economic news still good for the markets? Investors might be asking themselves that this morning as major stock indexes climbed just slightly in premarket trading despite a batch of inflation and retail sales data suggesting a slowing economy.,JNJ,0.031843,0.0,Neutral
Walgreens Strikes $83 Million Settlement With West Virginia Over Opioid Crisis,https://www.forbes.com/sites/tylerroush/2023/01/18/walgreens-strikes-83-million-settlement-with-west-virginia-over-opioid-crisis/,2023-01-18 18:26:44,"West Virginia-which has the nation's highest overdose death rate-has already reached settlements with other pharmacies, including Rite Aid and CVS, in similar litigation.",JNJ,0.071784,0.07005,Neutral
Moderna is the latest company to produce a promising RSV vaccine,https://www.marketwatch.com/story/moderna-is-the-latest-company-to-produce-a-promising-rsv-vaccine-11674062616,2023-01-18 17:23:00,The experimental respiratory syncytial virus vaccine prevented most infections in older adults in a Phase 3 clinical trial ...,JNJ,0.172097,0.0,Neutral
JNJ: 3 Stocks to Buy Right Now if You Want to Retire Early,https://stocknews.com/news/jnj-pfe-bmy-3-stocks-to-buy-right-now-if-you-want-to/,2023-01-18 17:01:25,"The U.S. inflation eased in December, supporting a moderation in the Fed's rate hikes for the upcoming months. Buoyed by the December jobs report and signs of a slowdown in inflation, investors are eyeing a 25-basis-point hike at the Fed's next policy meeting.",JNJ,0.202851,0.177755,Somewhat-Bullish
What To Expect From Johnson & Johnson's Q4?,https://www.forbes.com/sites/greatspeculations/2023/01/18/what-to-expect-from-johnson--johnsons-q4/,2023-01-18 16:00:44,"The company will likely see a steady rise in revenue led by continued market share gains for its drugs - Darzalex, Stelara, Erleada, and Tremfya.",JNJ,0.682689,0.328133,Somewhat-Bullish
"White River Bancshares Co. Earns $1.42 Million, or $1.42 Per Diluted Share, in Fourth Quarter 2022 and Earns $5.62 Million, or $5.64 Per Diluted Share for the Year; Highlighted By Strong Quarterly Loan and Deposit Growth",https://www.globenewswire.com/news-release/2023/01/18/2591001/0/en/White-River-Bancshares-Co-Earns-1-42-Million-or-1-42-Per-Diluted-Share-in-Fourth-Quarter-2022-and-Earns-5-62-Million-or-5-64-Per-Diluted-Share-for-the-Year-Highlighted-By-Strong-Qu.html,2023-01-18 14:00:00,"FAYETTEVILLE, Ark., Jan. 18, 2023 ( GLOBE NEWSWIRE ) -- White River Bancshares Company ( OTCQX: WRIV ) , ( the ""Company"" ) the holding company for Signature Bank of Arkansas ( the ""Bank"" ) , today reported net income of $1.42 million, or $1.42 per dilute share, in the fourth quarter of 2022, ...",JNJ,0.015716,0.116008,Neutral
J&J to discontinue trial after HIV vaccine found ineffective,https://www.reuters.com/business/healthcare-pharmaceuticals/jj-discontinue-hiv-vaccine-trial-2023-01-18/,2023-01-18 13:48:38,J&J to discontinue HIV vaccine trial ...,JNJ,0.224903,-0.162487,Somewhat-Bearish
Moderna Gets A 'Booster' Shot: Why Stock Is Up Nearly 7% Today,https://www.benzinga.com/analyst-ratings/analyst-color/23/01/30456278/moderna-gets-a-booster-shot-why-stock-is-up-nearly-7-today,2023-01-18 11:34:06,"Moderna, Inc. MRNA shares were solidly higher in premarket trading on Wednesday. What Happened: The upside in Moderna's shares comes in reaction to a clinical readout announced late Tuesday, which showed that the Cambridge, Massachusetts-based company's mRNA vaccine targeting the respiratory ...",JNJ,0.254307,0.12463,Neutral
Should Vanguard S&P 500 Value ETF  ( VOOV )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2040512/should-vanguard-sp-500-value-etf-voov-be-on-your-investing-radar,2023-01-18 11:20:09,Style Box ETF report for ...,JNJ,0.12645,0.069352,Neutral
Is iShares Core Dividend Growth ETF  ( DGRO )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2040520/is-ishares-core-dividend-growth-etf-dgro-a-strong-etf-right-now,2023-01-18 11:20:07,Smart Beta ETF report for ...,JNJ,0.118354,0.060615,Neutral
5 Warren Buffett Stocks to Buy Hand Over Fist in 2023,https://www.fool.com/investing/2023/01/18/5-buffett-stocks-to-buy-hand-over-fist-in-2023/,2023-01-18 10:30:00,These stocks deliver a lot of the elements Buffett loves most.,JNJ,0.074692,0.022513,Neutral
JNJ: Buy These 2 Stocks Now if You're Over the Age of 50,https://stocknews.com/news/jnj-ko-buy-these-2-stocks-now-if-youre-over-the-age/,2023-01-17 19:26:52,JNJ: Buy These 2 Stocks Now if You're Over the Age of ...,JNJ,0.331765,0.30354,Somewhat-Bullish
"Home and Away: Bank of Japan, China Data, Davos Distract From Bank Earnings as Yields Rise, Stocks Retreat",https://www.benzinga.com/markets/23/01/30448629/home-and-away-bank-of-japan-china-data-davos-distract-from-bank-earnings-as-yields-rise-stocks-retre,2023-01-17 19:19:51,"( Tuesday Market Open ) Following Friday's mixed earnings performance from four of the largest U.S. banks, Tuesday kicked off with more mixed results from two closely followed names in investment banking. That, along with overnight weakness in Europe and Asia, helped set a negative tone in the ...",JNJ,0.034087,0.0,Neutral
SXSW Announces Finalists For 2023 Pitch Competition,https://www.benzinga.com/pressreleases/23/01/n30448735/sxsw-announces-finalists-for-2023-pitch-competition,2023-01-17 19:00:00,"Fifteenth Annual Competition to showcase 40 interactive tech startups within 8 categories AUSTIN, Texas, Jan. 17, 2023 /PRNewswire/ -- South by SouthwestÂ® ( SXSWÂ® ) Conference and Festivals today announced the finalists for the 15th annual SXSW Pitch event, happening March 11 - 12 at the Hilton ...",JNJ,0.043342,0.224355,Somewhat-Bullish
Good Stocks To Invest In Right Now? 3 Defensive Stocks To Watch,https://stockmarket.com/featured/good-stocks-to-invest-in-right-now-3-defensive-stocks-to-watch-2023-01-17,2023-01-17 14:30:18,"To start off, defensive stocks are a category of stocks that tend to perform well during economic downturns. These are companies that provide essential goods or services that are in high demand. Even when the economy is not doing well. They are often referred to as ""recession-proof"" stocks.",JNJ,0.123209,0.106759,Neutral
Over $10 Million Bet On DiamondHead Holdings? Check Out These 4 Stocks Insiders Are Buying,https://www.benzinga.com/news/23/01/30440698/over-10-million-bet-on-diamondhead-holdings-check-out-these-4-stocks-insiders-are-buying,2023-01-17 14:04:19,"Although US stocks closed higher on Friday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock.",JNJ,0.091162,0.126919,Neutral
Investors Heavily Search Johnson & Johnson  ( JNJ ) : Here is What You Need to Know,https://www.zacks.com/stock/news/2040033/investors-heavily-search-johnson-johnson-jnj-here-is-what-you-need-to-know,2023-01-17 14:00:13,"Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",JNJ,0.475838,0.106246,Neutral
OR.com Premium Domain: Purchase Bids Due Immediately,https://www.prnewswire.com/news-releases/orcom-premium-domain-purchase-bids-due-immediately-301723381.html,2023-01-17 13:34:00,"LOS ANGELES and NEW YORK, Jan. 17, 2023 /PRNewswire/ -- The industry leader for six to eight-figure domain name sales announced the availability of another premium two letter domain name, OR.com, in late 2022 with a price of $1.25 million USD. Since then, multiple parties have come forward with ...",JNJ,0.077343,0.080976,Neutral
Pick Either Johnson & Johnson Stock Or Its Peer - Both May Offer Similar Returns,https://www.forbes.com/sites/greatspeculations/2023/01/17/pick-either-johnson--johnson-stock-or-its-peer--both-may-offer-similar-returns/,2023-01-17 12:00:32,We believe that pharmaceutical giants Johnson & Johnson stock (NYSE: JNJ) and Merck stock (NYSE: MRK) will likely offer similar returns over the next three years.,JNJ,0.398148,0.22503,Somewhat-Bullish
Should You Invest in the iShares U.S. Pharmaceuticals ETF  ( IHE ) ?,https://www.zacks.com/stock/news/2039890/should-you-invest-in-the-ishares-us-pharmaceuticals-etf-ihe,2023-01-17 11:20:07,Sector ETF report for ...,JNJ,0.13459,0.070304,Neutral
2 Dow Stocks to Buy Hand Over Fist in 2023 and 1 to Avoid Like the Plague,https://www.fool.com/investing/2023/01/17/2-dow-stocks-to-buy-and-1-to-avoid-like-the-plague/,2023-01-17 10:06:00,"Among the Dow Jones Industrial Average's 30 components, there are two jaw-dropping deals and one overachiever worth avoiding.",JNJ,0.209365,0.175813,Somewhat-Bullish
Cosmetics Market Size to Reach $415.29 Billion by 2028 | Industry to Generate 5.0% CAGR during  ( 2021-2028 ) ,https://www.benzinga.com/pressreleases/23/01/g30434086/cosmetics-market-size-to-reach-415-29-billion-by-2028-industry-to-generate-5-0-cagr-during-2021-20,2023-01-17 10:01:48,"Pune, India, Jan. 17, 2023 ( GLOBE NEWSWIRE ) -- According to Fortune Business Insights, the global cosmetics market size is expected to gain momentum by reaching USD 415.29 billion by 2028 from USD 287.94 billion in 2021 while exhibiting a CAGR of 5.0% between 2021 to 2028.",JNJ,0.03319,0.0,Neutral
How Do I Plan My Investing Strategy For 2023?,https://www.forbes.com/sites/jaimecatmull/2023/01/16/how-do-i-plan-my-investing-strategy-for-2023/,2023-01-16 14:15:00,"Knowing the best strategy for investing in 2023 takes experience and know-how, but a few helpful tips can get you started on the right track.",JNJ,0.055621,0.248988,Somewhat-Bullish
Parris Todd Earns A Triple Crown At APP Tour 2023 Opener,https://www.forbes.com/sites/toddboss/2023/01/16/parris-todd-earns-a-triple-crown-at-app-tour-2023-opener/,2023-01-16 14:14:17,"The first event of the 2023 Association of Pickleball Professionals (APP) tour is in the books, and Parris Todd wins the Triple Crown.",JNJ,0.039745,0.061943,Neutral
Surgical Power Tools Market Worth $3.25 Billion by 2030 - Exclusive Report by Meticulous ResearchÂ®,https://www.benzinga.com/pressreleases/23/01/g30428108/surgical-power-tools-market-worth-3-25-billion-by-2030-exclusive-report-by-meticulous-research,2023-01-16 14:00:00,"Redding, California, Jan. 16, 2023 ( GLOBE NEWSWIRE ) -- According to a new market research report titled, 'Surgical Power Tools Market by Product ( Drill, Saw, Reamer, Shaver, Wire Driver, Power Source, Accessories ) , Application ( Orthopedic, Neuro, Dental, ENT, Cardiothoracic ) , Usage ( ...",JNJ,0.029654,-0.060947,Neutral
ABBV: The #1 Pharma Stock to Buy in January 2023,https://stocknews.com/news/abbv-jnj-pfe-bmy-the-no-1-pharma-stock-to-buy-in-january-2023/,2023-01-16 13:20:02,ABBV: The No. 1 Pharma Stock to Buy in January ...,JNJ,0.099271,0.168077,Somewhat-Bullish
Biomarkers Market is expected to grow from USD 66.6 billion in 2022 to USD 183.42 billion by 2030 : GreyViews,https://www.benzinga.com/pressreleases/23/01/g30427462/biomarkers-market-is-expected-to-grow-from-usd-66-6-billion-in-2022-to-usd-183-42-billion-by-2030-,2023-01-16 13:00:00,"Pune India, Jan. 16, 2023 ( GLOBE NEWSWIRE ) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa. These are the key regions where the biomarkers market is operating and is ...",JNJ,0.024396,0.044526,Neutral
Cytovance Biologics Announces Ping Zhang as Chief Executive Officer,https://www.benzinga.com/pressreleases/23/01/g30427234/cytovance-biologics-announces-ping-zhang-as-chief-executive-officer,2023-01-16 12:30:00,"OKLAHOMA CITY, Jan. 16, 2023 ( GLOBE NEWSWIRE ) -- CytovanceÂ® Biologics, a leading biopharmaceutical contract development and manufacturing organization ( CDMO ) of mammalian and microbial biologics, announces the appointment of Mr. Ping Zhang as Chief Executive Officer.",JNJ,0.08687,0.033881,Neutral
Hip Replacement Market Size Worth USD 9.91 Billion by 2028 | Report by Fortune Business Insights,https://www.benzinga.com/pressreleases/23/01/g30425372/hip-replacement-market-size-worth-usd-9-91-billion-by-2028-report-by-fortune-business-insights,2023-01-16 06:41:09,"Pune, India, Jan. 16, 2023 ( GLOBE NEWSWIRE ) -- The global hip replacement market size is projected to hit USD 9.91 billion by 2028 and exhibit a CAGR of 5.3% during the forecast period. The increasing number of hip replacement surgeries due to the growing prevalence of osteoarthritis is ...",JNJ,0.046816,0.0,Neutral
The 5 Best-Performing Dividend Stocks In 2023?,https://www.forbes.com/sites/qai/2023/01/14/the-5-best-performing-dividend-stocks-in-2023/,2023-01-14 12:45:00,"With economic uncertainty ahead, many investors will be looking for the best dividend investment opportunities for 2023. Here are the top performers so far.",JNJ,0.077343,0.0,Neutral
"Prostate Cancer Therapeutics Market will worth to USD 19,619 million by 2030 : GreyViews",https://www.benzinga.com/pressreleases/23/01/g30416679/prostate-cancer-therapeutics-market-will-worth-to-usd-19-619-million-by-2030-greyviews,2023-01-13 20:00:00,"Pune India, Jan. 13, 2023 ( GLOBE NEWSWIRE ) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa.",JNJ,0.024273,-0.007536,Neutral
J&J slashes production of its unpopular COVID-19 shot,https://www.foxbusiness.com/healthcare/jj-slashes-production-unpopular-covid-19-shot,2023-01-13 18:39:18,"After mobilizing to quickly develop and manufacture a Covid-19 vaccine, Johnson & Johnson has vastly scaled back its efforts in producing the shots as it faces slumping demand.",JNJ,0.031364,-0.149807,Neutral
"Johnson & Johnson Cuts Production, Ends Contracts For Not So Successful COVID-19 Shot - Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/general/biotech/23/01/30414942/johnson-johnson-cuts-production-ends-contracts-for-not-so-successful-covid-19-shot,2023-01-13 18:22:37,Johnson & Johnson JNJ has significantly scaled back its efforts of manufacturing its COVID-19 vaccine after facing a fall in demand. The FDA approved the single-dose shot in February 2021 as it carried fewer cold-chain storage requirements than other shots. J&J's initial supply was small.,JNJ,0.531326,-0.317203,Somewhat-Bearish
"Big Bank Earnings Supported by Strong Net Interest Income, But Questions Arise on How Long it Can Last - Citigroup  ( NYSE:C ) , Bank of America  ( NYSE:BAC ) ",https://www.benzinga.com/markets/23/01/30412462/big-bank-earnings-supported-by-strong-net-interest-income-but-questions-arise-on-how-long-it-can-las,2023-01-13 16:11:48,( Friday Market Open ) Stocks wobbled Friday as investors digested a mixed set of earnings from four of the country's biggest banks.,JNJ,0.035555,0.0,Neutral
News Exclusive | J&J Slashes Production of Its Unpopular Covid-19 Shot,https://www.wsj.com/articles/j-j-slashes-production-of-its-unpopular-covid-19-shot-11673624729,2023-01-13 15:45:00,"After mobilizing to quickly develop and manufacture a Covid-19 vaccine, Johnson & Johnson has vastly scaled back its efforts in producing the shots as it faces slumping demand ...",JNJ,0.595343,-0.500063,Bearish
NVS: 1 Large-Cap Stock You Should Purchase This Week,https://stocknews.com/news/nvs-jnj-tak-nbix-1-large-cap-stock-you-should-purchase-this-week/,2023-01-13 15:31:40,"Large-cap companies are generally considered safer than small- or mid-cap companies because of their broader market reach, pricing power, and liquidity. Moreover, these businesses tend to be the least sensitive to economic headwinds.",JNJ,0.079261,0.078148,Neutral
Want to Get Richer? 3 Best Stocks to Buy Now and Hold Forever,https://www.fool.com/investing/2023/01/13/want-to-get-richer-3-best-stocks-to-buy-now-and-ho/,2023-01-13 14:45:00,Steady growth and dividends in an evergreen industry like healthcare can be a winning investment strategy.,JNJ,0.120431,0.0,Neutral
"Spot On: CPI Report, Eagerly Awaited, Meets Expectations For Easing Prices But Unlikely to Move Market Much - Apple  ( NASDAQ:AAPL ) , Amazon.com  ( NASDAQ:AMZN ) ",https://www.benzinga.com/markets/23/01/30394000/spot-on-cpi-report-eagerly-awaited-meets-expectations-for-easing-prices-but-unlikely-to-move-market,2023-01-12 16:27:03,"( Thursday Market Open ) Today's December Consumer Price Index ( CPI ) report was pretty much right down the middle-which means it may not change the Federal Reserve's thinking about rates. Headline CPI fell 0.1% in December from November, while core CPI, which strips out food and energy, ...",JNJ,0.035319,0.0,Neutral
"Marene Allison, former Vice President and CISO of Johnson & Johnson, joins Balbix's Advisory Board",https://www.prnewswire.com/news-releases/marene-allison-former-vice-president-and-ciso-of-johnson--johnson-joins-balbixs-advisory-board-301720104.html,2023-01-12 14:00:00,"Marene Allison, former Vice President and CISO of Johnson ... PR ...",JNJ,0.188193,0.13232,Neutral
"Big Tech's drop means more balance for S&P 500, 401 ( k ) s",https://apnews.com/article/technology-stocks-and-bonds-economy-pandemics-business-fee639cb5318ad31750ef0725819c6ac,2023-01-12 13:10:52,"The New York Stock Exchange is seen in New York, Thursday, Feb. 24, 2022. Markets are opening mostly higher on Wall Street Friday after a wild ride a day earlier. The S&P 500 added 0.4% in the early going, following even bigger gains in Europe. ( AP Photo/Seth Wenig )",JNJ,0.089797,0.102055,Neutral
How Doug Godshall Ignited the Spark at ShockWave,https://www.investors.com/news/management/leaders-and-success/shockwave-ceo-how-doug-godshall-ignited-the-spark/,2023-01-12 13:00:00,Shockwave CEO Doug Godshall Ignited the Spark Investor's Business Daily ...,JNJ,0.059049,0.271575,Somewhat-Bullish
Should You Buy This Promising New Healthcare Stock?,https://www.fool.com/investing/2023/01/12/should-you-buy-this-promising-new-healthcare-stock/,2023-01-12 11:42:00,Shares of GE Healthcare began trading last week after the company completed its spinoff from General Electric.,JNJ,0.074692,0.1151,Neutral
HC quashes Maha FDA order restraining J&J | The Financial Express,https://www.financialexpress.com/industry/hc-quashes-maha-fda-order-restraining-jampj/2945258/,2023-01-12 00:50:00,HC quashes Maha FDA order restraining J&J The Financial Express ...,JNJ,0.261117,-0.0445,Neutral
3 Dividend King Stocks That Can Make You Money in Your Sleep,https://www.fool.com/investing/2023/01/11/3-dividend-stocks-to-make-money-in-your-sleep/,2023-01-11 19:00:00,These players offer you passive income and a whole lot more.,JNJ,0.120733,-0.03451,Neutral
"How a Janitor Built an $8 Million Fortune Without Touching Cryptos, Stock Options or Leverage",https://www.benzinga.com/news/23/01/30365649/how-a-janitor-built-an-8-million-fortune-without-touching-cryptos-stock-options-or-leverage,2023-01-11 18:52:51,Ronald Reid was the last person you would expect to be a millionaire. He used safety pins to hold his old coats together and cut his own firewood well into his 90s. He drove a second-hand Toyota Yaris and resisted new purchases.,JNJ,0.06623,0.010115,Neutral
How to Use Zacks Earnings Surprise Charts,https://www.zacks.com/stock/news/2038072/how-to-use-zacks-earnings-surprise-charts,2023-01-11 17:40:00,"If you're trading on the earnings report, you will want to check out these charts.",JNJ,0.246167,0.363902,Bullish
Hemp Stock News - Global Hemp Group  ( CSE: GHG )  Announces Execution of Binding LOI with Apollon Formularies PLC,https://www.investorideas.com/news/2023/cannabis/01111CSE-GHG.asp,2023-01-11 16:47:42,Hemp Stock News - Global Hemp Group ( CSE: GHG ) Announces ... ...,JNJ,0.01282,0.186307,Somewhat-Bullish
Raydiant Launches Integrated AI & Computer Vision Technologies to Bridge the Gap Between Bricks and Clicks,https://www.prnewswire.com/news-releases/raydiant-launches-integrated-ai--computer-vision-technologies-to-bridge-the-gap-between-bricks-and-clicks-301719062.html,2023-01-11 12:58:00,Raydiant Launches Integrated AI & Computer Vision Technologies ... PR ...,JNJ,0.059194,0.12407,Neutral
PFE: The 4 Most Attractive Long-Term Stock Picks,https://stocknews.com/news/pfe-jnj-syy-osg-the-4-most-attractive-long-term-stock-picks/,2023-01-11 12:41:37,The stock market witnessed heightened volatility last year due to lingering macroeconomic and geopolitical headwinds.,JNJ,0.22421,0.213089,Somewhat-Bullish
Should You Invest in the iShares U.S. Healthcare ETF  ( IYH ) ?,https://www.zacks.com/stock/news/2037712/should-you-invest-in-the-ishares-us-healthcare-etf-iyh,2023-01-11 11:20:08,Sector ETF report for ...,JNJ,0.13347,0.070004,Neutral
Should You Invest in the Health Care Select Sector SPDR ETF  ( XLV ) ?,https://www.zacks.com/stock/news/2037716/should-you-invest-in-the-health-care-select-sector-spdr-etf-xlv,2023-01-11 11:20:07,Sector ETF report for ...,JNJ,0.128478,0.069872,Neutral
Should Vanguard Mega Cap Value ETF  ( MGV )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2037715/should-vanguard-mega-cap-value-etf-mgv-be-on-your-investing-radar,2023-01-11 11:20:07,Style Box ETF report for ...,JNJ,0.124164,0.068777,Neutral
"Bombay HC permits Johnson & Johnson to manufacture, sell baby powder",https://www.business-standard.com/article/current-affairs/hc-permits-johnson-johnson-to-manufacture-and-sell-its-baby-powder-quashes-maha-govt-order-revoking-license-123011100614_1.html,2023-01-11 08:01:00,"A division bench of Justices Gautam Patel and S G Dige permitted the company to manufacture, sell and distribute the products ...",JNJ,0.147818,-0.248386,Somewhat-Bearish
Why Johnson & Johnson Stock Slipped by Nearly 4% on Monday,https://www.fool.com/investing/2023/01/30/why-johnson-johnson-stock-slipped-by-nearly-4-on-m/,2023-01-30 23:43:00,The fallout from the baby powder controversy continues to damage the company.,JNJ,0.348919,-0.300782,Somewhat-Bearish
These 2 Stocks Led the Dow Lower Monday,https://www.fool.com/investing/2023/01/30/these-2-stocks-led-the-dow-lower-monday/,2023-01-30 23:05:00,Investors dealt with a pause in the January rally.,JNJ,0.314017,-0.087579,Neutral
Federal Appellate Court Rejects Controversial J&J Ploy to Dodge Talc Cancer Lawsuits - Investing News Network,https://investingnews.com/federal-appellate-court-rejects-controversial-jj-ploy-to-dodge-talc-cancer-lawsuits/,2023-01-30 22:25:42,Federal Appellate Court Rejects Controversial J&J Ploy to Dodge Talc Cancer Lawsuits Investing News Network ...,JNJ,0.169676,-0.253964,Somewhat-Bearish
Johnson & Johnson Shares Drop as Court Rejects Use of Bankruptcy in Talc Lawsuits,https://www.barrons.com/articles/johnson-johnson-bankruptcy-talc-lawsuits-51675114146,2023-01-30 21:53:00,Court Rejects Johnson & Johnson's Use of Bankruptcy in Talc Lawsuits ...,JNJ,0.985002,-0.770142,Bearish
Johnson And Johnson Stock Slips After Missing The Mark For Earnings,https://www.forbes.com/sites/qai/2023/01/30/johnson-and-johnson-stock-slips-after-missing-the-mark-for-earnings/,2023-01-30 21:26:19,"Johnson and Johnson's stock took a tumble before its Q4 2022 earnings call, and the numbers reported didn't help it bounce back. Here's what happened.",JNJ,0.506158,-0.185477,Somewhat-Bearish
Court tosses bankruptcy petition by Johnson & Johnson's talc unit,https://www.foxbusiness.com/markets/court-tosses-bankruptcy-petition-johnson-johnsons-talc-unit,2023-01-30 21:17:40,A federal appeals court has upended Johnson & Johnson's plan for resolving tens of thousands of lawsuits from consumers who claim the company's talc products cause cancer. The Third Circuit U.S.,JNJ,0.114682,0.0,Neutral
J&J Dives After Court Denies Bankruptcy For Baby Powder Unit,https://www.investors.com/news/technology/jnj-stock-dives-after-court-says-it-cannot-use-bankruptcy-to-resolve-baby-powder-lawsuits/,2023-01-30 18:40:00,JNJ Stock Dives After Court Says It Can't Use Bankruptcy To ... Investor's Business Daily ...,JNJ,0.778376,-0.004093,Neutral
JNJ: 2 Stocks That Can Create Lasting Generational Wealth,https://stocknews.com/news/jnj-ko-2-stocks-that-can-create-lasting-generational-wealth/,2023-01-30 18:17:32,"Retail sales in the United States decreased by 1.1% in December 2022, while manufacturing output fell by 1.3%, suggesting weakening economic development. However, according to the Commerce Department's report, the US economy demonstrated its strength with a better-than-expected GDP growth rate of ...",JNJ,0.467176,0.358456,Bullish
"J&J Can't Use Bankruptcy to Resolve Talc-Injury Lawsuits, Appeals Court Rules",https://www.wsj.com/articles/j-js-talc-bankruptcy-case-thrown-out-by-appeals-court-11675096308,2023-01-30 18:09:00,A federal appeals court said Johnson & Johnson's LTL Management can't use bankruptcy to resolve numerous talc-injury lawsuits.,JNJ,0.395012,-0.415279,Bearish
Bipolar Disorder Treatment Market will achieve USD 5.7 billion by 2030 : GreyViews,https://www.benzinga.com/pressreleases/23/01/g30626924/bipolar-disorder-treatment-market-will-achieve-usd-5-7-billion-by-2030-greyviews,2023-01-30 18:00:00,"Pune India, Jan. 30, 2023 ( GLOBE NEWSWIRE ) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa.",JNJ,0.02351,-0.019887,Neutral
"$1,000 Invested In 4 Of The 5 Vaccine Developers Back When WHO Declared COVID-19 An Emergency Yielded Returns",https://www.benzinga.com/general/biotech/23/01/30622252/1-000-invested-in-4-of-the-5-vaccine-developers-back-when-who-declared-covid-19-an-emergency-yiel,2023-01-30 15:28:16,"The COVID-19 pandemic emerged in 2019 in China and spread to the rest of the globe in early 2020. Since then, the virus has caused more than 6.8 million deaths. The urgency and the severity of COVID-19 forced biopharma companies to expeditiously develop a vaccine to counter the threat. Moderna, ...",JNJ,0.176502,-0.194074,Somewhat-Bearish
"Global Pharmaceutical Drug Delivery Market worth $2,206.5 billion by 2026 - Exclusive Report by MarketsandMarketsâ„¢",https://www.benzinga.com/pressreleases/23/01/g30622827/global-pharmaceutical-drug-delivery-market-worth-2-206-5-billion-by-2026-exclusive-report-by-marke,2023-01-30 14:30:00,"Chicago, Jan. 30, 2023 ( GLOBE NEWSWIRE ) -- According to the new market research report ""Pharmaceutical Drug Delivery Market Size, Growth by Route of Administration ( Oral, Injectors, Implantable, Syrups, Gels, Pulmonary, Solutions, Tablets, Syringes ) , Application ( Cancer, Diabetes ) , ...",JNJ,0.087503,0.021576,Neutral
Johnson & Johnson  ( JNJ )  Is a Trending Stock: Facts to Know Before Betting on It,https://www.zacks.com/stock/news/2046202/johnson-johnson-jnj-is-a-trending-stock-facts-to-know-before-betting-on-it,2023-01-30 14:00:13,"Recently, Zacks.com users have been paying close attention to Johnson & Johnson (JNJ). This makes it worthwhile to examine what the stock has in store.",JNJ,0.474082,0.120783,Neutral
3 Dividend Kings to Buy Hand Over Fist in 2023,https://www.fool.com/investing/2023/01/30/3-dividend-kings-to-buy-hand-over-fist-in-2023/,2023-01-30 13:08:00,These Dividend Kings have increased dividends consecutively for 55 years or more and look hugely compelling right now.,JNJ,0.170275,0.155,Somewhat-Bullish
Natural cosmetics market to grow by 19.55% Y-O-Y in 2023; Consumer demand for chemical-free and environment-friendly natural cosmetics products will drive growth - Technavio,https://www.prnewswire.com/news-releases/natural-cosmetics-market-to-grow-by-19-55-y-o-y-in-2023-consumer-demand-for-chemical-free-and-environment-friendly-natural-cosmetics-products-will-drive-growth---technavio-301732287.html,2023-01-30 11:00:00,Natural cosmetics market to grow by 19.55% Y-O-Y in 2023 ... PR ...,JNJ,0.082393,0.189734,Somewhat-Bullish
"With 14.1% CAGR, Monoclonal Antibody Therapy Market Size Worth USD 451.89 Billion by 2028",https://www.benzinga.com/pressreleases/23/01/g30618366/with-14-1-cagr-monoclonal-antibody-therapy-market-size-worth-usd-451-89-billion-by-2028,2023-01-30 10:54:18,"Pune, India, Jan. 30, 2023 ( GLOBE NEWSWIRE ) -- The global monoclonal antibody therapy market size was USD 157.33 billion in 2020. The market is projected to grow from USD 178.50 billion in 2021 to USD 451.89 billion in 2028 at a CAGR of 14.1% in the 2021-2028 period.",JNJ,0.035983,0.252645,Somewhat-Bullish
Personal care market to grow by 5.4% Y-O-Y from 2022 to 2023: Increasing number of male and female customers opting for personal care products will drive growth - Technavio,https://www.prnewswire.com/news-releases/personal-care-market-to-grow-by-5-4-y-o-y-from-2022-to-2023-increasing-number-of-male-and-female-customers-opting-for-personal-care-products-will-drive-growth---technavio-301732220.html,2023-01-30 06:30:00,Personal care market to grow by 5.4% Y-O-Y from 2022 to 2023 ... PR ...,JNJ,0.036869,0.054697,Neutral
"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against FATE, and Sotera and Encourages Investors to Contact the Firm",https://www.benzinga.com/pressreleases/23/01/g30616560/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-fate-,2023-01-30 02:00:00,"NEW YORK, Jan. 29, 2023 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Fate Therapeutics, Inc.",JNJ,0.021427,0.017941,Neutral
"SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fate Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - FATE",https://www.benzinga.com/pressreleases/23/01/g30616032/shareholder-alert-pomerantz-law-firm-reminds-shareholders-with-losses-on-their-investment-in-fate-,2023-01-29 19:18:14,"NEW YORK, Jan. 29, 2023 ( GLOBE NEWSWIRE ) -- Pomerantz LLP announces that a class action lawsuit has been filed against certain officers and directors of Fate Therapeutics, Inc. ( ""Fate"" or the ""Company"" ) FATE. The class action, filed in the United States District Court for the Southern ...",JNJ,0.053629,0.019992,Neutral
Is Intuitive Surgical Stock Still Worth Buying Hand Over Fist in 2023?,https://www.fool.com/investing/2023/01/29/is-intuitive-surgical-still-worth-buying-hand-over/,2023-01-29 14:00:00,Residual disruption from the pandemic is lasting longer than expected.,JNJ,0.055621,0.04805,Neutral
2 Blue Chips Under Pressure,https://www.fool.com/investing/2023/01/29/2-blue-chips-under-pressure/,2023-01-29 12:00:00,"Plus, Motley Fool personal finance expert Robert Brokamp answers your questions.",JNJ,0.07083,0.020288,Neutral
3 Beaten-Down Blue Chip Stocks to Buy Right Now,https://www.fool.com/investing/2023/01/29/3-beaten-down-blue-chip-stocks-to-buy-right-now/,2023-01-29 10:55:00,These solid stocks are down but definitely not out.,JNJ,0.244109,0.06826,Neutral
3 Low-Risk Dividend Stocks to Buy in 2023,https://www.fool.com/investing/2023/01/28/3-low-risk-dividend-stocks-to-buy-in-2023/,2023-01-28 10:52:00,These stocks should allow you to sleep peacefully no matter what happens with the stock market this year.,JNJ,0.331765,0.214563,Somewhat-Bullish
2 of the Best Dividend Stocks to Own in 2023,https://www.fool.com/investing/2023/01/28/2-of-the-best-dividend-stocks-to-own-in-2023/,2023-01-28 10:30:00,You can count on them for passive income and growth over time.,JNJ,0.131284,0.174561,Somewhat-Bullish
"Fate Therapeutics, Inc.  ( FATE )  Shareholder Notice: Robbins LLP Reminds Investors of Class Action Against Fate Therapeutics, Inc.",https://www.benzinga.com/pressreleases/23/01/g30611569/fate-therapeutics-inc-fate-shareholder-notice-robbins-llp-reminds-investors-of-class-action-agains,2023-01-27 22:23:55,"SAN DIEGO, Jan. 27, 2023 ( GLOBE NEWSWIRE ) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired shares Fate Therapeutics, Inc.",JNJ,0.071784,-0.00203,Neutral
13 Best Dividend ETFs To Outperform In 2023,https://www.forbes.com/sites/investor-hub/article/13-best-dividend-etfs-to-outperform/,2023-01-27 22:05:09,Ready to ramp up your income in 2023? The right dividend exchange-traded funds (ETFs) can make it happen.,JNJ,0.023169,0.229276,Somewhat-Bullish
Ritalin Drug Shortage Explained: Low Supplies Of Adderall And Prescription Startups Fueled Crisis,https://www.forbes.com/sites/conormurray/2023/01/27/ritalin-drug-shortage-explained-low-supplies-of-adderall-and-prescription-startups-fueled-crisis/,2023-01-27 20:46:37,"The increased demand for Adderall to treat ADHD amid shortages has created shortages in other drugs, like Ritalin.",JNJ,0.041323,-0.086173,Neutral
Shoulder Arthroplasty Market will value USD 2.6 billion by 2030 : GreyViews,https://www.benzinga.com/pressreleases/23/01/g30607766/shoulder-arthroplasty-market-will-value-usd-2-6-billion-by-2030-greyviews,2023-01-27 19:00:00,"Pune India, Jan. 27, 2023 ( GLOBE NEWSWIRE ) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa. These are the key regions where the shoulder arthroplasty market is operating and ...",JNJ,0.026415,0.042811,Neutral
"Author Post: New Buyers, New Motivations: Foreign Firms Join The US Biotech Buying Frenzy",https://www.forbes.com/sites/forbesbooksauthors/2023/01/27/new-buyers-new-motivations-foreign-firms-join-the-us-biotech-buying-frenzy/,2023-01-27 16:10:00,"""The depreciated value of US biotechnology companies has not gone unnoticed by traditional pharmaceutical conglomerates looking to augment their pipelines at attractive prices."" ...",JNJ,0.078611,0.118777,Neutral
JNJ: 3 Retirement Stocks Under $200 to Buy Now,https://stocknews.com/news/jnj-adm-ayi-3-retirement-stocks-under-200-to-buy-now/,2023-01-27 14:07:02,"Although cooling inflation for the sixth consecutive time in December 2022 has raised investor optimism, the Fed officials' hawkish comments signaling interest rate hikes throughout 2023 could keep the stock market under pressure.",JNJ,0.38489,0.183281,Somewhat-Bullish
J&J says blood cancer drug improves progression-free survival in patients,https://www.reuters.com/business/healthcare-pharmaceuticals/jjs-carvykti-succeeds-late-stage-trial-type-blood-cancer-2023-01-27/,2023-01-27 13:46:00,J&J's Carvykti succeeds in late-stage trial for a type of blood cancer ...,JNJ,0.170878,0.014771,Neutral
3 Alarming Red Flags That Could Signal It's Time to Sell Procter & Gamble Stock in 2023,https://www.fool.com/investing/2023/01/27/3-red-flags-sell-procter-gamble-stock-2023/,2023-01-27 13:15:00,This Dividend King's fundamentals are waning.,JNJ,0.084572,0.113387,Neutral
There's 3 New Standout Dividend Stocks - And 3 Pay The Most,https://www.investors.com/etfs-and-funds/sectors/sp500-theres-3-new-standout-dividend-stocks-and-pay-the-most/,2023-01-27 13:00:00,"It's tough to beat the ""Dividend Aristocrats"" for bankable dividend stocks. And investors now have three more in the S&P 500 to choose from - but can find even higher yields. Three stocks, including C.H. Robinson Worldwide ( CHRW ) , Nordson ( NDSN ) and J.M.",JNJ,0.166743,0.120721,Neutral
Should iShares Russell 1000 Value ETF  ( IWD )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2045273/should-ishares-russell-1000-value-etf-iwd-be-on-your-investing-radar,2023-01-27 11:20:05,Style Box ETF report for ...,JNJ,0.129168,-0.022811,Neutral
The National Association of County Veteran Service Officers  ( NACVSO )  partners with Ashcraft & Gerel LLP for Veterans,https://www.benzinga.com/pressreleases/23/01/n30591127/the-national-association-of-county-veteran-service-officers-nacvso-partners-with-ashcraft-gerel-ll,2023-01-26 18:04:00,"WASHINGTON, Jan. 26, 2023 /PRNewswire/ -- The National Association of County Veteran Service Officers ( NACVSO ) and the law firm of Ashcraft & Gerel LLP have entered into a Memorandum of Agreement whereby Ashcraft & Gerel LLP has agreed to review, at no cost or obligation, any potential claims ...",JNJ,0.080728,0.00832,Neutral
ETFs in Focus on JNJ's Mixed Q4 Earnings Results,https://www.zacks.com/stock/news/2044773/etfs-in-focus-on-jnjs-mixed-q4-earnings-results,2023-01-26 15:00:00,The world's biggest healthcare products' maker continued with its long streak of earnings beat and missed revenue estimates.,JNJ,0.321873,0.175048,Somewhat-Bullish
3 Warren Buffett Stocks That Could Make You Richer in 2023,https://www.fool.com/investing/2023/01/26/3-warren-buffett-stocks-that-could-make-you-richer/,2023-01-26 14:45:00,These Buffett stocks are poised for a big 2023.,JNJ,0.124164,0.036089,Neutral
MSFT: 3 Safe Stocks to Buy in an Unpredictable Market,https://stocknews.com/news/msft-jnj-nvs-3-safe-stocks-to-buy-in-an-unpredictable-market/,2023-01-26 14:07:41,"Despite inflation showing signs of easing, Fed policymakers signaled to continue raising interest rates throughout this year. In addition to hawkish comments from Fed officials, weak economic data fueled recession fears.",JNJ,0.281153,0.208374,Somewhat-Bullish
"Northpass Announces Executive Team Promotions in Marketing, Sales and Customer Success",https://www.prnewswire.com/news-releases/northpass-announces-executive-team-promotions-in-marketing-sales-and-customer-success-301731288.html,2023-01-26 13:39:00,Northpass Announces Executive Team Promotions in Marketing ... PR ...,JNJ,0.065866,0.248876,Somewhat-Bullish
Should Schwab U.S. LargeCap Value ETF  ( SCHV )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2044537/should-schwab-us-largecap-value-etf-schv-be-on-your-investing-radar,2023-01-26 11:20:07,Style Box ETF report for ...,JNJ,0.11983,-0.02555,Neutral
Abbott's Sales and Earnings Are Sinking: Should Investors Worry?,https://www.fool.com/investing/2023/01/26/abbotts-sales-and-earnings-are-sinking-should-inve/,2023-01-26 10:50:00,There's more to the story than the negative trends for Abbott's top and bottom lines.,JNJ,0.056011,0.057264,Neutral
Is Johnson & Johnson Still a Good Dividend Stock to Buy?,https://www.fool.com/investing/2023/01/26/is-johnson-johnson-still-a-good-dividend-stock-to/,2023-01-26 10:33:00,A disappointing fourth-quarter performance has some investors worried about the giant healthcare conglomerate's outlook.,JNJ,0.640683,0.21724,Somewhat-Bullish
3 Perfect Stocks for Retirees to Buy Hand Over Fist During the Nasdaq Bear Market,https://www.fool.com/investing/2023/01/26/3-perfect-stocks-retirees-can-buy-hand-over-fist/,2023-01-26 10:06:00,"These highly profitable, industry-leading companies are ideal for retired investors.",JNJ,0.131284,0.098781,Neutral
Jim Cramer picks his standout stocks in 4 bull market industries,https://www.cnbc.com/2023/01/25/jim-cramer-picks-his-standout-stocks-in-4-bull-market-industries.html,2023-01-25 23:35:32,"Companies in Cramer's list include Wells Fargo, Raytheon Technologies, Delta Air Lines, J.B. Hunt and Boeing.",JNJ,0.150592,0.20774,Somewhat-Bullish
How A 'Thanks Pfizer' Covid Misinformation Meme Went Viral,https://www.forbes.com/sites/conormurray/2023/01/25/how-a-thanks-pfizer-covid-misinformation-meme-went-viral/,2023-01-25 22:14:37,Viral videos falsely claiming the Covid-19 vaccine causes convulsions have inspired widespread mockery and internet jokes.,JNJ,0.046363,-0.156726,Somewhat-Bearish
Breg Partners with Correal International to Provide Orthopedic Products to Physicians & Patients in China,https://www.benzinga.com/pressreleases/23/01/n30575441/breg-partners-with-correal-international-to-provide-orthopedic-products-to-physicians-patients-in-,2023-01-25 20:45:00,"CARLSBAD, Calif., Jan. 25, 2023 /PRNewswire/ -- Breg, Inc., a leading orthopedic bracing and billing services company, announced today that it has partnered with medical device supplier Coreal International to bring its broad portfolio of bracing and cold therapy products to Chinese physicians ...",JNJ,0.104683,0.008876,Neutral
PFE: 3 Top Pharma Stocks to Buy for the Long Haul,https://stocknews.com/news/pfe-abbv-jnj-3-top-pharma-stocks-to-buy-for-the-long-haul/,2023-01-25 17:52:16,"The pharmaceutical sector played a critical role during the pandemic. Moreover, the industry is predicted to grow with an ageing population and the rise of chronic diseases. According to Statista, global pharmaceutical revenue is expected to expand at a 5.4% CAGR to $1.44 trillion by 2027.",JNJ,0.312599,0.310281,Somewhat-Bullish
Johnson & Johnson  ( JNJ )  is a Top Dividend Stock Right Now: Should You Buy?,https://www.zacks.com/stock/news/2044222/johnson-johnson-jnj-is-a-top-dividend-stock-right-now-should-you-buy,2023-01-25 16:45:08,"Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.",JNJ,0.443626,0.476005,Bullish
"Stock Market News for Jan 25, 2023",https://www.zacks.com/stock/news/2044032/stock-market-news-for-jan-25-2023,2023-01-25 14:30:00,Wall Street closed mixed on Tuesday as investors digested the latest batch of corporate earnings reports and gauged the state of the economy.,JNJ,0.088147,0.049847,Neutral
"Vir Biotechnology Announces Retirement of CEO George Scangos, Ph.D.; Appoints Marianne De Backer, MSc, Ph.D., MBA, as Successor",https://www.globenewswire.com/news-release/2023/01/25/2595175/0/en/Vir-Biotechnology-Announces-Retirement-of-CEO-George-Scangos-Ph-D-Appoints-Marianne-De-Backer-MSc-Ph-D-MBA-as-Successor.html,2023-01-25 13:29:00,- Dr. De Backer to assume CEO role on April ...,JNJ,0.026013,0.103507,Neutral
"Vir Biotechnology Announces Retirement of CEO George Scangos, Ph.D.; Appoints Marianne De Backer, MSc, Ph.D., MBA, as Successor",https://www.benzinga.com/pressreleases/23/01/g30566644/vir-biotechnology-announces-retirement-of-ceo-george-scangos-ph-d-appoints-marianne-de-backer-msc-,2023-01-25 13:29:00,"- Dr. De Backer to assume CEO role on April 3, 2023 - - Upon his retirement as CEO, Dr. Scangos will transition to an advisory role through June 2, 2023 and will continue providing strategic counsel to Vir as a member of the Board of Directors -",JNJ,0.025487,0.103213,Neutral
Want to avoid debt ceiling fallout? Invest in foreign stocks | Business,https://edition.cnn.com/2023/01/25/investing/premarket-stocks-trading,2023-01-25 13:18:00,Want to avoid debt ceiling fallout? Invest in foreign stocks CNN International ...,JNJ,0.061237,0.096403,Neutral
Want to avoid debt ceiling fallout? Invest in foreign stocks | Business,https://www.cnn.com/2023/01/25/investing/premarket-stocks-trading/index.html,2023-01-25 13:18:00,Want to avoid debt ceiling fallout? Invest in foreign stocks ...,JNJ,0.061237,0.096403,Neutral
Pliant Therapeutics Announces Appointment of Lily Cheung as Chief Human Resources Officer,https://www.globenewswire.com/news-release/2023/01/25/2595153/0/en/Pliant-Therapeutics-Announces-Appointment-of-Lily-Cheung-as-Chief-Human-Resources-Officer.html,2023-01-25 13:01:00,"SOUTH SAN FRANCISCO, Calif., Jan. 25, 2023 ( GLOBE NEWSWIRE ) -- Pliant Therapeutics, Inc. ( Nasdaq: PLRX ) , a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of fibrosis, today announced Ms. Lily Cheung as its Chief Human ...",JNJ,0.051003,0.024932,Neutral
Union Pacific To Rally Over 11%? Here Are 10 Other Analyst Forecasts For Wednesday,https://www.benzinga.com/news/23/01/30565467/union-pacific-to-rally-over-11-here-are-10-other-analyst-forecasts-for-wednesday,2023-01-25 12:37:13,Keybanc raised the price target for Reliance Steel & Aluminum Co. RS from $225 to $235. Keybanc analyst Philip Gibbs maintained an Overweight rating. Reliance Steel shares fell 0.2% to close at $215.79 on Tuesday. Raymond James boosted the price target for Avery Dennison Corporation AVY from $190 ...,JNJ,0.275867,0.10573,Neutral
3 Reasons to Buy AbbVie and 2 Reasons Not to Buy,https://www.fool.com/investing/2023/01/25/3-reasons-to-buy-abbvie-and-2-reasons-not-to-buy/,2023-01-25 12:05:00,"The pharmaceutical specialist is facing a pivotal year in 2023, thanks to growing competition.",JNJ,0.042196,-0.005912,Neutral
"Insights on the Hip Replacement Global Market to 2028 - Industry Trends, Growth, Impact of Inflation, Opportunities and Company Analysis",https://www.prnewswire.com/news-releases/insights-on-the-hip-replacement-global-market-to-2028---industry-trends-growth-impact-of-inflation-opportunities-and-company-analysis-301729768.html,2023-01-25 12:00:00,Insights on the Hip Replacement Global Market to 2028 - Industry ... PR ...,JNJ,0.055492,0.081861,Neutral
Nasdaq Futures Slump As Microsoft's Outlook Dampens Tech Recovery Expectations - Analyst Warns Of More Bumpiness By Mid-February,https://www.benzinga.com/news/earnings/23/01/30563847/nasdaq-futures-slump-as-microsofts-outlook-dampens-tech-recovery-expectations-analyst-warns-of-more,2023-01-25 11:20:39,U.S. stocks look set to start Wednesday's session on the back foot as traders digest mixed earnings news flow and continued pouring in of weak economic data points. The major averages closed Tuesday's session on a mixed note as profit-taking following two straight sessions of strong advances ...,JNJ,0.107736,-0.099104,Neutral
Should You Invest in the Fidelity MSCI Health Care Index ETF  ( FHLC ) ?,https://www.zacks.com/stock/news/2043784/should-you-invest-in-the-fidelity-msci-health-care-index-etf-fhlc,2023-01-25 11:20:07,Sector ETF report for ...,JNJ,0.128478,0.050009,Neutral
3 Reasons Why Johnson & Johnson Stock Could Rebound After a Bad Start in 2023,https://www.fool.com/investing/2023/01/25/3-reasons-why-johnson-johnson-stock-could-rebound/,2023-01-25 10:50:00,J&J's future prospects look brighter than its year-to-date stock performance might imply.,JNJ,0.56217,0.035086,Neutral
VR Workforce Training Leader Gemba Secures $18m to Become the Go-To Learning Platform of the Enterprise Metaverse,https://www.benzinga.com/pressreleases/23/01/g30562493/vr-workforce-training-leader-gemba-secures-18m-to-become-the-go-to-learning-platform-of-the-enterp,2023-01-25 09:00:00,"Pioneers in executive education offer a unique multiplayer, collaborative, VR training experience that delivers a powerful ROI for global companies going through digital transformation.",JNJ,0.189968,0.224326,Somewhat-Bullish
US Stocks end mixed,https://www.business-standard.com/article/news-cm/us-stocks-end-mixed-123012500167_1.html,2023-01-25 03:25:00,"At the close of trade, the Dow Jones Industrial Average index advanced 104.40 points, or 0.31%, to 33,733.96. The S&P500 index was down 2.86 points, or 0.07%, to 4,016.95. The tech-heavy Nasdaq Composite Index decreased by 30.14 points, or 0.27%, to 11,334.27.",JNJ,0.15347,0.03841,Neutral
Completion of Global3D Acquisition,https://investingnews.com/completion-of-global3d-acquisition/,2023-01-25 03:15:31,"Johnson & Johnson ( NYSE: JNJ ) today announced results for fourth-quarter and full year 2022. ""Our full year 2022 results reflect the continued strength and stability of our three business segments, despite macroeconomic challenges,"" said Joaquin Duato, Chairman of the Board and Chief Executive ...",JNJ,0.885652,0.511046,Bullish
Why Johnson & Johnson Stock Was Stagnant Today,https://www.fool.com/investing/2023/01/24/why-johnson-johnson-stock-was-stagnant-today/,2023-01-24 23:14:00,Investors were on the fence about the company's performance in the final months of last year.,JNJ,0.532941,0.334055,Somewhat-Bullish
Verizon Stock Chart Provides Clear Range After Mixed Earnings,https://www.thestreet.com/investing/stocks/verizon-stock-chart-provides-clear-range-after-mixed-earnings,2023-01-24 22:33:00,Verizon stock finished 2% up on the day after a mixed earnings report and an issue at the NYSE. The chart directions are clear.,JNJ,0.217834,0.592039,Bullish
Johnson & Johnson  ( JNJ )  Q4 2022 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/01/24/johnson-johnson-jnj-q4-2022-earnings-call-transcri/,2023-01-24 21:30:21,"JNJ earnings call for the period ending December 31, 2022.",JNJ,0.078099,0.143029,Neutral
Start of Earnings Traffic Jam Delivers Mixed Results as Market Waits for Microsoft,https://www.benzinga.com/news/earnings/23/01/30555728/start-of-earnings-traffic-jam-delivers-mixed-results-as-market-waits-for-microsoft,2023-01-24 19:08:26,"The fun starts today after the closing bell with Microsoft MSFT and Texas Instruments TXN. Then get ready for IBM IBM after tomorrow's close and Intel INTC the day after. There's a little concern about what MSFT might report, and that could be one factor pushing stock index futures lower this ...",JNJ,0.034136,0.133784,Neutral
XLV: 2 Sector ETFs to Keep an Eye on in 2023,https://stocknews.com/news/xlv-xle-2-sector-etfs-to-keep-an-eye-on-in-2023/,2023-01-24 18:54:37,XLV: 2 Sector ETFs to Keep an Eye on in ...,JNJ,0.106305,0.052878,Neutral
J&J Gets Ready to Break up With Tylenol,https://www.wsj.com/articles/j-j-gets-ready-to-break-up-with-tylenol-11674586145,2023-01-24 18:49:00,Johnson & Johnson's consumer business was the only division to deliver growth in the fourth quarter.,JNJ,0.636698,0.0,Neutral
"Dow Jones Stalls; Microsoft On Tap With Slowing Azure, Activision Blizzard In Limbo, OpenAI Deal To Take On Google, Amazon",https://www.investors.com/market-trend/stock-market-today/dow-jones-stalls-microsoft-on-tap-with-slowing-azure-activision-blizzard-in-limbo-openai-deal-to-take-on-google-amazon/,2023-01-24 18:44:00,"Dow Jones Stalls. Microsoft On Tap With Slowing Azure, Activision ... Investor's Business Daily ...",JNJ,0.21686,-0.324474,Somewhat-Bearish
"J&J Stock Jolted by NYSE Glitch, and Earnings Don't Help. Check the Chart.",https://www.thestreet.com/investing/stocks/jnj-stock-jolted-by-nyse-glitch-while-earnings-dont-help-check-the-chart,2023-01-24 18:40:00,Johnson & Johnson stock has fallen in 10 straight sessions and was jolted by NYSE issues and the earnings report. Here's the trade.,JNJ,0.523202,-0.310231,Somewhat-Bearish
The Worldwide Paraben Industry is Projected to Reach $164.8 Million by 2031,https://www.prnewswire.com/news-releases/the-worldwide-paraben-industry-is-projected-to-reach-164-8-million-by-2031--301729455.html,2023-01-24 18:30:00,The Worldwide Paraben Industry is Projected to Reach $164.8 ... PR ...,JNJ,0.044718,0.058921,Neutral
Johnson & Johnson fourth-quarter earnings down 25%,https://www.foxbusiness.com/healthcare/johnson-johnson-fourth-quarter-earnings-down-25-percent,2023-01-24 17:21:17,"Johnson & Johnson reported a 25% drop in earnings and declining sales for the fourth quarter as demand dropped for its Covid-19 vaccine, while providing a cautious forecast for sales growth as the company undergoes a big transformation.",JNJ,0.062761,-0.130779,Neutral
"Jim Cramer's Investing Club meeting Tuesday: J&J, Danaher, AMD",https://www.cnbc.com/2023/01/24/jim-cramers-investing-club-meeting-tuesday-jj-danaher-amd.html,2023-01-24 16:42:26,"The Investing Club holds its ""Morning Meeting"" every weekday at 10:20 a.m. ET.",JNJ,0.402618,0.151752,Somewhat-Bullish
Depression Treatment Market will manager to achieve USD 15.0 billion by 2030 : GreyViews,https://www.benzinga.com/pressreleases/23/01/g30552058/depression-treatment-market-will-manager-to-achieve-usd-15-0-billion-by-2030-greyviews,2023-01-24 16:30:00,"Pune India, Jan. 24, 2023 ( GLOBE NEWSWIRE ) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa. These are the key regions where the depression treatment market is operating and ...",JNJ,0.023743,-0.014126,Neutral
Earnings Data Deluge,https://www.zacks.com/stock/news/2043416/earnings-data-deluge,2023-01-24 15:59:00,"The busiest day of Q4 earnings season so far is here, with plenty of big-name companies reporting ahead of the opening bell. Whether pre-market futures are reacting to results or just doing some profit-taking off recent highs is hard to tell - the Dow is -150 points at this hour, the S&P 500 is ...",JNJ,0.193465,0.086779,Neutral
"Q4 Earnings Season Heats Up: JNJ, MMM, GE & More",https://www.zacks.com/stock/news/2043397/q4-earnings-season-heats-up-jnj-mmm-ge-more,2023-01-24 15:29:00,"Whether pre-market futures are reacting to results or just doing some profit-taking off recent highs is hard to tell -- the Dow is -150 points at this hour, the S&P 500 is -20 and the Nasdaq -85 points currently.",JNJ,0.178459,0.038221,Neutral
How J&J's Mostly Defunct Covid Shot Still Hampered Sales,https://www.investors.com/news/technology/jnj-stock-johnson-johnson-earnings-q4-2022/,2023-01-24 15:27:00,JNJ Stock: The Little Talked-About Vaccine That Slammed Sales Investor's Business Daily ...,JNJ,0.489807,0.092427,Neutral
JPST: 3 ETFs to Stock up on Before the End of January,https://stocknews.com/news/jpst-vht-schv-3-etfs-to-stock-up-on-before-the-end-of/,2023-01-24 15:26:59,"The latest Consumer Price Index ( CPI ) report revealed that inflation declined for the sixth consecutive month. After increasing 7.1% in November and 7.7% in October, inflation cooled in December to 6.5% compared with a year earlier.",JNJ,0.127908,0.012984,Neutral
Better Long-Term Buy in 2023: Exact Sciences or Veracyte?,https://www.fool.com/investing/2023/01/24/better-long-term-buy-exact-sciences-or-veracyte/,2023-01-24 15:23:00,"As cancer screenings are becoming covered more often, both companies stand to gain.",JNJ,0.054236,-0.077981,Neutral
"J&J  ( JNJ )  Q4 Earnings Beat, Sales Miss, 2023 EPS View Upbeat",https://www.zacks.com/stock/news/2043376/jj-jnj-q4-earnings-beat-sales-miss-2023-eps-view-upbeat,2023-01-24 15:18:00,J&J (JNJ) beats estimates for fourth-quarter earnings but misses the same for sales. Its EPS outlook for 2023 is above expectations while sales fall short.,JNJ,0.095138,0.135549,Neutral
Dental Adhesives Market will value USD 4.17 billion by 2030 : GreyViews,https://www.benzinga.com/pressreleases/23/01/g30548765/dental-adhesives-market-will-value-usd-4-17-billion-by-2030-greyviews,2023-01-24 15:00:00,"Pune India, Jan. 24, 2023 ( GLOBE NEWSWIRE ) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa. These are the key regions where the dental adhesives market is operating and is ...",JNJ,0.024622,0.085937,Neutral
"J&J tops 4Q earnings forecasts as profit, revenue slip",https://apnews.com/article/johnson-and-earnings-business-b623b481727b6d73304a46c35ecc707a,2023-01-24 14:20:28,Johnson & Johnson beat earnings expectations in the final quarter of 2022 even as a strong dollar and sinking COVID-19 vaccine sales hurt revenue. The health care giant also debuted on Tuesday a better-than-expected 2023 earnings forecast.,JNJ,0.166169,-0.085571,Neutral
"Top Stories Tuesday, Jan. 24",https://www.benzinga.com/general/biotech/23/01/30547461/trump-beefs-up-defamation-war-against-new-york-prosecutor-apple-weighs-content-deals-with-disney-,2023-01-24 14:18:51,"Former President Donald Trump has reportedly hired trial lawyer Joe Tacopina in a matter about alleged defamatory statements made by the former criminal division chief at the U.S. attorney's office in Manhattan, Mark Pomerantz.",JNJ,0.096283,-0.035921,Neutral
"Jim Cramer's top 10 things to watch in the market Tuesday: Club earnings, AMD downgrade, Disney hope",https://www.cnbc.com/2023/01/24/cramers-top-10-things-tuesday-earnings-amd-downgrade-disney-hope.html,2023-01-24 14:12:02,"Big day of earnings for Club holdings as the Dow, S&P 500 and Nasdaq look to open lower after back-to-back gains.",JNJ,0.193723,-0.071194,Neutral
"J&J forecasts strong profit, beats Wall Street estimates on pharma boost",https://www.business-standard.com/article/companies/j-j-forecasts-strong-profit-beats-wall-street-estimates-on-pharma-boost-123012401284_1.html,2023-01-24 14:12:00,Shares of the drugmaker were up nearly 1% at $170.28 in trading before the bell ...,JNJ,0.182506,0.082817,Neutral
Johnson & Johnson Guides Above Expectations for 2023,https://www.barrons.com/articles/johnson-jnj-earnings-stock-price-guidance-51674561550,2023-01-24 14:10:00,Johnson & Johnson Guides Above Expectations for ...,JNJ,0.622414,0.172221,Somewhat-Bullish
Futures Down: Economic Data Due; 6 Earnings Reporters,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-fall-as-6-key-earnings-movers-report-microsoft-earnings-due/,2023-01-24 13:27:00,Dow Jones Futures Fall As 6 Key Earnings Movers Report. Microsoft ... Investor's Business Daily ...,JNJ,0.086713,-0.027007,Neutral
Johnson & Johnson Reports Q4 and Full-Year 2022 Results,https://investingnews.com/johnson-johnson-reports-q4-and-full-year-2022-results-2659301917/,2023-01-24 13:05:52,"Johnson & Johnson ( NYSE: JNJ ) today announced results for fourth-quarter and full year 2022. ""Our full year 2022 results reflect the continued strength and stability of our three business segments, despite macroeconomic challenges,"" said Joaquin Duato, Chairman of the Board and Chief Executive ...",JNJ,0.28398,0.200781,Somewhat-Bullish
"Stocks making the biggest moves premarket: Bed Bath & Beyond, Verizon, Lululemon and more",https://www.cnbc.com/2023/01/24/stocks-making-the-biggest-moves-premarket-bed-bath-beyond-verizon-lululemon-and-more.html,2023-01-24 13:02:43,These are the stocks posting the biggest moves in early trading.,JNJ,0.223866,0.060317,Neutral
Johnson & Johnson  ( JNJ )  Q4 Earnings Top Estimates,https://www.zacks.com/stock/news/2043105/johnson-johnson-jnj-q4-earnings-top-estimates,2023-01-24 12:45:05,"Johnson & Johnson (JNJ) delivered earnings and revenue surprises of 5.86% and 0.22%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?",JNJ,0.393977,0.120735,Neutral
Johnson & Johnson Fourth-Quarter Earnings Down 25%,https://www.wsj.com/articles/johnson-johnson-jnj-q4-earnings-report-2022-11674563696,2023-01-24 12:43:00,The healthcare-products company reported declining sales in the fourth quarter as demand dropped for its Covid-19 vaccine.,JNJ,0.817578,-0.575147,Bearish
Johnson & Johnson Fourth-Quarter Earnings Down 25%,https://www.wsj.com/articles/johnson-johnson-jnj-q4-earnings-report-2023-11674563696,2023-01-24 12:43:00,The healthcare-products company reported declining sales in the fourth quarter as demand dropped for its Covid-19 vaccine.,JNJ,0.807885,-0.573167,Bearish
"Futures edge lower as earnings roll in, chipmakers retreat",https://www.reuters.com/markets/us/futures-edge-lower-earnings-roll-chipmakers-retreat-2023-01-24/,2023-01-24 12:36:00,"Jan 24 ( Reuters ) - U.S. stock index futures edged lower on Tuesday as corporate reports from bellwethers including 3M, Johnson & Johnson and GE pushed earnings season into high gear, while semiconductor shares pulled back from a bounce in the previous session.",JNJ,0.175859,0.073533,Neutral
"Johnson & Johnson Reports Mixed Q4 Earnings, Issues FY23 Guidance Edging Higher Than Street Consensus",https://www.benzinga.com/general/biotech/23/01/30542435/johnson-johnson-reports-mixed-q4-earnings-issues-fy23-guidance-edging-higher-than-street-consensu,2023-01-24 12:35:52,"Johnson & Johnson JNJ has reported Q4 FY22 adjusted earnings of $2.35 per share, up 10% Y/Y and beating the consensus of $2.23. Sales declined 4.4% to $23.7 billion, primarily driven by unfavorable foreign exchange and reduced COVID-19 vaccine sales, missing the consensus of $23.94 billion.",JNJ,0.699089,-0.236634,Somewhat-Bearish
Johnson & Johnson Reports Q4 and Full-Year 2022 Results,https://investingnews.com/johnson-johnson-reports-q4-and-full-year-2022-results/,2023-01-24 12:35:51,"Johnson & Johnson ( NYSE: JNJ ) today announced results for fourth-quarter and full year 2022. ""Our full year 2022 results reflect the continued strength and stability of our three business segments, despite macroeconomic challenges,"" said Joaquin Duato, Chairman of the Board and Chief Executive ...",JNJ,0.28398,0.200781,Somewhat-Bullish
"Johnson & Johnson Q4 Profit Down 26%, But Adj. EPS Tops Estimates",https://markets.businessinsider.com/news/stocks/johnson-johnson-q4-profit-down-26-but-adj-eps-tops-estimates-1032036523,2023-01-24 12:23:33,"( RTTNews ) - Healthcare company Johnson & Johnson ( JNJ ) on Tuesday reported that profit for fourth quarter declined 25.9 percent from last year, reflecting a sales decline and higher provisions for income taxes. Adjusted earnings per share topped analysts' expectations, while quarterly ...",JNJ,0.21686,-0.055962,Neutral
J&J forecasts strong 2023 profit on pharma boost,https://www.reuters.com/business/healthcare-pharmaceuticals/jj-quarterly-profit-beats-pharmaceuticals-strength-2023-01-24/,2023-01-24 12:22:00,"Jan 24 ( Reuters ) - Johnson & Johnson ( JNJ.N ) on Tuesday forecast annual profit above Wall Street estimates, as strong demand for its drugs such as cancer treatment Darzalex is expected to ease pressure from inflation and a strong dollar.",JNJ,0.165031,0.028074,Neutral
Fortune Selects Abu Dhabi as Host City of the 2023 Fortune Global Forum,https://www.prnewswire.com/in/news-releases/fortune-selects-abu-dhabi-as-host-city-of-the-2023-fortune-global-forum-301729148.html,2023-01-24 12:14:00,Fortune Selects Abu Dhabi as Host City of the 2023 Fortune Global ... PR ...,JNJ,0.043979,0.083265,Neutral
5 things to know before the stock market opens Tuesday,https://www.cnbc.com/2023/01/24/5-things-to-know-before-the-stock-market-opens-tuesday-january-24.html,2023-01-24 11:59:01,Here are the most important news items that investors need to start their trading day.,JNJ,0.065685,-0.077585,Neutral
"J&J tops 4Q earnings forecasts as profit, revenue slip",https://apnews.com/article/johnson-and-earnings-business-b623b481727b6d73304a46c35ecc707a,2023-01-24 11:49:17,Johnson & Johnson beat earnings expectations in the final quarter of 2022 even as a strong dollar and sinking COVID-19 vaccine sales hurt revenue. The health care giant also debuted on Tuesday a better-than-expected 2023 earnings forecast.,JNJ,0.166169,-0.085571,Neutral
"How a money drain in 2023 could upset the banks again and cause another market meltdown, investor warns",https://www.marketwatch.com/story/how-a-money-drain-in-2023-could-upset-the-banks-again-and-cause-another-market-meltdown-investor-warns-11674560661,2023-01-24 11:44:00,"Our call of the day from Thomas Kee Jr. says investors need to start paying attention to liquidity in the financial system, or a big lack thereof that could cause a market panic this year.",JNJ,0.081552,-0.106036,Neutral
US Stocks Look Set For Lower Start On Tuesday Ahead Of Microsoft's Earnings: Analysts Caution Of More Near-Term Volatility,https://www.benzinga.com/news/earnings/23/01/30540799/us-stocks-look-set-for-lower-start-on-tuesday-ahead-of-microsofts-earnings-analysts-caution-of-more,2023-01-24 11:32:09,The index futures signal a nervous start on Wall Street as the breathtaking rally of the past two sessions and the imminent tech earnings force traders to go on the defensive. U.S. stocks rallied out of the gate on Monday reflecting optimism among traders over soft landing and better-than-feared ...,JNJ,0.102231,0.0,Neutral
"Job Cuts Today, What Tomorrow? Big Tech Faces Some Big Tests.",https://www.barrons.com/amp/articles/what-to-know-today-51674547396,2023-01-24 11:31:00,"Tech stocks are having an impressive start to 2023 but several potential pitfalls are lying in wait. The tech-heavy Nasdaq Composite notched its second consecutive gain of 2% or more Monday, and is now close to 9% up so far in 2023.",JNJ,0.064507,0.027291,Neutral
Medical Aesthetics Market Size Worth USD 45.91 Billion by 2029 | Report by Fortune Business Insights,https://www.benzinga.com/pressreleases/23/01/g30541277/medical-aesthetics-market-size-worth-usd-45-91-billion-by-2029-report-by-fortune-business-insights,2023-01-24 11:30:08,"Pune, India, Jan. 24, 2023 ( GLOBE NEWSWIRE ) -- The global medical aesthetics market size was assessed at USD 18.46 billion in 2021. The market is anticipated to expand from USD 20.54 billion in 2022 to USD 45.91 billion by 2029, expanding at 12.2% CAGR during the forecast period.",JNJ,0.036643,0.0,Neutral
Genmab Announces Net Sales of DARZALEXÂ®  ( daratumumab )  for 2022,https://www.globenewswire.com/news-release/2023/01/24/2593980/0/en/Genmab-Announces-Net-Sales-of-DARZALEX-daratumumab-for-2022.html,2023-01-24 11:27:00,Company Announcement ...,JNJ,0.128822,0.011612,Neutral
Is WisdomTree U.S. Quality Dividend Growth ETF  ( DGRW )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2043043/is-wisdomtree-us-quality-dividend-growth-etf-dgrw-a-strong-etf-right-now,2023-01-24 11:20:08,Smart Beta ETF report for ...,JNJ,0.118064,0.060555,Neutral
3 Outstanding Dividend Stocks You Can Buy Now and Hold Forever,https://www.fool.com/investing/2023/01/24/3-top-dividend-stocks-you-can-buy-now-and-hold-for/,2023-01-24 10:13:00,"For years, these businesses have impressed investors with their ability to raise quarterly dividend payouts.",JNJ,0.22595,0.14237,Neutral
Stock futures pause after latest bounce as big batch of earnings reports loom,https://www.marketwatch.com/story/stock-futures-pause-after-latest-bounce-as-big-batch-of-earnings-reports-loom-11674553130,2023-01-24 09:38:00,Equity futures were a tad softer as the market paused for breath ahead of a big batch of earnings following a strong couple of days ...,JNJ,0.150122,0.0,Neutral
"Microsoft, Verizon Communications And 3 Stocks To Watch Heading Into Tuesday",https://www.benzinga.com/news/earnings/23/01/30539805/microsoft-verizon-communications-and-3-stocks-to-watch-heading-into-tuesday,2023-01-24 09:02:30,"With US stock futures trading mostly flat this morning on Tuesday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Verizon Communications Inc. VZ to post quarterly earnings at $1.19 per share on revenue of $35.14 billion before the opening bell.",JNJ,0.518022,0.134893,Neutral
Markets Turn More Bullish Ahead Of Earnings,https://www.benzinga.com/news/earnings/23/01/30539561/markets-turn-more-bullish-ahead-of-earnings,2023-01-24 08:23:00,"The CNN Money Fear and Greed index showed improvement in overall market sentiment among US investors. US stocks closed higher ahead of a busy week of earnings. Markets are expecting the US Federal Reserve to increase rates by 25 basis points at its upcoming meeting. Shares of Tesla, Inc.",JNJ,0.343279,0.0,Neutral
Morning Bid: It's all about the weather,https://www.reuters.com/markets/global-markets-view-europe-2023-01-24/,2023-01-24 05:32:00,A look at the day ahead in European and global markets from Wayne Cole. It's been another quiet session in Asia with many markets still on holiday. Japan was open and the BOJ's dogged defence of Yield Curve Control seems to be working with 10-year yields holding around 0.39% and away from the ...,JNJ,0.096671,-0.04937,Neutral
"US Markets climb ahead of earnings, economic data",https://www.business-standard.com/article/news-cm/us-markets-climb-ahead-of-earnings-economic-data-123012400138_1.html,2023-01-24 03:27:00,"At the close of trade, the Dow Jones Industrial Average index advanced 254.07 points, or 0.76%, to 33,629.56. The S&P500 index was up 47.20 points, or 1.19%, to 4,019.81. The tech-heavy Nasdaq Composite Index increased by 223.98 points, or 2.01%, to 11,364.41.",JNJ,0.122269,0.0,Neutral
Markets Stay Positive on Perceived Fed Slowing,https://www.zacks.com/stock/news/2042874/markets-stay-positive-on-perceived-fed-slowing,2023-01-23 22:41:00,We're either letting the stern part of the narrative get past us or we're breathing some life into oversold indices. Perhaps a little of both.,JNJ,0.194242,-0.014256,Neutral
"An Annual Covid Booster Could Be Coming. What It Means for Pfizer, Moderna.",https://www.barrons.com/amp/articles/fda-annual-covid-vaccine-booster-moderna-pfizer-51674506238,2023-01-23 20:40:00,An Annual Covid Booster May Be Coming. What It Means for Pfizer and Moderna. ...,JNJ,0.120431,0.167144,Somewhat-Bullish
Why stocks still could face a 1980s-style drop,https://www.marketwatch.com/story/why-stocks-still-could-face-a-1980s-style-drop-11674500903,2023-01-23 19:08:00,"A ""meaningful fall"" in earnings that isn't yet accounted for in U.S. stocks could still trigger a 30% drawdown, warns Principal Asset Management.",JNJ,0.183895,-0.120514,Neutral
2 Best Buffett Stocks to Buy for the Long Haul,https://www.fool.com/investing/2023/01/23/2-best-buffett-stocks-to-buy-for-the-long-haul/,2023-01-23 19:00:00,You won't ever want to sell these solid long-term favorites.,JNJ,0.135347,0.283801,Somewhat-Bullish
"Stocks Make a Quiet Move Upward Ahead of Thursday's GDP, 'Pause' Talk",https://www.benzinga.com/markets/23/01/30530192/stocks-make-a-quiet-move-upward-ahead-of-thursdays-gdp-pause-talk,2023-01-23 18:36:00,"( Monday Market Open ) This week and next could go a long way toward determining how the current quarter plays out on Wall Street. Between now and February 4, we'll receive earnings reports from close to half of S&P 500Â® companies, including 90 this seek.",JNJ,0.069445,0.050156,Neutral
"Stocks Make a Quiet Move Upward Ahead of Thursday's GDP, 'Pause' Talk",https://www.benzinga.com/markets/23/01/30530187/stocks-make-a-quiet-move-upward-ahead-of-thursdays-gdp-pause-talk,2023-01-23 18:35:46,"( Monday Market Open ) This week and next could go a long way toward determining how the current quarter plays out on Wall Street. Between now and February 4, we'll receive earnings reports from close to half of S&P 500Â® companies, including 90 this seek.",JNJ,0.069445,0.050156,Neutral
JNJ: 1 Stable Stock to Put on Your Buy List Now,https://stocknews.com/news/jnj-mrk-abbv-pfe-1-stable-stock-to-put-on-your-buy-list-now/,2023-01-23 17:11:26,The market's promising start to the year is at the risk of fizzling out amid underwhelming earnings releases and other indicators of an economy weighed down by increased borrowing costs due to the Federal Reserve's perpetual interest rate hikes.,JNJ,0.705377,0.401108,Bullish
ONWARD Strengthens Leadership Team with Key Appointments in Clinical & Regulatory and Marketing,https://www.globenewswire.com/news-release/2023/01/23/2593471/0/en/ONWARD-Strengthens-Leadership-Team-with-Key-Appointments-in-Clinical-Regulatory-and-Marketing.html,2023-01-23 16:30:00,"Erika Ross to join the company as VP Global Clinical & Regulatory, and Sarah Moore to join as VP Global Marketing Erika Ross to join the company as VP Global Clinical & Regulatory, and Sarah Moore to join as VP Global Marketing ...",JNJ,0.037098,0.029461,Neutral
"Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Fate Therapeutics, Inc.  ( FATE ) ",https://www.benzinga.com/pressreleases/23/01/g30527319/gainey-mckenna-egleston-announces-a-class-action-lawsuit-has-been-filed-against-fate-therapeutics-,2023-01-23 16:19:49,"NEW YORK, Jan. 23, 2023 ( GLOBE NEWSWIRE ) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of California on behalf of all persons or entities who purchased the securities of Fate ...",JNJ,0.0699,0.021284,Neutral
Lowey Dannenberg Notifies Fate Therapeutics Inc.  ( NASDAQ: FATE )  Investors of Securities Class Action Lawsuit and Upcoming Lead Plaintiff Deadline,https://www.benzinga.com/pressreleases/23/01/g30526597/lowey-dannenberg-notifies-fate-therapeutics-inc-nasdaq-fate-investors-of-securities-class-action-l,2023-01-23 15:56:52,"WHITE PLAINS, N.Y., Jan. 23, 2023 ( GLOBE NEWSWIRE ) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Fate Therapeutics Inc. ( ""Fate"" or the ""Company"" ) for violations of the federal ...",JNJ,0.065685,0.023218,Neutral
Here's Why You Should Retain Boston Scientific  ( BSX )  Now,https://www.zacks.com/stock/news/2042737/heres-why-you-should-retain-boston-scientific-bsx-now,2023-01-23 15:48:00,Investors are optimistic about Boston Scientific (BSX) on recent acquisitions and robust performance of the WATCHMAN device.,JNJ,0.04912,0.090171,Neutral
J&J Earnings Could Show Big Pharma Is No Longer a Haven,https://www.barrons.com/articles/jnj-johnson-earnings-stock-price-51674485969,2023-01-23 15:19:00,J&J Reports Earnings Tuesday. What to Expect. ...,JNJ,0.9545,-0.115485,Neutral
Market on Tipping Point of New Bull Trend: These 5 Charts Illustrate Why,https://www.zacks.com/commentary/2042682/market-on-tipping-point-of-new-bull-trend-these-5-charts-illustrate-why,2023-01-23 15:02:00,"You never really know when a new bull trend has arrived for sure. However, by looking at different sides of the market you can begin to put the pieces of the puzzle together.",JNJ,0.112008,0.0,Neutral
J&J Earnings Could Show Big Pharma Is No Longer a Haven,https://www.barrons.com/articles/jnj-johnson-earnings-stock-price-51674485969,2023-01-23 15:01:00,Johnson & Johnson CEO Joaquin Duato's warning earlier this month that the outlook for 2023 remains uncertain is tempering investor expectations ahead of the company's earnings reports on Tuesday. It could also signal an end to big pharma's status as a defensive stronghold.,JNJ,0.9545,-0.115485,Neutral
"Discover Financial, Kimberly Clark, Johnson & Johnson and Synchrony Financial are part of Zacks Earnings Preview",https://www.zacks.com/stock/news/2042621/discover-financial-kimberly-clark-johnson-johnson-and-synchrony-financial-are-part-of-zacks-earnings-preview,2023-01-23 14:05:00,"Discover Financial, Kimberly Clark, Johnson & Johnson and Synchrony Financial are highlights of Zacks Earnings Preview article.",JNJ,0.16099,-0.033445,Neutral
"Global Health and Wellness Market Anticipated to Generate a Revenue of $12,850.3 Billion and Rise at a CAGR of 10.9% during the Estimated Period 2022-2031| Report [250-Pages] by Research Dive",https://www.benzinga.com/pressreleases/23/01/g30523095/global-health-and-wellness-market-anticipated-to-generate-a-revenue-of-12-850-3-billion-and-rise-a,2023-01-23 14:01:00,"New York, USA, Jan. 23, 2023 ( GLOBE NEWSWIRE ) -- According to a report published by Research Dive, the global health and wellness market is envisioned to garner a revenue of $12,850.3 billion and rise at a CAGR of 10.9% during the analysis timeframe from 2022 to 2031.",JNJ,0.062434,-0.146084,Neutral
"Futures Rise Ahead Of Key Economic Data, Earnings Reports",https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-rise-ahead-of-key-economic-data-earnings-reports-amd-jumps-on-upgrade/,2023-01-23 13:28:00,"Dow Jones futures rose Monday ahead of a busy week of key economic data and as the dollar dropped to an eight-month low. A big week of earnings news includes results from Tesla, due out Wednesday. Advanced Micro Devices ( AMD ) jumped more than 2% after a Barclays upgrade to overweight.",JNJ,0.049526,0.0,Neutral
Hair Care Market Worth $121.08 Billion by 2030 - Exclusive Report by Meticulous ResearchÂ®,https://www.benzinga.com/pressreleases/23/01/g30521388/hair-care-market-worth-121-08-billion-by-2030-exclusive-report-by-meticulous-research,2023-01-23 13:05:54,"Redding, California, Jan. 23, 2023 ( GLOBE NEWSWIRE ) -- According to a new market research report titled, 'Hair Care Market by Product [Shampoo, Conditioner, Oil, Color, Serum, Styling Products ( Wax, Spray, Gel ) ], Type [Organic, Synthetic], Distribution Channel [Supermarket, Pharmacies, ...",JNJ,0.036983,0.013405,Neutral
PROFITOPTICS Promotes Geoff Marlatt to CEO to Lead Next Stage of Company Growth,https://www.prnewswire.com/news-releases/profitoptics-promotes-geoff-marlatt-to-ceo-to-lead-next-stage-of-company-growth-301726778.html,2023-01-23 13:00:00,PROFITOPTICS Promotes Geoff Marlatt to CEO to Lead Next Stage ... PR ...,JNJ,0.060085,0.142177,Neutral
5 things to know before the stock market opens Monday,https://www.cnbc.com/2023/01/23/5-things-to-know-before-the-stock-market-opens-monday-january-23.html,2023-01-23 12:14:08,Here are the most important news items that investors need to start their trading day.,JNJ,0.069094,0.0,Neutral
"Don't let the 'bear market house of mirrors' fool you, Morgan Stanley's Mike Wilson warns of the stock market",https://www.marketwatch.com/story/dont-let-the-bear-market-house-of-mirrors-fool-you-morgan-stanleys-mike-wilson-warns-of-the-stock-market-11674475020,2023-01-23 12:13:00,"Here's why Morgan Stanley's Mike Wilson is not biting on the early year gains for stocks. It's all down to earnings that are portending bad news, he says.",JNJ,0.074115,0.044318,Neutral
Want Safe and Growing Passive Income? Buy These 2 Dividend Kings In 2023,https://www.fool.com/investing/2023/01/23/safe-grow-passive-income-buy-dividend-jnj-abt/,2023-01-23 12:04:36,It doesn't get any safer for income investors than Dividend Kings.,JNJ,0.179788,0.023156,Neutral
My Top Dividend King to Buy for 2023  ( and It's Not Even Close ) ,https://www.fool.com/investing/2023/01/23/my-top-dividend-king-to-buy-2023-high-yield/,2023-01-23 11:29:41,This Dividend King is down big but could recover in a major way.,JNJ,0.036255,0.028224,Neutral
The Top Healthcare Stocks to Buy With $100,https://www.fool.com/investing/2023/01/23/the-top-healthcare-stocks-to-buy-with-100/,2023-01-23 10:35:00,Don't overlook these big-name foreign healthcare stocks.,JNJ,0.100308,-0.264403,Somewhat-Bearish
"Stocks Mixed, Tech Earnings, Salesforce, AMD, Debt Ceiling - Five Things To Know",https://www.thestreet.com/markets/stocks-mixed-tech-earnings-salesforce-amd-5-things-to-know,2023-01-23 10:10:00,"Stock futures mixed as market eyes tech, dollar slides. Week Ahead: big earnings wave, PCE inflation data in focus. Salesforce shares leap as Elliott Management builds activist stake. AMD shares extend gains after Barclays upgrade and lawmakers move to tweak debt ceiling calculation.",JNJ,0.059194,0.398514,Bullish
"Nicotine gum market size to grow by USD 1.01 billion from 2020 to 2025: A descriptive analysis of customer landscape, vendor assessment, and market dynamics - Technavio",https://www.prnewswire.com/news-releases/nicotine-gum-market-size-to-grow-by-usd-1-01-billion-from-2020-to-2025-a-descriptive-analysis-of-customer-landscape-vendor-assessment-and-market-dynamics---technavio-301726602.html,2023-01-23 10:00:00,Nicotine gum market size to grow by USD 1.01 billion from 2020 to ... PR ...,JNJ,0.032251,-0.011373,Neutral
Sports Medicine Market Worth USD 9.86 Billion by 2026 | Report by Fortune Business Insights,https://www.benzinga.com/pressreleases/23/01/g30517852/sports-medicine-market-worth-usd-9-86-billion-by-2026-report-by-fortune-business-insights,2023-01-23 09:26:32,"Pune, India, Jan. 23, 2023 ( GLOBE NEWSWIRE ) -- The global sports medicine market size is predicted to USD 9.86 billion by 2026, exhibiting a CAGR of 5.8% during the forecast period. The rising prevalence of chronic conditions, including cardiovascular diseases and obesity, is escalating ...",JNJ,0.032558,0.0,Neutral
"Tesla, AT&T, Visa, Chevron, Microsoft, and More Stocks to Watch This Week",https://www.barrons.com/articles/stocks-to-watch-this-week-tesla-att-visa-chevron-microsoft-51674417604,2023-01-23 02:15:00,"It will be a big week of fourth-quarter earnings, with about 90 S&P 500 companies scheduled to report. There will be plenty of notable economic data releases for investors to watch out for as well.",JNJ,0.407844,0.0,Neutral
"Tesla, Microsoft, Boeing earnings, along with GDP top week ahead",https://www.foxbusiness.com/markets/tesla-microsoft-boeing-earnings-gdp-top-week-ahead,2023-01-22 22:22:33,"This week will be a busy one for investors with earnings from defense, credit cards and airline companies all reporting quarterly results. The stock market is coming off a mixed week with the Dow Jones Industrial Average falling over 2%, while the S&P slipped marginally as the Nasdaq Composite ...",JNJ,0.05654,0.0,Neutral
"Tesla, Microsoft, IBM, Intel, TI Among Companies Reporting This Week: Can Netflix's Optimism Spill Over To Rest Of Tech Space?",https://www.benzinga.com/news/earnings/23/01/30515925/tesla-microsoft-ibm-intel-ti-among-companies-reporting-this-week-can-netflixs-optimism-spill-over-t,2023-01-22 21:30:43,"Netflix, Inc. NFLX shares jumped nearly 8.5% on Friday before settling at their highest level since April 19, 2022, when shares plunged after the company reported its first loss in net paid subscriber adds in a decade.",JNJ,0.062271,0.0,Neutral
"Tesla, AT&T, Visa, Chevron, Microsoft, and More Stocks for Investors to Watch This Week",https://www.barrons.com/articles/tesla-at-t-visa-chevron-microsoft-and-more-stocks-for-investors-to-watch-this-week-51674417604,2023-01-22 20:00:00,"It will be a big week of fourth-quarter earnings, with about 90 S&P 500 companies scheduled to report. There will be plenty of notable economic data releases for investors to watch out for as well.",JNJ,0.407844,0.0,Neutral
Did the economy end 2022 with a bang or a whimper? | Business,https://www.cnn.com/2023/01/22/investing/stocks-week-ahead/index.html,2023-01-22 12:16:00,Did the economy end 2022 with a bang or a whimper? ...,JNJ,0.089797,0.043399,Neutral
Did the economy end 2022 with a bang or a whimper? | Business,https://edition.cnn.com/2023/01/22/investing/stocks-week-ahead,2023-01-22 12:16:00,Did the economy end 2022 with a bang or a whimper? CNN International ...,JNJ,0.089797,0.043399,Neutral
This Recession Indicator Hasn't Been Wrong in 56 Years: Here's What It Says Happens Next,https://www.fool.com/investing/2023/01/22/this-recession-indicator-hasnt-been-wrong-56-years/,2023-01-22 10:06:00,Ominous warnings are adding up for Wall Street.,JNJ,0.106227,-0.001132,Neutral
Oral Care/Oral Hygiene Market will worth USD 100.40 billion by 2030 : GreyViews,https://www.benzinga.com/pressreleases/23/01/g30514451/oral-careoral-hygiene-market-will-worth-usd-100-40-billion-by-2030-greyviews,2023-01-21 19:00:00,"Pune India, Jan. 21, 2023 ( GLOBE NEWSWIRE ) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa. These are the key regions where the oral care/oral hygiene market is operating and ...",JNJ,0.024622,0.224255,Somewhat-Bullish
"Tesla, Microsoft Are Headlining First Busy Earnings Week of 2023",https://www.wsj.com/articles/tesla-microsoft-are-headlining-first-busy-earnings-week-of-2023-11674276881,2023-01-21 15:00:00,Verizon and Southwest are among other companies expected to report as economists gauge the effect of higher interest rates.,JNJ,0.485711,-0.360627,Bearish
3 Smart Stocks to Buy if a Recession Is on the Way,https://www.fool.com/investing/2023/01/21/3-smart-stocks-to-buy-if-a-recession-is-on-the-way/,2023-01-21 11:55:00,Their products will enjoy strong demand regardless of what happens with the economy.,JNJ,0.407844,0.005786,Neutral
"Elon Musk felt like he 'was dying' after 2nd COVID booster shot, cousin in 'peak health' suffered myocarditis",https://www.foxbusiness.com/business-leaders/elon-musk-felt-like-he-was-dying-2nd-covid-booster-shot-cousin-peak-health-suffered-myocarditis,2023-01-21 11:40:43,"Elon Musk took to Twitter late Friday evening to share his personal experience with the second COVID booster shot, explaining he ran into ""major side effects.""",JNJ,0.1331,0.024803,Neutral
"Fate Therapeutics, Inc.  ( FATE )  Class Action Alert: Contact Robbins LLP for Information Regarding the Class Action Against Fate Therapeutics, Inc. - Fate Therapeutics  ( NASDAQ:FATE ) ",https://www.benzinga.com/pressreleases/23/02/g30842803/fate-therapeutics-inc-fate-class-action-alert-contact-robbins-llp-for-information-regarding-the-cl,2023-02-09 19:46:11,"SAN DIEGO, Feb. 09, 2023 ( GLOBE NEWSWIRE ) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired shares of Fate Therapeutics, Inc.",JNJ,0.071784,-0.00203,Neutral
"Aligos Reprioritizes Pipeline With Focus On NASH, COVID Programs, Cuts Another 10% Of Its Workforce - Aligos Therapeutics  ( NASDAQ:ALGS ) ",https://www.benzinga.com/general/biotech/23/02/30837587/aligos-reprioritizes-pipeline-with-focus-on-nash-covid-programs-cuts-another-10-of-its-workforce,2023-02-09 16:39:57,"Aligos Therapeutics Inc ALGS announced a portfolio reprioritization, with priorities focused on the rapid advancement of its clinical NASH ( ALG-055009 ) and COVID-19 ( ALG-097558 ) programs. The company also plans to maintain its ongoing NASH oligonucleotide research collaborations with ...",JNJ,0.163909,-0.556465,Bearish
"AbbVie  ( ABBV )  Beats Q4 Earnings Estimates, Misses on Sales",https://www.zacks.com/stock/news/2052457/abbvie-abbv-beats-q4-earnings-estimates-misses-on-sales,2023-02-09 16:37:00,"AbbVie's Q4 earnings (ABBV) beat estimates, while sales miss the same. Full-year 2023 EPS falls short of estimates.",JNJ,0.082111,0.132794,Neutral
Highview Capital Expands through New Hires and Promotion,https://www.prnewswire.com/news-releases/highview-capital-expands-through-new-hires-and-promotion-301741236.html,2023-02-09 15:37:00,"LOS ANGELES, Feb. 9, 2023 /PRNewswire/ -- Highview Capital, LLC ( ""Highview"" ) , a Los Angeles-based middle-market private equity firm, today announced the hire of Jonathan Greenway as a Managing Director as well as the promotion of Dan Picmann to Managing Director.",JNJ,0.085324,0.205026,Somewhat-Bullish
Wall Street's frozen IPO market is thawing as companies take advantage of stock rally,https://www.cnbc.com/2023/02/09/ipos-wall-streets-frozen-market-is-thawing-after-stock-rally.html,2023-02-09 15:23:10,"Wall Street's so-called IPO window, allowing companies to readily tap investors for new stock, has been mostly shut for the past year.",JNJ,0.057907,0.069965,Neutral
GrowthSpace Referenced as 'White Hot' HR Tech for 2023 by Leading Analyst Josh Bersin,https://www.prnewswire.com/news-releases/growthspace-referenced-as-white-hot-hr-tech-for-2023-by-leading-analyst-josh-bersin-301742969.html,2023-02-09 14:00:00,GrowthSpace Referenced as 'White Hot' HR Tech for 2023 by ... PR ...,JNJ,0.071145,0.202955,Somewhat-Bullish
GrowthSpace Referenced as 'White Hot' HR Tech for 2023 by Leading Analyst Josh Bersin,https://www.prnewswire.com/il/news-releases/growthspace-referenced-as-white-hot-hr-tech-for-2023-by-leading-analyst-josh-bersin-301742969.html,2023-02-09 14:00:00,GrowthSpace Referenced as 'White Hot' HR Tech for 2023 by ... PR ...,JNJ,0.071145,0.202955,Somewhat-Bullish
"Hair Loss Treatment Market [2023-2030] Size, Share, Growth, Demand, Sales, Trends, Competitive Landscape And Regional Outlook, Analysis Report",https://www.benzinga.com/pressreleases/23/02/g30828684/hair-loss-treatment-market-2023-2030-size-share-growth-demand-sales-trends-competitive-landscape-a,2023-02-09 10:15:46,"Pune, India, Feb. 09, 2023 ( GLOBE NEWSWIRE ) -- As pe research by Fortune Business Insights, the market for Hair Loss Treatment is growing, driven by factors such as increasing prevalence of hair loss and baldness, rising consumer awareness of hair loss treatments, and increasing investment in ...",JNJ,0.03157,-0.078621,Neutral
"EMA Confirms Acceptance of Application for AVT04, a Proposed Biosimilar to StelaraÂ®  ( ustekinumab ) ",https://www.globenewswire.com/news-release/2023/02/09/2604642/0/en/EMA-Confirms-Acceptance-of-Application-for-AVT04-a-Proposed-Biosimilar-to-Stelara-ustekinumab.html,2023-02-09 07:30:00,"Alvotech ( NASDAQ: ALVO ) , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and global pharmaceutical company STADA Arzneimittel ( STADA ) today announced that the European Medicines Agency ( EMA ) has accepted a Marketing ...",JNJ,0.023395,0.0,Neutral
"EMA Confirms Acceptance of Application for AVT04, a Proposed Biosimilar to StelaraÂ®  ( ustekinumab ) ",https://www.globenewswire.com/news-release/2023/02/09/2604643/0/en/EMA-Confirms-Acceptance-of-Application-for-AVT04-a-Proposed-Biosimilar-to-Stelara-ustekinumab.html,2023-02-09 07:30:00,"REYKJAVIK, Iceland and BAD VILBEL, Germany, Feb. 09, 2023 ( GLOBE NEWSWIRE ) -- Alvotech ( NASDAQ: ALVO ) , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and global pharmaceutical company STADA Arzneimittel ( STADA ) ...",JNJ,0.022925,0.0,Neutral
"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bioventus, ESS, IBM, and FATE and Encourages Investors to Contact the Firm - Fate Therapeutics  ( NASDAQ:FATE ) , Bioventus  ( NASDAQ:BVS ) ",https://www.benzinga.com/pressreleases/23/02/g30826820/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-biove,2023-02-09 02:00:00,"NEW YORK, Feb. 08, 2023 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Bioventus Inc. BVS, ESS Tech, Inc.",JNJ,0.017269,0.017436,Neutral
"2023 CALIFORNIA CONFERENCE FOR WOMEN TO FOCUS ON LEADERSHIP, CONNECTION, AND BEING A FORCE FOR CHANGE",https://www.benzinga.com/pressreleases/23/02/n30821811/2023-california-conference-for-women-to-focus-on-leadership-connection-and-being-a-force-for-chang,2023-02-08 20:29:00,"SANTA CLARA, Feb. 8, 2023 /PRNewswire/ -- Leaders from corporate America, the media, sports, arts, and Hollywood will come together this Women's History Month to discuss women leading together to be a force for positive change in 2023. They include the former CEO of IBM Ginny Rometty.",JNJ,0.051551,0.15847,Somewhat-Bullish
Interim report 2022/23 - 15% revenue growth and DKK 145 million operating profit  ( +25% )  for the first half following a challenging second quarter,https://www.globenewswire.com/news-release/2023/02/08/2604335/0/en/Interim-report-2022-23-15-revenue-growth-and-DKK-145-million-operating-profit-25-for-the-first-half-following-a-challenging-second-quarter.html,2023-02-08 17:57:00,ANNOUNCEMENT NO. 2349 February 2023Interim report for the first half of ...,JNJ,0.080728,0.041655,Neutral
JNJ: 3 Stocks to Help You Build Wealth in the Market,https://stocknews.com/news/jnj-ko-azn-3-stocks-to-help-you-build-wealth-in-the-market/,2023-02-08 16:22:08,"Expansion of the U.S. economy for the fourth quarter of last year and moderating inflationary pressures led the Fed to choose a less aggressive stance. Hence, the central bank hiked rates by 0.25 percentage points. This revived investor optimism.",JNJ,0.318897,0.236437,Somewhat-Bullish
A Look at Pharma ETFs Post Q4 Earnings,https://www.zacks.com/stock/news/2051723/a-look-at-pharma-etfs-post-q4-earnings,2023-02-08 15:05:00,"Combining the actual results with the estimates for the still-to-report companies, total earnings for the healthcare sector are expected to decline 9% on revenue growth of 4.3%.",JNJ,0.077343,0.024707,Neutral
3 Blue Chip Stocks To Watch In February 2023,https://stockmarket.com/featured/3-blue-chip-stocks-to-watch-in-february-2023-2023-02-08,2023-02-08 15:02:03,"Blue chip stocks are highly respected and established companies that have a strong reputation for stability and steady growth. Blue chip companies are typically leaders in their respective industries and have a long history of profitability, making them potentially attractive to both individual ...",JNJ,0.118647,0.373929,Bullish
This Deadly Mistake Could Crush Your Dividends In 2023,https://www.forbes.com/sites/brettowens/2023/02/08/this-deadly-mistake-could-crush-your-dividends-in-2023/,2023-02-08 14:53:00,Do not trust your dividend income to ETFs!,JNJ,0.113597,0.0,Neutral
This Could Cost Johnson & Johnson Billions in Profit,https://www.fool.com/investing/2023/02/08/this-could-cost-johnson-johnson-billions-in-profit/,2023-02-08 13:20:00,The talc lawsuits create some risk for the business -- but is it enough of a reason to stay away from the stock?,JNJ,0.592742,-0.111353,Neutral
3 Dividend Stocks That Will Hold Up No Matter the Market Conditions,https://www.fool.com/investing/2023/02/08/3-dividend-stocks-that-hold-up-in-any-market/,2023-02-08 10:30:00,These stocks could boost your portfolio in bear markets and bull markets.,JNJ,0.107736,0.143776,Neutral
Don't 'Buy American',https://www.theatlantic.com/newsletters/archive/2023/02/buy-american-joe-biden-free-trade-industrial-policy-supply-chain/672977/,2023-02-08 10:00:00,"This is Work in Progress, a newsletter by Derek Thompson about work, technology, and how to solve some of America's biggest problems. Sign up here to get it every week. The free-trade era in America is over. Industrial policy is the new rage.",JNJ,0.028903,-0.001942,Neutral
Is It Time to Buy the Dow Jones' 3 Worst-Performing January Stocks?,https://www.fool.com/investing/2023/02/07/is-it-time-to-buy-the-dow-jones-3-worst-performing/,2023-02-07 20:05:00,"They aren't quite the Dogs of the Dow, but these blue chips are limping into February.",JNJ,0.260004,-0.04317,Neutral
"World's Largest Hedge Fund Founder Ray Dalio Says Cash Is ""In Jeopardy"" but Sees an Unexpected Solution",https://www.benzinga.com/markets/cryptocurrency/23/02/30773160/worlds-largest-hedge-fund-founder-ray-dalio-says-cash-is-in-jeopardy-but-sees-an-unexpecte,2023-02-07 18:03:10,"Inflation has been a massive issue for nearly every major country for the past year or so. Consumers and corporations alike have felt the pain, with the previous four quarters of earnings proving to be relatively lackluster. While inflation is slowly declining, it has caused the debt of the U.S. ...",JNJ,0.085022,0.071725,Neutral
Catalent  ( CTLT )  Surges on Rumors of Acquisition by Danaher,https://www.zacks.com/stock/news/2051034/catalent-ctlt-surges-on-rumors-of-acquisition-by-danaher,2023-02-07 15:09:00,"Catalent (CTLT) shares gain significantly, following a Bloomberg report about a potential acquisition of the CDMO company by Danaher, a life sciences company.",JNJ,0.227716,0.012362,Neutral
"Global Acne Medication Market to generate USD 14.26 Billion by 2030, Outlines a New Report by Next Move Strategy Consulting",https://www.benzinga.com/pressreleases/23/02/g30763059/global-acne-medication-market-to-generate-usd-14-26-billion-by-2030-outlines-a-new-report-by-next-,2023-02-07 14:00:00,"New York, Feb. 07, 2023 ( GLOBE NEWSWIRE ) -- According to a report published by Next Move Strategy Consulting, the Acne Medication Market generated USD 10.08 billion in 2021, and is projected to generate USD 14.26 billion by 2030, witnessing a CAGR of 3.02% from 2021 to 2030.",JNJ,0.044386,-0.03947,Neutral
"Appeals Court Clears The Way For 38,000 Johnson & Johnson Baby Powder Lawsuits",https://www.forbes.com/sites/korihale/2023/02/07/appeals-court-clears-the-way-for-38000-johnson--johnson-baby-powder-lawsuits/,2023-02-07 13:00:00,Pharmaceutical giant Johnson & Johnsonï»¿ has 99 problems and a Federal Appeals Court is one. The 3rd U.S. Circuit Court of Appeals dismissed a bankruptcy filing by a Johnson & Johnson spinoff company that clears the way for more lawsuits over its baby powder.,JNJ,0.411848,-0.141338,Neutral
Is Vanguard Dividend Appreciation ETF  ( VIG )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2050741/is-vanguard-dividend-appreciation-etf-vig-a-strong-etf-right-now,2023-02-07 11:20:07,Smart Beta ETF report for VIG ...,JNJ,0.118064,0.06168,Neutral
"Disposable Medical Gloves Market Size to Surpass USD 21.28 Billion by 2029, With 5.1% CAGR | Research by Fortune Business Insights",https://www.benzinga.com/pressreleases/23/02/g30755911/disposable-medical-gloves-market-size-to-surpass-usd-21-28-billion-by-2029-with-5-1-cagr-research-,2023-02-07 11:03:45,"Pune, India, Feb. 07, 2023 ( GLOBE NEWSWIRE ) -- The global disposable medical gloves market size was USD 14.17 billion in 2021. The market is expected to grow from USD 15.06 billion in 2022 to USD 21.28 billion by 2029, exhibiting a CAGR of 5.1% during the forecast period.",JNJ,0.031241,-0.197755,Somewhat-Bearish
How Does Johnson & Johnson Stock Compare With This Large Beverage Company?,https://www.forbes.com/sites/greatspeculations/2023/02/07/how-does-johnson--johnson-stock-compare-with-this-large-beverage-company/,2023-02-07 11:00:00,We believe that pharmaceutical giant Johnson & Johnson stock (NYSE: JNJ) and Coca-Cola stock (NYSE: KO) will likely offer similar returns over the next three years.,JNJ,0.356609,0.194701,Somewhat-Bullish
Sustainability platform abillion launches a crowdfunder,https://www.benzinga.com/pressreleases/23/02/n30753861/sustainability-platform-abillion-launches-a-crowdfunder,2023-02-07 09:11:00,"NEW YORK, Feb. 7, 2023 /PRNewswire/ -- abillion, the emerging sustainability-focused social media and e-commerce platform with over a million members globally, has launched a community investment round on Wefunder.",JNJ,0.089797,0.095229,Neutral
Idorsia announces financial results for 2022 - building momentum to become a leading mid-sized biopharmaceutical company,https://www.globenewswire.com/news-release/2023/02/07/2602587/0/en/Idorsia-announces-financial-results-for-2022-building-momentum-to-become-a-leading-mid-sized-biopharmaceutical-company.html,2023-02-07 06:00:00,Ad hoc announcement pursuant to Art. 53 LR ...,JNJ,0.007231,0.074804,Neutral
UM Appoints Sasha Savic Global CEO,https://www.prnewswire.com/news-releases/um-appoints-sasha-savic-global-ceo-301739644.html,2023-02-06 18:00:00,"Savic to Drive Industry-Leading Global Agency Network into Next Chapter of Growth NEW YORK, Feb. 6, 2023 /PRNewswire/ -- UM, a network of IPG Mediabrands, today announced the appointment of Sasha Savic to Global Chief Executive Officer.",JNJ,0.129168,0.166602,Somewhat-Bullish
Johnson & Johnson's Drug Acquired Via Momenta Deal Shows Encouraging Data In Fetal Disorder - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/general/biotech/23/02/30735767/johnson-johnsons-drug-acquired-via-momenta-deal-shows-encouraging-data-in-fetal-disorder,2023-02-06 17:40:41,"Janssen, a unit of Johnson & Johnson JNJ, announced topline results from the proof-of-concept Phase 2 open-label UNITY trial for pregnant adults at high risk for severe hemolytic disease of the fetus and newborn.",JNJ,0.612033,0.243429,Somewhat-Bullish
AbbVie  ( ABBV )  to Report Q4 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2050446/abbvie-abbv-to-report-q4-earnings-whats-in-the-cards,2023-02-06 16:01:00,AbbVie's (ABBV) Q4 performance will likely reflect strong drug demand from its immunology and neuroscience franchises. Investors will also enquire about ABBV's plans to counter Humira LOE.,JNJ,0.13409,0.057746,Neutral
"Biotech Stocks' Q4 Earnings Due on Feb 7: VRTX, INCY and EXEL",https://www.zacks.com/stock/news/2050425/biotech-stocks-q4-earnings-due-on-feb-7-vrtx-incy-and-exel,2023-02-06 15:30:00,"Let us take a look at what is in store for some of the biotech stocks VRTX, INCY and EXEL, which are scheduled to report on Feb 7.",JNJ,0.108466,0.041372,Neutral
The Pulmonary Edema Therapeutics market is expected to display a steady growth of 3% due to the increase in road accidents leading to severe injury to the chest | UnivDatos Market Insights,https://www.prnewswire.com/news-releases/the-pulmonary-edema-therapeutics-market-is-expected-to-display-a-steady-growth-of-3-due-to-the-increase-in-road-accidents-leading-to-severe-injury-to-the-chest--univdatos-market-insights-301739192.html,2023-02-06 14:30:00,The Pulmonary Edema Therapeutics market is expected to display a ... PR ...,JNJ,0.038717,0.0,Neutral
Johnson & Johnson's Latest Talcum Powder Development Could Be Costly,https://www.fool.com/investing/2023/02/06/johnson-johnsons-latest-talcum-powder-development/,2023-02-06 14:05:00,Johnson & Johnson's pockets could become billions lighter.,JNJ,0.602533,-0.101308,Neutral
"Why Catalent  ( CTLT )  Shares Are Gaining Today - Catalent  ( NYSE:CTLT ) , Danaher  ( NYSE:DHR ) ",https://www.benzinga.com/news/large-cap/23/02/30724852/danaher-shows-interest-in-acquiring-catalent-valued-at-significant-premium-report,2023-02-06 12:44:40,"Danaher Corporation DHR has reportedly expressed interest in acquiring the contract manufacturer Catalent Inc CTLT. According to the sources, the recent moves by the life science firm valued Catalent at a significant premium.",JNJ,0.29234,0.379958,Bullish
Viridian Appoints Scott Myers as President and Chief Executive Officer,https://www.globenewswire.com/news-release/2023/02/06/2601926/0/en/Viridian-Appoints-Scott-Myers-as-President-and-Chief-Executive-Officer.html,2023-02-06 12:00:00,Transition highlights Viridian's progression towards becoming a fully-integrated biopharmaceutical company Transition highlights Viridian's progression towards becoming a fully-integrated biopharmaceutical company ...,JNJ,0.035714,0.07427,Neutral
Viridian Appoints Scott Myers as President and Chief Executive Officer - Viridian Therapeutics  ( NASDAQ:VRDN ) ,https://www.benzinga.com/pressreleases/23/02/g30725677/viridian-appoints-scott-myers-as-president-and-chief-executive-officer,2023-02-06 12:00:00,"WALTHAM, Mass., Feb. 06, 2023 ( GLOBE NEWSWIRE ) -- Viridian Therapeutics, Inc.",JNJ,0.03463,0.073935,Neutral
"Baby Products Market to be Worth $352.65 Billion by 2030: Grand View Research, Inc.",https://www.prnewswire.com/news-releases/baby-products-market-to-be-worth-352-65-billion-by-2030-grand-view-research-inc-301739176.html,2023-02-06 10:30:00,Baby Products Market to be Worth $352.65 Billion by 2030: Grand ... PR ...,JNJ,0.068698,0.050428,Neutral
Addex Strategic Partner Completes Enrollment in ADX71149 Epilepsy Phase 2 Study Part 1,https://www.globenewswire.com/news-release/2023/02/06/2601761/0/en/Addex-Strategic-Partner-Completes-Enrollment-in-ADX71149-Epilepsy-Phase-2-Study-Part-1.html,2023-02-06 06:00:00,Ad Hoc Announcement Pursuant to Art. 53 LR ...,JNJ,0.074692,0.066736,Neutral
"2 Reasons to Buy Johnson & Johnson, and 2 Reasons to Sell",https://www.fool.com/investing/2023/02/05/2-reasons-to-buy-johnson-johnson-2-reason-to-sell/,2023-02-05 14:53:00,"If you're interested in a passive income stock, it's among the most reliable.",JNJ,0.244846,0.250085,Somewhat-Bullish
1 Resilient Blue Chip Stock to Buy on the Dip,https://www.fool.com/investing/2023/02/05/1-resilient-blue-chip-stock-to-buy-on-the-dip/,2023-02-05 13:20:00,You don't stay in business for decades unless you are doing something right.,JNJ,0.685724,0.155395,Somewhat-Bullish
"SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fate Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - FATE - Fate Therapeutics  ( NASDAQ:FATE ) ",https://www.benzinga.com/pressreleases/23/02/g30720185/shareholder-alert-pomerantz-law-firm-reminds-shareholders-with-losses-on-their-investment-in-fate-,2023-02-04 23:19:48,"NEW YORK, Feb. 04, 2023 ( GLOBE NEWSWIRE ) -- Pomerantz LLP announces that a class action lawsuit has been filed against certain officers and directors of Fate Therapeutics, Inc. ( ""Fate"" or the ""Company"" ) FATE. The class action, filed in the United States District Court for the Southern ...",JNJ,0.053271,0.019989,Neutral
These 2 dividend-stock ETFs are more like growth funds in disguise. Can either still work in your income portfolio?,https://www.marketwatch.com/story/these-2-dividend-stock-etfs-are-more-like-growth-funds-in-disguise-can-either-still-work-in-your-income-portfolio-11675089272,2023-02-04 13:32:00,Quality-stock and dividend-focused strategies shined during the market declines of 2022. One such fund is also designed to perform well in all markets.,JNJ,0.129342,0.210216,Somewhat-Bullish
2 Stocks Down More Than 6% to Buy Right Now,https://www.fool.com/investing/2023/02/04/2-stocks-down-more-than-6-to-buy-right-now/,2023-02-04 13:30:00,These companies outperformed the market last year.,JNJ,0.16171,-0.044952,Neutral
3 Unstoppable Dividend Stocks to Buy in February,https://www.fool.com/investing/2023/02/04/3-unstoppable-dividend-stocks-to-buy-in-february/,2023-02-04 12:45:00,All three belong to the elite group of stocks known as Dividend Kings.,JNJ,0.263467,-0.024967,Neutral
"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bioventus, ESS, IBM, and FATE and Encourages Investors to Contact the Firm - Fate Therapeutics  ( NASDAQ:FATE ) , Bioventus  ( NASDAQ:BVS ) ",https://www.benzinga.com/pressreleases/23/02/g30717789/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-biove,2023-02-04 02:00:00,"NEW YORK, Feb. 03, 2023 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Bioventus Inc. BVS, ESS Tech, Inc.",JNJ,0.017269,0.017436,Neutral
"Healthcare education solutions market recorded 8.25% growth between 2021 and 2022; Insights on top countries such as the UK, among others - Technavio",https://www.prnewswire.com/news-releases/healthcare-education-solutions-market-recorded-8-25-growth-between-2021-and-2022-insights-on-top-countries-such-as-the-uk-among-others--technavio-301736018.html,2023-02-04 01:00:00,Healthcare education solutions market recorded 8.25% growth ... PR ...,JNJ,0.04497,-0.018743,Neutral
First Look at Data on Biosense Webster's Investigational Pulsed Field Ablation Platform Presented at AF Symposium 2023,https://www.prnewswire.com/news-releases/first-look-at-data-on-biosense-websters-investigational-pulsed-field-ablation-platform-presented-at-af-symposium-2023-301738792.html,2023-02-04 00:04:00,First Look at Data on Biosense Webster's Investigational Pulsed ... PR ...,JNJ,0.298023,0.225294,Somewhat-Bullish
Late Breaking Data on Pulmonary Vein Isolation with HELIOSTARâ„¢ Balloon Ablation Catheter Presented at AF Symposium 2023,https://www.prnewswire.com/news-releases/late-breaking-data-on-pulmonary-vein-isolation-with-heliostar-balloon-ablation-catheter-presented-at-af-symposium-2023-301738674.html,2023-02-03 23:30:00,Late Breaking Data on Pulmonary Vein Isolation with HELIOSTAR ... PR ...,JNJ,0.318897,0.235546,Somewhat-Bullish
Wound Dressing Market will manage to achieve USD 20.52 billion by 2030 : GreyViews,https://www.benzinga.com/pressreleases/23/02/g30712096/wound-dressing-market-will-manage-to-achieve-usd-20-52-billion-by-2030-greyviews,2023-02-03 19:00:00,"Pune India, Feb. 03, 2023 ( GLOBE NEWSWIRE ) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa. These are the key regions where the wound dressing market is operating and is ...",JNJ,0.021679,0.098041,Neutral
U.S. military members suing 3M seek dismissal of subsidiary's bankruptcy,https://www.reuters.com/business/us-military-members-suing-3m-seek-dismissal-subsidiarys-bankruptcy-2023-02-03/,2023-02-03 17:55:00,U.S. military members suing 3M seek dismissal of subsidiary's ... ...,JNJ,0.073773,-0.271296,Somewhat-Bearish
PFE: The Safest Stock to Buy on Wall Street Right Now,https://stocknews.com/news/pfe-jnj-abbv-bmy-the-safest-stock-to-buy-on-wall-street-right-now/,2023-02-03 16:59:24,"While a 25-bps interest-rate hike announced on Wednesday by the Federal Reserve Chair Jerome Powell hardly came as a surprise, market participants seem to have gone overboard over a simple acknowledgment that inflation ""has eased somewhat"" and ""the disinflationary process"" had started.",JNJ,0.080188,0.0,Neutral
Veterans Suing Over 3M Earplugs Want Bankruptcy Case Tossed,https://www.wsj.com/articles/veterans-suing-over-3m-earplugs-want-bankruptcy-case-tossed-11675443182,2023-02-03 16:53:00,Plaintiffs say a ruling on the Johnson & Johnson talc case supports their opposition to 3M's plan for settling claims.,JNJ,0.310843,-0.338669,Somewhat-Bearish
3 Dow Stocks That Make for Screaming Buys in February,https://www.fool.com/investing/2023/02/03/3-dow-stocks-make-for-screaming-buys-in-february/,2023-02-03 10:06:00,"Out of the Dow Jones Industrial Average's 30 components, there are three amazing deals hiding in plain sight.",JNJ,0.188437,0.120545,Neutral
Johnson & Johnson to Participate in the Cowen 43rd Annual HealthCare Conference,https://investingnews.com/johnson-johnson-to-participate-in-the-cowen-43rd-annual-healthcare-conference/,2023-02-02 21:55:01,"Johnson & Johnson ( NYSE: JNJ ) will participate in the Cowen 43 rd Annual HealthCare Conference on Tuesday, March 7 th , at the Boston Marriott Copley Place, Boston, MA. Joseph J. Wolk, Executive Vice President and Chief Financial Officer will represent the Company in a session scheduled at ...",JNJ,0.879272,0.228601,Somewhat-Bullish
Merck  ( MRK )  Q4 2022 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/02/02/merck-mrk-q4-2022-earnings-call-transcript/,2023-02-02 19:30:29,"MRK earnings call for the period ending December 31, 2022.",JNJ,0.00512,0.145514,Neutral
"Johnson & Johnson's Upcoming Lung Cancer Data Could Offer Another Blockbuster Opportunity, Says Analyst - Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/analyst-ratings/analyst-color/23/02/30693552/johnson-johnsons-upcoming-lung-cancer-data-could-offer-another-blockbuster-opportun,2023-02-02 18:21:22,Cantor Fitzgerald is previewing its thoughts on a potential interim analysis for Johnson & Johnson's JNJ Phase 3 MARIPOSA study of Rybrevant ( amivantamab ) + lazertinib in first-line epidermal growth factor receptor ( EGFR ) mutation ( Ex19del or L858R ) positive nonsmall cell lung cancer ( ...,JNJ,0.561184,0.331914,Somewhat-Bullish
"Depression treatments haven't changed much in decades. Here are the promising new drugs that could be more precise, work faster, and help more people.",https://www.businessinsider.com/new-drugs-depression-treatments-auvelity-zuranolone-biomarkers-psychedelics-2023-2,2023-02-02 16:43:38,Depression Drugs That Could Revolutionize Treatment: Auvelity ... - Business Insider ...,JNJ,0.043979,-0.035998,Neutral
"Genscript Bio Gets Booster From Subsidiary's New Cancer Drug - Legend Biotech  ( NASDAQ:LEGN ) , Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/23/02/30691329/genscript-bio-gets-booster-from-subsidiarys-new-cancer-drug,2023-02-02 16:00:18,"After years of losses, Legend Biotech's new cancer drug Cavykti offers it a chance to finally start contributing revenue to its parent, Genscript Biotech Some analysts believe Genscript may have become profitable last year, but also worry over its mounting R&D and sales expenses",JNJ,0.114682,0.168368,Somewhat-Bullish
Wound Cleanser Products Market will surpass USD 2.08 billion by 2030 at a CAGR of 2.5% : GreyViews,https://www.benzinga.com/pressreleases/23/02/g30689608/wound-cleanser-products-market-will-surpass-usd-2-08-billion-by-2030-at-a-cagr-of-2-5-greyviews,2023-02-02 15:00:00,"Pune India, Feb. 02, 2023 ( GLOBE NEWSWIRE ) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa. These are the key regions where the wound cleanser products market is operating ...",JNJ,0.020686,0.02841,Neutral
Is A Rise Imminent For Johnson & Johnson Stock After An 8% Fall In A Month?,https://www.forbes.com/sites/greatspeculations/2023/02/02/is-a-rise-imminent-for-johnson--johnson-stock-after-an-8-fall-in-a-month/,2023-02-02 14:00:00,"Johnson & Johnson stock (NYSE: JNJ) is down 8% in a month, underperforming the broader markets, with the S&P 500 index up 6%.",JNJ,0.628066,-0.050886,Neutral
Looking for a Reliable Dividend Payer? Consider Buying This Blue-Chip Stock,https://www.fool.com/investing/2023/02/02/looking-for-a-reliable-dividend-payer-consider-jnj/,2023-02-02 13:59:49,This company has the most impressive dividend growth streak in the entire healthcare sector.,JNJ,0.101367,0.133438,Neutral
3 Vanguard ETFs That Could Help You Retire a Millionaire,https://www.fool.com/investing/2023/02/02/3-vanguard-etfs-that-could-help-you-retire-a-milli/,2023-02-02 13:40:00,"Whether you need accelerate the growth of your nest egg or protect its value, there's an exchange-traded fund for you.",JNJ,0.055621,0.083868,Neutral
3 Dividend Stocks to Buy in 2023 for a Lifetime of Passive Income,https://www.fool.com/investing/2023/02/02/3-dividend-stocks-buy-2023-lifetime-passive-income/,2023-02-02 12:45:00,"If you buy these passive-income machines now, you could build a fortune.",JNJ,0.336852,0.370114,Bullish
Is Johnson & Johnson Stock Worth Buying on the Dip?,https://www.fool.com/investing/2023/02/02/is-johnson-johnson-stock-worth-buying-on-the-dip/,2023-02-02 11:20:00,The healthcare giant's stock is facing headwinds.,JNJ,0.355588,-0.143779,Neutral
"This Low-Risk ETF Can Turn $39,000 Into $1 Million in 25 Years",https://www.fool.com/investing/2023/02/02/this-low-risk-etf-can-turn-39000-into-1-million-in/,2023-02-02 11:10:00,Funneling money into this fund can drastically simplify your investing strategy.,JNJ,0.069697,0.173953,Somewhat-Bullish
Merck Earnings Are Coming. What to Watch For.,https://www.barrons.com/articles/merck-earnings-stock-price-guidance-51675286601,2023-02-01 21:24:00,Merck Reports Earnings Thursday. What to Expect. ...,JNJ,0.615462,0.086483,Neutral
Skin Care Products Market will manage to achieve USD 163.45 billion by 2030 : GreyViews,https://www.benzinga.com/pressreleases/23/02/g30674172/skin-care-products-market-will-manage-to-achieve-usd-163-45-billion-by-2030-greyviews,2023-02-01 19:00:00,"Pune India, Feb. 01, 2023 ( GLOBE NEWSWIRE ) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa. These are the key regions where the skin care products market is operating and is ...",JNJ,0.023885,0.218608,Somewhat-Bullish
JNJ: 3 Reliable Stocks That Could Help You Make Money in 2023,https://stocknews.com/news/jnj-nvs-lcnb-3-reliable-stocks-that-could-help-you-make-money-in/,2023-02-01 18:29:30,JNJ: 3 Reliable Stocks That Could Help You Make Money in ...,JNJ,0.276179,0.292816,Somewhat-Bullish
JNJ: 3 Stocks Every Smart Investor Should Own in 2023,https://stocknews.com/news/jnj-kr-bvh-3-stocks-every-smart-investor-should-own-in-2023/,2023-02-01 17:20:07,JNJ: 3 Stocks Every Smart Investor Should Own in ...,JNJ,0.235823,0.179879,Somewhat-Bullish
An Increase In Investments In The R&D Of Autoimmune Disease Drugs Is Expected To Drive The Autoimmune Treatment Market As Per The Business Research Company's Autoimmune Treatment Global Market Report 2023,https://www.benzinga.com/pressreleases/23/02/g30671480/an-increase-in-investments-in-the-r-d-of-autoimmune-disease-drugs-is-expected-to-drive-the-autoimm,2023-02-01 16:30:00,"LONDON, Feb. 01, 2023 ( GLOBE NEWSWIRE ) -- The Business Research Company's research on the ""Autoimmune Treatment Market"" forecasts the global autoimmune treatment market size to grow from $6 billion in 2022 to $6.8 billion in 2023 at a compound annual growth rate ( CAGR ) of more than 12%.",JNJ,0.050572,-0.049564,Neutral
"Drug/Biotech Stocks Q4 Earnings Due on Feb 2: GILD, MRK & Others",https://www.zacks.com/stock/news/2047789/drugbiotech-stocks-q4-earnings-due-on-feb-2-gild-mrk-others,2023-02-01 15:44:00,Let's look at the four biotech/pharma companies slated to release quarterly results on Feb 2.,JNJ,0.043421,-0.131538,Neutral
"ARHT Beams Entrepreneur and Best-Selling Author Salim Ismail from NYC to Bogota to Deliver Keynote Address to the Chamber of Commerce of BogotÃ¡, Colombia - the Sixth Major Event with HiCue Speakers",https://www.benzinga.com/pressreleases/23/02/g30667544/arht-beams-entrepreneur-and-best-selling-author-salim-ismail-from-nyc-to-bogota-to-deliver-keynote,2023-02-01 14:13:50,"TORONTO, Feb. 01, 2023 ( GLOBE NEWSWIRE ) -- ARHT Media Inc. ( ""ARHT"" or ""the Company"" ) ART, the global leader in the development, production and distribution of high-quality, low latency hologram and 3D interactive content, today announced that it will beam entrepreneur and best-selling author ...",JNJ,0.033846,0.140627,Neutral
"ARHT Beams Entrepreneur and Best-Selling Author Salim Ismail from NYC to Bogota to Deliver Keynote Address to the Chamber of Commerce of BogotÃ¡, Colombia - the Sixth Major Event with HiCue Speakers",https://www.globenewswire.com/news-release/2023/02/01/2599609/0/en/ARHT-Beams-Entrepreneur-and-Best-Selling-Author-Salim-Ismail-from-NYC-to-Bogota-to-Deliver-Keynote-Address-to-the-Chamber-of-Commerce-of-Bogot%C3%A1-Colombia-the-Sixth-Major-Event-with-.html,2023-02-01 14:13:00,"TORONTO, Feb. 01, 2023 ( GLOBE NEWSWIRE ) -- ARHT Media Inc. ( ""ARHT"" or ""the Company"" ) ( TSXV: ART ) , the global leader in the development, production and distribution of high-quality, low latency hologram and 3D interactive content, today announced that it will beam entrepreneur and ...",JNJ,0.034332,0.146798,Neutral
"BioStem Technologies Poised for Growth with Two New Hires: Michael Sylvester Joins as Vice President of Sales, Neal Bhattacharya as Vice President of Marketing",https://www.globenewswire.com/news-release/2023/02/01/2599330/0/en/BioStem-Technologies-Poised-for-Growth-with-Two-New-Hires-Michael-Sylvester-Joins-as-Vice-President-of-Sales-Neal-Bhattacharya-as-Vice-President-of-Marketing.html,2023-02-01 12:30:00,"POMPANO BEACH, FLORIDA., Feb. 01, 2023 ( GLOBE NEWSWIRE ) -- BioStem Technologies Inc. ( ""BioStem"" or the ""Company ) ( OTCQB: BSEM ) , a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived tissue allografts for advanced wound ...",JNJ,0.066414,0.0671,Neutral
3 Stocks You Can Confidently Buy in a Market Downturn,https://www.fool.com/investing/2023/02/01/stocks-you-can-confidently-buy-market-downturn/,2023-02-01 11:05:00,"Investors can get a strong performance out of these stocks, even in a bear market.",JNJ,0.171181,0.214745,Somewhat-Bullish
3 Warren Buffett Stocks to Buy Hand Over Fist in February,https://www.fool.com/investing/2023/02/01/3-warren-buffett-stock-buy-hand-over-fist-february/,2023-02-01 10:06:00,Three plain-as-day bargains are hiding in plain sight among Berkshire Hathaway's roughly four dozen holdings.,JNJ,0.182736,0.018309,Neutral
"Earnings Roundup: Tesla, Intel, Chevron, and More",https://www.fool.com/investing/2023/01/31/earnings-roundup-tesla-intel-chevron-and-more/,2023-02-01 01:26:00,"Plus, Corrado Russo, head of global securities at Hazelview Investments, shares some insight for real estate investors.",JNJ,0.041548,0.066455,Neutral
J&J Faces Longer Path to Resolving Talc Lawsuits After Appeals Court Defeat,https://www.wsj.com/articles/j-j-faces-longer-path-to-resolving-talc-lawsuits-after-appeals-court-defeat-11675200131,2023-01-31 21:22:00,"The company's court loss over baby-powder litigation could force it to defend thousands of lawsuits case by case, just as it navigates the biggest restructuring in its 137-year history.",JNJ,0.407844,-0.260158,Somewhat-Bearish
VTV: The 3 Top ETFs to Purchase in 2023,https://stocknews.com/news/vtv-iwd-xle-the-3-top-etfs-to-purchase-in-2023/,2023-01-31 18:49:46,VTV: The 3 Top ETFs to Purchase in ...,JNJ,0.158519,0.110726,Neutral
The end of the Covid health emergency won't slow FDA clearance of shots and treatments,https://www.cnbc.com/2023/01/31/covid-fda-clearance-of-covid-shots-and-treatments-wont-slow-with-end-of-public-health-emergency.html,2023-01-31 18:32:32,"The FDA has used separate emergency powers to authorize the Pfizer, Moderna, Johnson & Johnson and Novavax vaccines.",JNJ,0.078354,-0.070659,Neutral
"Jim Cramer's Investing Club meeting Tuesday: Caterpillar, J&J, Humana",https://www.cnbc.com/2023/01/31/jim-cramers-investing-club-meeting-tuesday-caterpillar-jj-humana.html,2023-01-31 16:51:10,"The Investing Club holds its ""Morning Meeting"" every weekday at 10:20 a.m. ET.",JNJ,0.520477,0.24617,Somewhat-Bullish
J&J  ( JNJ )  Down as Court Rejects Bankruptcy Claim in Talc Lawsuits,https://www.zacks.com/stock/news/2047102/jj-jnj-down-as-court-rejects-bankruptcy-claim-in-talc-lawsuits,2023-01-31 15:52:00,"A federal appeals court rejects J&J's (JNJ) efforts to shift over 38,000 lawsuits related to its talcum-based baby powder out of trial courts and into bankruptcy court.",JNJ,0.172507,-0.087151,Neutral
"Company News for Jan 31, 2023",https://www.zacks.com/stock/news/2046962/company-news-for-jan-31-2023,2023-01-31 14:34:00,"Companies in The News Are: F, ...",JNJ,0.690822,-0.624395,Bearish
We're buying up more shares of this pharmaceuticals play on weakness,https://www.cnbc.com/2023/01/31/were-buying-up-more-shares-of-this-pharma-play-on-weakness-.html,2023-01-31 14:09:41,The Club is adding to our position in a key holding as its share price drops.,JNJ,0.291471,0.058183,Neutral
GrowthSpace Expands Leadership Team to Drive US Commercial Expansion,https://www.prnewswire.com/news-releases/growthspace-expands-leadership-team-to-drive-us-commercial-expansion-301734773.html,2023-01-31 14:00:00,GrowthSpace Expands Leadership Team to Drive US Commercial ... PR ...,JNJ,0.095899,0.278757,Somewhat-Bullish
GrowthSpace Expands Leadership Team to Drive US Commercial Expansion,https://www.prnewswire.com/il/news-releases/growthspace-expands-leadership-team-to-drive-us-commercial-expansion-301734773.html,2023-01-31 14:00:00,GrowthSpace Expands Leadership Team to Drive US Commercial ... PR ...,JNJ,0.095899,0.278757,Somewhat-Bullish
"The daily business briefing: January 31, 2023",https://theweek.com/briefing/business-briefing/1020533/the-daily-business-briefing-january-31-2023,2023-01-31 12:33:05,"Ford Motor Co. announced Monday it was cutting prices on its Mustang Mach-E electric crossover vehicles by up to $5,000.",JNJ,0.062597,-0.22143,Somewhat-Bearish
KemPharm Enhances Senior Management Team,https://www.globenewswire.com/news-release/2023/01/31/2598307/16626/en/KemPharm-Enhances-Senior-Management-Team.html,2023-01-31 12:30:00,"Daniel Gallo, Ph.D., Appointed Senior Vice President of Medical Affairs and Advocacy ...",JNJ,0.051111,0.066741,Neutral
KemPharm Enhances Senior Management Team,https://www.benzinga.com/pressreleases/23/01/g30639493/kempharm-enhances-senior-management-team,2023-01-31 12:30:00,"Daniel Gallo, Ph.D., Appointed Senior Vice President of Medical Affairs and Advocacy Abbi Maher, J.D., Named Vice President of Legal Affairs CELEBRATION, Fla., Jan. 31, 2023 ( GLOBE NEWSWIRE ) -- KemPharm, Inc.",JNJ,0.047559,0.065405,Neutral
"You have to actually be broke to file for bankruptcy, a court tells J&J",https://www.axios.com/2023/01/31/johnson-johnson-jj-third-circuit-ltl-talc-bankruptcy,2023-01-31 12:18:33,Johnson & Johnson talc bankruptcy case rejected: Must be broke ... ...,JNJ,0.054483,-0.041027,Neutral
Flagship Pioneering Announces Appointment of Christian Schade as Growth Partner,https://www.prnewswire.com/news-releases/flagship-pioneering-announces-appointment-of-christian-schade-as-growth-partner-301733853.html,2023-01-31 12:00:00,Flagship Pioneering Announces Appointment of Christian Schade ... PR ...,JNJ,0.054857,-0.016984,Neutral
Is Visa Stock a Buy?,https://www.fool.com/investing/2023/01/31/is-visa-stock-a-buy/,2023-01-31 10:05:00,"The payments processor enjoys strong growth when the economy is stable, leading to steady stock growth as well.",JNJ,0.100941,0.15592,Somewhat-Bullish
Idorsia submits European marketing authorisation application for aprocitentan for the treatment of patients with resistant hypertension,https://www.globenewswire.com/news-release/2023/01/31/2598042/0/en/Idorsia-submits-European-marketing-authorisation-application-for-aprocitentan-for-the-treatment-of-patients-with-resistant-hypertension.html,2023-01-31 06:00:00,"Allschwil, Switzerland - January 31, 2023 Idorsia Ltd ( SIX: IDIA ) today announced that it has submitted a marketing authorisation application ( MAA ) to the European Medicines Agency ( EMA ) for aprocitentan, Idorsia's investigational, novel dual endothelin receptor antagonist, for the ...",JNJ,0.035529,0.02783,Neutral
2 Best Buffett Stocks to Buy for the Long Haul,https://www.fool.com/investing/2023/02/19/2-best-buffett-stocks-to-buy-for-the-long-haul/,2023-02-19 12:15:00,Warren Buffett is known for picking great businesses.,JNJ,0.183895,0.13216,Neutral
3 Dow Stocks You Can Confidently Buy Now and Hold Forever,https://www.fool.com/investing/2023/02/19/3-dow-stocks-you-can-buy-now-and-hold-forever/,2023-02-19 10:21:00,"These highly profitable, time-tested companies can make their shareholders significantly richer over time.",JNJ,0.210405,0.048609,Neutral
The United States Orthopedic Imaging Modalities and Orthopedic Surgical Navigation Systems Industry is Expected to Reach $3.9 Billion by 2031: Technological Advancements in Imaging Drives Growth,https://www.prnewswire.com/news-releases/the-united-states-orthopedic-imaging-modalities-and-orthopedic-surgical-navigation-systems-industry-is-expected-to-reach-3-9-billion-by-2031-technological-advancements-in-imaging-drives-growth-301749857.html,2023-02-17 19:10:00,The United States Orthopedic Imaging Modalities and Orthopedic ... PR ...,JNJ,0.036983,0.117481,Neutral
Bladder Cancer Drugs Global Market Report 2023,https://www.prnewswire.com/news-releases/bladder-cancer-drugs-global-market-report-2023-301749125.html,2023-02-17 16:50:00,"NEW YORK, Feb. 17, 2023 /PRNewswire/ --Major players in the bladder cancer drugs market are Pfizer, Celgene Corporation, Eli Lilly, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Sanofi, Hoffmann-La Roche, Novartis International and Johnson & Johnson.",JNJ,0.031529,-0.124665,Neutral
Nutraceutical Ingredients Market to be Proliferated by Higher Prevalence in Chronic Diseases,https://www.benzinga.com/pressreleases/23/02/g30960183/nutraceutical-ingredients-market-to-be-proliferated-by-higher-prevalence-in-chronic-diseases,2023-02-17 14:15:25,"London, Feb. 17, 2023 ( GLOBE NEWSWIRE ) -- In recent years, there has been a steady increase in the prevalence of chronic diseases around the world.",JNJ,0.046724,0.057404,Neutral
Should Income Investors Buy This Dow Jones Stock?,https://www.fool.com/investing/2023/02/17/should-income-investors-buy-this-dow-jones-stock/,2023-02-17 14:15:00,This drugmaker boasts an impressive product portfolio and pipeline.,JNJ,0.136888,0.0,Neutral
JNJ: The 3 Best Pharma Stocks to Buy for Big Gains in 2023,https://stocknews.com/news/jnj-abbv-nvs-the-3-best-pharma-stocks-to-buy-for-big-gains/,2023-02-17 13:29:28,JNJ: The 3 Best Pharma Stocks to Buy for Big Gains in ...,JNJ,0.272408,0.066714,Neutral
SpinCos are the new SPACs | Business,https://www.cnn.com/2023/02/17/investing/premarket-stocks-trading/index.html,2023-02-17 12:39:00,SpinCos are the new ...,JNJ,0.041181,0.056195,Neutral
JNJ: The 3 Best Stocks to Buy Now for Long-Term Investors,https://stocknews.com/news/jnj-pfe-wmt-the-3-best-stocks-to-buy-now-for-long-term-investors/,2023-02-17 11:51:16,"Inflation for January 2023 increased 6.4% year-over-year, higher than the consensus estimate of 6.2%. Stubbornly high prices have increased the odds of continued rate hikes this year. Goldman Sachs expects the U.S. Federal Reserve to raise interest rates three more times in 2023 by 25 bps each.",JNJ,0.3907,0.211426,Somewhat-Bullish
2 Warren Buffett Stocks to Buy Hand Over Fist and Hold for 30 Years or More,https://www.fool.com/investing/2023/02/17/2-warren-buffett-stocks-to-buy-hand-over-fist-and/,2023-02-17 11:30:00,Johnson & Johnson and Apple both have the economic moats and powerful brands that Buffett craves.,JNJ,0.221819,0.28896,Somewhat-Bullish
3 Exceptional Dividend Stocks to Buy Right Now,https://www.fool.com/investing/2023/02/17/3-exceptional-dividend-stocks-to-buy-right-now/,2023-02-17 10:30:00,These stocks can add to your returns -- no matter what the stock itself or the general market is doing.,JNJ,0.106305,0.0,Neutral
7 internships that will pay you to film and post TikToks,https://www.businessinsider.com/paid-tiktok-internships-create-film-edit-videos-for-brands,2023-02-16 20:25:55,"â€¢ As the creator economy grows, so does the number of companies looking for candidates who know TikTok. â€¢ Insider found currently listed internships that require skills in brainstorming, filming, editing, and posting TikToks. â€¢ Most are paid, but pay was not disclosed on all the listings, and ...",JNJ,0.038101,0.138572,Neutral
EXL earns gold medal rating for sustainability efforts by EcoVadis,https://www.globenewswire.com/news-release/2023/02/16/2609791/9060/en/EXL-earns-gold-medal-rating-for-sustainability-efforts-by-EcoVadis.html,2023-02-16 13:33:00,"NEW YORK, Feb. 16, 2023 ( GLOBE NEWSWIRE ) -- EXL [NASDAQ: EXLS], a leading data analytics and digital operations and solutions company, announced that it has been awarded a gold medal sustainability rating from EcoVadis, the leading assessment platform for environmental, social, and ethical ...",JNJ,0.042953,0.24424,Somewhat-Bullish
"Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2022 and Provides Financial Expectations for 2023",https://www.prnewswire.com/news-releases/alkermes-plc-reports-financial-results-for-the-fourth-quarter-and-year-ended-dec-31-2022-and-provides-financial-expectations-for-2023-301748314.html,2023-02-16 12:00:00,Alkermes plc Reports Financial Results for the Fourth Quarter and ... PR ...,JNJ,0.024852,0.152948,Somewhat-Bullish
One of the World's Richest Investors Just Sent an Ominous Warning to Wall Street,https://www.fool.com/investing/2023/02/16/worlds-richest-investors-sent-warning-wall-street/,2023-02-16 10:21:00,This billionaire hedge fund manager foresees two difficult years ahead for stocks and the U.S. economy.,JNJ,0.085173,0.05992,Neutral
Virtualware to be Listed on the Paris Stock Exchange,https://www.benzinga.com/pressreleases/23/02/g30937610/virtualware-to-be-listed-on-the-paris-stock-exchange,2023-02-16 07:51:43,"BILBAO, Spain, Feb. 16, 2023 ( GLOBE NEWSWIRE ) -- Spanish technology company Virtualware, one of the European leaders in the virtual reality industry, will be listed on the Paris Stock Exchange in the coming weeks.",JNJ,0.077343,0.051578,Neutral
Analysis: Germany's oldest companies face fresh break-up calls,https://www.reuters.com/business/germanys-oldest-companies-face-fresh-break-up-calls-2023-02-16/,2023-02-16 05:05:00,"[1/4] The 3M Global Headquarters in Maplewood, Minnesota, U.S. is photographed on March 4, 2020. REUTERS/Nicholas Pfosi/File Photo",JNJ,0.055236,0.0,Neutral
"Fate Therapeutics, Inc.  ( FATE )  Class Action: Contact Robbins LLP for Information Regarding the Class Action and Lead Plaintiff Deadline - Fate Therapeutics  ( NASDAQ:FATE ) ",https://www.benzinga.com/pressreleases/23/02/g30931403/fate-therapeutics-inc-fate-class-action-contact-robbins-llp-for-information-regarding-the-class-ac,2023-02-15 19:59:43,"SAN DIEGO, Feb. 15, 2023 ( GLOBE NEWSWIRE ) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired shares of Fate Therapeutics, Inc.",JNJ,0.071784,-0.00203,Neutral
FDA panel weighs moving opioid antidote over the counter,https://apnews.com/article/business-medication-opioids-health-38ae986009788501bc418fe108593632,2023-02-15 17:03:45,WASHINGTON ( AP ) - U.S. health advisers on Wednesday were weighing whether the overdose-reversal drug naloxone should be made available as an over-the-counter medication to help fight the national opioid crisis.,JNJ,0.053749,-0.277928,Somewhat-Bearish
JNJ Terminates NASH Program Pact With Arrowhead Pharmaceuticals - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/general/biotech/23/02/30926495/jnj-terminates-nash-program-pact-with-arrowhead-pharmaceuticals,2023-02-15 16:29:56,"Arrowhead Pharmaceuticals Inc ARWR received written notice from Janssen, a unit of Johnson & Johnson JNJ, to terminate their rights to JNJ-75220795, now called ARO-PNPLA3, under the October 2018 research collaboration and option agreement.",JNJ,0.521465,0.307459,Somewhat-Bullish
3 Resilient Stocks to Help Solidify Your Portfolio in 2023,https://www.fool.com/investing/2023/02/15/3-resilient-stocks-to-help-solidify-your-portfolio/,2023-02-15 15:07:00,Choose companies with strong fundamentals that can withstand storms and continue to thrive.,JNJ,0.182162,0.006154,Neutral
"Got $10,000? Buy These 2 Market-Beating ETFs for the Long Haul",https://www.fool.com/investing/2023/02/15/got-10000-buy-these-2-market-beating-etfs-for-the/,2023-02-15 14:37:00,These exchange-traded funds have soundly beaten the S&P 500 over the past 10 years.,JNJ,0.063258,0.139111,Neutral
JNJ: 2 Stocks to Help You Sail Through This Volatile Market,https://stocknews.com/news/jnj-bmy-2-stocks-to-help-you-sail-through-this-volatile-market/,2023-02-15 13:16:54,"The Feds chose a less aggressive stance and dialed down rate hikes to 0.25 percentage points. This revived investor optimism. However, inflation reaccelerated in January, as the Consumer Price Index ( CPI ) rose 0.5% in January, translating to a 6.4% annual gain.",JNJ,0.411176,0.195706,Somewhat-Bullish
Metagenics Names Pat Smallcombe as New President and CEO,https://www.prnewswire.com/news-releases/metagenics-names-pat-smallcombe-as-new-president-and-ceo-301747207.html,2023-02-15 12:00:00,"ALISO VIEJO, Calif., Feb. 15, 2023 /PRNewswire/ -- Leading global nutritional supplement company Metagenics today announced it has named Pat Smallcombe, a current Board member and experienced industry executive, as President and CEO, effective February 13.",JNJ,0.074001,0.13626,Neutral
Worried About 2023? Park Your Money in These 2 Low-Volatility Dividend Stocks,https://www.fool.com/investing/2023/02/15/worried-2023-money-low-volatility-dividend-stock/,2023-02-15 10:25:00,These stocks are low-risk investments with dividends yielding more than 2%.,JNJ,0.479258,0.279722,Somewhat-Bullish
How a family's struggle to help their son gave rise to controversial $400 million psychedelics giant Compass Pathways,https://www.businessinsider.com/inside-compass-pathways-psychedelic-psilocybin-origin-story-2023-2,2023-02-15 10:00:00,Inside the Rise of Psychedelics Giant Compass Pathways - Business Insider ...,JNJ,0.016844,-0.013038,Neutral
"Johnson & Johnson Names Paula A. Johnson, President of Wellesley College, to its Board of Directors",https://investingnews.com/johnson-johnson-names-paula-a-johnson-president-of-wellesley-college-to-its-board-of-directors/,2023-02-14 22:05:54,"Johnson & Johnson ( NYSE: JNJ ) announced today that Paula A. Johnson, MD, MPH, President of Wellesley College, has been appointed to its Board of Directors.",JNJ,0.454174,0.622866,Bullish
Johnson & Johnson to Participate in the Barclays Global HealthCare Conference,https://investingnews.com/johnson-johnson-to-participate-in-the-barclays-global-healthcare-conference/,2023-02-14 14:11:36,"Johnson & Johnson ( NYSE: JNJ ) will participate in the Barclays Global HealthCare Conference on Tuesday, March 14 th , at the Loews Miami Beach Hotel, Miami Beach, Florida.",JNJ,0.879272,0.447293,Bullish
Johnson & Johnson  ( JNJ )  is Attracting Investor Attention: Here is What You Should Know,https://www.zacks.com/stock/news/2053958/johnson-johnson-jnj-is-attracting-investor-attention-here-is-what-you-should-know,2023-02-14 14:00:12,"Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",JNJ,0.474958,0.103108,Neutral
"""Giving Back: The Soul of Philanthropy Reframed and Exhibited"" Holds Ribbon Cutting",https://www.benzinga.com/pressreleases/23/02/n30898579/giving-back-the-soul-of-philanthropy-reframed-and-exhibited-holds-ribbon-cutting,2023-02-14 14:00:00,"Dramatic multi-media exhibition showcases the many faces of Black giving CHICAGO, Feb. 14, 2023 /PRNewswire/ -- Chicago African Americans in Philanthropy ( CAAIP ) hosted a ribbon cutting Feb. 2 for the outstanding multi-media photographic exhibition ""Giving Back: The Soul of Philanthropy ...",JNJ,0.21686,0.282646,Somewhat-Bullish
Better Buy: Johnson & Johnson or AbbVie?,https://www.fool.com/investing/2023/02/14/better-buy-johnson-johnson-or-abbvie/,2023-02-14 13:26:00,The healthcare giants are favored by income-oriented investors but have a potentially disruptive year ahead.,JNJ,0.470606,0.116561,Neutral
Parris Todd And Hunter Johnson Collect More Silverware At The APP Daytona Pickleball Open,https://www.forbes.com/sites/toddboss/2023/02/14/parris-todd-and-hunter-johnson-collect-more-silverware-at-the-app-daytona-pickleball-open/,2023-02-14 13:25:23,"More than 1,100 professionals and amateurs descended on Daytona Beach to compete in the Association of Pickleball Professionals Daytona Beach Open. Top-ranked APP pros Todd and Johnson continued their domination of the tour.",JNJ,0.025651,0.136471,Neutral
"Acurx is Setting a High Bar for New Treatments in C. diff - Johnson & Johnson  ( NYSE:JNJ ) , Finch Therapeutics Group  ( NASDAQ:FNCH ) ",https://www.benzinga.com/general/biotech/23/02/30896823/acurx-is-setting-a-high-bar-for-new-treatments-in-c-diff,2023-02-14 13:02:12,"Clostridioides difficile/Clostridium difficile ( C. diff ) is a bacterial infection and is the most common cause of healthcare-associated diarrhea. C. diff has two distinct presentations, primary and recurrent infection.",JNJ,0.085629,-0.042302,Neutral
4 Stock Market Sweethearts You'll Want to Call Your Own,https://www.fool.com/investing/2023/02/14/4-stock-market-sweethearts-youll-call-your-own/,2023-02-14 10:05:00,It's easy to fall in love with game-changing businesses.,JNJ,0.190417,0.075582,Neutral
Vertebroplasty and Kyphoplasty Market Is Expected to Reach $1.3 Billion by 2031: Allied Market Research,https://www.benzinga.com/pressreleases/23/02/g30893124/vertebroplasty-and-kyphoplasty-market-is-expected-to-reach-1-3-billion-by-2031-allied-market-resea,2023-02-14 09:41:05,"Portland, OR, Feb. 14, 2023 ( GLOBE NEWSWIRE ) -- According to the report published by Allied Market Research, the global Vertebroplasty And Kyphoplasty Market generated $757.1 million in 2021, and is estimated to reach $1.3 billion by 2031, witnessing a CAGR of 5.6% from 2022 to 2031.",JNJ,0.03704,0.053423,Neutral
"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Fate, Sotera, Argo, and National Vision and Encourages Investors to Contact the Firm - National Vision Holdings  ( NASDAQ:EYE ) , Argo Blockchain  ( NASDAQ:ARBK ) ",https://www.benzinga.com/pressreleases/23/02/g30891879/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-fate-,2023-02-14 02:00:00,"NEW YORK, Feb. 13, 2023 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Fate Therapeutics, Inc. FATE, Sotera Health Co. SHC, Argo Blockchain Plc, Inc.",JNJ,0.014648,0.017096,Neutral
"Johnson & Johnson names ex-Sanofi executive as pharma, R&D vice president",https://www.reuters.com/business/healthcare-pharmaceuticals/johnson-johnson-names-ex-sanofi-executive-pharma-rd-vice-president-2023-02-13/,2023-02-13 22:20:00,"Johnson & Johnson names ex-Sanofi executive as pharma, R&D ... ...",JNJ,0.451494,0.009148,Neutral
"Johnson & Johnson Appoints Dr. John Reed as Executive Vice President, Pharmaceuticals, R&D",https://investingnews.com/johnson-johnson-appoints-dr-john-reed-as-executive-vice-president-pharmaceuticals-rd/,2023-02-13 21:54:52,"Johnson & Johnson ( NYSE: JNJ ) ( the Company ) today announced the appointment of John Reed, M.D., Ph.D., to the Company's Executive Committee as Executive Vice President of Pharmaceuticals, R&D.",JNJ,0.500995,0.560809,Bullish
What Stocks To Buy Today? 2 Defensive Stocks To Know,https://stockmarket.com/featured/what-stocks-to-buy-today-2-defensive-stocks-to-know-2023-02-13,2023-02-13 15:16:19,The defensive sector is a group of industries and companies that are known to be less sensitive to economic downturns and market volatility. These industries and companies provide essential goods and services that are in constant demand. This comes regardless of the state of the economy.,JNJ,0.54816,0.071064,Neutral
"Time For SCOTUS To Set Meaningful Due-Process Standards For State ""UDAP"" Laws",https://www.forbes.com/sites/wlf/2023/02/13/time-for-scotus-to-set-meaningful-due-process-standards-for-state-udap-laws/,2023-02-13 15:04:31,"As soon as February 17, the U.S. Supreme Court will consider a certiorari petition urging review of a California court's $300 million penalty for violations of the state's ""unfair and deceptive acts and practices"" (UDAP) laws.",JNJ,0.070517,-0.134817,Neutral
"Windgap Medical Appoints Aaron Mann as CEO, Michael Samar as CFO",https://www.prnewswire.com/news-releases/windgap-medical-appoints-aaron-mann-as-ceo-michael-samar-as-cfo-301744227.html,2023-02-13 13:34:00,"Windgap Medical Appoints Aaron Mann as CEO, Michael Samar as ... PR ...",JNJ,0.066414,0.196621,Somewhat-Bullish
"Regenerative Medicine Market to Surpass USD 153.05 Billion by 2029, With 26.3% CAGR",https://www.benzinga.com/pressreleases/23/02/g30874563/regenerative-medicine-market-to-surpass-usd-153-05-billion-by-2029-with-26-3-cagr,2023-02-13 12:45:47,"Pune, India, Feb. 13, 2023 ( GLOBE NEWSWIRE ) -- The regenerative medicine market size was valued at USD 23.65 billion in 2021. The market is expected to grow from USD 29.86 billion in 2022 to USD 153.05 billion by 2029 with a CAGR of 26.3% during the forecast period.",JNJ,0.039548,0.0,Neutral
3 Supercharged Dividend Stocks to Buy if There's a Stock Market Sell-Off,https://www.fool.com/investing/2023/02/13/supercharged-dividend-stocks-buy-market-selloff/,2023-02-13 10:33:00,Income stocks can lend portfolio growth in both up and down markets.,JNJ,0.131643,0.0024,Neutral
"Global Outlook for Antacids Market | Growth rate at 4.5 percent during the forecast period, Regional Insights and Key Players",https://www.benzinga.com/pressreleases/23/02/g30872081/global-outlook-for-antacids-market-growth-rate-at-4-5-percent-during-the-forecast-period-regional-,2023-02-13 09:57:44,"NEW YORK, Feb. 13, 2023 ( GLOBE NEWSWIRE ) -- Maximize Market research, a global Healthcare market research firm, has published a competitive intelligence and market research report on the ""Antacids Market"".",JNJ,0.03319,-0.009406,Neutral
SciBase resolves on a fully guaranteed rights issue of approximately SEK 79.6 million,https://www.prnewswire.com/news-releases/scibase-resolves-on-a-fully-guaranteed-rights-issue-of-approximately-sek-79-6-million-301744897.html,2023-02-13 08:06:00,SciBase resolves on a fully guaranteed rights issue of approximately ... PR ...,JNJ,0.015695,0.159839,Somewhat-Bullish
JNJ Bought Up Biotech Stock MeiraGTx. It Sold Procept BioRobotics.,https://www.barrons.com/articles/jnj-biotech-stock-meiragtx-procept-2c46ad81,2023-02-13 08:00:00,"Johnson & Johnson recently increased an investment in an embattled biotech stock, and slashed a position in a maker of surgical robotics that rocketed last year. Johnson & Johnson ( ticker: JNJ ) more than doubled an investment in MeiraGTx Holdings ( MGTX ) , and more than halved a stake in ...",JNJ,0.944494,-0.038476,Neutral
This 7.3% Yielding Fund Runs Defense On Your Portfolio,https://www.forbes.com/sites/michaelfoster/2023/02/11/this-73-yielding-fund-runs-defense-on-your-portfolio/,2023-02-11 13:55:00,"With the markets off to a hot start so far this year, it's only natural to think things just might be getting a little toppy.",JNJ,0.09347,0.168709,Somewhat-Bullish
"Buy these 10 stocks right now to earn steady income from dividends and gain exposure to AI while preparing your portfolio for a long recession, according to a veteran strategist",https://www.businessinsider.com/investing-stock-picks-artificial-intelligence-ai-tech-recession-outlook-strategist-2023-2,2023-02-11 11:30:00,"10 Top Stock Picks for AI, Dividends As Markets Fall: Strategist - Business Insider ...",JNJ,0.128478,0.038064,Neutral
"Buy these 10 stocks right now to earn steady income from dividends and gain exposure to AI while preparing your portfolio for a long recession, according to a veteran strategist",https://markets.businessinsider.com/news/stocks/investing-stock-picks-artificial-intelligence-ai-tech-recession-outlook-strategist-2023-2,2023-02-11 11:30:00,"â€¢ However, investors can profit by targeting companies in defensive sectors and technology. â€¢ Here are 10 stocks to buy now for strong dividends or exposure to trends like AI. US stocks are off to a stronger start in 2023 than almost anyone on Wall Street expected.",JNJ,0.128478,0.038064,Neutral
3 Warren Buffett Stocks to Buy and Hold,https://www.fool.com/investing/2023/02/11/3-warren-buffett-stocks-to-buy-in-february/,2023-02-11 10:17:00,Adding shares of Berkshire Hathaway's top stocks to your equity portfolio could do wonders for your own performance.,JNJ,0.113062,0.196513,Somewhat-Bullish
Exclusive: Payments giant FIS prepares to break up-sources,https://www.reuters.com/business/finance/payments-giant-fis-prepares-break-up-sources-2023-02-11/,2023-02-11 00:22:00,Exclusive: Payments giant FIS prepares to break ...,JNJ,0.106541,-0.004564,Neutral
VOO: 3 Large-Cap Blend ETFs to Buy and Hold in 2023,https://stocknews.com/news/voo-vig-rsp-3-large-cap-blend-etfs-to-buy-and-hold-in-2023/,2023-02-10 18:43:57,VOO: 3 Large-Cap Blend ETFs to Buy and Hold in ...,JNJ,0.084423,0.114819,Neutral
Why Johnson & Johnson  ( JNJ )  is a Top Dividend Stock for Your Portfolio,https://www.zacks.com/stock/news/2052986/why-johnson-johnson-jnj-is-a-top-dividend-stock-for-your-portfolio,2023-02-10 16:45:06,"Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.",JNJ,0.442082,0.470454,Bullish
2 Top Stocks to Buy Without Hesitation in 2023,https://www.fool.com/investing/2023/02/10/2-top-stocks-to-buy-without-hesitation-in-2023/,2023-02-10 10:35:00,These healthcare giants have a long track record of enriching investors.,JNJ,0.156461,0.025288,Neutral
"Gynecological Devices Market [2023-2030], Industry Size, Share, Revenue, Key Players, CAGR, Demand and Sales Forecast",https://www.benzinga.com/pressreleases/23/02/g30850694/gynecological-devices-market-2023-2030-industry-size-share-revenue-key-players-cagr-demand-and-sal,2023-02-10 09:22:03,"Pune, India, Feb. 10, 2023 ( GLOBE NEWSWIRE ) -- As per Fortune Business Insights, the gynecological devices market is poised for growth in the coming years, driven by the increasing incidence of gynecological conditions and the growth of healthcare infrastructure.",JNJ,0.052455,0.0,Neutral
JNJ's Consumer Health Business Separation Will Remove Uncertainty Cloud From Company: Why This Analyst Wants Visibility - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/analyst-ratings/analyst-color/23/03/31135839/jnjs-consumer-health-business-separation-will-remove-uncertainty-cloud-from-company,2023-03-01 19:55:24,"Guggenheim initiated the coverage on Johnson & Johnson JNJ with a Neutral rating and a $161 price target. The analyst agrees with the company's decision to proceed with the Consumer Health separation and believes the MedTech segment is showing ""reasonable"" signs of recovery.",JNJ,0.830573,0.383187,Bullish
"FDA advisors recommend GSK's RSV vaccine for older adults, but flag potential safety risks",https://www.cnbc.com/2023/03/01/fda-advisors-recommend-gsks-rsv-vaccine-for-older-adults-but-flag-potential-safety-risks.html,2023-03-01 19:32:47,"A majority of the FDA panel said GSK's vaccine safety data was adequate, and the advisors were unanimous that the shot's efficacy was good.",JNJ,0.028937,-0.005597,Neutral
"SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fate Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - FATE - Fate Therapeutics  ( NASDAQ:FATE ) ",https://www.benzinga.com/pressreleases/23/03/g31135717/shareholder-alert-pomerantz-law-firm-reminds-shareholders-with-losses-on-their-investment-in-fate-,2023-03-01 18:42:28,"NEW YORK, March 01, 2023 ( GLOBE NEWSWIRE ) -- Pomerantz LLP announces that a class action lawsuit has been filed against certain officers and directors of Fate Therapeutics, Inc. ( ""Fate"" or the ""Company"" ) FATE. The class action, filed in the United States District Court for the Southern ...",JNJ,0.053629,0.019992,Neutral
"Jim Cramer Says He's Known Novavax Is 'Worthless' For 'Very Long Time,' Trashes Company For Being Too 'Promotional' - Novavax  ( NASDAQ:NVAX ) ",https://www.benzinga.com/general/biotech/23/03/31134429/jim-cramer-says-hes-known-novavax-is-worthless-for-very-long-time-trashes-company-for-being-too-p,2023-03-01 18:21:42,"Novavax Inc NVAX shares are crashing Wednesday after the company warned that substantial doubt exists regarding its ability to continue. ""I've been saying the thing is, not phony, but worthless for a very long time,"" Cramer said Wednesday on CNBC's ""Squawk On The Street.""",JNJ,0.268294,-0.078711,Neutral
"New Month, Old News? Stocks Retreat on Mixed Economic Data, China Signals - Tesla  ( NASDAQ:TSLA ) , Kohl's  ( NYSE:KSS ) ",https://www.benzinga.com/markets/23/03/31134116/new-month-old-news-stocks-retreat-on-mixed-economic-data-china-signals,2023-03-01 17:55:44,"( Wednesday market open ) The new month looked a lot like the old one early Wednesday as an overnight rally in stock futures pulled back ahead of the open. Recent rallies, including one that faded yesterday, haven't demonstrated staying power.",JNJ,0.035138,0.119016,Neutral
V: 3 S&P 500 Stocks to Buy If You Like Winning,https://stocknews.com/news/v-jnj-mrk-gs-abmd-imgo-3-sp-500-stocks-to-buy-if-you-like-winning/,2023-03-01 16:02:55,"Stronger-than-expected economic data, including solid job growth and a robust labor market in January, shows that the economy remains resilient, despite the Fed's interest rate hikes. After producing one of its worst returns in history last year, the S&P 500 could rebound sharply this year amid ...",JNJ,0.239436,0.174928,Somewhat-Bullish
Johnson & Johnson-Backed Antiviral Candidate Effectively Prevents Influenza Infection - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/general/biotech/23/03/31128534/johnson-johnson-backed-antiviral-candidate-effectively-prevents-influenza-infection,2023-03-01 15:54:12,Cidara Therapeutics Inc CDTX announced efficacy and safety data from a planned interim analysis of the ongoing Phase 2a trial evaluating the pre-exposure prophylactic activity of CD388 against the H3N2 influenza A virus strain.,JNJ,0.345674,0.255189,Somewhat-Bullish
"FATE's Q4 Loss Narrower Than Expected, Pipeline in Focus",https://www.zacks.com/stock/news/2060468/fates-q4-loss-narrower-than-expected-pipeline-in-focus,2023-03-01 14:59:00,FATE reports a narrower loss and higher collaboration revenues for the fourth quarter.,JNJ,0.097259,0.046281,Neutral
Is Medtronic Still a Great Dividend Stock?,https://www.fool.com/investing/2023/03/01/is-medtronic-still-a-great-dividend-stock/,2023-03-01 13:15:00,Innovation and consistent dividend increases attract investors.,JNJ,0.045396,0.126951,Neutral
Get a Dividend Every Month With These 3 Healthcare Stocks,https://www.fool.com/investing/2023/03/01/get-a-dividend-every-month-with-these-3-healthcare/,2023-03-01 12:59:00,"With a little planning, you can receive a dependable dividend payout every month.",JNJ,0.170576,0.111531,Neutral
2 Buffett-Approved Stocks to Ride Out the Next Recession,https://www.fool.com/investing/2023/03/01/2-buffett-approved-stocks-to-ride-out-recession/,2023-03-01 12:01:00,Both companies have survived many recessions in the past.,JNJ,0.461283,0.319681,Somewhat-Bullish
UNH: 3 Stocks to Buy Now if You Think a Bull Market Is on Its Way,https://stocknews.com/news/unh-jnj-crm-abmd-casy-3-stocks-to-buy-now-if-you-think-a-bull/,2023-03-01 10:59:06,"Amid speculation of easing inflation, booming economic data, and interest rate hikes concluding soon, the stock market kicked off with a strong start. However, amid anxieties over an impending Fed-induced recession, U.S. stocks closed out February in a subdued fashion.",JNJ,0.252463,0.186293,Somewhat-Bullish
"This Dividend Growth Stock Seemed Stable, But Just Suspended Its Payouts",https://www.fool.com/investing/2023/03/01/this-dividend-growth-stock-seemed-stable-but-just/,2023-03-01 10:57:00,Streaks can always be broken.,JNJ,0.238913,0.148707,Neutral
3 Warren Buffett Stocks Are Begging to Be Bought in March,https://www.fool.com/investing/2023/03/01/3-warren-buffett-stocks-begging-to-be-bought-march/,2023-03-01 10:06:00,These three stocks stand out as the best buys right now in Berkshire Hathaway's 49-security investment portfolio.,JNJ,0.150969,0.253193,Somewhat-Bullish
"Global Food Allergy Market Size Rise at 5.64% CAGR by 2030, Value to Cross US$ 54 Billion - Says Facts & Factors",https://www.benzinga.com/pressreleases/23/03/g31114880/global-food-allergy-market-size-rise-at-5-64-cagr-by-2030-value-to-cross-us-54-billion-says-facts-,2023-03-01 09:30:33,"NEW YORK, US, March 01, 2023 ( GLOBE NEWSWIRE ) -- ""[228+ Pages Report] According to the report published by Facts and Factors, the global food allergy market size was worth around USD 35 billion in 2021 and is predicted to grow to around USD 54 billion by 2030 with a compound annual growth rate ...",JNJ,0.023909,-0.197723,Somewhat-Bearish
Novavax Stock Plunges 25% As Vaccine Maker Has 'Substantial Doubt' About Staying In Business,https://www.forbes.com/sites/nicholasreimann/2023/02/28/novavax-stock-plunges-25-as-vaccine-maker-has-substantial-doubt-about-staying-in-business/,2023-03-01 00:21:49,Shares of the pharmaceutical company have slipped below $7 after trading well above $300 at points in 2021.,JNJ,0.089797,0.097184,Neutral
Jim Cramer says these three things can help you see through the market madness,https://www.cnbc.com/2023/02/28/jim-cramer-says-these-three-things-can-help-you-see-through-the-market-madness.html,2023-02-28 23:20:46,"""Put your emotions to the side and try to make reasonable decisions...without letting the irrational action infuriate you,"" said CNBC's Jim Cramer.",JNJ,0.100729,-0.013118,Neutral
Johnson & Johnson  ( JNJ )  Dips More Than Broader Markets: What You Should Know,https://www.zacks.com/stock/news/2060036/johnson-johnson-jnj-dips-more-than-broader-markets-what-you-should-know,2023-02-28 22:45:12,"Johnson & Johnson (JNJ) closed the most recent trading day at $153.26, moving -1.52% from the previous trading session.",JNJ,0.661658,0.226118,Somewhat-Bullish
"Emergent's  ( EBS )  Q4 Earnings Miss, Sales Beat Estimates",https://www.zacks.com/stock/news/2059947/emergents-ebs-q4-earnings-miss-sales-beat-estimates,2023-02-28 17:05:00,"Emergent (EBS) reported mixed fourth-quarter 2022 results. While the company significantly misses the mark on earnings, it beat sales estimates.",JNJ,0.086556,-0.096083,Neutral
JNJ: 3 Stocks to Help Grow Your Portfolio Over the Next Decade,https://stocknews.com/news/jnj-agco-ta-gs-bac-abmd-3-stocks-to-help-grow-your-portfolio-over-the-next/,2023-02-28 16:57:30,"With ongoing mania regarding the Fed's stance on monetary policy, this year's early rally seems to be fading out. While positive economic data depicts the economy's resilience, surprisingly high inflation has renewed fears of the Fed's potential interest rate hikes in the coming months.",JNJ,0.207967,0.208739,Somewhat-Bullish
Pulmonary Arterial Hypertension Market Worth  ( $10.88 Billion by 2028 )  Lead by Asia Pacific Region  ( 6.5% CAGR )  - Global Report by The Insight Partners,https://www.benzinga.com/pressreleases/23/02/g31091255/pulmonary-arterial-hypertension-market-worth-10-88-billion-by-2028-lead-by-asia-pacific-region-6-5,2023-02-28 14:03:29,"New York, Feb. 28, 2023 ( GLOBE NEWSWIRE ) -- According to The Insight Partners, ""Pulmonary Arterial Hypertension Market Size, Share, Growth, Trends and Global Forecast to 2028 - COVID-19 Impact and Global Analysis By Drugs [Endothelin Receptor Antagonists ( ERAs ) , Prostacyclin and ...",JNJ,0.021087,0.076814,Neutral
Vision Care Market Share Report  ( $98.96 Billion by 2028 )  Lead by Eyeglasses Segment - Exclusive Report by The Insight Partners,https://www.benzinga.com/pressreleases/23/02/g31089809/vision-care-market-share-report-98-96-billion-by-2028-lead-by-eyeglasses-segment-exclusive-report-,2023-02-28 13:25:56,"New York, Feb. 28, 2023 ( GLOBE NEWSWIRE ) -- According to The Insight Partners, ""Vision Care Market Size, Share, Growth, Trends and Global Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type ( Eye Glasses, Contact Lens, Intraocular Lens, and Others ) and Distribution Channel ...",JNJ,0.045353,0.073413,Neutral
"Pfizer, GSK face FDA panel review in race for RSV vaccines",https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-gsk-face-fda-panel-review-race-rsv-vaccines-2023-02-28/,2023-02-28 12:03:00,Feb 28 ( Reuters ) - The frontrunners in a crowded race to develop the first respiratory syncytial virus ( RSV ) vaccine - Pfizer Inc ( PFE.N ) and GSK ( GSK.L ) - will face scrutiny from a panel of experts to the U.S. Food and Drug Administration this week.,JNJ,0.112532,0.0,Neutral
Cosmeceuticals Market Exhibits 8.4% CAGR to Hit Reach USD 96.23 Billion by 2029 | Fortune Business Insights,https://www.benzinga.com/pressreleases/23/02/g31084072/cosmeceuticals-market-exhibits-8-4-cagr-to-hit-reach-usd-96-23-billion-by-2029-fortune-business-in,2023-02-28 10:07:33,"Pune, India, Feb. 28, 2023 ( GLOBE NEWSWIRE ) -- The global Cosmeceuticals Market size was valued at USD 50.75 billion in 2021 and is projected to grow from USD 54.57 billion in 2022 to USD 96.23 billion by 2029, exhibiting a CAGR of 8.4% during the forecast period.",JNJ,0.041901,-0.032927,Neutral
Why Johnson & Johnson  ( JNJ )  is a Great Dividend Stock Right Now,https://www.zacks.com/stock/news/2059411/why-johnson-johnson-jnj-is-a-great-dividend-stock-right-now,2023-02-27 16:45:12,"Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.",JNJ,0.445179,0.486077,Bullish
JNJ: The 4 Best Forever Stocks to Buy in February 2023,https://stocknews.com/news/jnj-gild-stla-cah-pltr-the-4-best-forever-stocks-to-buy-in-february-2023/,2023-02-27 16:32:54,JNJ: The 4 Best Forever Stocks to Buy in February ...,JNJ,0.204287,0.04087,Neutral
2 Forever Stocks to Buy and Hold for Long-Term Growth,https://www.fool.com/investing/2023/02/27/2-forever-stocks-buy-and-hold-for-long-term-growth/,2023-02-27 16:21:31,They'll both be paying out dividends to shareholders for many years to come.,JNJ,0.152821,0.122162,Neutral
Electrosurgery Devices Market to be Worth $8.73 Billion by 2030 - Exclusive Report by Meticulous ResearchÂ®,https://www.benzinga.com/pressreleases/23/02/g31070033/electrosurgery-devices-market-to-be-worth-8-73-billion-by-2030-exclusive-report-by-meticulous-rese,2023-02-27 15:00:00,"Redding, California, Feb. 27, 2023 ( GLOBE NEWSWIRE ) -- According to a new market research report titled, 'Electrosurgery Devices Market By Product ( Electrode, Smoke Evacuation System, Irrigation Device, Forcep, Generator ) , Surgery ( General, Gynecology, Oncology, Orthopedic, Cardiovascular, ...",JNJ,0.026503,-0.03058,Neutral
JNJ: 1 Dividend Stock to Buy for Passive Income in 2023,https://stocknews.com/news/jnj-nvo-bmy-nvs-1-dividend-stock-to-buy-for-passive-income-in-2023/,2023-02-27 14:02:34,JNJ: 1 Dividend Stock to Buy for Passive Income in ...,JNJ,0.680543,0.304594,Somewhat-Bullish
BDA Appoints Rob Martin for Newly Created Chief Experience Officer Role,https://www.prnewswire.com/news-releases/bda-appoints-rob-martin-for-newly-created-chief-experience-officer-role-301755907.html,2023-02-27 13:00:00,BDA Appoints Rob Martin for Newly Created Chief Experience ... PR ...,JNJ,0.150592,0.190657,Somewhat-Bullish
Why Should You Invest in Blue Chip Stocks?,https://www.fool.com/investing/2023/02/27/why-should-you-invest-in-blue-chip-stocks/,2023-02-27 10:20:00,These battle-tested companies can provide investors with reliability.,JNJ,0.055364,0.07101,Neutral
"EPA could charge Norfolk Southern $70,000 a day if their Ohio derailment clean-up isn't up to par. That could be on top of a growing number of lawsuits already piling up, legal expert says.",https://africa.businessinsider.com/news/epa-could-charge-norfolk-southern-dollar70000-a-day-if-their-ohio-derailment-clean-up/p711k84,2023-02-25 05:44:12,EPA could charge Norfolk Southern $70000 a day if their Ohio ... - Business Insider Africa ...,JNJ,0.089462,-0.34436,Somewhat-Bearish
"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Fate, Sotera, Argo, and National Vision and Encourages Investors to Contact the Firm - National Vision Holdings  ( NASDAQ:EYE ) , Argo Blockchain  ( NASDAQ:ARBK ) ",https://www.benzinga.com/pressreleases/23/02/g31059231/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-fate-,2023-02-25 02:00:00,"NEW YORK, Feb. 24, 2023 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Fate Therapeutics, Inc. FATE, Sotera Health Co. SHC, Argo Blockchain Plc, Inc.",JNJ,0.014648,0.017096,Neutral
Norfolk Southern hit with class-action suit over East Palestine train derailment,https://www.foxbusiness.com/industrials/norfolk-southern-hit-class-action-suit-east-palestine-train-derailment,2023-02-24 22:45:50,"A class action suit against Norfolk Southern Railway was filed in an Ohio court Thursday following a derailment earlier this month that released toxic chemicals in East Palestine, Ohio.",JNJ,0.092569,0.093283,Neutral
Is Abbott Stock A Better Pick Over This Pharmaceuticals Bellwether?,https://www.forbes.com/sites/greatspeculations/2023/02/24/is-abbott-stock-a-better-pick-over-this-pharmaceuticals-bellwether/,2023-02-24 13:00:00,Both stocks are trading at a similar valuation of a little over 4x trailing revenues.,JNJ,0.400749,0.269855,Somewhat-Bullish
Regenerative Medicine Market is Expected to Reach $40.6 Billion | MarketsandMarkets.,https://www.benzinga.com/pressreleases/23/02/g31045680/regenerative-medicine-market-is-expected-to-reach-40-6-billion-marketsandmarkets,2023-02-24 12:30:00,"Chicago, Feb. 24, 2023 ( GLOBE NEWSWIRE ) -- Regenerative medicine is an emerging field of medicine that is focused on using the body's natural healing processes to repair and regenerate damaged tissue.",JNJ,0.076358,0.158029,Somewhat-Bullish
This Could Be Warren Buffett's Most Underrated Dividend Stock,https://www.fool.com/investing/2023/02/24/warren-buffett-most-underrated-dividend-stock/,2023-02-24 10:50:00,This Berkshire Hathaway holding delivers the goods.,JNJ,0.061473,0.215159,Somewhat-Bullish
"Zacks Industry Outlook Highlights Edwards Lifesciences, IDEXX Laboratories and Hologic",https://www.zacks.com/stock/news/2058525/zacks-industry-outlook-highlights-edwards-lifesciences-idexx-laboratories-and-hologic,2023-02-24 08:13:00,"Edwards Lifesciences, IDEXX Laboratories and Hologic have been highlighted in this Industry Outlook article.",JNJ,0.026013,0.07173,Neutral
Stayfree announces Kiara Advani as its brand ambassador | The Financial Express,https://www.financialexpress.com/brandwagon/stayfree-announces-kiara-advani-as-its-brand-ambassador/2991533/,2023-02-24 07:36:03,Stayfree announces Kiara Advani as its brand ambassador The Financial Express ...,JNJ,0.131643,0.121174,Neutral
Johnson & Johnson  ( JNJ )  Down 6.9% Since Last Earnings Report: Can It Rebound?,https://www.zacks.com/stock/news/2058263/johnson-johnson-jnj-down-69-since-last-earnings-report-can-it-rebound,2023-02-23 16:30:22,Johnson & Johnson (JNJ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,JNJ,0.08398,0.018817,Neutral
"Jeff Bezos, George Soros, Mark Cuban, and Ray Dalio All Have One Thing in Common: They're Making a Big Bet on This Industry - Horizon Therapeutics  ( NASDAQ:HZNP ) , Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/news/23/02/31032506/jeff-bezos-george-soros-mark-cuban-and-ray-dalio-all-have-one-thing-in-common-theyre-making-a-big-be,2023-02-23 16:28:45,"When billionaires jump on the same trend, it's important for investors to take notice. The pieces often don't come together immediately, but these investors have millions of dollars in resources dedicated to getting the most up-to-date information as quickly as possible.",JNJ,0.173333,-0.030013,Neutral
JNJ: 3 Surefire Stocks You Can Buy Right Now,https://stocknews.com/news/jnj-caj-forr-3-surefire-stocks-you-can-buy-right-now/,2023-02-23 16:15:45,"Amid the current volatile macroeconomic situation, we suggest considering surefire stocks of financially resilient companies such as Johnson & Johnson ( JNJ ) , Canon Inc. ( CAJ ) , and Forrester Research, Inc. ( FORR ) . Let's delve deeper to understand why these stocks could rack up significant ...",JNJ,0.271651,0.189197,Somewhat-Bullish
3 Medical Instruments Stocks to Buy Amid Improving Industry Trends,https://www.zacks.com/commentary/2058036/3-medical-instruments-stocks-to-buy-amid-improving-industry-trends,2023-02-23 15:27:00,"The Zacks Medical - Instruments industry is growing on rising demand for digital health. EW, IDXX and HOLX are set to gain the most. Yet, the ongoing inflation, in the form of rising freight, raw material costs, is disrupting the trend.",JNJ,0.02692,0.010096,Neutral
"4 Drug, Biotech Stocks Poised to Beat Q4 Earnings Estimates",https://www.zacks.com/stock/news/2057943/4-drug-biotech-stocks-poised-to-beat-q4-earnings-estimates,2023-02-23 12:46:00,"We look at a few drug/biotech companies, TBPH, FGEN, AUPH, CYTK, which are poised to beat on earnings in the fourth quarter.",JNJ,0.046907,0.097373,Neutral
Johnson & Johnson  ( JNJ )  Stock Moves -0.14%: What You Should Know,https://www.zacks.com/stock/news/2057677/johnson-johnson-jnj-stock-moves--014-what-you-should-know,2023-02-22 22:45:21,"Johnson & Johnson (JNJ) closed the most recent trading day at $157.78, moving -0.14% from the previous trading session.",JNJ,0.656549,0.280222,Somewhat-Bullish
Relative Strength Alert For Johnson & Johnson,https://www.forbes.com/sites/dividendchannel/2023/02/22/relative-strength-alert-for-johnson--johnson/,2023-02-22 22:07:49,"But making Johnson & Johnson an even more interesting and timely stock to look at, is the fact that in trading on Wednesday, shares of JNJ entered into oversold territory, changing hands as low as $157.47 per share.",JNJ,0.560594,0.387313,Bullish
"How a Janitor Built an $8 Million Fortune Without Touching Cryptos, Stock Options or Leverage - Apple  ( NASDAQ:AAPL ) , Airbnb  ( NASDAQ:ABNB ) ",https://www.benzinga.com/news/23/02/31010746/how-a-janitor-built-an-8-million-fortune-without-touching-cryptos-stock-options-or-leverage,2023-02-22 16:41:55,Ronald Reid was the last person you would expect to be a millionaire. He used safety pins to hold his old coats together and cut his own firewood well into his 90s. He drove a second-hand Toyota Yaris and resisted new purchases.,JNJ,0.113062,0.010334,Neutral
Genmab Publishes 2022 Annual Report,https://www.globenewswire.com/news-release/2023/02/22/2613531/0/en/Genmab-Publishes-2022-Annual-Report.html,2023-02-22 16:01:00,Company Announcement ...,JNJ,0.028089,0.0,Neutral
Want to Get to $1 Million by Retirement? Here's How Much You Should Invest Today.,https://www.fool.com/investing/2023/02/22/want-to-get-to-1-million-by-retirement-heres-how-m/,2023-02-22 14:39:00,"If you want to be a millionaire more quickly, you can always invest more along the way.",JNJ,0.280938,0.279983,Somewhat-Bullish
JNJ: 2 Stable Stocks to Add to Your Portfolio in 2023,https://stocknews.com/news/jnj-nvs-2-stable-stocks-to-add-to-your-portfolio-in-2023/,2023-02-22 13:24:01,JNJ: 2 Stable Stocks to Add to Your Portfolio in ...,JNJ,0.369021,0.260469,Somewhat-Bullish
"IBN Announces Latest Episode of The Bell2Bell Podcast Featuring Return of Dr. Alan Baratz, CEO of D-Wave Quantum Inc. - D-Wave Quantum  ( NYSE:QBTS ) ",https://www.benzinga.com/pressreleases/23/02/g31005511/ibn-announces-latest-episode-of-the-bell2bell-podcast-featuring-return-of-dr-alan-baratz-ceo-of-d-,2023-02-22 13:17:00,"LOS ANGELES, Feb. 22, 2023 ( GLOBE NEWSWIRE ) -- via InvestorWire -- IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The Bell2Bell Podcast as part of its sustained ...",JNJ,0.025379,0.126999,Neutral
This Recession-Proof Company Has a Best-in-Class Dividend,https://www.fool.com/investing/2023/02/22/this-recession-proof-company-has-a-best-in-class-d/,2023-02-22 12:30:00,"Pfizer's highly attractive valuation, rock-solid dividend program, and enormous yield put it at the top of its big pharma peer group.",JNJ,0.139265,-0.114321,Neutral
Ultralife Corporation Adds Janie Goddard to its Board of Directors,https://www.globenewswire.com/news-release/2023/02/22/2613020/18622/en/Ultralife-Corporation-Adds-Janie-Goddard-to-its-Board-of-Directors.html,2023-02-22 12:00:00,"NEWARK, N.Y., Feb. 22, 2023 ( GLOBE NEWSWIRE ) -- Ultralife Corporation ( NASDAQ: ULBI ) announced today the addition of Janie Goddard as Director of the Company.",JNJ,0.120431,0.049711,Neutral
Performio Launches Business Intelligence and Advanced Reporting Capabilities with Analytics Studio,https://www.prnewswire.com/news-releases/performio-launches-business-intelligence-and-advanced-reporting-capabilities-with-analytics-studio-301752600.html,2023-02-22 11:05:00,Performio Launches Business Intelligence and Advanced Reporting ... PR ...,JNJ,0.074926,0.210342,Somewhat-Bullish
3 More Stocks Raising Their Dividends for Over 60 Years,https://www.fool.com/investing/2023/02/22/3-more-stocks-raising-their-dividends-for-over-60/,2023-02-22 10:07:00,The power of reinvesting in dividend-paying stocks becomes obvious with these three Dividend Kings.,JNJ,0.101582,0.041511,Neutral
Hair Care Industry Players Prioritizes ESG Goals to Boost Sustainable Business - Astra ESG Solutions,https://www.prnewswire.com/news-releases/hair-care-industry-players-prioritizes-esg-goals-to-boost-sustainable-business---astra-esg-solutions-301752920.html,2023-02-22 10:04:00,Hair Care Industry Players Prioritizes ESG Goals to Boost ... PR ...,JNJ,0.034039,0.0,Neutral
Tuesday's rough market gives us the chance to add to a health stock that's right for this environment,https://www.cnbc.com/2023/02/21/tuesdays-rough-market-gives-us-the-chance-to-add-to-a-health-stock-thats-right-for-environment.html,2023-02-21 18:30:49,The market sell-off creates an opportunity to buy stocks of companies that are doing well and will continue to do so even in a recession.,JNJ,0.345674,0.038086,Neutral
US Supreme Court Refuses To Reject $302M Judgment Against Johnson & Johnson Over Pelvic Mesh Marketing - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/news/large-cap/23/02/30992505/us-supreme-court-refuses-to-reject-302m-judgment-against-johnson-johnson-over-pelvic-mesh-marketin,2023-02-21 18:11:34,"The U.S. Supreme Court refused to hear Johnson & Johnson's JNJ regarding a $302 million judgment in a lawsuit brought by California, accusing the company of concealing the risks of its pelvic mesh products.",JNJ,0.524949,-0.294652,Somewhat-Bearish
"Exclusive: Caligan urges Anika Therapeutics to conduct strategic review, plans board challenge",https://www.reuters.com/business/healthcare-pharmaceuticals/caligan-urges-anika-therapeutics-conduct-strategic-review-plans-board-challenge-2023-02-21/,2023-02-21 12:10:17,Exclusive: Caligan urges Anika Therapeutics to conduct strategic ... ...,JNJ,0.087824,0.187534,Somewhat-Bullish
Baby Care Products Industry Players Unlock Business Values with ESG - Astra ESG Solutions,https://www.prnewswire.com/news-releases/baby-care-products-industry-players-unlock-business-values-with-esg---astra-esg-solutions-301751669.html,2023-02-21 11:58:00,Baby Care Products Industry Players Unlock Business Values with ... PR ...,JNJ,0.096932,0.046786,Neutral
3 Healthcare Stocks to Buy and Hold for the Next 10 Years,https://www.fool.com/investing/2023/02/21/3-healthcare-stocks-to-buy-and-hold-next-10-years/,2023-02-21 11:45:00,These stocks have something to offer every type of investor.,JNJ,0.21686,0.163779,Somewhat-Bullish
Baby Care Products Market to Reach $331.92 Billion by 2029 | Fortune Business Insightsâ„¢,https://www.benzinga.com/pressreleases/23/02/g30982387/baby-care-products-market-to-reach-331-92-billion-by-2029-fortune-business-insights,2023-02-21 11:31:06,"Pune, India, Feb. 21, 2023 ( GLOBE NEWSWIRE ) -- The global baby care products market size was valued at USD 204.75 billion in 2021 and USD 215.13 billion in 2022. The market is expected to reach USD 331.92 billion by 2029 with a CAGR of 6.4% during the forecast period.",JNJ,0.03642,0.148636,Neutral
MediSim VR ropes in Dr. Gianluca De Novi as Simulation Advisor | The Financial Express,https://www.financialexpress.com/healthcare/news-healthcare/medisim-vr-ropes-in-dr-gianluca-de-novi-as-simulation-advisor/2988087/,2023-02-21 11:06:00,MediSim VR ropes in Dr. Gianluca De Novi as Simulation Advisor The Financial Express ...,JNJ,0.088472,0.159455,Somewhat-Bullish
"This Is the Greatest Dividend Stock on the Planet, and Virtually No One Even Knows It Exists",https://www.fool.com/investing/2023/02/21/greatest-dividend-stock-on-the-planet-no-one-knows/,2023-02-21 10:21:00,This practically unknown company has been paying a consecutive dividend for more than two centuries.,JNJ,0.075279,0.167492,Somewhat-Bullish
"With 6.5% CAGR, Urology Devices Market Size to Surpass USD 55.91 Billion by 2029",https://www.benzinga.com/pressreleases/23/02/g30981516/with-6-5-cagr-urology-devices-market-size-to-surpass-usd-55-91-billion-by-2029,2023-02-21 10:14:09,"Pune, India, Feb. 21, 2023 ( GLOBE NEWSWIRE ) -- The global urology devices market size valued at USD 32.03 billion in 2021and the market valued at USD 35.93 billion in 2022 and reached USD 55.91 billion by 2029, exhibiting a CAGR of 6.5% during the forecast period.",JNJ,0.037271,0.0,Neutral
"Beauty and personal care products market size is set to grow at a CAGR of 5.06% by 2027, Evolving opportunities with Beiersdorf AG., Revlon Inc., among others - Technavio",https://www.prnewswire.com/news-releases/beauty-and-personal-care-products-market-size-is-set-to-grow-at-a-cagr-of-5-06-by-2027--evolving-opportunities-with-beiersdorf-ag-revlon-inc-among-others--technavio-301750570.html,2023-02-21 09:00:00,Beauty and personal care products market size is set to grow at a ... PR ...,JNJ,0.024126,0.139729,Neutral
"SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fate Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - FATE - Fate Therapeutics  ( NASDAQ:FATE ) ",https://www.benzinga.com/pressreleases/23/02/g30979717/shareholder-alert-pomerantz-law-firm-reminds-shareholders-with-losses-on-their-investment-in-fate-,2023-02-20 23:19:24,"NEW YORK, Feb. 20, 2023 ( GLOBE NEWSWIRE ) -- Pomerantz LLP announces that a class action lawsuit has been filed against certain officers and directors of Fate Therapeutics, Inc. ( ""Fate"" or the ""Company"" ) FATE. The class action, filed in the United States District Court for the Southern ...",JNJ,0.053629,0.019992,Neutral
World's Largest Hedge Fund Founder Ray Dalio Says Cash Is 'In Jeopardy' but Sees an Unexpected Solution,https://www.benzinga.com/markets/cryptocurrency/23/02/30978457/worlds-largest-hedge-fund-founder-ray-dalio-says-cash-is-in-jeopardy-but-sees-an-unexpecte,2023-02-20 17:26:11,"Inflation has been a massive issue for nearly every major country for the past year or so. Consumers and corporations alike have felt the pain, with the previous four quarters of earnings proving to be relatively lackluster. While inflation is slowly declining, it has caused the debt of the U.S. ...",JNJ,0.085022,0.071725,Neutral
These Are The Best  ( And Worst )  Performing Stocks Of 2023,https://www.forbes.com/sites/dereksaul/2023/02/20/these-are-the-best-and-worst-performing-stocks-of-2023/,2023-02-20 16:24:32,Tesla's 69% surge leads the charge.,JNJ,0.075635,0.021414,Neutral
JNJ: 2 Stocks That Could Help You Sleep Peacefully No Matter What the Market Does,https://stocknews.com/news/jnj-csco-2-stocks-that-could-help-you-sleep-peacefully-no-matter/,2023-02-20 13:43:55,JNJ: 2 Stocks That Could Help You Sleep Peacefully No Matter ... ...,JNJ,0.432291,0.244203,Somewhat-Bullish
Is This Supercharged Growth Stock a Buy?,https://www.fool.com/investing/2023/02/20/is-this-supercharged-growth-stock-a-buy/,2023-02-20 13:30:00,Shares of this drugmaker have trounced the S&P 500 index in the last decade.,JNJ,0.057079,0.0,Neutral
3 Top Dividend Kings to Buy for the Long Haul,https://www.fool.com/investing/2023/02/20/3-top-dividend-kings-to-buy-for-the-long-haul/,2023-02-20 12:25:00,These companies have more than 150 years of dividend growth between them.,JNJ,0.249531,0.082267,Neutral
Should Invesco Dividend Achievers ETF  ( PFM )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2056181/should-invesco-dividend-achievers-etf-pfm-be-on-your-investing-radar,2023-02-20 11:20:08,Style Box ETF report for ...,JNJ,0.122894,0.068464,Neutral
Is ALPS O'Shares U.S. Quality Dividend ETF  ( OUSA )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2056186/is-alps-oshares-us-quality-dividend-etf-ousa-a-strong-etf-right-now,2023-02-20 11:20:07,Smart Beta ETF report for ...,JNJ,0.116348,0.06132,Neutral
"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against IBM, Fate, Sotera, and Argo and Encourages Investors to Contact the Firm - Argo Blockchain  ( NASDAQ:ARBK ) , Fate Therapeutics  ( NASDAQ:FATE ) ",https://www.benzinga.com/pressreleases/23/02/g30974230/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-ibm-f,2023-02-20 02:00:00,"NEW YORK, Feb. 19, 2023 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of International Business Machines Corporation IBM, Fate Therapeutics, Inc.",JNJ,0.011722,0.016697,Neutral
3 No-Brainer Dividend Stocks to Buy in March,https://www.fool.com/investing/2023/03/11/3-no-brainer-dividend-stocks-to-buy-in-march/,2023-03-11 11:14:00,Going with these great dividend stocks is an easy choice.,JNJ,0.30158,0.274213,Somewhat-Bullish
The 3 Best S&P 500 Index Funds for 2023,https://www.fool.com/investing/how-to-invest/index-funds/best-sp-500-index-funds/,2023-03-10 22:20:41,"Find out which index funds tracking the S&P 500 have the lowest fees, highest assets under management, and most closely track the market.",JNJ,0.071145,0.046797,Neutral
"SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fate Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - FATE - Fate Therapeutics  ( NASDAQ:FATE ) ",https://www.benzinga.com/pressreleases/23/03/g31301173/shareholder-alert-pomerantz-law-firm-reminds-shareholders-with-losses-on-their-investment-in-fate-,2023-03-10 18:41:41,"NEW YORK, March 10, 2023 ( GLOBE NEWSWIRE ) -- Pomerantz LLP announces that a class action lawsuit has been filed against certain officers and directors of Fate Therapeutics, Inc. ( ""Fate"" or the ""Company"" ) FATE. The class action, filed in the United States District Court for the Southern ...",JNJ,0.053629,-0.030011,Neutral
JNJ: 2 Stocks That'll Help You Keep Money in Your Pockets,https://stocknews.com/news/jnj-pfe-bac-2-stocks-thatll-help-you-keep-money-in-your-pockets/,2023-03-10 16:34:07,The early-year market rally lost its steam gradually owing to the inpouring of hotter-than-anticipated macroeconomic data. The Fed's hawkish comments further aggravated the already existing investor anxieties.,JNJ,0.470714,0.159947,Somewhat-Bullish
Double-Digit Sales Growth: Is This Stock a Convincing Buy for Growth Investors?,https://www.fool.com/investing/2023/03/10/double-digit-sales-growth-is-this-stock-a-buy-vcyt/,2023-03-10 14:30:00,This diagnostics test maker has held up well over the last year.,JNJ,0.123526,-0.033707,Neutral
JNJ: 3 Powerhouse Stocks to Buy in 2023,https://stocknews.com/news/jnj-hum-azo-gs-c-abmd-3-powerhouse-stocks-to-buy-in-2023/,2023-03-10 12:42:59,JNJ: 3 Powerhouse Stocks to Buy in ...,JNJ,0.254042,0.198057,Somewhat-Bullish
Should You Invest in the Vanguard Health Care ETF  ( VHT ) ?,https://www.zacks.com/stock/news/2063946/should-you-invest-in-the-vanguard-health-care-etf-vht,2023-03-10 11:20:04,Sector ETF report for ...,JNJ,0.136113,0.064698,Neutral
Marksans Pharma climbs 2% after USFDA approval for Famotidine tablets,https://www.moneycontrol.com/news/business/markets/marksans-pharma-climbs-2-after-usfda-approval-for-famotidine-tablets-10229471.html,2023-03-10 10:30:13,"Famotidine tablets are bioequivalent to the reference listed drug Pepcid AC tablets, a registered trademark of Johnson Johnson Consumer Inc, which has sales of over $200 million in the US market.",JNJ,0.136888,0.0,Neutral
"Zacks Industry Outlook Highlights J&J, Novo Nordisk, AstraZeneca, Novartis and Sanofi",https://www.zacks.com/stock/news/2063910/zacks-industry-outlook-highlights-jj-novo-nordisk-astrazeneca-novartis-and-sanofi,2023-03-10 09:38:00,"J&J, Novo Nordisk, AstraZeneca, Novartis and Sanofi have been highlighted in this Industry Outlook article.",JNJ,0.050894,0.167372,Somewhat-Bullish
Marksans Pharma gets USFDA nod for generic version of Famotidine tablets,https://www.business-standard.com/article/companies/marksans-pharma-gets-usfda-nod-for-generic-version-of-famotidine-tablets-123031000436_1.html,2023-03-10 09:05:00,Marksans Pharma Ltd on Friday said it has received final approval from the US health regulator for its generic version of Famotidine tablets indicated for the treatment of acid indigestion and heartburn. The approval granted by the US Food & Drugs Administration (USFDA) for the abbreviated new ...,JNJ,0.200688,0.0,Neutral
3 Top Guru Favorites Trading Near 52-Week Lows,https://www.forbes.com/sites/gurufocus/2023/03/09/3-top-guru-favorites-trading-near-52-week-lows/,2023-03-09 21:11:18,These popular guru holdings are part of GuruFocus' top-performing model portfolio ...,JNJ,0.173333,0.046381,Neutral
New drugs are coming to market at sky-high prices,https://www.foxbusiness.com/healthcare/new-drugs-coming-market-sky-high-prices,2023-03-09 19:08:03,"A new Amgen Inc. lung-cancer treatment, Lumakras, carried a hefty price tag when it came out in 2021: $17,900 per patient monthly. Just over a year later, in December 2022, a second drug for the same type of cancer, Krazati from Mirati Therapeutics Inc., had an even higher price: $19,750 a month ...",JNJ,0.033052,0.120597,Neutral
Soap Market Size to Reach USD 55.29 Billion by 2027 | CAGR of 5.0%,https://www.benzinga.com/pressreleases/23/03/g31280733/soap-market-size-to-reach-usd-55-29-billion-by-2027-cagr-of-5-0,2023-03-09 16:25:39,"Pune, India, March 09, 2023 ( GLOBE NEWSWIRE ) -- The global soap market size is projected to reach USD 55.29 billion by 2027, exhibiting a CAGR of 5.0% during the forecast period.",JNJ,0.033515,0.0,Neutral
"Biotech Stock Roundup: PTGX Gains on Study Data, BMRN Faces Setback & More",https://www.zacks.com/stock/news/2063653/biotech-stock-roundup-ptgx-gains-on-study-data-bmrn-faces-setback-more,2023-03-09 16:14:00,Pipeline and regulatory updates from Protagonist (PTGX) and BioMarin (BMRN) are the key highlights from the biotech sector during the past week.,JNJ,0.299022,0.184937,Somewhat-Bullish
JNJ: 1 Stock to Buy for Safety in This Volatile Market,https://stocknews.com/news/jnj-nvo-bmy-nvs-1-stock-to-buy-for-safety-in-this-volatile-market/,2023-03-09 14:17:57,"Earlier this week, Fed Chair Jerome Powell cautioned that interest rates would likely rise higher than the central bank policymakers expected. As renewed recession fears will keep the stock market under pressure, investors looking for a safe stock may consider Johnson & Johnson ( JNJ ) .",JNJ,0.548633,0.333963,Somewhat-Bullish
3 Supercharged Dividend Stocks to Buy If There's a Stock Market Sell-Off,https://www.fool.com/investing/2023/03/09/3-supercharged-dividend-stocks-to-buy-if-theres-a/,2023-03-09 14:10:00,Income stocks can supercharge your portfolio's growth in a wide range of market environments.,JNJ,0.240014,0.112163,Neutral
Anti-Viral Therapies Market Growth  ( $82.92 Billion by 2028 )  Driven by Branded Drugs Segment during  ( 2022-2028 )  - Global Report by The Insight Partners,https://www.benzinga.com/pressreleases/23/03/g31276388/anti-viral-therapies-market-growth-82-92-billion-by-2028-driven-by-branded-drugs-segment-during-20,2023-03-09 13:46:17,"New York, March 09, 2023 ( GLOBE NEWSWIRE ) -- According to The Insight Partners, ""Anti-Viral Therapies Market Size, Share, Growth, Trends and Global Forecast to 2028 - COVID-19 Impact and Global Analysis by Type ( Generic Drugs and Branded Drugs ) , Mechanism of Action ( Nucleotide Polymerase ...",JNJ,0.049835,0.05679,Neutral
Predictive Oncology Issues Letter to Shareholders,https://www.globenewswire.com/news-release/2023/03/09/2624127/37244/en/Predictive-Oncology-Issues-Letter-to-Shareholders.html,2023-03-09 13:30:00,"EAGAN, Minn., March 09, 2023 ( GLOBE NEWSWIRE ) -- Predictive Oncology ( Nasdaq: POAI ) , a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities to accelerate oncologic drug discovery and enable drug development, today issued the following ...",JNJ,0.013732,0.112612,Neutral
5 Large Drug Stocks to Watch as Sector Picks Up in 2023,https://www.zacks.com/commentary/2063360/5-large-drug-stocks-to-watch-as-sector-picks-up-in-2023,2023-03-09 13:00:00,"Drug/biotech companies are likely to see significant advances in innovation in 2023. In the Large-Cap Pharmaceuticals industry, J&J (JNJ), Novo Nordisk (NVO), AstraZeneca (AZN), Novartis (NVS), and Sanofi (SNY) are worth retaining in your portfolio.",JNJ,0.052977,0.054058,Neutral
"Intrathecal Pumps Market Size [2023-2030] | Industry Share, Revenue, Key Players, CAGR, Demand and Forecast",https://www.benzinga.com/pressreleases/23/03/g31274907/intrathecal-pumps-market-size-2023-2030-industry-share-revenue-key-players-cagr-demand-and-forecas,2023-03-09 12:53:15,"Pune, India, March 09, 2023 ( GLOBE NEWSWIRE ) -- According to a study released in the New England Journal, approximately 67% of cancer patients experience pain and require effective pain management devices urgently.",JNJ,0.057215,0.0,Neutral
Johnson & Johnson Announces Pricing of $7.75 Billion of Senior Notes Issued by Kenvue Inc.,https://investingnews.com/johnson-johnson-announces-pricing-of-7-75-billion-of-senior-notes-issued-by-kenvue-inc/,2023-03-08 23:24:09,"Johnson & Johnson ( NYSE: JNJ ) today announced that Kenvue Inc. ( ""Kenvue"" ) , a wholly owned subsidiary of Johnson & Johnson, priced an offering of the following series of senior unsecured notes in an aggregate principal amount of $7.75 billion ( each series of notes collectively, the ""Notes"" ...",JNJ,0.442438,0.242094,Somewhat-Bullish
"Forget Stocks; 2-Year Treasury Bonds Could Pay You More Than These Major Dividend Players - Johnson & Johnson  ( NYSE:JNJ ) , Eli Lilly  ( NYSE:LLY ) ",https://www.benzinga.com/general/23/03/31264629/forget-stocks-2-year-treasury-bonds-could-pay-you-more-than-these-major-dividend-players,2023-03-08 21:17:46,"Fed Chair Jerome Powell confirmed in his testimony to Congress Tuesday and Wednesday the Federal Reserve is prepared to raise interest rates above 5% to combat inflation. As a result, the two-year treasury yield has reached a 15-year-high, hitting nearly 5% Wednesday.",JNJ,0.183895,0.135071,Neutral
Protagonist  ( PTGX )  Up on Positive Results From FRONTIER Study,https://www.zacks.com/stock/news/2063138/protagonist-ptgx-up-on-positive-results-from-frontier-study,2023-03-08 17:19:00,"Protagonist (PTGX) gains as the phase II study, conducted by Janssen, achieves its primary goal.",JNJ,0.766141,0.301556,Somewhat-Bullish
"Jim Cramer's Investing Club meeting Wednesday: Stick with stocks, Costco, P&G",https://www.cnbc.com/2023/03/08/jim-cramers-investing-club-meeting-wednesday-stick-with-stocks.html,2023-03-08 17:07:49,"The Investing Club holds its ""Morning Meeting"" every weekday at 10:20 a.m. ET.",JNJ,0.214304,0.149821,Neutral
Protagonist Therapeutics  ( PTGX )  Soars 51.9%: Is Further Upside Left in the Stock?,https://www.zacks.com/stock/news/2063013/protagonist-therapeutics-ptgx-soars-519-is-further-upside-left-in-the-stock,2023-03-08 15:02:00,Protagonist Therapeutics (PTGX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.,JNJ,0.366061,0.271598,Somewhat-Bullish
2 Top Healthcare Stocks to Buy Right Now,https://www.fool.com/investing/2023/03/08/2-top-healthcare-stocks-to-buy-right-now/,2023-03-08 13:59:00,Most people eventually need the healthcare goods/services that these companies provide.,JNJ,0.064449,0.0,Neutral
PHARMACEUTICAL INDUSTRY VETERAN JOINS NETRAMARK ADVISORY BOARD,https://www.newswire.ca/news-releases/pharmaceutical-industry-veteran-joins-netramark-advisory-board-805620045.html,2023-03-08 13:30:00,PHARMACEUTICAL INDUSTRY VETERAN JOINS NETRAMARK ... Canada ...,JNJ,0.047185,0.0,Neutral
ONL Therapeutics Closes First Tranche of $15 Million Series C Financing to Advance Lead Compound into Phase 2 Clinical Trial,https://www.benzinga.com/pressreleases/23/03/g31254378/onl-therapeutics-closes-first-tranche-of-15-million-series-c-financing-to-advance-lead-compound-in,2023-03-08 12:00:11,"ANN ARBOR, Mich., March 08, 2023 ( GLOBE NEWSWIRE ) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal disease, today announced it has closed on the first tranche of a $15 million Series C Preferred ...",JNJ,0.057767,0.175999,Somewhat-Bullish
Should iShares Russell Top 200 Value ETF  ( IWX )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2062772/should-ishares-russell-top-200-value-etf-iwx-be-on-your-investing-radar,2023-03-08 11:20:09,Style Box ETF report for ...,JNJ,0.122581,-0.022236,Neutral
Should Vanguard High Dividend Yield ETF  ( VYM )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2062779/should-vanguard-high-dividend-yield-etf-vym-be-on-your-investing-radar,2023-03-08 11:20:07,Style Box ETF report for ...,JNJ,0.122894,0.068464,Neutral
Beat the Dow Jones With This Unstoppable Dividend Stock,https://www.fool.com/investing/2023/03/08/beat-the-dow-jones-with-this-unstoppable-dividend/,2023-03-08 10:12:00,Merck had a strong year and has the portfolio and pipeline to increase its dividend.,JNJ,0.053153,0.303922,Somewhat-Bullish
Beat the Dow Jones With This Unstoppable Dividend Stock,https://www.fool.com/investing/2023/03/08/beat-the-dow-jones-with-this-unstoppable-dividend2/,2023-03-08 10:12:00,Merck had a strong year and has the portfolio and pipeline to increase its dividend.,JNJ,0.053153,0.303922,Somewhat-Bullish
"Zacks Investment Ideas feature highlights: Procter and Gamble, Johnson & Johnson and Abbott Labs",https://www.zacks.com/stock/news/2062753/zacks-investment-ideas-feature-highlights-procter-and-gamble-johnson-johnson-and-abbott-labs,2023-03-08 10:00:00,"Procter and Gamble, Johnson & Johnson and Abbott Labs have been highlighted in this Investment Ideas article.",JNJ,0.46648,0.155965,Somewhat-Bullish
3 Value Stocks on Sale Now,https://www.zacks.com/commentary/2062658/3-value-stocks-on-sale-now,2023-03-07 20:02:00,"Growth stocks have clearly led the market thus far in 2023, but will that continue?",JNJ,0.439026,0.15574,Somewhat-Bullish
"Fate Therapeutics, Inc.  ( FATE )  Lead Deadline Approaching: Contact Robbins LLP for Information Regarding the Class Action against Fate Therapeutics, Inc. - Fate Therapeutics  ( NASDAQ:FATE ) ",https://www.benzinga.com/pressreleases/23/03/g31244681/fate-therapeutics-inc-fate-lead-deadline-approaching-contact-robbins-llp-for-information-regarding,2023-03-07 19:17:00,"SAN DIEGO, March 07, 2023 ( GLOBE NEWSWIRE ) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired shares of Fate Therapeutics, Inc.",JNJ,0.071784,-0.00203,Neutral
BioNJ Announces Lineup for BioPartnering Conference,https://www.prnewswire.com/news-releases/bionj-announces-lineup-for-biopartnering-conference-301764824.html,2023-03-07 19:00:00,"TRENTON, N.J., March 7, 2023 /PRNewswire/ -- BioNJ is pleased to host its 13th Annual BioPartnering Conference on Tuesday, April 18, 2023, at The Palace at Somerset Park, Somerset, NJ. Back in person after three years, the Conference will bring together life sciences executives, investors, ...",JNJ,0.138464,0.311282,Somewhat-Bullish
BMY: 2 Dividend Stocks That Could Pay You for the Rest of Your Life,https://stocknews.com/news/bmy-gild-jnj-2-dividend-stocks-that-could-pay-you-for-the-rest/,2023-03-07 17:23:48,"Investors' confidence has taken a hit due to macroeconomic issues. As bear-market risks remain, I think it is ideal to invest in quality dividend stocks, Bristol-Myers Squibb Company ( BMY ) and Gilead Sciences, Inc. ( GILD ) , that can ensure a steady income source.",JNJ,0.064449,-0.035016,Neutral
"When quality stocks go on sale in a rough market, we like to go shopping. Here's our latest buy",https://www.cnbc.com/2023/03/07/when-quality-stocks-go-on-sale-we-like-to-go-shopping-heres-our-latest-buy.html,2023-03-07 17:21:58,"After keeping our powder dry since the end of February, we're making one small buy into weakness Tuesday.",JNJ,0.468029,0.280186,Somewhat-Bullish
Why Protagonist Therapeutics  ( PTGX )  Shares Are Trading Higher Today - Protagonist Therapeutics  ( NASDAQ:PTGX ) ,https://www.benzinga.com/general/biotech/23/03/31239091/why-protagonist-therapeutics-shares-are-trading-higher-today,2023-03-07 14:54:10,"Protagonist Therapeutics Inc PTGX announced topline results from its collaboration with Janssen Biotech Inc, a part of Johnson & Johnson JNJ, in the FRONTIER 1 Phase 2b trial of oral Interleukin-23 receptor ( IL-23R ) antagonist peptide JNJ-2113 in patients with moderate-to-severe plaque ...",JNJ,0.827318,0.203857,Somewhat-Bullish
"This 'Mini-Berkshire Hathaway' Style Company's Strategy Of Building And Spinning Off Companies Is Giving Retail Investors Pure-Play Opportunities For Additional Stock - DSS  ( AMEX:DSS ) , Berkshire Hathaway Inc. Common Stock  ( NYSE:BRK/A ) ",https://www.benzinga.com/news/23/03/31236155/this-mini-berkshire-hathaway-style-companys-strategy-of-building-and-spinning-off-companies-is-givin,2023-03-07 13:13:15,"A company with an investment style seemingly similar to the legendary Berkshire Hathaway Inc. ( NYSE: BRK-A ) is reporting significant gains in its portfolio of companies going through IPOs, uplists, and spinoffs.",JNJ,0.083687,0.096167,Neutral
"12% Dividend Yield Stock Set For Payout On Tuesday - Johnson & Johnson  ( NYSE:JNJ ) , Provident Finl Hldgs  ( NASDAQ:PROV ) , Flex LNG  ( NYSE:FLNG ) ",https://www.benzinga.com/news/23/03/31235098/this-12-dividend-yield-stock-is-set-for-payout-on-tuesday-what-else-to-watch-out-for,2023-03-07 12:32:53,"As markets continue to witness bouts of volatility led by economic data, Federal Reserve officials' remarks and inflation expectations, some investors continue to prefer buying and holding on to dividend-paying stocks that boast a higher yield.",JNJ,0.412298,0.259133,Somewhat-Bullish
PFE: 4 Stocks to Buy in Any Market Climate,https://stocknews.com/news/pfe-bmy-amgn-elv-jnj-azn-4-stocks-to-buy-in-any-market-climate/,2023-03-07 12:18:04,"The stock market remains volatile ahead of Fed chair Jerome Powell's Semiannual Monetary Policy Report delivery to Congress. Moreover, as recessionary fears are high, quality healthcare stocks Pfizer Inc. ( PFE ) , Bristol-Myers Squibb Company ( BMY ) , Amgen Inc. ( AMGN ) , and Elevance Health ...",JNJ,0.04823,-0.035493,Neutral
3 Dow Stocks That Are Screaming Buys in March,https://www.fool.com/investing/2023/03/07/3-dow-stocks-that-are-screaming-buys-in-march/,2023-03-07 10:06:00,"Among the Dow Jones Industrial Average's 30 components, there are three amazing deals hiding in plain sight.",JNJ,0.155652,0.174987,Somewhat-Bullish
JNJ: 3 Extremely Safe Stocks to Pick up in 2023,https://stocknews.com/news/jnj-dsgx-wmk-3-extremely-safe-stocks-to-pick-up-in-2023/,2023-03-07 07:18:32,JNJ: 3 Extremely Safe Stocks to Pick up in ...,JNJ,0.306538,-0.045823,Neutral
"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against IBM, Fate, Sotera, and Argo and Encourages Investors to Contact the Firm - Argo Blockchain  ( NASDAQ:ARBK ) , Fate Therapeutics  ( NASDAQ:FATE ) ",https://www.benzinga.com/pressreleases/23/03/g31230087/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-ibm-f,2023-03-07 02:00:00,"NEW YORK, March 06, 2023 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of International Business Machines Corporation IBM, Fate Therapeutics, Inc.",JNJ,0.011722,0.016697,Neutral
Johnson & Johnson  ( JNJ )  Outpaces Stock Market Gains: What You Should Know,https://www.zacks.com/stock/news/2062356/johnson-johnson-jnj-outpaces-stock-market-gains-what-you-should-know,2023-03-06 22:45:23,"In the latest trading session, Johnson & Johnson (JNJ) closed at $155.56, marking a +1% move from the previous day.",JNJ,0.545136,0.319919,Somewhat-Bullish
"ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Fate Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FATE - Fate Therapeutics  ( NASDAQ:FATE ) ",https://www.benzinga.com/pressreleases/23/03/g31228028/rosen-globally-respected-investor-counsel-encourages-fate-therapeutics-inc-investors-to-secure-cou,2023-03-06 22:16:00,"NEW YORK, March 06, 2023 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fate Therapeutics, Inc. FATE between April 2, 2020 and January 5, 2023, both dates inclusive ( the ""Class Period"" ) . A class action has already been ...",JNJ,0.051551,-0.062054,Neutral
Osteoarthritis therapeutics market to grow at a CAGR of 8.97% from 2022 to 2027: Growth opportunities led by Abbott Laboratories and Alvogen Iceland ehf among others- Technavio,https://www.prnewswire.com/news-releases/osteoarthritis-therapeutics-market-to-grow-at-a-cagr-of-8-97-from-2022-to-2027-growth-opportunities-led-by-abbott-laboratories-and-alvogen-iceland-ehf-among-others--technavio-301761982.html,2023-03-06 19:30:00,Osteoarthritis therapeutics market to grow at a CAGR of 8.97% from ... PR ...,JNJ,0.03878,-0.080555,Neutral
Best And Worst S&P Sectors Over The Last 12 Months,https://www.forbes.com/sites/johndorfman/2023/03/06/best-and-worst-sp-sectors-over-the-last-12-months/,2023-03-06 18:02:30,In investing the 11 sectors identified by Standard & Poor's influence investors' thinking. Here's a look at some sectors that have been hot or cold lately.,JNJ,0.110209,0.065583,Neutral
JNJ: 3 Hot Dividend Stocks to Buy Now and Hold Forever,https://stocknews.com/news/jnj-nvs-arc-sdy-abmd-3-hot-dividend-stocks-to-buy-now-and-hold-forever/,2023-03-06 17:27:22,The Fed will likely raise its benchmark interest rate by 25 basis points later this month due to a surge in labor costs and a strong labor market.,JNJ,0.252332,0.27285,Somewhat-Bullish
Bristol Myers  ( BMY )  Gets EU Nod for Anemia Drug Reblozyl,https://www.zacks.com/stock/news/2062273/bristol-myers-bmy-gets-eu-nod-for-anemia-drug-reblozyl,2023-03-06 16:56:00,"Bristol Myers Squibb (BMY) gets full marketing authorization from the European Commission, for Reblozyl for anemia associated with non-transfusion-dependent beta thalassemia treatment drug in adult patients.",JNJ,0.115787,-0.022198,Neutral
"Axogen, Inc. Appoints Marc Began as Executive Vice President and General Counsel",https://www.globenewswire.com/news-release/2023/03/06/2620902/0/en/Axogen-Inc-Appoints-Marc-Began-as-Executive-Vice-President-and-General-Counsel.html,2023-03-06 12:00:00,Company Reports Inducement Grants Under Nasdaq Listing Rule 5635 ( c ) ( 4 ) Company Reports Inducement Grants Under Nasdaq Listing Rule 5635 ( c ...,JNJ,0.038906,0.054331,Neutral
"Axogen, Inc. Appoints Marc Began as Executive Vice President and General Counsel - Axogen  ( NASDAQ:AXGN ) ",https://www.benzinga.com/pressreleases/23/03/g31213744/axogen-inc-appoints-marc-began-as-executive-vice-president-and-general-counsel,2023-03-06 12:00:00,"ALACHUA, Fla. and TAMPA, Fla., March 06, 2023 ( GLOBE NEWSWIRE ) -- Axogen, Inc. AXGN, a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced the appointment of Marc Began as Executive Vice President.",JNJ,0.038162,0.054244,Neutral
2 Best Buffett Stocks to Buy for the Long Haul,https://www.fool.com/investing/2023/03/05/2-best-buffett-stocks-to-buy-for-the-long-haul/,2023-03-05 14:30:00,Both businesses are known for their long-lived and nigh-indestructible brands.,JNJ,0.143131,0.162319,Somewhat-Bullish
My Favorite Dividend Stocks for 2023,https://www.fool.com/investing/2023/03/05/my-favorite-dividend-stocks-for-2023/,2023-03-05 13:45:00,Income stocks can provide more predictable returns in a wide range of market environments.,JNJ,0.293506,0.095778,Neutral
Could This Be the Next Blockbuster Vaccine for This Big Pharma Stock?,https://www.fool.com/investing/2023/03/05/could-this-be-the-next-blockbuster-vaccine-for-gsk/,2023-03-05 13:30:00,This vaccine candidate could help tackle the respiratory syncytial virus.,JNJ,0.063933,0.112094,Neutral
Is It Time to Buy the S&P 500's 4 Worst-Performing Stocks of 2023?,https://www.fool.com/investing/2023/03/05/time-to-buy-sp-500s-worst-performing-stocks-2023/,2023-03-05 12:38:00,"Can Lumen Technologies, Moderna, Baxter International, and Pfizer recover this year?",JNJ,0.05133,0.073007,Neutral
Can Business Rescue America?,https://www.forbes.com/sites/justcapital/2023/03/03/can-business-rescue-america/,2023-03-03 19:11:25,"Peter Georgescu, Chairman Emeritus of Young & Rubicam, argues that business can, and should, help rebuild a better U.S. economy.",JNJ,0.012624,0.046275,Neutral
Tissue Expanders Market is Expected to Generate $1.18 Billion by 2031: Allied Market Research,https://www.benzinga.com/pressreleases/23/03/g31194227/tissue-expanders-market-is-expected-to-generate-1-18-billion-by-2031-allied-market-research,2023-03-03 15:30:00,"Portland, OR, March 03, 2023 ( GLOBE NEWSWIRE ) -- According to the report published by Allied Market Research, the global Tissue Expanders Market garnered $671.5 million in 2021, and is estimated to generate $1.18 billion by 2031, manifesting a CAGR of 5.8% from 2022 to 2031.",JNJ,0.03798,0.048799,Neutral
How Dividend Investors Can Pick the Right Companies,https://www.wsj.com/articles/dividend-investors-how-dbaa60af,2023-03-03 15:00:00,"Don't look for companies with the biggest dividends, analysts say. Focus on cash flow.",JNJ,0.535653,0.4366,Bullish
"Dole Packaged Foods, LLC is Transforming into a Purpose-Led, Nutrition & Wellness Company with 11 New Product Launches in 2023",https://www.prnewswire.com/news-releases/dole-packaged-foods-llc-is-transforming-into-a-purpose-led-nutrition--wellness-company-with-11-new-product-launches-in-2023-301762152.html,2023-03-03 14:23:00,"Dole Packaged Foods, LLC is Transforming into a Purpose-Led ... PR ...",JNJ,0.044222,0.089316,Neutral
This Top Fund Manager Expects A Big Drop In Stocks,https://www.investors.com/etfs-and-funds/mutual-funds/stock-market-this-top-fund-manager-expects-a-big-drop/,2023-03-03 12:00:00,"Eli Salzmann, manager of the Neuberger Berman Large Cap Value Fund ( NPRTX ) , doesn't expect the early-year stock market rally to last. He expects another big leg down in stock prices. That's why he's positioning his top-performing $12.8 billion fund defensively.",JNJ,0.065866,0.387154,Bullish
"Robotic Surgical Systems Market Size [2023-2030] | Industry Share, Revenue, Key Players, CAGR, Demand and Forecast",https://www.benzinga.com/pressreleases/23/03/g31189114/robotic-surgical-systems-market-size-2023-2030-industry-share-revenue-key-players-cagr-demand-and-,2023-03-03 10:45:09,"Pune, , March 03, 2023 ( GLOBE NEWSWIRE ) -- The global robotic surgical systems market size is poised to gain impetus from rising demand for minimally invasive surgery ( MIS ) . Several studies have revealed that MIS results in better immune function and reduced post-operative hospital stays.",JNJ,0.048036,0.0,Neutral
VYM: 1 Exceptional ETF to Buy Before the Next Bull Market,https://stocknews.com/news/vym-schd-sdy-rdvy-1-exceptional-etf-to-buy-before-the-next-bull-market/,2023-03-02 20:19:48,Vanguard High Dividend Yield ETF ( VYM ) could be the ideal vehicle to anchor investors' portfolios to stable income-generating assets while market returns from capital appreciation remain anything but predictable and guaranteed.,JNJ,0.124164,0.104535,Neutral
JNJ: 2 No-Brainer Warren Buffett Stocks to Buy in 2023,https://stocknews.com/news/jnj-mck-abmd-brk-a-brk-b-2-no-brainer-warren-buffett-stocks-to-buy-in-2023/,2023-03-02 16:04:06,JNJ: 2 No-Brainer Warren Buffett Stocks to Buy in ...,JNJ,0.403813,0.198882,Somewhat-Bullish
Investors Heavily Search Johnson & Johnson  ( JNJ ) : Here is What You Need to Know,https://www.zacks.com/stock/news/2060940/investors-heavily-search-johnson-johnson-jnj-here-is-what-you-need-to-know,2023-03-02 14:00:12,"Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",JNJ,0.478494,0.103598,Neutral
Foundation Fighting Blindness to honor Doug Zarkin of Pearle Vision and Avi Kaner of Morton Williams Supermarket at 2023 Gala Night for Sight,https://markets.businessinsider.com/news/stocks/foundation-fighting-blindness-to-honor-doug-zarkin-of-pearle-vision-and-avi-kaner-of-morton-williams-supermarket-at-2023-gala-night-for-sight-1032140138,2023-03-02 12:30:00,The May 11th gala will raise awareness and fund research leading to treatments and cures for blinding retinal diseases.,JNJ,0.089462,0.302334,Somewhat-Bullish
"The Bristol Myers Squibb-Janssen Collaboration Launches Pivotal Phase 3 Librexia Clinical Trial Program Evaluating Milvexian, an Investigational Oral Factor XIa Inhibitor",https://investingnews.com/the-bristol-myers-squibb-janssen-collaboration-launches-pivotal-phase-3-librexia-clinical-trial-program-evaluating-milvexian-an-investigational-oral-factor-xia-inhibitor/,2023-03-02 12:21:15,"Bristol Myers Squibb ( NYSE: BMY ) in collaboration with Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson and Johnson ( Janssen ) today announced the launch of the Phase 3 Librexia program studying milvexian, an investigational oral factor XIa ( FXIa ) ...",JNJ,0.054732,0.161003,Somewhat-Bullish
"Sterilization Containers Market Size [2023-2030] | Industry Share, Revenue, Key Players, CAGR, Demand and Forecast",https://www.benzinga.com/pressreleases/23/03/g31162752/sterilization-containers-market-size-2023-2030-industry-share-revenue-key-players-cagr-demand-and-,2023-03-02 11:50:36,"Pune, India, March 02, 2023 ( GLOBE NEWSWIRE ) -- With advancements in the healthcare and medical industry, the demand for aesthetic packaging solutions is also increasing. This factor is considered an important boost for the global sterilization containers market, as revealed by Fortune Business ...",JNJ,0.0428,-0.079064,Neutral
"Hair Loss Treatment Market Size [2023-2030] | Share, Growth, Regional Insights, Analysis Report",https://www.benzinga.com/pressreleases/23/03/g31162559/hair-loss-treatment-market-size-2023-2030-share-growth-regional-insights-analysis-report,2023-03-02 11:44:25,"Pune, India, March 02, 2023 ( GLOBE NEWSWIRE ) -- The Hair Loss Treatment is demonstrating an escalating development as people are progressively aware of how the treatment can help prevent and regenerate hair loss and damage.",JNJ,0.028558,0.0,Neutral
Should SPDR Portfolio S&P 500 Value ETF  ( SPYV )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2060808/should-spdr-portfolio-sp-500-value-etf-spyv-be-on-your-investing-radar,2023-03-02 11:20:05,Style Box ETF report for ...,JNJ,0.121959,-0.022183,Neutral
Bavarian Nordic Publishes Annual Report 2022,https://www.globenewswire.com/news-release/2023/03/02/2618934/0/en/Bavarian-Nordic-Publishes-Annual-Report-2022.html,2023-03-02 07:11:00,"COPENHAGEN, Denmark, March 2, 2023 - Bavarian Nordic A/S ( OMX: BAVA ) today published its Annual Report for 2022. The consolidated, audited results were in line with the preliminary results, announced on January 16, 2023.",JNJ,0.03473,0.037011,Neutral
"Thousands of Women, Dozens of Top Employers Gather in Silicon Valley to Discuss Women in the Workplace",https://www.benzinga.com/pressreleases/23/03/n31151581/thousands-of-women-dozens-of-top-employers-gather-in-silicon-valley-to-discuss-women-in-the-workpl,2023-03-02 02:47:00,"SANTA CLARA,Calif., March 1, 2023 /PRNewswire/ -- Amid layoffs, economic headwinds, and backsliding on women's rights in many parts of the world, thousands of people from dozens of top employers gathered today to address women in the workplace at the 2023 California Conference for Women.",JNJ,0.076602,0.161138,Somewhat-Bullish
What Brands Need To Know: Social Marketing In 2023,https://www.forbes.com/sites/andreawasserman/2023/03/01/what-brands-need-to-know-social-marketing-in-2023/,2023-03-02 02:18:37,Search and display advertising aren't the only parts of the marketing landscape that have changed over the past three years.,JNJ,0.028288,0.1356,Neutral
"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Fate, Sotera, Argo, and National Vision and Encourages Investors to Contact the Firm - National Vision Holdings  ( NASDAQ:EYE ) , Argo Blockchain  ( NASDAQ:ARBK ) ",https://www.benzinga.com/pressreleases/23/03/g31150611/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-fate-,2023-03-02 02:00:00,"NEW YORK, March 01, 2023 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Fate Therapeutics, Inc. FATE, Sotera Health Co. SHC, Argo Blockchain Plc, Inc.",JNJ,0.014648,0.017096,Neutral
"FATE IMPORTANT DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Fate Therapeutics, Inc. Investors to Secure Counsel Before Important March 22 Deadline in Securities Class Action - FATE - Fate Therapeutics  ( NASDAQ:FATE ) ",https://www.benzinga.com/pressreleases/23/03/g31448876/fate-important-deadline-rosen-leading-investor-counsel-encourages-fate-therapeutics-inc-investors-,2023-03-21 22:50:00,"NEW YORK, March 21, 2023 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fate Therapeutics, Inc. FATE between April 2, 2020 and January 5, 2023, both dates inclusive ( the ""Class Period"" ) . A class action has already been ...",JNJ,0.051551,-0.062054,Neutral
3 Buffett Financial Stocks Approach 52-Week Lows Amid Banking Fears,https://www.forbes.com/sites/gurufocus/2023/03/21/3-buffett-financial-stocks-approach-52-week-lows-amid-banking-fears/,2023-03-21 20:13:19,Some of the guru's picks are on sale ...,JNJ,0.080865,0.055789,Neutral
JNJ: Want to Retire a Millionaire? 2 Stocks to Buy Now,https://stocknews.com/news/jnj-pfe-abmd-want-to-retire-a-millionaire-2-stocks-to-buy-now/,2023-03-21 14:44:29,"Concerns over the Fed's tighter monetary policy and the banking crisis will likely tip the economy into a recession. However, that should not deter investors from investing in quality stocks Johnson & Johnson ( JNJ ) and Pfizer Inc. ( PFE ) , which could help retire a millionaire.",JNJ,0.304585,0.06363,Neutral
IJH: 2 ETFs to Help Hedge Against a Potential Recession,https://stocknews.com/news/ijh-vym-gs-2-etfs-to-help-hedge-against-a-potential-recession/,2023-03-21 14:28:44,"Aggravated by the recent banking failures and associated recessionary risks, market volatility is anticipated to remain anchored for quite some time. Therefore, investors might delve into some quality ETFs iShares Core S&P Mid-Cap ETF ( IJH ) and Vanguard High Dividend Yield ETF ( VYM ) for 2023 ...",JNJ,0.096091,0.113644,Neutral
Beat the Dow Jones With This Unstoppable Dividend Stock,https://www.fool.com/investing/2023/03/21/beat-the-dow-jones-with-this-unstoppable-dividend/,2023-03-21 14:15:00,This drugmaker has trounced the Dow Jones Industrial Average in the last 10 years.,JNJ,0.063763,0.172224,Somewhat-Bullish
"What Is Autologous Cell-Based Therapy, The Treatment Revolutionizing Regenerative Medicine That Could Be Set To Explode Over The Next Few Years? - BioRestorative Therapies  ( NASDAQ:BRTX ) , Bristol-Myers Squibb  ( NYSE:BMY ) ",https://www.benzinga.com/general/biotech/23/03/31438097/what-is-autologous-cell-based-therapy-the-treatment-revolutionizing-regenerative-medicine-that-co,2023-03-21 13:07:08,Autologous cell based therapies are personalized therapies using your own cells to target a disease or disorder. Personalized therapies targeting cancer such CAR-T cell therapies have generated impressive clinical results with complete remission rates in B-acute lymphoblastic leukemia in over ...,JNJ,0.050044,0.190246,Somewhat-Bullish
Should You Buy The Botox Maker Over Johnson & Johnson Stock?,https://www.forbes.com/sites/greatspeculations/2023/03/21/should-you-buy-the-botox-maker-over-johnson--johnson-stock/,2023-03-21 12:00:02,"Even if we look at a longer time frame, AbbVie fares better, with its sales rising at an average annual growth rate of 21% to $58 billion in 2022, compared to $33 billion in 2019, while J&J's saw its revenue rise at an average annual rate of just 5% to $95 billion in 2022, compared to $82 ...",JNJ,0.437375,0.264021,Somewhat-Bullish
Johnson & Johnson  ( JNJ )  Outpaces Stock Market Gains: What You Should Know,https://www.zacks.com/stock/news/2068178/johnson-johnson-jnj-outpaces-stock-market-gains-what-you-should-know,2023-03-20 21:45:22,"Johnson & Johnson (JNJ) closed at $153.89 in the latest trading session, marking a +0.99% move from the prior day.",JNJ,0.554916,0.250132,Somewhat-Bullish
JNJ: 3 Stocks to Buy Now That Are Worth Every Penny,https://stocknews.com/news/jnj-abbv-ibm-gs-3-stocks-to-buy-now-that-are-worth-every-penny/,2023-03-20 18:04:56,"The Federal Reserve's aggressive rate hikes in the past year to curb inflation have proven minimally successful. However, inflation is still far above the Fed's target of 2%. Furthermore, the recent collapse of the banking system has made it even more challenging to achieve this target.",JNJ,0.249106,0.213413,Somewhat-Bullish
JNJ: 3 Highly Rated Blue-Chip Stocks for Your Portfolio,https://stocknews.com/news/jnj-ko-abbv-sivb-3-highly-rated-blue-chip-stocks-for-your-portfolio/,2023-03-20 17:46:25,"Elevated inflation, combined with a strong labor market and solid consumer spending, positioned the Fed to hike the interest rate by 50 basis points this week until the sudden collapse of the Silicon Valley Bank and other financial institutions sparked calls for a potential pause.",JNJ,0.176341,0.14199,Neutral
"SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fate Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - FATE - Fate Therapeutics  ( NASDAQ:FATE ) ",https://www.benzinga.com/pressreleases/23/03/g31424897/shareholder-alert-pomerantz-law-firm-reminds-shareholders-with-losses-on-their-investment-in-fate-,2023-03-20 17:04:50,"NEW YORK, March 20, 2023 ( GLOBE NEWSWIRE ) -- Pomerantz LLP announces that a class action lawsuit has been filed against certain officers and directors of Fate Therapeutics, Inc. ( ""Fate"" or the ""Company"" ) FATE. The class action, filed in the United States District Court for the Southern ...",JNJ,0.053629,0.019992,Neutral
Here's Why You Should Retain Boston Scientific  ( BSX )  Now,https://www.zacks.com/stock/news/2067900/heres-why-you-should-retain-boston-scientific-bsx-now,2023-03-20 13:07:00,"Investors are optimistic about Boston Scientific (BSX), led by impressive value-added acquisitions.",JNJ,0.048327,0.070172,Neutral
"The Zacks Analyst Blog Highlights Johnson & Johnson, Toyota Motor, Infosys, Novartis and Equinix",https://www.zacks.com/stock/news/2067868/the-zacks-analyst-blog-highlights-johnson-johnson-toyota-motor-infosys-novartis-and-equinix,2023-03-20 11:52:00,"Johnson & Johnson, Toyota Motor, Infosys, Novartis and Equinix are part of the Zacks top Analyst Blog.",JNJ,0.733479,0.0,Neutral
JNJ: The Best Medical Stock That Money Can Buy,https://stocknews.com/news/jnj-nvo-bmy-nvs-the-best-medical-stock-that-money-can-buy/,2023-03-20 11:42:41,"Amid a volatile macroeconomic environment and heightened recessionary fears, medical stock Johnson and Johnson ( JNJ ) , with a history of stable dividend payments, could be a wise choice for investors to safeguard themselves against market downturns. Let us delve deeper to find more.",JNJ,0.641267,0.102412,Neutral
Is Roche a Buy Now?,https://www.fool.com/investing/2023/03/20/is-roche-a-buy-now/,2023-03-20 11:35:00,Roche focuses on the long-term.,JNJ,0.041394,0.135909,Neutral
3 Dow Stocks Near 52-Week Lows That Look Like Bargains Now,https://www.fool.com/investing/2023/03/20/3-dow-stocks-near-52-week-lows-that-look-like-barg/,2023-03-20 10:23:00,These businesses are performing much better than their stock prices would suggest.,JNJ,0.107016,0.0023,Neutral
Should Vanguard S&P 500 Value ETF  ( VOOV )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2067779/should-vanguard-sp-500-value-etf-voov-be-on-your-investing-radar,2023-03-20 10:20:08,Style Box ETF report for ...,JNJ,0.127456,0.069608,Neutral
Should You Invest in the iShares U.S. Pharmaceuticals ETF  ( IHE ) ?,https://www.zacks.com/stock/news/2067786/should-you-invest-in-the-ishares-us-pharmaceuticals-etf-ihe,2023-03-20 10:20:06,Sector ETF report for ...,JNJ,0.1331,0.069906,Neutral
3 Retirement Investing Moves to Help Get You Back on Track,https://www.fool.com/investing/2023/03/19/3-retirement-investing-moves-to-help-get-you-back/,2023-03-19 09:30:00,"If you've fallen behind on funding your retirement, it's important to do what you can to get yourself on a path to recovery.",JNJ,0.110632,0.040105,Neutral
Ready to Buy the Dip? Johnson & Johnson Stock Is a Smart Buy,https://www.fool.com/investing/2023/03/18/buy-the-dip-johnson-johnson-is-a-smart-buy/,2023-03-18 13:15:00,"Close to its 52-week low, this healthcare stalwart remains a good purchase.",JNJ,0.472821,0.388177,Bullish
5 Stocks You Can Confidently Invest $500 in Right Now,https://www.fool.com/investing/2023/03/18/5-stocks-you-can-confidently-invest-500-in-right-n/,2023-03-18 13:00:00,These companies have the balance sheets and growth prospects to continue growing shareholder value in the coming years.,JNJ,0.367606,0.358964,Bullish
"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Fate, Sotera, Argo, and National Vision and Encourages Investors to Contact the Firm - National Vision Holdings  ( NASDAQ:EYE ) , Argo Blockchain  ( NASDAQ:ARBK ) ",https://www.benzinga.com/pressreleases/23/03/g31408382/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-fate-,2023-03-18 01:00:00,"NEW YORK, March 17, 2023 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Fate Therapeutics, Inc. FATE, Sotera Health Co. SHC, Argo Blockchain Plc, Inc.",JNJ,0.014648,0.017096,Neutral
JNJ: 3 Stocks That Could Deliver Healthy Returns in 2023,https://stocknews.com/news/jnj-abt-hum-abmd-csii-3-stocks-that-could-deliver-healthy-returns-in-2023/,2023-03-17 18:07:29,JNJ: 3 Stocks That Could Deliver Healthy Returns in ...,JNJ,0.198855,0.093474,Neutral
Looking Into Johnson & Johnson's Recent Short Interest - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/short-sellers/23/03/31401984/looking-into-johnson-johnsons-recent-short-interest,2023-03-17 17:45:34,"Johnson & Johnson's JNJ short percent of float has risen 32.35% since its last report. The company recently reported that it has 11.72 million shares sold short, which is 0.45% of all regular shares that are available for trading.",JNJ,0.221819,0.15378,Somewhat-Bullish
"Top Stock Reports for Johnson & Johnson, Toyota Motor & Infosys",https://www.zacks.com/research-daily/2067318/top-stock-reports-for-johnson-johnson-toyota-motor-infosys,2023-03-17 16:49:00,"Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), Toyota Motor Corporation (TM) and Infosys Limited (INFY).",JNJ,0.249744,0.058665,Neutral
"Walmart, Johnson & Johnson Join Dow Jones Industrial Average On This Day In Market History - Global X Funds Global X Dow 30 Covered Call ETF  ( ARCA:DJIA ) ",https://www.benzinga.com/general/education/22/03/20213759/this-day-in-market-history-walmart-johnson-johnson-join-dow-jones-1,2023-03-17 15:06:00,"Benzinga takes a look back at a notable market-related moment that occurred on this date. What Happened? On this day in 1997, Walmart Inc WMT, Johnson & Johnson JNJ, Travelers Companies Inc TRV and Hewlett Packard Enterprise Co HPE joined the Dow Jones Industrial Average.",JNJ,0.509589,0.2535,Somewhat-Bullish
Two Biotech Stocks Hit In Medicare Negotiation Crossfire,https://www.investors.com/research/ibd-industry-themes/regn-stock-halo-stock-tumble-on-cms-negotiation-confusion/,2023-03-17 14:50:45,"REGN Stock, HALO Stock Tumble On CMS Negotiation Confusion ... Investor's Business Daily ...",JNJ,0.127795,-0.070561,Neutral
"SNDL: If You Own This Drug Manufacturer Stock, It's Time to Sell",https://stocknews.com/news/sndl-bmy-nvs-jnj-if-you-own-this-drug-manufacturer-stock-its-time-to/,2023-03-17 14:16:43,"Canada-based medical and adult-use cannabis producer SNDL Inc. ( SNDL ) has been struggling to grow and make profits. While SNDL has made several acquisitions to support its growth, in this piece, I will discuss why the stock is still not worth buying now.",JNJ,0.087185,0.088554,Neutral
"Eyewear Market to grow at a growth rate of 8.19 percent, reaching USD 214.25 Bn by 2029",https://www.benzinga.com/pressreleases/23/03/g31394432/eyewear-market-to-grow-at-a-growth-rate-of-8-19-percent-reaching-usd-214-25-bn-by-2029,2023-03-17 10:23:22,"Dublin, March 17, 2023 ( GLOBE NEWSWIRE ) -- Maximize Market research, a global Consumer Goods & Services business-consulting firm, has published a market intelligence and competitive landscape report on the ""Eyewear Market"".",JNJ,0.035241,0.368875,Bullish
"SpaceX, Netflix, Boeing to join ""biggest-ever"" US business mission to Vietnam",https://www.reuters.com/business/spacex-netflix-boeing-join-biggest-ever-us-business-mission-vietnam-2023-03-17/,2023-03-17 04:42:56,"SpaceX, Netflix, Boeing to join ""biggest-ever"" US business mission ... ...",JNJ,0.070105,-0.007058,Neutral
How The Robert Wood Johnson Foundation Has Influenced Health Policy - And My Own Life - For Five Decades,https://www.forbes.com/sites/billfrist/2023/03/16/how-the-robert-wood-johnson-foundation-has-influenced-health-policy--and-my-own-life--for-five-decades/,2023-03-16 21:13:04,Private foundations in America play a unique and vital role in advancing social progress. That is well known. What is less recognized is the impact such Foundations have on individuals who work within them. This story is a personal one.,JNJ,0.029167,0.137802,Neutral
Johnson & Johnson Unusual Options Activity - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/03/31388417/johnson-johnson-unusual-options-activity,2023-03-16 20:15:45,"Someone with a lot of money to spend has taken a bullish stance on Johnson & Johnson JNJ. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",JNJ,0.68732,0.342661,Somewhat-Bullish
"ROSEN, A LEADING LAW FIRM, Encourages Fate Therapeutics, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important March 22 Deadline in Securities Class Action - FATE - Fate Therapeutics  ( NASDAQ:FATE ) ",https://www.benzinga.com/pressreleases/23/03/g31388035/rosen-a-leading-law-firm-encourages-fate-therapeutics-inc-investors-with-losses-exceeding-100k-to-,2023-03-16 20:08:51,"NEW YORK, March 16, 2023 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fate Therapeutics, Inc. FATE between April 2, 2020 and January 5, 2023, both dates inclusive ( the ""Class Period"" ) . A class action has already been ...",JNJ,0.053992,-0.062131,Neutral
Two Biotech Stocks Hit In Medicare Negotiation Crossfire,https://www.investors.com/news/technology/regn-stock-halo-stock-tumble-on-cms-negotiation-confusion/,2023-03-16 16:05:45,"REGN Stock, HALO Stock Tumble On CMS Negotiation Confusion Investor's Business Daily ...",JNJ,0.1331,-0.086582,Neutral
VIG: 1 Dividend ETF to Buy Amid Uncertain Market Conditions,https://stocknews.com/news/vig-moat-qyld-gs-1-dividend-etf-to-buy-amid-uncertain-market-conditions/,2023-03-16 16:03:23,"While consumer prices eased slightly in February, the stubborn inflation and tight job market could compel the Fed to raise interest rates. This and the recent turmoil in the banking sector could keep the stock market under pressure.",JNJ,0.098456,0.052775,Neutral
Seldon secures $20 Million in Series B funding led by Bright Pixel,https://www.prnewswire.com/news-releases/seldon-secures-20-million-in-series-b-funding-led-by-bright-pixel-301774266.html,2023-03-16 14:48:00,"""AI is in everything, and Seldon is uniquely positioned to ensure a return on ML investment by providing robust, scalable and secure infrastructure, pioneering a data-centric approach to ML pipelines, prioritizing team collaboration across the organization and making sure teams are able to solve ...",JNJ,0.083833,0.0,Neutral
AC Immune Reports Full Year 2022 Financial Results and Provides Corporate Update,https://www.globenewswire.com/news-release/2023/03/16/2628465/0/en/AC-Immune-Reports-Full-Year-2022-Financial-Results-and-Provides-Corporate-Update.html,2023-03-16 11:00:00,"AC Immune Reports Full Year 2022 Financial Results and Provides Corporate Update â€¢ Clinical-stage vaccine programs targeting amyloid-beta ( Abeta ) , phosphorylated-Tau ( pTau ) , and alpha-synuclein ( a-syn ) are all on track to reach important milestones in 2023 â€¢ ACI-24.060 anti-amyloid-beta ...",JNJ,0.017072,0.072878,Neutral
Patient Square Capital Partners with Health Care Veteran John Marotta to Focus on Life Science Tools and Diagnostics Opportunities,https://www.prnewswire.com/news-releases/patient-square-capital-partners-with-health-care-veteran-john-marotta-to-focus-on-life-science-tools-and-diagnostics-opportunities-301773673.html,2023-03-16 10:57:00,Patient Square Capital Partners with Health Care Veteran John ... PR ...,JNJ,0.065506,-0.076213,Neutral
Should You Invest in the iShares U.S. Healthcare ETF  ( IYH ) ?,https://www.zacks.com/stock/news/2066522/should-you-invest-in-the-ishares-us-healthcare-etf-iyh,2023-03-16 10:20:06,Sector ETF report for ...,JNJ,0.135347,0.070508,Neutral
Janssen's novel Dengue antiviral demonstrates 'strong protection' in pre-clinical data | The Financial Express,https://www.financialexpress.com/healthcare/pharma-healthcare/janssens-novel-dengue-antiviral-demonstrates-strong-protection-in-pre-clinical-data/3011789/,2023-03-16 08:56:00,Janssen's novel Dengue antiviral demonstrates 'strong protection' in ... The Financial Express ...,JNJ,0.496069,0.336802,Somewhat-Bullish
Dengue Treatment Advances In Animal Trials,https://www.barrons.com/news/dengue-treatment-advances-in-animal-trials-a676c152,2023-03-16 02:15:50,"A new dengue treatment that could become the first to prevent and treat the virus has proven effective in initial trials in monkeys, according to new research. Dengue is transmitted by mosquitoes and affects tens of millions each year, producing brutal symptoms that have earned it the moniker ...",JNJ,0.149192,0.039526,Neutral
"J&J's experimental dengue pill prevents infection in mice, monkeys",https://www.reuters.com/business/healthcare-pharmaceuticals/jjs-experimental-dengue-pill-prevents-infection-mice-monkeys-2023-03-15/,2023-03-15 16:40:36,"CHICAGO, March 15 ( Reuters ) - An experimental pill for dengue developed by Johnson & Johnson ( JNJ.N ) proved effective against all four types of the virus in mice and prevented infection from two types in monkeys, according to data published on Wednesday.",JNJ,0.439786,0.266197,Somewhat-Bullish
Janssen Announces Novel Dengue Antiviral Demonstrates Efficacy in Pre-Clinical Data Published in Nature,https://investingnews.com/janssen-announces-novel-dengue-antiviral-demonstrates-efficacy-in-pre-clinical-data-published-in-nature/,2023-03-15 16:34:40,"The antiviral is efficacious in non-human primates, and is safe and well-tolerated in humans Findings support further clinical development for prevention and treatment of dengue, which impacts millions of people today and is poised to threaten many more due to climate change",JNJ,0.411596,0.247479,Somewhat-Bullish
Are You Looking for a High-Growth Dividend Stock?,https://www.zacks.com/stock/news/2066215/are-you-looking-for-a-high-growth-dividend-stock,2023-03-15 15:45:13,"Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.",JNJ,0.43303,0.455644,Bullish
Protagonist Therapeutics Touts Positive Data From Bone Marrow Disorder Study - Protagonist Therapeutics  ( NASDAQ:PTGX ) ,https://www.benzinga.com/general/biotech/23/03/31363197/protagonist-therapeutics-touts-positive-data-from-bone-marrow-disorder-study,2023-03-15 15:39:59,"Protagonist Therapeutics Inc PTGX announced topline results from the blinded, placebo-controlled, randomized withdrawal portion of REVIVE of rusfertide for polycythemia vera, causing the bone marrow to make too many red blood cells.",JNJ,0.622414,0.064239,Neutral
Johnson & Johnson  ( JNJ )  Is a Trending Stock: Facts to Know Before Betting on It,https://www.zacks.com/stock/news/2065995/johnson-johnson-jnj-is-a-trending-stock-facts-to-know-before-betting-on-it,2023-03-15 13:00:14,"Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",JNJ,0.475838,0.11832,Neutral
Should You Invest in the Health Care Select Sector SPDR ETF  ( XLV ) ?,https://www.zacks.com/stock/news/2065877/should-you-invest-in-the-health-care-select-sector-spdr-etf-xlv,2023-03-15 10:20:08,Sector ETF report for ...,JNJ,0.129168,0.063018,Neutral
Indian companies need to reduce corporate flying emissions: Report,https://www.business-standard.com/article/companies/indian-companies-need-to-reduce-corporate-flying-emissions-report-123031500095_1.html,2023-03-15 07:25:00,"Globally, only 50 companies out of 322 have set targets to reduce business travel, with technology company Wipro paving the way in India ...",JNJ,0.055492,0.09486,Neutral
"Global Antiviral Therapies Market Predicted to Generate a Revenue of $66,016.5 Million, Growing at a CAGR of 3.1% over the 2020-2027 Timeframe [208-Pages] | Explicated by Research Dive",https://www.benzinga.com/pressreleases/23/03/g31339569/global-antiviral-therapies-market-predicted-to-generate-a-revenue-of-66-016-5-million-growing-at-a,2023-03-14 13:05:00,"New York, USA, March 14, 2023 ( GLOBE NEWSWIRE ) -- According to a report published by Research Dive, the global antiviral therapies market is projected to garner a revenue of $66,016.5 million and rise at a CAGR of 3.1% throughout the estimated period from 2020 to 2027.",JNJ,0.068502,0.0,Neutral
Bone Growth Stimulators Market to be Worth $1.94 Billion by 2030 - Exclusive Report by Meticulous ResearchÂ®,https://www.benzinga.com/pressreleases/23/03/g31339065/bone-growth-stimulators-market-to-be-worth-1-94-billion-by-2030-exclusive-report-by-meticulous-res,2023-03-14 12:52:36,"Redding, California, March 14, 2023 ( GLOBE NEWSWIRE ) -- According to a new market research report titled, 'Bone Growth Stimulators Market by Product ( Stimulation Device [External, Ultrasonic, Implantable], Bone Morphogenetic Proteins, Platelet Rich Plasma ) , Application ( Spinal Fusion, ...",JNJ,0.030331,0.009312,Neutral
JNJ: 3 Hot Stocks You Don't Want to Miss out on Right Now,https://stocknews.com/news/jnj-wmt-ge-3-hot-stocks-you-dont-want-to-miss-out-on/,2023-03-14 12:45:47,The hotter-than-expected employment report and the Silicon Valley Bank crisis have dampened investor sentiment lately.,JNJ,0.206906,0.142414,Neutral
Larimar Therapeutics Reports Fourth Quarter and Full Year 2022 Operating and Financial Results,https://www.globenewswire.com/news-release/2023/03/14/2626441/0/en/Larimar-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2022-Operating-and-Financial-Results.html,2023-03-14 11:00:00,"BALA CYNWYD, Pa., March 14, 2023 ( GLOBE NEWSWIRE ) -- Larimar Therapeutics, Inc. ( ""Larimar"" ) ( Nasdaq: LRMR ) , a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today reported its fourth quarter and full year 2022 operating and financial ...",JNJ,0.045396,0.06617,Neutral
Should Vanguard Mega Cap Value ETF  ( MGV )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2065166/should-vanguard-mega-cap-value-etf-mgv-be-on-your-investing-radar,2023-03-14 10:20:06,Style Box ETF report for ...,JNJ,0.122581,0.068387,Neutral
Johnson & Johnson  ( JNJ )  Gains As Market Dips: What You Should Know,https://www.zacks.com/stock/news/2065006/johnson-johnson-jnj-gains-as-market-dips-what-you-should-know,2023-03-13 21:45:22,"In the latest trading session, Johnson & Johnson (JNJ) closed at $153.06, marking a +0.96% move from the previous day.",JNJ,0.540358,0.226452,Somewhat-Bullish
"Dow Jones Rises With Gold, Bitcoin Amid Bank Sell-Off; Analysts See Rate Freeze In March",https://www.investors.com/market-trend/stock-market-today/dow-jones-falls-as-gold-bitcoin-rise-amidst-bank-run-fears-analysts-see-rate-hike-pause-as-banks-crater/,2023-03-13 17:10:31,"Dow Jones Rises With Gold, Bitcoin Amid Bank Sell-Off. Analysts ... Investor's Business Daily ...",JNJ,0.109705,0.436994,Bullish
"Jeff Bezos, George Soros, Mark Cuban, and Ray Dalio All Have One Thing in Common: They're Making a Big Bet on This Industry - Horizon Therapeutics  ( NASDAQ:HZNP ) , Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/news/23/03/31324559/jeff-bezos-george-soros-mark-cuban-and-ray-dalio-all-have-one-thing-in-common-theyre-making-a-big-be,2023-03-13 16:07:48,"When billionaires jump on the same trend, it's important for investors to take notice. The pieces often don't come together immediately, but these investors have millions of dollars in resources dedicated to getting the most up-to-date information as quickly as possible.",JNJ,0.157483,-0.028124,Neutral
JNJ: This Big Pharma Stock Is a Clear Buy in 2023,https://stocknews.com/news/jnj-nvo-bmy-nvs-abmd-this-big-pharma-stock-is-a-clear-buy-in-2023/,2023-03-13 15:56:47,JNJ: This Big Pharma Stock Is a Clear Buy in ...,JNJ,0.453501,0.300159,Somewhat-Bullish
Looking At Johnson & Johnson's Recent Unusual Options Activity - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/03/31324090/looking-at-johnson-johnsons-recent-unusual-options-activity,2023-03-13 15:45:53,"A whale with a lot of money to spend has taken a noticeably bearish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson JNJ we detected 23 strange trades. If we consider the specifics of each trade, it is accurate to state that 30% of the investors opened trades with ...",JNJ,0.780579,0.226633,Somewhat-Bullish
"Two Industry Veterans Join Acuitive Technologies, Inc. Board of Directors as Independent Members",https://www.benzinga.com/pressreleases/23/03/g31320001/two-industry-veterans-join-acuitive-technologies-inc-board-of-directors-as-independent-members,2023-03-13 13:14:07,"ALLENDALE, N.J., March 13, 2023 ( GLOBE NEWSWIRE ) -- Acuitive Technologies announced that Vince Forlenza and Gary Fischetti will join their Board of Directors.",JNJ,0.072876,-0.028157,Neutral
"DSS Inc  ( NYSE American: DSS )  Has Three IPO Spinoffs Planned For 2023 - Is It On Your Watchlist? - DSS  ( AMEX:DSS ) , General Electric  ( NYSE:GE ) ",https://www.benzinga.com/news/23/03/31316894/dss-inc-nyse-american-dss-has-three-ipo-spinoffs-planned-for-2023-is-it-on-your-watchlist,2023-03-13 11:58:29,"Since 2019 when DSS Inc. DSS embarked on a major transformation journey, the company has evolved into a multinational company operating businesses in nine divisions with over 40 subsidiaries.",JNJ,0.106541,0.089825,Neutral
Should Invesco S&P 500 Low Volatility ETF  ( SPLV )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2064534/should-invesco-sp-500-low-volatility-etf-splv-be-on-your-investing-radar,2023-03-13 10:20:06,Style Box ETF report for ...,JNJ,0.136113,0.070716,Neutral
"Bristol Myers, Pfizer, AbbVie drugs likely to face U.S. price negotiation",https://www.reuters.com/business/healthcare-pharmaceuticals/bristol-myers-pfizer-abbvie-drugs-likely-face-us-price-negotiation-2023-03-13/,2023-03-13 10:09:00,"[1/3] A pharmacist holds a bottle of the drug Eliquis, made by Bristol Myers Squibb and Pfizer, at a pharmacy in Provo, Utah, U.S. January 9, 2020. REUTERS/George Frey",JNJ,0.044551,0.102184,Neutral
3 Reliable Dividend Stocks to Buy and Hold for Decades of Passive Income,https://www.fool.com/investing/2023/03/13/3-reliable-dividend-stocks-to-buy-and-hold-for-dec/,2023-03-13 09:41:00,These healthcare-focused businesses should be able to raise their quarterly payouts for many years to come.,JNJ,0.114682,0.138073,Neutral
These 3 Dow Stocks Are the Cheapest They've Been in Over a Decade,https://www.fool.com/investing/2023/03/13/3-dow-stocks-cheapest-theyve-been-in-over-a-decade/,2023-03-13 09:21:00,"By one valuation standard or another, these Dow components are screaming values.",JNJ,0.126951,0.001214,Neutral
"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Y-mAbs, Fate, Sotera, and Argo and Encourages Investors to Contact the Firm - Argo Blockchain  ( NASDAQ:ARBK ) , Fate Therapeutics  ( NASDAQ:FATE ) ",https://www.benzinga.com/pressreleases/23/03/g31312347/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-y-mab,2023-03-13 01:00:00,"NEW YORK, March 12, 2023 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Y-mAbs Therapeutics, Inc. YMAB, Fate Therapeutics, Inc.",JNJ,0.011154,0.016618,Neutral
"These 7 Dividend Stocks Pay $96 Billion a Year, Combined, to Their Shareholders",https://www.fool.com/investing/2023/03/12/7-dividend-stocks-pay-96-billion-year-shareholders/,2023-03-12 09:21:00,"These widely owned, brand-name income stocks are parsing out between $11 billion and $20.2 billion annually to their shareholders.",JNJ,0.054545,0.102972,Neutral
9 Best Index Funds for Long-Term Investors,https://www.fool.com/investing/how-to-invest/index-funds/best-index-funds/,2023-03-31 22:21:40,"Here are the nine best index funds to add to your portfolio for steady, low-cost growth.",JNJ,0.043421,0.115452,Neutral
Investing in Johnson & Johnson Stock,https://www.fool.com/investing/how-to-invest/stocks/how-to-invest-in-johnson-and-johnson-stock/,2023-03-31 21:35:25,"Johnson & Johnson ( NYSE:JNJ ) is an iconic global healthcare company. It was originally formed in 1866 when three brothers ( Robert, Edward, and James Johnson ) founded the company to focus on producing bandages and baby products.",JNJ,0.932935,0.511008,Bullish
Here are our 4 best stocks - and 4 worst stocks - of the first quarter,https://www.cnbc.com/2023/03/31/first-quarter-2023-best-and-worst-stocks-investing-club.html,2023-03-31 21:14:11,"Club holding Nvidia (NVDA) has soared more than 90% this year, while Halliburton (HAL) and other energy stocks slid.",JNJ,0.065091,-0.002014,Neutral
Johnson & Johnson unit loses bid to stay in bankruptcy during Supreme Court appeal,https://www.reuters.com/business/healthcare-pharmaceuticals/johnson-johnson-unit-loses-bid-stay-bankruptcy-during-supreme-court-appeal-2023-03-31/,2023-03-31 19:52:59,Johnson & Johnson unit loses bid to stay in bankruptcy during ... ...,JNJ,0.183895,-0.158064,Somewhat-Bearish
Johnson & Johnson  ( JNJ )  Could Be a Great Choice,https://www.zacks.com/stock/news/2073104/johnson-johnson-jnj-could-be-a-great-choice,2023-03-31 15:45:12,"Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.",JNJ,0.448316,0.479986,Bullish
Personal care market size to grow by USD 169.7 billion between 2022 and 2027; Offline segment to account for maximum growth - Technavio,https://www.prnewswire.com/news-releases/personal-care-market-size-to-grow-by-usd-169-7-billion-between-2022-and-2027-offline-segment-to-account-for-maximum-growth---technavio-301784571.html,2023-03-31 15:30:00,Personal care market size to grow by USD 169.7 billion between ... PR ...,JNJ,0.092824,0.0,Neutral
"J&J Drops Out Of A Key Race With Pfizer, GSK, Moderna",https://www.investors.com/research/ibd-industry-themes/jnj-stock-johnson-johnson-drops-out-of-rsv-vaccine-race-pfizer-gsk-moderna-duke-it-out/,2023-03-31 12:48:00,JNJ Stock: Johnson & Johnson Drops Out Of RSV Vaccine Race ... Investor's Business Daily ...,JNJ,0.527969,-0.10458,Neutral
Minimally Invasive Surgical Instruments Market to Hit USD 71.6 Bn by 2032 | TMR,https://www.benzinga.com/pressreleases/23/03/g31607356/minimally-invasive-surgical-instruments-market-to-hit-usd-71-6-bn-by-2032-tmr,2023-03-31 12:30:00,"Wilmington, Delaware, United States, March 31, 2023 ( GLOBE NEWSWIRE ) -- The global minimally invasive surgical instruments market is forecast to expand at a value CAGR of 14.8% from 2022 to 2032. As per Transparency Market Research's findings, global sales stood at USD 15.7 Bn as of 2021.",JNJ,0.085936,0.126754,Neutral
"Nexcella, an Immix Biopharma Subsidiary, Announces 2023 Haematologica Editorial Highlighting NXC-201 Efficacy In The Context of U.S. Food And Drug Administration Approved BCMA CAR T Cells",https://www.globenewswire.com/news-release/2023/03/31/2638581/0/en/Nexcella-an-Immix-Biopharma-Subsidiary-Announces-2023-Haematologica-Editorial-Highlighting-NXC-201-Efficacy-In-The-Context-of-U-S-Food-And-Drug-Administration-Approved-BCMA-CAR-T-C.html,2023-03-31 12:00:00,"LOS ANGELES, March 31, 2023 ( GLOBE NEWSWIRE ) -- Nexcella, Inc., a subsidiary of Immix Biopharma, Inc. ( Nasdaq: IMMX ) ( ""ImmixBio"", ""Company"", ""We"" or ""Us"" ) today announced that an editorial written by Maria SjÃ¶strand and Michel Sadelain of Memorial Sloan Kettering Cancer Center was ...",JNJ,0.025845,0.055979,Neutral
Should iShares Russell 1000 Value ETF  ( IWD )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2072825/should-ishares-russell-1000-value-etf-iwd-be-on-your-investing-radar,2023-03-31 10:20:09,Style Box ETF report for ...,JNJ,0.126784,-0.022599,Neutral
Why Is Fate Therapeutics  ( FATE )  Down 8.9% Since Last Earnings Report?,https://www.zacks.com/stock/news/2072512/why-is-fate-therapeutics-fate-down-89-since-last-earnings-report,2023-03-30 15:30:40,Fate Therapeutics (FATE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,JNJ,0.087185,0.050374,Neutral
Amyotrophic Lateral Sclerosis Treatment Market Size to Hit USD 436.17 Million by 2027 at 5.52% CAGR Reported by Brandessence Market Research,https://www.prnewswire.com/news-releases/amyotrophic-lateral-sclerosis-treatment-market-size-to-hit-usd-436-17-million-by-2027-at-5-52-cagr-reported-by-brandessence-market-research-301785993.html,2023-03-30 14:20:00,Amyotrophic Lateral Sclerosis Treatment Market Size to Hit USD ... PR ...,JNJ,0.030759,0.160638,Somewhat-Bullish
2 Unstoppable Stocks to Buy Without Hesitation Right Now,https://www.fool.com/investing/2023/03/30/2-unstoppable-stocks-to-buy-this-month/,2023-03-30 13:20:00,These industry giants are going from strength to strength in a volatile market.,JNJ,0.204763,0.068822,Neutral
EDAP Reports Record Fourth Quarter and Full-Year 2022 Results and Announces Leadership Succession Plan to Develop Global Group Strategy,https://www.globenewswire.com/news-release/2023/03/30/2637451/9622/en/EDAP-Reports-Record-Fourth-Quarter-and-Full-Year-2022-Results-and-Announces-Leadership-Succession-Plan-to-Develop-Global-Group-Strategy.html,2023-03-30 10:30:00,"LYON, France, March 30, 2023 -- EDAP TMS SA ( Nasdaq: EDAP ) ( the ""Company"" ) , a global leader in robotic energy-based therapies, announced today unaudited financial results for the fourth quarter and full-year 2022 and announced a change in its leadership, effective May 1, 2023.",JNJ,0.020491,0.114063,Neutral
Should Schwab U.S. Large-Cap Value ETF  ( SCHV )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2072228/should-schwab-us-large-cap-value-etf-schv-be-on-your-investing-radar,2023-03-30 10:20:10,Style Box ETF report for ...,JNJ,0.11894,-0.025465,Neutral
Best Blue Chip Stocks To Invest In Right Now? 3 To Know,https://stockmarket.com/featured/best-blue-chip-stocks-to-invest-in-right-now-3-to-know-2023-03-29,2023-03-29 20:04:57,"Blue chip stocks are the metaphorical gold standard of the investing world. Generally, they represent well-established, financially stable, and consistently profitable companies that have demonstrated a long track record of success. These stocks are typically issued by large-cap companies.",JNJ,0.293741,0.09992,Neutral
"Johnson & Johnson Pulls Plug On Large Late-Stage Study Of RSV Vaccine Candidate; GSK, Pfizer Shots Are Under FDA Review - Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/general/biotech/23/03/31556135/johnson-johnson-pulls-plug-on-large-late-stage-study-of-rsv-vaccine-candidate-gsk-pfizer-shots-ar,2023-03-29 18:41:37,"After reviewing its portfolio to prioritize and assessing the respiratory syncytial virus ( RSV ) vaccine landscape, Janssen, a unit of Johnson & Johnson JNJ, will exit its investigational RSV adult vaccine program and discontinue its Phase 3 EVERGREEN study.",JNJ,0.514619,-0.045064,Neutral
"Grant Weinstein joins Performio as Head of Sales, APAC -- Performio Strengthens Global Sales Leadership Team",https://www.prnewswire.com/apac/news-releases/grant-weinstein-joins-performio-as-head-of-sales-apac--performio-strengthens-global-sales-leadership-team-301784328.html,2023-03-29 18:00:00,"Grant Weinstein joins Performio as Head of Sales, APAC ... PR ...",JNJ,0.071784,0.218563,Somewhat-Bullish
"Grant Weinstein joins Performio as Head of Sales, APAC -- Performio Strengthens Global Sales Leadership Team",https://www.prnewswire.com/news-releases/grant-weinstein-joins-performio-as-head-of-sales-apac--performio-strengthens-global-sales-leadership-team-301784161.html,2023-03-29 18:00:00,"Grant Weinstein joins Performio as Head of Sales, APAC ... PR ...",JNJ,0.071784,0.218563,Somewhat-Bullish
J&J backs out of RSV vaccine race with rivals Pfizer and GSK,https://www.cnbc.com/2023/03/29/jj-backs-out-of-rsv-vaccine-race-with-rivals-pfizer-and-gsk-.html,2023-03-29 16:28:06,"J&J lagged behind rival drugmakers Pfizer and GSK, both of which made major strides toward U.S. approval of their RSV vaccines in the last month.",JNJ,0.160099,0.039934,Neutral
Emergent Biosolutions  ( EBS )  Down 28.1% Since Last Earnings Report: Can It Rebound?,https://www.zacks.com/stock/news/2071947/emergent-biosolutions-ebs-down-281-since-last-earnings-report-can-it-rebound,2023-03-29 15:30:29,Emergent Biosolutions (EBS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,JNJ,0.042571,-0.112268,Neutral
"J&J Drops Out Of A Key Race With Pfizer, GSK, Moderna",https://www.investors.com/news/technology/jnj-stock-johnson-johnson-drops-out-of-rsv-vaccine-race-pfizer-gsk-moderna-duke-it-out/,2023-03-29 15:05:00,JNJ Stock: Johnson & Johnson Drops Out Of RSV Vaccine Race ... Investor's Business Daily ...,JNJ,0.526455,-0.155234,Somewhat-Bearish
J&J bows out of RSV vaccine race after scrapping trial,https://www.reuters.com/business/healthcare-pharmaceuticals/jj-bows-out-rsv-vaccine-race-after-scrapping-trial-2023-03-29/,2023-03-29 13:09:00,"March 29 ( Reuters ) - Johnson & Johnson ( JNJ.N ) said it will discontinue the late-stage study of its experimental respiratory syncytial virus ( RSV ) adult vaccine, weeks after rivals Pfizer and GSK gained a lead in the race for the first vaccine against the virus.",JNJ,0.146916,-0.039943,Neutral
"Got $5,000? These 2 Blue Chip Stocks Are Near Multi-Year Lows",https://www.fool.com/investing/2023/03/29/got-5000-these-2-blue-chip-stocks-are-near-multi-y/,2023-03-29 12:10:00,Both of these stocks also provide investors with attractive dividend yields of around 3%.,JNJ,0.521151,0.056892,Neutral
15 advertising executives leading the industry's charge into generative AI,https://www.businessinsider.com/agency-executives-leading-advertisers-charge-into-generative-ai-2023-3,2023-03-29 11:57:38,15 Advertising Executives Leading the Industry's Charge Into ... - Business Insider ...,JNJ,0.013261,0.094483,Neutral
Is It Time to Buy the Dow Jones' 3 Worst-Performing Stocks This Year?,https://www.fool.com/investing/2023/03/29/is-it-time-to-buy-these-dogs-of-the-dow-in-2023/,2023-03-29 09:33:00,"Curious about the ""dogs of the Dow"" in 2023? Here's what's happening in the darkest corner of Wall Street's most exclusive club.",JNJ,0.228073,0.077846,Neutral
"How a Janitor Built an $8 Million Fortune Without Touching Cryptos, Stock Options or Leverage",https://www.benzinga.com/news/23/03/31540765/how-a-janitor-built-an-8-million-fortune-without-touching-cryptos-stock-options-or-leverage,2023-03-28 23:21:43,Ronald Reid was the last person you would expect to be a millionaire. He used safety pins to hold his old coats together and cut his own firewood well into his 90s. He drove a second-hand Toyota Yaris and resisted new purchases.,JNJ,0.063594,0.010081,Neutral
Bristol Myers  ( BMY )  Gets Approval of Psoriasis Drug in EU,https://www.zacks.com/stock/news/2071518/bristol-myers-bmy-gets-approval-of-psoriasis-drug-in-eu,2023-03-28 19:22:00,Bristol Myers' (BMY) Sotyktu gets approval from the European Commission to treat adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy.,JNJ,0.065866,-0.036034,Neutral
CURE Media Group Announces the 2023 Extraordinary HealerÂ® Award Finalists,https://www.benzinga.com/pressreleases/23/03/g31537126/cure-media-group-announces-the-2023-extraordinary-healer-award-finalists,2023-03-28 19:02:01,"SAN ANTONIO, Texas, March 28, 2023 ( GLOBE NEWSWIRE ) -- CUREÂ®, the industry-leading multimedia platform devoted to cancer updates and research that reaches more than 1 million patients, survivors and caregivers, today announced the finalists for the 2023 Extraordinary HealerÂ® award.",JNJ,0.096091,0.084132,Neutral
Johnson & Johnson Unusual Options Activity - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/03/31537110/johnson-johnson-unusual-options-activity,2023-03-28 19:01:30,"Someone with a lot of money to spend has taken a bearish stance on Johnson & Johnson JNJ. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",JNJ,0.7629,0.281998,Somewhat-Bullish
Could This Drug Candidate Be a Winner for These 2 Big Pharma Stocks?,https://www.fool.com/investing/2023/03/28/could-this-drug-candidate-be-a-winner-for-these-2/,2023-03-28 14:15:00,These titans of big pharma just enrolled patients into phase 3 clinical trials for this promising blood thinner.,JNJ,0.195287,0.055534,Neutral
Should You Invest in the Fidelity MSCI Health Care Index ETF  ( FHLC ) ?,https://www.zacks.com/stock/news/2071149/should-you-invest-in-the-fidelity-msci-health-care-index-etf-fhlc,2023-03-28 10:20:08,Sector ETF report for ...,JNJ,0.127456,0.04982,Neutral
It's a Mistake to Ignore the Growth Potential of These 3 Dividend Stocks,https://www.fool.com/investing/2023/03/28/its-a-mistake-to-ignore-the-growth-potential-of-th/,2023-03-28 09:10:00,"Coca-Cola, J&J, and IBM are still solid long-term income investments.",JNJ,0.152821,0.157177,Somewhat-Bullish
Johnson & Johnson  ( JNJ )  Outpaces Stock Market Gains: What You Should Know,https://www.zacks.com/stock/news/2071013/johnson-johnson-jnj-outpaces-stock-market-gains-what-you-should-know,2023-03-27 21:45:19,"In the latest trading session, Johnson & Johnson (JNJ) closed at $153.30, marking a +0.43% move from the previous day.",JNJ,0.585687,0.324704,Somewhat-Bullish
ONWARD Reports 2022 Full Year Financial and Operating Results,https://www.globenewswire.com/news-release/2023/03/27/2635161/0/en/ONWARD-Reports-2022-Full-Year-Financial-and-Operating-Results.html,2023-03-27 18:00:00,"Company also Provides Business Update and Outlook for 2023 - Conference Call and Webcast ( in English ) March 28, 2023, at 2:00 PM CEST/8:00 AM EDT Company also Provides Business Update and Outlook for 2023 - Conference Call and Webcast ( in English ) March 28, 2023, at 2:00 PM CEST/8:00 AM ...",JNJ,0.015284,0.088117,Neutral
"Inflation, TikTok, and Other Hot Stories Investors Are Talking About",https://www.fool.com/investing/2023/03/27/inflation-tiktok-and-other-hot-stories-investors-a/,2023-03-27 16:27:55,"We've also got the latest in automotive, homebuilding, and the war on cash.",JNJ,0.005769,-0.00737,Neutral
Tencent's Cash Dividend Weighs On Meituan,https://www.forbes.com/sites/brendanahern/2023/03/27/tencents-cash-dividend-weighs-on-meituan/,2023-03-27 14:36:16,Asian equity markets were mixed overnight on light volumes as investors worried about financial contagion.,JNJ,0.057767,0.050009,Neutral
Johnson & Johnson  ( JNJ )  is Attracting Investor Attention: Here is What You Should Know,https://www.zacks.com/stock/news/2070711/johnson-johnson-jnj-is-attracting-investor-attention-here-is-what-you-should-know,2023-03-27 13:00:13,"Recently, Zacks.com users have been paying close attention to Johnson & Johnson (JNJ). This makes it worthwhile to examine what the stock has in store.",JNJ,0.477606,0.142359,Neutral
Business Coach Angeline Gillings: 4 Ways Transportation Executives Can Feel Comfortable Delegating,https://www.prnewswire.com/news-releases/business-coach-angeline-gillings-4-ways-transportation-executives-can-feel-comfortable-delegating-301781398.html,2023-03-27 12:51:00,Business Coach Angeline Gillings: 4 Ways Transportation ... PR ...,JNJ,0.055751,0.178937,Somewhat-Bullish
"Impact Biomedical Preparing A Potential Spinoff - What Does This Mean For Investors Of Holding Company DSS, Inc  ( NYSE American: DSS ) ? - DSS  ( AMEX:DSS ) , General Electric  ( NYSE:GE ) ",https://www.benzinga.com/general/biotech/23/03/31507945/impact-biomedical-preparing-a-potential-spinoff-what-does-this-mean-for-investors-of-holding-comp,2023-03-27 12:04:03,"Impact Biomedical, a biotechnology company focused on developing innovative treatments for a wide range of diseases and conditions and one of the key businesses in the DSS Inc. DSS portfolio, is preparing for a potential spinoff that could also have implications for the pharmaceutical industry at ...",JNJ,0.076358,0.134644,Neutral
Is WisdomTree U.S. Quality Dividend Growth ETF  ( DGRW )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2070607/is-wisdomtree-us-quality-dividend-growth-etf-dgrw-a-strong-etf-right-now,2023-03-27 10:20:09,Smart Beta ETF report for ...,JNJ,0.112008,0.059342,Neutral
"2 Clinical Research Stocks That Could Grow by More Than 10% This Year, and 1 to Watch",https://www.fool.com/investing/2023/03/25/2-clinical-research-stocks-that-could-grow-by-more/,2023-03-25 11:20:00,These companies strive to bring down the cost of developing new therapies.,JNJ,0.033656,0.061205,Neutral
Better Buy: AbbVie vs. Johnson & Johnson,https://www.fool.com/investing/2023/03/25/better-buy-abbvie-vs-johnson-johnson/,2023-03-25 09:30:00,These pharma giants beat the bear market last year.,JNJ,0.109206,0.156565,Somewhat-Bullish
"Orthopedic soft tissue repair devices market size to grow by USD 5,633.11 million from 2022 to 2027; The rising geriatric population across the globe will drive growth - Technavio",https://www.prnewswire.com/news-releases/orthopedic-soft-tissue-repair-devices-market-size-to-grow-by-usd-5-633-11-million-from-2022-to-2027-the-rising-geriatric-population-across-the-globe-will-drive-growth---technavio-301779859.html,2023-03-25 00:00:00,Orthopedic soft tissue repair devices market size to grow by USD ... PR ...,JNJ,0.047988,0.026993,Neutral
JNJ: 3 Popular Large-Cap Stocks to Buy Right Now,https://stocknews.com/news/jnj-v-mrk-imgo-3-popular-large-cap-stocks-to-buy-right-now/,2023-03-24 16:17:46,"The recent ups and downs of the stock market have been jarring inventors of late. Although the latest inflation and employment reports indicate a resilient economy, the Fed's persistence to quell inflation has caused widespread concerns about an economic slowdown.",JNJ,0.184422,0.133686,Neutral
2 Dow Stocks To Watch Today,https://stockmarket.com/featured/2-dow-stocks-to-watch-today-2023-03-24,2023-03-24 15:53:36,"The Dow Jones Industrial Average ( DJIA ) is one of the world's most popular stock market indices. It is made up of 30 large-cap blue-chip companies that are industry leaders in their respective fields. These businesses were chosen for their reputation, growth potential, and overall financial ...",JNJ,0.170275,0.190035,Somewhat-Bullish
Orthopedic Devices Market is Expected to Reach $48.1 billion | MarketsandMarkets.,https://www.benzinga.com/pressreleases/23/03/g31491185/orthopedic-devices-market-is-expected-to-reach-48-1-billion-marketsandmarkets,2023-03-24 13:30:00,"Chicago, March 24, 2023 ( GLOBE NEWSWIRE ) -- The orthopedic devices industry is expected to grow steadily over the next few years, driven by increasing demand for orthopedic devices as a result of rising rates of chronic conditions such as osteoarthritis and obesity, as well as increasing rates ...",JNJ,0.037446,-0.031419,Neutral
4 Healthcare Mutual Funds to Act as a Hedge Against Volatility,https://www.zacks.com/stock/news/2070104/4-healthcare-mutual-funds-to-act-as-a-hedge-against-volatility,2023-03-24 13:19:00,"Invest in healthcare funds like FSHCX, PCHSX, SWHFX, and VGHCX to diversify your portfolio against uncertain market conditions.",JNJ,0.043579,0.047785,Neutral
"Johnson & Johnson Loses Key Tuberculosis Drug Patent In India, Makes Way For Domestic Generic Players - Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/general/biotech/23/03/31488562/johnson-johnson-loses-key-tuberculosis-drug-patent-in-india-makes-way-for-domestic-generic-player,2023-03-24 13:06:52,"The Indian Patent Office rejected Johnson and Johnson's JNJ application to extend its patent on tuberculosis treatment, bedaquiline, beyond July 2023. The decision paves the way for the entry of cheaper generics by domestic players.",JNJ,0.560594,0.027517,Neutral
JNJ: 3 Large-Cap Pharma Stocks to Protect Your Portfolio Through 2023,https://stocknews.com/news/jnj-mrk-bmy-3-large-cap-pharma-stocks-to-protect-your-portfolio-through-2023/,2023-03-24 13:06:18,JNJ: 3 Large-Cap Pharma Stocks to Protect Your Portfolio Through ... ...,JNJ,0.222582,0.158851,Somewhat-Bullish
JNJ: 4 Best Pharma Stocks to Buy for the Long Haul,https://stocknews.com/news/jnj-azn-nvs-bmy-abmd-cinc-4-best-pharma-stocks-to-buy-for-the-long-haul/,2023-03-24 12:33:33,"Despite the banking crisis, the Fed raised interest rates by a quarter of a percentage point, bringing the benchmark funds rate to a range of 4.75% to 5%, the highest since October 2007.",JNJ,0.178624,0.194087,Somewhat-Bullish
Is iShares Core Dividend Growth ETF  ( DGRO )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2069990/is-ishares-core-dividend-growth-etf-dgro-a-strong-etf-right-now,2023-03-24 10:20:08,Smart Beta ETF report for ...,JNJ,0.123209,0.061659,Neutral
"World TB Day: Equitable access to treatments, adherence and timely diagnosis still a challenge in India | The Financial Express",https://www.financialexpress.com/healthcare/news-healthcare/world-tb-day-equitable-access-to-treatments-adherence-and-timely-diagnosis-still-a-challenge-in-india/3021000/,2023-03-24 08:26:00,"World TB Day: Equitable access to treatments, adherence and timely ... The Financial Express ...",JNJ,0.024126,-0.033919,Neutral
"NEI sets human rights, inequality, net zero, nature as focus themes for corporate engagement",https://www.benzinga.com/pressreleases/23/03/n31483109/nei-sets-human-rights-inequality-net-zero-nature-as-focus-themes-for-corporate-engagement,2023-03-23 20:30:00,"Focus theme topics include digital rights, human capital, reducing methane emissions, and deforestation 40 companies identified for engagement include Apple, Meta, Johnson & Johnson, Lowe's, Microsoft, NextEra Energy, Taiwan Semiconductor, and Canada's banks",JNJ,0.073773,0.023616,Neutral
"NEI sets human rights, inequality, net zero, nature as focus themes for corporate engagement",https://www.newswire.ca/news-releases/nei-sets-human-rights-inequality-net-zero-nature-as-focus-themes-for-corporate-engagement-847177464.html,2023-03-23 20:30:00,"NEI sets human rights, inequality, net zero, nature as focus themes ... Canada ...",JNJ,0.038655,-0.011913,Neutral
JNJ: The Strongest Pharma Stock This Week,https://stocknews.com/news/jnj-nvo-bmy-nvs-the-strongest-pharma-stock-this-week/,2023-03-23 17:31:12,"Despite the current banking crisis, the Federal Reserve went ahead with a 25-basis-point interest rate hike, bringing the federal funds rate to a new range of 4.75% to 5%, the highest since October 2007.",JNJ,0.501568,0.371769,Bullish
J&J Loses Key Tuberculosis Drug Patent In India,https://www.barrons.com/news/j-j-loses-key-tuberculosis-drug-patent-in-india-f83f3333,2023-03-23 17:05:50,"India's Patent Office rejected on Thursday US pharmaceutical giant Johnson and Johnson's application to extend its patent on a key tuberculosis treatment, allowing local companies to make cheaper generic versions.",JNJ,0.381463,-0.109221,Neutral
Cidara's Lower Than Expected Q4 Earnings Overshadows FDA Nod For Antifungal Treatment - Cidara Therapeutics  ( NASDAQ:CDTX ) ,https://www.benzinga.com/general/biotech/23/03/31474735/cidaras-lower-than-expected-q4-earnings-overshadows-fda-nod-for-antifungal-treatment,2023-03-23 14:35:33,"The FDA approved Cidara Therapeutics Inc's CDTX antifungal Rezzayo ( rezafungin ) under priority review for treating candidemia and invasive candidiasis in adults with limited or no alternative treatment options, the company announced Wednesday.",JNJ,0.15347,0.136653,Neutral
"Have $1,000? 2 Smart Stocks to Buy This Month",https://www.fool.com/investing/2023/03/23/have-1000-2-smart-stocks-to-buy-this-month/,2023-03-23 14:15:00,The market is still giving investors great opportunities to buy exceptional companies.,JNJ,0.275867,0.146332,Neutral
Janssen's tuberculosis drug patent application gets rejected; Generics to be available soon | The Financial Express,https://www.financialexpress.com/healthcare/pharma-healthcare/janssens-tuberculosis-drug-patent-application-gets-rejected-generics-to-be-soon-available/3020205/,2023-03-23 13:41:00,Janssen's tuberculosis drug patent application gets rejected ... The Financial Express ...,JNJ,0.08687,-0.046623,Neutral
3 Safe Dow Dividend Stocks to Buy Now,https://www.fool.com/investing/2023/03/23/3-safe-dow-dividend-stocks-to-buy-now/,2023-03-23 13:07:36,These companies combine regimented growth with income for a balanced overall value.,JNJ,0.134214,0.012064,Neutral
Biopharmaceuticals Market Growth: Worth $700Bn by 2028 Led by Monoclonal Antibodies Held Market Share of 48.42% in 2022 | The Insight Partners,https://www.benzinga.com/pressreleases/23/03/g31473568/biopharmaceuticals-market-growth-worth-700bn-by-2028-led-by-monoclonal-antibodies-held-market-shar,2023-03-23 12:46:11,"New York, March 23, 2023 ( GLOBE NEWSWIRE ) -- According to The Insight Partners, ""Biopharmaceuticals Market Size, Share, Trends, Growth and Report Forecasts to 2028 - COVID-19 Impact and Global Analysis By Product Type ( Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, ...",JNJ,0.0362,0.086993,Neutral
Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results,https://www.globenewswire.com/news-release/2023/03/23/2633001/0/en/Cidara-Therapeutics-Provides-Corporate-Update-and-Reports-Fourth-Quarter-and-Full-Year-2022-Financial-Results.html,2023-03-23 11:12:00,"SAN DIEGO, March 23, 2023 ( GLOBE NEWSWIRE ) -- Cidara Therapeutics, Inc. ( Nasdaq: CDTX ) , a biotechnology company developing long-acting therapeutics designed to help improve the standard of care for patients facing serious diseases, today reported financial results for the three months and ...",JNJ,0.018861,0.038629,Neutral
Is Vanguard High Dividend Yield ETF  ( VYM )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2069411/is-vanguard-high-dividend-yield-etf-vym-a-strong-etf-right-now,2023-03-23 10:20:09,Smart Beta ETF report for ...,JNJ,0.116631,0.066983,Neutral
Should Vanguard Russell 1000 Value ETF  ( VONV )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2069417/should-vanguard-russell-1000-value-etf-vonv-be-on-your-investing-radar,2023-03-23 10:20:06,Style Box ETF report for ...,JNJ,0.127795,0.069696,Neutral
Talc Plaintiffs Will Press to Reopen Courthouse Doors - Investing News Network,https://investingnews.com/talc-plaintiffs-will-press-to-reopen-courthouse-doors/,2023-03-22 20:59:23,Talc Plaintiffs Will Press to Reopen Courthouse Doors Investing News Network ...,JNJ,0.185306,-0.156731,Somewhat-Bearish
J&J to seek US Supreme Court review on unit's bankruptcy,https://www.foxbusiness.com/healthcare/johnson-johnson-seek-us-supreme-court-review-units-bankruptcy,2023-03-22 18:45:25,"Johnson & Johnson said on Wednesday that it would ask the U.S. Supreme Court to revive its effort to resolve tens of thousands of lawsuits over its talc products through the bankruptcy of a subsidiary, after an appeals court refused to reconsider its ruling that the bankruptcy was improper.",JNJ,0.110973,-0.100566,Neutral
Looking At Johnson & Johnson's Recent Unusual Options Activity - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/03/31460535/looking-at-johnson-johnsons-recent-unusual-options-activity,2023-03-22 16:31:59,"Someone with a lot of money to spend has taken a bullish stance on Johnson & Johnson JNJ. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",JNJ,0.691995,0.343654,Somewhat-Bullish
Thinking of Buying Biotech Stocks? Do These 3 Things First,https://www.fool.com/investing/2023/03/22/thinking-of-biotech-stocks-do-these-3-things-first/,2023-03-22 14:15:00,It's better to plan ahead than to get caught by surprise.,JNJ,0.060694,-0.015045,Neutral
"Think the Bear Market Is Over? Here's How to Invest $5,000",https://www.fool.com/investing/2023/03/22/think-the-bear-market-is-over-heres-how-to-invest/,2023-03-22 13:45:00,The worst might be in the rearview mirror as far as the latest bear market is concerned.,JNJ,0.186738,0.262226,Somewhat-Bullish
2 Stocks That Should Be Better Buys After Their Spinoffs This Year,https://www.fool.com/investing/2023/03/22/2-stocks-that-should-be-better-buys-after-their-sp/,2023-03-22 10:38:00,The growth prospects for these two businesses should improve as they become leaner.,JNJ,0.352557,0.386073,Bullish
3 Signs That It's Time to Sell Your Favorite Biotech Stock,https://www.fool.com/investing/2023/03/22/signs-its-time-to-sell-favorite-biotech-stock/,2023-03-22 09:31:00,It's in your interest to know when things aren't going to go your way with a stock.,JNJ,0.051441,-0.041678,Neutral
"Hywin Holdings, Leonteq AG, and ARTA TechFin jointly launch principal-protected note linked to FactSet Hywin Global Health Care Indexâ„¢",https://www.globenewswire.com/news-release/2023/04/11/2644010/0/en/Hywin-Holdings-Leonteq-AG-and-ARTA-TechFin-jointly-launch-principal-protected-note-linked-to-FactSet-Hywin-Global-Health-Care-Index.html,2023-04-11 00:00:00,"HONG KONG, April 11, 2023 ( GLOBE NEWSWIRE ) -- Hywin Holdings Ltd. ( ""Hywin Wealth"" or ""Hywin"" ) ( NASDAQ: HYW ) , a leading independent wealth management service provider in China, Leonteq Securities AG ( ""Leonteq"" ) , a Swiss fintech company with a leading marketplace for structured ...",JNJ,0.036869,0.079891,Neutral
"Hywin Holdings, Leonteq AG, and ARTA TechFin jointly launch principal-protected note linked to FactSet Hywin Global Health Care Indexâ„¢ - Hywin Holdings  ( NASDAQ:HYW ) ",https://www.benzinga.com/pressreleases/23/04/g31736283/hywin-holdings-leonteq-ag-and-arta-techfin-jointly-launch-principal-protected-note-linked-to-facts,2023-04-11 00:00:00,"HONG KONG, April 11, 2023 ( GLOBE NEWSWIRE ) -- Hywin Holdings Ltd. ( ""Hywin Wealth"" or ""Hywin"" ) HYW, a leading independent wealth management service provider in China, Leonteq Securities AG ( ""Leonteq"" ) , a Swiss fintech company with a leading marketplace for structured investment solutions, ...",JNJ,0.036091,0.079702,Neutral
Johnson & Johnson  ( JNJ )  Stock Sinks As Market Gains: What You Should Know,https://www.zacks.com/stock/news/2076534/johnson-johnson-jnj-stock-sinks-as-market-gains-what-you-should-know,2023-04-10 21:45:25,"In the latest trading session, Johnson & Johnson (JNJ) closed at $164.32, marking a -0.5% move from the previous day.",JNJ,0.606946,0.222507,Somewhat-Bullish
An Investor's View of Johnson & Johnson's Talc Settlement,https://www.fool.com/investing/2023/04/10/an-investors-view-of-johnson-johnsons-talc-settlem/,2023-04-10 19:37:40,We also take a look at Chewy's growth initiatives.,JNJ,0.043201,-0.094575,Neutral
Looking At Johnson & Johnson's Recent Unusual Options Activity - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/04/31732168/looking-at-johnson-johnsons-recent-unusual-options-activity,2023-04-10 18:46:09,"A whale with a lot of money to spend has taken a noticeably bearish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson JNJ we detected 15 strange trades. If we consider the specifics of each trade, it is accurate to state that 46% of the investors opened trades with ...",JNJ,0.736015,0.046453,Neutral
Raydiant Launches Task Management Feature on Employee Experience  ( EX )  Platform to Better Engage Brick-and-Mortar Workers,https://www.prnewswire.com/news-releases/raydiant-launches-task-management-feature-on-employee-experience-ex-platform-to-better-engage-brick-and-mortar-workers-301793367.html,2023-04-10 15:45:00,Raydiant Launches Task Management Feature on Employee ... PR ...,JNJ,0.073321,0.132793,Neutral
3 Things About Johnson & Johnson Smart Investors Know,https://www.fool.com/investing/2023/04/10/things-about-johnson-johnson-smart-investors-know/,2023-04-10 15:39:37,The healthcare giant's stock is looking like less of a safe bet than it was in the past.,JNJ,0.175859,-0.016275,Neutral
Pfizer CEO signs letter in support of FDA after federal judge suspends approval of abortion pill,https://www.cnbc.com/2023/04/10/abortion-pill-ruling-pfizer-ceo-signs-letter-in-support-of-fda.html,2023-04-10 15:34:02,Pfizer's CEO was among the more than 200 pharmaceutical company executives who signed the letter after a federal judge's controversial ruling on mifepristone.,JNJ,0.155451,0.0,Neutral
"AbbVie  ( ABBV ) , J&J to Withdraw 2 Blood Cancer Nods for Imbruvica",https://www.zacks.com/stock/news/2076361/abbvie-abbv-jj-to-withdraw-2-blood-cancer-nods-for-imbruvica,2023-04-10 15:03:00,AbbVie (ABBV)/J&J's (JNJ) decision to withdraw the FDA's accelerated approval for Imbruvica in two blood cancer treatments is based on confirmatory studies data that do not support full approval.,JNJ,0.251032,0.061028,Neutral
3 Sector ETFs to Play as Recession Fears Are on the Rise,https://www.zacks.com/stock/news/2076344/3-sector-etfs-to-play-as-recession-fears-are-on-the-rise,2023-04-10 14:41:00,"With recession fears on the rise, look into some sectors that can shield from market volatility.",JNJ,0.116914,-0.021983,Neutral
Can You Still Buy the Dow Jones' Best-Performing April Stocks?,https://www.fool.com/investing/2023/04/10/can-you-still-buy-the-dow-jones-best-performing-ap/,2023-04-10 13:05:00,"Each is benefiting from recent good news, but there's also a theme-based tailwind brewing that could last a while.",JNJ,0.158519,0.117766,Neutral
Investors Heavily Search Johnson & Johnson  ( JNJ ) : Here is What You Need to Know,https://www.zacks.com/stock/news/2076171/investors-heavily-search-johnson-johnson-jnj-here-is-what-you-need-to-know,2023-04-10 13:00:13,"Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",JNJ,0.47672,0.15377,Somewhat-Bullish
How Johnson & Johnson's Attempt At A $9 Billion Baby Powder Settlement Impacts Black Women,https://www.forbes.com/sites/korihale/2023/04/10/how-johnson--johnsons-attempt-at-a-9-billion-baby-powder-settlement-impacts-black-women/,2023-04-10 12:46:34,"Pharmaceutical giant Johnson & Johnsonï»¿JNJï»¿ wants to do a one-time lump sum payment of at least $8.9 billion to thousands of talc-powder claimants. For Black women, who were selected by J&J as ""the right place"" to sell more baby powder to,"" this is perhaps an opportunity for financial reciprocity.",JNJ,0.306963,-0.016151,Neutral
Northpass Launches First of a Kind Resources to Help Companies Scale Customer Success Through Digital Customer Education,https://www.prnewswire.com/news-releases/northpass-launches-first-of-a-kind-resources-to-help-companies-scale-customer-success-through-digital-customer-education-301793165.html,2023-04-10 12:14:00,Northpass Launches First of a Kind Resources to Help Companies ... PR ...,JNJ,0.063763,0.251543,Somewhat-Bullish
"The European Patent Office announced U.S. companies and inventors filed more patent applications in Europe in 2022, buoyed by innovation in digital communication and semiconductors",https://www.prnewswire.com/news-releases/the-european-patent-office-announced-us-companies-and-inventors-filed-more-patent-applications-in-europe-in-2022-buoyed-by-innovation-in-digital-communication-and-semiconductors-301793057.html,2023-04-10 11:00:00,The European Patent Office announced U.S. companies and ... PR ...,JNJ,0.100729,0.082971,Neutral
2 Warren Buffett Favorites to Buy on the Dip,https://www.fool.com/investing/2023/04/10/2-warren-buffett-favorites-to-buy-on-the-dip/,2023-04-10 09:30:00,These stocks have what it takes to perform over the long term.,JNJ,0.12013,0.155535,Somewhat-Bullish
2 Top Stocks to Buy in April and Hold Forever,https://www.fool.com/investing/2023/04/08/2-top-stocks-to-buy-in-april-and-hold-forever/,2023-04-08 11:39:00,The need for healthcare goods and/or services is here to stay.,JNJ,0.062597,0.142085,Neutral
S&P 500 Volatility Continues As Investors Digest Latest Labor Market Data - SPDR S&P 500  ( ARCA:SPY ) ,https://www.benzinga.com/news/23/04/31714148/s-p-500-volatility-continues-as-investors-digest-latest-labor-market-data,2023-04-07 19:20:33,"The SPDR S&P 500 ETF Trust SPY snapped a three-week winning streak as the latest economic data suggests the U.S. labor market is cooling. On Friday, the Labor Department reported the U.S. economy added 236,000 jobs in March, just shy of economist estimates of 240,000 new jobs.",JNJ,0.28442,-0.29254,Somewhat-Bearish
Unemployment Report Out Today: Here's The Latest On The Job Market,https://www.forbes.com/sites/qai/2023/04/07/unemployment-report-out-today-heres-the-latest-on-the-job-market/,2023-04-07 14:33:41,"This follows on from the ADP private payrolls report and the jobless claims data from earlier in the week, giving us a solid overview of where the job market is at right now.",JNJ,0.032825,0.050541,Neutral
2 Supercharged Dividend Stocks to Buy If There's a Stock Market Sell-Off,https://www.fool.com/investing/2023/04/07/2-supercharged-dividend-stocks-to-buy-if-theres-a/,2023-04-07 14:00:00,These two pharma stocks have kept their businesses stable and have steadily paid dividends.,JNJ,0.1331,0.046135,Neutral
"B2B start-up ElasticRun takes a step back, to focus on core strategy",https://www.business-standard.com/companies/start-ups/b2b-startup-elasticrun-takes-a-step-back-refocuses-on-core-strategy-123040700638_1.html,2023-04-07 13:26:32,ElasticRun extends the reach of a brand's direct distribution network to deep rural markets ...,JNJ,0.086556,0.105998,Neutral
This Industry Leader Will Have to Spend Big if It Wants to Keep Growing,https://www.fool.com/investing/2023/04/07/industry-leader-spend-big-growing-realty-income/,2023-04-07 09:57:00,"Realty Income is a giant in the net-lease REIT space, but investors need to understand this can be both good and bad.",JNJ,0.055621,0.046097,Neutral
Lanier Law Firm Responds to Proposed Plan to Resolve Talc Litigation,https://www.prnewswire.com/news-releases/lanier-law-firm-responds-to-proposed-plan-to-resolve-talc-litigation-301792283.html,2023-04-07 02:16:00,Lanier Law Firm Responds to Proposed Plan to Resolve Talc ... PR ...,JNJ,0.16849,-0.085165,Neutral
Build a Unique Portfolio with 3 Top Ranked ETFs,https://www.zacks.com/commentary/2075769/build-a-unique-portfolio-with-3-top-ranked-etfs,2023-04-06 19:38:00,The universe of ETFs these days is practically as diverse as the whole stock market ...,JNJ,0.099683,0.068892,Neutral
Will Bristol Myers  ( BMY )  Gain From New Drugs' Label Expansion?,https://www.zacks.com/stock/news/2075733/will-bristol-myers-bmy-gain-from-new-drugs-label-expansion,2023-04-06 16:44:00,Label expansion of Bristol Myers' (BMY) new drugs should help it somewhat combat the decline in Revlimid sales due to generic competition.,JNJ,0.053992,-0.023887,Neutral
2 Elite Dividend Stocks That Won't Wilt in a Recessionary Environment,https://www.fool.com/investing/2023/04/06/2-elite-dividend-stocks-that-wont-wilt-in-a-recess/,2023-04-06 13:45:00,"Johnson & Johnson and Ford have resilient businesses, stellar dividend programs, and wide economic moats.",JNJ,0.13347,0.323483,Somewhat-Bullish
Boston Scientific  ( BSX )  Hits 52-Week High: What's Driving It?,https://www.zacks.com/stock/news/2075403/boston-scientific-bsx-hits-52-week-high-whats-driving-it,2023-04-06 13:05:00,Boston Scientific (BSX) outperforms the industry and the S&P 500 due to several new acquisitions and the long-term growth prospects of the WATCHMAN device.,JNJ,0.045482,0.069733,Neutral
Here's Why Chevron Is a No-Brainer Dividend Stock,https://www.fool.com/investing/2023/04/06/heres-why-chevron-is-a-no-brainer-dividend-stock/,2023-04-06 12:45:00,The integrated oil giant has proven it knows how to handle adversity while continuing to grow its dividend.,JNJ,0.060236,0.033248,Neutral
Johnson & Johnson  ( JNJ )  Soars 4.5%: Is Further Upside Left in the Stock?,https://www.zacks.com/stock/news/2075276/johnson-johnson-jnj-soars-45-is-further-upside-left-in-the-stock,2023-04-06 08:05:00,Johnson & Johnson (JNJ) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.,JNJ,0.47672,0.440368,Bullish
Asian shares mostly fall amid worries about slowing economy,https://apnews.com/article/stock-markets-banks-rates-recession-b123b54a2436b2afd62fb2a9fad26149,2023-04-06 07:05:59,"A man walks near a sign of foreign currency outside a money exchange office at a shopping district in Seoul, South Korea, Thursday, April 6, 2023. Asian shares were trading mostly lower Thursday as investors turned their attention to upcoming earnings reports and other economic indicators. ( AP ...",JNJ,0.05387,-0.018058,Neutral
S&P 500 ends lower as recession fears take center stage,https://www.moneycontrol.com/news/business/markets/sp-500-ends-lower-as-recession-fears-take-center-stage-10369971.html,2023-04-06 00:34:25,Nvidia Corp ( NVDA.O ) dropped 2.1% and was among the stocks weighing most on the SP 500 after Alphabet Inc's ( GOOGL.O ) Google unit said the supercomputers it uses to train its artificial intelligence models were faster and more power-efficient than comparable components made by the chipmaker.,JNJ,0.058047,0.181129,Somewhat-Bullish
"Look to 3 'great American companies' in this market, Jim Cramer says",https://www.cnbc.com/2023/04/05/look-to-3-great-american-companies-in-this-market-jim-cramer-says.html,2023-04-05 22:45:53,"There are three companies that Cramer thinks have compelling stories and strength: Johnson & Johnson, Eli Lilly, and Procter & Gamble.",JNJ,0.217834,-0.165418,Somewhat-Bearish
"J&J, Walmart Lift Dow In Down Day For US Stocks",https://www.barrons.com/news/j-j-walmart-lift-dow-in-down-day-for-us-stocks-cdb4b0c4,2023-04-05 20:30:57,"Wall Street stocks mostly fell on Wednesday following data that showed a weakening US economy, but the Dow advanced on gains by Johnson & Johnson and Walmart.",JNJ,0.269776,-0.033677,Neutral
Cash Is 'In Jeopardy': World's Largest Hedge Fund Founder Ray Dalio Says but Sees an Unexpected Solution,https://www.benzinga.com/markets/cryptocurrency/23/04/31688001/cash-is-in-jeopardy-worlds-largest-hedge-fund-founder-ray-dalio-says-but-sees-an-unexpecte,2023-04-05 20:30:53,"Inflation has been a massive issue for nearly every major country for the past year or so. Consumers and corporations alike have felt the pain, with the previous four quarters of earnings proving to be relatively lackluster. While inflation is slowly declining, it has caused the debt of the U.S. ...",JNJ,0.109956,0.076502,Neutral
How major US stock indexes fared Wednesday 4/5/2023,https://apnews.com/article/business-johnson-and-stocks-bonds-financial-markets-4a7e173a96d68514a8ebc2bc7a7dd35b,2023-04-05 20:17:35,Stocks closed lower on Wall Street Wednesday and Treasury yields fell following the latest signals that the U.S. economy is slowing. The S&P 500 slid 0.2% and the Nasdaq lost 1.1%. Reports on both services industries and the jobs market came in weaker than expected.,JNJ,0.245339,-0.102909,Neutral
Stock Market Today: Weak Economic Data Weighs on Stocks,https://www.kiplinger.com/investing/stocks/stock-market-today-weak-economic-data-weighs-on-stocks,2023-04-05 20:15:25,Weakness in the tech sector and strength in healthcare stocks resulted in a mixed finish for the major indexes Wednesday. It's already been a shaky week for stocks as recent economic data elevated worries about a potential recession this year.,JNJ,0.107255,-0.026347,Neutral
Why Johnson & Johnson Stock Was Climbing Today,https://www.fool.com/investing/2023/04/05/why-johnson-johnson-stock-was-climbing-today/,2023-04-05 19:38:42,The healthcare giant reached a $8.9 billion settlement over allegations that its baby powder caused cancer.,JNJ,0.560594,0.238591,Somewhat-Bullish
JNJ: Investors Are Keeping This Healthcare Stock Long-Term,https://stocknews.com/news/jnj-nvo-nvs-bmy-abmd-investors-are-keeping-this-healthcare-stock-long-term/,2023-04-05 19:25:40,JNJ: Investors Are Keeping This Healthcare Stock ...,JNJ,0.488161,0.405846,Bullish
This portfolio manager's frugality and eye for income protected her fund from the worst of 2022's tumult,https://www.cnbc.com/2023/04/05/this-portfolio-managers-eye-for-income-protected-her-fund-from-2022s-tumult.html,2023-04-05 18:51:07,"Ramona Persaud manages the Fidelity Equity-Income Fund (FEQIX). The fund posted a total return of -5.07% in 2022, avoiding the worst of last year's turmoil.",JNJ,0.048327,-0.010026,Neutral
J&J's $8.9 Billion Agreement Doesn't End Its Talc Worries,https://www.barrons.com/articles/johnson-johnson-talc-lawsuit-settlement-bc2d3aea,2023-04-05 18:41:00,Will J&J's $8.9 Billion Talc Agreement Make It Through the Courts? ...,JNJ,0.795061,-0.451557,Bearish
Stock Market Posts Mixed Results; Health Care Stocks Lead The Day,https://www.investors.com/market-trend/stock-market-today/stock-market-posts-mixed-results-health-care-stocks-lead/,2023-04-05 17:50:00,Stock Market Posts Mixed Results. Health Care Stocks Lead The Day Investor's Business Daily ...,JNJ,0.215574,0.003466,Neutral
"Stocks making the biggest moves midday: Nvidia, Palantir, Western Alliance, Johnson & Johnson and more",https://www.cnbc.com/2023/04/05/stocks-moving-big-midday-nvda-pltr-wal-jnj.html,2023-04-05 16:57:59,These are the stocks posting the largest moves in midday trading.,JNJ,0.068698,-0.092778,Neutral
IBD Stock Of The Day: Why 2024 Could Be A Game-Changer,https://www.investors.com/research/ibd-stock-of-the-day/isrg-stock-why-2024-could-be-a-game-changer-for-robotic-surgery/,2023-04-05 16:28:00,ISRG Stock: Why 2024 Could Be A Game-Changer For Robotic ... Investor's Business Daily ...,JNJ,0.202932,0.028709,Neutral
Club meeting recap: Jim Cramer says 'the existential threat is gone for J&J',https://www.cnbc.com/2023/04/05/jim-cramer-says-the-existential-threat-is-gone-for-jj-.html,2023-04-05 16:23:16,"The Investing Club holds its ""Morning Meeting"" every weekday at 10:20 a.m. ET.",JNJ,0.219477,0.075777,Neutral
Dow Jones Rises But Big Tech Gets Sold; Gold Holds $2000; Johnson & Johnson Settles Baby Powder Claims,https://www.investors.com/market-trend/stock-market-today/dow-jones-rises-but-big-tech-gets-sold-gold-holds-2000-johnson-johnson-settles-baby-powder-claims/,2023-04-05 14:50:00,Dow Jones Rises But Big Tech Gets Sold. Gold Holds $2000 ... Investor's Business Daily ...,JNJ,0.256989,-0.07716,Neutral
"Johnson & Johnson to pay $8.9B to resolve claims baby powder, talc products caused cancer",https://www.foxbusiness.com/retail/johnson-johnson-to-pay-resolve-claims-baby-powder-talc-products-caused-cancer,2023-04-05 14:48:13,Johnson & Johnson announced Tuesday that it would pay $8.9 billion to resolve all allegations that talc in its baby powder and other products caused cancer. That amount was more than quadruple what the company previously set aside to pay for its potential liability.,JNJ,0.264897,-0.219463,Somewhat-Bearish
Johnson & Johnson shares rise after company proposes baby powder cancer settlement,https://www.cnbc.com/2023/04/05/johnson-and-johnson-shares-rise-talc-settlement.html,2023-04-05 14:46:29,Wall Street analysts were encouraged by J&J's proposal to pay $8.9 billion to settle claims that its baby powder and other talc products caused cancer.,JNJ,0.092927,-0.073817,Neutral
J&J Sweetens Its Talc Deal By $7 Billion And Shares Pop,https://www.investors.com/news/technology/jnj-stock-rises-after-sweetening-its-talc-settlement/,2023-04-05 14:19:00,JNJ Stock Rises After Sweetening Its Talc Settlement By $6.9 Billion ... Investor's Business Daily ...,JNJ,0.731269,-0.140861,Neutral
US Stocks Mixed As Data Suggests Slowing Economy,https://www.barrons.com/news/us-stocks-mixed-as-data-suggests-slowing-economy-4f7078ac,2023-04-05 13:56:59,"Wall Street stocks were mixed Wednesday as markets digested employment and trade data that suggest a slowing in the economy. Employers added 145,000 jobs last month, according to payroll firm ADP, much below the February level and weaker than analysts expected.",JNJ,0.192694,0.003186,Neutral
J&J  ( JNJ )  Offers $8.9B Settlement for Talc Cancer Lawsuits,https://www.zacks.com/stock/news/2074891/jj-jnj-offers-89b-settlement-for-talc-cancer-lawsuits,2023-04-05 13:53:00,"To completely resolve its cosmetic talc litigation, J&J (JNJ) offers a settlement amount of $8.9 billion payable over a period of 25 years.",JNJ,0.108222,-0.129435,Neutral
"Farallon Capital Might Undertake Proxy Fight Against Exelixis, Nominates Three Directors - Exelixis  ( NASDAQ:EXEL ) ",https://www.benzinga.com/general/biotech/23/04/31674132/farallon-capital-might-undertake-proxy-fight-against-exelixis-nominates-three-directors,2023-04-05 13:17:13,"Farallon Capital Management is planning to start a proxy battle at Exelixis Inc EXEL and has nominated three director candidates, it signaled in an SEC filing. The firm hadn't decided to move forward with a proxy fight, Wall Street Journal reported and was still trying to work with the company.",JNJ,0.277433,0.0,Neutral
What's Going On With Johnson & Johnson Stock? - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/news/23/04/31677727/whats-going-on-with-johnson-johnson-stock,2023-04-05 13:15:03,Johnson & Johnson JNJ shares are trading higher Wednesday after the company's subsidiary LTL Management re-filed for bankruptcy to resolve all talc-based baby powder claims.,JNJ,0.77688,-0.049042,Neutral
Better Dividend Stock: AbbVie vs. Johnson & Johnson,https://www.fool.com/investing/2023/04/05/better-dividend-stock-abbvie-vs-johnson-johnson/,2023-04-05 12:55:00,Both companies have a lot to offer income-seekers.,JNJ,0.416844,0.393482,Bullish
"J&J's on the Rise, but This Fintech Stock Is Falling Hard",https://www.fool.com/investing/2023/04/05/jjs-on-the-rise-but-this-fintech-stock-is-falling/,2023-04-05 12:52:51,Investors looked prepared for a quiet stock market open on Wednesday morning.,JNJ,0.310843,0.207908,Somewhat-Bullish
"Jim Cramer's top 10 things to watch in the stock market Wednesday: New dawn for JNJ, Disney push, Meta upgrade",https://www.cnbc.com/2023/04/05/cramers-things-to-watch-in-stock-market-wednesday.html,2023-04-05 12:51:53,"Big victory for an embattled Club name, positive analyst calls for META and Apple.",JNJ,0.25168,0.031223,Neutral
Futures Turn Mixed After ADP Jobs Data,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-fall-ahead-of-adp-jobs-data-c3-ai-extends-losses-after-short-seller-letter/,2023-04-05 12:21:00,Dow Jones Futures Fall On Weak ADP Jobs Data. C3.ai Extends ... Investor's Business Daily ...,JNJ,0.089685,-0.193354,Somewhat-Bearish
"Global Non-Invasive Surgical Wound Closure Market Size and Share Revenue to Surpass $25.64 Billion by 2030, Exhibit a CAGR of 7.2%",https://www.benzinga.com/pressreleases/23/04/g31676572/global-non-invasive-surgical-wound-closure-market-size-and-share-revenue-to-surpass-25-64-billion-,2023-04-05 12:08:34,"Boston, MA, April 05, 2023 ( GLOBE NEWSWIRE ) -- Zion Market Research has published a new research report titled ""Non-Invasive Surgical Wound Closure Market By Product Type ( Adhesive, Natural, Synthetic, , Hemostats, Mechanical Active, Flowable, Sealants, Fibrin, And Surgical ) , By Application ...",JNJ,0.017394,-0.033482,Neutral
J&J rises as $8.9 bln talc lawsuit settlement eases overhang on consumer unit spinoff,https://www.reuters.com/business/healthcare-pharmaceuticals/jj-rises-89-bln-talc-lawsuit-settlement-eases-overhang-consumer-unit-spinoff-2023-04-05/,2023-04-05 12:01:00,J&J rises as $8.9 bln talc lawsuit settlement eases overhang on ... ...,JNJ,0.116914,0.0,Neutral
2 Dividend Kings That Are Likely to Raise Their Payouts This Month,https://www.fool.com/investing/2023/04/05/2-dividend-kingsthat-are-likely-to-raise-their-pay/,2023-04-05 12:00:00,These companies have been increasing their dividends for a combined 126 years.,JNJ,0.353562,0.244493,Somewhat-Bullish
"Stocks making the biggest moves premarket: Johnson & Johnson, FedEx, Zions and more",https://www.cnbc.com/2023/04/05/stocks-making-the-biggest-moves-premarket-jnj-fdx-zion.html,2023-04-05 11:59:48,FedEx's shares gained more than 2% before the bell after announcing a dividend hike and a corporate reorganization.,JNJ,0.118647,-0.122099,Neutral
"The daily business briefing: April 5, 2023",https://theweek.com/briefing/business-briefing/1022410/the-daily-business-briefing-april-5-2023,2023-04-05 11:43:20,Johnson & Johnson said Tuesday it had agreed to pay $8.9 billion over the next 25 years to settle tens of thousands of lawsuits over claims its iconic Baby Powder and other talc products caused cancer. The company originally offered $2 billion.,JNJ,0.068306,-0.113414,Neutral
These are the only stocks that matter right now | Business,https://www.cnn.com/2023/04/05/investing/premarket-stocks-trading/index.html,2023-04-05 11:33:00,These are the only stocks that matter right now ...,JNJ,0.072435,0.049276,Neutral
"J&J firmer on hopes for talc deal, but Western Alliance Bancorp slides as regional bank fears revive",https://www.marketwatch.com/story/j-j-firmer-on-hopes-for-talc-deal-but-western-alliance-bancorp-slides-as-regional-bank-fears-revive-2fa90cc8,2023-04-05 11:31:00,C3.ai extends its slide after attack from short seller Kerrisdale Capital.,JNJ,0.554365,-0.239447,Somewhat-Bearish
"The commodity supercycle is still young, these strategists say. Here's why.",https://www.marketwatch.com/story/the-commodity-supercycle-is-still-young-these-strategists-say-heres-why-e84f5496,2023-04-05 10:31:00,"Strategists at Wells Fargo investment Institute argue it's year three of a commodity supercycle, which they say has plenty more room to run.",JNJ,0.082535,-0.161677,Somewhat-Bearish
Should Vanguard Value ETF  ( VTV )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2074662/should-vanguard-value-etf-vtv-be-on-your-investing-radar,2023-04-05 10:20:05,Style Box ETF report for ...,JNJ,0.125134,0.069019,Neutral
Futures fall as investors await key economic data amid recession fears,https://www.reuters.com/markets/us/futures-fall-investors-await-key-economic-data-amid-recession-fears-2023-04-05/,2023-04-05 09:59:00,"April 5 ( Reuters ) - U.S. stock index futures slipped on Wednesday in the run up to a fresh batch of economic data, expected to give more clarity on the state of the U.S. economy amid worries that rapid rate hikes by the Federal Reserve may trigger a steep downturn. At 5:03 a.m.",JNJ,0.081552,-0.194394,Somewhat-Bearish
Johnson & Johnson to pay $8.9 billion to settle talc-cancer lawsuits | The Financial Express,https://www.financialexpress.com/healthcare/news-healthcare/johnson-johnson-to-pay-8-9-billion-to-settle-talc-cancer-lawsuits/3034671/,2023-04-05 07:16:00,Johnson & Johnson to pay $8.9 billion to settle talc-cancer lawsuits The Financial Express ...,JNJ,0.080458,-0.010787,Neutral
"Futures: AI Stock Keeps Sliding, Dow Giant Rises",https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-ai-stock-keeps-sliding-johnson-and-johnson-rises/,2023-04-05 02:09:00,Dow Jones Futures: AI Stock Keeps Sliding. Johnson & Johnson ... Investor's Business Daily ...,JNJ,0.152018,-0.067845,Neutral
"TSLA, AI, JNJ, CDLX, BFRG: Top Trending Stocks - Cardlytics  ( NASDAQ:CDLX ) , Tesla  ( NASDAQ:TSLA ) , Bullfrog AI Hldgs  ( NASDAQ:BFRG ) , Johnson & Johnson  ( NYSE:JNJ ) , C3.ai  ( NYSE:AI ) ",https://www.benzinga.com/news/23/04/31672113/tesla-c3-ai-johnson-amp-johnson-cardlytics-bullfrog-ai-holdings-why-these-5-stocks-are-drawing-inves,2023-04-05 01:00:14,Major Wall Street indices closed in the red on Monday after U.S. job openings in February declined to the lowest level in about two years while factory orders dropped for a second straight month.,JNJ,0.220809,0.144829,Neutral
Johnson & Johnson is again trying to use bankruptcy to settle talc cases for $8.9 billion | Business,https://www.cnn.com/2023/04/04/investing/johnson-and-johnson-talc-bankruptcy/index.html,2023-04-04 22:00:00,Johnson & Johnson is again trying to use bankruptcy to settle talc cases for $8.9 billion ...,JNJ,0.246582,-0.15722,Somewhat-Bearish
Johnson & Johnson  ( JNJ )  Gains As Market Dips: What You Should Know,https://www.zacks.com/stock/news/2074520/johnson-johnson-jnj-gains-as-market-dips-what-you-should-know,2023-04-04 21:45:22,"Johnson & Johnson (JNJ) closed the most recent trading day at $158.49, moving +1.05% from the previous trading session.",JNJ,0.546745,0.123205,Neutral
Johnson & Johnson offers to pay $8.9B in talc baby powder lawsuit over cancer claims,https://www.axios.com/2023/04/04/jnj-talc-lawsuit-payment-cancer,2023-04-04 21:14:51,Johnson & Johnson offers to pay $8.9B in talc baby powder lawsuit ... ...,JNJ,0.113597,-0.343183,Somewhat-Bearish
Johnson & Johnson sets aside $8.9 billion to settle talc claims; stock up 3%,https://www.marketwatch.com/story/johnson-johnson-stock-up-nearly-3-after-talc-litigation-unit-re-files-for-bankruptcy-bc258245,2023-04-04 21:05:00,Johnson & Johnson stock rises more than 3% in the extended session Tuesday after the company proposes to pay up to $8.9 billion to settle claims connected with cosmetic-talc litigation.,JNJ,0.701875,-0.031196,Neutral
Why Johnson & Johnson Stock Is Moving Higher After Hours - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/news/23/04/31668369/why-johnson-johnson-stock-is-moving-higher-after-hours,2023-04-04 21:02:21,Johnson & Johnson JNJ shares are trading higher in Tuesday's after-hours session after the company's subsidiary LTL Management re-filed for bankruptcy to resolve all talc-based baby powder claims.,JNJ,0.887767,0.131888,Neutral
"Dow Jones Falls On Recession Fears; AI Stock Crashes, Many Groups Sell Off",https://www.investors.com/market-trend/stock-market-today/dow-jones-falls-on-recession-fears-ai-stock-crashes-many-groups-sell-off/,2023-04-04 20:55:00,"Dow Jones Falls On Recession Fears. AI Stock Crashes, Many ... Investor's Business Daily ...",JNJ,0.153634,-0.081745,Neutral
Johnson & Johnson to Settle Talc Claims for $8.9 Billion. The Stock Is Jumping.,https://www.barrons.com/articles/jnj-stock-price-talc-cancer-14ee8132,2023-04-04 20:44:00,"JNJ to Settle Talc Claims for $8.9 Billion, Stock Jumps ...",JNJ,0.699089,-0.103305,Neutral
Johnson & Johnson Proposes Paying $9 Billion to Settle Talc Lawsuits,https://www.wsj.com/articles/johnson-johnson-proposes-paying-9-billion-to-settle-talc-lawsuits-2fcc672a,2023-04-04 20:36:00,A unit of the health-products company is also refiling for bankruptcy protection to seek approval for the settlement plan.,JNJ,0.636698,-0.609214,Bearish
"2 Biotech Stocks That Could Soar by 130% and 92%, According to Wall Street",https://www.fool.com/investing/2023/04/04/2-biotech-stocks-that-could-soar-by-130-and-92-acc/,2023-04-04 20:30:00,"Arrowhead Pharmaceuticals and Seres Therapeutics are screaming buys, according to some Wall Street analysts.",JNJ,0.074692,0.090087,Neutral
Johnson & Johnson Subsidiary LTL Management LLC Re-Files for Voluntary Chapter 11 to Equitably Resolve All Current and Future Talc Claims,https://investingnews.com/johnson-johnson-subsidiary-ltl-management-llc-re-files-for-voluntary-chapter-11-to-equitably-resolve-all-current-and-future-talc-claims/,2023-04-04 20:27:49,LTL's Reorganization Plan Has Significant Support From Claimants The Plan Includes LTL's Present Value Commitment of $8.9 Billion Payable Over 25 Years For Complete Resolution,JNJ,0.207064,0.153044,Somewhat-Bullish
J&J will pay $8.9 billion to settle claims cosmetic talc products caused cancer,https://www.cnbc.com/2023/04/04/jj-will-pay-8point9-billion-to-settle-claims-cosmetic-talc-products-caused-cancer.html,2023-04-04 20:25:38,Johnson & Johnson said it would pay an $8.9 billion settlement over claims that its talc-based baby powder caused cancer.,JNJ,0.269776,-0.447193,Bearish
Oncternal  ( ONCT )  Down on Restructuring Plan to Extend Runway,https://www.zacks.com/stock/news/2074388/oncternal-onct-down-on-restructuring-plan-to-extend-runway,2023-04-04 16:02:00,Oncternal (ONCT) closes the development program for zilovertamab to extend its cash runway into 2025. Shares are down on the same.,JNJ,0.062761,0.095187,Neutral
This Is What Whales Are Betting On Johnson & Johnson - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/04/31657740/this-is-what-whales-are-betting-on-johnson-johnson,2023-04-04 14:01:06,"Someone with a lot of money to spend has taken a bullish stance on Johnson & Johnson JNJ. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",JNJ,0.691995,0.343654,Somewhat-Bullish
3 Top Healthcare Stocks to Buy for April,https://www.fool.com/investing/2023/04/04/3-top-healthcare-stocks-to-buy-for-april/,2023-04-04 13:12:00,"These pharmaceutical companies' shares are down, but their prospects are rising.",JNJ,0.120885,0.142034,Neutral
David Gabriel Joins Warburg Pincus as Senior Advisor,https://www.prnewswire.com/news-releases/david-gabriel-joins-warburg-pincus-as-senior-advisor-301788835.html,2023-04-04 13:00:00,"Former CEO of Sonepar USA and COO of Sonepar SAS to Support Industrials Investment Opportunities NEW YORK, April 4, 2023 /PRNewswire/ -- Warburg Pincus, a leading global growth investor, today announced the appointment of David Gabriel as a Senior Advisor working with its Industrials group.",JNJ,0.065866,0.091135,Neutral
Biogen Appoints Adam Keeney as Head of Corporate Development,https://www.globenewswire.com/news-release/2023/04/04/2640516/0/en/Biogen-Appoints-Adam-Keeney-as-Head-of-Corporate-Development.html,2023-04-04 11:30:00,"CAMBRIDGE, Mass., April 04, 2023 ( GLOBE NEWSWIRE ) -- Biogen Inc. ( Nasdaq: BIIB ) today announced the appointment of Adam Keeney, Ph.D., as Executive Vice President, Head of Corporate Development effective 17 April 2023. Dr. Keeney will be a member of Biogen's Executive Committee reporting to ...",JNJ,0.043186,0.122623,Neutral
Biogen Appoints Adam Keeney as Head of Corporate Development - Biogen  ( NASDAQ:BIIB ) ,https://www.benzinga.com/pressreleases/23/04/g31651697/biogen-appoints-adam-keeney-as-head-of-corporate-development,2023-04-04 11:30:00,"CAMBRIDGE, Mass., April 04, 2023 ( GLOBE NEWSWIRE ) -- Biogen Inc. BIIB today announced the appointment of Adam Keeney, Ph.D., as Executive Vice President, Head of Corporate Development effective 17 April 2023. Dr. Keeney will be a member of Biogen's Executive Committee reporting to Christopher A.",JNJ,0.039033,0.121225,Neutral
4 Best Stocks to Set You Up for Early Retirement,https://www.fool.com/investing/2023/04/04/4-best-stocks-to-set-you-up-for-early-retirement/,2023-04-04 09:55:00,"Cloudflare, ServiceNow, The Trade Desk, and Airbnb are all long-term winners.",JNJ,0.051221,-0.01601,Neutral
3 Dow Stocks That Are Screaming Buys in April,https://www.fool.com/investing/2023/04/04/3-dow-stocks-that-are-screaming-buys-in-april/,2023-04-04 09:06:00,"Among the Dow Jones Industrial Average's 30 components, there are three plain-as-day bargains.",JNJ,0.16594,0.031572,Neutral
Group steers Swiss billionaire's money to liberal causes,https://apnews.com/article/dark-money-democrats-wyss-politics-elections-601d40cd01569190559d545418afe396,2023-04-03 22:58:59,"WASHINGTON ( AP ) - The Berger Action Fund is a nondescript name for a group with a rather specific purpose: steering the wealth of HansjÃ¶rg Wyss, a Swiss billionaire, into the world of American politics and policy. As a foreign national, Wyss is prohibited from donating to candidates or ...",JNJ,0.029691,0.121739,Neutral
Novartis  ( NVS )  Gets CHMP Positive Opinion for Entresto Approval,https://www.zacks.com/stock/news/2073837/novartis-nvs-gets-chmp-positive-opinion-for-entresto-approval,2023-04-03 15:55:00,Novartis (NVS) receives a positive opinion from the CHMP for Entresto (sacubitril/valsartan) for a new indication in pediatric patients.,JNJ,0.301315,0.211232,Somewhat-Bullish
Is It Time to Buy the Dow Jones' 3 Worst-Performing Stocks This Year?,https://www.fool.com/investing/2023/04/03/is-it-time-to-buy-the-dow-jones-3-worst-performing/,2023-04-03 13:17:00,These blue chips are down. Is it time to buy?,JNJ,0.240489,-0.127518,Neutral
"Nium Names Payments Veteran, Volker Steinle, as Senior Vice President and General Manager Americas",https://www.prnewswire.com/news-releases/nium-names-payments-veteran-volker-steinle-as-senior-vice-president-and-general-manager-americas-301788332.html,2023-04-03 13:01:00,"Nium Names Payments Veteran, Volker Steinle, as Senior Vice ... PR ...",JNJ,0.076847,0.047497,Neutral
Peering Into Johnson & Johnson's Recent Short Interest - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/short-sellers/23/04/31632670/peering-into-johnson-johnsons-recent-short-interest,2023-04-03 13:00:58,"Johnson & Johnson's JNJ short percent of float has fallen 15.56% since its last report. The company recently reported that it has 11.72 million shares sold short, which is 0.38% of all regular shares that are available for trading.",JNJ,0.221819,0.081322,Neutral
Reunion Neuroscience Appoints Dr. Fred Grossman to Board of Directors,https://www.globenewswire.com/news-release/2023/04/03/2639431/0/en/Reunion-Neuroscience-Appoints-Dr-Fred-Grossman-to-Board-of-Directors.html,2023-04-03 11:30:00,"- Seasoned Psychiatrist and Global Pharmaceutical R&D Executive with Over Two Decades of Experience in Clinical Development, Including at Eli Lilly, Johnson & Johnson, Bristol Myers Squibb and Sunovion Pharmaceuticals ...",JNJ,0.074576,0.001012,Neutral
Reunion Neuroscience Appoints Dr. Fred Grossman to Board of Directors - Reunion Neuroscience  ( NASDAQ:REUN ) ,https://www.benzinga.com/pressreleases/23/04/g31629773/reunion-neuroscience-appoints-dr-fred-grossman-to-board-of-directors,2023-04-03 11:30:00,"- Seasoned Psychiatrist and Global Pharmaceutical R&D Executive with Over Two Decades of Experience in Clinical Development, Including at Eli Lilly, Johnson & Johnson, Bristol Myers Squibb and Sunovion Pharmaceuticals TORONTO, April 03, 2023 ( GLOBE NEWSWIRE ) -- Reunion Neuroscience Inc.",JNJ,0.07157,0.001008,Neutral
3 Dow Stocks With Above-Average Dividends Yields to Buy in April,https://www.fool.com/investing/2023/04/03/3-dow-stocks-with-above-average-dividends-yields-t/,2023-04-03 09:39:00,Income-seeking investors are going to love the annual payout raises and yields of 2.9% or better that these legendary dividend payers offer right now.,JNJ,0.109705,0.032261,Neutral
3 Top S&P 500 Stocks Near 52-Week Lows That Look Like Bargains Now,https://www.fool.com/investing/2023/04/03/3-top-sp-500-stocks-near-52-week-lows-that-look-li/,2023-04-03 09:27:00,Now's a great time to buy some shares of these highly reliable dividend-payers.,JNJ,0.109705,0.0,Neutral
3 Warren Buffett Stocks That Are No-Brainer Buys in April,https://www.fool.com/investing/2023/04/03/3-warren-buffett-stocks-no-brainer-buys-in-april/,2023-04-03 09:06:00,"Out of Berkshire Hathaway's more than four dozen holdings, there are three stocks that stand out as absolute steals right now.",JNJ,0.244723,0.1841,Somewhat-Bullish
Virtual Reality company Virtualware to start trading in Euronext Paris on April 20,https://www.benzinga.com/pressreleases/23/04/g31626457/virtual-reality-company-virtualware-to-start-trading-in-euronext-paris-on-april-20,2023-04-03 08:23:36,"BILBAO, Spain and PARIS, April 03, 2023 ( GLOBE NEWSWIRE ) -- European company Virtualware, one of the European leaders in the Virtual Reality industry, will start trading on Euronext Paris on April 20.",JNJ,0.136113,0.098444,Neutral
Could This Move by Johnson & Johnson Equal Billions for Moderna?,https://www.fool.com/investing/2023/04/02/could-this-j-and-j-move-equal-billions-for-moderna/,2023-04-02 09:30:00,An RSV vaccine could be a driver of blockbuster revenue.,JNJ,0.179788,0.019279,Neutral
Value Investing Is Back,https://www.kiplinger.com/investing/stocks/value-investing-is-back,2023-04-01 13:30:00,"It looks like value investing is making a comeback. Growth stocks clobbered value for about a decade. In 2020, they beat value by more than 30 percentage points - the widest margin since at least 1927. Then, in 2022, growth took a sickening dive.",JNJ,0.050894,0.066862,Neutral
3 Surprisingly Underrated Stocks to Buy in April,https://www.fool.com/investing/2023/04/01/3-surprisingly-underrated-stocks-to-buy-in-april/,2023-04-01 10:14:00,These drugmakers could deliver greater gains than many investors expect.,JNJ,0.306963,0.0,Neutral
Genmab Announces Initial Resolution of Its Second Arbitration Under License Agreement with Janssen,https://www.globenewswire.com/news-release/2023/04/20/2651670/0/en/Genmab-Announces-Initial-Resolution-of-Its-Second-Arbitration-Under-License-Agreement-with-Janssen.html,2023-04-20 23:45:00,Company Announcement ...,JNJ,0.052112,0.0,Neutral
"Pearpop Launches Fake Products to Show it Can Drive ""Real Results"" for Anything - Omnicom Group  ( NYSE:OMC ) ",https://www.benzinga.com/pressreleases/23/04/n31920638/pearpop-launches-fake-products-to-show-it-can-drive-real-results-for-anything,2023-04-20 17:10:00,"DDB Chicago launches new campaign for Creator Economy startup Pearpop to show it can make any brand famous, even ones that don't exist.",JNJ,0.051003,0.128378,Neutral
Why Shares of Geron Are Up 30% This Week,https://www.fool.com/investing/2023/04/20/why-shares-of-geron-are-up-30-this-week/,2023-04-20 16:18:00,The company's CEO was scheduled to speak at a virtual conference on Thursday.,JNJ,0.112008,0.012354,Neutral
"Surging S&P 500 Breaks Above 4150 Threshold With Unprecedented Momentum, Driven By Strong Earnings And Economic Recovery",https://www.benzinga.com/23/04/31919329/surging-s-p-500-breaks-above-4150-threshold-with-unprecedented-momentum-driven-by-strong-earnings-an,2023-04-20 16:07:34,"The S&P 500 has seen a 1.72% rise over the past week, with a promising start to the earnings season and potential for greater market returns. Major companies like Netflix, Nokia, American Express, and Johnson & Johnson have released earnings, with J&J beating expectations at $2.68 per share ...",JNJ,0.18967,0.141357,Neutral
Johnson & Johnson  ( JNJ )  Could Be a Great Choice,https://www.zacks.com/stock/news/2082304/johnson-johnson-jnj-could-be-a-great-choice,2023-04-20 15:45:04,"Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.",JNJ,0.448316,0.456589,Bullish
Business | Apr 22nd 2023 Edition,https://www.economist.com/the-world-this-week/2023/04/20/business,2023-04-20 15:11:14,"Elon Musk said he would launch a new artificial- intelligence platform called Truth as a rival to Chat and other generative- bots, somewhat contradicting his recent call for a moratorium on developing such technology.",JNJ,0.049322,-0.190098,Somewhat-Bearish
Home Medical Equipment Market in United States Is Expected to Reach $20.39 Billion by 2031: Allied Market Research,https://www.benzinga.com/pressreleases/23/04/g31917234/home-medical-equipment-market-in-united-states-is-expected-to-reach-20-39-billion-by-2031-allied-m,2023-04-20 15:01:40,"Portland, OR, April 20, 2023 ( GLOBE NEWSWIRE ) -- According to the report published by Allied Market Research, the U.S. home medical equipment market generated $12.38 billion in 2021, and is estimated to reach $20.39 billion by 2031, witnessing a CAGR of 5.1% from 2022 to 2031.",JNJ,0.041039,-0.016685,Neutral
MRK: 1 Pharma Stock You'll Regret Not Buying Earlier,https://stocknews.com/news/mrk-nvo-tak-jnj-rxdx-imgo-1-pharma-stock-youll-regret-not-buying-earlier/,2023-04-20 14:43:36,"The current macroeconomic climate is highly uncertain. The likelihood of a recession is high as the Fed will likely keep raising interest rates, and lending standards are expected to be tightened. Minutes from the Fed's March meeting show that the staff believes the economy could be in a mild ...",JNJ,0.076479,0.051938,Neutral
WBA: Just In: WBA Named the Top Dividend Stock With Insider Buying. Is It a Buy?,https://stocknews.com/news/wba-jnj-bmy-cvs-opch-just-in-wba-named-the-top-dividend-stock-with-insider/,2023-04-20 14:00:35,WBA: Just In: WBA Named the Top Dividend Stock With Insider ... ...,JNJ,0.077593,0.03172,Neutral
"Novartis AG  ( NVS )  Hit a 52 Week High, Can the Run Continue?",https://www.zacks.com/stock/news/2081908/novartis-ag-nvs-hit-a-52-week-high-can-the-run-continue,2023-04-20 13:15:05,"Novartis (NVS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.",JNJ,0.433523,0.449924,Bullish
3 of the Best Dividend Kings to Buy for the Rest of 2023,https://www.fool.com/investing/2023/04/20/3-of-the-best-dividend-kings-to-buy-for-the-rest-o/,2023-04-20 12:18:00,"All three of these stocks are trading at great valuations, providing for a nice entry point ...",JNJ,0.769861,0.450704,Bullish
"Where Is The Current Bull Market? Scan Of Stocks Gaining Over 20% Over The Past Week Almost Exclusively Yields Biotech Names - CRISPR Therapeutics  ( NASDAQ:CRSP ) , Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/trading-ideas/23/04/31911510/where-is-the-current-bull-market-scan-of-stocks-gaining-over-20-over-the-past-week-almost-exclusive,2023-04-20 12:07:05,"Where is the current bull market? All indications would be that it's in biotech! The broader market is not really moving. There have been plenty of attention-grabbing headlines, and earnings season is upon us, yet the S&P 500 has been largely stagnant in recent trading sessions.",JNJ,0.066414,0.184069,Somewhat-Bullish
Altair Launches Future Says Podcast - Altair Engineering  ( NASDAQ:ALTR ) ,https://www.benzinga.com/pressreleases/23/04/n31909679/altair-launches-future-says-podcast,2023-04-20 11:00:00,"Podcast features leading experts discussing the convergence of artificial intelligence, high-performance computing ( HPC ) , data analytics, and more",JNJ,0.108958,0.188421,Somewhat-Bullish
Altair Launches Future Says Podcast - Altair Engineering  ( NASDAQ:ALTR ) ,https://www.benzinga.com/pressreleases/23/04/n31909688/altair-launches-future-says-podcast,2023-04-20 11:00:00,"Podcast features leading experts discussing the convergence of artificial intelligence, high-performance computing ( HPC ) , data analytics, and more",JNJ,0.106541,0.187009,Somewhat-Bullish
Supreme Court delays ruling on abortion pill mifepristone restrictions until at least Friday,https://www.cnbc.com/2023/04/19/supreme-court-rules-on-abortion-pill-mifepristone.html,2023-04-19 19:17:15,Supreme Court Justice Samuel Alito on Wednesday issued an order allowing the abortion pill mifepristone to remain on the market without restrictions until at least Friday. Alito's decision punts a ruling by the high court on how the legal battle over mifepristone should proceed.,JNJ,0.091335,-0.009612,Neutral
Abortion pill company GenBioPro asks U.S. court to keep generic mifepristone on market,https://www.cnbc.com/2023/04/19/abortion-pill-company-genbiopro-seeks-mifepristone-order.html,2023-04-19 19:06:08,The Supreme Court is considering whether to maintain a court order that would severely restrict access to the abortion drug mifepristone.,JNJ,0.166169,-0.012849,Neutral
"Abbott Labs shares pop as revenue, earnings defy steep drop in Covid test sales",https://www.cnbc.com/2023/04/19/abbott-labs-shares-pop-as-revenue-earnings-defy-drop-in-covid-sales.html,2023-04-19 17:57:22,Abbott Laboratories said Covid-related headwinds may actually be easing.,JNJ,0.099476,0.236587,Somewhat-Bullish
"Abbott Labs stock soars 8% as medical tests, procedures rebound from COVID lull",https://www.marketwatch.com/story/abbott-labs-stock-up-2-premarket-after-earnings-beat-despite-declining-covid-testing-sales-8cb12c61,2023-04-19 16:42:00,Abbott's stock is the second biggest gainer on the S&P 500 index after company tops consensus estimates for the first quarter.,JNJ,0.058188,-0.140995,Neutral
Why Shares of Legend Biotech Jumped Wednesday,https://www.fool.com/investing/2023/04/19/why-shares-of-legend-biotech-jumped-wednesday/,2023-04-19 16:40:19,A leaked abstract on a phase 3 trial for the company's multiple myeloma drug Carvykti gave the stock a jolt.,JNJ,0.114682,-0.105055,Neutral
ETFs to Buy on Solid Q1 JNJ Earnings Results,https://www.zacks.com/stock/news/2081411/etfs-to-buy-on-solid-q1-jnj-earnings-results,2023-04-19 15:10:00,Johnson & Johnson (JNJ) continued with its long streak of earnings beat. It topped the revenue estimate as well as lifted the full-year outlook.,JNJ,0.359447,0.204828,Somewhat-Bullish
Is Merck Stock a Screaming Buy After This $11 Billion Acquisition?,https://www.fool.com/investing/2023/04/19/is-merck-stock-a-screaming-buy-after-this-11-billi/,2023-04-19 14:45:00,Merck's move into immunology is a risky proposition.,JNJ,0.072,0.03238,Neutral
Here's Why You Should Buy Boston Scientific  ( BSX )  Stock,https://www.zacks.com/stock/news/2081423/heres-why-you-should-buy-boston-scientific-bsx-stock,2023-04-19 14:26:00,Investors are optimistic about Boston Scientific (BSX) owing to impressive growth in MedSurg market share.,JNJ,0.051003,0.090435,Neutral
How A Data Leak Pushed This Biotech To Break Out,https://www.investors.com/news/technology/legn-stock-breaks-out-on-an-unexpectedly-positive-data-leak/,2023-04-19 14:22:00,LEGN Stock Breaks Out On An Unexpectedly Positive Dats Leak ... Investor's Business Daily ...,JNJ,0.166743,-0.12204,Neutral
"Stock Market News for Apr 19, 2023",https://www.zacks.com/stock/news/2081029/stock-market-news-for-apr-19-2023,2023-04-19 13:32:00,U.S. stocks finished little changed on Tuesday as investors digested a slew of corporate earnings reports from big banks and blue chip companies and also tried to gauge the future interest rate hike path.,JNJ,0.132733,0.084662,Neutral
Short Volatility Alert: Johnson & Johnson - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/23/04/31890878/short-volatility-alert-johnson-johnson,2023-04-19 13:26:05,"On Tuesday, shares of Johnson & Johnson JNJ experienced volatile short activity. After the activity, the stock price went down -2.81% to $161.01. The overall sentiment for JNJ has been Bearish. The signal from the volatility alert is trending Bullish. Therefore, the recommendation is to Strong Buy.",JNJ,0.350564,-0.211763,Somewhat-Bearish
"US Stocks: Wall Street set to open lower as Treasury yields rise, Tesla slides | The Financial Express",https://www.financialexpress.com/market/us-stocks-wall-street-set-to-open-lower-as-treasury-yields-rise-tesla-slides/3054352/,2023-04-19 13:19:50,US Stocks: Wall Street set to open lower as Treasury yields rise ... The Financial Express ...,JNJ,0.070517,0.0,Neutral
Looking Into Johnson & Johnson's Recent Short Interest - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/short-sellers/23/04/31890504/looking-into-johnson-johnsons-recent-short-interest,2023-04-19 13:15:57,"Johnson & Johnson's JNJ short percent of float has fallen 15.56% since its last report. The company recently reported that it has 11.72 million shares sold short, which is 0.38% of all regular shares that are available for trading.",JNJ,0.221819,0.081322,Neutral
"GS1 Connect 2023 Agenda Offers Supply Chain Visibility Best Practices From More Than 275 Companies Across Retail, Grocery, Foodservice and Healthcare",https://www.prnewswire.com/news-releases/gs1-connect-2023-agenda-offers-supply-chain-visibility-best-practices-from-more-than-275-companies-across-retail-grocery-foodservice-and-healthcare-301800955.html,2023-04-19 13:15:00,GS1 Connect 2023 Agenda Offers Supply Chain Visibility Best ... PR ...,JNJ,0.120733,0.047494,Neutral
2 Top Dividend Stocks You Can Buy and Hold Forever,https://www.fool.com/investing/2023/04/19/2-top-dividend-stocks-you-can-buy-and-hold-forever/,2023-04-19 12:30:00,These companies arguably pay the safest dividends in the world.,JNJ,0.464844,0.484599,Bullish
"SPY, QQQ: What Options Market Indicates During Earnings - Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , Tesla  ( NASDAQ:TSLA ) , Bank of America  ( NYSE:BAC ) , Johnson & Johnson  ( NYSE:JNJ ) , Procter & Gamble  ( NYSE:PG ) , Goldman Sachs Gr  ( NYSE:GS ) , SPDR S&P 500  ( ARCA:SPY ) ",https://www.benzinga.com/markets/equities/23/04/31888509/spy-qqq-as-earnings-season-gathers-pace-heres-what-options-market-indicates-about-these-etfs,2023-04-19 12:23:10,U.S. markets closed flat on Tuesday following a mixed set of earnings announcements. The SPDR S&P 500 ETF Trust SPY closed 0.07% higher at 414.21 while the Invesco QQQ Trust Series 1 QQQ ended almost flat at 318.86.,JNJ,0.266828,0.1708,Somewhat-Bullish
Internet of Things  ( IoT )  in Healthcare Market to be Worth $312.7 Billion by 2030 - Exclusive Report by Meticulous ResearchÂ®,https://www.benzinga.com/pressreleases/23/04/g31887285/internet-of-things-iot-in-healthcare-market-to-be-worth-312-7-billion-by-2030-exclusive-report-by-,2023-04-19 11:46:14,"Redding, California, April 19, 2023 ( GLOBE NEWSWIRE ) -- According to a new market research report titled, 'IoT in Healthcare Market by Component ( Monitoring Devices ( Glucose, Cardiac, Respiratory, Blood Pressure ) , Pacemaker, Ventilator, Infusion Pump}, Software ) , Application ( ...",JNJ,0.020722,0.037308,Neutral
The earnings recession is here. There could be worse to come | Business,https://www.cnn.com/2023/04/19/investing/premarket-stocks-trading/index.html,2023-04-19 11:42:00,The earnings recession is here. There could be worse to come ...,JNJ,0.063763,-0.082599,Neutral
"Futures retreat as Treasury yields rise, Tesla slides",https://www.reuters.com/markets/us/futures-retreat-treasury-yields-rise-tesla-slides-2023-04-19/,2023-04-19 10:19:00,"April 19 ( Reuters ) - U.S. stock index futures fell on Wednesday as Treasury yields rose on expectations the Federal Reserve could keep interest rates higher for longer, while a slide in Tesla and Netflix shares was set to weigh on the tech-heavy Nasdaq.",JNJ,0.085022,0.0,Neutral
"S&P 500 Settles Slightly Higher, Market Volatility Drops - Apple  ( NASDAQ:AAPL ) , Goldman Sachs Gr  ( NYSE:GS ) ",https://www.benzinga.com/news/earnings/23/04/31884744/s-p-500-settles-slightly-higher-market-volatility-drops,2023-04-19 09:54:38,"The S&P 500 closed slightly higher on Tuesday following the release of earnings results from major companies. Johnson & Johnson JNJ shares fell 2.8% on Tuesday after the company reported better-than-expected Q1 results, raised its 2023 guidance and increased its quarterly dividend.",JNJ,0.338582,0.426399,Bullish
2 Buffett Stocks With Above-Average Dividend Yields to Buy Now,https://www.fool.com/investing/2023/04/19/2-buffett-stocks-with-above-average-dividend-yield/,2023-04-19 09:27:00,"Not every stock in the Berkshire Hathaway portfolio will be a home run, but these have great chances to outperform.",JNJ,0.108958,0.067511,Neutral
"Nifty to gain above 17,700 or extend losses? Check 7 key things to know before share market opens | The Financial Express",https://www.financialexpress.com/market/nifty-to-gain-above-17700-or-extend-losses-check-7-key-things-to-know-before-share-market-opens/3053224/,2023-04-19 02:30:45,Nifty to gain above 17700 or extend losses? Check 7 key things to ... The Financial Express ...,JNJ,0.064276,-0.039581,Neutral
"TSLA, NFLX, WAL, DKNG, UAL: Top Trending Stocks - DraftKings  ( NASDAQ:DKNG ) , Netflix  ( NASDAQ:NFLX ) , United Airlines Holdings  ( NASDAQ:UAL ) , Tesla  ( NASDAQ:TSLA ) , Western Alliance  ( NYSE:WAL ) , Bank of America  ( NYSE:BAC ) , Johnson & Johnson  ( NYSE:JNJ ) , Goldman Sachs Gr  ( NYSE:GS ) ",https://www.benzinga.com/markets/equities/23/04/31876886/tesla-netflix-western-alliance-draftkings-united-airlines-why-these-5-stocks-are-drawing-investo,2023-04-19 01:08:51,"Major U.S. equity indices closed flat on Tuesday following a mixed set of earnings announcements. While market participants were disappointed with Goldman Sachs Group Inc GS and Johnson & Johnson JNJ earnings, Bank of America Corp BAC results surpassed estimates.",JNJ,0.210274,-0.146153,Neutral
"S&P 500 ekes out gain as tech supports, J&J, Goldman disappoint",https://www.moneycontrol.com/news/business/markets/sp-500-ekes-out-gain-as-tech-supports-jj-goldman-disappoint-10435971.html,2023-04-19 00:24:58,JJ ( JNJ.N ) shares fell 2.8% after the healthcare conglomerate cautioned investors over the lingering impact of inflation-driven costs this year. Goldman ( GS.N ) shares dropped 1.7% after the Wall Street firm's profit fell 19% as dealmaking and bond trading slumped.,JNJ,0.066784,0.089165,Neutral
US stocks trade mixed as investors assess wave of earnings results from big companies,https://markets.businessinsider.com/news/stocks/stock-market-news-today-bofa-gs-jnj-corporate-earnings-economy-2023-4,2023-04-18 20:23:34,Stock Market News Today: US Stocks Mixed Amid Corporate Earnings - Markets Insider ...,JNJ,0.087824,-0.179008,Somewhat-Bearish
ClearPoint Neuro Announces Agreement with NE Scientific to Integrate Gene Therapy Infusion Coverage Tool into ClearPoint MaestroÂ® Brain Model - ClearPoint Neuro  ( NASDAQ:CLPT ) ,https://www.benzinga.com/pressreleases/23/04/g31869193/clearpoint-neuro-announces-agreement-with-ne-scientific-to-integrate-gene-therapy-infusion-coverag,2023-04-18 20:05:00,"SOLANA BEACH, Calif., April 18, 2023 ( GLOBE NEWSWIRE ) -- ClearPoint Neuro, Inc.",JNJ,0.040829,0.096008,Neutral
Stock Market Today: Stocks Waver Amid a Flurry of Quarterly Reports,https://www.kiplinger.com/investing/stocks/stock-market-today-stocks-waver-amid-a-flurry-of-quarterly-reports,2023-04-18 20:03:25,Equity markets had a hard time making up their minds Tuesday amid a heavy day of earnings reports from big banks and other blue chip stocks. Hawkish commentary from two Fed officials also caused markets to waver.,JNJ,0.158173,-0.016252,Neutral
Why Johnson & Johnson Stock Is Slumping Today,https://www.fool.com/investing/2023/04/18/why-johnson-johnson-stock-is-slumping-today/,2023-04-18 19:52:00,J&J's ongoing talcum-powder litigation is weighing on its shares.,JNJ,0.262522,0.240895,Somewhat-Bullish
Dow Jones Fades As Goldman Sachs Earnings Drop; These 3 Bill Ackman Stocks Are Near Buy Points,https://www.investors.com/market-trend/stock-market-today/dow-jones-up-as-goldman-sachs-earnings-drop-these-bill-ackman-stocks-are-near-buy-points-netflix-earnings-nflx-stock/,2023-04-18 19:14:00,Dow Jones Fades As Goldman Sachs Earnings Drop. These 3 Bill ... Investor's Business Daily ...,JNJ,0.088964,-0.355517,Bearish
Johnson and Johnson Beats Estimates and Raises Guidance,https://www.zacks.com/stock/news/2080673/johnson-and-johnson-beats-estimates-and-raises-guidance,2023-04-18 18:49:00,"Johnson and Johnson JNJ reported Q1 2023 earnings on Tuesday, April 18 before the market opened ...",JNJ,0.885652,0.596653,Bullish
Anti-abortion group asks Supreme Court to keep mifepristone restrictions,https://www.cnbc.com/2023/04/18/anti-abortion-group-supreme-court-mifepristone-restrictions.html,2023-04-18 18:02:30,Supreme Court Justice Samuel Alito on Friday temporarily blocked abortion pill restrictions until 11:59 p.m. Wednesday.,JNJ,0.050465,0.199342,Somewhat-Bullish
"J&J lifts profit forecast as cancer drugs, Stelara buoy pharma unit",https://www.foxbusiness.com/markets/jj-lifts-profit-forecast-cancer-drugs-stelara-buoy-pharma-unit,2023-04-18 17:31:25,"Johnson & Johnson beat first-quarter profit estimates and raised its 2023 profit forecast on Tuesday, as cancer drugs such as Erleada and Crohn's disease treatment Stelara boost sales at its large pharmaceuticals unit.",JNJ,0.12165,0.12507,Neutral
"On a Roll: Earnings Season Off To Solid Start, With Strength From Bank Of America, J&J Boosting Market - Bank of America  ( NYSE:BAC ) , Goldman Sachs Gr  ( NYSE:GS ) ",https://www.benzinga.com/news/earnings/23/04/31864600/on-a-roll-earnings-season-off-to-solid-start-with-strength-from-bank-of-america-j-j-boosting-market,2023-04-18 17:13:06,"( Tuesday market open ) Earnings season accelerates from zero to 60 this week-with 60 S&P 500 companies expected to report between now and Friday. Things are off to a roaring start. Of the names that reported during Week 1, 90% topped EPS estimates, according to Bank of America BAC data.",JNJ,0.058711,-0.017119,Neutral
"Stocks making the biggest moves midday: Southwest Airlines, Goldman Sachs, Bellus Health and more",https://www.cnbc.com/2023/04/18/stocks-moving-big-midday-luv-gs-blu-nvda.html,2023-04-18 17:02:29,These are the stocks posting the largest moves in midday trading.,JNJ,0.064449,-0.01913,Neutral
J&J May Need to Defend Baby Powder Cancer Suits After 19-Month Pause,https://www.business-standard.com/world-news/j-j-may-need-to-defend-baby-powder-cancer-suits-after-19-month-pause-123041801131_1.html,2023-04-18 16:08:29,J&J May Need to Defend Baby Powder Cancer Suits After 19-Month ... Business Standard ...,JNJ,0.160633,-0.303323,Somewhat-Bearish
Yet Again: Johnson & Johnson Subsidiary Seeks Stay On Thousands Of Cancer Lawsuits Associated With Talc Products - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/general/biotech/23/04/31860039/yet-again-johnson-johnson-subsidiary-seeks-stay-on-thousands-of-cancer-lawsuits-associated-with-t,2023-04-18 15:57:09,"Johnson & Johnson's JNJ subsidiary, LTL Management, has reportedly requested a U.S. judge to delay 38,000 lawsuits again. These lawsuits accuse their baby powder and other talc products of causing cancer.",JNJ,0.362505,-0.151939,Somewhat-Bearish
FDA authorizes additional omicron Covid shots for seniors and people with weak immune systems,https://www.cnbc.com/2023/04/18/covid-seniors-immunocompromised-can-receive-additional-omicron-shots.html,2023-04-18 15:52:31,"Although the burden of the pandemic has eased substantially, the CDC says Covid continues to kill more than 1,300 people per week.",JNJ,0.093289,0.209811,Somewhat-Bullish
Club meeting recap: Jim Cramer says Johnson & Johnson's post-earnings sell-off is wrong and a chance to buy,https://www.cnbc.com/2023/04/18/jim-cramer-says-jj-post-earnings-sell-off-is-wrong-and-a-chance-to-buy.html,2023-04-18 15:39:55,"The Investing Club holds its ""Morning Meeting"" every weekday at 10:20 a.m. ET.",JNJ,0.21686,0.073031,Neutral
Recent Report Shows That Rep. Daniel Goldman Bought Up to $100K Worth of Johnson & Johnson Stock - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/government/23/04/31860312/recent-report-shows-that-rep-daniel-goldman-bought-up-to-100k-worth-of-johnson-johnson-stock,2023-04-18 15:06:19,"The Office of New York Representative Daniel Goldman has reported a purchase of Johnson & Johnson JNJ stock on April 17, 2023. According to the Periodic Transaction Report the transaction was placed on April 17, 2023.",JNJ,0.580018,0.075109,Neutral
Building Permits Declined in March,https://www.zacks.com/stock/news/2080499/building-permits-declined-in-march,2023-04-18 14:59:00,"We've got a healthy amount of grist for the trading mill ahead of today's opening bell, with fresh Q1 earnings reports from major household firms joining housing data from last month. All major indices are up at this hour, led by the Nasdaq, which is +110 points roughly 40 minutes prior to the ...",JNJ,0.137671,0.229245,Somewhat-Bullish
"Dow Jones Falls; Tesla Chief Musk Founds New AI Company, Offers 100 Million Shares In Private Sale",https://www.investors.com/market-trend/stock-market-today/dow-jones-falls-tesla-chief-musks-new-ai-company-offers-100-million-private-shares-sale/,2023-04-18 14:54:00,"Dow Jones Falls. Tesla Chief Musk Founds New AI Company, Offers ... Investor's Business Daily ...",JNJ,0.127795,-0.203602,Somewhat-Bearish
"Ericsson, Johnson & Johnson, Goldman Sachs And Other Big Stocks Moving Lower On Tuesday - CBL International  ( NASDAQ:BANL ) , Alignment Healthcare  ( NASDAQ:ALHC ) ",https://www.benzinga.com/news/23/04/31859838/ericsson-johnson-johnson-goldman-sachs-and-other-big-stocks-moving-lower-on-tuesday,2023-04-18 14:51:52,"U.S. stocks traded lower, with the Dow Jones dropping over 100 points on Tuesday. Here are some big stocks recording losses in today's session. Relay Therapeutics, Inc. RLAY fell 11.5% to $16.12. Merus N.V. MRUS dropped 10.8% to $21.35. FiscalNote Holdings, Inc. NOTE declined 10.3% to $2.42.",JNJ,0.504646,0.555666,Bullish
Housing Data Muted but Decent; JNJ and BAC Beat on Q1 Earnings,https://www.zacks.com/stock/news/2080475/housing-data-muted-but-decent-jnj-and-bac-beat-on-q1-earnings,2023-04-18 14:26:00,Fresh Q1 earnings reports from major household firms join housing data from last month ahead of today's open.,JNJ,0.131284,0.115203,Neutral
"Morning Update: This ""Hated"" Rally Could Send the S&P 500 to 4,300",https://moneymorning.com/investing/morning-update-this-hated-rally-could-send-the-sp-500-to-4300/,2023-04-18 14:11:57,"Morning Update: This ""Hated"" Rally Could Send the S&P 500 to 4300 Money Morning ...",JNJ,0.152499,0.265681,Somewhat-Bullish
"US Stocks: Wall Street set for gains after upbeat BofA, J&J earnings | The Financial Express",https://www.financialexpress.com/market/us-stocks-wall-street-set-for-gains-after-upbeat-bofa-jampj-earnings/3052724/,2023-04-18 13:41:08,"US Stocks: Wall Street set for gains after upbeat BofA, J&J earnings The Financial Express ...",JNJ,0.146025,0.146897,Neutral
US stocks climb on strong Chinese economic growth and upbeat earnings,https://markets.businessinsider.com/news/stocks/stock-market-news-today-china-gdp-growth-goldman-sachs-earnings-2023-4,2023-04-18 13:33:50,Stock Market News Today: China's Economic Growth Beats Views - Markets Insider ...,JNJ,0.217834,0.010106,Neutral
Jim Cramer's top 10 things to watch in the stock market Tuesday,https://www.cnbc.com/2023/04/18/jim-cramers-top-10-things-to-watch-in-the-stock-market-tuesday.html,2023-04-18 13:20:51,"The Dow, the S&P 500 and the Nasdaq are set to open higher on strong J&J and BofA earnings.",JNJ,0.162437,0.103842,Neutral
Tech Futures Lead As Q1 Earnings Heats Up,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-rise-as-goldman-sachs-dives-on-earnings-nvidia-jumps-on-buy-rating/,2023-04-18 13:01:00,Dow Jones Futures Rise As Goldman Sachs Dives On Earnings ... Investor's Business Daily ...,JNJ,0.087931,0.100696,Neutral
Health Care Bellwether Sets Bullish Tone With Beat And Raise,https://www.investors.com/news/technology/jnj-stock-johnson-johnson-earnings-q1-2023/,2023-04-18 13:01:00,JNJ Stock: Health Care Behemoth Sets Bullish First-Quarter Tone Investor's Business Daily ...,JNJ,0.862496,0.523526,Bullish
Johnson & Johnson Reports Q1 2023 Results - Investing News Network,https://investingnews.com/johnson-johnson-reports-q1-2023-results-2659871740/,2023-04-18 12:42:19,Johnson & Johnson Reports Q1 2023 Results Investing News Network ...,JNJ,0.317206,0.23109,Somewhat-Bullish
S&P 500 Futures Gain as Bank Earnings Roll In,https://www.wsj.com/articles/global-stocks-markets-dow-update-04-18-2023-e370a36,2023-04-18 12:33:00,"Stock futures ticked up as results from major banks including Goldman Sachs, Bank of America and Bank of New York Mellon trickled in. Other companies reporting Tuesday included Johnson & Johnson.",JNJ,0.459624,-0.211395,Somewhat-Bearish
"Bellus Health's stock climbs on GSK deal, while Goldman Sachs is hurt by a revenue miss",https://www.marketwatch.com/story/bellus-healths-stock-climbs-on-gsk-deal-while-goldman-sachs-is-hurt-by-a-revenue-miss-794e522d,2023-04-18 12:31:00,Johnson & Johnson's stock rise on estimate-topping results and Bank of America's stock gets an earnings boost.,JNJ,0.252987,0.289083,Somewhat-Bullish
"J&J sales in US rise 10 per cent, health care giant raises dividend",https://www.business-standard.com/companies/news/j-j-sales-in-us-rise-10-per-cent-health-care-giant-raises-dividend-123041800775_1.html,2023-04-18 12:30:52,"Johnson & Johnson beat first-quarter expectations, as growth in the health care giant's home market helped counter another revenue hit overseas from a strong dollar. The health care giant booked a USD 68 million loss on a one-time charge in the quarter, and revenue grew more than 5 per cent to ...",JNJ,0.265378,0.346347,Somewhat-Bullish
Johnson & Johnson Reports Q1 2023 Results - Investing News Network,https://investingnews.com/johnson-johnson-reports-q1-2023-results/,2023-04-18 12:25:32,Johnson & Johnson Reports Q1 2023 Results Investing News Network ...,JNJ,0.317206,0.23109,Somewhat-Bullish
"Stock market today: US futures up on US earns, China growth",https://apnews.com/article/stock-market-today-april-18-c002eafd2651de107efec1ccd3b960ec,2023-04-18 12:11:15,"Stock market today: US futures up on US earns, China growth Pedestrians pass by the Hong Kong Stock Exchange electronic screen in Hong Kong, Tuesday, April 18, 2023.",JNJ,0.117486,0.105675,Neutral
"Stocks making the biggest moves premarket: Johnson & Johnson, Goldman Sachs, Sunrun and more",https://www.cnbc.com/2023/04/18/stocks-making-the-biggest-moves-premarket-jnj-gs-run.html,2023-04-18 12:06:38,Shares of Goldman Sachs shed nearly 4% after missing revenue estimates in its first-quarter earnings released before Tuesday's opening bell.,JNJ,0.075635,0.160921,Somewhat-Bullish
These 10 Crummy Stocks Already Cost Investors $300 Billion,https://www.investors.com/etfs-and-funds/sectors/sp500-these-crummy-stocks-already-cost-investors-billions/,2023-04-18 12:00:00,S&P 500: These 10 Crummy Stocks Already Cost Investors $300 ... Investor's Business Daily ...,JNJ,0.193207,0.034072,Neutral
Futures gain as investors cheer resilient earnings,https://www.reuters.com/markets/us/futures-gain-investors-cheer-resilient-earnings-2023-04-18/,2023-04-18 11:54:00,"April 18 ( Reuters ) - U.S. stock index futures climbed on Tuesday as Bank of America and Johnson & Johnson reported upbeat earnings, while signs of uneven economic recovery in China and prospects of more Federal Reserve interest rate hikes capped gains.",JNJ,0.130217,0.096862,Neutral
Tesla Earnings: Why Guidance Is Key,https://www.fool.com/investing/2023/04/18/tesla-earnings-why-guidance-is-key/,2023-04-18 11:51:00,Are recent price cuts a sign of trouble?,JNJ,0.073773,0.037509,Neutral
Johnson & Johnson  ( JNJ )  Q1 Earnings and Revenues Top Estimates,https://www.zacks.com/stock/news/2080100/johnson-johnson-jnj-q1-earnings-and-revenues-top-estimates,2023-04-18 11:45:02,"Johnson & Johnson (JNJ) delivered earnings and revenue surprises of 6.77% and 5.01%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?",JNJ,0.396052,0.144512,Neutral
Why Johnson & Johnson  ( JNJ )  Shares Are Trading Higher Premarket Today? - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/general/biotech/23/04/31851333/johnson-johnson-q1-beats-street-view-on-strong-performance-across-all-segments-lifts-guidance-div,2023-04-18 11:39:07,"Johnson & Johnson JNJ has reported Q1 FY23 adjusted earnings of $2.68 per share, up 0.4% Y/Y and beating the consensus of $2.51. Sales increased 5.6% to $24.75 billion, beating the consensus of $23.67 billion, with operational growth of 9.0% and adjusted operational growth of 7.6%.",JNJ,0.660632,0.175011,Somewhat-Bullish
"The daily business briefing: April 18, 2023",https://theweek.com/briefing/business-briefing/1022766/the-daily-business-briefing-april-18-2023,2023-04-18 11:16:25,"China's National Bureau of Statistics reported Tuesday that the Chinese economy expanded 4.5 percent in the first quarter compared to the same period in 2022 as the world's second biggest economy bounced back after lifting its strict ""zero-COVID"" lockdowns.",JNJ,0.063091,0.045656,Neutral
"Johnson & Johnson Posts Higher Quarterly Sales, Raises 2023 Outlook",https://www.wsj.com/articles/johnson-johnson-jnj-q1-earnings-report-2023-8592c66,2023-04-18 11:12:00,First-quarter earnings were wiped out by a $6.9 billion charge tied to litigation and other costs from its Covid-19 vaccine commitments.,JNJ,0.674691,-0.109681,Neutral
J&J raises annual profit forecast on cancer drug strength,https://www.reuters.com/business/healthcare-pharmaceuticals/jj-raises-annual-profit-forecast-cancer-drug-strength-2023-04-18/,2023-04-18 11:05:27,"April 18 ( Reuters ) - Johnson & Johnson ( JNJ.N ) beat first-quarter profit estimates on Tuesday and raised its 2023 profit forecast, as it banks on its newer cancer treatments and multiple myeloma drug Darzalex to soften the blow from declining demand for older drugs.",JNJ,0.126784,-0.125541,Neutral
"Why US Stocks Look Poised For A Rally This Earnings Season - Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , SPDR S&P 500  ( ARCA:SPY ) ",https://www.benzinga.com/news/earnings/23/04/31850201/us-stocks-ready-to-rally-amid-earnings-optimism-analyst-sees-upward-momentum-on-outlier-s-p-500-ret,2023-04-18 10:58:48,"The positive mood seen in late trading on Monday appears to be spilling over into Tuesday's session, with futures pointing to a higher open. A slew of bank earnings, energy prices and a housing market reading are all in the mix, as traders position themselves for the earnings season.",JNJ,0.107978,0.0,Neutral
"J&J sales in US rise 10%, health care giant raises dividend",https://apnews.com/article/johnson-first-quarter-stelara-ebbdc0c3a79531b2af4dab8785b5f341,2023-04-18 10:54:23,"Johnson & Johnson beat first-quarter expectations, as growth in the health care giant's home market helped counter another revenue hit overseas from a strong dollar. The health care giant booked a $68 million loss on a one-time charge in the quarter, and revenue grew more than 5% to $24.75 ...",JNJ,0.294093,0.373106,Bullish
"Johnson & Johnson beats on earnings and revenue, raises full-year guidance",https://www.cnbc.com/2023/04/18/johnson-johnson-jnj-earnings-q1-2023.html,2023-04-18 10:50:01,"J&J, whose financial results are considered a bellwether for many health companies, said its first-quarter sales grew 5.6% over the same quarter last year.",JNJ,0.137671,0.0,Neutral
Genmab Announces Net Sales of DARZALEXÂ®  ( daratumumab )  for First Quarter of 2023,https://www.globenewswire.com/news-release/2023/04/18/2648749/0/en/Genmab-Announces-Net-Sales-of-DARZALEX-daratumumab-for-First-Quarter-of-2023.html,2023-04-18 10:25:00,Company Announcement ...,JNJ,0.12546,0.010322,Neutral
"Morning Bid: Global pulse picks up, rates creep higher again",https://www.reuters.com/markets/us/global-markets-view-usa-2023-04-18/,2023-04-18 10:07:16,"A look at the day ahead in U.S. and global markets from Mike Dolan With investors largely assuming recession ahead, an accelerating global economic pulse challenges the narrative and is seeing interest rates tick back higher again as the March banking wobble subsides.",JNJ,0.048327,0.0,Neutral
The Fed Thinks a Recession Is More Likely: Here Are 3 Great Stocks to Buy Now,https://www.fool.com/investing/2023/04/18/fed-recession-more-likely-stocks-buy-now/,2023-04-18 09:52:00,These stocks should hold up quite well regardless of what happens with the U.S. economy.,JNJ,0.211191,0.072575,Neutral
3 Robinhood Stocks to Buy and Hold Forever,https://www.fool.com/investing/2023/04/18/3-robinhood-stocks-to-buy-and-hold-forever/,2023-04-18 09:19:00,There are solid reasons for the trio's popularity with retail investors.,JNJ,0.252114,0.315626,Somewhat-Bullish
"Virtualware will start trading in Paris on Thursday, at 27.25 million valuation",https://www.benzinga.com/pressreleases/23/04/g31848161/virtualware-will-start-trading-in-paris-on-thursday-at-27-25-million-valuation,2023-04-18 09:10:15,"BILBAO, Spain and PARIS, April 18, 2023 ( GLOBE NEWSWIRE ) -- Virtualware, which develops industrial virtual reality platforms for the nuclear, medical, educational and defense industries, will be listed on Euronext Access Paris next Thursday, April 20, at a valuation of 27.25 million euros.",JNJ,0.129516,0.096012,Neutral
"Bank of America, Goldman Sachs, J&J, Netflix, and More Stock Market Movers",https://www.barrons.com/articles/stock-market-movers-da2446ae,2023-04-18 08:59:00,"Stock futures pointed mostly higher Tuesday with earnings reports coming from the likes of Bank of America, Goldman Sachs, and Johnson & Johnson, and as China's economy rebounded at a faster-than-expected pace in the first quarter. These stocks were poised to make moves Tuesday:",JNJ,0.716023,0.311218,Somewhat-Bullish
Stock futures nudge higher as fresh batch of earnings eyed.,https://www.marketwatch.com/story/stock-futures-nudge-higher-as-fresh-batch-of-earnings-eyed-2f26483,2023-04-18 08:46:00,"Futures firm as traders await results from Goldman Sachs and Bank of America, among others.",JNJ,0.090474,0.0,Neutral
"Goldman Sachs, Bank of America And 3 Stocks To Watch Heading Into Tuesday - Bank of America  ( NYSE:BAC ) , Goldman Sachs Gr  ( NYSE:GS ) ",https://www.benzinga.com/news/earnings/23/04/31847066/goldman-sachs-bank-of-america-and-3-stocks-to-watch-heading-into-tuesday,2023-04-18 08:01:28,"With US futures trading slightly higher this morning on Tuesday, some of the stocks that may grab investor focus today are as follows: Wall Street expects The Goldman Sachs Group, Inc. GS to post quarterly earnings at $2.51 per share on revenue of $23.67 billion before the opening bell.",JNJ,0.514619,0.127745,Neutral
Asian Markets Drop But Pare Losses After China Data,https://www.barrons.com/news/asian-markets-drop-but-pare-losses-after-china-data-a7224ed9,2023-04-18 03:10:36,Asian markets fell Tuesday but pared early losses after data showed China's economy grew far more than expected in the first quarter as activity resumed after three years of painful zero-Covid measures.,JNJ,0.069697,0.091364,Neutral
"Stocks Rise, Dollar Drops As China Posts Bumper Growth",https://www.barrons.com/news/asian-markets-drop-but-pare-losses-after-china-data-a7224ed9,2023-04-18 03:10:36,Asian Markets Drop But Pare Losses After China Data ...,JNJ,0.069094,0.099363,Neutral
Asian Markets Drop As China Growth Data Fails To Impress Traders,https://www.barrons.com/news/asian-markets-drop-but-pare-losses-after-china-data-a7224ed9,2023-04-18 03:10:36,Asian Markets Drop But Pare Losses After China Data ...,JNJ,0.060388,0.091001,Neutral
Asian Markets Drop As China Growth Data Fails To Impress Traders,https://www.barrons.com/news/asian-markets-drop-but-pare-losses-after-china-data-a7224ed9,2023-04-18 03:10:36,Asian Markets Drop But Pare Losses After China Data ...,JNJ,0.060236,0.091,Neutral
SGK expands APAC network and opens its tenth office in Seoul,https://www.prnewswire.com/apac/news-releases/sgk-expands-apac-network-and-opens-its-tenth-office-in-seoul-301798754.html,2023-04-18 00:25:00,"SGK continues its growth trajectory in the APAC region to shape the future of brand and consumer connection, with the opening of a Seoul office.",JNJ,0.06623,0.157392,Somewhat-Bullish
"Wall Street ends higher; investors await earnings, Fed cues",https://www.moneycontrol.com/news/business/markets/wall-street-ends-higher-investors-await-earnings-fed-cues-10429271.html,2023-04-18 00:20:10,Markets are gauging the health of corporate profits and the economy after several banks kicked off first-quarter reports with strong results last week.,JNJ,0.068698,0.0,Neutral
Q1 Earnings Season Kicks Off Better than Expected,https://www.zacks.com/stock/news/2079938/q1-earnings-season-kicks-off-better-than-expected,2023-04-17 21:53:00,"We've got a long way to go, but some key regional banks have already reported and offered some relief to market participants.",JNJ,0.140896,0.034048,Neutral
"J&J's Earnings Are Tuesday. Watch for News on Spinoff, Talc Litigation.",https://www.barrons.com/articles/jnj-earnings-stock-price-a9883ad9,2023-04-17 21:00:00,Johnson & Johnson Reports Earnings Tuesday. Here's What to Watch. ...,JNJ,0.961451,0.025486,Neutral
"Dow Jones Futures: Netflix, Tesla Earnings On Deck",https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-netflix-tesla-earnings-on-deck-what-to-do-now-todays-stock-market/,2023-04-17 20:54:00,"Dow Jones futures were little changed ahead of Tuesday's open, with first-quarter earnings season set to heat up this week. Netflix ( NFLX ) earnings are out Tuesday, while Tesla ( TSLA ) earnings are set for Wednesday.",JNJ,0.070414,0.0,Neutral
Check Out What Whales Are Doing With JNJ - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/04/31840860/check-out-what-whales-are-doing-with-jnj,2023-04-17 20:01:18,"A whale with a lot of money to spend has taken a noticeably bullish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson JNJ we detected 30 strange trades. If we consider the specifics of each trade, it is accurate to state that 60% of the investors opened trades with ...",JNJ,0.73856,0.260004,Somewhat-Bullish
Monday's Market Minute: This Week's Primary Focus: Earnings,https://www.benzinga.com/news/earnings/23/04/31838477/mondays-market-minute-this-weeks-primary-focus-earnings,2023-04-17 17:48:15,The focus for market participants will shift from inflation and the Fed to companies reporting quarterly results and the housing data due out this week.,JNJ,0.199037,-0.020277,Neutral
"Earnings Extravaganza: More Big Banks Report This Week, Along with Tesla, Netflix and Other",https://www.benzinga.com/markets/23/04/31838272/earnings-extravaganza-more-big-banks-report-this-week-along-with-tesla-netflix-and-other,2023-04-17 17:40:44,"( Monday market open ) Welcome to the first full week of Q1 earnings season. Today's a relatively quiet day on the reporting calendar, but it's the proverbial calm before the storm. Solid earnings from three of the country's largest banks fueled financials sector gains Friday, but the broader ...",JNJ,0.15347,-0.073947,Neutral
Merck's takeover of Prometheus gives it a foothold in immunology,https://www.marketwatch.com/story/mercks-10-8-billion-takeover-of-prometheus-is-a-good-strategic-move-that-gives-it-a-foothold-in-immunology-2f922a41,2023-04-17 16:19:00,Merck's acquisition of Prometheus Biosciences will help the drug company diversify and reduce the risk of overreliance on its cancer drug Keytruda.,JNJ,0.118064,0.0,Neutral
Rate-hike Fears Keep Stocks Rangebound,https://www.barrons.com/amp/news/rate-hike-fears-keep-stocks-rangebound-e3bc109f,2023-04-17 16:01:21,Rate-hike Fears Keep Stocks ...,JNJ,0.072,0.0,Neutral
Rate-hike Fears Keep Stocks Rangebound,https://www.barrons.com/news/rate-hike-fears-keep-stocks-rangebound-e3bc109f,2023-04-17 16:01:21,Rate-hike Fears Keep Stocks ...,JNJ,0.072,0.0,Neutral
"Club meeting recap: Cramer applauds Well Fargo's 'amazing' quarter, as the stock jumps",https://www.cnbc.com/2023/04/17/club-meeting-recap-cramer-applauds-well-fargos-amazing-quarter.html,2023-04-17 16:00:51,"The Investing Club holds its ""Morning Meeting"" every weekday at 10:20 a.m. ET.",JNJ,0.238133,0.085746,Neutral
Surgical Sutures Market to be Worth $4.42 Billion by 2030 - Exclusive Report by Meticulous ResearchÂ®,https://www.benzinga.com/pressreleases/23/04/g31833643/surgical-sutures-market-to-be-worth-4-42-billion-by-2030-exclusive-report-by-meticulous-research,2023-04-17 15:00:00,"Redding, California, April 17, 2023 ( GLOBE NEWSWIRE ) -- According to a new market research report titled, 'Surgical Sutures Market by Type [Absorbable {Polyglactin, Polydioxanone, Poliglecaprone, Collagen} Nonabsorbable {Polypropylene, Nylon, Silk}] Structure [Monofilament, Multifilament] ...",JNJ,0.024724,0.007192,Neutral
CRH: 3 Quality and Inexpensive Stocks Above the 100-Day Moving Average,https://stocknews.com/news/crh-egiey-hyw-3-quality-and-inexpensive-stocks-above-the-100-day-moving-average/,2023-04-17 14:20:40,CRH: 3 Quality and Inexpensive Stocks Above the 100-Day Moving ... ...,JNJ,0.051221,0.025954,Neutral
"ESG activities correlate to stronger financial performance, reveals new study from Bain & Company and EcoVadis",https://www.prnewswire.com/news-releases/esg-activities-correlate-to-stronger-financial-performance-reveals-new-study-from-bain--company-and-ecovadis-301798933.html,2023-04-17 13:50:00,"ESG activities correlate to stronger financial performance, reveals ... PR ...",JNJ,0.039811,0.242805,Somewhat-Bullish
Will J&J  ( JNJ )  Pharma Unit Outperform Market & Drive Q1 Results?,https://www.zacks.com/stock/news/2079631/will-jj-jnj-pharma-unit-outperform-market-drive-q1-results,2023-04-17 13:31:00,"In J&J's (JNJ) Pharma segment, its oncology drug, Darzalex as well as a psoriasis treatment, Stelara is likely to have driven sales growth in the first quarter ...",JNJ,0.230235,0.300558,Somewhat-Bullish
Earnings Season Picks Up Steam,https://www.forbes.com/sites/jjkinahan/2023/04/17/earnings-season-picks-up-steam/,2023-04-17 13:27:58,It was a quiet week for stocks with both the S&P 500 and Nasdaq Composite both up less than 1%.,JNJ,0.061159,-0.048135,Neutral
Is Johnson & Johnson a Buy After Its Proposed $8.9 Billion Talc Settlement?,https://www.fool.com/investing/2023/04/17/is-johnson-johnson-a-buy-after-proposed-89-billion/,2023-04-17 12:36:00,The controversial company could soon take a big step forward.,JNJ,0.489163,0.237213,Somewhat-Bullish
"Regeneron Announces Retirement of Board Chair, Dr. P. Roy Vagelos, Accomplished Physician-Businessman and Industry Luminary",https://www.globenewswire.com/news-release/2023/04/17/2647803/0/en/Regeneron-Announces-Retirement-of-Board-Chair-Dr-P-Roy-Vagelos-Accomplished-Physician-Businessman-and-Industry-Luminary.html,2023-04-17 11:30:00,Dr. Leonard S. Schleifer and Dr. George D. Yancopoulos to become Co-Chairs of the Board and Christine A. Poon to be named Lead Independent Director Dr. Leonard S. Schleifer and Dr. George D. Yancopoulos to become Co-Chairs of the Board and Christine A. Poon to be named Lead Independent ...,JNJ,0.069294,0.154735,Somewhat-Bullish
"Regeneron Announces Retirement of Board Chair, Dr. P. Roy Vagelos, Accomplished Physician-Businessman and Industry Luminary - Regeneron Pharmaceuticals  ( NASDAQ:REGN ) ",https://www.benzinga.com/pressreleases/23/04/g31826057/regeneron-announces-retirement-of-board-chair-dr-p-roy-vagelos-accomplished-physician-businessman-,2023-04-17 11:30:00,"TARRYTOWN, N.Y., April 17, 2023 ( GLOBE NEWSWIRE ) -- Regeneron Pharmaceuticals, Inc. REGN today announced that P. Roy Vagelos, M.D., will retire from his role as Chair of the Company's Board of Directors and will not stand for reelection at the Company's 2023 Annual Meeting of Shareholders.",JNJ,0.067727,0.154425,Somewhat-Bullish
"Lack of Volatility, Weak Macro, Mixed Fed Messages, Earnings, Charting Markets",https://realmoney.thestreet.com/investing/lack-of-volatility-weak-macro-mixed-fed-messages-earnings-charting-markets-16121271,2023-04-17 11:28:08,"Lack of Volatility, Weak Macro, Mixed Fed Messages, Earnings ... ...",JNJ,0.035929,0.0,Neutral
"JPMorgan, Citigroup and even Wells Fargo are part of Zacks Earnings Preview",https://www.zacks.com/stock/news/2079476/jpmorgan-citigroup-and-even-wells-fargo-are-part-of-zacks-earnings-preview,2023-04-17 11:00:00,"JPMorgan, Citigroup and Wells Fargo are highlights of Zacks Earnings Preview article.",JNJ,0.029691,-0.039501,Neutral
Global Markets: European stocks touch fresh highs ahead of US earnings | The Financial Express,https://www.financialexpress.com/market/global-markets-european-stocks-touch-fresh-highs-ahead-of-us-earnings/3050511/,2023-04-17 09:47:37,Global Markets: European stocks touch fresh highs ahead of US ... The Financial Express ...,JNJ,0.051774,0.0,Neutral
1 Warren Buffett Index Fund Could Turn $100 Per Week into $1 Million,https://www.fool.com/investing/2023/04/17/1-warren-buffett-index-fund-turn-100-to-1-million/,2023-04-17 09:15:00,Warren Buffett believes this strategy can help the average investor outperform professional money managers.,JNJ,0.060085,0.036997,Neutral
U.S. stock futures near highs of the year as earnings season eyed,https://www.marketwatch.com/story/u-s-stock-futures-near-highs-of-the-year-as-earnings-season-eyed-f30a4a9b,2023-04-17 09:11:00,"The S&P 500 is in line to begin Monday near the top of the 3,800 to 4,200 range within which it has vacillated for about five months.",JNJ,0.152983,0.069151,Neutral
2 Best Biotech Stocks to Buy for the Long Haul,https://www.fool.com/investing/2023/04/17/2-best-biotech-stocks-to-buy-for-the-long-haul/,2023-04-17 09:10:00,These two are among the largest pharma companies in the world.,JNJ,0.212425,-0.082507,Neutral
The Fed Expects a Recession: 2 Warren Buffett Stocks to Buy Now and 1 to Avoid Like the Plague,https://www.fool.com/investing/2023/04/17/fed-recession-2-warren-buffett-stocks-buy-1-avoid/,2023-04-17 09:06:00,"Two Berkshire Hathaway holdings are well positioned for a possible economic downturn, while another Buffett favorite is best avoided.",JNJ,0.149285,0.06077,Neutral
Appointment of new CEO,https://www.globenewswire.com/news-release/2023/04/17/2647616/0/en/Appointment-of-new-CEO.html,2023-04-17 08:00:00,ANNOUNCEMENT NO. ...,JNJ,0.120431,0.046311,Neutral
FMCG market size to grow by USD 310.5 billion from 2021 to 2026; Growth driven by growing preference for e-commerce online distribution - Technavio,https://www.prnewswire.com/news-releases/fmcg-market-size-to-grow-by-usd-310-5-billion-from-2021-to-2026-growth-driven-by-growing-preference-for-e-commerce-online-distribution---technavio-301798236.html,2023-04-17 04:30:00,FMCG market size to grow by USD 310.5 billion from 2021 to 2026 ... PR ...,JNJ,0.109242,0.157685,Somewhat-Bullish
Wall Street ticks higher ahead of another busy earnings week,https://apnews.com/article/inflation-federal-reserve-system-financial-markets-business-f2678ffc2c6a9f415a652c6b5ebf3968,2023-04-17 03:48:17,"Asian shares mixed over economic growth, rate worries The Associated Press ...",JNJ,0.063258,0.0,Neutral
Stocks drift to open first full week of earnings season,https://apnews.com/article/inflation-federal-reserve-system-financial-markets-business-f2678ffc2c6a9f415a652c6b5ebf3968,2023-04-17 03:48:17,"Asian shares mixed over economic growth, rate worries The Associated Press ...",JNJ,0.051774,0.0,Neutral
Wall Street holds steady as earnings season kicks into gear,https://apnews.com/article/inflation-federal-reserve-system-financial-markets-business-f2678ffc2c6a9f415a652c6b5ebf3968,2023-04-17 03:48:17,"Asian shares mixed over economic growth, rate worries The Associated Press ...",JNJ,0.049629,0.0,Neutral
Wall Street drifts lower as earnings season kicks into gear,https://apnews.com/article/inflation-federal-reserve-system-financial-markets-business-f2678ffc2c6a9f415a652c6b5ebf3968,2023-04-17 03:48:17,"Asian shares mixed over economic growth, rate worries The Associated Press ...",JNJ,0.049322,0.0,Neutral
Wall Street drifts as earnings season kicks into gear,https://apnews.com/article/inflation-federal-reserve-system-financial-markets-business-f2678ffc2c6a9f415a652c6b5ebf3968,2023-04-17 03:48:17,"Asian shares mixed over economic growth, rate worries The Associated Press ...",JNJ,0.048523,0.0,Neutral
Stocks drift higher as earnings season kicks into gear,https://apnews.com/article/inflation-federal-reserve-system-financial-markets-business-f2678ffc2c6a9f415a652c6b5ebf3968,2023-04-17 03:48:17,"Asian shares mixed over economic growth, rate worries The Associated Press ...",JNJ,0.048327,0.0,Neutral
Stocks Mixed As Rate-hike Fears Resurface,https://www.barrons.com/news/asian-markets-mixed-as-wary-traders-weigh-latest-data-9aa1db,2023-04-17 03:11:06,Asian Markets Mixed As Wary Traders Weigh Latest Data ...,JNJ,0.084722,0.0,Neutral
"Asia stocks on edge for earnings, China data | The Financial Express",https://www.financialexpress.com/market/asia-stocks-on-edge-for-earnings-china-data/3049805/,2023-04-17 02:46:21,"Asia stocks on edge for earnings, China data The Financial Express ...",JNJ,0.059488,0.024004,Neutral
"Tesla, AT&T, Goldman Sachs, Netflix, Charles Schwab, and More Stocks to Watch This Week",https://www.barrons.com/articles/stocks-to-watch-this-week-tesla-att-goldman-sachs-netflix-charles-schwab-9d157291,2023-04-16 23:51:00,It will be a busy week of first-quarter earnings reports and with several of the latest indicators on the U.S. economy and housing market on deck. Charles Schwab and J.B.,JNJ,0.546745,0.0,Neutral
"Tesla, AT&T, Goldman Sachs, Netflix, Charles Schwab, and More Stocks to Watch This Week",https://www.barrons.com/articles/tesla-at-t-goldman-sachs-netflix-charles-schwab-and-more-stocks-to-watch-this-week-9d157291,2023-04-16 19:00:00,It will be a busy week of first-quarter earnings reports and with several of the latest indicators on the U.S. economy and housing market on deck. Charles Schwab and J.B.,JNJ,0.546745,0.0,Neutral
"Tesla, Netflix earnings and Apple's India debut top week ahead",https://www.foxbusiness.com/markets/tesla-netflix-earnings-apple-india-debut-top-week-ahead,2023-04-16 17:48:45,"Investors head into a busy week as earnings season continues with tech and bank companies on the docket. Additionally, Apple is set to make a big splash in India. notched weekly gains, led by the Dow Jones Industrial Average, while the S&P 500 and Nasdaq Composite posted smaller increases.",JNJ,0.049939,0.0,Neutral
2 of the Lowest-Risk Dividend Stocks in the World,https://www.fool.com/investing/2023/04/16/2-of-the-lowest-risk-dividend-stocks-in-the-world/,2023-04-16 14:31:00,The companies backing these dividends generate massive cash flows and have fortress-like balance sheets.,JNJ,0.488777,0.285198,Somewhat-Bullish
"Tesla, Netflix earnings due: Cheaper cars, cheaper content, more workout videos, as 'earnings recession' seems likely",https://www.marketwatch.com/story/tesla-netflix-earnings-due-cheaper-cars-cheaper-content-more-workout-videos-as-earnings-recession-seems-likely-bf4ebc54,2023-04-16 14:01:00,"Netflix, Tesla, banks and credit-card companies report in the week ahead.",JNJ,0.068404,-0.119409,Neutral
Three investors on how to protect your portfolio | Business,https://www.cnn.com/2023/04/16/business/stocks-week-ahead/index.html,2023-04-16 11:35:00,Three investors on how to protect your portfolio ...,JNJ,0.089797,0.0,Neutral
Why Johnson & Johnson Is Such an Impressive Dividend Stock,https://www.fool.com/investing/2023/04/15/why-johnson-johnson-is-such-an-impressive-dividend/,2023-04-15 13:50:00,"For dividend investors, this stock can be a solid pillar to build your portfolio around.",JNJ,0.405651,0.28873,Somewhat-Bullish
Farallon steps up activism at biotech company Exelixis. Here's what could happen next,https://www.cnbc.com/2023/04/15/-farallon-steps-up-activism-at-biotech-company-exelixis-heres-what-could-happen-next.html,2023-04-15 11:26:07,"Farallon isn't an activist investor, but it won't shy away from a battle if necessary.",JNJ,0.027571,0.091125,Neutral
Johnson & Johnson Stock: Bear vs. Bull,https://www.fool.com/investing/2023/04/15/johnson-johnson-stock-bear-vs-bull/,2023-04-15 11:20:00,"The stock's proponents are facing upcoming uncertainty, but its detractors aren't as much.",JNJ,0.282777,0.141795,Neutral
3 Dividend Stocks to Buy and Hold for the Next Decade,https://www.fool.com/investing/2023/04/15/3-dividend-stocks-to-buy-and-hold-for-the-next-dec/,2023-04-15 10:14:00,Long-term investors looking for income should especially like these stocks.,JNJ,0.286002,0.192414,Somewhat-Bullish
Analyzing Q1 Bank Earnings: Good or Bad?,https://www.zacks.com/commentary/2079235/analyzing-q1-bank-earnings-good-or-bad,2023-04-14 22:16:00,"There was plenty to like in these quarterly results, with higher interest rates helping these big players expand their margins while demand for loans remained strong, helping loan portfolios grow.",JNJ,0.027508,-0.036258,Neutral
"Investing Action Plan: Tesla, Netflix, Goldman Sachs Earnings Amid Young Uptrend",https://www.investors.com/research/investing-action-plan/stock-trading-action-plan-tesla-netflix-goldman-sachs-earnings-amid-young-uptrend/,2023-04-14 22:03:00,"Investing Action Plan: Tesla, Netflix, Goldman Sachs Earnings Amid ... Investor's Business Daily ...",JNJ,0.042762,0.093831,Neutral
"Time of the Season: Banks Get Quarterly Reporting Off to Strong Start, but Retail Sales Disappoint",https://www.benzinga.com/markets/23/04/31810522/time-of-the-season-banks-get-quarterly-reporting-off-to-strong-start-but-retail-sales-disappoint,2023-04-14 16:57:10,"( Friday market open ) The biggest U.S. banks have a reputation for beating Wall Street's earnings estimates, and they lived up to it again Friday morning.",JNJ,0.038499,0.0,Neutral
"Spencer Breithaupt Joins PetVivo Holdings, Inc. Board of Directors",https://www.globenewswire.com/news-release/2023/04/14/2647269/0/en/Spencer-Breithaupt-Joins-PetVivo-Holdings-Inc-Board-of-Directors.html,2023-04-14 16:35:00,"MINNEAPOLIS, MN, US, April 14, 2023 ( GLOBE NEWSWIRE ) -- PetVivo Holdings, Inc. ( NASDAQ: PETV & PETVW ) ( the ""Company"" ) an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for companion animals and animal athletes is pleased to announce ...",JNJ,0.049835,0.121196,Neutral
StockNews.com Issues Imperative Report on Heska Corporation's Healthcare Stock,https://beststocks.com/stocknews-com-issues-imperative-report-on-heska-co/,2023-04-14 15:14:47,StockNews.com Issues Imperative Report on Heska Corporation's ... Best Stocks ...,JNJ,0.059488,0.175014,Somewhat-Bullish
Drug manufacturer Catalent's stock tumbles 25% after profit warning and CFO departure,https://www.marketwatch.com/story/catalent-issues-profit-warning-for-fiscal-q3-after-manufacturing-and-cost-issues-at-three-plants-sending-stock-down-20-120d0af5,2023-04-14 14:57:00,Drug manufacturer Catalent said higher-than-expected costs and productivity issues at three plants would have a material adverse impact on fiscal third-quarter earnings.,JNJ,0.143843,0.053048,Neutral
FDA Strikes Down Eli Lilly's Application Seeking Approval For Ulcerative Colitis Drug - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/general/biotech/23/04/31803789/fda-strikes-down-eli-lillys-application-seeking-approval-for-ulcerative-colitis-drug,2023-04-14 13:33:50,"The FDA has issued a complete response letter for Eli Lilly And Co's LLY mirikizumab biologic license application ( BLA ) for ulcerative colitis ( UC ) . In the letter, the FDA cited issues related to the proposed manufacturing of mirikizumab, with no concerns about the clinical data ...",JNJ,0.277433,0.0,Neutral
J&J  ( JNJ )  to Initiate Q1 Earnings Season for Pharma Sector,https://www.zacks.com/stock/news/2078827/jj-jnj-to-initiate-q1-earnings-season-for-pharma-sector,2023-04-14 13:15:00,"Growth in J&J's (JNJ) Pharma unit is expected to have been driven by drugs like Darzalex and Stelara. In the MedTech segment, continued recovery in worldwide procedure volume should drive sales.",JNJ,0.100518,0.07225,Neutral
Wall Street: All eyes on earnings announcements as recession fears take centre stage | The Financial Express,https://www.financialexpress.com/business/investing-abroad-wall-street-all-eyes-on-earnings-announcements-as-recession-fears-take-centre-stage-3047210/,2023-04-14 12:57:00,Wall Street: All eyes on earnings announcements as recession fears ... The Financial Express ...,JNJ,0.080728,0.0,Neutral
Why Johnson & Johnson Paying $8.9 Billion to Settle Its Talc Lawsuits Would Be Good News,https://www.fool.com/investing/2023/04/14/why-johnson-johnson-paying-89-billion-for-talc-law/,2023-04-14 12:45:00,Is now the time to buy the stock?,JNJ,0.665714,0.15239,Somewhat-Bullish
Take Five: How bad is it?,https://www.reuters.com/business/take-five/global-markets-themes-takealook-2023-04-14/,2023-04-14 06:25:00,"LONDON, April 14 ( Reuters ) - Earnings season gets into full swing, while the first snapshot of business activity in April could provide a sense of how much pain the turmoil in the banking sector has inflicted on the world economy.",JNJ,0.044801,0.0,Neutral
"Sri Balaji University, Pune invites applications for UG, PG programmes | The Financial Express",https://www.financialexpress.com/education-2/sri-balaji-university-pune-invites-applications-for-ug-pg-programmes/3046543/,2023-04-14 05:30:11,"Sri Balaji University, Pune invites applications for UG, PG programmes The Financial Express ...",JNJ,0.109455,0.242917,Somewhat-Bullish
"Acne Drugs Market size to grow by USD 907.11 million from 2022 to 2027, Driven by the emergence of improved diagnostic modalities - Technavio",https://www.prnewswire.com/news-releases/acne-drugs-market-size-to-grow-by-usd-907-11-million-from-2022-to-2027--driven-by-the-emergence-of-improved-diagnostic-modalities---technavio-301795679.html,2023-04-14 03:30:00,Acne Drugs Market size to grow by USD 907.11 million from 2022 to ... PR ...,JNJ,0.050625,0.060964,Neutral
Congestive Heart Failure Drugs Market Size to Cross USD 13.5 Bn Revenue by 2031 | TMR Study,https://www.benzinga.com/pressreleases/23/04/g31798962/congestive-heart-failure-drugs-market-size-to-cross-usd-13-5-bn-revenue-by-2031-tmr-study,2023-04-13 21:30:00,"Wilmington, Delaware, United States, April 14, 2023 ( GLOBE NEWSWIRE ) -- The global congestive heart failure drugs market was valued at USD 6.7 Bn in 2022 and is estimated to reach USD 13.5 Bn by 2031, expanding at a CAGR of 7.6% between 2023 and 2031.",JNJ,0.041466,0.0,Neutral
Anika Enters Into Cooperation Agreement with Caligan Partners - Anika Therapeutics  ( NASDAQ:ANIK ) ,https://www.benzinga.com/pressreleases/23/04/g31797973/anika-enters-into-cooperation-agreement-with-caligan-partners,2023-04-13 21:00:25,"BEDFORD, Mass., April 13, 2023 ( GLOBE NEWSWIRE ) -- Anika Therapeutics, Inc. ANIK ( ""Anika"" or the ""Company"" ) , a global joint preservation company in early intervention orthopedics, today announced that it has entered into a cooperation agreement with Caligan Partners LP ( ""Caligan"" ) .",JNJ,0.028089,0.004561,Neutral
Anika Enters Into Cooperation Agreement with Caligan Partners,https://www.globenewswire.com/news-release/2023/04/13/2646752/28467/en/Anika-Enters-Into-Cooperation-Agreement-with-Caligan-Partners.html,2023-04-13 21:00:00,Gary Fischetti Joins Anika Board ...,JNJ,0.028937,0.004584,Neutral
The Largest Companies by Market Cap in 2023,https://www.fool.com/research/largest-companies-by-market-cap/,2023-04-13 18:08:33,"Apple, Microsoft, and Saudi Aramco are the biggest companies measured by market cap.",JNJ,0.051663,-0.169939,Somewhat-Bearish
"Jeff Bezos, George Soros, Mark Cuban, and Ray Dalio All Have One Thing in Common: They're Making a Big Bet on This Industry - Horizon Therapeutics  ( NASDAQ:HZNP ) , Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/news/23/04/31792814/jeff-bezos-george-soros-mark-cuban-and-ray-dalio-all-have-one-thing-in-common-theyre-making-a-big-be,2023-04-13 16:33:20,"When billionaires jump on the same trend, it's important for investors to take notice. The pieces often don't come together immediately, but these investors have millions of dollars in resources dedicated to getting the most up-to-date information as quickly as possible.",JNJ,0.155954,-0.027918,Neutral
Don't Celebrate Yet: Lower Wholesale Inflation Data Mainly Reflected Drop in Energy Prices,https://www.benzinga.com/markets/23/04/31791322/dont-celebrate-yet-lower-wholesale-inflation-data-mainly-reflected-drop-in-energy-prices,2023-04-13 15:27:33,"( Thursday market open ) More signs emerged early Thursday of cooler inflation, as the March Producer Price Index ( PPI ) fell 0.5%. It was the first monthly slide in PPI since December, and while it reflected a big drop in volatile energy prices, other areas also showed progress.",JNJ,0.034831,0.0,Neutral
Will Q1 Earnings Fuel a Rally in Dow ETF?,https://www.zacks.com/stock/news/2078322/will-q1-earnings-fuel-a-rally-in-dow-etf,2023-04-13 15:15:00,"As the index is closely tied to the cyclical sectors, the banking turmoil hit hard the Dow last month. Recession fears have added to the woes.",JNJ,0.130689,0.040755,Neutral
Earnings season guidance will give recession clues,https://www.investorideas.com/news/2023/main/04131Earnings-Season-Guidance.asp,2023-04-13 13:53:38,"April 13, 2023 ( Investorideas.com Newswire ) Investor focus is set to shift from inflation to earnings season, which starts on Friday, as it will give us more insight about a forthcoming recession, says the CEO of one of the world's largest independent financial advisory, asset management and ...",JNJ,0.075874,0.0,Neutral
Buy These 3 PIMCO Mutual Funds for Amazing Returns,https://www.zacks.com/stock/news/2078001/buy-these-3-pimco-mutual-funds-for-amazing-returns,2023-04-13 10:11:00,"Below, we share with you three PIMCO mutual funds, namely PKAPX, PZRAX and PQICX. Each has earned a Zacks Mutual Fund Rank #1.",JNJ,0.085022,0.054226,Neutral
Can Pfizer Beat GSK and Moderna in This $10 Billion Market?,https://www.fool.com/investing/2023/04/13/can-pfizer-beat-gsk-and-moderna-in-this-10-billion/,2023-04-13 09:52:00,There's such a big need in preventing RSV that multiple companies should be big winners.,JNJ,0.059194,0.021009,Neutral
Can AI answer your money questions? We put chatbots to the test,https://www.reuters.com/markets/wealth/can-ai-answer-your-money-questions-we-put-chatbots-test-2023-04-13/,2023-04-13 04:13:36,"NEW YORK, April 13 ( Reuters ) - Face it, we could all use a little help with our money. So who better to ask for personal finance advice than a couple of the most powerful chatbots on the planet?",JNJ,0.050465,0.086378,Neutral
Check Out What Whales Are Doing With JNJ - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/04/31769989/check-out-what-whales-are-doing-with-jnj,2023-04-12 14:15:57,"Someone with a lot of money to spend has taken a bullish stance on Johnson & Johnson JNJ. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",JNJ,0.720339,0.308543,Somewhat-Bullish
Jim Cramer's top 10 things to watch in the stock market Wednesday,https://www.cnbc.com/2023/04/12/jim-cramers-top-10-things-to-watch-in-the-stock-market-wednesday-.html,2023-04-12 13:10:05,Club holding Emerson Electric (EMR) announced an $8.2 billion deal to acquire National Instruments (NATI) - and other market developments Cramer's watching.,JNJ,0.187221,0.053241,Neutral
Will Johnson & Johnson Stock Rise Post Q1?,https://www.forbes.com/sites/greatspeculations/2023/04/12/will-johnson--johnson-stock-rise-post-q1/,2023-04-12 13:00:07,"We expect J&J to report revenues and earnings slightly above the consensus estimate, and JNJ stock appears to have more room for growth.",JNJ,0.716023,0.247286,Somewhat-Bullish
Is Vanguard Dividend Appreciation ETF  ( VIG )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2077293/is-vanguard-dividend-appreciation-etf-vig-a-strong-etf-right-now,2023-04-12 10:20:09,Smart Beta ETF report for VIG ...,JNJ,0.113062,0.059546,Neutral
Which Healthcare Company Will Be the First to Get to a $1 Trillion Market Cap?,https://www.fool.com/investing/2023/04/12/which-healthcare-stock-first-trillion-market-cap/,2023-04-12 09:20:00,These businesses all show promise and should get much bigger in the future.,JNJ,0.211191,0.185587,Somewhat-Bullish
"Home Healthcare Market to Expand at a 10.5% CAGR from 2021-2028, Globally: TMR Report",https://www.benzinga.com/pressreleases/23/04/g31758515/home-healthcare-market-to-expand-at-a-10-5-cagr-from-2021-2028-globally-tmr-report,2023-04-11 21:30:00,"Wilmington, Delaware, United States, April 12, 2023 ( GLOBE NEWSWIRE ) -- According to the recent study by Transparency Market Research, the global home healthcare market is anticipated to flourish at a staggering 10.5% CAGR from 2021 to 2028.",JNJ,0.03798,0.0,Neutral
Carrier plots separation of fire unit,https://www.foxbusiness.com/markets/carrier-plots-separation-fire-unit,2023-04-11 18:24:26,"Carrier Global Corp. is working on a plan to sell or spin off its Fire & Security business segment, which accounts for about 17% of the air-conditioning company's sales, according to people familiar with the matter. The process is in an early stage, the people said, and there is no guarantee the ...",JNJ,0.107978,-0.086945,Neutral
Club meeting recap: Jim Cramer says stick with health care stocks in uncertain times,https://www.cnbc.com/2023/04/11/club-meeting-recap-jim-cramer-says-stick-with-health-care-stocks.html,2023-04-11 16:00:52,"The Investing Club holds its ""Morning Meeting"" every weekday at 10:20 a.m. ET.",JNJ,0.227007,0.166886,Somewhat-Bullish
Analysts Estimate Johnson & Johnson  ( JNJ )  to Report a Decline in Earnings: What to Look Out for,https://www.zacks.com/stock/news/2076955/analysts-estimate-johnson-johnson-jnj-to-report-a-decline-in-earnings-what-to-look-out-for,2023-04-11 14:00:20,Johnson & Johnson (JNJ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,JNJ,0.295273,0.002206,Neutral
"Hillstream BioPharma's Drug Candidate HSB-1216 Could Be One To Watch As Global Oncology Market Continues To Grow - BeiGene  ( NASDAQ:BGNE ) , Bristol-Myers Squibb  ( NYSE:BMY ) ",https://www.benzinga.com/general/biotech/23/04/31741766/hillstream-biopharmas-drug-candidate-hsb-1216-could-be-one-to-watch-as-global-oncology-market-con,2023-04-11 12:28:09,"A surge in oncology drug development, coupled with increased patient access and early diagnosis, has resulted in a massive increase in global spending on cancer treatments. Due to this, the global oncology market has been growing at an unprecedented pace over the past few years.",JNJ,0.104683,-0.151137,Somewhat-Bearish
"Hillstream BioPharma's Drug Candidate HSB-1216 Could Be One To Watch As Global Oncology Market Continues To Grow - BeiGene  ( NASDAQ:BGNE ) , Bristol-Myers Squibb  ( NYSE:BMY ) ",https://www.benzinga.com/general/biotech/23/04/31741764/hillstream-biopharmas-drug-candidate-hsb-1216-could-be-one-to-watch-as-global-oncology-market-con,2023-04-11 12:28:08,"A surge in oncology drug development, coupled with increased patient access and early diagnosis, has resulted in a massive increase in global spending on cancer treatments. Due to this, the global oncology market has been growing at an unprecedented pace over the past few years.",JNJ,0.104683,-0.151137,Somewhat-Bearish
Best Inverse/Leveraged ETFs of Last Week,https://www.zacks.com/stock/news/2076739/best-inverseleveraged-etfs-of-last-week,2023-04-11 12:00:00,"Wall Street put up a mixed show in the holiday-shortened last week. Leveraged gold miners, healthcare, utilities and energy ETFs/ETNs were among the winning investing areas.",JNJ,0.063091,0.270538,Somewhat-Bullish
Is Johnson & Johnson About to Put Its Talc Lawsuits to Bed?,https://www.fool.com/investing/2023/04/11/is-johnson-johnson-about-to-put-its-talc-lawsuits/,2023-04-11 10:00:00,The company took an important step toward that goal.,JNJ,0.682689,0.191802,Somewhat-Bullish
"Hywin Holdings, Leonteq AG, and ARTA TechFin jointly launch principal-protected note linked to FactSet Hywin Global Health Care Indexâ„¢",https://www.globenewswire.com/news-release/2023/04/11/2644010/0/en/Hywin-Holdings-Leonteq-AG-and-ARTA-TechFin-jointly-launch-principal-protected-note-linked-to-FactSet-Hywin-Global-Health-Care-Index.html,2023-04-11 00:00:00,"HONG KONG, April 11, 2023 ( GLOBE NEWSWIRE ) -- Hywin Holdings Ltd. ( ""Hywin Wealth"" or ""Hywin"" ) ( NASDAQ: HYW ) , a leading independent wealth management service provider in China, Leonteq Securities AG ( ""Leonteq"" ) , a Swiss fintech company with a leading marketplace for structured ...",JNJ,0.036869,0.079891,Neutral
"Hywin Holdings, Leonteq AG, and ARTA TechFin jointly launch principal-protected note linked to FactSet Hywin Global Health Care Indexâ„¢ - Hywin Holdings  ( NASDAQ:HYW ) ",https://www.benzinga.com/pressreleases/23/04/g31736283/hywin-holdings-leonteq-ag-and-arta-techfin-jointly-launch-principal-protected-note-linked-to-facts,2023-04-11 00:00:00,"HONG KONG, April 11, 2023 ( GLOBE NEWSWIRE ) -- Hywin Holdings Ltd. ( ""Hywin Wealth"" or ""Hywin"" ) HYW, a leading independent wealth management service provider in China, Leonteq Securities AG ( ""Leonteq"" ) , a Swiss fintech company with a leading marketplace for structured investment solutions, ...",JNJ,0.036091,0.079702,Neutral
SoftBank Group's chip maker Arm registers for blockbuster US IPO,https://www.business-standard.com/world-news/softbank-group-s-chip-maker-arm-registers-for-blockbuster-us-ipo-123043000988_1.html,2023-04-30 18:15:50,"The IPO registration shows that SoftBank is pressing ahead with the blockbuster offering despite adverse market conditions, after saying in March that it planned to list Arm in the US stock market.",JNJ,0.09989,0.08811,Neutral
"Sales, spins and splits - what are the differences and why do they matter for investors like us?",https://www.cnbc.com/2023/04/30/sales-spin-offs-and-splits-the-differences-and-why-they-matter-for-investors.html,2023-04-30 14:37:52,"While each transaction needs to be evaluated on its own merits, the Club has come to recognize that sometimes, less is more.",JNJ,0.913524,0.537717,Bullish
"Alzheimer's patients may wait years to get treated with new drugs, putting them at risk of more severe disease",https://www.cnbc.com/2023/04/30/alzheimers-treatment-patients-may-wait-years-for-new-drugs.html,2023-04-30 13:00:01,Patients could face wait times ranging from 18 months to four years or more to get diagnosed and then treated for Alzheimer's disease.,JNJ,0.029078,-0.008616,Neutral
"2 Simple Ways to Make $40,000 in Passive Income",https://moneymorning.com/investing/2-simple-ways-to-make-40000-in-passive-income/,2023-04-30 09:52:00,"Most people work hard for their money. That's admirable. But it's also smart to let your money work hard for you. Some avenues for putting your money to work can be super complicated. There are less complex approaches, though. Here are two simple ways to make $40,000 in passive income.",JNJ,0.183198,0.311202,Somewhat-Bullish
"2 Simple Ways to Make $40,000 in Passive Income",https://www.fool.com/investing/2023/04/30/simple-ways-to-make-passive-income/,2023-04-30 09:52:00,Make your money work for you with these two investment options.,JNJ,0.13347,0.257971,Somewhat-Bullish
Exclusive: SoftBank's Arm registers for blockbuster US IPO,https://www.reuters.com/markets/deals/softbanks-arm-registers-blockbuster-us-ipo-sources-2023-04-29/,2023-04-29 15:08:00,Exclusive: SoftBank's Arm registers for blockbuster US ...,JNJ,0.09402,0.077332,Neutral
Initial public offerings scheduled to debut next week,https://apnews.com/article/ipos-business-f3e7cbb42bfc422886d2510a5ebd2b89,2023-04-29 02:48:17,"NEW YORK ( AP ) - The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings. CaliberCos - Scottsdale, Ariz., 1.2 million shares, priced at $5, managed by Scottsdale, Ariz.",JNJ,0.355588,0.20397,Somewhat-Bullish
Initial public offerings scheduled to debut next week,https://apnews.com/article/ipos-business-dcde52c917c74fcd9451bc9344e1ef91,2023-04-29 02:48:17,"NEW YORK ( AP ) - The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings. CaliberCos - Scottsdale, Ariz., 1.2 million shares, priced at $5, managed by Scottsdale, Ariz.",JNJ,0.355588,0.20397,Somewhat-Bullish
"Merit Medical  ( MMSI )  Tops Q1 Earnings Estimates, Ups FY23 View",https://www.zacks.com/stock/news/2087122/merit-medical-mmsi-tops-q1-earnings-estimates-ups-fy23-view,2023-04-28 17:27:00,Merit Medical (MMSI) benefits from revenue growth in both segments and all product categories within its Cardiovascular unit in the first quarter.,JNJ,0.143629,0.02131,Neutral
"Integer Holdings  ( ITGR )  Q1 Earnings, Revenues Beat Estimates",https://www.zacks.com/stock/news/2087031/integer-holdings-itgr-q1-earnings-revenues-beat-estimates,2023-04-28 16:01:00,"Integer Holdings' (ITGR) first-quarter results reflect robust Medical and Non-Medical sales, besides strength in all the product lines.",JNJ,0.144275,0.022642,Neutral
2 Dow 30 Stocks To Watch Before May 2023,https://stockmarket.com/featured/2-dow-30-stocks-to-watch-before-may-2023-2023-04-28,2023-04-28 15:26:51,"The Dow Jones Industrial Average ( DJIA ) , often referred to as ""the Dow,"" is a widely followed stock market index. In addition, Dow Jones tracks the performance of 30 blue-chip companies listed on the New York Stock Exchange and NASDAQ. The index serves as a barometer for the health of the U.S. ...",JNJ,0.154455,0.191474,Somewhat-Bullish
ResMed  ( RMD )  Q3 Earnings and Revenues Surpass Estimates,https://www.zacks.com/stock/news/2086818/resmed-rmd-q3-earnings-and-revenues-surpass-estimates,2023-04-28 13:16:00,"ResMed (RMD) reports a solid third-quarter top line, led by strong device sales growth through steady production and delivery of its cloud-connected flow generator devices to meet high market demand.",JNJ,0.169378,0.05441,Neutral
Is It Too Late to Buy Johnson & Johnson's Stock?,https://moneymorning.com/investing/is-it-too-late-to-buy-johnson-johnsons-stock/,2023-04-28 12:30:00,"Johnson & Johnson ( NYSE: JNJ ) ( J&J ) is a renowned name in the healthcare and consumer goods industries. Band-Aids, Listerine, Neutrogena, and Tylenol are among its most well-known brands. The company has been around for over a century and has a strong global presence.",JNJ,0.152983,0.199503,Somewhat-Bullish
Is It Too Late to Buy Johnson & Johnson's Stock?,https://www.fool.com/investing/2023/04/28/is-it-too-late-to-buy-johnson-johnsons-stock/,2023-04-28 12:30:00,This healthcare juggernaut's recent quarterly results prove just how strong its business is.,JNJ,0.149346,0.257961,Somewhat-Bullish
Government Drug Price Curbs Could Sound A Death Knell For Industry,https://www.investors.com/news/technology/biotech-stocks-brace-for-the-worst-as-government-drug-price-negotiations-loom/,2023-04-28 12:00:00,Biotech Stocks Brace For The Worst As Government Drug Price ... Investor's Business Daily ...,JNJ,0.027118,0.044929,Neutral
Pharmaceutical Company Sets Gold Standard for New Drugs,https://www.investorideas.com/news/2023/biotech/04271Pharmaceutical-Drug-Standard.asp,2023-04-27 19:20:04,"April 27, 2023 ( Investorideas.com Newswire ) Algernon Pharmaceuticals Inc. has received a U.S. patent for a ground-breaking new Non-Alcoholic Steatohepatitis ( NASH ) drug under investigation, and is developing another for refractory chronic cough ( RCC ) .",JNJ,0.052169,0.125845,Neutral
The Fed Forecasts a Recession: 2 Top Warren Buffett Stocks to Buy Now,https://moneymorning.com/investing/the-fed-forecasts-a-recession-2-top-warren-buffett-stocks-to-buy-now/,2023-04-27 18:00:00,The Fed Forecasts a Recession: 2 Top Warren Buffett Stocks to Buy ... Money Morning ...,JNJ,0.162255,-0.080192,Neutral
The Fed Forecasts a Recession: 2 Top Warren Buffett Stocks to Buy Now,https://www.fool.com/investing/2023/04/27/fed-forecasts-a-recession-2-top-buffett-stocks/,2023-04-27 18:00:00,These two stocks will bring you passive income and growth over time.,JNJ,0.136113,-0.072159,Neutral
"AbbVie  ( ABBV )  Q1 Earnings Beat, Skyrizi Sales Underperform",https://www.zacks.com/stock/news/2086355/abbvie-abbv-q1-earnings-beat-skyrizi-sales-underperform,2023-04-27 16:33:00,"AbbVie's (ABBV) first-quarter 2023 earnings and sales beat estimates. However, share price dives as some key drugs miss sales estimates.",JNJ,0.084722,0.13344,Neutral
Accuray  ( ARAY )  Q3 Earnings and Revenues Surpass Estimates,https://www.zacks.com/stock/news/2086215/accuray-aray-q3-earnings-and-revenues-surpass-estimates,2023-04-27 15:42:00,Accuray (ARAY) reports a solid fiscal third-quarter top line on the back of robust segmental performances.,JNJ,0.18856,0.060288,Neutral
DOJ sues Tennessee for discriminating against transgender youth with new law,https://www.cnbc.com/2023/04/27/transgender-biden-doj-sues-tennessee-for-discrimination.html,2023-04-27 15:29:07,The Biden administration asked a judge to declare that a Tennessee law targeting gender-affirming care for transgender kids violates the U.S. Constitution.,JNJ,0.122269,-0.010718,Neutral
Nevro  ( NVRO )  Q1 Earnings and Revenues Surpass Estimates,https://www.zacks.com/stock/news/2086189/nevro-nvro-q1-earnings-and-revenues-surpass-estimates,2023-04-27 14:57:00,"Nevro's (NVRO) worldwide revenues improve on a year-over-year basis in Q1, partly owing to robust domestic performance.",JNJ,0.164749,0.052012,Neutral
Abortion pill mifepristone is banned or restricted in some states despite Supreme Court ruling,https://www.cnbc.com/2023/04/27/supreme-court-abortion-pill-mifepristone-still-limited-in-some-states.html,2023-04-27 14:55:59,Mifepristone will remain largely unavailable in 13 states that have banned abortion despite the Supreme Court's decision last week to uphold FDA rules.,JNJ,0.142989,-0.011665,Neutral
The Shake-Up at NBCUniversal and Johnson & Johnson's Spinoff Plans,https://moneymorning.com/investing/the-shake-up-at-nbcuniversal-and-johnson-johnsons-spinoff-plans/,2023-04-27 14:43:29,"â€¢ Ripple effects for Peacock in the wake of NBCUniversal CEO Jeff Shell resigning. â€¢ Disney, and the fate of NBCUniversal's minority stake in Hulu. â€¢ Johnson & Johnson aiming to raise $3.5 billion in the IPO spinoff of its consumer healthcare division.",JNJ,0.089129,0.0,Neutral
The Shake-Up at NBCUniversal and Johnson & Johnson's Spinoff Plans,https://www.fool.com/investing/2023/04/27/the-shake-up-at-nbcuniversal-and-johnson-johnsons/,2023-04-27 14:43:29,"Plus, ""Doomberg"" talks about Tesla.",JNJ,0.027871,0.058155,Neutral
"Surmodics  ( SRDX )  Q2 Earnings Top Estimates, FY23 View Revised",https://www.zacks.com/stock/news/2086168/surmodics-srdx-q2-earnings-top-estimates-fy23-view-revised,2023-04-27 14:29:00,Surmodics (SRDX) reports a solid fiscal second-quarter top line on the back of robust Medical Device revenues.,JNJ,0.141517,0.049828,Neutral
Feminine Hygiene Products Market Size Worth USD 31.51 Billion by 2027 - Emergen Research,https://markets.businessinsider.com/news/stocks/feminine-hygiene-products-market-size-worth-usd-31-51-billion-by-2027---emergen-research-1032267941,2023-04-27 14:26:06,"Discover the latest trends and insights into the feminine hygiene products market. Learn about the drivers, restraints, growth factors, and government statistics that are shaping this rapidly expanding industry.",JNJ,0.035189,-0.072185,Neutral
"CURE Media Group announces Abbey Kaler, MS, APRN, FNP-C, CMSRN, as winner of 2023 Extraordinary HealerÂ® Award",https://www.benzinga.com/pressreleases/23/04/g32047083/cure-media-group-announces-abbey-kaler-ms-aprn-fnp-c-cmsrn-as-winner-of-2023-extraordinary-healer-,2023-04-27 13:40:15,Kaler was recognized for her remarkable contributions in oncology care,JNJ,0.132855,0.255242,Somewhat-Bullish
"Chemed  ( CHE )  Lags Q1 Earnings Estimates, Reaffirms Guidance",https://www.zacks.com/stock/news/2085874/chemed-che-lags-q1-earnings-estimates-reaffirms-guidance,2023-04-27 13:33:00,Strength in the VITAS and Roto-Rooter branches contributes to Chemed's (CHE) first-quarter top line.,JNJ,0.167904,0.054084,Neutral
Eli Lilly says obesity drug tirzepatide resulted in weight loss of up to 34 pounds,https://www.cnbc.com/2023/04/27/eli-lilly-weight-loss-drug-tirzepatide-data-released.html,2023-04-27 13:15:23,Eli Lilly plans to complete its application for FDA approval of tirzepatide in the coming weeks and expects regulatory action as early as later this year.,JNJ,0.127119,-0.010928,Neutral
Eli Lilly misses on earnings but raises full-year guidance,https://www.cnbc.com/2023/04/27/eli-lilly-lly-q1-earnings-2023.html,2023-04-27 12:07:03,"The company reported adjusted earnings of $1.62, which missed analyst expectations of $1.73 for the quarter.",JNJ,0.167904,-0.012942,Neutral
"Fanatics moves one step closer to IPO, hiring Meta's head of investor relations",https://www.cnbc.com/2023/04/27/fanatics-moves-closer-to-ipo-with-hire-of-meta-investor-relations-head.html,2023-04-27 11:30:01,"Fanatics hires Meta IR head Deborah Crawford, who had also run investor relations at Netflix, as the sports platform company takes another step closer to IPO.",JNJ,0.038906,0.140884,Neutral
Merck revenue falls after dramatic drop in sales of Covid antiviral treatment,https://www.cnbc.com/2023/04/27/merck-mrk-q1-earnings-report-2023.html,2023-04-27 10:33:20,"Despite the drop in molnupiravir sales, Merck's revenue and adjusted earnings for Q1 2023 beat Wall Street's expectations.",JNJ,0.076358,0.095058,Neutral
Russian oil sanctions appear to be working - crude still flows even as Moscow's pulling in less money. But there's more to it than that.,https://www.businessinsider.com/russia-oil-exports-sanctions-war-ukraine-markets-economy-flows-putin-2023-4,2023-04-27 10:30:00,Russian Oil Sanctions Appear to Be Working - but It's Complicated. - Business Insider ...,JNJ,0.048919,0.157988,Somewhat-Bullish
2 High-Yielding Dividend Stocks That Just Boosted Their Payouts,https://moneymorning.com/investing/2-high-yielding-dividend-stocks-that-just-boosted-their-payouts/,2023-04-27 09:31:00,"If earning dividend income is a priority for you, it's important to focus on quality stocks that offer above-average yields and that also regularly increase their payouts. That way, you can ensure you're collecting a good yield today and that it's likely to rise in the future, giving you an ...",JNJ,0.52949,0.446535,Bullish
2 High-Yielding Dividend Stocks That Just Boosted Their Payouts,https://www.fool.com/investing/2023/04/27/high-yielding-dividend-stocks-boosted-payouts/,2023-04-27 09:31:00,These are ideal stocks for long-term investors who crave dividends.,JNJ,0.508345,0.407442,Bullish
The Fed Expects a Recession: 2 Dow Stocks to Buy Hand Over Fist and 1 to Avoid Like the Plague,https://moneymorning.com/investing/the-fed-expects-a-recession-2-dow-stocks-to-buy-hand-over-fist-and-1-to-avoid-like-the-plague/,2023-04-27 09:06:00,The Fed Expects a Recession: 2 Dow Stocks to Buy Hand Over Fist ... Money Morning ...,JNJ,0.42503,0.358379,Bullish
The Fed Expects a Recession: 2 Dow Stocks to Buy Hand Over Fist and 1 to Avoid Like the Plague,https://www.fool.com/investing/2023/04/27/fed-recession-2-dow-stocks-to-buy-and-1-to-avoid/,2023-04-27 09:06:00,"Two time-tested Dow stocks are perfectly positioned if the U.S. dips into a recession, while another Dow component has an abysmal track record during economic downturns.",JNJ,0.179565,0.192248,Somewhat-Bullish
"Alzheimer's: Medicare will cover Leqembi for all patients if FDA approves drug, CMS chief says",https://www.cnbc.com/2023/04/26/medicare-will-cover-alzheimers-treatment-leqembi-after-fda-approves.html,2023-04-26 17:44:14,"Medicare has severely restricted access to the medication Leqembi, which costs $26,500 per year, because the FDA approved it just on an expedited basis.",JNJ,0.097062,-0.009783,Neutral
Why Legend Biotech Stock Is Having Its Best Month Yet - Legend Biotech  ( NASDAQ:LEGN ) ,https://www.benzinga.com/general/biotech/23/04/32007247/why-legend-biotech-stock-is-having-its-best-month-yet,2023-04-26 16:37:45,"Legend Biotech Corporation LEGN is among the many healthcare names vying for a breakthrough in cancer treatment. Last week, the New Jersey-based company had just that. On April 19th, a data leak revealed that Legend Biotech's Carvykti, a blood cancer therapy, performed extremely well in a recent ...",JNJ,0.089965,0.106771,Neutral
"Market Pullback Ahead: 2 Stocks To Sell, 2 Soaring Dividends To Buy",https://www.forbes.com/sites/brettowens/2023/04/26/market-pullback-ahead-2-stocks-to-sell-2-soaring-dividends-to-buy/,2023-04-26 14:42:00,"If you're caught holding the wrong dividend payers, you could be in for some serious losses.",JNJ,0.258351,0.200121,Somewhat-Bullish
"How a Janitor Built an $8 Million Fortune Without Touching Cryptos, Stock Options or Leverage",https://www.benzinga.com/news/23/04/32012718/how-a-janitor-built-an-8-million-fortune-without-touching-cryptos-stock-options-or-leverage,2023-04-26 14:38:43,Ronald Reid was the last person you would expect to be a millionaire. He used safety pins to hold his old coats together and cut his own firewood well into his 90s. He drove a second-hand Toyota Yaris and resisted new purchases.,JNJ,0.065506,0.010105,Neutral
"Drug/Biotech Stocks' Q1 Earnings Due Apr 27: LLY, ABBV & More",https://www.zacks.com/stock/news/2084870/drugbiotech-stocks-q1-earnings-due-apr-27-lly-abbv-more,2023-04-26 13:28:00,Let's look at the five biotech/pharma companies slated to release quarterly results on Apr 27.,JNJ,0.038407,0.106241,Neutral
Boston Scientific lifts annual profit forecast on heart devices strength,https://www.reuters.com/business/healthcare-pharmaceuticals/boston-scientific-lifts-annual-profit-forecast-heart-devices-strength-2023-04-26/,2023-04-26 12:23:00,"April 26 ( Reuters ) - Boston Scientific Corp ( BSX.N ) raised its full-year profit forecast on Wednesday, after strong sales in its cardiovascular devices unit helped the company beat first-quarter estimates.",JNJ,0.12165,0.119638,Neutral
"Johnson & Johnson, A. O. Smith And This Health Insurer On CNBC's 'Final Trades' - A.O. Smith  ( NYSE:AOS ) , Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/trading-ideas/long-ideas/23/04/32004328/johnson-johnson-a-o-smith-and-this-health-insurer-on-cnbcs-final-trades,2023-04-26 12:12:27,"On CNBC's ""Halftime Report Final Trades,"" Joshua Brown of Ritholtz Wealth Management said A. O. Smith Corporation AOS is scheduled to release earnings this week and is about to approach a 52-week high. ""I like it long term,"" he added. Analysts expect A. O.",JNJ,0.550532,0.39694,Bullish
Alkermes plc Reports First Quarter 2023 Financial Results,https://www.prnewswire.com/news-releases/alkermes-plc-reports-first-quarter-2023-financial-results-301807602.html,2023-04-26 11:00:00,- First Quarter Revenues of $287.6 Million Reflect Strong Performance of Proprietary Product Portfolio - - GAAP Loss per Share of $0.25 and Basic and Diluted Non-GAAP Earnings per Share of $0.01 - - Planned Separation of Oncology Business Expected to be Completed in Second Half of 2023 -,JNJ,0.033632,0.040587,Neutral
The Fed Thinks a Recession Is Likely: 5 Warren Buffett Stocks to Buy Now,https://www.fool.com/investing/2023/04/26/the-fed-thinks-a-recession-is-likely-5-warren-buff/,2023-04-26 09:50:00,These stocks owned by Buffett's Berkshire Hathaway can be safe havens during economic downturns.,JNJ,0.220809,0.12016,Neutral
Johnson & Johnson to Participate in the Bernstein 39th Annual Strategic Decisions Conference,https://investingnews.com/johnson-johnson-to-participate-in-the-bernstein-39th-annual-strategic-decisions-conference/,2023-04-25 20:51:58,"Johnson & Johnson ( NYSE: JNJ ) will participate in the Bernstein 39 th Annual Strategic Decisions Conference on Wednesday, May 31 st , at the New York Hilton Midtown in New York. Joaquin Duato, Chairman of the Board and Chief Executive Officer will represent the Company in a session scheduled at ...",JNJ,0.922387,0.384122,Bullish
Dow Jones Falls Sharply As Google Earnings Loom; First Republic Craters,https://www.investors.com/market-trend/stock-market-today/dow-jones-falls-as-google-earnings-microsoft-earnings-loom-first-republic-stock-craters-amid-barrage-of-sell-signals/,2023-04-25 19:22:00,Dow Jones Falls Sharply As Google Earnings Loom. First Republic ... Investor's Business Daily ...,JNJ,0.085022,0.065005,Neutral
Looking At Johnson & Johnson's Recent Unusual Options Activity - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/04/31996287/looking-at-johnson-johnsons-recent-unusual-options-activity,2023-04-25 18:15:41,"Someone with a lot of money to spend has taken a bullish stance on Johnson & Johnson JNJ. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",JNJ,0.818461,0.291217,Somewhat-Bullish
Medtronic Is Partnering With Nvidia to Create Potentially Game-Changing Tech. Is the Stock a Buy?,https://www.fool.com/investing/2023/04/25/medtronic-partnering-with-nvidia-is-it-a-buy/,2023-04-25 18:14:00,Medtronic may be among the companies to dominate the AI healthcare market.,JNJ,0.045743,0.050754,Neutral
"Calm Before The Storm? Markets Await Tech Earnings, PCE, And FOMC - Morgan Stanley  ( NYSE:MS ) , Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/federal-reserve/23/04/31995497/calm-before-the-storm-markets-await-tech-earnings-pce-and-fomc,2023-04-25 17:39:07,Market activity has been muted lately. investors are seemingly cautious ahead of the next FOMC meeting.,JNJ,0.114865,-0.029441,Neutral
"A Rotation Into Defensive Stocks? Market Strength Seen In Consumer Defensive And Healthcare On Tuesday - Centene  ( NYSE:CNC ) , AbbVie  ( NYSE:ABBV ) ",https://www.benzinga.com/general/health-care/23/04/31995117/a-rotation-into-defensive-stocks-market-strength-seen-in-consumer-defensive-and-healthcare-on,2023-04-25 17:23:37,"The U.S. stock market is seeing some modest selling on Tuesday morning after a series of largely uneventful sessions last week. Two hours into the trading day, the S&P 500 was down around 0.75% and the Nasdaq had pared 0.90%.",JNJ,0.141171,0.074575,Neutral
FDA grants accelerated approval for Biogen ALS drug that treats rare form of the disease,https://www.cnbc.com/2023/04/25/fda-grants-accelerated-approval-biogen-als-drug.html,2023-04-25 17:20:41,The FDA's approval requires Biogen to further study its ALS drug tofersen to further verify its clinical benefits.,JNJ,0.110717,-0.010255,Neutral
J&J's $40 Billion Spinoff Has One Rival. Who Will Rule Consumer Health.,https://www.barrons.com/articles/johnson-and-johnson-kenvue-ipo-8800eb5f,2023-04-25 17:10:00,J&J's Spinoff Kenvue Valued at $40 Billion. What's Ahead for Consumer Health. ...,JNJ,0.958038,0.255508,Somewhat-Bullish
"Mpox outbreak was wake-up call for smallpox preparation, vaccine maker Bavarian Nordic says",https://www.cnbc.com/2023/04/25/mpox-shows-smallpox-risk-vaccine-maker-bavarian-nordic-says.html,2023-04-25 16:25:46,"Bavarian Nordic plans to sharply scale up production of its Jynneos vaccine to prepare for a smallpox emergency, CEO Paul Chaplin said.",JNJ,0.047797,-0.008994,Neutral
Are Investors Undervaluing Johnson & Johnson's Stock?,https://www.fool.com/investing/2023/04/25/are-investors-undervaluing-johnson-johnson-stock/,2023-04-25 15:30:08,The stock isn't as expensive as it may look at first glance.,JNJ,0.52612,0.103413,Neutral
This Supercharged Dividend King Stock Might Soon Run Out of Steam,https://www.fool.com/investing/2023/04/25/this-supercharged-dividend-king-stock-may-soon-run/,2023-04-25 13:45:00,"Emerging competitive threats in immunology, oncology, and medical aesthetics, along with a highly leveraged balance sheet, might dampen the drugmaker's growth trajectory post-2025.",JNJ,0.038223,0.056664,Neutral
Open Book Extracts Announces Allen Olson as VP of Supply Chain,https://www.prnewswire.com/news-releases/open-book-extracts-announces-allen-olson-as-vp-of-supply-chain-301806759.html,2023-04-25 12:00:00,Olson will focus on driving operational excellence to deliver quality products and services,JNJ,0.067347,0.240094,Somewhat-Bullish
The banking crisis may have set the stage for an IPO comeback | Business,https://www.cnn.com/2023/04/25/investing/premarket-stocks-trading/index.html,2023-04-25 11:50:00,The banking crisis may have set the stage for an IPO comeback ...,JNJ,0.07157,0.0,Neutral
Want Consistently Growing Passive Income? Buy Johnson & Johnson Stock,https://www.fool.com/investing/2023/04/25/want-consistently-growing-passive-income-buy-johns/,2023-04-25 10:50:00,The healthcare juggernaut recently extended its illustrious dividend growth streak.,JNJ,0.128478,0.195915,Somewhat-Bullish
Idorsia announces financial results for the first quarter 2023 - QUVIVIQ now the leading branded insomnia medicine in the commercial market in the US,https://www.globenewswire.com/news-release/2023/04/25/2653493/0/en/Idorsia-announces-financial-results-for-the-first-quarter-2023-QUVIVIQ-now-the-leading-branded-insomnia-medicine-in-the-commercial-market-in-the-US.html,2023-04-25 05:00:00,Ad hoc announcement pursuant to Art. 53 LR ...,JNJ,0.015644,0.029107,Neutral
Point-of-Care Diagnostics Market Worth USD 66.0 Bn by 2028: Says Transparency Market Research,https://www.benzinga.com/pressreleases/23/04/g31972595/point-of-care-diagnostics-market-worth-usd-66-0-bn-by-2028-says-transparency-market-research,2023-04-24 21:30:00,"Wilmington, Delaware, United States, April 25, 2023 ( GLOBE NEWSWIRE ) -- According to the recent study published by Transparency Market Research, the global point-of-care diagnostics market stood at USD 34.1 billion in 2020 and the global market is projected to reach USD 66.0 billion by 2028.",JNJ,0.038101,0.0,Neutral
Johnson & Johnson Announces Launch of Kenvue Inc. IPO Roadshow - Investing News Network,https://investingnews.com/johnson-johnson-announces-launch-of-kenvue-inc-ipo-roadshow/,2023-04-24 21:18:37,Johnson & Johnson Announces Launch of Kenvue Inc. IPO Roadshow Investing News Network ...,JNJ,0.393884,0.327889,Somewhat-Bullish
J&J aims for up to $43 bln valuation for consumer health unit Kenvue,https://www.reuters.com/markets/deals/jj-aims-up-43-bln-valuation-consumer-health-unit-kenvue-2023-04-24/,2023-04-24 20:52:00,J&J aims for up to $43 bln valuation for consumer health unit ...,JNJ,0.214937,0.0,Neutral
Johnson & Johnson to price shares of consumer spinoff Kenvue at $20 to $23 in IPO,https://www.cnbc.com/2023/04/24/johnson-johnson-to-price-shares-of-consumer-spinoff-kenvue-at-20-to-23-in-ipo.html,2023-04-24 20:41:56,J&J said it launched a roadshow for Kenvue's IPO of more than 151 million shares of common stock.,JNJ,0.285526,0.145711,Neutral
Investors Discuss News From Bank of America and Johnson & Johnson,https://www.fool.com/investing/2023/04/24/investors-discuss-news-from-bank-of-america-and-jo/,2023-04-24 20:13:55,"And we answer listener questions about retirement accounts, buying stock in your employer, and more.",JNJ,0.067051,0.067508,Neutral
"Wall Street Headlines, International Investing, and Stocks to Watch",https://www.fool.com/investing/2023/04/24/wall-street-headlines-international-investing-and/,2023-04-24 19:49:11,"The ""Motley Fool Money"" crew kicks things off with a look at what's going on with Netflix.",JNJ,0.006492,-0.167535,Somewhat-Bearish
"Wall Street optimistic on Disney and AMD, while J&J prepares for consumer brand IPO. Here's our take on these Club stocks in the news",https://www.cnbc.com/2023/04/24/wall-street-optimistic-on-disney-amd-jj-prepares-for-consumer-brand-ipo.html,2023-04-24 19:21:31,"Club holdings Disney (DIS), Johnson & Johnson (JNJ) and Advanced Micro Devices (AMD) are in the headlines. Here's our take on the news.",JNJ,0.947069,0.466161,Bullish
J&J consumer-health IPO process to kick off key test for moribund new-issue market,https://www.foxbusiness.com/markets/jj-consumer-health-ipo-process-kick-off-key-test-moribund-new-issue-market,2023-04-24 18:33:45,"Johnson & Johnson is poised to begin a roadshow to pitch shares of its consumer-healthcare business, the producer of household names such as Tylenol, in a test for an IPO market that has been in the doldrums for the past year.",JNJ,0.050044,0.027987,Neutral
"Top Stories Monday, Apr. 24: Elon Musk Plans Next Starship Launch Within Two Months, NBCUniversal CEO Resigns Amid 'Inappropriate Relationship, Micron Tech Caught Between US-China Tensions - Alibaba Group Holding  ( NYSE:BABA ) , Amphastar Pharma  ( NASDAQ:AMPH ) ",https://www.benzinga.com/general/biotech/23/04/31956134/elon-musk-plans-next-starship-launch-within-two-months-nbcuniversal-ceo-resigns-amid-inappropriat,2023-04-24 14:34:06,"SpaceX CEO Elon Musk on Saturday said that Starship could be ready to launch again in 1 to 2 months. Starship can be ready to launch again in 1 to 2 months post-repairs of damage at the Starbase launch site, said Elon Musk in a Twitter reply on Saturday.",JNJ,0.080865,0.096718,Neutral
AbbVie  ( ABBV )  to Report Q1 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2083516/abbvie-abbv-to-report-q1-earnings-whats-in-the-cards,2023-04-24 14:29:00,AbbVie's (ABBV) Q1 performance will likely reflect declining sales of Humira following the loss of exclusivity. Sales of Rinvoq and Skyrizi are expected to partially offset this fall.,JNJ,0.172919,0.04057,Neutral
Jim Cramer's top 10 things to watch in the stock market Monday,https://www.cnbc.com/2023/04/24/jim-cramers-top-10-things-to-watch-in-the-stock-market-monday.html,2023-04-24 13:20:01,"The Dow, the S&P 500 and the Nasdaq are set for a mixed open Monday ahead of big earnings and inflation week.",JNJ,0.179788,0.010144,Neutral
ZyVersa Therapeutics Adds Dr. Douglas Golenbock to Its Inflammatory Disease Scientific Advisory Board to Support Advancement of Inflammasome ASC Inhibitor IC 100,https://www.globenewswire.com/news-release/2023/04/24/2652790/0/en/ZyVersa-Therapeutics-Adds-Dr-Douglas-Golenbock-to-Its-Inflammatory-Disease-Scientific-Advisory-Board-to-Support-Advancement-of-Inflammasome-ASC-Inhibitor-IC-100.html,2023-04-24 13:07:00,"WESTON, Fla., April 24, 2023 ( GLOBE NEWSWIRE ) -- ZyVersa Therapeutics, Inc. ( Nasdaq: ZVSA. ""ZyVersa"" ) , a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of patients with renal and inflammatory diseases who have unmet medical needs, announces ...",JNJ,0.05333,0.016994,Neutral
ZyVersa Therapeutics Adds Dr. Douglas Golenbock to Its Inflammatory Disease Scientific Advisory Board to Support Advancement of Inflammasome ASC Inhibitor IC 100 - ZyVersa Therapeutics  ( NASDAQ:ZVSA ) ,https://www.benzinga.com/pressreleases/23/04/g31956019/zyversa-therapeutics-adds-dr-douglas-golenbock-to-its-inflammatory-disease-scientific-advisory-boa,2023-04-24 13:07:00,"Dr. Golenbock is The Neil and Margery Blacklow Chair in Infectious Diseases and Immunology and Professor and Chief, Division of Infectious Diseases and Immunology at the UMass Chan Medical School",JNJ,0.051386,-0.079995,Neutral
Johnson & Johnson  ( JNJ )  Is a Trending Stock: Facts to Know Before Betting on It,https://www.zacks.com/stock/news/2083298/johnson-johnson-jnj-is-a-trending-stock-facts-to-know-before-betting-on-it,2023-04-24 13:00:11,"Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",JNJ,0.474958,0.177124,Somewhat-Bullish
Medical Aesthetics and Technology Leader Cynosure Appoints Nadav Tomer as its Chief Executive Officer,https://www.prnewswire.com/news-releases/medical-aesthetics-and-technology-leader-cynosure-appoints-nadav-tomer-as-its-chief-executive-officer-301805470.html,2023-04-24 13:00:00,Medical Aesthetics and Technology Leader Cynosure Appoints ... PR ...,JNJ,0.053749,0.149933,Neutral
Medical Aesthetics and Technology Leader Cynosure Appoints Nadav Tomer as its Chief Executive Officer,https://www.prnewswire.com/in/news-releases/medical-aesthetics-and-technology-leader-cynosure-appoints-nadav-tomer-as-its-chief-executive-officer-301805484.html,2023-04-24 13:00:00,Medical Aesthetics and Technology Leader Cynosure Appoints ... PR ...,JNJ,0.053749,0.149933,Neutral
Medical Aesthetics and Technology Leader Cynosure Appoints Nadav Tomer as its Chief Executive Officer,https://www.newswire.ca/news-releases/medical-aesthetics-and-technology-leader-cynosure-appoints-nadav-tomer-as-its-chief-executive-officer-831449751.html,2023-04-24 13:00:00,Medical Aesthetics and Technology Leader Cynosure Appoints ... Canada ...,JNJ,0.053749,0.149933,Neutral
"4 Pharma, Biotech Stocks Poised to Beat Q1 Earnings Estimates",https://www.zacks.com/stock/news/2083259/4-pharma-biotech-stocks-poised-to-beat-q1-earnings-estimates,2023-04-24 12:38:00,"We look at a few pharma/biotech companies, SNY, AMGN, REGN, ACAD, which are poised to beat on earnings in the first quarter.",JNJ,0.134339,-0.001252,Neutral
Why First Republic Has Not Done a Deal,https://www.nytimes.com/2023/04/24/business/dealbook/first-republic.html,2023-04-24 12:35:14,"Big banks gave the regional lender a $30 billion lifeline following the collapse of Silicon Valley Bank, but it has yet to raise more cash, sell assets - or itself.",JNJ,0.021542,0.039164,Neutral
"Mixed Macro, Fed Debate, Earnings in Full Swing, S&P, Busy Week Ahead",https://realmoney.thestreet.com/investing/mixed-macro-fed-debate-earnings-in-full-swing-s-p-busy-week-ahead-16121922,2023-04-24 12:22:40,"Mixed Macro, Fed Debate, Earnings in Full Swing, S&P, Busy Week ... ...",JNJ,0.039128,-0.005964,Neutral
"Johnson & Johnson Unleashes Kenvue: Tylenol to Neutrogena, $40B Revenue Unit Spinoff Preps for IPO Blitz - Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/news/large-cap/23/04/31953000/johnson-johnson-unleashes-kenvue-tylenol-to-neutrogena-40b-revenue-unit-spinoff-preps-for-ipo-blit,2023-04-24 12:19:52,"Johnson & Johnson JNJ is reportedly readying an investor roadshow to pitch shares of its consumer-healthcare spinoff business, dubbed Kenvue, as early as Monday.",JNJ,0.399204,0.272594,Somewhat-Bullish
Is ALPS O'Shares U.S. Quality Dividend ETF  ( OUSA )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2083181/is-alps-oshares-us-quality-dividend-etf-ousa-a-strong-etf-right-now,2023-04-24 10:20:10,Smart Beta ETF report for ...,JNJ,0.117774,0.060494,Neutral
Should Invesco Dividend Achievers ETF  ( PFM )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2083186/should-invesco-dividend-achievers-etf-pfm-be-on-your-investing-radar,2023-04-24 10:20:07,Style Box ETF report for ...,JNJ,0.123526,0.068619,Neutral
News Exclusive | J&J Consumer-Health IPO Process to Kick Off Key Test for Moribund New-Issue Market,https://www.wsj.com/articles/j-j-consumer-health-ipo-process-to-kick-off-key-test-for-moribund-new-issue-market-3c978f38,2023-04-23 21:43:00,Kenvue plans to start meeting with prospective investors as early as Monday.,JNJ,0.421485,0.080352,Neutral
Cancer Immunotherapy Market Size Worth USD 388.25 Billion in 2030 - Emergen Research,https://markets.businessinsider.com/news/stocks/cancer-immunotherapy-market-size-worth-usd-388-25-billion-in-2030-%E2%80%93-emergen-research-1032251605,2023-04-23 13:22:00,"The global Cancer Immunotherapy Market size was USD 119.39 Billion in 2021 and is expected to register a revenue CAGR of 14.0% during the forecast period, according to latest analysis by Emergen Research Cancer immunotherapy, also known as immuno-oncology, is a fast expanding specialty in cancer ...",JNJ,0.034282,-0.109525,Neutral
"If You're a Dividend Investor, You'll Love This News From Johnson & Johnson",https://www.fool.com/investing/2023/04/22/if-youre-dividend-investor-youll-love-j-and-j-news/,2023-04-22 18:00:00,The company offers you growing recurrent income -- just for holding its shares.,JNJ,0.202932,0.177638,Somewhat-Bullish
3 Top Dividend Kings to Buy for the Long Haul,https://www.fool.com/investing/2023/04/22/3-top-dividend-kings-to-buy-for-the-long-haul/,2023-04-22 11:20:00,These healthcare stocks all have above-average dividends.,JNJ,0.151159,0.107797,Neutral
J&J to Lift Dividend for 61st Year. These 6 Others Are Raising Payouts Too.,https://www.barrons.com/articles/stocks-raising-dividends-j-j-costco-60f5d6ad,2023-04-22 08:00:00,J&J to Lift Dividend for 61st Year Plus 6 More Firms Raising ...,JNJ,0.999463,0.636157,Bullish
HVAC equipment market size in Europe to grow by USD 9.49 billion between 2022 and 2027; Increasing use of renewable energy sources for HVAC systems to be key trend - Technavio,https://www.prnewswire.com/news-releases/hvac-equipment-market-size-in-europe-to-grow-by-usd-9-49-billion-between-2022-and-2027-increasing-use-of-renewable-energy-sources-for-hvac-systems-to-be-key-trend---technavio-301803193.html,2023-04-22 02:30:00,HVAC equipment market size in Europe to grow by USD 9.49 billion ... PR ...,JNJ,0.029327,-0.044058,Neutral
Supreme Court says abortion pill mifepristone will remain broadly available during legal battle,https://www.cnbc.com/2023/04/21/supreme-court-says-abortion-pill-mifepristone-will-remain-broadly-available-during-legal-battle.html,2023-04-21 22:41:06,Mifepristone has become the central flashpoint in the legal battle over abortion since the Supreme Court last summer overturned Roe v. Wade.,JNJ,0.155451,-0.012288,Neutral
"3 Very Low-Risk Ways to Invest $1,000 Right Now",https://www.fool.com/investing/2023/04/21/3-very-low-risk-ways-to-invest-1000-right-now/,2023-04-21 19:45:00,These companies have durable businesses and elite financial profiles.,JNJ,0.323785,0.271095,Somewhat-Bullish
Why This Top 5% Biotech Just Hit A Profit-Taking Zone,https://www.investors.com/news/technology/legn-stock-hits-profit-taking-zone-after-reportedly-confirming-cancer-test/,2023-04-21 18:14:00,LEGN Stock Hits Profit-Taking Zone After Reportedly Confirming ... Investor's Business Daily ...,JNJ,0.182506,-0.378465,Bearish
Johnson & Johnson Stock: Should You Buy Before This Big Transition?,https://www.fool.com/investing/2023/04/21/j-and-j-stock-should-you-buy-before-transition/,2023-04-21 18:00:00,J&J may have reached a major turning point.,JNJ,0.1331,0.222953,Somewhat-Bullish
"Eli Lilly, Novo Nordisk and Sanofi CEOs to testify before Senate on lowering insulin prices",https://www.cnbc.com/2023/04/21/insulin-eli-lilly-sanofi-novo-nordisk-testify-to-senate-on-prices.html,2023-04-21 16:52:55,"Eli Lilly, Novo Nordisk and Sanofi control 90% of the insulin market in the U.S, where a quarter of all health care spending is on people with diabetes.",JNJ,0.120431,-0.010641,Neutral
Plaintiffs' Attorneys Representing Talc-Cancer Victims Form Ad Hoc Committee to Support J&J Settlement,https://investingnews.com/plaintiffs-attorneys-representing-talc-cancer-victims-form-ad-hoc-committee-to-support-jj-settlement/,2023-04-21 16:48:47,"Leadership committee seeks to bring resolution to decade-long legal battle Lawyers representing approximately 55,000 plaintiffs in the litigation against Johnson & Johnson ( NYSE: JNJ ) over its cancer-causing talcum powder products have formed an Ad Hoc Committee to support an $8.9 billion deal ...",JNJ,0.172097,-0.005874,Neutral
Alyssa Milano - Even Elmo - React To Elon Musk's Twitter Changes: 'We Are Officially Blue Check Mark Free',https://www.benzinga.com/general/entertainment/23/04/31937599/alyssa-milano-even-elmo-react-to-elon-musks-twitter-changes-we-are-officially-blue-check-ma,2023-04-21 15:52:16,"Since taking over social media platform Twitter, new owner and CEO Elon Musk has put forth many changes. Among the biggest changes is the Twitter Blue subscription program, charging users to have their accounts verified. A change to the verification process happened on Thursday and many ...",JNJ,0.050148,-0.134235,Neutral
Plaintiffs' Attorneys Representing Talc-Cancer Victims Form Ad Hoc Committee to Support J&J Settlement,https://www.prnewswire.com/news-releases/plaintiffs-attorneys-representing-talc-cancer-victims-form-ad-hoc-committee-to-support-jj-settlement-301804295.html,2023-04-21 15:51:00,Plaintiffs' Attorneys Representing Talc-Cancer Victims Form Ad Hoc ... PR ...,JNJ,0.177802,-0.005967,Neutral
Market Rally Drifts Lower; Tesla Dives On Margins: Weekly Review,https://www.investors.com/news/stock-market-rally-drifts-lower-tesla-dives-on-margins-isrg-dhi-lvs-are-winners/,2023-04-21 15:16:00,Market Rally Drifts Lower. Tesla Dives On Margins: Weekly Review Investor's Business Daily ...,JNJ,0.062271,-0.0486,Neutral
"Dow Jones Edges Lower, But Procter & Gamble Jumps On Blowout Results; Why Shockwave Is Soaring Today",https://www.investors.com/dow-jones-edges-higher-soaring-pg-stock-tesla-unfazed-cathie-woods-bullish-call/,2023-04-21 14:50:00,"Dow Jones Mixed, Helped By Soaring Procter & Gamble Stock ... Investor's Business Daily ...",JNJ,0.097062,0.081098,Neutral
Intrathecal Pumps Market to Grow at CAGR of 5.50% through 2030 - Advancements in Pump Technology to Bolster Growth: The Brainy Insights,https://markets.businessinsider.com/news/stocks/intrathecal-pumps-market-to-grow-at-cagr-of-5-50-through-2030-%E2%80%93-advancements-in-pump-technology-to-bolster-growth-the-brainy-insights-1032249762,2023-04-21 14:16:00,"As per the report published by The Brainy Insights, the global intrathecal pumps market is expected to grow from USD 384.59 million in 2021 to USD 622.68 million by 2030, at a CAGR of 5.50% during the forecast period 2022-2030. With a market share of around 39.02% and USD 242.96 â€¦",JNJ,0.062597,0.211242,Somewhat-Bullish
UM and Roku Partner to Increase Equity For Minority-Owned Networks Ahead of TV Upfronts,https://www.prnewswire.com/news-releases/um-and-roku-partner-to-increase-equity-for-minority-owned-networks-ahead-of-tv-upfronts-301804143.html,2023-04-21 14:00:00,UM and Roku Partner to Increase Equity For Minority-Owned ... PR ...,JNJ,0.033703,0.181627,Somewhat-Bullish
"Top Stories Friday, Apr. 23: Carlyle Seeks New Investors For McDonald's China Arm, US Judge Halts Several Johnson & Johnson's Talc-Related Lawsuits, How Much Alphabet Analysts, Managers And Engineers Get Paid - BYD  ( OTC:BYDDY ) , Amazon.com  ( NASDAQ:AMZN ) ",https://www.benzinga.com/news/earnings/23/04/31934504/carlyle-seeks-new-investors-for-mcdonalds-china-arm-us-judge-halts-several-johnson-johnsons-talc-re,2023-04-21 13:21:48,"Private equity company Carlyle Group Inc CG reportedly intends to find new investors for its investment in McDonald's Corp's MCD Chinese operations. The buyout firm, which controls McDonald's China, together with Trustar Capital, has been discussing shifting its ownership to a new investment ...",JNJ,0.075161,-0.253451,Somewhat-Bearish
MeiraGTx Announces Upcoming Presentations at the Association for Research in Vision and Ophthalmology  ( ARVO )  2023 Annual Meeting,https://www.globenewswire.com/news-release/2023/04/21/2651924/0/en/MeiraGTx-Announces-Upcoming-Presentations-at-the-Association-for-Research-in-Vision-and-Ophthalmology-ARVO-2023-Annual-Meeting.html,2023-04-21 12:30:00,"LONDON and NEW YORK, April 21, 2023 ( GLOBE NEWSWIRE ) -- MeiraGTx Holdings plc ( Nasdaq: MGTX ) , a vertically integrated, clinical stage gene therapy company, today announced two abstract presentations at the Association for Research in Vision and Ophthalmology ( ARVO ) 2023 Annual Meeting.",JNJ,0.043342,0.053631,Neutral
US Judge Halts Several Lawsuits Related To Johnson & Johnson's Talc Products Caused Cancer - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/general/biotech/23/04/31931708/us-judge-halts-several-lawsuits-related-to-johnson-johnsons-talc-products-caused-cancer,2023-04-21 11:28:01,"A federal bankruptcy judge Michael Kaplan temporarily held around 38,000 lawsuits alleging Johnson & Johnson's JNJ baby powder and other talc products caused cancer as a part of J&J's second attempt to settle thousands of talc cases in bankruptcy proceedings.",JNJ,0.392948,-0.439723,Bearish
Senate legislation would cap insulin at $35 per month for people with private insurance,https://www.cnbc.com/2023/04/21/senate-bill-proposes-insulin-price-cap-diabetes.html,2023-04-21 09:00:01,"More than 2 million patients with diabetes who take insulin are privately insured, according to the Health and Human Services Department.",JNJ,0.126119,-0.010884,Neutral
Why Shares of Protagonist Therapeutics Rose This Week,https://www.fool.com/investing/2023/04/20/why-shares-of-protagonist-therapeutics-rose-this-w/,2023-04-21 01:51:13,The company's lead pipeline candidate is making news.,JNJ,0.348919,0.154657,Somewhat-Bullish
Levy Konigsberg Partner Jerome Block Discusses J&J Talc Powder Claims on CNN's The Whole Story with Anderson Cooper,https://www.benzinga.com/pressreleases/23/05/n32324617/levy-konigsberg-partner-jerome-block-discusses-j-j-talc-powder-claims-on-cnns-the-whole-story-with,2023-05-10 18:54:00,"NEW YORK, May 10, 2023 /PRNewswire/ -- Levy Konigsberg Partner Jerome Block was recently featured in a CNN investigation that premiered on Sunday, May 7th on The Whole Story with Anderson Cooper.",JNJ,0.072,-0.108488,Neutral
"SmileDirectClub  ( SDC )  Q1 Earnings Miss, Gross Margin Up",https://www.zacks.com/stock/news/2093682/smiledirectclub-sdc-q1-earnings-miss-gross-margin-up,2023-05-10 15:42:00,SmileDirectClub (SDC) Q1 revenues are affected by persistent macroeconomic headwinds.,JNJ,0.21686,0.067141,Neutral
Genmab Announces Financial Results for the First Quarter of 2023,https://www.globenewswire.com/news-release/2023/05/10/2665762/0/en/Genmab-Announces-Financial-Results-for-the-First-Quarter-of-2023.html,2023-05-10 15:01:00,"May 10, 2023 Copenhagen, Denmark. Interim Report for the First Quarter Ended March ...",JNJ,0.040969,0.0,Neutral
"Emergent  ( EBS )  Q1 Earnings Miss Estimates, Revenues Beat",https://www.zacks.com/stock/news/2093582/emergent-ebs-q1-earnings-miss-estimates-revenues-beat,2023-05-10 14:47:00,Emergent (EBS) reports wider-than-expected first-quarter loss. The company updates its 2023 guidance for selected categories.,JNJ,0.100941,-0.045831,Neutral
"Exact Sciences  ( EXAS )  Q1 Earnings Top, Sales View Raised",https://www.zacks.com/stock/news/2093375/exact-sciences-exas-q1-earnings-top-sales-view-raised,2023-05-10 13:37:00,The upside in Exact Sciences' (EXAS) screening revenues is primarily coming from broad-based momentum in Cologuard adoption.,JNJ,0.199447,0.0629,Neutral
Breast Reconstruction Market is Expected to Reach $647 million | MarketsandMarkets.,https://www.benzinga.com/pressreleases/23/05/g32316473/breast-reconstruction-market-is-expected-to-reach-647-million-marketsandmarkets,2023-05-10 13:30:00,"Chicago, May 10, 2023 ( GLOBE NEWSWIRE ) -- The breast reconstruction industry is expected to witness significant advancements and growth in the near future. With the increasing focus on breast cancer awareness and improved patient outcomes, breast reconstruction procedures are becoming more ...",JNJ,0.072217,0.103677,Neutral
Ireland wants to put its soaring corporate tax receipts into a new sovereign wealth fund,https://www.cnbc.com/2023/05/10/ireland-wants-to-put-soaring-corporate-taxes-into-a-new-sovereign-wealth-fund-.html,2023-05-10 07:01:19,"Multinationals in Ireland have paid record amounts of corporate tax in recent years, and the country estimates its budget surplus could hit 6.3% of GDP.",JNJ,0.06515,0.082087,Neutral
Addex Announces ADX71149 Phase 2 Epilepsy Clinical Study's Independent Interim Review Committee Recommends Continuing Study,https://www.globenewswire.com/news-release/2023/05/10/2665174/0/en/Addex-Announces-ADX71149-Phase-2-Epilepsy-Clinical-Study-s-Independent-Interim-Review-Committee-Recommends-Continuing-Study.html,2023-05-10 05:00:00,Ad Hoc Announcement Pursuant to Art. 53 LR ...,JNJ,0.072326,0.062359,Neutral
Covid vaccine maker Novavax plans to cut 25% jobs to slash expenses,https://www.business-standard.com/companies/news/covid-vaccine-maker-novavax-plans-to-cut-25-jobs-to-slash-expenses-123050901043_1.html,2023-05-09 15:50:17,"Novavax is cutting about a quarter of its workforce as the COVID-19 vaccine maker seeks to slash expenses while dealing with uncertain future revenue. The company said on Tuesday that it expects to trim next year's costs for research and development as well as selling, general and administrative ...",JNJ,0.107495,0.103186,Neutral
Johnson & Johnson Unusual Options Activity - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/05/32294792/johnson-johnson-unusual-options-activity,2023-05-09 15:31:22,"A whale with a lot of money to spend has taken a noticeably bearish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson JNJ we detected 13 strange trades. If we consider the specifics of each trade, it is accurate to state that 38% of the investors opened trades with ...",JNJ,0.827318,0.100692,Neutral
Pharma ETFs Gain Post Q1 Earnings,https://www.zacks.com/stock/news/2092464/pharma-etfs-gain-post-q1-earnings,2023-05-09 15:15:00,"Many industry bigwigs reported solid results, with some beating on earnings or revenues or both. As such, pharma ETFs have been in the green over the past month.",JNJ,0.156461,0.043614,Neutral
"Henry Schein  ( HSIC )  Q1 Earnings Miss, Operating Margin Dips",https://www.zacks.com/stock/news/2092454/henry-schein-hsic-q1-earnings-miss-operating-margin-dips,2023-05-09 15:03:00,Henry Schein's (HSIC) first-quarter results largely reflect lower contributions from the sales of PPE products and COVID-19 test kits.,JNJ,0.153961,0.052409,Neutral
"Omnicell's  ( OMCL )  New Acquisitions Aid Growth, Cost Woes Stay",https://www.zacks.com/stock/news/2092444/omnicells-omcl-new-acquisitions-aid-growth-cost-woes-stay,2023-05-09 14:51:00,"Omnicell (OMCL) remains well-positioned to meet pharmacy and hospital needs, backed by the recent acquisitions and expansion of its advanced services solutions.",JNJ,0.194632,0.063365,Neutral
Bruker's  ( BRKR )  New Buyout to Advance Digital Transformation,https://www.zacks.com/stock/news/2092451/brukers-brkr-new-buyout-to-advance-digital-transformation,2023-05-09 14:02:00,Bruker's (BRKR) IDS division expands its unique vendor-agnostic software solutions portfolio by integrating ZONTAL with the Mestrelab Research and Arxspan scientific software solutions.,JNJ,0.185662,0.061169,Neutral
Here's Why You Should Retain Abbott  ( ABT )  Stock For Now,https://www.zacks.com/stock/news/2092431/heres-why-you-should-retain-abbott-abt-stock-for-now,2023-05-09 13:37:00,Investors are optimistic about Abbott (ABT) on continued growth in the core Diagnostics arm.,JNJ,0.195419,0.063559,Neutral
"COVID-19 vaccine maker Novavax to chop workforce, expenses",https://apnews.com/article/novavax-covid-vaccine-b78ec71aa83eb7b4496b35a307787e09,2023-05-09 13:33:33,"Novavax is cutting about a quarter of its workforce as the COVID-19 vaccine maker seeks to slash expenses while dealing with uncertain future revenue. The company said Tuesday that it expects to trim next year's costs for research and development as well as selling, general and administrative ...",JNJ,0.116348,0.1062,Neutral
The Honest Company Announces Appointment of Kate Barton as Chief Growth Officer,https://www.globenewswire.com/news-release/2023/05/09/2664194/0/en/The-Honest-Company-Announces-Appointment-of-Kate-Barton-as-Chief-Growth-Officer.html,2023-05-09 10:45:00,"LOS ANGELES, May 09, 2023 ( GLOBE NEWSWIRE ) -- The Honest Company, a digitally-native consumer products company dedicated to creating clean- and sustainably-designed products spanning baby care, beauty, personal care, wellness and household care, announced today that experienced innovator, ...",JNJ,0.052685,0.238762,Somewhat-Bullish
The Honest Company Announces Appointment of Kate Barton as Chief Growth Officer - Honest Co  ( NASDAQ:HNST ) ,https://www.benzinga.com/pressreleases/23/05/g32282711/the-honest-company-announces-appointment-of-kate-barton-as-chief-growth-officer,2023-05-09 10:45:00,"LOS ANGELES, May 09, 2023 ( GLOBE NEWSWIRE ) -- The Honest Company, a digitally-native consumer products company dedicated to creating clean- and sustainably-designed products spanning baby care, beauty, personal care, wellness and household care, announced today that experienced innovator, ...",JNJ,0.051551,0.238611,Somewhat-Bullish
3 Obvious Truths About Growth Stocks That Investors Often Forget,https://www.fool.com/investing/2023/05/09/3-obvious-truths-about-growth-stocks-that-investor/,2023-05-09 10:29:00,It's easy to get caught up in hype and miss what actually makes stocks go up.,JNJ,0.128822,-0.167293,Somewhat-Bearish
Should iShares Russell Top 200 Value ETF  ( IWX )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2092039/should-ishares-russell-top-200-value-etf-iwx-be-on-your-investing-radar,2023-05-09 10:20:07,Style Box ETF report for ...,JNJ,0.12165,-0.022157,Neutral
Unlock the Profit Potential in AI Healthcare Innovation with This Leading Biotech Stock,https://moneymorning.com/investing/unlock-the-profit-potential-in-ai-healthcare-innovation-with-this-leading-biotech-stock/,2023-05-08 21:00:12,"Before we dive into today's top tech stock for cryptocurrency investors, let me introduce myself... ...I'm Alex Kagin, Director of Technology Investing Research at Money Map Press.",JNJ,0.076602,-0.130624,Neutral
"Mineral Sunscreen Market Revenue to Reach USD 1.6 Bn by 2031, growing at a CAGR of 5.4%: Reveals TMR Study",https://www.benzinga.com/pressreleases/23/05/g32268955/mineral-sunscreen-market-revenue-to-reach-usd-1-6-bn-by-2031-growing-at-a-cagr-of-5-4-reveals-tmr-,2023-05-08 16:30:00,"Wilmington, Delaware, United States, May 08, 2023 ( GLOBE NEWSWIRE ) -- The global mineral sunscreen market was valued at USD 960.0 Mn in 2021 and is anticipated to reach USD 1.6 Bn by 2031, expanding at a CAGR of 5.4% between 2022 and 2031.",JNJ,0.045918,0.198223,Somewhat-Bullish
Q3 2022/23 - Solid operating result in a challenging market,https://www.globenewswire.com/news-release/2023/05/08/2663630/0/en/Q3-2022-23-Solid-operating-result-in-a-challenging-market.html,2023-05-08 15:50:00,ANNOUNCEMENT NO. ...,JNJ,0.024622,0.036512,Neutral
"Teleflex  ( TFX )  Q1 Earnings Top Estimates, 2023 Sales View Up",https://www.zacks.com/stock/news/2091676/teleflex-tfx-q1-earnings-top-estimates-2023-sales-view-up,2023-05-08 14:50:00,"Teleflex (TFX) registers growth across the majority of its businesses, including double-digit increases in interventional and surgical revenues in Q1.",JNJ,0.178459,0.057908,Neutral
Does Johnson & Johnson's Kenvue Spinoff Make Sense?,https://www.fool.com/investing/2023/05/08/does-johnson-johnsons-kenvue-spinoff-make-sense/,2023-05-08 13:45:00,We also look at Darden Restaurants' acquisition and Yum! Brands' quarter.,JNJ,0.040061,0.118434,Neutral
Short Sellers Won't Bet Against 8 Rock-Solid Buffett-Like Stocks,https://www.investors.com/etfs-and-funds/sectors/sp500-even-short-sellers-wont-bet-against-buffett-like-stocks/,2023-05-08 12:00:00,Short sellers aren't afraid of many stocks in the S&P 500. But one stock they won't touch is Warren Buffett's Berkshire Hathaway.,JNJ,0.135729,0.189944,Somewhat-Bullish
These 2 Top Stocks Just Declared Dividend Raises,https://www.fool.com/investing/2023/05/08/these-2-top-stocks-just-declared-dividend-raises/,2023-05-08 09:15:00,"These companies manage to keep growing and generating excess profits, which is admirable given their age and size.",JNJ,0.407844,0.168145,Somewhat-Bullish
3 Things About Eli Lilly That Smart Investors Know,https://www.fool.com/investing/2023/05/08/3-things-about-eli-lilly-that-smart-investors-know/,2023-05-08 09:05:00,"There are quite a few details to keep track of with this company, and they all matter.",JNJ,0.063933,-0.029181,Neutral
"The Global Skin Care Product Market Expected to Grow by $180 Billion by 2026, According to Brandessence Market Research",https://www.prnewswire.com/news-releases/the-global-skin-care-product-market-expected-to-grow-by-180-billion-by-2026-according-to-brandessence-market-research-301818025.html,2023-05-08 08:30:00,The Global Skin Care Product Market Expected to Grow by $180 ... PR ...,JNJ,0.025087,0.08803,Neutral
"Exelixis, facing challenge from Farallon, says Willsey to exit board",https://www.reuters.com/business/healthcare-pharmaceuticals/exelixis-facing-challenge-farallon-says-willsey-exit-board-2023-05-07/,2023-05-07 23:43:00,"BOSTON, May 7 ( Reuters ) - Biotechnology company Exelixis ( EXEL.O ) said on Sunday that Lance Willsey was leaving its board and that it would not contest the election of a dissident director candidate amid a proxy battle with investor Farallon Capital Management.",JNJ,0.144275,0.019118,Neutral
This Incredible Growth Stock Has All the Hallmarks of a Prototypical Warren Buffett Stock,https://www.fool.com/investing/2023/05/06/this-incredible-growth-stock-has-all-the-hallmarks/,2023-05-06 17:00:00,"Vertex Pharmaceuticals faces limited competition in its core area of expertise, has a top-shelf CEO, and is building out a profoundly valuable pipeline of next-generation assets.",JNJ,0.089965,0.063792,Neutral
"Looking for Steady, Passive Income? Buy AbbVie Stock",https://www.fool.com/investing/2023/05/06/looking-for-steady-passive-income-buy-abbvie-stock/,2023-05-06 13:00:00,The drugmaker looks poised to rebound from its Humira loss of exclusivity.,JNJ,0.073546,0.077916,Neutral
3 Great Income Stocks That Retirees Should Love,https://www.fool.com/investing/2023/05/06/3-great-income-stocks-that-retirees-should-love/,2023-05-06 10:14:00,"If you're looking for additional retirement income, these three stocks should be right up your alley.",JNJ,0.365464,0.348602,Somewhat-Bullish
Empowering Innovation to the Global Market with Acro Certify,https://www.prnewswire.com/news-releases/empowering-innovation-to-the-global-market-with-acro-certify-301817589.html,2023-05-06 02:18:00,"NEWARK, Del., May 5, 2023 /PRNewswire/ -- For many companies, entering the global market is a daunting challenge. These obstacles can come in various forms. Sometimes the problem is finding the right target customer base or establishing an appropriate quality management system and shipping ...",JNJ,0.052918,0.126637,Neutral
Uber and Pfizer Update Their Investors About How Things Are Going,https://www.fool.com/investing/2023/05/05/uber-and-pfizer-update-their-investors/,2023-05-05 22:26:19,"We also chat about whether there is a ""new normal"" for start-ups and venture capital.",JNJ,0.011306,0.007,Neutral
S&P 500 Finishes Strong Following Wild Week Of Bank Stock Volatility - JPMorgan Chase  ( NYSE:JPM ) ,https://www.benzinga.com/news/23/05/32246312/s-p-500-finishes-strong-following-wild-week-of-bank-stock-volatility,2023-05-05 19:59:37,"The Fed's tenth consecutive interest rate hike, the buyout of First Republic's assets by JPMorgan Chase & Co JPM and a hot April jobs report gave investors plenty to digest this week. On Wednesday, the Federal Open Market Committee raised its fed funds target range by 0.25% to between 5% and ...",JNJ,0.183198,0.125991,Neutral
"Acelyrin Raises $540M In IPO, Stock Gains Over 20% In Trading Debut - Acelyrin  ( NASDAQ:SLRN ) ",https://www.benzinga.com/general/biotech/23/05/32244803/acelyrin-raises-540m-in-ipo-stock-gains-over-20-in-trading-debut,2023-05-05 17:52:06,"Acelyrin Inc SLRN, a late-stage clinical biopharma company, started trading today and opened at $23/share compared to IPO pricing of $18/share. Acelyrin has raised $540 million in an upsized initial public offering, and it sold 30 million shares at $18 apiece, exceeding the projections it set ...",JNJ,0.306963,0.0,Neutral
"Globus Medical  ( GMED )  Q1 Earnings Beat, Operating Margin Dips",https://www.zacks.com/stock/news/2091102/globus-medical-gmed-q1-earnings-beat-operating-margin-dips,2023-05-05 17:23:00,The significant year-over-year surge in Globus Medical's (GMED) Enabling Technologies sales is driven by ongoing demand for the company's robotics and imaging system technologies.,JNJ,0.174903,0.057083,Neutral
"Insulet  ( PODD )  Q1 Earnings Beat Estimates, Sales View Up",https://www.zacks.com/stock/news/2091100/insulet-podd-q1-earnings-beat-estimates-sales-view-up,2023-05-05 17:21:00,"Omnipod 5 continues to be a driving force of Insulet's (PODD) strong U.S. growth, representing almost 95% of U.S. new customer starts in the first quarter.",JNJ,0.196212,0.060554,Neutral
Biopharma firm Acelyrin valued at $2.1 billion in strong market debut,https://www.reuters.com/markets/deals/biopharma-firm-acelyrin-valued-21-billion-strong-market-debut-2023-05-05/,2023-05-05 16:10:45,"May 5 ( Reuters ) - Shares of Acelyrin Inc ( SLRN.O ) rose 28% in their Nasdaq debut on Friday, giving the biopharma company a market capitalization of $2.1 billion. The Los Angeles-based company, which had priced its shares at $18 apiece, raised $540 million by selling 30 million shares in ...",JNJ,0.227007,0.190789,Somewhat-Bullish
The $25.3 Billion Market That Sent This Top 1% Stock Into A Breakout,https://www.investors.com/news/technology/ptgx-stock-briefly-breaks-out-as-it-eyes-a-big-market/,2023-05-05 15:58:00,PTGX Stock Briefly Breaks Out As It Eyes A $25.3 Billion Market Investor's Business Daily ...,JNJ,0.48268,-0.086401,Neutral
ETFs to Bet on the Successful Debut of Kenvue,https://www.zacks.com/stock/news/2090987/etfs-to-bet-on-the-successful-debut-of-kenvue,2023-05-05 15:20:00,"Kenvue is the world's largest pure-play consumer health company by revenue, and makes well-known products, including Tylenol, Neutrogena, Listerine, Johnson???s', Band-Aid, Aveeno, Zyrtec and Nicorette.",JNJ,0.193078,0.10231,Neutral
Epilepsy Drugs Market Is Expected to Reach $9.8 Billion by 2032: Allied Market Research,https://www.benzinga.com/pressreleases/23/05/g32241720/epilepsy-drugs-market-is-expected-to-reach-9-8-billion-by-2032-allied-market-research,2023-05-05 15:16:17,"Portland, OR, May 05, 2023 ( GLOBE NEWSWIRE ) -- According to the report published by Allied Market Research, the global epilepsy drugs market generated $7 billion in 2022, and is estimated to reach $9.8 billion by 2032, witnessing a CAGR of 3.5% from 2023 to 2032.",JNJ,0.036756,0.063953,Neutral
ABNB Stock In Holding Pattern Ahead Of Q1 Results; Warren Buffett Favorite Occidental Petroleum Set To Report,https://www.investors.com/research/earnings-preview/abnb-stock-holding-pattern-q1-results-warren-buffett-favorite-occidental-petroleum-oxy-earnings/,2023-05-05 14:43:00,ABNB Stock In Holding Pattern Ahead Of Q1 Results. Warren Buffett ... Investor's Business Daily ...,JNJ,0.065506,0.043037,Neutral
"Kenvue CEO looks to brand, product innovation to drive growth after IPO",https://www.cnbc.com/2023/05/05/jj-spinoff-kenvue-ceo-looks-to-innovation-after-ipo.html,2023-05-05 13:37:45,"Kenvue CEO Thibaut Mongon said the spinoff's portfolio of brands, which includes Band-Aid, Tylenol and Neutrogena, has ""ample opportunity"" to grow.",JNJ,0.044304,0.038076,Neutral
Johnson & Johnson  ( JNJ )  is Attracting Investor Attention: Here is What You Should Know,https://www.zacks.com/stock/news/2090794/johnson-johnson-jnj-is-attracting-investor-attention-here-is-what-you-should-know,2023-05-05 13:00:13,"Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",JNJ,0.473208,0.176729,Somewhat-Bullish
"Bruker  ( BRKR )  Tops Q1 Earnings Estimates, Raises '23 Outlook",https://www.zacks.com/stock/news/2090714/bruker-brkr-tops-q1-earnings-estimates-raises-23-outlook,2023-05-05 11:59:00,"Bruker (BRKR) delivers a year-over-year revenue increase across all its segments in the first quarter, led by the strong demand for differentiated, high-performance scientific instruments and life-science solutions.",JNJ,0.159043,0.05351,Neutral
"Bio-Rad  ( BIO )  Q1 Earnings Beat Estimates, Operating Margin Down",https://www.zacks.com/stock/news/2090697/bio-rad-bio-q1-earnings-beat-estimates-operating-margin-down,2023-05-05 11:35:00,Bio-Rad's (BIO) first-quarter results reflect core strength across the Life Science and Clinical Diagnostics segments amid ongoing supply-chain constraints.,JNJ,0.166455,0.055156,Neutral
J&J's Kenvue rallies out of the gate,https://www.axios.com/2023/05/04/kenvue-ipo,2023-05-04 22:25:53,"There was a giant IPO today. We haven't been able to write that since November 2021, when Rivian went public.",JNJ,0.139265,0.072279,Neutral
US Stocks End Lower As Regional Banks Dive Again,https://www.barrons.com/news/us-stocks-end-lower-as-regional-banks-dive-again-24dbec8f,2023-05-04 20:16:20,"Wall Street stocks dropped Thursday following another brutal sell-off in regional banking shares, in the wake of four bank failures since early March. The broad-based S&P 500 shed 0.7 percent to 4,061.22, while the tech-rich Nasdaq Composite Index lost 0.5 percent at 11,966.40.",JNJ,0.16171,-0.156478,Somewhat-Bearish
Stock Market Today: Stocks Slide as Regional Bank Rout Worsens,https://www.kiplinger.com/investing/stocks/stock-market-today-stocks-slide-as-regional-bank-rout-worsens,2023-05-04 20:15:32,Panic selling in regional bank stocks resulted in losses for the major indexes Thursday.,JNJ,0.192183,0.061366,Neutral
"Kenvue IPO: Profitable Company, Expensive Stock",https://www.forbes.com/sites/greatspeculations/2023/05/04/kenvue-ipo-profitable-company-expensive-stock/,2023-05-04 19:02:54,"At its expected valuation, KVUE looks fully valued and does not provide investors with much upside potential.",JNJ,0.242587,-0.019315,Neutral
"Kenvue stock cheered in Wall Street debut, as Tylenol and Band-Aid brand parent is valued at $48 billion",https://www.marketwatch.com/story/kenvue-stock-opens-16-above-ipo-valuing-the-company-at-47-7-billion-ff0c65cb,2023-05-04 18:01:00,"Kenvue's stock was cheered in its Wall Street debut Thursday, as the J&J spinoff saw its stock open 16.0% above where the initial public offering was priced.",JNJ,0.259727,0.222733,Somewhat-Bullish
"Amedisys  ( AMED )  Q1 Earnings Beat Estimates, Margins Dip",https://www.zacks.com/stock/news/2090275/amedisys-amed-q1-earnings-beat-estimates-margins-dip,2023-05-04 16:47:00,Amedisys (AMED) sees a year-over-year decline in the Hospice segment's revenues.,JNJ,0.195419,0.061929,Neutral
"Tandem Diabetes  ( TNDM )  Q1 Earnings Miss, Gross Margin Dips",https://www.zacks.com/stock/news/2090267/tandem-diabetes-tndm-q1-earnings-miss-gross-margin-dips,2023-05-04 16:43:00,"According to Tandem Diabetes (TNDM), Q1 revenues are in line with the high end of its expectations.",JNJ,0.213517,0.066323,Neutral
"Club meeting recap: Equities slide, J&J consumer IPO, Costco sales",https://www.cnbc.com/2023/05/04/club-meeting-recap-equities-slide-jj-consumer-ipo-costco-sales.html,2023-05-04 16:03:07,"The Investing Club holds its ""Morning Meeting"" every weekday at 10:20 a.m. ET.",JNJ,0.206392,0.051684,Neutral
FATE Incurs Narrower-Than-Expected Q1 Loss on Lower Expenses,https://www.zacks.com/stock/news/2090210/fate-incurs-narrower-than-expected-q1-loss-on-lower-expenses,2023-05-04 15:59:00,FATE reports lower-than-expected loss on higher collaboration revenues and lower operating expenses in first-quarter 2023.,JNJ,0.104002,0.036407,Neutral
A stock portfolio created by ChatGPT is outperforming the top UK investment funds,https://markets.businessinsider.com/news/stocks/chatgpt-ai-stock-portfolio-outperforming-investment-uk-funds-finder-outlook-2023-5,2023-05-04 15:31:00,ChatGPT Built a Stock Portfolio That's Outperforming Top UK Funds - Markets Insider ...,JNJ,0.089129,0.0,Neutral
"Sports Medicine Market Size, Share, Revenue, Trends And Drivers For 2023-2032 As Per The Business Research Company's Sports Medicine Global Market Report 2023",https://www.benzinga.com/pressreleases/23/05/g32217713/sports-medicine-market-size-share-revenue-trends-and-drivers-for-2023-2032-as-per-the-business-res,2023-05-04 15:30:00,"LONDON, May 04, 2023 ( GLOBE NEWSWIRE ) -- The Business Research Company's research on the sports medicine market identifies the sports medicine market share to grow at a compound annual growth rate ( CAGR ) of more than 7% from $7 billion in 2022 to $7.6 billion in 2023.",JNJ,0.06515,-0.002006,Neutral
Johnson & Johnson Spins Off Kenvue in Biggest IPO Haul Since 2021,https://www.kiplinger.com/investing/johnson-and-johnson-spins-off-kenvue-in-biggest-ipo-haul-since-2021,2023-05-04 15:25:08,"Johnson & Johnson ( JNJ ( opens in new tab ) ) spun off its Kenvue ( KVUE ( opens in new tab ) ) consumer brands division on Thursday, raising the most cash from an initial public offering ( IPO ) in more than a year.",JNJ,0.755649,0.278952,Somewhat-Bullish
"Phibro  ( PAHC )  Q3 Earnings Miss Estimates, Gross Margin Up",https://www.zacks.com/stock/news/2090216/phibro-pahc-q3-earnings-miss-estimates-gross-margin-up,2023-05-04 15:12:00,Higher domestic demand and higher average selling prices for dairy products and growth in the companion animal product drive Phibro's (PAHC) Q3 revenues.,JNJ,0.182506,0.058855,Neutral
"Envista  ( NVST )  Q1 Earnings Miss Estimates, Margins Down",https://www.zacks.com/stock/news/2090207/envista-nvst-q1-earnings-miss-estimates-margins-down,2023-05-04 14:55:00,Weakness in China and Russia and lower demand for large capital equipment hurts Envista's (NVST) Q1 revenues.,JNJ,0.199447,0.0629,Neutral
Should Investors Buy This Hot Growth Stock?,https://www.fool.com/investing/2023/05/04/should-investors-buy-this-hot-growth-stock/,2023-05-04 14:15:00,This pharmaceutical giant has proved to be a tremendous wealth creator for its shareholders in recent years.,JNJ,0.063258,0.0,Neutral
J&J Consumer-Health IPO Kenvue to Raise $3.8 Billion,https://www.barrons.com/articles/jnj-stock-ipo-kenvue-5cc1207d,2023-05-04 14:15:00,J&J Consumer-Health IPO Stock Kenvue to Raise $3.8 Billion ...,JNJ,0.608634,0.222028,Somewhat-Bullish
Want to Get Richer? 2 Best Stocks to Buy Now and Hold Forever,https://www.fool.com/investing/2023/05/04/want-to-get-richer-2-best-stocks-to-buy-and-hold/,2023-05-04 13:53:00,These two high-growth stocks have the potential to deliver solid long-term returns.,JNJ,0.053992,0.104986,Neutral
5 Mid-Cap Stocks With Large Yields,https://www.barrons.com/articles/federated-hermes-hanover-hf-sinclair-dividend-stocks-yields-89ffeafc,2023-05-04 12:40:00,"Federated HermÃ¨s, Hanover Insurance, and 3 Other Mid-Cap Stocks With Large Yields ...",JNJ,0.130926,0.296984,Somewhat-Bullish
"Qiagen  ( QGEN )  Q1 Earnings Top Estimates, Operating Margin Down",https://www.zacks.com/stock/news/2089830/qiagen-qgen-q1-earnings-top-estimates-operating-margin-down,2023-05-04 12:27:00,"Amid an uncertain macroeconomic environment, Qiagen's (QGEN) first-quarter results reflect an impressive organic top line, led by strength in non-COVID-19 product groups.",JNJ,0.145364,0.050607,Neutral
"Myriad Genetics  ( MYGN )  Lags Q1 Earnings, Updates '23 View",https://www.zacks.com/stock/news/2089774/myriad-genetics-mygn-lags-q1-earnings-updates-23-view,2023-05-04 12:00:00,"Myriad Genetics (MYGN) delivers a year-over-year increase in first-quarter revenues, reflecting a positive volume improvement across the portfolio.",JNJ,0.177802,0.057755,Neutral
"Psychedelic Drug Industry Analysis: Forecast Market Size, Major Players And Their Strategies, And Key Segments - By The Business Research Company",https://www.prnewswire.com/news-releases/psychedelic-drug-industry-analysis-forecast-market-size-major-players-and-their-strategies-and-key-segments--by-the-business-research-company-301814512.html,2023-05-04 09:30:00,"Psychedelic Drug Industry Analysis: Forecast Market Size, Major ... PR ...",JNJ,0.072,0.018172,Neutral
"J&J, cancer victims ordered to start settlement talks in bankruptcy",https://www.business-standard.com/companies/news/j-j-cancer-victims-ordered-to-start-settlement-talks-in-bankruptcy-123050400455_1.html,2023-05-04 07:44:03,A federal judge ordered a new round of settlement talks between Johnson & Johnson and lawyers who spurned the company's offer to pay $8.9 billion to end tens of thousands of cancer claims ...,JNJ,0.108466,-0.071662,Neutral
5 Mid-Cap Stocks With Large Yields,https://www.barrons.com/articles/mid-cap-dividend-stocks-yields-89ffeafc,2023-05-04 07:00:00,"When it comes to dividend stocks, large-cap names command a lot of attention. But the likes of Johnson & Johnson ( ticker: JNJ ) , AT&T ( T ) , and Coca-Cola ( KO ) aren't the only places to find nice yields. Mid-cap stocks are worth a look as well.",JNJ,0.130926,0.296984,Somewhat-Bullish
Weight-Loss Drugs Will Be Blockbusters. Here's the Stock to Buy.,https://www.barrons.com/articles/weight-loss-drugs-buy-this-stock-c5d4418c,2023-05-04 05:30:00,"In the year since Eli Lilly announced trial results showing that tirzepatide-best known by the brand name Mounjaro-helped patients drop more than 20% of their weight, the drug has become the most talked about, and most hyped, pharmaceutical in recent memory.",JNJ,0.353059,0.092107,Neutral
Johnson & Johnson and Kenvue Announce Pricing of Upsized Kenvue Inc. Initial Public Offering,https://investingnews.com/johnson-johnson-and-kenvue-announce-pricing-of-upsized-kenvue-inc-initial-public-offering/,2023-05-03 23:52:41,"Johnson & Johnson ( NYSE: JNJ ) and Kenvue Inc. ( ""Kenvue"" ) , a wholly owned subsidiary of Johnson & Johnson, today announced the pricing of Kenvue's upsized initial public offering ( ""IPO"" ) of 172,812,560 shares of Kenvue's common stock at a price to the public of $22.00 per share.",JNJ,0.381625,0.279357,Somewhat-Bullish
Johnson & Johnson's Kenvue IPO to command valuation of more than $40 billion in biggest public debut since 2021,https://www.marketwatch.com/story/johnson-johnsons-kenvue-ipo-to-command-valuation-of-more-than-40-billion-in-biggest-public-debut-since-2021-7974a202,2023-05-03 23:38:00,A unit of Johnson & Johnson is headed for the biggest initial public offering in more than a year after its shares priced near the top of the range.,JNJ,0.916507,0.415128,Bullish
THE PALEY CENTER FOR MEDIA ANNOUNCES NEW MEMBERS TO ITS ESTEEMED BOARD OF TRUSTEES AND LOS ANGELES BOARD OF GOVERNORS,https://www.benzinga.com/pressreleases/23/05/n32202093/the-paley-center-for-media-announces-new-members-to-its-esteemed-board-of-trustees-and-los-angeles,2023-05-03 22:19:00,"Sean ""Diddy"" Combs, Robert Kyncl, Ryan Roslansky, and Joseph C. Tsai Join the Paley Center's Board of Trustees",JNJ,0.028764,0.100327,Neutral
J&J Prices Consumer Unit IPO at $22 a Share,https://www.wsj.com/articles/j-j-prices-consumer-unit-ipo-at-22-a-share-1950af12,2023-05-03 21:55:00,The listing of the Tylenol maker would be by far the biggest initial public offering so far this year.,JNJ,0.504646,0.290171,Somewhat-Bullish
J&J's Kenvue prices IPO within range to raise $3.7 bln - source,https://www.reuters.com/markets/us/jjs-kenvue-prices-ipo-within-range-raise-37-bln-source-2023-05-03/,2023-05-03 21:07:00,"NEW YORK, May 3 ( Reuters ) - Johnson & Johnson ( JNJ.N ) on Wednesday priced the initial public offering ( IPO ) of its consumer-health business at the upper end of its target range to raise $3.66 billion, people familiar with the matter said,",JNJ,0.306963,0.065349,Neutral
"CVS Health  ( CVS )  Q1 Earnings Surpass Estimates, EPS View Cut",https://www.zacks.com/stock/news/2089344/cvs-health-cvs-q1-earnings-surpass-estimates-eps-view-cut,2023-05-03 18:22:00,CVS Health's (CVS) robust sales growth across all three operating segments drives top-line results.,JNJ,0.170576,0.05609,Neutral
Syniti to Showcase New Cloud-Native Data Migration Platform at SAPÂ® Sapphire Conferences,https://www.prnewswire.com/news-releases/syniti-to-showcase-new-cloud-native-data-migration-platform-at-sap-sapphire-conferences-301815018.html,2023-05-03 18:06:00,Syniti to Showcase New Cloud-Native Data Migration Platform at ... PR ...,JNJ,0.048036,0.051582,Neutral
Iron Pillar leads supply chain tech firm Pando's $30 mn Series B Funding,https://www.business-standard.com/companies/news/iron-pillar-leads-supply-chain-tech-firm-pando-s-30-mn-series-b-funding-123050301094_1.html,2023-05-03 17:50:06,"With the global logistics SaaS tech market estimated to grow to $25 billion by 2025, Pando said it is well-positioned to benefit from the broader tailwinds ...",JNJ,0.091162,0.204527,Somewhat-Bullish
"Powell Takes the Stage: Another Rate Increase Widely Expected as Investors Eye Banks, Debt Ceiling - First Republic Bank  ( NYSE:FRC ) ",https://www.benzinga.com/markets/penny-stocks/23/05/32189679/powell-takes-the-stage-another-rate-increase-widely-expected-as-investors-eye-banks-debt-cei,2023-05-03 14:50:46,"( Wednesday market open ) For the second straight meeting, the Federal Open Market Committee ( FOMC ) arrives at an interest rate decision today just as the market gets jittery over small banks.",JNJ,0.03878,0.097216,Neutral
DENTSPLY SIRONA  ( XRAY )  Q1 Earnings & Revenues Beat Estimates,https://www.zacks.com/stock/news/2089149/dentsply-sirona-xray-q1-earnings-revenues-beat-estimates,2023-05-03 14:49:00,"DENTSPLY SIRONA's (XRAY) Q1 earnings and revenues decline year over year, driven by the unfavorable foreign currency movement and soft demand across all geographical segments.",JNJ,0.194632,0.098356,Neutral
2 Stocks to Buy With $200 That Can Survive Any Recession,https://www.fool.com/investing/2023/05/03/2-stocks-to-buy-that-can-survive-any-recession/,2023-05-03 14:00:00,These businesses have an excellent track record of surviving difficult economic times.,JNJ,0.273807,0.121883,Neutral
"Penumbra  ( PEN )  Q1 Earnings Top Estimates, Sales Remain Robust",https://www.zacks.com/stock/news/2089135/penumbra-pen-q1-earnings-top-estimates-sales-remain-robust,2023-05-03 13:28:00,Penumbra's (PEN) sales during the first quarter reflect continued demand for its products. The 2023 outlook is encouraging as earnings improve despite macro challenges.,JNJ,0.210731,0.10455,Neutral
How Long Could It Take for Johnson & Johnson's Dividend Yield to Get to 5%?,https://www.fool.com/investing/2023/05/03/how-long-could-it-take-for-johnson-johnsons-divide/,2023-05-03 13:09:00,"Over time, your dividend payments from the stock are likely to rise significantly.",JNJ,0.497126,0.387217,Bullish
J&J's consumer health business Kenvue is going public this week. Here's what to know,https://www.cnbc.com/2023/05/03/jj-kenvue-ipo-what-to-know.html,2023-05-03 12:38:40,J&J's consumer health spinoff Kenvue is expected to set an initial public offering price Wednesday night and trade Thursday on the New York Stock Exchange.,JNJ,0.109956,0.018271,Neutral
Only 2 Companies Are AAA Rated As U.S. Risks Being A Deadbeat,https://www.investors.com/etfs-and-funds/sectors/sp500-companies-cling-to-aaa-rating-as-u-s-risks-being-a-deadbeat/,2023-05-03 12:00:00,Lawmakers are playing chicken with the debt ceiling - and the U.S.' creditworthiness. Luckily there are still two U.S. S&P 500 companies left with perfect AAA credit ratings - a key asset with interest rates on the rise.,JNJ,0.181137,0.181451,Somewhat-Bullish
"Omnicell  ( OMCL )  Q1 Earnings Top Estimates, Margins Down",https://www.zacks.com/stock/news/2088752/omnicell-omcl-q1-earnings-top-estimates-margins-down,2023-05-03 11:22:00,"Despite a year-over-year decrease, Omnicell's (OMCL) first-quarter revenues and earnings exceed the top end of the previously announced outlook amid an uncertain macroeconomic environment.",JNJ,0.162255,0.054218,Neutral
"Key Marijuana Executive Changes You Should Know About: New Appointments And Promotions - Humble & Fume  ( OTC:HUMBF ) , Green Thumb Industries  ( OTC:GTBIF ) ",https://www.benzinga.com/markets/cannabis/23/05/32164073/key-marijuana-executive-changes-you-should-know-about-new-appointments-and-promotions,2023-05-02 22:15:01,Cannabis operator Humble & Fume Inc. HMBL HUMBF has appointed Chris Candelario as the president of US distribution. Candelario is a veteran of nearly twenty years in the distribution industry.,JNJ,0.06211,0.326672,Somewhat-Bullish
Stanley Black & Decker Appoints Chris Nelson Chief Operating Officer and Executive Vice President and President of Tools & Outdoor,https://www.prnewswire.com/news-releases/stanley-black--decker-appoints-chris-nelson-chief-operating-officer-and-executive-vice-president-and-president-of-tools--outdoor-301813814.html,2023-05-02 20:36:00,Stanley Black & Decker Appoints Chris Nelson Chief Operating ... PR ...,JNJ,0.063091,0.0,Neutral
"Zimmer Biomet  ( ZBH )  Q1 Earnings Beat Estimates, View Raised",https://www.zacks.com/stock/news/2088455/zimmer-biomet-zbh-q1-earnings-beat-estimates-view-raised,2023-05-02 18:03:00,Each of Zimmer Biomet's (ZBH) geographic segments and product divisions records strong year-over-year sales growth at CER.,JNJ,0.212115,0.02799,Neutral
Sylvia Banderas Coffinet Named CEO of Latino Media Network,https://www.benzinga.com/pressreleases/23/05/n32168573/sylvia-banderas-coffinet-named-ceo-of-latino-media-network,2023-05-02 17:54:00,"Sylvia joins founders Stephanie Valencia and Jessica Morales Rocketto in scaling one of the largest, Latina owned multi-platform audio & media companies serving the Latino market in the US",JNJ,0.057767,0.075962,Neutral
"Biotech/Drug Stocks' Q1 Earnings Due May 3: UTHR, PCRX & More",https://www.zacks.com/stock/news/2088427/biotechdrug-stocks-q1-earnings-due-may-3-uthr-pcrx-more,2023-05-02 17:32:00,"Let us take a look at what's in store for biotech/drug stocks UTHR, PCRX, CORT, AMRN and IONS, which are scheduled to report on May 3.",JNJ,0.04497,-0.053922,Neutral
"Hologic's  ( HOLX )  Q2 Earnings Beat Estimates, 2023 View Up",https://www.zacks.com/stock/news/2088415/hologics-holx-q2-earnings-beat-estimates-2023-view-up,2023-05-02 16:27:00,The year-over-year growth in Breast Health and GYN Surgical Businesses contributed to Hologic's (HOLX) Q2 revenues.,JNJ,0.150357,0.051644,Neutral
2 Biotech IPOs Are Thursday. Why the Window Is Still Shut.,https://www.barrons.com/articles/kenvue-acelyrin-stocks-ipos-3f9805ab,2023-05-02 16:24:00,"Kenvue, Acelyrin Go Public on Thursday. Don't Expect a Flood of Biotech ...",JNJ,0.108466,0.077237,Neutral
Johnson & Johnson Ignites CAR-T Ambitions With Licensing Pact With Cellular Biomedicine - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/general/biotech/23/05/32165424/johnson-johnson-ignites-car-t-ambitions-with-licensing-pact-with-cellular-biomedicine,2023-05-02 16:14:29,"Johnson & Johnson's JNJ pharma unit Janssen entered into a worldwide collaboration and license agreement with Cellular Biomedicine Group Inc to develop, manufacture and commercialize next-generation chimeric antigen receptor ( CAR ) T-cell therapies for B-cell malignancies.",JNJ,0.56415,0.057639,Neutral
"IDEXX  ( IDXX )  Q1 Earnings Beat Estimates, Margins Increase",https://www.zacks.com/stock/news/2088405/idexx-idxx-q1-earnings-beat-estimates-margins-increase,2023-05-02 16:02:00,Continued solid demand for veterinary services and record global premium instrument placements drive IDEXX's (IDXX) Q1 revenues.,JNJ,0.185662,0.0596,Neutral
Looking At Johnson & Johnson's Recent Unusual Options Activity - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/05/32164112/looking-at-johnson-johnsons-recent-unusual-options-activity,2023-05-02 15:16:09,"Someone with a lot of money to spend has taken a bearish stance on Johnson & Johnson JNJ. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",JNJ,0.823771,0.167301,Somewhat-Bullish
NCLAT sets aside CCI's six-year-old penalty on ITC for not furnishing info on Savlon deal | The Financial Express,https://www.financialexpress.com/industry/nclat-sets-aside-ccis-six-year-old-penalty-on-itc-for-not-furnishing-info-on-savlon-deal/3071960/,2023-05-02 15:08:57,NCLAT sets aside CCI's six-year-old penalty on ITC for not ... The Financial Express ...,JNJ,0.098659,0.020617,Neutral
NCLAT sets aside CCI penalty on ITC for not furnishing info on Savlon deal,https://www.business-standard.com/companies/news/nclat-sets-aside-cci-penalty-on-itc-for-not-furnishing-info-on-savlon-deal-123050201083_1.html,2023-05-02 14:48:37,The National Company Law Appellate Tribunal (NCLAT) has set aside the penalty imposed on multi-conglomerate ITC by fair trade regulator CCI for not notifying for the acquisition of brands 'Savlon' and 'Shower to Shower' in 2017.,JNJ,0.098659,0.152828,Somewhat-Bullish
2 Incredibly Cheap Dividend Stocks to Buy in May,https://www.fool.com/investing/2023/05/02/2-incredibly-cheap-dividend-stocks-to-buy-in-may/,2023-05-02 13:45:00,These two dividend-paying pharma stocks both screen as significantly undervalued right now.,JNJ,0.100099,0.177057,Somewhat-Bullish
Better Growth Stock: Johnson & Johnson vs. Intuitive Surgical,https://www.fool.com/investing/2023/05/02/better-growth-stock-johnson-johnson-vs-intuitive-s/,2023-05-02 11:20:00,"Both are great companies, but one might be a slightly better option.",JNJ,0.13409,0.01854,Neutral
Biden will end Covid vaccine mandates for federal workers and international travelers on May 11,https://www.cnbc.com/2023/05/01/covid-biden-will-end-vaccine-mandates-for-federal-workers-travelers.html,2023-05-02 00:39:01,"The Biden administration will end Covid vaccine mandates for federal employees, contractors and air travelers on May 11.",JNJ,0.082677,0.148346,Neutral
Politan nominates two director candidates at Masimo -filing,https://www.reuters.com/business/sustainable-business/politan-nominates-two-director-candidates-masimo-filing-2023-05-01/,2023-05-01 21:11:00,Politan nominates two director candidates at ...,JNJ,0.092927,0.024951,Neutral
Daescu Dominates In Doubles At The Association Of Pickleball Professionals Sacramento Open,https://www.forbes.com/sites/toddboss/2023/05/01/daescu-dominates-in-doubles-at-the-association-of-pickleball-professionals-sacramento-open/,2023-05-01 14:29:45,"Andrei Daescu too both Men's and Mixed doubles gold in Sacramento, his second straight Double Double on the APP tour. Meanwhile, Yates Johnson wins his first ever gold medal in any competition and the Jardim & Todd doubles freight train continues on.",JNJ,0.032825,0.161623,Somewhat-Bullish
"After Jumping 49% in 1 Month, Is It Too Late to Buy Legend Biotech?",https://moneymorning.com/investing/after-jumping-49-in-1-month-is-it-too-late-to-buy-legend-biotech/,2023-05-01 13:25:00,"With its shares up by 49% in one month and 80% in one year, shareholders of Legend Biotech ( NASDAQ: LEGN ) are bound to be feeling pretty smart right about now.",JNJ,0.081001,0.131379,Neutral
"After Jumping 49% in 1 Month, Is It Too Late to Buy Legend Biotech?",https://www.fool.com/investing/2023/05/01/after-jumping-49-in-1-month-is-it-too-late-to-buy/,2023-05-01 13:25:00,"Legend's cell therapy seems like it's a winner, but it might be priced in already.",JNJ,0.049732,0.127668,Neutral
Bipartisan attorneys general call on Medicare to cover Alzheimer's treatments,https://www.cnbc.com/2023/05/01/states-medicare-alzheimers-treatments.html,2023-05-01 13:00:01,"Attorneys general from 23 states, Washington D.C., and two U.S. territories called on Medicare to cover Alzheimer's treatments without restrictions.",JNJ,0.041181,0.141776,Neutral
Biopharma firm Acelyrin seeks $1.5 bln valuation in US IPO,https://www.reuters.com/markets/deals/biopharma-firm-acelyrin-seeks-15-bln-valuation-us-ipo-2023-05-01/,2023-05-01 12:25:00,Biopharma firm Acelyrin seeks $1.5 bln valuation in US ...,JNJ,0.158519,0.097032,Neutral
JPMorgan Chase Returns to a Familiar Role: Bank Rescuer,https://www.nytimes.com/2023/05/01/business/dealbook/jpmorgan-first-republic-rescue.html,2023-05-01 11:33:00,The lending giant's shares jumped on the news that it is buying First Republic. But investors are watching to see if the deal ends the regional banking crisis.,JNJ,0.02083,0.109665,Neutral
"If I Could Buy Only 1 Warren Buffett Stock in May, This Would Be It",https://www.fool.com/investing/2023/05/01/if-i-could-buy-only-1-warren-buffett-stock-in-may/,2023-05-01 09:54:00,Buffett would probably agree with this choice.,JNJ,0.236972,0.104581,Neutral
"If I Could Buy Only 1 Warren Buffett Stock in May, This Would Be It",https://moneymorning.com/investing/if-i-could-buy-only-1-warren-buffett-stock-in-may-this-would-be-it/,2023-05-01 09:54:00,"It's a new month and a new opportunity to invest. When it comes to investing ideas, I can't think of a better fount of wisdom than Warren Buffett. His Berkshire Hathaway ( NYSE: BRK.A ) ( NYSE: BRK.B ) portfolio features plenty of great stocks.",JNJ,0.155451,-0.098445,Neutral
Healthium Medtech appoints Prashant Krishnan as Global Business Head for Advanced Wound Care and Surgery | The Financial Express,https://www.financialexpress.com/healthcare/healthtech/healthium-medtech-appoints-prashant-krishnan-as-global-business-head-for-advanced-wound-care-and-surgery/3070089/,2023-05-01 09:25:00,Healthium Medtech appoints Prashant Krishnan as Global Business ... The Financial Express ...,JNJ,0.074926,0.100958,Neutral
3 Relatively Safe Stocks to Buy if a Recession Is on the Way,https://www.fool.com/investing/2023/05/20/3-relatively-safe-stocks-to-buy-if-a-recession-is/,2023-05-20 10:14:00,"If the economy falters, these stocks should hold up better than most.",JNJ,0.214937,-0.11223,Neutral
"Global Surgical Procedures Market to Generate 372,837 thousand units by 2030, Outlines a New Report by Next Move Strategy Consulting",https://www.benzinga.com/pressreleases/23/05/g32497992/global-surgical-procedures-market-to-generate-372-837-thousand-units-by-2030-outlines-a-new-report,2023-05-20 04:00:00,"New York, May 20, 2023 ( GLOBE NEWSWIRE ) -- According to a new research report by Next Move Strategy Consulting, the Surgical Procedures Market size was 2,94,237 thousand units in 2022, and is predicted to reach 3,72,837 thousand units by 2030, with a CAGR of 3.1% during the forecast period, ...",JNJ,0.036587,0.059758,Neutral
"Echocardiography  ( ECG )  Devices Market size to grow by USD 4,102.12 million from 2022 and 2027; Allengers Medical Systems Ltd., Bionet Co. Ltd., identified as key vendors - Technavio",https://www.prnewswire.com/news-releases/echocardiography-ecg-devices-market-size-to-grow-by-usd-4-102-12-million-from-2022-and-2027-allengers-medical-systems-ltd-bionet-co-ltd-identified-as-key-vendors--technavio-301828858.html,2023-05-20 00:45:00,Echocardiography ( ECG ) Devices Market size to grow by USD ... PR ...,JNJ,0.048327,0.0,Neutral
Clinical Project Manager  ( CPM )  Beginner Training Course,https://www.prnewswire.com/news-releases/clinical-project-manager-cpm-beginner-training-course-301829578.html,2023-05-20 00:00:00,"DUBLIN, May 19, 2023 /PRNewswire/ -- The ""Clinical Project Manager ( CPM ) Beginner"" training has been added to ResearchAndMarkets.com's offering. If you are looking to enter the field of clinical research, this CPD-accredited is for you.",JNJ,0.072655,0.158298,Somewhat-Bullish
Global Cellulite Treatment Global Market 2023-2030: Increasing Trend of Anti-Cellulite Massage Presents Opportunities,https://www.prnewswire.com/news-releases/global-cellulite-treatment-global-market-2023-2030-increasing-trend-of-anti-cellulite-massage-presents-opportunities-301829574.html,2023-05-19 23:45:00,Global Cellulite Treatment Global Market 2023-2030: Increasing ... PR ...,JNJ,0.077593,0.085064,Neutral
"Autoimmune Drugs Market size to grow by USD 29,314.5 million between 2022 and 2027; AbbVie Inc., and AdvaCare Pharma among others, identified as key vendors - Technavio",https://www.prnewswire.com/news-releases/autoimmune-drugs-market-size-to-grow-by-usd-29-314-5-million-between-2022-and-2027-abbvie-inc-and-advacare-pharma-among-others-identified-as-key-vendors--technavio-301828870.html,2023-05-19 23:15:00,"Autoimmune Drugs Market size to grow by USD 29,314.5 million ... PR ...",JNJ,0.075161,0.137715,Neutral
What Are Penny Stocks & Should You Buy Them In 2023?,https://pennystocks.com/featured/2023/05/19/what-are-penny-stocks-should-you-buy-them-2023/,2023-05-19 19:32:22,"In this article, we're going to go over some basics. We'll discuss the definition of penny stocks, the pros & cons, plus some extra details you should know before jumping into the market. A penny stock represents the stock of a company that trades for less than $5 per share.",JNJ,0.052169,0.120545,Neutral
Most stocks end up losing you money. What's an investor to do?,https://www.marketwatch.com/story/most-stocks-end-up-losing-you-money-whats-an-investor-to-do-996e8326,2023-05-19 15:01:00,Read this before trying to pick stocks.,JNJ,0.102231,0.21384,Somewhat-Bullish
"STERIS  ( STE )  Continues to Face Dull Dental Sales, Margin Woes",https://www.zacks.com/stock/news/2097434/steris-ste-continues-to-face-dull-dental-sales-margin-woes,2023-05-19 14:48:00,"STERIS (STE) competes for pharmaceutical, research and industrial customers against several large companies that have robust product portfolios and global reach.",JNJ,0.072,0.078811,Neutral
2 Healthcare Stocks You Can Buy and Hold for the Next Decade,https://www.fool.com/investing/2023/05/19/2-healthcare-stocks-you-can-hold-for-next-decade/,2023-05-19 14:23:00,These two solid companies should be buoyed by recent tailwinds.,JNJ,0.045054,0.013906,Neutral
"Kenvue Just IPO'd, but Is the Stock a Buy?",https://www.fool.com/investing/2023/05/19/kenvue-just-ipod-but-is-the-stock-a-buy/,2023-05-19 09:24:00,"The Johnson & Johnson spinoff is worth considering, but it's not a must-buy.",JNJ,0.144275,0.091031,Neutral
"Tesla, Apple, Microsoft Stakes Slashed By New York State Retirement Fund In Q1: Here's What It Bought - Microsoft  ( NASDAQ:MSFT ) , Apple  ( NASDAQ:AAPL ) , Tesla  ( NASDAQ:TSLA ) , Johnson & Johnson  ( NYSE:JNJ ) , Charles Schwab  ( NYSE:SCHW ) , Texas Instruments  ( NASDAQ:TXN ) , Amazon.com  ( NASDAQ:AMZN ) , Taiwan Semiconductor  ( NYSE:TSM ) ",https://www.benzinga.com/markets/equities/23/05/32480849/tesla-apple-microsoft-stakes-slashed-by-new-york-state-retirement-fund-in-q1-heres-what-it-bough,2023-05-19 07:31:44,"The New York State Common Retirement Fund, a public pension plan for the employees of the New York State government, cut down on its holdings of mega-cap technology stocks in the first quarter, according to its latest 13F filing with the Securities and Exchange Commission.",JNJ,0.285526,0.151986,Somewhat-Bullish
RSV Vaccine: FDA Advisors Recommend Pfizer Shot To Protect Infants From Infection-Here's What To Know,https://www.forbes.com/sites/roberthart/2023/05/18/rsv-vaccine-fda-advisors-recommend-pfizer-shot-to-protect-infants-from-infection-heres-what-to-know/,2023-05-18 23:46:50,The vaccine is given to pregnant people to protect infants from RSV in their first months of life.,JNJ,0.042122,0.074325,Neutral
UM Crowned Campaign's Media Agency Global Network of the Year,https://www.prnewswire.com/news-releases/um-crowned-campaigns-media-agency-global-network-of-the-year-301828905.html,2023-05-18 17:28:00,"Campaign's 2022 Global Agency of the Year Awards Celebrate the Very Best All-round Performers on the Globe NEW YORK, May 18, 2023 /PRNewswire/ -- UM, a global media agency network of IPG Mediabrands, was awarded ""Media Agency Global Network of the Year"" in Campaign's 2022 Global Agency of the ...",JNJ,0.095138,0.198052,Somewhat-Bullish
Johnson & Johnson  ( JNJ )  Down 2.2% Since Last Earnings Report: Can It Rebound?,https://www.zacks.com/stock/news/2096971/johnson-johnson-jnj-down-22-since-last-earnings-report-can-it-rebound,2023-05-18 15:30:10,Johnson & Johnson (JNJ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,JNJ,0.096866,0.071051,Neutral
RSV Vaccine: Here's What To Know As FDA Advisors Consider Approving Pfizer's Shot,https://www.forbes.com/sites/roberthart/2023/05/18/rsv-vaccine-heres-what-to-know-as-fda-advisors-consider-approving-pfizers-shot/,2023-05-18 12:31:07,"FDA analysts have flagged concerns over the risk of preterm birth for the shot, which is given to pregnant people to protect infants from RSV in their first months of life.",JNJ,0.041538,0.074247,Neutral
3 Goldman Sachs Mutual Funds for Excellent Returns,https://www.zacks.com/stock/news/2096715/3-goldman-sachs-mutual-funds-for-excellent-returns,2023-05-18 11:23:00,"Below, we share with you three top-ranked Goldman Sachs mutual funds. Each has earned a Zacks Mutual Fund Rank #1.",JNJ,0.081276,0.152256,Somewhat-Bullish
Is 3M Company Stock a Buy?,https://www.fool.com/investing/2023/05/18/is-3m-company-stock-a-buy/,2023-05-18 10:35:00,Uncertainty around litigation is weighing on the stock.,JNJ,0.056674,0.027005,Neutral
Should Invesco S&P 500 Low Volatility ETF  ( SPLV )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2096645/should-invesco-sp-500-low-volatility-etf-splv-be-on-your-investing-radar,2023-05-18 10:20:07,Style Box ETF report for ...,JNJ,0.133841,0.071297,Neutral
"Got $2,500? 2 Top Stocks That You Can Buy and Hold for a Lifetime",https://www.fool.com/investing/2023/05/18/got-2500-2-top-stocks-that-you-can-buy-and-hold-fo/,2023-05-18 09:52:00,"Buy these stocks, then...do nothing.",JNJ,0.061631,0.149452,Neutral
"Virtualware rewards its employees with more than 52,000 shares during its first month as a listed company on the Paris Stock Exchange",https://www.globenewswire.com/news-release/2023/05/17/2671266/0/en/Virtualware-rewards-its-employees-with-more-than-52-000-shares-during-its-first-month-as-a-listed-company-on-the-Paris-Stock-Exchange.html,2023-05-17 15:13:00,"PARIS and BILBAO, Spain, May 17, 2023 ( GLOBE NEWSWIRE ) -- Virtual reality company Virtualware ( EPA:MLVIR ) has distributed in its first month of trading a total of 52,602 shares among most of its employees, with a total value of more than 315,612 euros.",JNJ,0.115232,0.132715,Neutral
2 Dividend Stocks to Double Up On Right Now,https://www.fool.com/investing/2023/05/17/2-dividend-stocks-to-double-up-on-right-now/,2023-05-17 12:35:00,These dividend stocks look attractive right now.,JNJ,0.355588,0.344567,Somewhat-Bullish
Johnson & Johnson Sets Aside $400M To End US State Consumer Protection Claims - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/government/23/05/32440362/johnson-johnson-sets-aside-400m-to-end-us-state-consumer-protection-claims,2023-05-17 12:20:39,"As a part of the $8.9 billion effort to settle claims related to talc products, Johnson & Johnson JNJ has earmarked $400 million to end claims alleging it violated state unfair business practices and consumer protection laws by misleading consumers about the safety of its talc products.",JNJ,0.465196,-0.096279,Neutral
Which Pharmaceuticals Stock Is A Better Pick: Johnson & Johnson Or Eliquis' Maker?,https://www.forbes.com/sites/greatspeculations/2023/05/17/which-pharmaceuticals-stock-is-a-better-pick-johnson--johnson-or-eliquis-maker/,2023-05-17 12:00:00,"There is more to the comparison, and in the sections below, we discuss why we believe BMY stock will offer higher returns than JNJ stock in the next three years.",JNJ,0.424207,0.250228,Somewhat-Bullish
Should You Invest in the iShares U.S. Healthcare ETF  ( IYH ) ?,https://www.zacks.com/stock/news/2096105/should-you-invest-in-the-ishares-us-healthcare-etf-iyh,2023-05-17 10:20:05,Sector ETF report for ...,JNJ,0.130926,0.069334,Neutral
3 High-Yield Dividend Stocks You Probably Didn't Know Warren Buffett Owns,https://www.fool.com/investing/2023/05/17/high-yield-dividend-stocks-warren-buffett-owns/,2023-05-17 09:50:00,Buffett has a few cards up his sleeve with these stocks.,JNJ,0.065327,0.0,Neutral
"AstraZeneca's Tagrisso, chemo combination shows promise in lung cancer trial",https://www.reuters.com/business/healthcare-pharmaceuticals/astrazenecas-tagrisso-chemo-combination-shows-promise-lung-cancer-trial-2023-05-17/,2023-05-17 09:26:00,"AstraZeneca's Tagrisso, chemo combination shows promise in lung ... ...",JNJ,0.213048,-0.328832,Somewhat-Bearish
"3 No-Brainer Stocks to Buy With $1,000 Right Now",https://www.fool.com/investing/2023/05/17/3-no-brainer-stocks-to-buy-with-1000-right-now/,2023-05-17 09:21:00,You don't need a mountain of cash to build wealth on Wall Street.,JNJ,0.156055,0.153663,Somewhat-Bullish
FTC Seeks to Block Amgen's Acquisition of Horizon Therapeutics: What's Next for Both Stocks?,https://www.fool.com/investing/2023/05/17/ftc-seeks-to-block-amgens-acquisition-of-horizon-t/,2023-05-17 09:13:00,Don't bank on the FTC winning in its attempt to stop Amgen's buyout of Horizon just yet.,JNJ,0.061631,0.006099,Neutral
"Got $5,000? These 3 High-Yielding Dividend Stocks Are Trading Near Their 52-Week Lows",https://www.fool.com/investing/2023/05/17/got-5000-high-yield-dividend-stocks-near-lows/,2023-05-17 09:10:00,These stocks provide good value and can be excellent sources of recurring income.,JNJ,0.224903,0.176886,Somewhat-Bullish
Is Novavax Finally Turning Things Around? - Novavax  ( NASDAQ:NVAX ) ,https://www.benzinga.com/news/earnings/23/05/32422604/is-novavax-finally-turning-things-around,2023-05-16 20:47:22,"Vaccine developer Novavax Inc. NVAX stock shot up 28% following its Q1 2023 earnings report. The company specializes in vaccines for infectious diseases, including COVID-19, influenza, respiratory syncytial and Ebola. Its shares ran up to $331.68 on Feb. 9, 2021, on its COVID-19 vaccine, ...",JNJ,0.098659,0.088878,Neutral
FTC Suing To Stop Amgen's $27.8 Billion Purchase Of Horizon Therapeutics,https://www.forbes.com/sites/mollybohannon/2023/05/16/ftc-suing-to-stop-amgens-278-billion-purchase-of-horizon-therapeutics/,2023-05-16 16:21:41,The FTC is attempting to stop the sale out of fears it will give the company too much power over rare disease treatments.,JNJ,0.104683,0.07514,Neutral
UnitedHealth Group is an AI Stock That Isn't Beating Expectations - UnitedHealth Group  ( NYSE:UNH ) ,https://www.benzinga.com/news/earnings/23/05/32420786/unitedhealth-group-is-an-ai-stock-that-isnt-beating-expectations,2023-05-16 14:26:48,"UnitedHealth Group Inc. UNH is down 7.2% in 2023. The health maintenance organization ( HMO ) sector in general is lagging in the market. So, investors may simply be taking a pause on a stock that's climbed 100% over the last five years.",JNJ,0.172919,-0.077724,Neutral
Kenvue Has Gone Public: Should You Buy the Stock?,https://www.fool.com/investing/2023/05/16/kenvue-has-gone-public-should-you-buy-the-stock/,2023-05-16 13:38:57,Its business could be resistant to the effects of inflation.,JNJ,0.348103,0.049813,Neutral
Which Is the Better Forever Stock: Johnson & Johnson or UnitedHealth Group?,https://www.fool.com/investing/2023/05/16/which-is-the-better-forever-stock-johnson-johnson/,2023-05-16 13:10:00,Both stocks have built-in economic diversity and are solid long-term investments.,JNJ,0.453905,0.301486,Somewhat-Bullish
Is Trending Stock Johnson & Johnson  ( JNJ )  a Buy Now?,https://www.zacks.com/stock/news/2095715/is-trending-stock-johnson-johnson-jnj-a-buy-now,2023-05-16 13:00:11,"Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",JNJ,0.479385,0.142699,Neutral
Should You Invest in the Health Care Select Sector SPDR ETF  ( XLV ) ?,https://www.zacks.com/stock/news/2095596/should-you-invest-in-the-health-care-select-sector-spdr-etf-xlv,2023-05-16 10:20:07,Sector ETF report for ...,JNJ,0.125789,0.062237,Neutral
Aspergillosis Treatment Market is to reach USD 3569.72 Mn by 2029 at a growth rate of 5.4 percent over the forecast period,https://www.benzinga.com/pressreleases/23/05/g32416515/aspergillosis-treatment-market-is-to-reach-usd-3569-72-mn-by-2029-at-a-growth-rate-of-5-4-percent-,2023-05-16 10:16:55,"Pune, May 16, 2023 ( GLOBE NEWSWIRE ) -- Maximize Market Research, a global Healthcare market research firm has published a competitive intelligence and market research report on the ""Aspergillosis Treatment Market"". The Aspergillosis Treatment Market size was valued at USD 2470.30 Mn in 2022.",JNJ,0.031159,0.133497,Neutral
Major Shareholder Announcement - AIM international Mutual Funds,https://www.globenewswire.com/news-release/2023/05/16/2669724/0/en/Major-Shareholder-Announcement-AIM-international-Mutual-Funds.html,2023-05-16 09:32:00,ANNOUNCEMENT NO. ...,JNJ,0.288893,0.08505,Neutral
ONWARD Reports Q1 Business Update and Year-To-Date Highlights,https://www.globenewswire.com/news-release/2023/05/16/2669545/0/en/ONWARD-Reports-Q1-Business-Update-and-Year-To-Date-Highlights.html,2023-05-16 05:30:00,"EINDHOVEN, the Netherlands, May 16, 2023 ( GLOBE NEWSWIRE ) -- ONWARD Medical N.V. ( Euronext: ONWD ) , the medical technology company creating innovative therapies to restore movement, function, and independence in people with spinal cord injury ( SCI ) , today provided a first quarter 2023 ...",JNJ,0.026591,0.115531,Neutral
People used to fight over getting a COVID-19 vaccine. Now millions of doses are getting tossed in the trash because no one's using them.,https://www.businessinsider.com/johnson-and-johnson-vaccine-thrown-out-us-2023-5,2023-05-15 21:02:00,Johnson & Johnson Vaccine Doses Getting Thrown Out in the - Business Insider ...,JNJ,0.230235,-0.191105,Somewhat-Bearish
"3 Recession-Proof Stocks With Nice Dividends - Kimberly-Clark  ( NYSE:KMB ) , Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/news/23/05/32378094/3-recession-proof-stocks-with-nice-dividends,2023-05-15 13:41:19,Prices and interest rates are higher. American households are strapped for cash. But is the economy really headed into a recession? The Federal Reserve Bank of New York's latest U.S. Recession Probabilities model has the odds of the country entering a negative growth period at 68%.,JNJ,0.094576,0.107016,Neutral
Accumulus Synergy Announces the Appointment of New Leadership Team Members,https://www.benzinga.com/pressreleases/23/05/g32393385/accumulus-synergy-announces-the-appointment-of-new-leadership-team-members,2023-05-15 13:22:00,"BURLINGAME, Calif., May 15, 2023 ( GLOBE NEWSWIRE ) -- Accumulus Synergy ( ""Accumulus"" ) , a nonprofit trade association working to address the global need for digital transformation within the life sciences - health authority ecosystem, today announced the appointment of two new executive ...",JNJ,0.070517,0.292523,Somewhat-Bullish
Ray Dalio's Bridgewater fund dumped GameStop and AMC last quarter - while Jim Simons' RenTech bet on Tesla and Bed Bath & Beyond,https://markets.businessinsider.com/news/stocks/dalio-bridgewater-simons-rentech-gamestop-amc-tesla-bbby-meme-stocks-2023-5,2023-05-15 12:00:02,"Dalio's Bridgewater Sells GameStop, AMC. RenTech Buys Tesla ... - Markets Insider ...",JNJ,0.07157,0.146997,Neutral
Major shareholder announcement - Invesco Ltd.,https://www.globenewswire.com/news-release/2023/05/15/2668634/0/en/Major-shareholder-announcement-Invesco-Ltd.html,2023-05-15 11:20:00,ANNOUNCEMENT NO. ...,JNJ,0.306963,0.089308,Neutral
3 PIMCO Mutual Funds to Buy for Excellent Returns,https://www.zacks.com/stock/news/2095120/3-pimco-mutual-funds-to-buy-for-excellent-returns,2023-05-15 11:05:00,"Below, we share with you three top-ranked PIMCO mutual funds. Each has earned a Zacks Mutual Fund Rank #1.",JNJ,0.083541,0.054034,Neutral
Global Home Health Hub Market to Garner High Returns by 2029 - Brandessence Market Research,https://www.prnewswire.com/news-releases/global-home-health-hub-market-to-garner-high-returns-by-2029---brandessence-market-research-301824468.html,2023-05-15 10:48:00,Global Home Health Hub Market to Garner High Returns by 2029 ... PR ...,JNJ,0.019879,0.108575,Neutral
Size of Microalgae Market to Grow at 4.5% CAGR and Reach $4996.8 Million by 2027: Brandessence Market Research,https://www.prnewswire.com/news-releases/size-of-microalgae-market-to-grow-at-4-5-cagr-and-reach-4996-8-million-by-2027-brandessence-market-research-301824453.html,2023-05-15 10:35:00,Size of Microalgae Market to Grow at 4.5% CAGR and Reach ... PR ...,JNJ,0.022243,0.110124,Neutral
Digital Lending Market: How Digital Platforms are Democratizing Access to Finance | Brandessence Market Research,https://www.prnewswire.com/news-releases/digital-lending-market-how-digital-platforms-are-democratizing-access-to-finance--brandessence-market-research-301824432.html,2023-05-15 10:14:00,Digital Lending Market: How Digital Platforms are Democratizing ... PR ...,JNJ,0.019846,0.114533,Neutral
Some rural communities use opioid settlement funds to pay off debt instead of investing in addiction programs,https://www.cnn.com/2023/05/15/health/opioid-crisis-settlement-funds-kff-health-news-partner/index.html,2023-05-15 10:13:00,"Over the past two years, rural Greene County in northeastern Tennessee has collected more than $2.7 million from regional and national settlements with opioid manufacturers and distributors. But instead of helping people harmed by addiction, county officials are finding other ways to spend it.",JNJ,0.023349,-0.107571,Neutral
Global Acute Repetitive Seizures Market to Showcase Promising Growth says Brandessence Market Research,https://www.prnewswire.com/news-releases/global-acute-repetitive-seizures-market-to-showcase-promising-growth-says-brandessence-market-research-301824427.html,2023-05-15 10:06:00,Global Acute Repetitive Seizures Market to Showcase Promising ... PR ...,JNJ,0.018146,0.10739,Neutral
Report Forecasts Promising Future for Alzheimer's Disease Market with New Therapeutic Approaches | Brandessence Market Research,https://www.prnewswire.com/news-releases/report-forecasts-promising-future-for-alzheimers-disease-market-with-new-therapeutic-approaches--brandessence-market-research-301824407.html,2023-05-15 09:32:00,Report Forecasts Promising Future for Alzheimer's Disease Market ... PR ...,JNJ,0.03478,0.124339,Neutral
2 No-Brainer Healthcare Stocks to Buy Right Now,https://www.fool.com/investing/2023/05/13/2-no-brainer-healthcare-stocks-to-buy-right-now/,2023-05-13 12:55:00,Boring businesses can make for beautiful lifelong holdings -- these two stocks show us why.,JNJ,0.21156,0.151679,Somewhat-Bullish
Amazon sponsored 'small business week' in San Francisco and hosted a panel on how to start selling goods on its website,https://africa.businessinsider.com/retail/amazon-sponsored-small-business-week-in-san-francisco-and-hosted-a-panel-on-how-to/rrtqlqk,2023-05-13 09:36:29,Amazon sponsored 'small business week' in San Francisco and ... - Business Insider Africa ...,JNJ,0.105604,0.114543,Neutral
"Where to Invest $10,000 in a Bear Market",https://www.fool.com/investing/2023/05/13/where-to-invest-10000-in-a-bear-market/,2023-05-13 09:30:00,Cautious and aggressive investors both might find opportunities in a bear market.,JNJ,0.111747,0.20793,Somewhat-Bullish
Amazon sponsored 'small business week' in San Francisco and hosted a panel on how to start selling goods on its website,https://www.businessinsider.com/amazon-sponsored-san-franciscos-small-business-week-2023-5,2023-05-12 17:35:38,Amazon Sponsored San Francisco's Small Business Week. Really. - Business Insider ...,JNJ,0.07887,0.107615,Neutral
Promising Phase 1 Results: Protagonist Therapeutics and Janssen Biotech Unlock New Potential in Colitis and Inflammation Treatment - Protagonist Therapeutics  ( NASDAQ:PTGX ) ,https://www.benzinga.com/general/biotech/23/05/32367591/promising-phase-1-results-protagonist-therapeutics-and-janssen-biotech-unlock-new-potential-in-co,2023-05-12 17:14:30,"Protagonist Therapeutics PTGX reported data from its collaboration with Janssen Biotech Inc, a unit of Johnson & Johnson JNJ, on Phase 1 and preclinical studies of JNJ-2113 ( formerly PN-235 ) .",JNJ,0.89979,-0.39755,Bearish
Eli Lilly on track to close with a higher market cap than J&J for first time since 1997,https://www.marketwatch.com/story/eli-lilly-on-track-to-close-with-a-higher-market-cap-than-j-j-for-first-time-since-1997-a718df7f,2023-05-12 16:55:00,Eli Lilly's stock has benefited from positive data in trials of an obesity drug and a treatment for Alzheimer's disease.,JNJ,0.165598,0.0,Neutral
How Apple Pleased Investors,https://www.fool.com/investing/2023/05/12/how-apple-pleased-investors/,2023-05-12 16:43:00,We've got a lot of ground to cover as company earnings reports continue to flood in.,JNJ,0.012193,-0.033856,Neutral
"UM Announces New U.S. Leadership Across Growth, Strategy, Planning, Intelligence, Client Services and Operations",https://www.prnewswire.com/news-releases/um-announces-new-us-leadership-across-growth-strategy-planning-intelligence-client-services-and-operations-301823355.html,2023-05-12 14:11:00,"UM Announces New U.S. Leadership Across Growth, Strategy ... PR ...",JNJ,0.061949,0.225224,Somewhat-Bullish
"STERIS  ( STE )  Q4 Earnings Beat Estimates, Gross Margin Falls",https://www.zacks.com/stock/news/2094734/steris-ste-q4-earnings-beat-estimates-gross-margin-falls,2023-05-12 13:47:00,"Heading into fiscal 2024, STERIS (STE) expects many of its fiscal 2023 challenges to abate, including procedure volumes and supply chain constraints.",JNJ,0.187463,0.060027,Neutral
"BeiGene Goes For Global Growth With Sales And R&D Push - BeiGene  ( NASDAQ:BGNE ) , Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/23/05/32364362/beigene-goes-for-global-growth-with-sales-and-r-d-push,2023-05-12 13:23:14,BeiGene's revenue in the first quarter grew 56% while global sales of its core cancer drug doubled The company's sales costs are rising even faster than its R&D spending It ranks as China's market leader for innovative cancer drugs and is rapidly raising its global profile. But BeiGene Ltd.,JNJ,0.072655,0.107355,Neutral
Haemonetics  ( HAE )  Q4 Earnings and Revenues Top Estimates,https://www.zacks.com/stock/news/2094599/haemonetics-hae-q4-earnings-and-revenues-top-estimates,2023-05-12 12:32:00,"Amid a challenging economic environment, Haemonetics (HAE) delivers impressive fiscal fourth-quarter organic revenues, led by the stellar performance across the Plasma and Hospital business.",JNJ,0.157483,0.05317,Neutral
Should Vanguard High Dividend Yield ETF  ( VYM )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2094527/should-vanguard-high-dividend-yield-etf-vym-be-on-your-investing-radar,2023-05-12 10:20:09,Style Box ETF report for ...,JNJ,0.124809,0.068938,Neutral
3 Things About Intuitive Surgical That Smart Investors Know,https://www.fool.com/investing/2023/05/12/things-about-intuitive-surgical-smart-investors/,2023-05-12 09:50:00,Intuitive's business model makes it stand out in the medical device industry.,JNJ,0.060236,0.173506,Somewhat-Bullish
"TSLA, IONQ, NNOX, PTON, HEPA: Top 5 Trending Stocks - PacWest Banc  ( NASDAQ:PACW ) , Alphabet  ( NASDAQ:GOOG ) , Alphabet  ( NASDAQ:GOOGL ) , Tesla  ( NASDAQ:TSLA ) , Peloton Interactive  ( NASDAQ:PTON ) , Johnson & Johnson  ( NYSE:JNJ ) , IonQ  ( NYSE:IONQ ) , Nano X Imaging  ( NASDAQ:NNOX ) , Walt Disney  ( NYSE:DIS ) , Hepion Pharmaceuticals  ( NASDAQ:HEPA ) ",https://www.benzinga.com/markets/equities/23/05/32356575/tesla-ionq-nano-x-peloton-hepion-why-these-five-stocks-are-drawing-investors-attention-today,2023-05-12 01:22:42,"U.S. markets ended mixed on Thursday with the S&P 500 and the Dow Jones recording losses dragged by Walt Disney Co DIS and PacWest Bancorp PACW and the Nasdaq registering gains led by Alphabet Inc GOOG GOOGL. In another development, President Joe Biden and House Speaker Kevin McCarthy have ...",JNJ,0.377142,0.443115,Bullish
"With debt crisis looming, look to these names and sectors, Jim Cramer says",https://www.cnbc.com/2023/05/11/jim-cramer-with-debt-crisis-looming-look-to-these-names-and-sectors.html,2023-05-11 23:57:48,"""Be careful and use the parameters I've laid out,"" CNBC's Jim Cramer said.",JNJ,0.235823,0.16645,Somewhat-Bullish
The Surprising Reason Nanox Stock Jumped Again Today,https://www.fool.com/investing/2023/05/11/surprising-reason-nanox-nnox-stock-jumped-today/,2023-05-11 20:27:00,This $400 billion dollar company just increased its investment in Nanox by 62%.,JNJ,0.546745,0.573021,Bullish
RealTruck adds talent and expertise in key executive positions,https://www.prnewswire.com/news-releases/realtruck-adds-talent-and-expertise-in-key-executive-positions-301822580.html,2023-05-11 18:00:00,Manufacturer and online retailer continues to grow leadership team under CEO Lindahl's tenure,JNJ,0.071784,0.067361,Neutral
3 Healthcare Stocks to Buy and Hold for the Next 10 Years,https://www.fool.com/investing/2023/05/11/3-stocks-to-buy-and-hold-for-the-next-10-years/,2023-05-11 18:00:00,These stocks may help your portfolio thrive over time.,JNJ,0.104002,0.235613,Somewhat-Bullish
"Alcon  ( ALC )  Q1 Earnings Surpass Estimates, 23' EPS View Up",https://www.zacks.com/stock/news/2094384/alcon-alc-q1-earnings-surpass-estimates-23-eps-view-up,2023-05-11 16:40:00,Alcon (ALC) Q1 revenues were driven by strong consumables and equipment sales.,JNJ,0.176502,0.058966,Neutral
Here's Why You Should Retain Walgreens Boots  ( WBA )  For Now,https://www.zacks.com/stock/news/2094383/heres-why-you-should-retain-walgreens-boots-wba-for-now,2023-05-11 16:37:00,Investors are optimistic about Walgreens Boots (WBA) on consistent partnership growth and a strong focus on strategic execution.,JNJ,0.199447,0.064556,Neutral
"Charles River  ( CRL )  Q1 Earnings Top Estimates, View Narrowed",https://www.zacks.com/stock/news/2094318/charles-river-crl-q1-earnings-top-estimates-view-narrowed,2023-05-11 15:42:00,"Charles River (CRL) registers robust growth in small research models, research model services and the Cell Solutions business.",JNJ,0.17813,0.057831,Neutral
"NuVasive  ( NUVA )  Q1 Earnings Beat Estimates, Margins Fall",https://www.zacks.com/stock/news/2094294/nuvasive-nuva-q1-earnings-beat-estimates-margins-fall,2023-05-11 15:26:00,NuVasive's (NUVA) strong sales across the U.S. Spinal Hardware and U.S. Surgical Support businesses instill optimism.,JNJ,0.185662,0.0596,Neutral
Saucony and Galen College of Nursing Launch the First-Ever NIL Student Nurse Initiative in Recognition of National Student Nurse Day - Wolverine World Wide  ( NYSE:WWW ) ,https://www.benzinga.com/pressreleases/23/05/n32344138/saucony-and-galen-college-of-nursing-launch-the-first-ever-nil-student-nurse-initiative-in-recogni,2023-05-11 15:00:00,"Partnership Aims to Recognize, Support and Celebrate Critical Next Generation of Nurses",JNJ,0.03786,0.157825,Somewhat-Bullish
2 Warren Buffett Stocks to Buy Hand Over Fist in May,https://www.fool.com/investing/2023/05/11/2-warren-buffett-stocks-to-buy-hand-over-fist-in-m/,2023-05-11 13:45:00,These two Berkshire Hathaway holdings are solid picks in May.,JNJ,0.136113,0.259305,Somewhat-Bullish
"Syneos Health  ( SYNH )  Tops Q1 Earnings, Announces Merger Plan",https://www.zacks.com/stock/news/2094120/syneos-health-synh-tops-q1-earnings-announces-merger-plan,2023-05-11 13:19:00,Syneos Health's (SYNH) first-quarter 2023 earnings and revenues beat estimates. The company enters into a definitive merger agreement to be acquired by a private investment consortium.,JNJ,0.186738,0.059855,Neutral
Baldwin & Obenauf Named to Inc's Best Workplaces of 2023,https://www.prnewswire.com/news-releases/baldwin--obenauf-named-to-incs-best-workplaces-of-2023-301821701.html,2023-05-11 12:54:00,"SOMERVILLE, N.J., May 11, 2023 /PRNewswire/ -- Creative agency Baldwin & Obenauf, Inc. ( BNO ) today announced that the company has been named to Inc's annual Best Workplaces list. With over 40 years in business, BNO also earned special recognition in the Enduring Impact category.",JNJ,0.058615,0.213015,Somewhat-Bullish
"Cancer Immunotherapy Market to reach USD 261.7 Bn in 2031, expanding at a CAGR of 13.6%: TMR Report",https://www.benzinga.com/pressreleases/23/05/g32335317/cancer-immunotherapy-market-to-reach-usd-261-7-bn-in-2031-expanding-at-a-cagr-of-13-6-tmr-report,2023-05-11 10:30:00,"Wilmington, Delaware, United States, May 11, 2023 ( GLOBE NEWSWIRE ) -- The global cancer immunotherapy market is projected to flourish at a CAGR of 13.6% from 2022 to 2031. As per the report published by TMR, the global cancer immunotherapy market is expected to exceed a value of US$ 261.7 ...",JNJ,0.043186,0.089004,Neutral
Should You Invest in the Vanguard Health Care ETF  ( VHT ) ?,https://www.zacks.com/stock/news/2093950/should-you-invest-in-the-vanguard-health-care-etf-vht,2023-05-11 10:20:06,Sector ETF report for ...,JNJ,0.136888,0.072135,Neutral
Johnson & Johnson  ( JNJ )  Stock Moves 0.01%: What You Should Know,https://www.zacks.com/stock/news/2101628/johnson-johnson-jnj-stock-moves-001-what-you-should-know,2023-05-30 21:45:17,"In the latest trading session, Johnson & Johnson (JNJ) closed at $154.37, marking a +0.01% move from the previous day.",JNJ,0.617188,0.330766,Somewhat-Bullish
Johnson & Johnson Unusual Options Activity - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/05/32633618/johnson-johnson-unusual-options-activity,2023-05-30 19:46:46,"A whale with a lot of money to spend has taken a noticeably bearish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson JNJ we detected 14 strange trades. If we consider the specifics of each trade, it is accurate to state that 35% of the investors opened trades with ...",JNJ,0.696319,0.056816,Neutral
Nvidia Becomes Ninth Company To Hit $1 Trillion Market Cap - Who Could Be Next To Join Elusive Club? - NVIDIA  ( NASDAQ:NVDA ) ,https://www.benzinga.com/news/23/05/32630114/nvidia-becomes-ninth-company-to-hit-1-trillion-market-cap-who-could-be-next-to-join-elusive-club,2023-05-30 18:20:11,A surge in price for shares of Nvidia Corporation NVDA after the company's quarterly earnings results and guidance has put the semiconductor company in the elusive $1 trillion market capitalization club. Here's a look at the past and current members of the club and who could be next to join.,JNJ,0.042271,0.220918,Somewhat-Bullish
Kenvue's Growth Forecast: Exploring The Future Of Johnson & Johnson's Carve-Out - Kenvue  ( NYSE:KVUE ) ,https://www.benzinga.com/analyst-ratings/analyst-color/23/05/32630411/kenvues-growth-forecast-exploring-the-future-of-johnson-johnsons-carve-out,2023-05-30 17:57:27,"RBC Capital Markets analyst Nik Modi initiated coverage on Kenvue Inc KVUE with an Outperform rating and a price target of $29. Kenvue is Johnson & Johnson's JNJ consumer-healthcare business carve-out, which debuted on the U.S. stock exchange earlier this month.",JNJ,0.301315,0.506045,Bullish
"Ruling clears way for Purdue Pharma to settle opioid claims, protect Sacklers from lawsuits",https://apnews.com/article/opioid-crisis-purdue-settlement-bankruptcy-sackler-9d1f39c52d8d0f4f0c79960d930a5b84,2023-05-30 14:42:40,"Ruling clears way for Purdue Pharma to settle opioid claims, protect ... The Associated Press ...",JNJ,0.054483,-0.031,Neutral
Ceramedix Joins Johnson & Johnson Innovation - JLABS as a Resident Company,https://www.benzinga.com/pressreleases/23/05/n32622393/ceramedix-joins-johnson-johnson-innovation-jlabs-as-a-resident-company,2023-05-30 12:17:00,"NEW YORK, May 30, 2023 /PRNewswire/ -- Ceramedix, Inc., a privately-held biotherapeutics company developing a new class of antibody-based drugs designed with the aim to address novel disease targets involving the microvasculature, today announced it has joined Johnson & Johnson Innovation - ...",JNJ,0.294682,0.310661,Somewhat-Bullish
Ceramedix Joins Johnson & Johnson Innovation - JLABS as a Resident Company,https://www.prnewswire.com/news-releases/ceramedix-joins-johnson--johnson-innovation--jlabs-as-a-resident-company-301836181.html,2023-05-30 12:17:00,Ceramedix Joins Johnson & Johnson Innovation - JLABS as a ... PR ...,JNJ,0.210274,0.225926,Somewhat-Bullish
Here's Why You Should Retain Integra  ( IART )  Stock Now,https://www.zacks.com/stock/news/2101232/heres-why-you-should-retain-integra-iart-stock-now,2023-05-30 12:07:00,Investors continue to be optimistic about Integra Lifesciences (IART) based on the prospect of its CSS segment and ample liquidity to support M&A strategies.,JNJ,0.044885,0.047625,Neutral
Should iShares Core High Dividend ETF  ( HDV )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2101184/should-ishares-core-high-dividend-etf-hdv-be-on-your-investing-radar,2023-05-30 10:20:06,Style Box ETF report for ...,JNJ,0.123526,0.068619,Neutral
"The Zacks Analyst Blog Highlights InMode, Johnson & Johnson, Intuitive Surgical and GE HealthCare",https://www.zacks.com/stock/news/2101176/the-zacks-analyst-blog-highlights-inmode-johnson-johnson-intuitive-surgical-and-ge-healthcare,2023-05-30 10:15:00,"InMode, Johnson & Johnson, Intuitive Surgical and GE HealthCare are included in this Analyst Blog.",JNJ,0.40375,0.274014,Somewhat-Bullish
Idorsia announces a change to commercial leadership,https://www.globenewswire.com/news-release/2023/05/30/2677964/0/en/Idorsia-announces-a-change-to-commercial-leadership.html,2023-05-30 05:00:00,Ad hoc announcement pursuant to Art. 53 LR ...,JNJ,0.058615,0.030025,Neutral
Pain Relief Therapeutics Market to Grow Significantly by 2029- Brandessence Market Research,https://www.prnewswire.com/news-releases/pain-relief-therapeutics-market-to-grow-significantly-by-2029--brandessence-market-research-301836608.html,2023-05-29 15:15:00,Pain Relief Therapeutics Market to Grow Significantly by 2029 ... PR ...,JNJ,0.046953,0.122326,Neutral
Intraocular Lens  ( IOL )  Market to Grow Phenomenally by 2029- Brandessence Market Research,https://www.prnewswire.com/news-releases/intraocular-lens-iol-market-to-grow-phenomenally-by-2029--brandessence-market-research-301836613.html,2023-05-29 15:00:00,Intraocular Lens ( IOL ) Market to Grow Phenomenally by 2029 ... PR ...,JNJ,0.044801,0.135743,Neutral
Coronary Stents Market to Witness Phenomenal Gains by 2029- Brandessence Market Research,https://www.prnewswire.com/news-releases/coronary-stents-market-to-witness-phenomenal-gains-by-2029--brandessence-market-research-301836605.html,2023-05-29 14:45:00,Coronary Stents Market to Witness Phenomenal Gains by 2029 ... PR ...,JNJ,0.020615,0.121535,Neutral
Arthroscopy Market to Showcase Remarkable Growth by 2029- Brandessence Market Research,https://www.prnewswire.com/news-releases/arthroscopy-market-to-showcase-remarkable-growth-by-2029--brandessence-market-research-301836603.html,2023-05-29 14:30:00,Arthroscopy Market to Showcase Remarkable Growth by 2029 ... PR ...,JNJ,0.042085,0.122174,Neutral
Here is What to Know Beyond Why Johnson & Johnson  ( JNJ )  is a Trending Stock,https://www.zacks.com/stock/news/2100815/here-is-what-to-know-beyond-why-johnson-johnson-jnj-is-a-trending-stock,2023-05-29 13:00:11,"Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",JNJ,0.482078,0.107154,Neutral
How - and Why - to Give to Your Grandkids,https://www.kiplinger.com/personal-finance/family-savings/how-and-why-to-give-to-your-grandkids,2023-05-29 11:00:58,"Over the next couple of decades, Americans - mostly aging Baby Boomers and Gen Xers - are expected to pass along about $73 trillion in wealth to their heirs. They will give another $12 trillion to charity.",JNJ,0.016738,-0.119947,Neutral
Lung Cancer Therapies Market to Amplify Significantly over 2022-2029 - Brandessence Market Research,https://www.prnewswire.com/news-releases/lung-cancer-therapies-market-to-amplify-significantly-over-2022-2029---brandessence-market-research-301836472.html,2023-05-29 10:26:00,Lung Cancer Therapies Market to Amplify Significantly over 2022 ... PR ...,JNJ,0.070656,0.127303,Neutral
Is WisdomTree U.S. Quality Dividend Growth ETF  ( DGRW )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2100737/is-wisdomtree-us-quality-dividend-growth-etf-dgrw-a-strong-etf-right-now,2023-05-29 10:20:08,Smart Beta ETF report for ...,JNJ,0.114137,0.066424,Neutral
US Default Looks To Be Avoided At Eleventh Hour - Here's What Investors Should Know,https://www.forbes.com/sites/qai/2023/05/29/us-default-looks-to-be-avoided-at-eleventh-hourheres-what-investors-should-know/,2023-05-29 09:00:36,"All in all, the atmosphere of uncertainty and this close call on the U.S. default have many investors wondering how to shore up their portfolios.",JNJ,0.109956,-0.035525,Neutral
Want to Grow Richer? These Stocks Have Doubled in the Past 5 Years,https://www.fool.com/investing/2023/05/28/want-to-grow-richer-these-stocks-have-doubled-in-5/,2023-05-28 13:15:00,These two pharmaceutical companies have created value for shareholders.,JNJ,0.147366,0.116756,Neutral
Buy the Dip On These Warren Buffett Stocks,https://www.fool.com/investing/2023/05/28/buy-the-dip-on-these-warren-buffett-stocks/,2023-05-28 09:30:00,You'll want to follow Buffett's lead and hold on to these stocks forever.,JNJ,0.204072,0.191842,Somewhat-Bullish
US-China relations continue to thaw as trade officials meet in Detroit,https://www.scmp.com/news/china/diplomacy/article/3222006/us-china-relations-continue-thaw-meeting-between-trade-officials-detroit,2023-05-26 19:18:43,Chinese Commerce Minister Wang Wentao and US Trade Representative Katherine Tai hold talks on the margin of the Asia-Pacific Economic Cooperation session.,JNJ,0.061473,0.067003,Neutral
Cummins spinoff Atmus Filtration's stock soars 14% in trading debut,https://www.marketwatch.com/story/atmus-filtrations-stock-soars-14-in-trading-debut-d746dc8a,2023-05-26 18:28:00,"Atmus makes products for commercial vehicles and agriculture, construction, mining and power-generation vehicles and equipment.",JNJ,0.194242,0.058835,Neutral
Bristol Myers  ( BMY )  Thrombosis Drug Gets Fast Track Designation,https://www.zacks.com/stock/news/2100517/bristol-myers-bmy-thrombosis-drug-gets-fast-track-designation,2023-05-26 16:32:00,"Bristol Myers (BMY) obtains Fast Track Designation from the FDA for milvexian, which is being developed in collaboration with Johnson and Johnson's Janssen.",JNJ,0.123526,-0.029656,Neutral
Cummins' filtration unit valued at $1.8 billion in strong market debut,https://www.reuters.com/markets/deals/cummins-filtration-unit-valued-18-billion-strong-market-debut-2023-05-26/,2023-05-26 16:03:00,"May 26 ( Reuters ) - Atmus Filtration Technologies Inc ( ATMU.N ) , the filtration solutions business of U.S. diesel engine maker Cummins Inc ( CMI.N ) , fetched a valuation of $1.8 billion in a strong market debut on Friday.",JNJ,0.185306,0.0,Neutral
Want Passive Income Forever? Buy These 2 Magnificent Stocks Now,https://www.fool.com/investing/2023/05/26/want-passive-income-forever-buy-these-magnificent/,2023-05-26 13:53:00,You can take these companies' dividends straight to the bank.,JNJ,0.314151,0.213914,Somewhat-Bullish
Solid Earnings Fuel Potential Bull Market in Medical Devices,https://www.zacks.com/stock/news/2100240/solid-earnings-fuel-potential-bull-market-in-medical-devices,2023-05-26 13:51:00,"CNBC's Jim Cramer predicts a booming bull market for medical devices, with positive earnings reports across the space. INMD, JNJ, ISRG and GEHC can emerge as potential winners.",JNJ,0.384608,0.31924,Somewhat-Bullish
A Challenger to J&J's Top Blockbuster Is on the Way. Here's What You Need to Know.,https://www.fool.com/investing/2023/05/26/a-challenger-to-jjs-top-blockbuster-is-on-the-way/,2023-05-26 09:30:00,Biotech-giant Amgen aims to launch a rival.,JNJ,0.110717,0.0,Neutral
Cummins braving debt ceiling jitters with $275M engine filter unit IPO,https://www.foxbusiness.com/markets/cummins-braving-debt-ceiling-jitters-275m-engine-filter-unit-ipo,2023-05-26 06:30:23,"Diesel engine maker Cummins is going to buck the recent initial public offering draught and bring its engine filtration unit to market on Friday. Cummings priced the IPO of its unit to raise about $275 million on Thursday, defying volatile markets which are being shaken by uncertainty over a deal ...",JNJ,0.146025,0.0,Neutral
"Hair Products Market to grow at a CAGR of 4.12% between 2022 and 2027, Growing demand for natural and organic hair products expected to be a primary trend -Technavio",https://www.prnewswire.com/news-releases/hair-products-market-to-grow-at-a-cagr-of-4-12-between-2022-and-2027--growing-demand-for-natural-and-organic-hair-products-expected-to-be-a-primary-trend--technavio-301834376.html,2023-05-26 05:15:00,Hair Products Market to grow at a CAGR of 4.12% between 2022 ... PR ...,JNJ,0.055492,0.096014,Neutral
"Value Stocks Hit 15-Month Low Against Growth As AI Fuels Tech's Vengeance Over 2022's Rate-Hike-Induced Market Fall - iShares Core S&P U.S. Growth ETF  ( NASDAQ:IUSG ) , iShares Core S&P U.S. Value ETF  ( NASDAQ:IUSV ) ",https://www.benzinga.com/news/large-cap/23/05/32583715/value-stocks-hit-15-month-low-against-growth-as-ai-fuels-techs-vengeance-over-2022s-rate-hike-indu,2023-05-25 21:18:09,"Value stocks fell to a seven-month low in relation to growth stocks, already lagging by more than 20% year to date on the heels of an AI-related rally propelling equities in the technology sector.",JNJ,0.178459,-0.075643,Neutral
Alkermes Files Definitive Proxy Statement and Issues Letter to Shareholders Detailing Business Execution That Has Driven Strong Performance and Delivered Shareholder Value,https://www.prnewswire.com/news-releases/alkermes-files-definitive-proxy-statement-and-issues-letter-to-shareholders-detailing-business-execution-that-has-driven-strong-performance-and-delivered-shareholder-value-301835124.html,2023-05-25 20:15:00,Alkermes Files Definitive Proxy Statement and Issues Letter to ... PR ...,JNJ,0.008968,0.110344,Neutral
Alkermes Files Definitive Proxy Statement and Issues Letter to Shareholders Detailing Business Execution That Has Driven Strong Performance and Delivered Shareholder Value - Alkermes  ( NASDAQ:ALKS ) ,https://www.benzinga.com/pressreleases/23/05/n32584139/alkermes-files-definitive-proxy-statement-and-issues-letter-to-shareholders-detailing-business-exe,2023-05-25 20:15:00,"Company Has Outperformed Peers and Relevant Indices Since Unveiling its December 2020 Value Enhancement Plan 70% of Board's Independent Directors Have Been Appointed Over the Last Four Years, Including Four Directors Designated or Supported by Shareholders",JNJ,0.008935,0.110316,Neutral
Worried About a Recession? Stash Your Cash in These 2 ETFs.,https://www.fool.com/investing/2023/05/25/worried-about-a-recession-stash-your-cash-in-these/,2023-05-25 12:45:00,"Rather than holding your cash, consider investing it in these stable ETFs.",JNJ,0.067347,0.033053,Neutral
Agios Appoints Catherine Owen to Board of Directors,https://www.globenewswire.com/news-release/2023/05/25/2675968/31990/en/Agios-Appoints-Catherine-Owen-to-Board-of-Directors.html,2023-05-25 11:00:00,- John Maraganore Completes Tenure on Agios Board After Nearly a Dozen Years of Service ...,JNJ,0.028868,0.141476,Neutral
Agios Appoints Catherine Owen to Board of Directors - Agios Pharmaceuticals  ( NASDAQ:AGIO ) ,https://www.benzinga.com/pressreleases/23/05/g32569894/agios-appoints-catherine-owen-to-board-of-directors,2023-05-25 11:00:00,"- John Maraganore Completes Tenure on Agios Board After Nearly a Dozen Years of Service - - Kaye Foster to Be Appointed Lead Independent Director - CAMBRIDGE, Mass., May 25, 2023 ( GLOBE NEWSWIRE ) -- Agios Pharmaceuticals, Inc.",JNJ,0.027958,0.138966,Neutral
Adverum Biotechnologies Announces New Executive Leadership Roles,https://www.globenewswire.com/news-release/2023/05/25/2675941/32452/en/Adverum-Biotechnologies-Announces-New-Executive-Leadership-Roles.html,2023-05-25 10:30:00,"- Richard Beckman, M.D., chief medical officer, transitions to senior medical advisor ...",JNJ,0.02692,0.043135,Neutral
Adverum Biotechnologies Announces New Executive Leadership Roles - Adverum Biotechnologies  ( NASDAQ:ADVM ) ,https://www.benzinga.com/pressreleases/23/05/g32569208/adverum-biotechnologies-announces-new-executive-leadership-roles,2023-05-25 10:30:00,"- Richard Beckman, M.D., chief medical officer, transitions to senior medical advisor - - Star Seyedkazemi, Pharm.D., chief development officer, expands her responsibilities to lead Adverum's clinical development, medical affairs and pharmacovigilance teams -",JNJ,0.025596,0.04281,Neutral
Is Vanguard High Dividend Yield ETF  ( VYM )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2099432/is-vanguard-high-dividend-yield-etf-vym-a-strong-etf-right-now,2023-05-25 10:20:08,Smart Beta ETF report for ...,JNJ,0.116348,0.06132,Neutral
"Boyu, Hillhouse, others vie for HK-based medical device firm Quasar -sources",https://www.reuters.com/markets/deals/boyu-hillhouse-others-vie-hk-based-medical-device-firm-quasar-sources-2023-05-25/,2023-05-25 03:56:03,"Boyu, Hillhouse, others vie for HK-based medical device firm Quasar ... ...",JNJ,0.111488,0.068056,Neutral
Johnson & Johnson  ( JNJ )  Stock Moves -0.1%: What You Should Know,https://www.zacks.com/stock/news/2099322/johnson-johnson-jnj-stock-moves--01-what-you-should-know,2023-05-24 21:45:08,"Johnson & Johnson (JNJ) closed the most recent trading day at $156.66, moving -0.1% from the previous trading session.",JNJ,0.658245,0.242794,Somewhat-Bullish
"Boston Scientific  ( BSX )  Gains From Acquisitions, New Launches",https://www.zacks.com/stock/news/2099237/boston-scientific-bsx-gains-from-acquisitions-new-launches,2023-05-24 16:38:00,Boston Scientific (BSX) remains excited about 2023 performance and expects to continue to outpace its peers within the EMEA market.,JNJ,0.056143,0.061901,Neutral
Check Out What Whales Are Doing With JNJ - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/05/32554353/check-out-what-whales-are-doing-with-jnj,2023-05-24 15:02:47,"Someone with a lot of money to spend has taken a bullish stance on Johnson & Johnson JNJ. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",JNJ,0.723441,0.353392,Bullish
Hemostasis Diagnostics Market to Grow Significantly by 2029- Brandessence Market Research,https://www.prnewswire.com/news-releases/hemostasis-diagnostics-market-to-grow-significantly-by-2029--brandessence-market-research-301833482.html,2023-05-24 14:20:00,Hemostasis Diagnostics Market to Grow Significantly by 2029 ... PR ...,JNJ,0.019474,0.103792,Neutral
"Wall Street's Most Accurate Analysts Say Buy These 3 Health Care Stocks With Over 3% Dividend Yields - CVS Health  ( NYSE:CVS ) , AbbVie  ( NYSE:ABBV ) ",https://www.benzinga.com/trading-ideas/long-ideas/23/05/32550121/wall-streets-most-accurate-analysts-say-buy-these-3-health-care-stocks-with-over-3-divid,2023-05-24 12:35:38,"During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.",JNJ,0.09402,-0.087733,Neutral
"New Data Out Of Cleveland Clinic Shows BioSig PURE EP May Be Used For More Precise Approach For $6 Billion Annual Atrial Fibrillation Market - Abbott Laboratories  ( NYSE:ABT ) , AtriCure  ( NASDAQ:ATRC ) ",https://www.benzinga.com/general/biotech/23/05/32548741/new-data-out-of-cleveland-clinic-shows-biosig-pure-ep-may-be-used-for-more-precise-approach-for-6,2023-05-24 12:00:52,"Cleveland Clinic researchers presented data from three new studies involving BioSig Technologies' BSGM proprietary PURE EP Platform at the annual Heart Rhythm 2023 meeting in New Orleans, LA last week.",JNJ,0.101154,0.103909,Neutral
"The daily business briefing: May 24, 2023",https://theweek.com/briefing/business-briefing/1023762/the-daily-business-briefing-may-24-2023,2023-05-24 11:16:32,Kevin McCarthy and President Biden have yet to reach a deal on raising the debt limit Jabin Botsford/The Washington Post via Getty Images House Speaker Kevin McCarthy ( R ) left the Capitol late Tuesday without a deal to raise the debt ceiling and avert an unprecedented default.,JNJ,0.059341,-0.08316,Neutral
"10 things you need to know today: May 24, 2023",https://theweek.com/briefing/daily-briefing/1023761/10-things-you-need-to-know-today-may-24-2023,2023-05-24 10:57:18,A judge scheduled Trump's trial on criminal charges for March 2024 A Manhattan judge on Tuesday scheduled a March 2024 trial for former President Donald Trump on criminal charges of falsifying business records to hide hush money payments to cover up alleged extramarital affairs during his 2016 ...,JNJ,0.031322,-0.065359,Neutral
Medtronic Stock: Bull vs. Bear,https://www.fool.com/investing/2023/05/24/medtronic-stock-bull-vs-bear/,2023-05-24 09:53:00,This medical device giant has its positives and negatives.,JNJ,0.063933,-0.154186,Somewhat-Bearish
Better Buy: Medtronic vs. Johnson & Johnson,https://www.fool.com/investing/2023/05/24/better-buy-medtronic-vs-johnson-johnson/,2023-05-24 09:30:00,Both companies are medical device leaders.,JNJ,0.16171,0.236908,Somewhat-Bullish
Beijing moves to limit collateral damage from Micron sales ban,https://www.scmp.com/tech/big-tech/article/3221571/tech-war-beijing-moves-limit-collateral-damage-micron-sales-ban-muted-reaction-consumers,2023-05-24 00:00:21,"China's foreign ministry, the commerce ministry and tabloid Global Times have all described the Micron ban as an individual case, and not a signal that other US firms may be in jeopardy.",JNJ,0.059636,0.1,Neutral
Microsoft bonds are seen as safer than Treasury bills due this summer as the default X-date nears,https://markets.businessinsider.com/news/bonds/microsoft-jnj-corporate-bonds-safe-haven-treasury-debt-default-ceiling-2023-5,2023-05-23 19:58:00,Microsoft Bonds Are Seen As Safer Than Treasurys As Default X ... - Markets Insider ...,JNJ,0.205807,0.200412,Somewhat-Bullish
Amgen settles patent lawsuit over biosimilar of J&J's big-selling Stelara,https://www.reuters.com/business/healthcare-pharmaceuticals/amgen-settles-jj-patent-lawsuit-over-drug-similar-blockbuster-stelara-2023-05-23/,2023-05-23 15:35:00,Amgen settles patent lawsuit over biosimilar of J&J's big-selling ... ...,JNJ,0.18967,-0.078613,Neutral
Buying These 2 Stocks Is a Good Way to Hedge Against a Market Crash,https://www.fool.com/investing/2023/05/23/buying-these-2-stocks-is-a-good-way-to-hedge-again/,2023-05-23 14:07:00,Both companies have produced consistent revenue growth and predictable profitability.,JNJ,0.350564,0.113499,Neutral
"Star Equity Fund Launches Proxy Solicitation at Servotronics - Servotronics  ( AMEX:SVT ) , Star Equity Hldgs  ( NASDAQ:STRR ) ",https://www.benzinga.com/pressreleases/23/05/g32527808/star-equity-fund-launches-proxy-solicitation-at-servotronics,2023-05-23 12:30:23,Urges All Shareholders to Vote the WHITE Proxy Card Today to Elect Mark Pomeroy and Rick Coleman to SVT'S Board at Upcoming Annual Meeting,JNJ,0.030563,0.067076,Neutral
"Medical device companies are in an 'emerging bull market,' Jim Cramer says",https://www.cnbc.com/2023/05/22/medical-device-companies-are-in-an-emerging-bull-market-jim-cramer-says.html,2023-05-22 23:13:40,"CNBC's Jim Cramer touted the burgeoning bull market of medical devices, which is taking off post Covid.",JNJ,0.146469,0.389319,Bullish
JNJ: Johnson & Johnson  ( JNJ )  and SNDL Inc.  ( SNDL )  -- Buy or Sell?,https://stocknews.com/news/jnj-sndl-johnson-johnson-jnj-and-sndl-inc-sndl-buy/,2023-05-22 19:08:30,"Although healthcare stocks could help hedge some market risks, not all stocks are worth owning. While Johnson & Johnson ( JNJ ) could be an ideal buy, fundamentally weak SNDL Inc. ( SNDL ) might be best avoided.",JNJ,0.544495,0.225766,Somewhat-Bullish
RUBICON BAKERS HIRE SEB SIETHOFF AS CEO,https://www.prnewswire.com/news-releases/rubicon-bakers-hire-seb-siethoff-as-ceo-301829852.html,2023-05-22 16:00:00,"RICHMOND, Calif., May 22, 2023 /PRNewswire/ -- Rubicon Bakers ( ""Rubicon"" or the ""Company"" ) is pleased to announce the hiring of Sebastian ""Seb"" Siethoff as Chief Executive Officer. Mr. Siethoff comes to Rubicon from Ball Corporation where he served as General Manager.",JNJ,0.084423,0.062411,Neutral
Sports Medicine Market to Grow Exponentially by 2029- Brandessence Market Research,https://www.prnewswire.com/news-releases/sports-medicine-market-to-grow-exponentially-by-2029--brandessence-market-research-301830920.html,2023-05-22 14:42:00,Sports Medicine Market to Grow Exponentially by 2029 ... PR ...,JNJ,0.019978,0.107246,Neutral
"US-China Relations To Improve ""Very Shortly"", Examining The Micron ""Ban"", Full Truck & Kuaishou Beat",https://www.forbes.com/sites/brendanahern/2023/05/22/us-china-relations-to-improve-very-shortly-examining-the-micron-ban-full-truck--kuaishou-beat/,2023-05-22 14:16:25,Asian equities had a strong start to the week as Hong Kong outperformed the region.,JNJ,0.049322,0.050443,Neutral
Should You Invest in the iShares U.S. Pharmaceuticals ETF  ( IHE ) ?,https://www.zacks.com/stock/news/2097784/should-you-invest-in-the-ishares-us-pharmaceuticals-etf-ihe,2023-05-22 10:20:06,Sector ETF report for ...,JNJ,0.13347,0.061665,Neutral
"ACCENTURE, BIC TO LEAD AFRICA'S MOST INSPIRATIONAL WOMEN IN LEADERSHIP AT 2023 AFRICA BREAK THE CEILING TOUCH THE SKYÂ® SUMMIT.",https://www.prnewswire.com/news-releases/accenture-bic-to-lead-africas-most-inspirational-women-in-leadership-at-2023-africa-break-the-ceiling-touch-the-sky-summit-301830566.html,2023-05-22 08:45:00,"ACCENTURE, BIC TO LEAD AFRICA'S MOST INSPIRATIONAL ... PR ...",JNJ,0.08687,0.022644,Neutral
"Got $1,000? 5 Buffett Stocks to Buy and Hold Forever",https://www.fool.com/investing/2023/05/21/got-1000-5-buffett-stocks-to-buy-and-hold-forever/,2023-05-21 10:04:00,"Warren Buffett owns many stocks, but these five have solid growth potential.",JNJ,0.204359,0.123881,Neutral
"Global Contact Lenses Marketplace 2023-2028: Soft Contact Lenses Continue to Dominate, Silicone Hydrogel  ( SiHy )  Lenses Projected to Increase in Popularity",https://www.prnewswire.com/news-releases/global-contact-lenses-marketplace-2023-2028-soft-contact-lenses-continue-to-dominate-silicone-hydrogel-sihy-lenses-projected-to-increase-in-popularity-301847074.html,2023-06-09 18:45:00,Global Contact Lenses Marketplace 2023-2028: Soft Contact ... PR ...,JNJ,0.146618,0.054653,Neutral
"[2023-2028] Transdermal Medical Patch Market Size to Hit $10.79 Billion, Globally by 2028 - Exclusive Report by The Insight Partners",https://www.benzinga.com/pressreleases/23/06/g32796568/2023-2028-transdermal-medical-patch-market-size-to-hit-10-79-billion-globally-by-2028-exclusive-re,2023-06-09 14:32:00,"Pune, India, June 09, 2023 ( GLOBE NEWSWIRE ) -- According to our latest study on ""Transdermal Medical Patch Market Size Report, Forecast to 2028 - COVID-19 Impact and Global Analysis - by Type, Application, and Distribution Channel,"" the market is projected to reach USD 10.79 billion by 2028 ...",JNJ,0.027763,0.06777,Neutral
Investors Heavily Search Johnson & Johnson  ( JNJ ) : Here is What You Need to Know,https://www.zacks.com/stock/news/2106294/investors-heavily-search-johnson-johnson-jnj-here-is-what-you-need-to-know,2023-06-09 13:00:12,"Recently, Zacks.com users have been paying close attention to Johnson & Johnson (JNJ). This makes it worthwhile to examine what the stock has in store.",JNJ,0.475838,0.130066,Neutral
Is Emergent BioSolutions Stock a Buy Now?,https://www.fool.com/investing/2023/06/09/is-emergent-biosolutions-stock-a-buy-now/,2023-06-09 12:20:00,"The deluge of bad news seems to be over, and a recovery could be in the works.",JNJ,0.061315,0.0,Neutral
"Retailers are gamifying shopping with virtual storefronts to boost engagement, loyalty",https://www.cnbc.com/2023/06/09/j-crew-launches-virtual-beach-house-storefront-for-40th-anniversary.html,2023-06-09 12:00:01,J. Crew and a string of other retailers are turning to gamified shopping in virtual storefronts to boost engagement and customer loyalty.,JNJ,0.036587,0.0,Neutral
JNJ: 3 Medical Stock Picks for Investors,https://stocknews.com/news/jnj-azn-alpmy-isee-3-medical-stock-picks-for-investors/,2023-06-08 16:52:42,"Regardless of the economy, the healthcare industry has proven to be resilient because of the inelastic demand for its products and services, thereby making it a great long-term choice.",JNJ,0.167156,0.15011,Somewhat-Bullish
Alkermes Publishes Investor Presentation Detailing Company's Transformation and Value Creation,https://www.prnewswire.com/news-releases/alkermes-publishes-investor-presentation-detailing-companys-transformation-and-value-creation-301846055.html,2023-06-08 11:00:00,Alkermes Publishes Investor Presentation Detailing Company's ... PR ...,JNJ,0.021778,0.322255,Somewhat-Bullish
Johnson & Johnson Unusual Options Activity - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/06/32768555/johnson-johnson-unusual-options-activity,2023-06-07 20:46:32,"A whale with a lot of money to spend has taken a noticeably bearish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson JNJ we detected 10 strange trades. If we consider the specifics of each trade, it is accurate to state that 40% of the investors opened trades with ...",JNJ,0.73856,0.046521,Neutral
"Alkermes  ( ALKS )  Gets Final Award in Janssen Arbitration, Ups View",https://www.zacks.com/stock/news/2105317/alkermes-alks-gets-final-award-in-janssen-arbitration-ups-view,2023-06-07 16:31:00,Alkermes (ALKS) receives final award in arbitration proceedings with partner Janssen. It also raises its financial outlook for 2023.,JNJ,0.144708,0.151781,Somewhat-Bullish
"Hand-held Surgical Instruments Market Size is projected to reach USD 9.62 billion by 2030, growing at a CAGR of 7.26%: Straits Research",https://www.benzinga.com/pressreleases/23/06/g32761711/hand-held-surgical-instruments-market-size-is-projected-to-reach-usd-9-62-billion-by-2030-growing-,2023-06-07 15:30:00,"New York, United States, June 07, 2023 ( GLOBE NEWSWIRE ) -- The medical equipment that is utilized to carry out a variety of surgeries is hand-held surgical tools. The hand-held surgical tools are mainly utilized for minimally invasive procedures, such as precise incisions and post-operative ...",JNJ,0.035983,0.102449,Neutral
"Entera Bio Adds Sanofi Commercial Leader, Haya Taitel to its Board of Directors",https://www.globenewswire.com/news-release/2023/06/07/2683653/0/en/Entera-Bio-Adds-Sanofi-Commercial-Leader-Haya-Taitel-to-its-Board-of-Directors.html,2023-06-07 11:30:00,"JERUSALEM, June 07, 2023 ( GLOBE NEWSWIRE ) -- Entera Bio Ltd. ( NASDAQ: ENTX ) , ( ""Entera"" or the ""Company"" ) a leader in the development of orally delivered peptides and therapeutic proteins, today announced that it has appointed Haya Taitel, Head of Sanofi's Global Transplant Franchise as an ...",JNJ,0.031282,0.06713,Neutral
Is iShares Core High Dividend ETF  ( HDV )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2104844/is-ishares-core-high-dividend-etf-hdv-a-strong-etf-right-now,2023-06-07 10:20:06,Smart Beta ETF report for ...,JNJ,0.113062,0.059546,Neutral
3 No-Brainer Stocks to Buy With $300 Right Now,https://www.fool.com/investing/2023/06/07/3-no-brainer-stocks-to-buy-with-300-right-now/,2023-06-07 09:21:00,A reasonably small amount of money can go a long way when it's invested in industry-leading businesses.,JNJ,0.166551,0.08574,Neutral
Alkermes Raises FY23 Outlook Following Arbitration Award from Janssen Agreements - Alkermes  ( NASDAQ:ALKS ) ,https://www.benzinga.com/general/biotech/23/06/32741779/alkermes-raises-fy23-outlook-following-arbitration-award-from-janssen-agreements,2023-06-06 17:50:47,"Alkermes plc ALKS increased its FY23 outlook by $425 million to reflect a final award the company received from arbitration proceedings related to two licensing agreements with Janssen Pharmaceutica N.V., a subsidiary of Johnson & Johnson JNJ.",JNJ,0.310843,0.41996,Bullish
Missed Out On Intuitive Surgical's Boom? This Stock May Be a Better Buy Now,https://www.fool.com/investing/2023/06/06/missed-out-on-intuitive-surgicals-boom-this-stock/,2023-06-06 11:00:00,Alphatec's strong revenue growth makes it worth watching.,JNJ,0.055236,0.054864,Neutral
Alkermes Announces Final Award in Janssen Pharmaceutica Arbitration and Provides Updated Financial Expectations,https://www.prnewswire.com/news-releases/alkermes-announces-final-award-in-janssen-pharmaceutica-arbitration-and-provides-updated-financial-expectations-301843004.html,2023-06-06 10:00:00,Alkermes Announces Final Award in Janssen Pharmaceutica ... PR ...,JNJ,0.032916,0.07977,Neutral
Johnson & Johnson  ( JNJ )  Gains As Market Dips: What You Should Know,https://www.zacks.com/stock/news/2104081/johnson-johnson-jnj-gains-as-market-dips-what-you-should-know,2023-06-05 21:45:23,"Johnson & Johnson (JNJ) closed at $158.32 in the latest trading session, marking a +0.86% move from the prior day.",JNJ,0.639942,0.200958,Somewhat-Bullish
BlackRock CEO slammed for 'force behaviors' comment after 2017 interview re-emerges about DEI initiatives,https://www.foxbusiness.com/politics/blackrock-ceo-slammed-force-behaviors-dei-initiatives,2023-06-05 19:19:30,"Larry Fink, CEO of investment firm BlackRock, is facing backlash over a 2017 comment admitting his company would ""force behaviors"" on inclusion efforts, amid a rise in pushback against companies making environmental, social and corporate governance ( ESG ) investments on behalf of everyday ...",JNJ,0.073098,0.087191,Neutral
Biotech stocks could soon get a M&A boost. Here are 3 likely takeover plays.,https://www.marketwatch.com/story/biotech-stocks-could-soon-get-a-m-a-boost-here-are-3-likely-takeover-plays-206b79c3,2023-06-05 19:05:00,Big pharma will be looking to acquire companies with promsing new medicines.,JNJ,0.097193,0.061044,Neutral
Microsoft-backed Rubrik hires banks for IPO -sources,https://www.reuters.com/markets/deals/microsoft-backed-rubrik-hires-banks-ipo-sources-2023-06-05/,2023-06-05 17:30:33,Microsoft-backed Rubrik hires banks for ...,JNJ,0.066784,0.063104,Neutral
Johnson & Johnson Unusual Options Activity - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/06/32719656/johnson-johnson-unusual-options-activity,2023-06-05 16:16:33,"Someone with a lot of money to spend has taken a bearish stance on Johnson & Johnson JNJ. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",JNJ,0.77688,0.28762,Somewhat-Bullish
BDA Secures Gold Sustainability Rating from EcoVadis,https://www.prnewswire.com/news-releases/bda-secures-gold-sustainability-rating-from-ecovadis-301841644.html,2023-06-05 13:00:00,Award Places BDA in Top 6 Percent of All Companies Vetted Worldwide,JNJ,0.194763,0.312857,Somewhat-Bullish
2 Dividend Kings Down 12% and 14% You'll Regret Not Buying on The Dip,https://www.fool.com/investing/2023/06/04/2-dividend-kings-down-youll-regret-not-buying/,2023-06-04 14:15:00,Recent troubles won't stop these companies' long-term trajectories.,JNJ,0.308891,0.112808,Neutral
New Long-Term Data from the CHRYSALIS Study Show Median Progression-Free Survival Not Reached after 33.6 Months of Follow-Up with First-Line Use of RYBREVANTÂ®  ( amivantamab-vmjw )  and Lazertinib Combination Therapy in Patients with Treatment-NaÃ¯ve EGFR-Mutated Advanced Non-Small Cell Lung Cancer,https://www.prnewswire.com/news-releases/new-long-term-data-from-the-chrysalis-study-show-median-progression-free-survival-not-reached-after-33-6-months-of-follow-up-with-first-line-use-of-rybrevant-amivantamab-vmjw-and-lazertinib-combination-therapy-in-patients-with--301841867.html,2023-06-04 13:14:00,New Long-Term Data from the CHRYSALIS Study Show Median ... PR ...,JNJ,0.067919,0.011136,Neutral
1 Ultra-Elite Dividend Stock to Buy Hand Over Fist in June,https://www.fool.com/investing/2023/06/04/1-ultra-elite-dividend-stock-to-buy-hand-over-fist/,2023-06-04 11:36:00,The company offers a super-safe dividend with a compelling upside catalyst.,JNJ,0.640349,0.472761,Bullish
2 Warren Buffett Stocks to Buy in June and Hold Forever,https://www.fool.com/investing/2023/06/04/2-warren-buffett-stocks-to-buy-in-june-and-hold-fo/,2023-06-04 10:43:00,These time-tested businesses produce reliable cash flows that they're committed to sharing with investors.,JNJ,0.11983,0.137111,Neutral
Janssen Presents Longer-Term Talquetamab Follow-Up Data Showing Overall Response Rates of More Than 70 Percent in Heavily Pretreated Patients with Multiple Myeloma,https://www.prnewswire.com/news-releases/janssen-presents-longer-term-talquetamab-follow-up-data-showing-overall-response-rates-of-more-than-70-percent-in-heavily-pretreated-patients-with-multiple-myeloma-301841822.html,2023-06-03 19:28:00,Janssen Presents Longer-Term Talquetamab Follow-Up Data ... PR ...,JNJ,0.060562,0.013065,Neutral
Janssen Presents First-Ever Results from Dual Bispecific Combination Study Showing 96 Percent Overall Response Rate in Patients with Relapsed or Refractory Multiple Myeloma,https://www.prnewswire.com/news-releases/janssen-presents-first-ever-results-from-dual-bispecific-combination-study-showing-96-percent-overall-response-rate-in-patients-with-relapsed-or-refractory-multiple-myeloma-301841813.html,2023-06-03 18:15:00,Janssen Presents First-Ever Results from Dual Bispecific ... PR ...,JNJ,0.082963,0.028183,Neutral
Janssen Presents First-Ever Results from Dual Bispecific Combination Study Showing 96 Percent Overall Response Rate in Patients with Relapsed or Refractory Multiple Myeloma,https://markets.businessinsider.com/news/stocks/janssen-presents-first-ever-results-from-dual-bispecific-combination-study-showing-96-percent-overall-response-rate-in-patients-with-relapsed-or-refractory-multiple-myeloma-1032368689,2023-06-03 18:15:00,"CHICAGO, June 3, 2023 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the first-ever results from the Phase 1b RedirecTT-1 study of TECVAYLIÂ® ( teclistamab-cqyv ) , a first-in-class BCMAxCD3 bispecific antibody, and talquetamab, a first-in-class ...",JNJ,0.052512,0.069949,Neutral
The Little-Known Secret to Beating the S&P 500,https://www.fool.com/investing/2023/06/03/the-little-known-secret-to-beating-the-sp-500/,2023-06-03 14:45:00,The data on dividends is indisputable.,JNJ,0.286193,0.437641,Bullish
Where Will Veeva Systems Stock Be in 1 Year?,https://www.fool.com/investing/2023/06/03/where-will-veeva-systems-stock-be-in-1-year/,2023-06-03 11:55:00,The cloud software company's near-term headwinds are dissipating.,JNJ,0.059194,0.147159,Neutral
Two Dow Stocks to Buy in June and Hold for the Next Decade,https://www.fool.com/investing/2023/06/03/two-dow-stocks-to-buy-in-june-and-hold-for-the-nex/,2023-06-03 09:19:00,These two stocks look like the best options among the Dow Jones Industrial Average's 30 components right now.,JNJ,0.128822,0.122801,Neutral
Autoinjectors Global Market Report 2023: Increasing Prevalence of Chronic Disease Drives Growth,https://www.prnewswire.com/news-releases/autoinjectors-global-market-report-2023-increasing-prevalence-of-chronic-disease-drives-growth-301841281.html,2023-06-03 01:00:00,Autoinjectors Global Market Report 2023: Increasing Prevalence of ... PR ...,JNJ,0.03853,0.12297,Neutral
Buy These 3 Top-Ranked ETFs and Never Sell,https://www.zacks.com/commentary/2103447/buy-these-3-top-ranked-etfs-and-never-sell,2023-06-02 20:45:00,"ETFs provide instant diversification by pooling together a basket of securities across various sectors, industries, or asset classes ...",JNJ,0.078482,0.064853,Neutral
LAVA  ( LVTX )  Up on J&J's  ( JNJ )  Cancer Study Candidate Selection,https://www.zacks.com/stock/news/2103223/lava-lvtx-up-on-jjs-jnj-cancer-study-candidate-selection,2023-06-02 14:59:00,LAVA's (LVTX) shares soar as partner J&J (JNJ) selects a lead candidate for development in clinical studies for cancer.,JNJ,0.204072,-0.006601,Neutral
These 5 Dividend ETFs Are a Retiree's Best Friend,https://www.fool.com/investing/2023/06/02/dividend-etf-retiree-best-friend-vym-jepi/,2023-06-02 12:46:50,These dividend-producing ETFs earn their keep in different ways.,JNJ,0.067536,0.197796,Somewhat-Bullish
3 High-Quality Dividend Stocks Yielding 3% to Buy in June,https://www.fool.com/investing/2023/06/02/3-high-quality-dividend-stocks-yielding-3-to-buy-i/,2023-06-02 12:32:00,These companies offer above-average and steadily rising payouts.,JNJ,0.309539,0.334388,Somewhat-Bullish
Illumina's Board of Directors elects two experienced Independent Directors to Board,https://www.prnewswire.com/news-releases/illuminas-board-of-directors-elects-two-experienced-independent-directors-to-board-301841153.html,2023-06-02 11:30:00,Illumina's Board of Directors elects two experienced Independent ... PR ...,JNJ,0.046363,0.034351,Neutral
Should iShares Russell 1000 Value ETF  ( IWD )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2102949/should-ishares-russell-1000-value-etf-iwd-be-on-your-investing-radar,2023-06-02 10:20:10,Style Box ETF report for ...,JNJ,0.126119,-0.02254,Neutral
Should Schwab U.S. Large-Cap Value ETF  ( SCHV )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2102950/should-schwab-us-large-cap-value-etf-schv-be-on-your-investing-radar,2023-06-02 10:20:09,Style Box ETF report for ...,JNJ,0.12013,-0.025579,Neutral
"Mix Talent Launches Contract Talent Organization Solution, Mix CTO",https://www.prnewswire.com/news-releases/mix-talent-launches-contract-talent-organization-solution-mix-cto-301840598.html,2023-06-01 19:08:00,The life sciences talent leader has assembled a team of industry veterans to provide greater flexibility through their new contract talent solutions.,JNJ,0.060541,0.082,Neutral
"Biotech Stock Roundup: MRTX Falls on Study Failure, LXRX Drug Wins Approval & More",https://www.zacks.com/stock/news/2102778/biotech-stock-roundup-mrtx-falls-on-study-failure-lxrx-drug-wins-approval-more,2023-06-01 15:35:00,Regulatory and pipeline updates from Mirati (MRTX) and Lexicon (LXRX) are in focus in the biotech sector.,JNJ,0.049424,0.044633,Neutral
5 Large Drug Stocks to Watch From a Thriving Industry,https://www.zacks.com/commentary/2101789/5-large-drug-stocks-to-watch-from-a-thriving-industry,2023-05-31 13:42:00,"Drug/biotech companies are likely to see significant advances in innovation in 2023. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), J&J (JNJ), Novo Nordisk (NVO), Roche (RHHBY) and Novartis (NVS) are worth retaining in your portfolio.",JNJ,0.051663,0.170943,Somewhat-Bullish
Next AI winners are not your usual suspects,https://www.foxbusiness.com/markets/next-ai-winners-not-usual-suspects,2023-05-31 12:03:07,The rapid rise of technologies is driving movement in financial markets and some companies that stand to benefit from it may not be the traditional tech names that typically come up in AI discussions.,JNJ,0.063425,0.083038,Neutral
Should You Invest in the Fidelity MSCI Health Care Index ETF  ( FHLC ) ?,https://www.zacks.com/stock/news/2101734/should-you-invest-in-the-fidelity-msci-health-care-index-etf-fhlc,2023-05-31 10:20:08,Sector ETF report for ...,JNJ,0.128135,0.051111,Neutral
Best Of: Inside Johnson & Johnson's bankruptcy two-step,https://www.ft.com/content/aae0a7f0-ad08-437d-adba-3fa883b5be66,2023-05-31 04:09:56,"This is an audio transcript of the Behind the Money podcast episode: 'Best Of: Inside Johnson & Johnson's bankruptcy two-step' Hey, everyone. Just to note that we're taking a break this week. So instead, today we're resharing one of our episodes. Now be sure to stick around till the end.",JNJ,0.155007,-0.035439,Neutral
Best Of: Inside Johnson & Johnson's bankruptcy two-step,https://www.ft.com/content/08388420-cf6d-47e1-bd22-7a2b1504aa89,2023-05-31 04:00:00,"This week, we're revisiting an episode from last year.",JNJ,0.295867,-0.211099,Somewhat-Bearish
Big Pharma Vs. Washington - An Opportunity To Buy Merck & Co.  ( MRK ) ,https://www.forbes.com/sites/johnbuckingham/2023/06/19/big-pharma-vs-washingtonan-opportunity-to-buy-merck--co-mrk/,2023-06-19 23:34:34,"Warren Buffett states, ""Uncertainty is the friend of the buyer of long-term values,"" and Washington represents a big question mark these days for the pharma sector.",JNJ,0.051886,0.033,Neutral
"Spine Biologics Market to Surpass USD 3.5 billion in 2033, expected to expand at a 4.2% CAGR: TMR Report",https://www.benzinga.com/pressreleases/23/06/g32913860/spine-biologics-market-to-surpass-usd-3-5-billion-in-2033-expected-to-expand-at-a-4-2-cagr-tmr-rep,2023-06-19 16:30:00,"Wilmington, Delaware, United States, June 19, 2023 ( GLOBE NEWSWIRE ) -- The global spine biologics market is anticipated to be valued at US$ 3.5 billion by 2031, expected to incline at a CAGR of 4.2% from 2023 to 2031.",JNJ,0.037622,0.0,Neutral
"Got $1,000? 3 Elite Dividend Stocks to Buy Right Now",https://www.fool.com/investing/2023/06/18/got-1000-3-elite-dividend-stocks-to-buy-right-now/,2023-06-18 14:15:00,These stocks can turn idle cash into a growing dividend income stream.,JNJ,0.348919,0.266259,Somewhat-Bullish
Is a New Bull Market Around the Corner? Here's What to Do Next,https://www.fool.com/investing/2023/06/18/is-a-new-bull-market-around-the-corner-heres-what/,2023-06-18 09:45:00,Many top growth stocks have climbed so far this year.,JNJ,0.061631,0.302089,Somewhat-Bullish
"For groups fighting U.S. opioid crisis, settlement money can be hard to come by",https://www.reuters.com/business/healthcare-pharmaceuticals/groups-fighting-us-opioid-crisis-settlement-money-can-be-hard-come-by-2023-06-17/,2023-06-17 11:12:00,"[1/5] Cataldo Ambulance medics and other first responders revive a 32-year-old man who was found unresponsive and not breathing after an opioid overdose on a sidewalk in the Boston suburb of Everett, Massachusetts, U.S., August 23, 2017. REUTERS/Brian Snyder/File Photo",JNJ,0.053212,0.046943,Neutral
3 Bargain Stocks to Buy on the Dip,https://www.fool.com/investing/2023/06/17/3-bargain-stocks-to-buy-on-the-dip/,2023-06-17 10:10:00,These stocks should be poised to rebound.,JNJ,0.086713,0.233732,Somewhat-Bullish
"FATE THERAPEUTICS INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Fate Therapeutics, Inc. - FATE - Fate Therapeutics  ( NASDAQ:FATE ) ",https://www.benzinga.com/pressreleases/23/06/g32904263/fate-therapeutics-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc,2023-06-17 02:50:00,"NEW ORLEANS, June 16, 2023 ( GLOBE NEWSWIRE ) -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ( ""KSF"" ) , announces that KSF has commenced an investigation into Fate Therapeutics, Inc. FATE.",JNJ,0.097457,0.043196,Neutral
Why Shares of Fate Therapeutics Soared This Week,https://www.fool.com/investing/2023/06/16/why-shares-of-fate-therapeutics-soared-this-week/,2023-06-16 19:53:25,The company's shares bounced back after a stock sale last week.,JNJ,0.185306,0.0,Neutral
Mersana  ( MRSN )  Down on Partial Ovarian Cancer Study Hold,https://www.zacks.com/stock/news/2109488/mersana-mrsn-down-on-partial-ovarian-cancer-study-hold,2023-06-16 14:43:00,Mersana's (MRSN) shares decline on partial clinical hold by the FDA on UP-NEXT and UPGRADE-A studies evaluating upifitamab rilsodotin to treat platinum-sensitive ovarian cancer.,JNJ,0.143415,0.043922,Neutral
2 Growth Stocks to Buy and Hold for 10 Years,https://www.fool.com/investing/2023/06/16/2-growth-stocks-to-buy-and-hold-for-10-years/,2023-06-16 13:53:00,Both companies are benefiting from industries with a bright future.,JNJ,0.053153,0.211952,Somewhat-Bullish
"Immix Biopharma Subsidiary Nexcella Appoints Mary Sue Coleman, former Johnson & Johnson Independent Director, to Board of Directors",https://www.globenewswire.com/news-release/2023/06/16/2689773/0/en/Immix-Biopharma-Subsidiary-Nexcella-Appoints-Mary-Sue-Coleman-former-Johnson-Johnson-Independent-Director-to-Board-of-Directors.html,2023-06-16 13:43:00,"â€¢ Dr. Coleman joins the Nexcella, Inc. Board of Directors with over a decade of experience as an Independent Director of Johnson & Johnson from 2003-2016 â€¢ Dr. Coleman is President Emerita of the University of Michigan where she was named one of ""10 Best College Presidents"" by TIME Magazine and ...",JNJ,0.107615,0.107901,Neutral
Cross-Sector Comparison: Is Caterpillar Stock A Better Pick Over J&J?,https://www.forbes.com/sites/greatspeculations/2023/06/16/cross-sector-comparison-is-caterpillar-stock-a-better-pick-over-jj/,2023-06-16 12:00:00,"Although these companies are from different sectors, we compare them because they have a similar P/EBIT ratio of 15x-17x.",JNJ,0.294289,0.254836,Somewhat-Bullish
AbbVie's  ( ABBV )  Skyrizi Meets Ulcerative Colitis Study Goals,https://www.zacks.com/stock/news/2109293/abbvies-abbv-skyrizi-meets-ulcerative-colitis-study-goals,2023-06-16 11:45:00,AbbVie's (ABBV) Skyrizi achieves statistical significance with its primary endpoint of clinical remission in a late-stage study as a maintenance treatment for ulcerative colitis.,JNJ,0.104683,0.072563,Neutral
Does Cava's Massive IPO Suggest a Shifting Landscape?,https://www.thedailyupside.com/does-cavas-massive-ipo-suggest-a-shifting-landscape/,2023-06-16 00:07:19,"It's an oasis in the desert, a sanctuary for restless capital. It's a -- two words -- vibe shift. Amid a dismal year for the IPO market,...",JNJ,0.078354,0.039694,Neutral
"Eye Care Surgical Devices Market Expected to Hit US$ 10.7 Billion by 2031, Growing at 5.5% CAGR, TMR Study",https://www.benzinga.com/pressreleases/23/06/g32883720/eye-care-surgical-devices-market-expected-to-hit-us-10-7-billion-by-2031-growing-at-5-5-cagr-tmr-s,2023-06-15 20:30:00,"Wilmington, Delaware, United States, June 16, 2023 ( GLOBE NEWSWIRE ) -- The global eye care surgical devices market stood at US$ 6.1 billion in 2021, and the global market is projected to reach US$ 10.7 billion by 2031. The global industry is anticipated to expand at a CAGR of 5.5% between 2022 ...",JNJ,0.0378,0.180949,Somewhat-Bullish
Beyond AirÂ® Licenses Commercial Rights to Selective Neuronal Nitric Oxide Synthase  ( nNOS )  Inhibitors for the Treatment of Autism Spectrum Disorder from Hebrew University of Jerusalem,https://www.globenewswire.com/news-release/2023/06/15/2689366/0/en/Beyond-Air-Licenses-Commercial-Rights-to-Selective-Neuronal-Nitric-Oxide-Synthase-nNOS-Inhibitors-for-the-Treatment-of-Autism-Spectrum-Disorder-from-Hebrew-University-of-Jerusalem.html,2023-06-15 20:05:00,"Hebrew University's preclinical results recently published in Advanced Science show a reversal of the molecular, synaptic and behavioral autism spectrum disorder ( ASD ) phenotypes ...",JNJ,0.017716,0.105684,Neutral
Beyond AirÂ® Licenses Commercial Rights to Selective Neuronal Nitric Oxide Synthase  ( nNOS )  Inhibitors for the Treatment of Autism Spectrum Disorder from Hebrew University of Jerusalem - Beyond Air  ( NASDAQ:XAIR ) ,https://www.benzinga.com/pressreleases/23/06/g32882839/beyond-air-licenses-commercial-rights-to-selective-neuronal-nitric-oxide-synthase-nnos-inhibitors-,2023-06-15 20:05:00,"Hebrew University's preclinical results recently published in Advanced Science show a reversal of the molecular, synaptic and behavioral autism spectrum disorder ( ASD ) phenotypes Plan to initiate a first-in-human clinical trial of nNOS for treatment of ASD in 2025",JNJ,0.017471,0.10551,Neutral
"Sports Medicine Devices Market Size, Share, Revenue, Trends And Drivers For 2023-2032 As Per The Business Research Company's Sports Medicine Devices Global Market Report 2023",https://www.benzinga.com/pressreleases/23/06/g32878178/sports-medicine-devices-market-size-share-revenue-trends-and-drivers-for-2023-2032-as-per-the-busi,2023-06-15 15:50:00,"LONDON, June 15, 2023 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Sports Medicine Devices Market Report 2023, the market will grow from $6.8 billion in 2022 to $7.4 billion in 2023, at a compound annual growth rate ( CAGR ) of more than 8%.",JNJ,0.054857,0.0,Neutral
AbbVie Says BeiGene's Flagship Blood Cancer Drug Infringes Imbruvica Patent - BeiGene  ( NASDAQ:BGNE ) ,https://www.benzinga.com/general/biotech/23/06/32875595/abbvie-says-beigenes-flagship-blood-cancer-drug-infringes-imbruvica-patent,2023-06-15 15:20:54,"BeiGene Ltd BGNE says it is aware that Pharmacyclics LLC has filed a complaint alleging that BeiGene's blood cancer therapy Brukinsa ( zanubrutinib ) infringes a Pharmacyclics patent issued on June 13, 2023. Pharmacyclics is an AbbVie Inc ABBV company.",JNJ,0.348103,0.0,Neutral
"NVIDIA, Johnson & Johnson And 2 Other Stocks Insiders Are Selling - Johnson & Johnson  ( NYSE:JNJ ) , Robinhood Markets  ( NASDAQ:HOOD ) ",https://www.benzinga.com/news/23/06/32872021/nvidia-johnson-johnson-and-2-other-stocks-insiders-are-selling,2023-06-15 12:21:10,"The S&P 500 closed slightly higher on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it indicates their concern in the company's prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to go short on ...",JNJ,0.415927,0.019702,Neutral
Anaemia Drugs Market to Grow Exponentially by 2029 Says Brandessence Market Research,https://www.prnewswire.com/news-releases/anaemia-drugs-market-to-grow-exponentially-by-2029-says-brandessence-market-research-301851868.html,2023-06-15 10:22:00,"LONDON, June 15, 2023 /PRNewswire/ -- Anaemia is a disorder occurrence by the deficiency of red blood cells or decreasing amount of haemoglobin in the blood. It often leads to extreme weakness, fatigue, pale skin and irregular heartbeat, among others.",JNJ,0.028626,0.100156,Neutral
One Change Could Help U.S. Drugmakers Save 11 Million Trees a Year,https://www.wsj.com/articles/one-change-could-help-u-s-drugmakers-save-11-million-trees-a-year-74c077f2,2023-06-15 09:30:00,Paper and pharmaceutical lobbies are clashing over rules to digitize drug information leaflets which ensure up-to-date information while also cutting emissions and waste.,JNJ,0.04161,0.144907,Neutral
"If I Had $1,000 to Invest Between Amazon, Johnson & Johnson, and Tesla Stocks, Here's How I'd Do It",https://www.fool.com/investing/2023/06/15/if-i-had-1000-to-invest-between-amazon-johnson-joh/,2023-06-15 09:30:00,These top stocks could deliver both in the near term and over time.,JNJ,0.100518,0.109663,Neutral
"ETC Announces Appointment of Timothy Kennedy, CPA, CMA as Chief Financial Officer - Environmental Tectonics  ( OTC:ETCC ) ",https://www.benzinga.com/pressreleases/23/06/g32863751/etc-announces-appointment-of-timothy-kennedy-cpa-cma-as-chief-financial-officer,2023-06-14 20:15:39,"SOUTHAMPTON, Pa., June 14, 2023 ( GLOBE NEWSWIRE ) -- Environmental Tectonics Corporation ETCC ( ""ETC"" or the ""Company"" ) today announces the appointment of Timothy Kennedy, CPA, CMA as the Company's Chief Financial Officer and Treasurer, effective today.",JNJ,0.116914,0.036803,Neutral
"ETC Announces Appointment of Timothy Kennedy, CPA, CMA as Chief Financial Officer",https://www.globenewswire.com/news-release/2023/06/14/2688469/0/en/ETC-Announces-Appointment-of-Timothy-Kennedy-CPA-CMA-as-Chief-Financial-Officer.html,2023-06-14 20:15:00,"SOUTHAMPTON, Pa., June 14, 2023 ( GLOBE NEWSWIRE ) -- Environmental Tectonics Corporation ( OTC Pink: ETCC ) ( ""ETC"" or the ""Company"" ) today announces the appointment of Timothy Kennedy, CPA, CMA as the Company's Chief Financial Officer and Treasurer, effective today.",JNJ,0.121037,0.03733,Neutral
Black Executive CMO Alliance Heightens the Urgency and Responsibility for Greater Diversity in Marketing at Cannes Lions International Festival of Creativity,https://www.benzinga.com/pressreleases/23/06/n32862178/black-executive-cmo-alliance-heightens-the-urgency-and-responsibility-for-greater-diversity-in-mar,2023-06-14 18:46:00,Top Black-marketing leaders to take the international stage and hold discussions with influentials like Spike Lee and Byron Allen to increase awareness of persistent diversity issues in the world's C-suites,JNJ,0.045224,0.152159,Somewhat-Bullish
"Constructor Named Best 'AI Solution' in Inaugural Convrt Awards, Celebrating Innovation in Retail",https://www.prnewswire.com/news-releases/constructor-named-best-ai-solution-in-inaugural-convrt-awards-celebrating-innovation-in-retail-301850981.html,2023-06-14 17:00:00,"Constructor's product search and discovery platform honored among 'the absolute best in today's retail and ecommerce innovation' for helping retailers increase engagement, loyalty and revenue",JNJ,0.042723,0.210186,Somewhat-Bullish
Alkermes To Spin-Off Mural Oncology In 2H23,https://www.forbes.com/sites/joecornell/2023/06/14/alkermes-to-spin-off-mural-oncology-in-2h23/,2023-06-14 15:11:02,"ALKS, $31.48, Market Capitalization: $5.2 billion), a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience ...",JNJ,0.024801,0.088816,Neutral
Jim Cramer's top 10 things to watch in the stock market Wednesday,https://www.cnbc.com/2023/06/14/jim-cramers-top-10-things-to-watch-in-the-stock-market-wednesday.html,2023-06-14 13:24:09,"The Dow, S&P 500 and Nasdaq are set for a relatively muted open as traders seem content to wait for the Fed.",JNJ,0.118064,0.024457,Neutral
We're adding to our position in this health insurer on an unwarranted pullback,https://www.cnbc.com/2023/06/14/were-adding-to-our-position-in-this-health-insurer-on-a-pullback.html,2023-06-14 13:18:12,Managed-care providers are nose-diving in early trading Wednesday.,JNJ,0.256538,0.206491,Somewhat-Bullish
"3 Contrarian Buys For 15% Yields, 300% Payout Growth As AI Takes Off",https://www.forbes.com/sites/brettowens/2023/06/14/3-contrarian-buys-for-15-yields-300-payout-growth-as-ai-takes-off/,2023-06-14 13:05:00,"All the ""basic"" investors out there are busy chasing this AI-driven rally. It's like the crypto and meme-stock messes of 2021 all over again!",JNJ,0.074001,0.159565,Somewhat-Bullish
BUSINESS LOCATION SWITZERLAND - A THRIVING HUB FOR HEALTH TECH,https://www.prnewswire.com/news-releases/business-location-switzerland--a-thriving-hub-for-health-tech-301850632.html,2023-06-14 12:00:00,"ZURICH, June 14, 2023 /PRNewswire/ -- Switzerland is home to a globally unique life science cluster.",JNJ,0.024648,0.127229,Neutral
Health Canada Authorizes AKEEGAâ„¢  ( niraparib and abiraterone acetate )  Dual Action Tablets for Targeted Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer  ( mCRPC )  with BRCA  ( 1/2 )  Gene Mutations,https://www.newswire.ca/news-releases/health-canada-authorizes-akeega-tm-niraparib-and-abiraterone-acetate-dual-action-tablets-for-targeted-treatment-of-patients-with-metastatic-castration-resistant-prostate-cancer-mcrpc-with-brca-1-2-gene-mutations-837132131.html,2023-06-14 12:00:00,Health Canada Authorizes AKEEGAâ„¢ ( niraparib and abiraterone acetate ) Dual Action Tablets for Targeted Treatment ... Canada ...,JNJ,0.107289,0.015844,Neutral
2 Unstoppable Warren Buffett Stocks That Can Turn Sitting Cash into Growing Wealth,https://www.fool.com/investing/2023/06/14/2-buffett-stocks-to-turn-cash-into-wealth/,2023-06-14 09:30:00,These stocks have rewarded Buffett and other long-term investors.,JNJ,0.180685,0.260549,Somewhat-Bullish
Nearing Retirement? These Stocks Will Pay You For Life,https://www.fool.com/investing/2023/06/14/nearing-retirement-stocks-will-pay-you-for-life/,2023-06-14 09:26:00,Every retired investor deserves passive income and peace of mind. These stocks will help achieve that.,JNJ,0.1437,0.187921,Somewhat-Bullish
Low-tax Switzerland votes on global minimum corporate tax rate,https://www.reuters.com/markets/europe/low-tax-switzerland-votes-global-minimum-corporate-tax-rate-2023-06-14/,2023-06-14 07:21:00,"[1/2] The snow-covered peaks of Bernese Oberland are seen behind Lake Zug and the city of Zug, Switzerland August 20, 2020. REUTERS/Arnd Wiegmann/File Photo",JNJ,0.064973,0.11916,Neutral
"LSI USA Emerging Medtech Summit Returns to Dana Point March 18, 2024",https://www.prnewswire.com/news-releases/lsi-usa-emerging-medtech-summit-returns-to-dana-point-march-18-2024-301849891.html,2023-06-13 17:57:00,"HUNTINGTON BEACH, Calif., June 13, 2023 /PRNewswire/ -- LSI, the company behind LSI Emerging Medtech Summits, the partnering events for global leaders building breakthrough healthcare businesses, today announced it will host its next USA Emerging Medtech Summit, LSI USA '24, on March 18 through ...",JNJ,0.074001,0.053388,Neutral
"The Weight-Loss Battle Has A New Contender; Why Novo, Lilly Still Dominate",https://www.investors.com/news/technology/merck-stock-the-battle-among-weight-loss-drugs-has-a-new-contender/,2023-06-13 16:05:00,"The Weight-Loss Battle Has A New Contender. Why Novo, Lilly Still ... Investor's Business Daily ...",JNJ,0.136499,-0.063589,Neutral
"Lactose-Free Dairy Market Size, Share, Revenue, Trends And Drivers For 2023-2032 As Per The Business Research Company's Lactose-Free Dairy Global Market Report 2023",https://www.benzinga.com/pressreleases/23/06/g32839677/lactose-free-dairy-market-size-share-revenue-trends-and-drivers-for-2023-2032-as-per-the-business-,2023-06-13 15:40:00,"LONDON, June 13, 2023 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Lactose-Free Dairy Market Report 2023, the market will grow from $10.9 billion in 2022 to $11.8 billion in 2023, at a compound annual growth rate ( CAGR ) of more than 8%.",JNJ,0.066047,0.074103,Neutral
3 High-Yielding Dividend Stocks That Can Help You Save For Retirement,https://www.fool.com/investing/2023/06/13/high-yielding-dividend-stocks-save-retirement/,2023-06-13 14:27:45,These are stable businesses that you can invest in for decades.,JNJ,0.310843,0.52754,Bullish
PFE: Should You Buy Into Pfizer  ( PFE )  Today?,https://stocknews.com/news/pfe-jnj-mrk-alpmy-should-you-buy-into-pfizer-pfe-today/,2023-06-13 13:57:17,"Pfizer Inc.'s ( PFE ) first-quarter results were in-line with the company's expectations, underlining its continued confidence in achieving 7% to 9% operational revenue growth for the fiscal year 2023.",JNJ,0.070002,0.006067,Neutral
5 Biotech Stocks to Buy as Industry Prospects for 2H23 Look Good,https://www.zacks.com/commentary/2107444/5-biotech-stocks-to-buy-as-industry-prospects-for-2h23-look-good,2023-06-13 13:30:00,"New drug approvals and pipeline progress are likely to help maintain momentum for the Zacks Biomedical and Genetics industry. A strong portfolio and a solid pipeline progress position PCVX, PTGX, LGND, MESO and PBYI well amid volatility.",JNJ,0.069495,0.228442,Somewhat-Bullish
Could Johnson & Johnson Stock Help You Become a Millionaire?,https://www.fool.com/investing/2023/06/13/could-johnson-johnson-stock-help-you-become-a-mill/,2023-06-13 12:42:00,"A fantastic dividend stock with promising opportunities ahead, is it also a no-brainer buy for growth-oriented investors?",JNJ,0.391486,0.235848,Somewhat-Bullish
"The Zacks Analyst Blog Highlights Johnson & Johnson, Oracle, HSBC, NVIDIA and The Cigna Group",https://www.zacks.com/stock/news/2107557/the-zacks-analyst-blog-highlights-johnson-johnson-oracle-hsbc-nvidia-and-the-cigna-group,2023-06-13 12:27:00,"Johnson & Johnson, Oracle, HSBC, NVIDIA and The Cigna Group are part of the Zacks top Analyst Blog.",JNJ,0.733479,0.0,Neutral
Virtualware's VIROO set to support Mixed Reality capabilities upon its new release,https://www.benzinga.com/pressreleases/23/06/g32832191/virtualwares-viroo-set-to-support-mixed-reality-capabilities-upon-its-new-release,2023-06-13 11:38:50,"BILBAO, Spain, June 13, 2023 ( GLOBE NEWSWIRE ) -- Spanish listed company Virtualware MLVIR, a global leader in immersive technology solutions, today announced its readiness to support mixed reality ( MR ) capabilities on its VIROO 2.4 release coming in July.",JNJ,0.103331,0.128897,Neutral
Virtualware's VIROO set to support Mixed Reality capabilities upon its new release,https://www.globenewswire.com/news-release/2023/06/13/2687037/0/en/Virtualware-s-VIROO-set-to-support-Mixed-Reality-capabilities-upon-its-new-release.html,2023-06-13 11:38:00,"BILBAO, Spain, June 13, 2023 ( GLOBE NEWSWIRE ) -- Spanish listed company Virtualware ( EPA:MLVIR ) , a global leader in immersive technology solutions, today announced its readiness to support mixed reality ( MR ) capabilities on its VIROO 2.4 release coming in July.",JNJ,0.107495,0.130525,Neutral
Why 3M's Aearo bankruptcy gambit failed,https://www.axios.com/2023/06/13/3m-aearo-bankruptcy-dismissed,2023-06-13 10:58:53,Why a bankruptcy court rejected 3M's Aearo gambit ...,JNJ,0.061003,-0.042158,Neutral
The stock market is in a bull market? What bull market?,https://www.marketwatch.com/story/the-stock-market-is-in-a-bull-market-what-bull-market-52b36828,2023-06-13 09:01:00,Most of the S&P 500 isn't in a bull market. Far from it.,JNJ,0.107495,0.01777,Neutral
Johnson & Johnson  ( JNJ )  Stock Sinks As Market Gains: What You Should Know,https://www.zacks.com/stock/news/2107272/johnson-johnson-jnj-stock-sinks-as-market-gains-what-you-should-know,2023-06-12 21:45:18,"Johnson & Johnson (JNJ) closed the most recent trading day at $159.90, moving -0.07% from the previous trading session.",JNJ,0.523451,0.272534,Somewhat-Bullish
"Top Research Reports for Johnson & Johnson, Oracle & HSBC",https://www.zacks.com/research-daily/2107095/top-research-reports-for-johnson-johnson-oracle-hsbc,2023-06-12 17:42:00,"Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), Oracle Corporation (ORCL) and HSBC Holdings plc (HSBC).",JNJ,0.240489,0.220514,Somewhat-Bullish
Where Will Intuitive Surgical Be in 10 Years?,https://www.fool.com/investing/2023/06/12/where-will-intuitive-surgical-be-in-10-years/,2023-06-12 14:00:00,"It'll be even bigger, but it probably won't be the only player in its space anymore.",JNJ,0.046095,0.141338,Neutral
"If You Invested $10,000 in Novo Nordisk in 2018, This Is How Much You Would Have Today",https://www.fool.com/investing/2023/06/12/if-you-invested-10000-in-novo-nordisk-in-2018-this/,2023-06-12 13:45:00,The drugmaker has blown away the S&P 500 index in the past five years.,JNJ,0.067536,0.0,Neutral
Akumin appoints President and Chief Operating Officer,https://www.prnewswire.com/news-releases/akumin-appoints-president-and-chief-operating-officer-301847951.html,2023-06-12 11:00:00,"PLANTATION, Fla., June 12, 2023 /PRNewswire/ - Akumin Inc. ( ""Akumin"" or the ""Company"" ) ( NASDAQ: AKU ) ( TSX: AKU ) today announced the appointment of Krishna Kumar as President and Chief Operating Officer of the Company, effective as of June 16, 2023.",JNJ,0.057767,0.195,Somewhat-Bullish
Akumin appoints President and Chief Operating Officer,https://www.newswire.ca/news-releases/akumin-appoints-president-and-chief-operating-officer-803965635.html,2023-06-12 11:00:00,"PLANTATION, Fla., June 12, 2023 /CNW/ - Akumin Inc. ( ""Akumin"" or the ""Company"" ) ( NASDAQ: AKU ) ( TSX: AKU ) today announced the appointment of Krishna Kumar as President and Chief Operating Officer of the Company, effective as of June 16, 2023.",JNJ,0.057767,0.195,Somewhat-Bullish
Drug trial results could boost 2 Club pharma stocks. Here's what to expect,https://www.cnbc.com/2023/06/12/upcoming-trial-results-could-boost-2-club-pharma-stocks.html,2023-06-12 10:00:01,Eli Lilly and Johnson & Johnson are set to present fresh drug-trial data at a conference later this month.,JNJ,0.922387,0.240876,Somewhat-Bullish
BC Platforms Expands Data Partner Network with Major Brazilian Cardiovascular Health Institution,https://www.benzinga.com/pressreleases/23/06/g32810675/bc-platforms-expands-data-partner-network-with-major-brazilian-cardiovascular-health-institution,2023-06-12 07:00:39,"ZURICH, Switzerland, June 12, 2023 ( GLOBE NEWSWIRE ) -- BC Platforms ( BCP ) , a global leader in healthcare data management and analytics, today announces the addition of one of Brazil's leading cardiology centres, Hospital do CoraÃ§Ã£o ( HCor ) , to its Global Data Partner network, ...",JNJ,0.037098,0.093124,Neutral
"Alvotech and Teva Secure U.S. License Date for AVT04, a Proposed Biosimilar to StelaraÂ®",https://www.globenewswire.com/news-release/2023/06/12/2685977/0/en/Alvotech-and-Teva-Secure-U-S-License-Date-for-AVT04-a-Proposed-Biosimilar-to-Stelara.html,2023-06-12 07:00:00,"Alvotech ( NASDAQ: ALVO ) , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. ( NYSE and TASE: TEVA ) , today announced they have reached ...",JNJ,0.020387,0.086826,Neutral
"Alvotech and Teva Secure U.S. License Date for AVT04, a Proposed Biosimilar to StelaraÂ®",https://www.globenewswire.com/news-release/2023/06/12/2685980/0/en/Alvotech-and-Teva-Secure-U-S-License-Date-for-AVT04-a-Proposed-Biosimilar-to-Stelara.html,2023-06-12 07:00:00,"REYKJAVIK, Iceland and TEL AVIV, Israel and PARSIPPANY, N.J., June 12, 2023 ( GLOBE NEWSWIRE ) -- Alvotech ( NASDAQ: ALVO ) , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals, Inc., a U.S. affiliate ...",JNJ,0.020215,0.072374,Neutral
Why Metaverse Beauty Week Matters: The Strategic Approach Beyond The Gloss,https://www.forbes.com/sites/stephaniehirschmiller/2023/06/11/why-metaverse-beauty-week-matters-the-strategic-approach-beyond-the-gloss/,2023-06-11 06:00:00,"Metaverse Beauty Week is taking place across Decentraland, Spatial, Roblox plus an immersive IRL installation at Flannels London with AR smart mirrors and more.",JNJ,0.064276,0.290864,Somewhat-Bullish
China is rolling out the red carpet for US CEOs,https://www.foxbusiness.com/markets/china-rolling-out-red-carpet-us-ceos,2023-06-10 11:03:27,"China is not interested in talking politics with its biggest rival - it is interested in its business muscle. After closing the country for more than three years to curb the spread of COVID-19, China is trying to reconnect with the world.",JNJ,0.040829,0.121869,Neutral
3 Best Ways to Invest for Retirement,https://www.fool.com/retirement/2023/06/10/3-best-ways-to-invest-for-retirement/,2023-06-10 10:25:00,This three-pronged investing approach can help set you up for a relaxing retirement.,JNJ,0.061473,0.231198,Somewhat-Bullish
Blue Chip Bargain Hunting: 2 Top Stocks to Buy Now,https://www.fool.com/investing/2023/06/10/blue-chip-bargain-hunting-2-top-stocks-to-buy-now/,2023-06-10 09:30:00,You can pick up shares of these market leaders for a song.,JNJ,0.116631,0.063591,Neutral
The Supreme Court knocked down affirmative action in colleges - and companies could feel the effects too,https://www.marketwatch.com/story/the-supreme-court-knocked-down-affirmative-action-in-colleges-and-companies-could-feel-the-effects-too-98bd511c,2023-06-29 21:12:00,"College admission can often be the ""entry ticket to top jobs,"" said dissenting Justice Sonia Sotomayor.",JNJ,0.109289,0.209616,Somewhat-Bullish
Is Johnson & Johnson Stock a Strong Buy?,https://www.fool.com/investing/2023/06/29/is-johnson-johnson-stock-a-strong-buy/,2023-06-29 18:00:00,The healthcare giant should deliver strong returns for shareholders over the long term.,JNJ,0.152018,0.073086,Neutral
Where Will Johnson & Johnson Be in 5 Years?,https://www.fool.com/investing/2023/06/29/where-will-johnson-johnson-be-in-5-years/,2023-06-29 14:07:00,The stock's returns over the past decade haven't been great -- should investors expect that to change?,JNJ,0.688485,0.227443,Somewhat-Bullish
5 High-Yielding Dividend Stocks That Are Bargain Buys,https://www.fool.com/investing/2023/06/29/5-high-yielding-dividend-stocks-that-are-bargain/,2023-06-29 14:00:00,This is a good time for investors to load up on healthcare companies.,JNJ,0.210092,0.215259,Somewhat-Bullish
Reunion Neuroscience Reports Fiscal Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update,https://www.globenewswire.com/news-release/2023/06/29/2696901/0/en/Reunion-Neuroscience-Reports-Fiscal-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provides-a-Corporate-Update.html,2023-06-29 11:30:00,Common Shareholders to Receive Consideration of US$1.12 Per Share in Cash from the Arrangement Agreement with MPM BioImpact. Special Shareholder Meeting Scheduled July ...,JNJ,0.022947,0.022298,Neutral
This Sentiment Gauge Just Reached Its Most Optimistic Level Since Pre-Covid Days. Time to Buy Stocks?,https://www.fool.com/investing/2023/06/29/this-sentiment-gauge-just-reached-its-most-optimis/,2023-06-29 09:30:00,Many stocks are trading at reasonable levels after declines last year.,JNJ,0.06179,-0.115027,Neutral
"Google Accused of Breaching Promised Ad Standards, Big Brands and Government Agencies Affected - Alphabet  ( NASDAQ:GOOG ) , Alphabet  ( NASDAQ:GOOGL ) ",https://www.benzinga.com/news/23/06/33037585/google-accused-of-breaching-promised-ad-standards-big-brands-and-government-agencies-affected,2023-06-28 19:01:29,"Alphabet Inc GOOG GOOGL Google violated its promised standards when placing video ads on other websites, claims a new study. Google's YouTube hosts ads on its platform and places video ads on other sites through the Google Video Partners program.",JNJ,0.279015,0.089852,Neutral
"Is A VIX Floor Approaching? - BlackBerry  ( NYSE:BB ) , Concentrix  ( NASDAQ:CNXC ) ",https://www.benzinga.com/economics/macro-economic-events/23/06/33048077/is-a-vix-floor-approaching,2023-06-28 18:02:12,"The housing market is resilient. Sales of newly constructed homes were up 12.2% in May from April, and up 20% from a year ago. Homeowners with ultra-low mortgage rates don't want to sell and buy another home at a much higher rate according to Bloomberg. Will this continue?",JNJ,0.038468,0.076031,Neutral
Johnson & Johnson Unusual Options Activity For June 28 - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/06/33045821/johnson-johnson-unusual-options-activity-for-june-28,2023-06-28 15:48:51,"Someone with a lot of money to spend has taken a bullish stance on Johnson & Johnson JNJ. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",JNJ,0.731269,0.310454,Somewhat-Bullish
Google's Ad Scam Eerily Similar To Facebook's Metric Inflation Scam,https://www.forbes.com/sites/joetoscano1/2023/06/28/googles-ad-scam-eerily-similar-to-facebooks-metric-inflation-scam/,2023-06-28 15:28:42,"The magnitude of the deception becomes clear, media buyers are calling for justice, and their first demand is full refunds for the misrepresentation.",JNJ,0.050894,-0.089155,Neutral
1 Sickly Dividend Stock to Avoid Like the Plague Right Now  ( and 2 Much Healthier Ones to Buy Instead ) ,https://www.fool.com/investing/2023/06/28/1-sickly-dividend-stock-to-avoid-like-the-plague-r/,2023-06-28 13:32:00,This REIT's dividend remains at high risk of a reduction.,JNJ,0.388126,0.200597,Somewhat-Bullish
"Appia Bio Expands Leadership Team With Sylvaine Cases, Ph.D. Appointed Chief Business Officer and Alex Babayan, Ph.D. as Vice President, Head of Regulatory Affairs",https://www.prnewswire.com/news-releases/appia-bio-expands-leadership-team-with-sylvaine-cases-phd-appointed-chief-business-officer-and-alex-babayan-phd-as-vice-president-head-of-regulatory-affairs-301865343.html,2023-06-28 13:15:00,"Appia Bio Expands Leadership Team With Sylvaine Cases, Ph.D. Appointed Chief Business Officer and Alex Babayan ... PR ...",JNJ,0.088964,0.018858,Neutral
BDA EXPANDS GLOBAL FOOTPRINT WITH ACQUISITION OF TOP GERMANY-BASED DISTRIBUTOR IPM I GRUPPE,https://www.prnewswire.com/news-releases/bda-expands-global-footprint-with-acquisition-of-top-germany-based-distributor-ipm-i-gruppe-301865059.html,2023-06-28 13:00:00,"Deal Strengthens Presence in Europe, Creates First BDA-Germany Offices, and Furthers Business Plan of European Coverage and Expansion",JNJ,0.100518,0.180493,Somewhat-Bullish
"The Best Stocks to Invest $20,000 in Right Now",https://www.fool.com/investing/2023/06/28/the-best-stocks-to-invest-20000-in-right-now/,2023-06-28 09:30:00,"You can invest in these companies with $20,000 -- or even a lot less.",JNJ,0.075516,0.213808,Somewhat-Bullish
Platelet-Rich Plasma Global Market to Grow Substantially at a CAGR of ~11% by 2028 | DelveInsight,https://www.prnewswire.com/news-releases/platelet-rich-plasma-global-market-to-grow-substantially-at-a-cagr-of-11-by-2028--delveinsight-301863904.html,2023-06-27 21:01:00,"Platelet-rich plasma ( PRP ) demand is being driven primarily by an increase in the number of patients suffering from orthopedic diseases, sports injuries, acute and chronic wounds, gynecological diseases, and urological diseases, among other conditions.",JNJ,0.050679,0.118786,Neutral
Johnson & Johnson's Talc Cancer Claims Saga: $8.9B Settlement Under Scrutiny - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/general/biotech/23/06/33029971/johnson-johnsons-talc-cancer-claims-saga-8-9b-settlement-under-scrutiny,2023-06-27 17:43:45,"Johnson & Johnson's JNJ proposed $8.9 billion settlement of lawsuits alleging cancer-causing talc products faces a key test in a U.S. bankruptcy court in New Jersey this week. J&J subsidiary, LTL Management, is attempting to resolve the lawsuits through bankruptcy for the second time.",JNJ,0.352223,-0.185988,Somewhat-Bearish
"IPO Market Gains 25% In First Half Of Year, With Improved Outlook For Second Half",https://www.investors.com/research/ipo-market-gains-in-first-half-of-year-with-improved-outlook-for-q3/,2023-06-27 17:37:00,IPO Market Coming Back To Life After Q2 Pickup. These Companies ... Investor's Business Daily ...,JNJ,0.132733,0.0,Neutral
"Questex's Fierce Clinical Summit Returns to Discuss All Things Clinical, Brings the Clinical Research and Trial Management Ecosystem Together September 26-28 in Philadelphia",https://www.benzinga.com/pressreleases/23/06/g33025104/questexs-fierce-clinical-summit-returns-to-discuss-all-things-clinical-brings-the-clinical-researc,2023-06-27 14:00:00,"NEW YORK, June 27, 2023 ( GLOBE NEWSWIRE ) -- Questex's Fierce Pharma today announces the Fierce Clinical Summit will take place September 26-28 in Philadelphia. The Summit is Fierce Pharma's flagship event for the clinical research and trial management ecosystem.",JNJ,0.044885,-0.045099,Neutral
Here's How Much a $1000 Investment in Abbott Made 10 Years Ago Would Be Worth Today,https://www.zacks.com/stock/news/2113465/heres-how-much-a-1000-investment-in-abbott-made-10-years-ago-would-be-worth-today,2023-06-27 12:30:05,"Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.",JNJ,0.063425,0.168187,Somewhat-Bullish
SonoTheraâ„¢ Expands Leadership Team Appointing Carolyne Zimmermann as Chief Business Officer,https://www.prnewswire.com/news-releases/sonothera-expands-leadership-team-appointing-carolyne-zimmermann-as-chief-business-officer-301863631.html,2023-06-27 11:00:00,"â€¢ Zimmermann brings more than two decades of experience in business development, merger and acquisition strategy, deals and partnership development. â€¢ Prior to SonoThera, Zimmermann held senior leadership roles at Johnson & Johnson, Novartis and 4D Molecular Therapeutics. â€¢ SonoThera is ...",JNJ,0.128478,0.066363,Neutral
Boston Scientific Elects Dr. Jessica L. Mega and Susan E. Morano to Board of Directors,https://www.prnewswire.com/news-releases/boston-scientific-elects-dr-jessica-l-mega-and-susan-e-morano-to-board-of-directors-301864104.html,2023-06-27 10:30:00,"MARLBOROUGH, Mass., June 27, 2023 /PRNewswire/ -- Boston Scientific Corporation ( NYSE: BSX ) announced today the election of Dr. Jessica L. Mega and Susan E. Morano to its board of directors, each effective immediately.",JNJ,0.282234,-0.124107,Neutral
Analysis: Companies' derivative bets to save on US debt costs turn riskier,https://www.reuters.com/markets/us/companies-derivative-bets-save-us-debt-costs-turn-riskier-2023-06-27/,2023-06-27 04:00:17,"NEW YORK, June 27 ( Reuters ) - A type of derivative trade that became popular with companies over the past year to save on interest costs is seeing demand slow, with risk increasing that the bets could backfire as the Federal Reserve nears the end of its policy tightening cycle.",JNJ,0.050679,0.066483,Neutral
Johnson & Johnson  ( JNJ )  Dips More Than Broader Markets: What You Should Know,https://www.zacks.com/stock/news/2113266/johnson-johnson-jnj-dips-more-than-broader-markets-what-you-should-know,2023-06-26 21:45:18,"Johnson & Johnson (JNJ) closed the most recent trading day at $163.63, moving -1.12% from the previous trading session.",JNJ,0.603594,0.245835,Somewhat-Bullish
New Phase 3 data with aprocitentan for patients with resistant hypertension has been presented at the European Society of Hypertension Annual Meeting 2023,https://www.globenewswire.com/news-release/2023/06/26/2694683/0/en/New-Phase-3-data-with-aprocitentan-for-patients-with-resistant-hypertension-has-been-presented-at-the-European-Society-of-Hypertension-Annual-Meeting-2023.html,2023-06-26 15:45:00,"Allschwil, Switzerland - June ...",JNJ,0.01441,0.014321,Neutral
"Take the Zacks Approach to Beat the Market: Shopify, Oracle, Uber in Focus",https://www.zacks.com/stock/news/2112971/take-the-zacks-approach-to-beat-the-market-shopify-oracle-uber-in-focus,2023-06-26 12:12:00,"Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.",JNJ,0.069294,0.061391,Neutral
2 Best Buffett Stocks to Buy for the Long Haul,https://www.fool.com/investing/2023/06/26/2-best-buffett-stocks-to-buy-for-the-long-haul/,2023-06-26 11:45:00,Warren Buffett is selective when it comes to healthcare stocks.,JNJ,0.390396,0.242972,Somewhat-Bullish
Recently-Appointed Independent Directors of Alkermes Issue Open Letter to Shareholders,https://www.prnewswire.com/news-releases/recently-appointed-independent-directors-of-alkermes-issue-open-letter-to-shareholders-301862757.html,2023-06-26 11:00:00,"Recommend Shareholders Vote ""For"" Alkermes' Seven Director Nominees On Company's Proxy Card",JNJ,0.018995,0.234978,Somewhat-Bullish
Recently-Appointed Independent Directors of Alkermes Issue Open Letter to Shareholders - Alkermes  ( NASDAQ:ALKS ) ,https://www.benzinga.com/pressreleases/23/06/n33002604/recently-appointed-independent-directors-of-alkermes-issue-open-letter-to-shareholders,2023-06-26 11:00:00,"Recommend Shareholders Vote ""For"" Alkermes' Seven Director Nominees On Company's White Proxy Card",JNJ,0.018439,0.234378,Somewhat-Bullish
Better Recovery-Story Buy: Emergent BioSolutions or Invitae?,https://www.fool.com/investing/2023/06/26/better-recovery-story-buy-emergent-biosolutions-or/,2023-06-26 09:30:00,Both of these stocks have plummeted more than 50% over the past year.,JNJ,0.060236,-0.076412,Neutral
Got $500? 3 Magnificent Dividend Stocks to Buy Without Hesitation Right Now,https://www.fool.com/investing/2023/06/25/got-500-3-magnificent-dividend-stocks-to-buy-witho/,2023-06-25 13:09:00,These companies pay elite dividends.,JNJ,0.304679,0.488845,Bullish
"Oral Care Market to grow by USD 11,147.45 million between 2022 to 2027; Growth opportunities led by 3M Co. and Amway Corp.| Technavio",https://www.prnewswire.com/news-releases/oral-care-market-to-grow-by-usd-11-147-45-million-between-2022-to-2027-growth-opportunities-led-by-3m-co-and-amway-corp-technavio-301860899.html,2023-06-25 05:30:00,"Oral Care Market to grow by USD 11,147.45 million between 2022 to 2027. Growth opportunities led by 3M Co. and ... PR ...",JNJ,0.026328,0.046503,Neutral
Expect a Roaring S&P 500 Bull Market? Here Are the 10 Stocks You'll Want to Own,https://www.fool.com/investing/2023/06/24/expect-a-roaring-sp-500-bull-market-here-are-the-1/,2023-06-24 09:50:00,These stocks are the S&P 500's heavyweight champions.,JNJ,0.058903,0.229343,Somewhat-Bullish
3 Reliable Dividend Stocks to Buy Now and Hold Forever,https://www.fool.com/investing/2023/06/24/3-reliable-dividend-stocks-to-buy-now-and-hold-for/,2023-06-24 09:23:00,These stocks are poised to provide increasing amounts of passive income for years to come.,JNJ,0.098255,-0.007483,Neutral
Big Pharma Vs. Washington-An Opportunity To Buy Bristol Myers,https://www.forbes.com/sites/johnbuckingham/2023/06/23/big-pharma-vs-washington-an-opportunity-to-buy-bristol-myers/,2023-06-23 22:27:12,"After all, news broke on Friday that Bristol Myers Squibb has sued Uncle Sam over a Medicare price renegotiation program in the Inflation Reduction Act (IRA) that was ...",JNJ,0.043738,0.032788,Neutral
Data shows nearly 19% weight loss in people with overweight or obesity in Boehringer Ingelheim and Zealand Pharma Phase II trial with survodutide  ( BI 456906 ) ,https://www.globenewswire.com/news-release/2023/06/23/2693928/0/en/Data-shows-nearly-19-weight-loss-in-people-with-overweight-or-obesity-in-Boehringer-Ingelheim-and-Zealand-Pharma-Phase-II-trial-with-survodutide-BI-456906.html,2023-06-23 21:15:00,Press ReleaseÂ­Â­Â­Â­Â­Â­Â­ No. ...,JNJ,0.027011,0.05729,Neutral
Medical Aesthetics Market 2023-2027; Segmentation by geography type and end user. CAGR accelerating at 8.6% by 2027- Technavio,https://www.prnewswire.com/news-releases/medical-aesthetics-market-2023-2027-segmentation-by-geography-type-and-end-user-cagr-accelerating-at-8-6-by-2027--technavio-301858358.html,2023-06-23 15:00:00,Medical Aesthetics Market 2023-2027. Segmentation by geography type and end user. CAGR accelerating at 8.6% by ... PR ...,JNJ,0.03631,0.0,Neutral
Boston Scientific's  ( BSX )  New Launches Aid Amid Cost Pressure,https://www.zacks.com/stock/news/2112440/boston-scientifics-bsx-new-launches-aid-amid-cost-pressure,2023-06-23 14:52:00,Boston Scientific (BSX) remains excited about the rest of 2023 and expects to continue to outpace its peers within the EMEA market.,JNJ,0.052801,0.061696,Neutral
"Bone grafts and substitutes market size to grow by USD 1,450.51 million from 2022 to 2027: Growing prevalence of orthopedic conditions to boost growth - Technavio",https://www.prnewswire.com/news-releases/bone-grafts-and-substitutes-market-size-to-grow-by-usd-1-450-51-million-from-2022-to-2027-growing-prevalence-of-orthopedic-conditions-to-boost-growth---technavio-301858327.html,2023-06-23 12:30:00,"Bone grafts and substitutes market size to grow by USD 1,450.51 million from 2022 to 2027: Growing prevalence of ... PR ...",JNJ,0.024273,0.016363,Neutral
"Cramer Says Datadog Will 'Put Up Some Good Numbers,' And 9 More Stock Takes From 'Mad Money' Host - ADT  ( NYSE:ADT ) , AbbVie  ( NYSE:ABBV ) ",https://www.benzinga.com/trading-ideas/long-ideas/23/06/32980350/cramer-says-datadog-will-put-up-some-good-numbers-and-9-more-stock-takes-from-mad-money-,2023-06-23 12:13:12,"On CNBC's ""Mad Money Lightning Round,"" Jim Cramer said Cummins CMI is a buy. ""Longer term, Cummins is the best there is,"" he added. Cramer said it's never too late to sell ADT ADT, ""that's how bad that is."" When asked about Simon Property Group, Inc. SPG, he said, ""Look, it is a tough situation.",JNJ,0.294093,-0.358793,Bearish
The Orthopedic Device Market size is to grow by USD 12.11 billion from 2022 to 2027; new product launches coupled with R&D activities are the major trend - Technavio,https://www.prnewswire.com/news-releases/the-orthopedic-device-market-size-is-to-grow-by-usd-12-11-billion-from-2022-to-2027-new-product-launches-coupled-with-rd-activities-are-the-major-trend---technavio-301858321.html,2023-06-23 09:15:00,The Orthopedic Device Market size is to grow by USD 12.11 billion from 2022 to 2027. new product launches coupled ... PR ...,JNJ,0.027667,0.07358,Neutral
"Moderating Inflation, a Tasty IPO, Bull Market Talk, and More",https://www.fool.com/investing/2023/06/22/the-new-bull-market/,2023-06-22 17:06:00,We've also got two stocks worth watching: Chevron and Burford Capital.,JNJ,0.01215,-0.034131,Neutral
Austin J. Franklin Named Keynote Speaker for 2023 Billion Dollar Roundtable Summit,https://www.prnewswire.com/news-releases/austin-j-franklin-named-keynote-speaker-for-2023-billion-dollar-roundtable-summit-301858276.html,2023-06-22 15:38:00,"FLEMING ISLAND, Fla., June 22, 2023 /PRNewswire/ -- The Billion Dollar Roundtable ( BDR ) has named leadership expert and author, Austin J. Franklin, as a Keynote Speaker for its 2023 Summit in Chicago, Illinois.",JNJ,0.103331,0.167865,Somewhat-Bullish
Ranking These 5 Dividend Kings From Highest to Lowest Quality,https://www.fool.com/investing/2023/06/22/ranking-these-5-dividend-kings-from-highest-to-low/,2023-06-22 13:45:00,Dividend Kings have grown their dividend for 50+ consecutive years.,JNJ,0.807885,-0.032407,Neutral
Will Johnson & Johnson Be a Trillion-Dollar Stock by 2038?,https://www.fool.com/investing/2023/06/22/will-jnj-be-a-trillion-dollar-stock-by-2038/,2023-06-22 12:10:00,The healthcare company is already almost halfway there.,JNJ,0.2035,0.101528,Neutral
"Cidara Therapeutics Receives U.S. FDA Fast Track Designation for CD388, a Novel Drug-Fc Conjugate Targeting Influenza A and B - Cidara Therapeutics  ( NASDAQ:CDTX ) ",https://www.benzinga.com/pressreleases/23/06/g32963803/cidara-therapeutics-receives-u-s-fda-fast-track-designation-for-cd388-a-novel-drug-fc-conjugate-ta,2023-06-22 12:00:00,"SAN DIEGO, June 22, 2023 ( GLOBE NEWSWIRE ) -- Cidara Therapeutics, Inc. CDTX, a biotechnology company developing long-acting therapeutics designed to save lives and improve the standard of care for patients facing serious diseases, today announced that the U.S.",JNJ,0.090816,0.02443,Neutral
AI May Transform Healthcare: 2 Top Stocks to Buy Now,https://www.fool.com/investing/2023/06/22/ai-may-transform-healthcare-2-top-stocks-buy-now/,2023-06-22 09:30:00,These players already are using AI -- and could become AI leaders over time.,JNJ,0.129516,0.0,Neutral
How artificial intelligence can make hiring bias worse,https://www.marketwatch.com/story/how-artificial-intelligence-can-make-hiring-bias-worse-f23850c4,2023-06-22 09:01:00,"In some cases, AI has been shown to filter out women, black applicants and older candidates, and can eliminate someone merely for a facial expression.",JNJ,0.028056,-0.026774,Neutral
Pharmaceutical trade group sues Biden administration over Medicare drug price negotiations,https://www.cnbc.com/2023/06/21/phrma-sues-biden-administration-over-medicare-drug-negotiations-.html,2023-06-21 21:08:48,"PhRMA's lawsuit is the fourth legal challenge to the law after separate suits from Merck, Bristol Myers Squibb and the U.S. Chamber of Commerce.",JNJ,0.096283,0.0,Neutral
"Integra LifeSciences Appoints Lea Daniels Knight, Executive Vice President and Chief Financial Officer",https://www.globenewswire.com/news-release/2023/06/21/2692506/1063/en/Integra-LifeSciences-Appoints-Lea-Daniels-Knight-Executive-Vice-President-and-Chief-Financial-Officer.html,2023-06-21 20:15:00,"PRINCETON, N.J., June 21, 2023 ( GLOBE NEWSWIRE ) -- Integra LifeSciences Holdings Corporation ( Nasdaq:IART ) today announced the appointment of Lea Daniels Knight as executive vice president and chief financial officer, effective June 28, 2023.",JNJ,0.066047,0.114777,Neutral
"Integra LifeSciences Appoints Lea Daniels Knight, Executive Vice President and Chief Financial Officer - Integra Lifesciences  ( NASDAQ:IART ) ",https://www.benzinga.com/pressreleases/23/06/g32956066/integra-lifesciences-appoints-lea-daniels-knight-executive-vice-president-and-chief-financial-offi,2023-06-21 20:15:00,"PRINCETON, N.J., June 21, 2023 ( GLOBE NEWSWIRE ) -- Integra LifeSciences Holdings Corporation IART today announced the appointment of Lea Daniels Knight as executive vice president and chief financial officer, effective June 28, 2023.",JNJ,0.063425,0.11449,Neutral
Looking At Johnson & Johnson's Recent Unusual Options Activity - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/06/32955121/looking-at-johnson-johnsons-recent-unusual-options-activity,2023-06-21 19:34:03,"Someone with a lot of money to spend has taken a bearish stance on Johnson & Johnson JNJ. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",JNJ,0.812186,0.262402,Somewhat-Bullish
"Breast Reconstruction Market Revenue to Cross US$ 2.5 Bn, Globally by 2031 - Comprehensive Study by Transparency Market Research",https://www.benzinga.com/pressreleases/23/06/g32955063/breast-reconstruction-market-revenue-to-cross-us-2-5-bn-globally-by-2031-comprehensive-study-by-tr,2023-06-21 19:30:00,"Wilmington, Delaware, United States, June 22, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global breast reconstruction market is anticipated to reach more than US$ 2.5 Bn by 2031 and is projected to grow at a CAGR of 5.3% during the forecast period from 2022 to 2031.",JNJ,0.041682,0.058241,Neutral
PASQAL will Open a Quantum Computer Factory in Canada,https://www.newswire.ca/news-releases/pasqal-will-open-a-quantum-computer-factory-in-canada-854118672.html,2023-06-21 13:00:00,The Canadian subsidiary of PASQAL is setting up a quantum computer factory in the DistriQ - Quantum Innovation Zone in Sherbrooke,JNJ,0.05833,0.060056,Neutral
Johnson & Johnson  ( JNJ )  Stock Moves -0.06%: What You Should Know,https://www.zacks.com/stock/news/2110816/johnson-johnson-jnj-stock-moves--006-what-you-should-know,2023-06-20 21:45:22,"Johnson & Johnson (JNJ) closed at $164.13 in the latest trading session, marking a -0.06% move from the prior day.",JNJ,0.598621,0.184732,Somewhat-Bullish
"The Josh Bersin Company Unveils Breakthrough AI Solution and ""Organizational Ingenuity"" at Irresistible 2023",https://www.prnewswire.com/news-releases/the-josh-bersin-company-unveils-breakthrough-ai-solution-and-organizational-ingenuity-at-irresistible-2023-301855966.html,2023-06-20 21:34:00,"â€¢ Company to introduce its groundbreaking AI solution, The Josh Bersin Company HR Copilot, at Irresistible 2023, transforming the way organizations access a wealth of extensive HR knowledge produced over 25 years â€¢ ""The Post-Industrial Age"" and ""Systemic HR in the Age of AI"" will be core themes, ...",JNJ,0.038969,0.136018,Neutral
"Biomea Fusion to Present Late Breaking Data from Ongoing Phase II Trial, COVALENT-111, Evaluating BMF-219 in Patients with Type 2 Diabetes at ADA 2023",https://www.globenewswire.com/news-release/2023/06/20/2691625/0/en/Biomea-Fusion-to-Present-Late-Breaking-Data-from-Ongoing-Phase-II-Trial-COVALENT-111-Evaluating-BMF-219-in-Patients-with-Type-2-Diabetes-at-ADA-2023.html,2023-06-20 20:30:00,"REDWOOD CITY, Calif., June 20, 2023 ( GLOBE NEWSWIRE ) -- Biomea Fusion, Inc. ( ""Biomea"" ) ( Nasdaq: BMEA ) , a clinical-stage biopharmaceutical company dedicated to discovering and developing novel covalent small molecules to treat and improve the lives of patients with genetically defined ...",JNJ,0.025192,0.058505,Neutral
Best ETFs For Income Investing: 2023,https://www.forbes.com/sites/investor-hub/article/best-etfs-for-income-investing-2023/,2023-06-20 19:52:12,"ETFs are a great way to generate income. Here's a look at some of the best ETFs for income investors, based on factors such as dividend yield, expense ratio and risk.",JNJ,0.045962,0.137343,Neutral
Discovering The Top Dogs: A Guide To Woofing Up Your Returns With Dogs Of The Dow Investing - American Express  ( NYSE:AXP ) ,https://www.benzinga.com/23/06/32932681/discovering-the-top-dogs-a-guide-to-woofing-up-your-returns-with-dogs-of-the-dow-investing,2023-06-20 18:21:55,"The Dogs of the Dow is an investing strategy that focuses on investing in the top 10 highest dividend-yielding stocks in the Dow Jones 30 index every single year. The Dow Jones Industrial Average Index, also known as The DIJA or just ""The Dow"", is an index of only 30 large companies, weighted by ...",JNJ,0.135347,0.0,Neutral
Here's Why You Should Buy Boston Scientific  ( BSX )  Stock,https://www.zacks.com/stock/news/2110733/heres-why-you-should-buy-boston-scientific-bsx-stock,2023-06-20 15:19:00,"Investors are optimistic about Boston Scientific's (BSX) strong improvement in organic sales, indicating a solid rebound in the legacy business.",JNJ,0.047654,0.089929,Neutral
These 3 stocks are troubled but I'm not ready to give up,https://www.cnbc.com/2023/06/20/jim-cramer-acknowledges-these-3-stocks-are-troubled-but-says-hes-not-ready-to-give-up.html,2023-06-20 15:00:07,"Johnson & Johnson, Estee Lauder and Danaher are why this business of stock picking and running a portfolio can be so daunting.",JNJ,0.807885,-0.232706,Somewhat-Bearish
The 'Perfect Storm' That Led To A Patient Death And Arcellx's Dive,https://www.investors.com/news/technology/aclx-stock-plunges-after-perfect-storm-leads-to-patient-death-in-cancer-drug-study/,2023-06-20 14:38:00,ACLX Stock Plunges After 'Perfect Storm' Leads To Patient Death In ... Investor's Business Daily ...,JNJ,0.136113,0.088358,Neutral
"Pfizer, Moderna and Novavax gear up for fall Covid vaccine rollout with an important head start",https://www.cnbc.com/2023/06/20/covid-vaccines-pfizer-moderna-and-novavax-gear-up-for-fall-rollout.html,2023-06-20 13:07:05,"The FDA's strain selection puts Pfizer, Moderna and Novavax on track to deliver updated coronavirus shots in time for the fall.",JNJ,0.06179,-0.150062,Somewhat-Bearish
Johnson & Johnson  ( JNJ )  Is a Trending Stock: Facts to Know Before Betting on It,https://www.zacks.com/stock/news/2110478/johnson-johnson-jnj-is-a-trending-stock-facts-to-know-before-betting-on-it,2023-06-20 13:00:10,"Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",JNJ,0.470606,0.129149,Neutral
Why Investors Need to Take Advantage of These 2 Medical Stocks Now,https://www.zacks.com/stock/news/2110463/why-investors-need-to-take-advantage-of-these-2-medical-stocks-now,2023-06-20 12:50:06,Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.,JNJ,0.390904,0.395317,Bullish
Attovia Therapeutics Launches with $60 Million Series A Financing to Unlock Potential of Novel Biparatopic Nanobody Platform,https://www.benzinga.com/pressreleases/23/06/g32919682/attovia-therapeutics-launches-with-60-million-series-a-financing-to-unlock-potential-of-novel-bipa,2023-06-20 11:30:00,Company Formed by Alamar Biosciences and Frazier Life Sciences Attobodyâ„¢ Platform Generates Small Format Binders for Hard-to-drug Targets,JNJ,0.038717,-0.004871,Neutral
Drugmakers aim to strike down Medicare drug-price negotiations at Supreme Court,https://www.cnbc.com/2023/06/20/drug-prices-drugmakers-aim-to-fight-medicare-negotiations-at-scotus.html,2023-06-20 11:00:02,The lawsuits are the opening salvo in a historic and potentially decisive battle over Medicare's efforts to bring rising drug prices under control.,JNJ,0.023327,-0.06237,Neutral
Independent Proxy Advisory Firm ISS Recommends Alkermes Shareholders Vote Against Sarissa Employees' Election to Alkermes Board,https://www.prnewswire.com/news-releases/independent-proxy-advisory-firm-iss-recommends-alkermes-shareholders-vote-against-sarissa-employees-election-to-alkermes-board-301854859.html,2023-06-20 11:00:00,Independent Proxy Advisory Firm ISS Recommends Alkermes Shareholders Vote Against Sarissa Employees' Election ... PR ...,JNJ,0.019286,-0.009931,Neutral
Judge dismisses lawsuit seeking reparations for the 1921 Tulsa Race Massacre,https://apnews.com/article/tulsa-race-racist-massacre-lawsuit-faa7f699092b40c7ea568f0e8459c979,2023-07-09 16:29:00,An Oklahoma judge has thrown out a lawsuit seeking reparations for the 1921 dashing an effort to obtain some measure of legal justice by survivors of the deadly racist rampage.,JNJ,0.091509,-0.072428,Neutral
Is Johnson & Johnson Stock a Buy Now?,https://www.fool.com/investing/2023/07/09/is-johnson-johnson-stock-a-buy-now/,2023-07-09 11:45:00,Some businesses never go out of style.,JNJ,0.118647,0.187733,Somewhat-Bullish
Is Johnson & Johnson Stock a Buy?,https://www.fool.com/investing/2023/07/08/is-johnson-johnson-stock-a-buy/,2023-07-08 11:20:00,Let's take a look at this Dividend King after its spin-off of Kenvue and its proposed $8.7 billion litigation settlement.,JNJ,0.608634,0.214133,Somewhat-Bullish
Passive Income: 3 Dividend Kings Worth a Look,https://www.zacks.com/stock/news/2118297/passive-income-3-dividend-kings-worth-a-look,2023-07-07 21:34:00,"Dividends soften the blow from drawdowns in other positions, provide more than one way to reap a return from an investment, and allow maximum returns through dividend reinvestment.",JNJ,0.385286,0.160401,Somewhat-Bullish
"WBA: Is Walgreens Boots Alliance  ( WBA )  a Buy, Sell, or Hold This Month?",https://stocknews.com/news/wba-nvo-jnj-cvs-is-walgreens-boots-alliance-wba-a-buy-sell-or-hold/,2023-07-07 17:01:38,"Pharmaceutical retailer Walgreens Boots Alliance, Inc. ( WBA ) warned of facing lower sales persisting into next year due to inflation affecting consumers' spending. The end of the COVID emergency led to a sharp drop in the sale of vaccines and tests, according to the company's executives.",JNJ,0.047371,0.209658,Somewhat-Bullish
Global 2000 List 2023: The Top 200,https://www.forbes.com/sites/forbesstaff/2023/07/07/forbes-global-2000-list-2023-the-top-200/,2023-07-07 15:45:31,"Two years after the start of the pandemic, Covid casualties like airlines and oil producers have reclaimed top spots among the largest companies in the world.",JNJ,0.010247,0.074214,Neutral
The Other Important Board Director Qualifications,https://www.forbes.com/sites/patricialenkov/2023/07/07/the-other-important-board-director-qualifications/,2023-07-07 15:44:18,"What needs to be added to the often nebulous board recruitment and decision-making process is reference to personality traits, values, and soft skills.",JNJ,0.067158,0.212844,Somewhat-Bullish
Is The Stock Market In A Bubble Right Now?,https://www.forbes.com/sites/qai/2023/07/07/is-the-stock-market-in-a-bubble-right-now/,2023-07-07 11:02:05,The rapid growth against a mixed economic backdrop has some analysts questioning whether we're entering bubble territory ...,JNJ,0.035929,0.199227,Somewhat-Bullish
ASEP MEDICAL HOLDINGS INC. ANNOUNCES RESULTS OF ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS AND PROVIDES CORPORATE UPDATE,https://www.newswire.ca/news-releases/asep-medical-holdings-inc-announces-results-of-annual-general-and-special-meeting-of-shareholders-and-provides-corporate-update-813190839.html,2023-07-07 11:00:00,ASEP MEDICAL HOLDINGS INC. ANNOUNCES RESULTS OF ANNUAL GENERAL AND SPECIAL MEETING OF ... Canada ...,JNJ,0.03468,0.175302,Somewhat-Bullish
"2 Reasons to Buy Johnson & Johnson, and 1 Reason to Sell",https://www.fool.com/investing/2023/07/07/2-reasons-to-buy-johnson-johnson-1-reason-to-sell/,2023-07-07 10:00:00,This pharma company has reached an important transition point.,JNJ,0.091335,0.108149,Neutral
Sensor-Based Smart Catheters Market to Exceed US$ 7 Billion by 2031 growing with CAGR of 8.0%: TMR Study,https://www.benzinga.com/pressreleases/23/07/g33144679/sensor-based-smart-catheters-market-to-exceed-us-7-billion-by-2031-growing-with-cagr-of-8-0-tmr-st,2023-07-07 10:00:00,"Wilmington, Delaware, United States, July 07, 2023 ( GLOBE NEWSWIRE ) -- The global market for sensor-based smart catheters stood at US$ 3.5 billion in 2021 and the global sensor-based smart catheters market is projected to reach US$ 7 billion in 2031.",JNJ,0.043818,0.084217,Neutral
"Global Lactose Intolerance Treatment Market Forecast 2023-2032 - Market Size, Drivers, Trends, And Competitors As Per The Business Research Company's Lactose Intolerance Treatment Global Market Report 2023",https://www.benzinga.com/pressreleases/23/07/g33135424/global-lactose-intolerance-treatment-market-forecast-2023-2032-market-size-drivers-trends-and-comp,2023-07-06 15:30:00,"LONDON, July 06, 2023 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Lactose Intolerance Treatment Global Market Report 2023, the market will grow from $28.3 billion in 2022 to $30.3 billion in 2023, with a compound annual growth rate ( CAGR ) of more than 7%.",JNJ,0.051221,-0.053597,Neutral
2 Best Biotech Stocks to Buy in July,https://www.fool.com/investing/2023/07/06/2-best-biotech-stocks-to-buy-in-july/,2023-07-06 14:00:00,These are two of the largest pharmaceutical companies on the planet.,JNJ,0.132004,0.126656,Neutral
Johnson & Johnson  ( JNJ )  is Attracting Investor Attention: Here is What You Should Know,https://www.zacks.com/stock/news/2117431/johnson-johnson-jnj-is-attracting-investor-attention-here-is-what-you-should-know,2023-07-06 13:00:12,"Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",JNJ,0.474958,0.138862,Neutral
"7 Of The Top 10 Most-Valuable Stocks Are Still Cheap, Analysts Say",https://www.investors.com/etfs-and-funds/sectors/sp500-of-the-top-most-valuable-stocks-are-still-cheap-analysts/,2023-07-06 12:00:00,Think you missed your chance to profit on the S&P 500's most valuable stocks? Good news: analysts say there's still upside for most of them - just not Tesla ( TSLA ) .,JNJ,0.167322,0.282544,Somewhat-Bullish
Worried About the Markets? Buy and Hold These 2 Cheap ETFs.,https://www.fool.com/investing/2023/07/06/worried-about-the-markets-buy-and-hold-these-2-che/,2023-07-06 11:10:00,These funds have generated returns north of 60% over the past five years and make for relatively safe investments.,JNJ,0.077593,0.174632,Somewhat-Bullish
Moderna inks deal to make mRNA medicines in China | Business,https://www.cnn.com/2023/07/06/business/china-moderna-investment-mrna-hnk-intl/index.html,2023-07-06 06:32:00,Moderna inks deal to make mRNA medicines in China ...,JNJ,0.078099,0.087157,Neutral
Prostate Cancer Global Market to Witness Upsurge in Growth at a CAGR of ~5% by 2028 | DelveInsight,https://www.prnewswire.com/news-releases/prostate-cancer-global-market-to-witness-upsurge-in-growth-at-a-cagr-of-5-by-2028--delveinsight-301869890.html,2023-07-05 21:01:00,"The prostate cancer market is anticipated to propel owing to the increasing incidence of prostate cancer around the world, the rising number of risk factors for prostate cancer, growing technological advancements in prostate cancer diagnostics, government, and non-government awareness ...",JNJ,0.027195,-0.051647,Neutral
"Where to Invest $1,000 Right Now",https://www.fool.com/investing/2023/07/05/where-to-invest-1000-right-now/,2023-07-05 18:00:00,Holding on to your investments for the long term is a key part of the strategy.,JNJ,0.097062,0.04415,Neutral
Johnson & Johnson Unusual Options Activity For July 05 - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/07/33116399/johnson-johnson-unusual-options-activity-for-july-05,2023-07-05 14:04:17,"Someone with a lot of money to spend has taken a bearish stance on Johnson & Johnson JNJ. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",JNJ,0.740156,0.145639,Neutral
Can Eli Lilly's  ( LLY )  Continue its Ride on Obesity Drug Wave?,https://www.zacks.com/stock/news/2117034/can-eli-lillys-lly-continue-its-ride-on-obesity-drug-wave,2023-07-05 13:51:00,Lilly (LLY) continues to raise the bar on obesity drugs as latest data show that participants treated with these experimental drugs achieved mean weight reduction of up to 24%.,JNJ,0.09347,0.176096,Somewhat-Bullish
"Protagonist Therapeutics-Janssen Partnered Psoriasis Candidate Fall Short Of Rival Treatment - Protagonist Therapeutics  ( NASDAQ:PTGX ) , Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/general/biotech/23/07/33111866/protagonist-therapeutics-janssen-partnered-psoriasis-candidate-fall-short-of-rival-treatment,2023-07-05 11:33:37,Protagonist Therapeutics Inc PTGX announced topline results from the Phase 2b FRONTIER 1 trial of the oral interleukin-23 receptor ( IL-23R ) antagonist JNJ-2113 ( formerly PN-235 ) in adult patients with moderate-to-severe plaque psoriasis presented at World Congress of Dermatology in Singapore.,JNJ,0.772973,-0.090679,Neutral
3 Spectacular Dividend Stocks to Buy in July,https://www.fool.com/investing/2023/07/04/3-spectacular-dividend-stocks-to-buy-in-july/,2023-07-04 12:14:00,Heat up your portfolio this month with these dividend stocks.,JNJ,0.420705,0.566194,Bullish
Opinion | No One Can Stop Rupert Murdoch. That's Increasingly a Problem.,https://www.nytimes.com/2023/07/04/opinion/rupert-murdoch-fox-news-dual-class-corporate-governance.html,2023-07-04 09:04:14,Opinion | Rupert Murdoch Can Do Whatever He Wants. It's Becoming a Problem. The New York Times ...,JNJ,0.03473,0.036008,Neutral
"Janssen Announces Positive Topline Results for JNJ-2113--a Novel, First and Only Oral IL-23 Receptor Antagonist Peptide in Development for Moderate-to-Severe Plaque Psoriasis",https://www.prnewswire.com/news-releases/janssen-announces-positive-topline-results-for-jnj-2113a-novel-first-and-only-oral-il-23-receptor-antagonist-peptide-in-development-for-moderate-to-severe-plaque-psoriasis-301869349.html,2023-07-04 06:51:00,"Janssen Announces Positive Topline Results for JNJ-2113--a Novel, First and Only Oral IL-23 Receptor Antagonist ... PR ...",JNJ,0.551226,0.07456,Neutral
Disposable Medical Supplies Market to grow by USD 38.36 billion from 2022 to 2027|Growing need for disposable medical suppliers is one of the key drivers- Technavio,https://www.prnewswire.com/news-releases/disposable-medical-supplies-market-to-grow-by-usd-38-36-billion-from-2022-to-2027growing-need-for-disposable-medical-suppliers-is-one-of-the-key-drivers--technavio-301868304.html,2023-07-04 02:45:00,Disposable Medical Supplies Market to grow by USD 38.36 billion from 2022 to 2027|Growing need for disposable ... PR ...,JNJ,0.023649,0.057945,Neutral
Toothpaste Market size to grow by USD 3.99 billion from 2021 to 2026| Rising dental issues in the children and elderly population to drive the market - Technavio,https://www.prnewswire.com/news-releases/toothpaste-market-size-to-grow-by-usd-3-99-billion-from-2021-to-2026--rising-dental-issues-in-the-children-and-elderly-population-to-drive-the-market---technavio-301868281.html,2023-07-03 23:45:00,Toothpaste Market size to grow by USD 3.99 billion from 2021 to 2026| Rising dental issues in the children and elderly ... PR ...,JNJ,0.032781,0.148683,Neutral
Johnson & Johnson  ( JNJ )  Stock Sinks As Market Gains: What You Should Know,https://www.zacks.com/stock/news/2116219/johnson-johnson-jnj-stock-sinks-as-market-gains-what-you-should-know,2023-07-03 21:45:19,"Johnson & Johnson (JNJ) closed at $163.35 in the latest trading session, marking a -1.31% move from the prior day.",JNJ,0.6809,0.232217,Somewhat-Bullish
JNJ: Which Pharma Stock Is the Better July Pick: Johnson & Johnson  ( JNJ )  or Curaleaf Holdings  ( CURLF ) ?,https://stocknews.com/news/jnj-curlf-which-pharma-stock-is-the-better-july-pick-johnson/,2023-07-03 15:07:37,JNJ: Which Pharma Stock Is the Better July Pick: Johnson ... ...,JNJ,0.328035,0.155581,Somewhat-Bullish
Bone Cement Market Zooms Towards Billion-Dollar Valuation: Estimated to Reach USD 1.99 Billion by 2030: Verified Market ResearchÂ®,https://www.prnewswire.com/news-releases/bone-cement-market-zooms-towards-billion-dollar-valuation-estimated-to-reach-usd-1-99-billion-by-2030-verified-market-research-301868864.html,2023-07-03 14:15:00,Bone Cement Market Zooms Towards Billion-Dollar Valuation: Estimated to Reach USD 1.99 Billion by 2030: Verified ... PR ...,JNJ,0.0312,0.080351,Neutral
"Psoriasis Treatment Market Size to reach USD 44 Bn by 2031, growing at a CAGR of 8.7% from 2022-2031: TMR Report",https://www.benzinga.com/pressreleases/23/07/g33094975/psoriasis-treatment-market-size-to-reach-usd-44-bn-by-2031-growing-at-a-cagr-of-8-7-from-2022-2031,2023-07-03 11:30:00,"Wilmington, Delaware, United States, July 03, 2023 ( GLOBE NEWSWIRE ) -- The global psoriasis treatment market is estimated to flourish at a CAGR of 8.7% from 2022 to 2031. According to Transparency Market Research, sales of Psoriasis Treatment are slated to total US$ 44 billion by the end of the ...",JNJ,0.035345,0.158918,Somewhat-Bullish
Why Veeva Systems Is a Top Pick for Investors in 2023,https://www.fool.com/investing/2023/07/01/why-veeva-systems-is-a-top-pick-for-investors-2023/,2023-07-01 17:30:00,This leading provider of cloud-based software solutions is well-positioned to benefit from the life sciences industry's steady growth.,JNJ,0.04161,0.259707,Somewhat-Bullish
Indian Intraocular Lens Market size to grow at a CAGR of 9.2% from 2022 to 2027|Increasing prevalence of ophthalmic diseases drives the market growth -Technavio,https://www.prnewswire.com/news-releases/indian-intraocular-lens-market-size-to-grow-at-a-cagr-of-9-2-from-2022-to-2027increasing-prevalence-of-ophthalmic-diseases-drives-the-market-growth--technavio-301867471.html,2023-07-01 03:15:00,Indian Intraocular Lens Market size to grow at a CAGR of 9.2% from 2022 to 2027|Increasing prevalence of ophthalmic ... PR ...,JNJ,0.060464,0.152176,Somewhat-Bullish
Check Out What Whales Are Doing With JNJ - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/06/33082963/check-out-what-whales-are-doing-with-jnj,2023-06-30 17:47:33,"Someone with a lot of money to spend has taken a bearish stance on Johnson & Johnson JNJ. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",JNJ,0.812186,0.258643,Somewhat-Bullish
"Like shoppers, IPO investors are demanding discounts and showing price sensitivity",https://www.marketwatch.com/story/like-shoppers-ipo-investors-are-demanding-discounts-and-showing-price-sensitivity-1544c027,2023-06-30 16:17:00,"IPO investors, much like shoppers in the current inflationary environment, are demanding discounts, according to Renaissance Capital.",JNJ,0.113866,0.0,Neutral
"If You Invested $5,000 In Johnson & Johnson In 2018, This Is How Much You Would Have Today",https://www.fool.com/investing/2023/06/30/if-you-invested-5000-in-johnson-johnson-in-2018-th/,2023-06-30 12:25:00,"The longer you can stand to wait, the more this investment will pay off.",JNJ,0.217346,0.375719,Bullish
Corporate diversity policies may face scrutiny after Supreme Court's affirmative action ruling,https://www.foxbusiness.com/politics/corporate-diversity-policies-may-face-scrutiny-after-supreme-courts-affirmative-action-ruling,2023-06-30 11:05:08,The rejecting the use of affirmative action policies by colleges could lead to new scrutiny of corporate diversity initiatives.,JNJ,0.099476,0.282266,Somewhat-Bullish
5 Genius Safe Stocks to Buy for the Second Half of 2023,https://www.fool.com/investing/2023/06/30/5-genius-safe-stocks-to-buy-for-second-half-2023/,2023-06-30 09:21:00,"These profitable, time-tested businesses are smart buys in an uncertain environment.",JNJ,0.096801,0.170784,Somewhat-Bullish
Organic Sanitary Napkins Market size to grow at a CAGR of 7.46% from 2022 to 2027: Organic Menstrual Pads to be a leading segment - Technavio,https://www.prnewswire.com/news-releases/organic-sanitary-napkins-market-size-to-grow-at-a-cagr-of-7-46-from-2022-to-2027-organic-menstrual-pads-to-be-a-leading-segment---technavio-301866537.html,2023-06-30 03:15:00,Organic Sanitary Napkins Market size to grow at a CAGR of 7.46% from 2022 to 2027: Organic Menstrual Pads to be a ... PR ...,JNJ,0.028764,0.181235,Somewhat-Bullish
Pharmaceutical Industry Overview: Top Regions  ( Updated 2023 ) ,https://investingnews.com/daily/life-science-investing/pharmaceutical-investing/top-pharmaceutical-regions/,2023-07-19 21:15:00,"The pharmaceutical industry has a global presence, but the world's biggest markets are the US and Europe. Regions such as China and India have seen growth in recent years, but when it comes to the life science space - particularly the pharma industry - the US and Europe remain on top for ...",JNJ,0.043499,0.117759,Neutral
"Tesla On Tap: ""Mega-cap"" Reporting Season Gets Underway After Close With EV Giant's Earnings - Apple  ( NASDAQ:AAPL ) , Albertsons Companies  ( NYSE:ACI ) ",https://www.benzinga.com/markets/23/07/33291567/tesla-on-tap-mega-cap-reporting-season-gets-underway-after-close-with-ev-giants-earnings,2023-07-19 19:36:45,"( Wednesday market open ) Major indexes ride into Tesla's TSLA earnings later today on a long winning streak that carried stocks to new 15-month highs yesterday. Hopes for an economic ""soft landing"" based on recent positive data drove gains. Investors appear to expect more positive news after ...",JNJ,0.038811,0.043159,Neutral
Dow Poised For Longest Winning Streak Since 2019-Up 4% Over 8 Days,https://www.forbes.com/sites/dereksaul/2023/07/19/dow-poised-for-longest-winning-streak-since-2019-up-4-over-8-days/,2023-07-19 16:23:40,The historically positive stretch came as volatility slid to a multi-year low and fund manager profit outlook surged to a 17-month high.,JNJ,0.101582,0.114259,Neutral
Institutional Vs. Retail Investors: Who Ya Got?,https://www.benzinga.com/markets/cryptocurrency/23/07/33286883/institutional-vs-retail-investors-who-ya-got,2023-07-19 15:03:15,"Are we inching closer to the elusive ""soft landing""? An increasing share of global fund managers sees it as the most likely outcome over the next 12 months: Here are some highlights from BofA's latest Global Fund Manager Survey: Investors still expect global growth to weaken in the next 12 months.",JNJ,0.036983,-0.09114,Neutral
"Top Stories Wednesday, July 19: Microsoft-Activision Adjust Deal Deadline Terms, Goldman Sachs' Q2 Profits Fall 60%, Johnson & Johnson Joins Legal Battle Against US Government On Drug Pricing Negotiation - Apple  ( NASDAQ:AAPL ) , American Airlines Group  ( NASDAQ:AAL ) ",https://www.benzinga.com/news/23/07/33285781/microsoft-activision-adjust-deal-deadline-terms-goldman-sachs-q2-profits-fall-60-johnson-johnson-joi,2023-07-19 14:09:58,Microsoft Corp MSFT and Activision Blizzard Inc ATVI stocks are grabbing attention amid reports of the companies extending the $69 billion takeover deal to October 18.,JNJ,0.146692,-0.131772,Neutral
Jim Cramer's top 10 things to watch in the stock market Wednesday,https://www.cnbc.com/2023/07/19/jim-cramers-top-10-things-to-watch-in-the-stock-market-wednesday.html,2023-07-19 13:39:55,"The Dow on Wednesday looks to make it eight straight sessions higher. Boosted in recent days, with earnings season off to a strong start ...",JNJ,0.102013,-0.013896,Neutral
Why Johnson & Johnson  ( JNJ )  Shares Are Trading Lower Premarket Today? - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/general/biotech/23/07/33280766/johnson-johnsons-first-talc-related-trial-in-two-years-court-orders-to-pay-around-19m,2023-07-19 11:50:57,"Johnson & Johnson JNJ has been ordered to pay $18.8 million to Emory Hernandez Valadez, a California man who allegedly developed cancer due to exposure to the company's baby powder. J&J's subsidiary LTL Management filed for bankruptcy in April, proposing to pay $8.9 billion to settle over 38,000 ...",JNJ,0.399204,-0.203191,Somewhat-Bearish
Drug Pricing Negotiation Program: Johnson & Johnson Joins Legal Battle Against US Government - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/general/biotech/23/07/33280064/drug-pricing-negotiation-program-johnson-johnson-joins-legal-battle-against-us-government,2023-07-19 11:48:29,"Johnson & Johnson JNJ has reportedly taken legal action against the U.S. government, following the lead of other pharmaceutical companies aiming to obstruct a program that empowers the Medicare government health insurance plan to negotiate lower prices for medication.",JNJ,0.274834,0.016858,Neutral
"The daily business briefing: July 19, 2023",https://theweek.com/briefing/business-briefing/1025129/the-daily-business-briefing-july-19-2023,2023-07-19 11:38:54,"Hernandez Valadez says he developed cancer from heavy exposure to Johnson's Baby Powder since childhood Morgan Stanley shares jumped 6.5% on Tuesday after it reported better-than-expected second-quarter earnings, even though profit fell 13% compared to a year earlier.",JNJ,0.122581,-0.105964,Neutral
3 No-Brainer Stocks to Buy With $400 Right Now,https://www.fool.com/investing/2023/07/19/3-no-brainer-stocks-to-buy-with-400-right-now/,2023-07-19 09:21:00,A modest amount of money can go a long way when it's invested in industry-leading businesses.,JNJ,0.131823,0.122841,Neutral
"A terminally-ill man won $18 million in a lawsuit after saying he got cancer from Johnson & Johnson's baby powder, but a bankruptcy court order means he likely won't live long enough to see the money",https://www.businessinsider.com/cancer-patient-18m-from-johnson-and-johnson-baby-powder-bankruptcy-2023-7,2023-07-19 05:41:00,"Cancer patient wins $18M from J&J over baby powder, unlikely to see cash - Business Insider ...",JNJ,0.558244,-0.581236,Bearish
Johnson & Johnson must pay $18.8 million to California cancer patient in baby powder suit | Business,https://www.cnn.com/2023/07/18/business/johnson-and-johnson-baby-powder-suit/index.html,2023-07-19 00:30:00,Johnson & Johnson must pay $18.8 million to California cancer patient in baby powder suit ...,JNJ,0.063763,-0.208348,Somewhat-Bearish
Johnson & Johnson sues Biden administration over drug-pricing policies - .com,https://www.upi.com/Top_News/US/2023/07/18/johnson-and-johnson-sues-biden-administration-inflation-reduction-act/7411689709051/,2023-07-18 21:32:09,Johnson & Johnson sues Biden administration over drug-pricing policies UPI News ...,JNJ,0.392537,-0.159291,Somewhat-Bearish
Johnson & Johnson Unusual Options Activity - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/07/33274964/johnson-johnson-unusual-options-activity,2023-07-18 20:45:34,"A whale with a lot of money to spend has taken a noticeably bearish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson JNJ we detected 11 strange trades. If we consider the specifics of each trade, it is accurate to state that 36% of the investors opened trades with ...",JNJ,0.812724,0.202687,Somewhat-Bullish
"Celebrating Excellence In Gospel Music: Winners Of The 38th Annual Stellar Gospel Music Awards Revealed, With Pastor Mike, Jr. Sweeping The Ceremony With Eight Trophies - Paramount Global  ( NASDAQ:PARAA ) ",https://www.benzinga.com/pressreleases/23/07/n33273544/celebrating-excellence-in-gospel-music-winners-of-the-38th-annual-stellar-gospel-music-awards-reve,2023-07-18 19:35:00,"Other Multiple Winners Include DOE and Zacardi Cortez with Three Awards; Maverick City Music x Kirk Franklin and Tye Tribbett with Two Trophies Each; The Greatest Night in Gospel Music, 2023 Stellar Awards, Set to Premiere on Stellar Network July 30, BET on August 6, and Bounce TV on September 3",JNJ,0.023281,0.296836,Somewhat-Bullish
"Subdued Tone: Major Indexes Waver Despite Earnings Beats by Bank of America, Morgan Stanley - American Express  ( NYSE:AXP ) , American Airlines Group  ( NASDAQ:AAL ) ",https://www.benzinga.com/markets/23/07/33272167/subdued-tone-major-indexes-waver-despite-earnings-beats-by-bank-of-america-morgan-stanley,2023-07-18 17:57:32,"( Tuesday market open ) The morning kicks off with more big banks beating analysts' earnings expectations, but major indexes were barely changed in premarket trading. Retail Sales-an important barometer of consumer health-rose less than expected in June.",JNJ,0.079788,0.029409,Neutral
Johnson & Johnson sues Biden administration over Medicare drug price negotiations,https://www.cnbc.com/2023/07/18/jj-sues-biden-administration-over-medicare-drug-negotiations.html,2023-07-18 17:07:47,"Merck, Bristol Myers Squibb, the U.S. Chamber of Commerce and PhRMA filed separate lawsuits against the provision last month.",JNJ,0.207571,-0.3699,Bearish
"J&J  ( JNJ )  to Begin Q2 Earnings Season for Drug, Biotech Sector",https://www.zacks.com/stock/news/2123096/jj-jnj-to-begin-q2-earnings-season-for-drug-biotech-sector,2023-07-18 15:56:00,"Growth in J&J's (JNJ) Pharma unit is expected to have been driven by drugs like Darzalex. In the MedTech segment, recovery in surgical procedures and new product launches are likely to have pushed sales growth.",JNJ,0.18602,0.084827,Neutral
"Collagen Dressings Market Soars to New Heights; Set to Surpass US$ 1.7 Billion by 2031, Driven by Steady 5.5% CAGR Growth: TMR Report",https://www.benzinga.com/pressreleases/23/07/g33265884/collagen-dressings-market-soars-to-new-heights-set-to-surpass-us-1-7-billion-by-2031-driven-by-ste,2023-07-18 13:00:00,"Wilmington, Delaware, United States, July 18, 2023 ( GLOBE NEWSWIRE ) -- The global collagen dressings market is estimated to flourish at a CAGR of 5.5% from 2022 to 2031. According to Transparency Market Research, sales of collagen dressings are slated to total US$ 1.7 billion by the end of the ...",JNJ,0.035768,0.0,Neutral
Tactile Medical Appoints Sherri Ferstler as Senior Vice President of Sales,https://www.globenewswire.com/news-release/2023/07/18/2706337/0/en/Tactile-Medical-Appoints-Sherri-Ferstler-as-Senior-Vice-President-of-Sales.html,2023-07-18 12:00:00,"MINNEAPOLIS, July 18, 2023 ( GLOBE NEWSWIRE ) -- Tactile Systems Technology, Inc. ( ""Tactile Medical"" ) ( Nasdaq: TCMD ) , a medical technology company providing therapies for people with chronic disorders, today announced the appointment of Sherri Ferstler to the position of Senior Vice ...",JNJ,0.098255,0.202861,Somewhat-Bullish
"9 'Safer Than AT&T' Stocks Pay The Plumpest, Lead-Free Dividends",https://www.investors.com/etfs-and-funds/sectors/sp500-safer-than-att-stocks-pay-the-plumpest-lead-free-dividends/,2023-07-18 12:00:00,AT&T's plump dividend used to be like money in the bank. But now investors seeking income and safety might look elsewhere as Ma Bell sinks like a ton of lead.,JNJ,0.272029,0.037036,Neutral
Virtualware  ( EPA:MLVIR )  Announces record-breaking First-Half 2023 Results: VR SaaS Business Line Records Steady 208% Growth,https://www.globenewswire.com/news-release/2023/07/18/2706087/0/en/Virtualware-EPA-MLVIR-Announces-record-breaking-First-Half-2023-Results-VR-SaaS-Business-Line-Records-Steady-208-Growth.html,2023-07-18 05:57:00,"BILBAO, Spain, July 18, 2023 ( GLOBE NEWSWIRE ) -- Virtualware ( EPA:MLVIR ) , a pioneering VR company employing a SaaS business model, today announced record-breaking H1 2023 financial results, just three months after it went public in Euronext Access Paris.",JNJ,0.052801,0.098632,Neutral
3 Quarterly Reports Investors Can't Ignore This Week,https://www.zacks.com/stock/news/2122473/3-quarterly-reports-investors-cant-ignore-this-week,2023-07-17 23:31:00,"We've got a loaded slate, including quarterly results from Netflix, American Express, and Johnson & Johnson. But how do estimates stack up heading into their respective prints?",JNJ,0.337427,0.084511,Neutral
Futures: Stocks Hit 2023 Highs; What To Do Now,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-tesla-stock-cybertruck-t-stock-verizon-plunge/,2023-07-17 21:10:00,"Dow Jones Futures: Tesla Hits 2023 High On First Austin Cybertruck. AT&T, Verizon Plunge Investor's Business Daily ...",JNJ,0.068698,0.0,Neutral
5 Uses for AI in Customer Service,https://www.fool.com/investing/stock-market/market-sectors/information-technology/ai-stocks/ai-in-customer-service/,2023-07-17 20:20:41,"Of all the applications for artificial intelligence ( AI ) , customer service is one of the most common.Companies big and small have been using tools like AI customer service bots and voice assistants in order to handle customer requests, and businesses have also used algorithms to improve ...",JNJ,0.067064,0.179951,Somewhat-Bullish
Johnson & Johnson Unusual Options Activity For July 17 - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/07/33255040/johnson-johnson-unusual-options-activity-for-july-17,2023-07-17 19:01:23,"A whale with a lot of money to spend has taken a noticeably bearish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson JNJ we detected 10 strange trades. If we consider the specifics of each trade, it is accurate to state that 10% of the investors opened trades with ...",JNJ,0.733479,0.046384,Neutral
"Electric Week Ahead: Tesla Earnings Among Highlights Along with Retail Sales, but Soft China Growth in Focus - Apple  ( NASDAQ:AAPL ) , American Airlines Group  ( NASDAQ:AAL ) ",https://www.benzinga.com/markets/23/07/33254739/electric-week-ahead-tesla-earnings-among-highlights-along-with-retail-sales-but-soft-china-growth-in,2023-07-17 18:31:57,"( Monday market open ) Earnings season spreads its wings this week with reports from several giant banks and a mega-cap company on the schedule, along with a dose of consumer-oriented retail sales and housing data.",JNJ,0.08398,0.060311,Neutral
Stock Market Sleepy To Start The Week; Ventilation Products Stock Breaks Out,https://www.investors.com/market-trend/stock-market-today/stock-market-sleepy-to-start-the-week-hvac-stock-breaks-out/,2023-07-17 14:51:00,Stock Market Sleepy To Start The Week. Ventilation Products Stock Breaks Out Investor's Business Daily ...,JNJ,0.129516,0.0,Neutral
Jim Cramer's top 10 things to watch in the stock market Monday,https://www.cnbc.com/2023/07/17/jim-cramers-top-10-things-to-watch-in-the-stock-market-monday.html,2023-07-17 13:33:02,The Dow opens lower Monday after Friday completed a five-session winning streak and the best weekly performance since March.,JNJ,0.187221,0.027836,Neutral
Treatment with RYBREVANTÂ®  ( amivantamab-vmjw )  Plus Chemotherapy Resulted in Statistically Significant and Clinically Meaningful Improvement in Progression-Free Survival in Patients with Newly Diagnosed EGFR Exon 20 Insertion Mutation-Positive Non-Small Cell Lung Cancer,https://www.prnewswire.com/news-releases/treatment-with-rybrevant-amivantamab-vmjw-plus-chemotherapy-resulted-in-statistically-significant-and-clinically-meaningful-improvement-in-progression-free-survival-in-patients-with-newly-diagnosed-egfr-exon-20-insertion-mutati-301878443.html,2023-07-17 12:30:00,Treatment with RYBREVANTÂ® ( amivantamab-vmjw ) Plus Chemotherapy Resulted in Statistically Significant and ... PR ...,JNJ,0.086156,0.036812,Neutral
Futures Sag; Tesla Completes First Austin Cybertruck,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-tesla-stock-jumps-on-first-cybertruck/,2023-07-17 12:24:00,Dow Jones Futures Fall. Tesla Stock Jumps On First Austin Cybertruck Investor's Business Daily ...,JNJ,0.063008,0.0,Neutral
"China's Economy is Stuttering, Posing a Challenge for Global Growth",https://www.nytimes.com/2023/07/17/business/china-economy-slowdown-global-growth.html,2023-07-17 12:16:11,New data published on Monday shows a post-pandemic recovery has not materialized after restrictions were lifted last year.,JNJ,0.020995,-0.113484,Neutral
"Inflation Fight, Endless Data, Bonds, Fed Funds Futures, China, Busy Week Ahead",https://realmoney.thestreet.com/investing/inflation-fight-endless-data-bonds-fed-funds-futures-china-busy-week-ahead-16128817,2023-07-17 11:52:04,"One week ago, professional traders and the investing public were not quite sure what to expect.",JNJ,0.022696,0.0,Neutral
Should You Invest in the Health Care Select Sector SPDR ETF  ( XLV ) ?,https://www.zacks.com/stock/news/2121856/should-you-invest-in-the-health-care-select-sector-spdr-etf-xlv,2023-07-17 10:20:09,Sector ETF report for ...,JNJ,0.126784,0.062464,Neutral
Should You Invest in the iShares U.S. Healthcare ETF  ( IYH ) ?,https://www.zacks.com/stock/news/2121860/should-you-invest-in-the-ishares-us-healthcare-etf-iyh,2023-07-17 10:20:06,Sector ETF report for ...,JNJ,0.135729,0.070611,Neutral
2 Monster Stocks to Buy Without Any Hesitation,https://www.fool.com/investing/2023/07/17/2-monster-stocks-to-buy-without-any-hesitation/,2023-07-17 09:30:00,These players each bring in billions of dollars in earnings every year.,JNJ,0.130217,0.14593,Neutral
"JPMorgan, Citigroup and Wells Fargo are part of Zacks Earnings Preview",https://www.zacks.com/stock/news/2121821/jpmorgan-citigroup-and-wells-fargo-are-part-of-zacks-earnings-preview,2023-07-17 09:00:00,"Chicago, IL - July 17, 2023 - Zacks.com releases the list of companies likely to issue earnings surprises. This week's list includes JPMorgan ( JPM Quick QuoteJPM - ) , Citigroup ( C Quick QuoteC - ) and Wells Fargo ( WFC Quick QuoteWFC - ) .",JNJ,0.027763,0.0,Neutral
3 Dividend Growth Stocks to Buy and Hold,https://www.fool.com/investing/2023/07/16/3-dividend-growth-stocks-to-buy-and-hold/,2023-07-16 10:15:00,Where these dividends are going is even more important than where they've been.,JNJ,0.271489,0.262351,Somewhat-Bullish
2 Warren Buffett Stocks to Buy Hand Over Fist,https://www.fool.com/investing/2023/07/15/2-warren-buffett-stocks-to-buy-hand-over-fist/,2023-07-15 09:30:00,Buffett's strategy involves buying top companies for reasonable prices -- and holding on to them.,JNJ,0.127119,0.294142,Somewhat-Bullish
"Investing Action Plan: Tesla, Netflix And Airlines Fly Into The Q2 Season",https://www.investors.com/research/investing-action-plan/stock-market-action-plan-tesla-netflix-and-airlines-fly-into-the-q2-earnings-season/,2023-07-14 21:54:00,"After a rousing week of stock market gains, earnings season is upon us. Analysts and companies have lowered their expectations for second-quarter earnings. Early rounds of reports, however, have shown investors briskly rewarding performances that top those low targets.",JNJ,0.073154,0.046641,Neutral
"S&P Makes Weekly Advance As Inflation Reaches Lowest Level Since March 2021; Amazon, Microsoft, Alphabet And Major Banks Lead Market Optimism - Netflix  ( NASDAQ:NFLX ) , Alphabet  ( NASDAQ:GOOG ) , Alphabet  ( NASDAQ:GOOGL ) , Interactive Brokers Gr  ( NASDAQ:IBKR ) , Citigroup  ( NYSE:C ) , SAP  ( NYSE:SAP ) , Bank of America  ( NYSE:BAC ) , JPMorgan Chase  ( NYSE:JPM ) , Morgan Stanley  ( NYSE:MS ) , Novartis  ( NYSE:NVS ) , Goldman Sachs Gr  ( NYSE:GS ) , ASML Holding  ( NASDAQ:ASML ) , Taiwan Semiconductor  ( NYSE:TSM ) , Microsoft  ( NASDAQ:MSFT ) , Lockheed Martin  ( NYSE:LMT ) , Tesla  ( NASDAQ:TSLA ) , IBM  ( NYSE:IBM ) , Wells Fargo  ( NYSE:WFC ) , Activision Blizzard  ( NASDAQ:ATVI ) , American Express  ( NYSE:AXP ) , Charles Schwab  ( NYSE:SCHW ) , Amazon.com  ( NASDAQ:AMZN ) ",https://www.benzinga.com/markets/equities/23/07/33235717/s-p-makes-weekly-advance-as-inflation-reaches-lowest-level-since-march-2021-amazon-microsoft-alp,2023-07-14 19:50:57,"The S&P 500 is closing the week in the green in light of positive inflation data. The index was 2.48% higher on the week ahead of the market close Friday. Other major market indexes also showed an upward trajectory, with the Dow Jones rising 2.36% on the week.",JNJ,0.05234,0.0,Neutral
Q2 Earnings Season: A Good Start So Far,https://www.zacks.com/commentary/2121584/q2-earnings-season-a-good-start-so-far,2023-07-14 19:06:00,"There was plenty to like from the banks, with the resilient economy helping keep credit demand positive and higher interest rates allowing them to charge more for those loans.",JNJ,0.027042,0.0,Neutral
"Bank Domination: Earnings Season Kicks Off With A Hat Trick As Three Major Banks Post Beats - American Express  ( NYSE:AXP ) , American Airlines Group  ( NASDAQ:AAL ) ",https://www.benzinga.com/markets/23/07/33233267/bank-domination-earnings-season-kicks-off-with-a-hat-trick-as-three-major-banks-post-beats,2023-07-14 16:01:50,"( Friday market open ) After scampering to 15-month highs this week as investors cheered signs of slowing inflation, major stock indexes embark today on a voyage through earnings season, starting with three of the biggest U.S. banks.",JNJ,0.07959,0.005082,Neutral
Johnson & Johnson Poised For A Muted Q2?,https://www.forbes.com/sites/greatspeculations/2023/07/14/johnson--johnson-poised-for-a-muted-q2/,2023-07-14 14:00:20,"We expect the company's revenues to come in at $24.6 billion, marginally below the consensus estimate of $24.7 billion.",JNJ,0.441698,0.176414,Somewhat-Bullish
"Vaccine research market to grow at a CAGR of 9.88% from 2022 to 2027 | Abbott Laboratories, Astellas Pharma Inc., AstraZeneca Plc, more to emerge as key players- Technavio",https://www.prnewswire.com/news-releases/vaccine-research-market-to-grow-at-a-cagr-of-9-88-from-2022-to-2027--abbott-laboratories-astellas-pharma-inc-astrazeneca-plc-more-to-emerge-as-key-players--technavio-301876877.html,2023-07-14 11:01:00,"Vaccine research market to grow at a CAGR of 9.88% from 2022 to 2027 | Abbott Laboratories, Astellas Pharma Inc ... PR ...",JNJ,0.068112,0.088244,Neutral
This Week in Environment News: 11 Stories You Need to See,https://www.prnewswire.com/news-releases/this-week-in-environment-news-11-stories-you-need-to-see-301877108.html,2023-07-14 10:32:00,"A roundup of the week's most newsworthy environment industry press releases from PR Newswire, including eco-friendly cruise ships and charcuterie packaging. NEW YORK, July 14, 2023 /PRNewswire/ -- With thousands of press releases published each week, it can be difficult to keep up with everything ...",JNJ,0.03878,0.111384,Neutral
3 Best Buffett Stocks to Buy for the Long Haul,https://www.fool.com/investing/2023/07/14/3-best-buffett-stocks-to-buy-for-the-long-haul/,2023-07-14 09:50:00,Warren Buffett owns plenty of great stocks. These could be the best to buy and hold over the long run.,JNJ,0.319725,0.221141,Somewhat-Bullish
In Vitro Diagnostics Market to Grow Rapidly at a CAGR of 4.2% by 2030 | DataM Intelligence,https://www.benzinga.com/pressreleases/23/07/g33227633/in-vitro-diagnostics-market-to-grow-rapidly-at-a-cagr-of-4-2-by-2030-datam-intelligence,2023-07-14 09:00:00,"USA, New York, July 14, 2023 ( GLOBE NEWSWIRE ) -- The Global In Vitro Diagnostics Market reached USD 101.1 billion in 2022 and is expected to reach USD 139.7 billion by 2030 and is expected to grow with a CAGR of 4.2% during the forecast period 2023-2030.",JNJ,0.053992,0.0,Neutral
"Take Five: Buddy, can you spare a dollar?",https://www.reuters.com/business/take-five/global-markets-themes-graphic-2023-07-14/,2023-07-14 06:34:00,"July 14 ( Reuters ) - A meeting of global finance ministers, earnings from U.S. companies whose market value exceeds that of some nations' entire economies, and a pulse-check for Chinese growth are in the market spotlight.",JNJ,0.047278,0.0,Neutral
Johnson & Johnson Sues Doctors Over Studies Linking Talc-Based Products and Cancer,https://www.wsj.com/articles/johnson-johnson-sues-doctors-over-studies-linking-talc-based-products-and-cancer-78ffd2a7,2023-07-13 23:57:00,Company says the studies played a significant role in lawsuits over its Baby Powder and Shower to Shower products.,JNJ,0.666827,-0.577481,Bearish
"Point of Care Diagnostics Market to Grow by 10.65% from 2022 to 2027|Abbott Laboratories, altona Diagnostics GmbH, and more to emerge as key players -Technavio",https://www.prnewswire.com/news-releases/point-of-care-diagnostics-market-to-grow-by-10-65-from-2022-to-2027abbott-laboratories-altona-diagnostics-gmbh-and-more-to-emerge-as-key-players--technavio-301875838.html,2023-07-13 23:00:00,"Point of Care Diagnostics Market to Grow by 10.65% from 2022 to 2027|Abbott Laboratories, altona Diagnostics GmbH ... PR ...",JNJ,0.063425,0.076032,Neutral
Johnson & Johnson Letting Nonprofit Distribute Life-Saving Generic Tuberculosis Drug-Greatly Expanding Access In Poorer Countries,https://www.forbes.com/sites/willskipworth/2023/07/13/johnson--johnson-letting-nonprofit-distribute-life-saving-generic-tuberculosis-drug-greatly-expanding-access-in-poorer-countries/,2023-07-13 17:51:19,"The drug manufacturer faced an online pressure campaign championed by novelist John Green before the announcement Thursday, which lets Stop TB Partnership offer cheaper generic versions of Johnson & Johnson's tuberculosis drug in 44 more countries.",JNJ,0.462395,-0.073622,Neutral
3 health-care stocks are in the headlines. How the news impacts our investments,https://www.cnbc.com/2023/07/13/3-health-care-stocks-are-in-the-news-how-the-news-impacts-our-stocks.html,2023-07-13 17:23:30,"The latest developments on Johnson & Johnson (JNJ), Humana (HUM) and Eli Lilly (LLY), and how they affect our thinking on the stocks.",JNJ,0.817578,0.233466,Somewhat-Bullish
"More Inflation Cheer As June PPI Lighter Than Expected, Lifting Markets Ahead Of Friday's Bank Earnings - Citigroup  ( NYSE:C ) , Activision Blizzard  ( NASDAQ:ATVI ) ",https://www.benzinga.com/markets/23/07/33219704/more-inflation-cheer-as-june-ppi-lighter-than-expected-lifting-markets-ahead-of-fridays-bank-earning,2023-07-13 16:46:35,"( Thursday market open ) ) It's dÃ©jÃ  vu on Wall Street this morning. For the second straight session, major indexes rose ahead of the opening bell on signs of U.S. inflation easing, this time as the June Producer Price Index ( PPI ) rose less than analysts had expected.",JNJ,0.039878,0.043331,Neutral
Johnson & Johnson  ( JNJ )  Reports Next Week: Wall Street Expects Earnings Growth,https://www.zacks.com/stock/news/2120611/johnson-johnson-jnj-reports-next-week-wall-street-expects-earnings-growth,2023-07-13 14:01:00,Johnson & Johnson (JNJ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,JNJ,0.296463,0.059313,Neutral
Is Johnson & Johnson Stock Overvalued?,https://www.fool.com/investing/2023/07/13/is-johnson-johnson-stock-overvalued/,2023-07-13 09:35:00,The stock's premium valuation could be justified.,JNJ,0.227538,0.162744,Somewhat-Bullish
Healthtech Startup Fitelo appoints ex-RenewBuy executive Gautam Bansal as CFO - ETCFO,https://cfo.economictimes.indiatimes.com/news/leadership/healthtech-startup-fitelo-appoints-ex-renewbuy-executive-gautam-bansal-as-cfo/101721582,2023-07-13 07:20:30,Bansal's appointment comes in a little over a year since the startup last raised $1.5 million during May 2022 in a pre-series A round. Bansal told ETCFO about the appointment which was later confirmed by the company.,JNJ,0.209365,0.121536,Neutral
Johnson & Johnson  ( JNJ )  Stock Sinks As Market Gains: What You Should Know,https://www.zacks.com/stock/news/2120223/johnson-johnson-jnj-stock-sinks-as-market-gains-what-you-should-know,2023-07-12 21:45:18,"In the latest trading session, Johnson & Johnson (JNJ) closed at $157.97, marking a -0.42% move from the previous day.",JNJ,0.603594,0.300372,Somewhat-Bullish
Will Q2 Earnings Drive Dow ETFs Higher?,https://www.zacks.com/stock/news/2120089/will-q2-earnings-drive-dow-etfs-higher,2023-07-12 16:05:00,Nearly one-fourth of the blue-chip firms are expected to announce results this week and the next.,JNJ,0.140076,0.025798,Neutral
What Stocks To Buy Today? 3 Good Dividend Stocks In Focus,https://stockmarket.com/featured/what-stocks-to-buy-today-3-good-dividend-stocks-in-focus-2023-07-12,2023-07-12 15:03:30,"Dividends represent a portion of a company's earnings that are paid out to shareholders, typically on a quarterly basis, as a way of sharing the company's success. Dividend stocks are those stocks issued by companies that regularly pay out dividends.",JNJ,0.270523,0.024203,Neutral
"How to Turn $10,000 Into $1,000,000 by Retirement",https://www.fool.com/investing/2023/07/12/how-to-turn-10000-into-1000000-by-retirement/,2023-07-12 10:59:00,There's no big secret to earning outsize gains -- simply invest in quality businesses for the long haul.,JNJ,0.124486,0.245067,Somewhat-Bullish
Should Vanguard High Dividend Yield ETF  ( VYM )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2119610/should-vanguard-high-dividend-yield-etf-vym-be-on-your-investing-radar,2023-07-12 10:20:09,Style Box ETF report for ...,JNJ,0.128135,0.069783,Neutral
Should You Invest in the Vanguard Health Care ETF  ( VHT ) ?,https://www.zacks.com/stock/news/2119617/should-you-invest-in-the-vanguard-health-care-etf-vht,2023-07-12 10:20:07,Sector ETF report for ...,JNJ,0.138066,0.072464,Neutral
3 Dow Stocks That Are Stand-Out Buys for July  ( and Beyond ) ,https://www.fool.com/investing/2023/07/12/3-dow-stocks-stand-out-buys-for-july-and-beyond/,2023-07-12 09:06:00,"Although the iconic Dow has its flaws, it's home to three stunning deals hiding in plain sight.",JNJ,0.179343,0.016567,Neutral
Indra Nooyi to Neerja Sethi: Indian-origin women who made it to Forbes' list of America's 100 most successful businesswomen in 2023 | The Financial Express,https://www.financialexpress.com/lifestyle/indra-nooyi-to-neerja-sethi-indian-origin-women-who-made-it-to-forbes-list-of-americas-100-most-successful-businesswomen-in-2023/3166399/,2023-07-12 08:59:54,Indra Nooyi to Neerja Sethi: Indian-origin women who made it to Forbes' list of America's 100 most successful businesswomen in 2023 The Financial Express ...,JNJ,0.063933,0.173241,Somewhat-Bullish
Neurocrine Biosciences Announces Appointment of Christine A. Poon to Board of Directors,https://www.prnewswire.com/news-releases/neurocrine-biosciences-announces-appointment-of-christine-a-poon-to-board-of-directors-301874728.html,2023-07-11 20:05:00,"SAN DIEGO, July 11, 2023 /PRNewswire/ -- Neurocrine Biosciences, Inc. ( Nasdaq: NBIX ) today announced that it appointed Christine A. Poon, a business leader with extensive experience in the pharmaceutical industry, to its Board of Directors.",JNJ,0.308891,-0.011001,Neutral
Johnson & Johnson's Unit Recalls Certain Electrosurgical Tools Due Risk Of Burn Injuries - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/news/23/07/33188883/johnson-johnsons-unit-recalls-certain-electrosurgical-tools-due-risk-of-burn-injuries,2023-07-11 17:08:53,"The FDA classified the recall of certain electrosurgery tools manufactured by a Johnson & Johnson JNJ unit as the most serious, saying their use could lead to injuries or death.",JNJ,0.524949,0.05383,Neutral
"Campaign aims to create ""world's largest library"" of diverse medical illustrations",https://www.axios.com/2023/07/11/chidiebere-ibe-medical-illustration-black-fetus,2023-07-11 17:04:21,"Chidiebere Ibe, whose illustration of a Black fetus went viral a year and a half ago, is helping launch a campaign to diversify images used in medical textbooks and diagnosis manuals.",JNJ,0.244109,-0.018477,Neutral
U.S. FDA classifies recall of J&J's electrosurgical tools as most serious,https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-classifies-recall-jjs-electrosurgical-tools-most-serious-2023-07-11/,2023-07-11 15:32:00,"July 11 ( Reuters ) - The U.S. Food and Drug Administration ( FDA ) on Tuesday classified the recall of certain electrosurgery tools manufactured by a Johnson & Johnson unit ( JNJ.N ) as the most serious, saying their use could lead to injuries or death.",JNJ,0.182506,-0.047605,Neutral
Jim Cramer's top 10 things to watch in the stock market Tuesday,https://www.cnbc.com/2023/07/11/jim-cramers-top-10-things-to-watch-in-the-stock-market-tuesday.html,2023-07-11 13:30:01,"The Dow, S&P 500 and Nasdaq open higher after breaking three-session losing streaks.",JNJ,0.136113,-0.209176,Somewhat-Bearish
Johnson & Johnson Asbestos Claims Continue: California Man Alleges Baby Powder Led to Rare Cancer - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/general/biotech/23/07/33178880/johnson-johnson-asbestos-claims-continue-california-man-alleges-baby-powder-led-to-rare-cancer,2023-07-11 12:31:43,"A California man, Emory Hernandez Valadez, claims he developed a rare form of cancer due to exposure to asbestos in Johnson & Johnson's JNJ talc-based baby powder. Lawyers for Valadez are urging a jury to order Johnson & Johnson to pay heavy punitive damages, citing the company's conduct as ...",JNJ,0.677342,-0.513574,Bearish
"""Exploring the Global Sustainable Innovation Landscape: The Top 100 Companies and Beyond"" reveals the companies championing innovation to solve critical sustainability challenges",https://www.prnewswire.com/news-releases/exploring-the-global-sustainable-innovation-landscape-the-top-100-companies-and-beyond-reveals-the-companies-championing-innovation-to-solve-critical-sustainability-challenges-301874146.html,2023-07-11 12:08:00,"""Exploring the Global Sustainable Innovation Landscape: The Top 100 Companies and Beyond"" reveals the ... PR ...",JNJ,0.182162,0.308614,Somewhat-Bullish
"""Exploring the Global Sustainable Innovation Landscape: The Top 100 Companies and Beyond"" reveals the companies championing innovation to solve critical sustainability challenges",https://www.prnewswire.com/news-releases/exploring-the-global-sustainable-innovation-landscape-the-top-100-companies-and-beyond-reveals-the-companies-championing-innovation-to-solve-critical-sustainability-challenges-301874104.html,2023-07-11 12:00:00,"""Exploring the Global Sustainable Innovation Landscape: The Top 100 Companies and Beyond"" reveals the ... PR ...",JNJ,0.128684,0.237451,Somewhat-Bullish
"10 things you need to know today: July 11, 2023",https://theweek.com/briefing/daily-briefing/1024911/10-things-you-need-to-know-today-july-11-2023,2023-07-11 11:01:24,"Joe Biden met with King Charles III at Windsor Castle President Biden on Monday had his first meeting with King Charles III since his coronation, with the pair discussing how to combat climate change.",JNJ,0.030292,-0.27189,Somewhat-Bearish
Top suspect in transformative 1982 cyanide-laced Tylenol murders dies uncharged,https://theweek.com/drugs/1024921/top-suspect-in-transformative-1982-cyanide-laced-tylenol-murders-dies-uncharged,2023-07-11 10:29:40,"Stacey Wescott / Chicago Tribune / Tribune News Service via Getty Images The top suspect in a rash of unsolved 1982 murders in Chicago involving cyanide-laced Tylenol capsules died at his home in Cambridge, Massachusetts, on Sunday, police said Monday.",JNJ,0.115232,-0.366373,Bearish
"3 Reasons to Buy Eli Lilly, and 1 Reason to Sell",https://www.fool.com/investing/2023/07/11/3-reasons-to-buy-eli-lilly-and-1-reason-to-sell/,2023-07-11 09:34:00,This drugmaker is a compelling dividend growth play.,JNJ,0.059636,0.0,Neutral
Meet Wall Street's Greatest Dividend Stock: A Small-Cap Company 99.9% of Investors Have Probably Never Heard Of,https://www.fool.com/investing/2023/07/11/meet-wall-street-greatest-dividend-stock-small-cap/,2023-07-11 09:21:00,This company has been consistently paying a dividend since James Madison was president of the United States... in 1816.,JNJ,0.109455,0.187522,Somewhat-Bullish
"James W. Lewis, Suspect in the 1982 Tylenol Murders, Dies at 76",https://www.nytimes.com/2023/07/10/us/james-lewis-tylenol-poisonings-dead.html,2023-07-10 21:10:31,"James W. Lewis, the prime suspect in the deaths of seven people in 1982 from cyanide-laced Tylenol, a poisoning that terrified the nation and changed the way manufacturers packaged medications, died on Sunday in Cambridge, Mass. He was 76.",JNJ,0.095327,-0.109692,Neutral
"James Lewis, suspect in Tylenol poisonings that killed 7 people in the Chicago area in 1982, dead",https://apnews.com/article/tylenol-killings-chicago-suspect-death-af8a7b44d2f45cb438bd7caf8cdb171c,2023-07-10 17:10:00,"CAMBRIDGE, Mass. ( AP ) - The suspect in the 1982 Tylenol poisonings that killed seven people in the Chicago area and triggered a nationwide scare has died, police confirmed on Monday. Officers, firefighters and EMTs responding to a report of unresponsive person about 4 p.m.",JNJ,0.235823,-0.507396,Bearish
Here's why we're bullish on this mega-cap stock and cautious on this health name,https://www.cnbc.com/2023/07/10/heres-why-were-bullish-on-this-mega-cap-stock-and-cautious-on-this-health-name.html,2023-07-10 15:49:22,"The Investing Club holds its ""Morning Meeting"" every weekday at 10:20 a.m. ET.",JNJ,0.259267,0.064156,Neutral
"Top Stories Monday, July 10: Meta's Threads Hits 100M Users In Five Days, Foxconn Pulls Out From $19.5B Semiconductor India JV, Novo Nordisk's Weight-Loss Medications Under European Investigation Over Suicidal Risks - Alibaba Group Holding  ( NYSE:BABA ) , Apple  ( NASDAQ:AAPL ) ",https://www.benzinga.com/news/23/07/33167658/metas-threads-hits-100m-users-in-five-days-foxconn-pulls-out-from-19-5b-semiconductor-india-jv-novo,2023-07-10 14:29:56,"Meta Platforms Inc's META Threads app has hit the milestone of 100 million users in the first five days of its launch, making it the fastest-growing consumer application in history. Threads beat ChatGPT's record by a wide margin, which achieved the milestone in two months.",JNJ,0.080458,0.160062,Somewhat-Bullish
Johnson & Johnson Bolsters Its Oncology Pipeline With Nanobiotix Radiotherapy Pact - Nanobiotix  ( NASDAQ:NBTX ) ,https://www.benzinga.com/general/biotech/23/07/33166414/johnson-johnson-bolsters-its-oncology-pipeline-with-nanobiotix-radiotherapy-pact,2023-07-10 13:52:22,"Nanobiotix NBTX shares are trading higher after the company announced a global licensing, co-development, and commercialization agreement with Janssen Pharmaceutica NV, a unit of Johnson & Johnson JNJ, for the investigational radioenhancer NBTXR3.",JNJ,0.454174,0.615673,Bullish
Why Nanobiotix Stock Is Soaring Monday - Nanobiotix  ( NASDAQ:NBTX ) ,https://www.benzinga.com/news/23/07/33165021/why-nanobiotix-stock-is-soaring-monday,2023-07-10 13:00:05,Nanobiotix S.A. NBTX shares are trading higher Monday after the company entered into a license agreement with Janssen Pharmaceutical for global co-development and commercialization of NBTXR3. What To Know: Janssen Pharmaceutical is a subsidiary of Johnson & Johnson JNJ.,JNJ,0.38588,0.0,Neutral
Major business group slams disclosure rules as House Republicans probe ESG investing,https://www.cnbc.com/2023/07/10/national-association-of-manufacturers-esg-disclosures.html,2023-07-10 13:00:01,"House Republicans scheduled several hearings this month to probe ESG investing, which has become a big target on the right.",JNJ,0.063763,-0.09406,Neutral
'Radical Reinvention' - Fearless Realignment in a Post-Covid Complex World,https://www.prnewswire.com/news-releases/radical-reinvention--fearless-realignment-in-a-post-covid-complex-world-301872300.html,2023-07-10 12:05:00,"- Former Fashion, Beauty and Health Editor of Vogue and Harper's Bazaar, Maureen Lippe, Shares Her Most Personal Journey and One-of-a-Kind Formula for Success in Debut Book - All Proceeds to Benefit Non-Profit, Step Up Women's Network",JNJ,0.048327,0.097008,Neutral
Nanobiotix In License Deal With Johnson & Johnson Unit; Stock Climbs In Pre Market,https://markets.businessinsider.com/news/stocks/nanobiotix-in-license-deal-with-johnson-johnson-unit-stock-climbs-in-pre-market-1032434507,2023-07-10 11:10:58,Nanobiotix In License Deal With Johnson & Johnson Unit. Stock Climbs In Pre Market - Markets Insider ...,JNJ,0.313817,0.234615,Somewhat-Bullish
Should iShares Russell Top 200 Value ETF  ( IWX )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2118506/should-ishares-russell-top-200-value-etf-iwx-be-on-your-investing-radar,2023-07-10 10:20:07,Style Box ETF report for ...,JNJ,0.122269,-0.022209,Neutral
"Prostate Cancer Therapeutics Market Projected to Grow at 6.9% CAGR, Reaching USD 21.7 Billion by 2031: TMR Study",https://www.benzinga.com/pressreleases/23/07/g33160411/prostate-cancer-therapeutics-market-projected-to-grow-at-6-9-cagr-reaching-usd-21-7-billion-by-203,2023-07-10 09:30:00,"Wilmington, Delaware, United States, July 10, 2023 ( GLOBE NEWSWIRE ) -- The global prostate cancer therapeutics market is projected to expand at a CAGR of 6.9% from 2022 to 2031 to reach US$ 21.7 Bn by 2031. In 2021, the market size was valued at US$ 11.14 Bn.",JNJ,0.040691,0.0,Neutral
Should You Buy the First Half's Worst-Performing Sector?,https://www.fool.com/investing/2023/07/10/should-you-buy-the-worst-performing-sector/,2023-07-10 09:30:00,Healthcare stocks may not lead gains in the next bull market.,JNJ,0.121037,0.076734,Neutral
NANOBIOTIX Announces License Agreement for Worldwide Co-development and Commercialization of Potential First-In-Class Radioenhancer NBTXR3,https://www.globenewswire.com/news-release/2023/07/10/2701468/0/en/NANOBIOTIX-Announces-License-Agreement-for-Worldwide-Co-development-and-Commercialization-of-Potential-First-In-Class-Radioenhancer-NBTXR3.html,2023-07-10 06:00:00,"PARIS and CAMBRIDGE, Mass., July 10, 2023 ( GLOBE NEWSWIRE ) -- NANOBIOTIX ( Euronext: NANO -- NASDAQ: NBTX - the ''Company'' ) , a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced a global ...",JNJ,0.069028,0.087642,Neutral
NANOBIOTIX Announces License Agreement for Worldwide Co-development and Commercialization of Potential First-In-Class Radioenhancer NBTXR3 - Nanobiotix  ( NASDAQ:NBTX ) ,https://www.benzinga.com/pressreleases/23/07/g33159526/nanobiotix-announces-license-agreement-for-worldwide-co-development-and-commercialization-of-poten,2023-07-10 06:00:00,"PARIS and CAMBRIDGE, Mass., July 10, 2023 ( GLOBE NEWSWIRE ) -- NANOBIOTIX NBTX, a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced a global licensing, co-development, and commercialization ...",JNJ,0.068112,0.08452,Neutral
2 Healthcare Stocks That Could Make You Richer,https://www.fool.com/investing/2023/07/29/2-healthcare-stocks-that-could-make-you-richer/,2023-07-29 13:30:00,Investors see the obvious potential in both companies.,JNJ,0.102231,0.098131,Neutral
These 3 Quarterly Releases Positively Shocked the Market,https://www.zacks.com/stock/news/2129684/these-3-quarterly-releases-positively-shocked-the-market,2023-07-28 21:43:00,"There have been several notable surprises throughout the Q2 earnings season so far, including those from these three companies.",JNJ,0.492324,0.396478,Bullish
"Crude Oil Edges Higher; Colgate-Palmolive Posts Upbeat Earnings - Colgate-Palmolive  ( NYSE:CL ) , Business First Bancshares  ( NASDAQ:BFST ) ",https://www.benzinga.com/news/earnings/23/07/33448340/crude-oil-edges-higher-colgate-palmolive-posts-upbeat-earnings,2023-07-28 18:30:06,"U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 250 points on Friday. The Dow traded up 0.42% to 35,432.07 while the NASDAQ rose 1.79% to 14,301.74. The S&P 500, also rose, gaining, 0.87% to 4,576.83.",JNJ,0.081276,-0.145926,Neutral
"Johnson & Johnson, Other Pharma Makers Anticipate Reformulated Injectable Drugs May Exclude Price Negotiations - Roche Holding  ( OTC:RHHBF ) , Roche Holding  ( OTC:RHHVF ) , Roche Holding  ( OTC:RHHBY ) ",https://www.benzinga.com/general/biotech/23/07/33447281/johnson-johnson-other-pharma-makers-anticipate-reformulated-injectable-drugs-may-exclude-price-ne,2023-07-28 17:47:18,"Cancer drug manufacturers, including Johnson & Johnson JNJ, anticipate that injectable versions of some popular treatments will not be included in U.S. government price negotiations for several years, thereby safeguarding substantial revenue.",JNJ,0.546745,0.070035,Neutral
"Dow Surges 250 Points; Exxon Mobil Earnings Miss Expectations - Business First Bancshares  ( NASDAQ:BFST ) , Eos Energy Enterprises  ( NASDAQ:EOSE ) ",https://www.benzinga.com/news/earnings/23/07/33446102/dow-surges-250-points-exxon-mobil-earnings-miss-expectations,2023-07-28 16:08:19,"U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 250 points on Friday. The Dow traded up 0.72% to 35,535.23 while the NASDAQ rose 1.89% to 14,316.53. The S&P 500, also rose, gaining, 1.09% to 4,587.09. Exxon Mobil Corp XOM reported weaker-than-expected ...",JNJ,0.085629,-0.14712,Neutral
Johnson & Johnson Unusual Options Activity For July 28 - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/07/33444576/johnson-johnson-unusual-options-activity-for-july-28,2023-07-28 15:01:17,"Someone with a lot of money to spend has taken a bullish stance on Johnson & Johnson JNJ. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",JNJ,0.806129,0.28963,Somewhat-Bullish
Dorian and Oxford Industries have been highlighted as Zacks Bull and Bear of the Day,https://www.zacks.com/stock/news/2129539/dorian-and-oxford-industries-have-been-highlighted-as-zacks-bull-and-bear-of-the-day,2023-07-28 14:31:00,Dorian and Oxford Industries are part of the Zacks Bull and Bear of the Day article.,JNJ,0.132806,0.122263,Neutral
"Nasdaq Jumps 200 Points; Procter & Gamble Posts Upbeat Earnings - Bluejay Diagnostics  ( NASDAQ:BJDX ) , Mallinckrodt  ( AMEX:MNK ) ",https://www.benzinga.com/news/earnings/23/07/33443571/nasdaq-jumps-200-points-procter-gamble-posts-upbeat-earnings,2023-07-28 14:10:07,"U.S. stocks traded higher this morning, with the Nasdaq Composite gaining more than 200 points on Friday. Following the market opening Friday, the Dow traded up 0.39% to 35,419.43 while the NASDAQ rose 1.57% to 14,271.37. The S&P 500, also rose, gaining, 0.84% to 4,575.45.",JNJ,0.084127,-0.146687,Neutral
3 Things About Johnson & Johnson Every Smart Investor Knows,https://www.fool.com/investing/2023/07/28/3-things-about-johnson-johnson-every-smart-investo/,2023-07-28 12:37:00,The company has been a strong value stock but faces big changes this year.,JNJ,0.413878,0.028474,Neutral
"SLB, Johnson & Johnson And 2 Other Stocks Insiders Are Selling - Johnson & Johnson  ( NYSE:JNJ ) , Capital One Finl  ( NYSE:COF ) ",https://www.benzinga.com/news/23/07/33440554/slb-johnson-johnson-and-2-other-stocks-insiders-are-selling,2023-07-28 11:56:57,"The Nasdaq 100 closed lower on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it could be a preplanned sale, or could indicate their concern in the company's prospects or that they view the stock as being overpriced.",JNJ,0.406526,0.276722,Somewhat-Bullish
"Got $2,500? 2 Top Stocks You Can Buy and Hold for a Lifetime",https://www.fool.com/investing/2023/07/28/got-2500-2-top-stocks-to-buy-and-hold-for-lifetime/,2023-07-28 11:21:00,These two rock-solid stocks are rejigging their portfolios to boost dividends and overall shareholder returns.,JNJ,0.488469,0.328824,Somewhat-Bullish
How A Talented Jerk Can Learn To Be A Better Leader In 3 Steps,https://www.investors.com/news/management/leaders-and-success/better-leader-how-a-talented-jerk-can-improve/,2023-07-28 11:00:00,Better Leader: How A Talented Jerk Can Improve Investor's Business Daily ...,JNJ,0.087503,0.183048,Somewhat-Bullish
"Virtualware  ( MLVIR )  launches VIROO 2.4, the new version of its Virtual Reality as a service  ( VRaaS )  platform",https://www.globenewswire.com/news-release/2023/07/28/2712895/0/en/Virtualware-MLVIR-launches-VIROO-2-4-the-new-version-of-its-Virtual-Reality-as-a-service-VRaaS-platform.html,2023-07-28 06:38:00,"BILBAO, July 28, 2023 - Spanish publicly traded company, Virtualware ( EPA:MLVIR ) , one of the leaders in virtual reality, announced today the release of the new version 2.4 of its VRaaS platfom, VIROO, which incorporates, among other capabilities, Mixed Reality ( MR ) and VR CAVEs integration ...",JNJ,0.076847,0.100195,Neutral
Endoprosthesis Market size to grow by USD 18.24 billion from 2022 to 2027|Growth driven by increasing prevalence of ... - PR Newswire,https://www.prnewswire.com/news-releases/endoprosthesis-market-size-to-grow-by-usd-18-24-billion-from-2022-to-2027growth-driven-by-increasing-prevalence-of-orthopedic-diseases-and-associated-risk-factors---technavio-301886538.html,2023-07-28 02:00:00,Endoprosthesis Market size to grow by USD 18.24 billion from 2022 to 2027|Growth driven by increasing prevalence of ... PR ...,JNJ,0.037446,0.039495,Neutral
Bitcoin traders put eyes on $31K even as $2B in BTC options expire on Friday,https://cointelegraph.com/news/bitcoin-traders-put-eyes-on-31k-price-as-2b-options-expire-friday,2023-07-28 00:43:26,"BTC traders fix their eyes on $31,000 even as $2 billion in Bitcoin options are set to expire this Friday.",JNJ,0.05257,0.145604,Neutral
Genmab Updates 2023 Financial Guidance,https://www.globenewswire.com/news-release/2023/07/27/2712801/0/en/Genmab-Updates-2023-Financial-Guidance.html,2023-07-27 22:01:00,Company Announcement ...,JNJ,0.055109,0.0,Neutral
JNJ: Top 3 Pharma Stocks You Can't Miss out On,https://stocknews.com/news/jnj-lly-rdy-sgtx-top-3-pharma-stocks-you-cant-miss-out-on/,2023-07-27 17:48:32,"Medical innovations like precision medicine, cell and gene therapy, and immuno-oncology fuel new ways of preventing and detecting various diseases and creating tailwinds for the pharmaceutical industry. In addition, technology is powering the industry in activities like drug discovery, ...",JNJ,0.182678,0.211152,Somewhat-Bullish
Company Updates and Marketing Lessons From the Grateful Dead,https://www.fool.com/investing/2023/07/27/company-updates-and-marketing-lessons-from-the-gra/,2023-07-27 17:24:00,Netflix and Tesla are two of the big names giving investor updates.,JNJ,0.012555,0.027451,Neutral
"AbbVie  ( ABBV )  Beats on Q2 Earnings & Sales, Raises '23 View",https://www.zacks.com/stock/news/2128992/abbvie-abbv-beats-on-q2-earnings-sales-raises-23-view,2023-07-27 17:05:00,AbbVie's (ABBV) second-quarter 2023 earnings and sales beat estimates. The company raises its EPS guidance. Stock rises post the announcement.,JNJ,0.073659,0.131144,Neutral
How Is The Market Feeling About Johnson & Johnson? - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/short-sellers/23/07/33423315/how-is-the-market-feeling-about-johnson-johnson,2023-07-27 15:15:16,"Johnson & Johnson's JNJ short percent of float has fallen 8.0% since its last report. The company recently reported that it has 12.08 million shares sold short, which is 0.46% of all regular shares that are available for trading.",JNJ,0.221819,0.081322,Neutral
AI Stocks Are Overpriced. The Next Big Growth Opportunity Could Instead Be in This Industry,https://www.fool.com/investing/2023/07/27/ai-stocks-overpriced-next-big-growth-opportunity/,2023-07-27 13:40:14,Healthcare stocks are underrated buys right now.,JNJ,0.059785,0.113109,Neutral
Johnson & Johnson's Inflection Point: What It Means For Investors - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/news/earnings/23/07/33408984/johnson-johnsons-inflection-point-what-it-means-for-investors,2023-07-27 13:15:59,"After three years of waiting, Johnson & Johnson JNJ shares have returned to trend, a monumental event for the market which presents a potential buying opportunity for income investors.",JNJ,0.684036,0.411772,Bullish
Law Enforcement Adopts BolaWrap Solution: Advancing Safer Outcomes with Opioid Settlement Funds,https://www.globenewswire.com/news-release/2023/07/27/2712272/0/en/Law-Enforcement-Adopts-BolaWrap-Solution-Advancing-Safer-Outcomes-with-Opioid-Settlement-Funds.html,2023-07-27 13:05:00,"TEMPE,Ariz., July 27, 2023 ( GLOBE NEWSWIRE ) -- Wrap Technologies, Inc. ( NASDAQ: WRAP ) , a leading global innovator in public safety solutions, commends law enforcement agencies for adopting its BolaWrapÂ® solution with the support of opioid settlement funds.",JNJ,0.029327,-0.017271,Neutral
Law Enforcement Adopts BolaWrap Solution: Advancing Safer Outcomes with Opioid Settlement Funds - Wrap Technologies  ( NASDAQ:WRAP ) ,https://www.benzinga.com/pressreleases/23/07/g33419615/law-enforcement-adopts-bolawrap-solution-advancing-safer-outcomes-with-opioid-settlement-funds,2023-07-27 13:05:00,"TEMPE,Ariz., July 27, 2023 ( GLOBE NEWSWIRE ) -- Wrap Technologies, Inc. WRAP, a leading global innovator in public safety solutions, commends law enforcement agencies for adopting its BolaWrapÂ® solution with the support of opioid settlement funds.",JNJ,0.028626,-0.017222,Neutral
"The Galien Foundation Announces 2023 Prix Galien USA Nominees for ""Best Digital Health Solution,"" ""Best Medical Technology,"" ""Incubators, Accelerators and Equity,"" and ""Best Startup""",https://www.prnewswire.com/news-releases/the-galien-foundation-announces-2023-prix-galien-usa-nominees-for-best-digital-health-solution-best-medical-technology-incubators-accelerators-and-equity-and-best-startup-301887144.html,2023-07-27 13:00:00,"The Galien Foundation Announces 2023 Prix Galien USA Nominees for ""Best Digital Health Solution,"" ""Best Medical ... PR ...",JNJ,0.054483,0.345,Somewhat-Bullish
Bluecrux and One Network Enterprises Join Forces to Offer Advanced and Sustainable Supply Chain Transformation Capabilities,https://www.prnewswire.com/news-releases/bluecrux-and-one-network-enterprises-join-forces-to-offer-advanced-and-sustainable-supply-chain-transformation-capabilities-301886678.html,2023-07-27 12:57:00,Bluecrux and One Network Enterprises Join Forces to Offer Advanced and Sustainable Supply Chain Transformation ... PR ...,JNJ,0.060085,0.137007,Neutral
Fed's July Rate Hike and Comments Match Expectations: 5 Picks,https://www.zacks.com/stock/news/2128716/feds-july-rate-hike-and-comments-match-expectations-5-picks,2023-07-27 12:29:00,"We have narrowed our search to five U.S. corporate behemoths. These are: META, GOOGL, ISRG, JNJ, PEP.",JNJ,0.157741,0.163709,Somewhat-Bullish
3 Top Blue Chip Stocks to Ride the Dow Rally,https://www.zacks.com/stock/news/2128715/3-top-blue-chip-stocks-to-ride-the-dow-rally,2023-07-27 12:25:00,"As the Dow continues to scale upward, it's prudent to invest in stocks such as JPMorgan (JPM), Walmart (WMT) and Johnson & Johnson (JNJ) that are listed on the said index and are financially sound.",JNJ,0.199859,0.191439,Somewhat-Bullish
Dow Jones ETFs Continue Winning Run as Rates at 2001 High,https://www.zacks.com/stock/news/2128598/dow-jones-etfs-continue-winning-run-as-rates-at-2001-high,2023-07-27 12:00:00,"Fed raised its benchmark interest rate by 0.25% on Wednesday, leaving room for more hikes this year. Such rising rate environment is a plus for the Dow Jones ETFs.",JNJ,0.156461,0.143308,Neutral
"If You Invested $25,000 in Johnson & Johnson 20 Years Ago, This Is How Much You Would Have Today",https://www.fool.com/investing/2023/07/27/if-you-invested-25000-in-johnson-johnson-20-years/,2023-07-27 11:55:00,"It's a big name in healthcare, but has Johnson & Johnson been a great investment over the past two decades?",JNJ,0.646056,0.347087,Somewhat-Bullish
Boston Scientific lifts annual profit forecast on heart devices strength,https://www.reuters.com/business/healthcare-pharmaceuticals/boston-scientific-lifts-annual-profit-forecast-heart-devices-strength-2023-07-27/,2023-07-27 11:55:00,"July 27 ( Reuters ) - Boston Scientific ( BSX.N ) raised its annual profit forecast for a second straight quarter on Thursday, banking on resilient demand for its cardiovascular devices as surgical procedure volumes pick up pace.",JNJ,0.140896,-0.034586,Neutral
3 PIMCO Mutual Funds for Excellent Returns,https://www.zacks.com/stock/news/2128663/3-pimco-mutual-funds-for-excellent-returns,2023-07-27 11:37:00,"Below, we share with you three top-ranked PIMCO mutual funds. Each has earned a Zacks Mutual Fund Rank #1.",JNJ,0.085022,0.054226,Neutral
BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR SECOND QUARTER 2023,https://www.prnewswire.com/news-releases/boston-scientific-announces-results-for-second-quarter-2023-301887271.html,2023-07-27 10:34:00,"MARLBOROUGH, Mass., July 27, 2023 /PRNewswire/ -- Boston Scientific Corporation ( NYSE: BSX ) generated net sales of $3.599 billion during the second quarter of 2023, growing 11.0 percent on a reported basis, 12.0 percent on an operational1 basis and 11.6 percent on an organic2 basis, all ...",JNJ,0.016327,0.116123,Neutral
Better Medtech Buy: J&J vs. Medtronic,https://www.fool.com/investing/2023/07/27/better-medtech-buy-jj-vs-medtronic/,2023-07-27 09:30:00,These players have a track record of delivering billions in annual earnings.,JNJ,0.115509,0.200384,Somewhat-Bullish
"The Zacks Analyst Blog Highlights Johnson & Johnson, Zoetis, Lam Research, Aon and Dominion Energy",https://www.zacks.com/stock/news/2128519/the-zacks-analyst-blog-highlights-johnson-johnson-zoetis-lam-research-aon-and-dominion-energy,2023-07-27 09:00:00,"Johnson & Johnson, Zoetis, Lam Research, Aon and Dominion Energy are included in this Analyst Blog.",JNJ,0.360752,0.08156,Neutral
Alkermes Clocks Over 100% Jump In Q2 Sales and Profits On Reinstated Product Royalty From Long-Acting Invega - Alkermes  ( NASDAQ:ALKS ) ,https://www.benzinga.com/general/biotech/23/07/33394290/alkermes-clocks-over-100-jump-in-q2-sales-and-profits-on-reinstated-product-royalty-from-long-act,2023-07-26 15:58:24,"Alkermes plc ALKS reported Q2 adjusted EPS of $0.55 compared to $0.06 a year ago, missing the consensus of $0.56. The company reported sales of $617.40 million, 124% higher than the $276.22 million reported a year, beating the consensus estimate of $585.02 million.",JNJ,0.297661,0.411192,Bullish
Like Growing Dividend Income? Buy This Dividend King,https://www.fool.com/investing/2023/07/26/like-growing-dividend-income-buy-this-dividend-kin/,2023-07-26 14:10:00,The company boasts a six-decade dividend growth streak.,JNJ,0.142989,0.169177,Somewhat-Bullish
3 No-Brainer Warren Buffett Stocks to Buy Right Now,https://www.fool.com/investing/2023/07/26/3-no-brainer-warren-buffett-stocks-to-buy-right-no/,2023-07-26 12:30:00,Berkshire Hathaway's portfolio can be a great place to find compelling investment ideas.,JNJ,0.182506,0.027199,Neutral
Monte Rosa Therapeutics Appoints Dr. Anthony M. Manning to Board of Directors - Monte Rosa Therapeutics  ( NASDAQ:GLUE ) ,https://www.benzinga.com/pressreleases/23/07/g33389178/monte-rosa-therapeutics-appoints-dr-anthony-m-manning-to-board-of-directors,2023-07-26 11:30:00,"BOSTON, July 26, 2023 ( GLOBE NEWSWIRE ) -- Monte Rosa Therapeutics, Inc. GLUE, a clinical stage biotechnology company developing novel molecular glue degrader ( MGD ) -based medicines, today announced the appointment of Anthony M. Manning, Ph.D., to its Board of Directors.",JNJ,0.069495,0.074263,Neutral
Monte Rosa Therapeutics Appoints Dr. Anthony M. Manning to Board of Directors,https://www.globenewswire.com/news-release/2023/07/26/2711202/0/en/Monte-Rosa-Therapeutics-Appoints-Dr-Anthony-M-Manning-to-Board-of-Directors.html,2023-07-26 11:30:00,"BOSTON, July 26, 2023 ( GLOBE NEWSWIRE ) -- Monte Rosa Therapeutics, Inc. ( NASDAQ: GLUE ) , a clinical stage biotechnology company developing novel molecular glue degrader ( MGD ) -based medicines, today announced the appointment of Anthony M. Manning, Ph.D., to its Board of Directors.",JNJ,0.046006,0.072788,Neutral
Alkermes plc Reports Second Quarter 2023 Financial Results,https://www.prnewswire.com/news-releases/alkermes-plc-reports-second-quarter-2023-financial-results-301885734.html,2023-07-26 11:00:00,- Second Quarter Revenues of $617.4 Million Reflect Strong Performance of Proprietary Product Portfolio and Reinstatement of Long-Acting INVEGAÂ® Product Royalties - - Net Sales of Proprietary Products Increased Approximately 21% Year-Over-Year - - Prevailed in Janssen Arbitration.,JNJ,0.033632,0.017988,Neutral
J&J's Medtech Business Is Soaring. Time to Buy the Stock?,https://www.fool.com/investing/2023/07/26/jjs-medtech-business-is-soaring-time-to-buy-the-st/,2023-07-26 10:00:00,J&J's medtech business posted double-digit growth in the most recent quarter.,JNJ,0.124486,0.069175,Neutral
4 Stocks to Buy Following Beat-and-Raise Quarters,https://www.zacks.com/commentary/2127252/4-stocks-to-buy-following-beat-and-raise-quarters,2023-07-25 18:16:00,"These companies beat expectations and raised their outlooks, undeniably a positive sign for investors. Is it time to buy following the better-than-expected results?",JNJ,0.335519,0.345871,Somewhat-Bullish
4 Best-Performing ETFs of Last Week,https://www.zacks.com/stock/news/2127237/4-best-performing-etfs-of-last-week,2023-07-25 17:00:00,Wall Street delivered a mixed performance last week with the Dow Jones hogging special attention.,JNJ,0.098255,0.229678,Somewhat-Bullish
5 ETFs That Pulled in Maximum Capital Last Week,https://www.zacks.com/stock/news/2127183/5-etfs-that-pulled-in-maximum-capital-last-week,2023-07-25 16:05:00,"Overall, ETFs pulled in $5.1 billion in capital last week, taking year-to-date inflows to $257.3 billion.",JNJ,0.091335,0.335307,Somewhat-Bullish
Johnson & Johnson Unusual Options Activity - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/07/33373279/johnson-johnson-unusual-options-activity,2023-07-25 16:01:06,"Someone with a lot of money to spend has taken a bearish stance on Johnson & Johnson JNJ. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",JNJ,0.766141,0.170414,Somewhat-Bullish
GE HealthCare says Alzheimer's drug approval to drive imaging equipment sales,https://www.reuters.com/business/healthcare-pharmaceuticals/ge-healthcare-raises-2023-profit-forecast-supply-chain-woes-ease-2023-07-25/,2023-07-25 15:04:00,July 25 ( Reuters ) - GE HealthCare Technologies Inc ( GEHC.O ) said on Tuesday that the commercial launch of Alzheimer's treatment and related testing for patients would help drive demand for its imaging equipment at hospitals and medical centers next year. The U.S.,JNJ,0.113597,0.146717,Neutral
Value ETFs Make the Most of the Dow Jones Surge,https://www.zacks.com/stock/news/2127083/value-etfs-make-the-most-of-the-dow-jones-surge,2023-07-25 15:00:00,"Amid the Dow Jones rally, value stocks have made an impressive comeback, with investors looking for bargains.",JNJ,0.132733,0.33327,Somewhat-Bullish
2 Top Dividend Stocks to Buy and Hold Forever,https://www.fool.com/investing/2023/07/25/2-top-dividend-stocks-to-buy-and-hold-forever/,2023-07-25 14:07:00,They have been paying dividends for a long time.,JNJ,0.315493,0.148128,Neutral
Is Johnson & Johnson Stock a Buy Now?,https://www.fool.com/investing/2023/07/25/is-johnson-johnson-stock-a-buy-now/,2023-07-25 13:37:00,"The gigantic healthcare conglomerate recently raised its outlook, suggesting its plan to slim down is working as intended.",JNJ,0.105836,0.199728,Somewhat-Bullish
Johnson & Johnson  ( JNJ )  Is a Trending Stock: Facts to Know Before Betting on It,https://www.zacks.com/stock/news/2126789/johnson-johnson-jnj-is-a-trending-stock-facts-to-know-before-betting-on-it,2023-07-25 13:00:11,"Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",JNJ,0.482078,0.167266,Somewhat-Bullish
Shoulder Replacement Market to Surpass USD 4.1 billion in 2031 growing at a CAGR of 6.9%: TMR Study,https://www.benzinga.com/pressreleases/23/07/g33366958/shoulder-replacement-market-to-surpass-usd-4-1-billion-in-2031-growing-at-a-cagr-of-6-9-tmr-study,2023-07-25 12:30:00,"Wilmington, Delaware, United States, July 25, 2023 ( GLOBE NEWSWIRE ) -- The global shoulder replacement market stood at US$ 2.24 billion in 2021 and the global market is projected to reach US$ 4.1 billion in 2031. Global shoulder replacement market is anticipated to expand at a CAGR of 6.9% ...",JNJ,0.040969,0.167498,Somewhat-Bullish
3 Stocks You Can Keep Forever,https://www.fool.com/investing/2023/07/25/3-stocks-you-can-keep-forever/,2023-07-25 12:25:00,These companies have been successful for a long time.,JNJ,0.22574,0.225639,Somewhat-Bullish
Big Tech Earnings Will Test Investors' Fervor for A.I.,https://www.nytimes.com/2023/07/25/business/tech-earnings-ai-microsoft-alphabet.html,2023-07-25 12:09:57,"Microsoft and Alphabet will report results on Tuesday, as investors look for signs that a rally in stocks tied to artificial intelligence is justified.",JNJ,0.023281,0.0,Neutral
Dividend Investors in This Unique Stock-Split Stock Have a Decision to Make,https://www.fool.com/investing/2023/07/25/dividend-investors-in-this-unique-stock-split-stoc/,2023-07-25 11:30:00,Johnson & Johnson's upcoming split gives income investors an interesting choice.,JNJ,0.672712,0.431155,Bullish
"The Nasdaq 100 Has Been Rebalanced, but It Still Has a ""Big"" Problem",https://www.fool.com/investing/2023/07/25/nasdaq-100-rebalanced-but-still-has-a-big-problem/,2023-07-25 09:06:00,A special rebalancing of the Nasdaq 100 did little to resolve its concentration issue.,JNJ,0.043342,0.0,Neutral
Idorsia announces financial results for the first half 2023 - adapting the company to create sustainable value,https://www.globenewswire.com/news-release/2023/07/25/2710056/0/en/Idorsia-announces-financial-results-for-the-first-half-2023-adapting-the-company-to-create-sustainable-value.html,2023-07-25 05:00:00,Ad hoc announcement pursuant to Art. 53 LR ...,JNJ,0.012225,0.028266,Neutral
"Psyched: Germany Ships LSD Prodrugs Via DHL, Minneapolis Decriminalizes, Wiz Khalifa's Magic Pitch & More - Compass Pathways  ( NASDAQ:CMPS ) , Filament Health  ( OTC:FLHLF ) , AdvisorShares Psychedelics ETF  ( ARCA:PSIL ) , Enveric Biosciences  ( NASDAQ:ENVB ) , Johnson & Johnson  ( NYSE:JNJ ) , PharmaTher Holdings  ( OTC:PHRRF ) , Reunion Neuroscience  ( NASDAQ:REUN ) , Core One Labs  ( OTC:CLABF ) ",https://www.benzinga.com/markets/cannabis/23/07/33352650/psyched-germany-ships-lsd-prodrugs-via-dhl-minneapolis-decriminalizes-wiz-khalifas-magic-pitch-m,2023-07-24 21:14:56,"Minneapolis Mayor Jacob Frey recently signed an executive order effectively deprioritizing criminal prosecution for possession, use, purchase, cultivation and engaging in practices with ""entheogenic plants or plant compounds.""",JNJ,0.117486,0.0,Neutral
"Russia Is Seizing European Company Assets - What US Businesses Are Still At Risk? - Deere  ( NYSE:DE ) , United Airlines Holdings  ( NASDAQ:UAL ) , Ford Motor  ( NYSE:F ) , Danone  ( OTC:DANOY ) , Johnson & Johnson  ( NYSE:JNJ ) , Merck & Co  ( NYSE:MRK ) , HP  ( NYSE:HPQ ) , Kellogg  ( NYSE:K ) , Pfizer  ( NYSE:PFE ) , Abbott Laboratories  ( NYSE:ABT ) , Starbucks  ( NASDAQ:SBUX ) , IBM  ( NYSE:IBM ) , Qualcomm  ( NASDAQ:QCOM ) , Carlsberg  ( OTC:CABGY ) , Eli Lilly  ( NYSE:LLY ) , United Parcel Service  ( NYSE:UPS ) , FedEx  ( NYSE:FDX ) , Uber Technologies  ( NYSE:UBER ) , Dell Technologies  ( NYSE:DELL ) , General Electric  ( NYSE:GE ) , Netflix  ( NASDAQ:NFLX ) , Whirlpool  ( NYSE:WHR ) , Kimberly-Clark  ( NYSE:KMB ) , NVIDIA  ( NASDAQ:NVDA ) , Coca-Cola  ( NYSE:KO ) , Micron Technology  ( NASDAQ:MU ) , Colgate-Palmolive  ( NYSE:CL ) , Nike  ( NYSE:NKE ) , Delta Air Lines  ( NYSE:DAL ) , Tupperware Brands  ( NYSE:TUP ) , McDonald's  ( NYSE:MCD ) , Restaurant Brands Intl  ( NYSE:QSR ) , Intel  ( NASDAQ:INTC ) , Procter & Gamble  ( NYSE:PG ) , PepsiCo  ( NASDAQ:PEP ) , Cloudflare  ( NYSE:NET ) , Philip Morris Intl  ( NYSE:PM ) ",https://www.benzinga.com/markets/asia/23/07/33354641/russia-is-seizing-european-company-assets-what-us-businesses-are-still-at-risk,2023-07-24 20:45:18,"In recent months, Russia began seizing assets from companies based in Western countries. The most recent development came last week, when the Russian government seized the local operations of two of the world's largest consumer packaged goods manufacturers.",JNJ,0.09186,-0.187684,Somewhat-Bearish
3 Reasons Why Growth Investors Shouldn't Overlook Johnson & Johnson  ( JNJ ) ,https://www.zacks.com/stock/news/2126372/3-reasons-why-growth-investors-shouldnt-overlook-johnson-johnson-jnj,2023-07-24 16:45:07,"Johnson & Johnson (JNJ) possesses solid growth attributes, which could help it handily outperform the market.",JNJ,0.55971,0.495655,Bullish
Johnson & Johnson Lost Its Court Battle But Won The Q2 Match - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/23/07/33349650/johnson-johnson-lost-its-court-battle-but-won-the-q2-match,2023-07-24 16:04:06,"Last Thursday, Johnson & Johnson JNJ has topped earnings estimates and uplifted its full-year guidance on the back of a strong medtech sales momentum. The healthcare conglomerate reported strong results with plenty of legal anxiety in the air owed to thousands of lawsuits claiming its products, ...",JNJ,0.165409,0.107307,Neutral
Are You Looking for a High-Growth Dividend Stock?,https://www.zacks.com/stock/news/2126275/are-you-looking-for-a-high-growth-dividend-stock,2023-07-24 15:45:05,"Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.",JNJ,0.451494,0.472539,Bullish
3 Ultrareliable Dividend Stocks to Buy and Hold for Decades,https://www.fool.com/investing/2023/07/24/3-ultra-reliable-dividend-stocks-buy-and-hold-for/,2023-07-24 14:37:16,"These stocks have decades of annual dividend raises under their belts, and rising healthcare costs mean there could be plenty more to come.",JNJ,0.112008,0.027997,Neutral
"Medical Aesthetics Market size worth $ 27.55 Billion, Globally, by 2028 at 10.6% CAGR: Verified Market ResearchÂ®",https://www.prnewswire.com/news-releases/medical-aesthetics-market-size-worth--27-55-billion-globally-by-2028-at-10-6-cagr-verified-market-research-301883877.html,2023-07-24 14:30:00,"The ""Global Medical Aesthetics Market Size By Product, By End User, By Geographic Scope And Forecast"" report has been published by Verified Market ResearchÂ®. The report provides an in-depth analysis of the global Medical Aesthetics Market, including its growth prospects, market trends, and market ...",JNJ,0.03448,0.168288,Somewhat-Bullish
Johnson & Johnson to reduce its Kenvue stake by at least 80% through exchange offer,https://www.cnbc.com/2023/07/24/jj-to-reduce-kenvue-stake-by-80percent-through-stock-exchange-offer.html,2023-07-24 13:03:42,J&J said it received a waiver that dismisses the share lockup period associated with Kenvue's initial public offering in May.,JNJ,0.115232,0.0,Neutral
We're selling some shares of this health-care company and changing our rating,https://www.cnbc.com/2023/07/24/were-selling-shares-of-this-health-care-company-and-changing-our-rating.html,2023-07-24 12:49:09,We believe the stock popped last week on reasons that have little to do with company fundamentals.,JNJ,0.635085,0.39464,Bullish
"Johnson & Johnson Bankruptcy Talk: Q2 Earnings Soar, But Litigation Looms On Horizon",https://www.forbes.com/sites/qai/2023/07/24/johnson--johnson-bankruptcy-talk-q2-earnings-soar-but-litigation-looms-on-horizon/,2023-07-24 12:36:48,The company has proposed a $8.9 billion settlement to end tens of thousands of cases and stop new ones from coming through ...,JNJ,0.623692,-0.095728,Neutral
5 Best Inverse/Leveraged ETF Areas of Last Week,https://www.zacks.com/stock/news/2125918/5-best-inverseleveraged-etf-areas-of-last-week,2023-07-24 12:00:00,Wall Street delivered a mixed performance last week due to the steepening of the yield curve.,JNJ,0.09239,0.22623,Somewhat-Bullish
Biosense Webster Launches the OPTRELLâ„¢ Mapping Catheter with TRUErefâ„¢ Technology for Mapping of Complex Cardiac Arrhythmias,https://www.prnewswire.com/news-releases/biosense-webster-launches-the-optrell-mapping-catheter-with-trueref-technology-for-mapping-of-complex-cardiac-arrhythmias-301883781.html,2023-07-24 12:00:00,Biosense Webster Launches the OPTRELLâ„¢ Mapping Catheter with TRUErefâ„¢ Technology for Mapping of Complex ... PR ...,JNJ,0.285526,-0.045184,Neutral
"Apple To Rally Over 17%? Here Are 10 Other Analyst Forecasts For Monday - Apple  ( NASDAQ:AAPL ) , Abbott Laboratories  ( NYSE:ABT ) ",https://www.benzinga.com/news/23/07/33342531/apple-to-rally-over-17-here-are-10-other-analyst-forecasts-for-monday,2023-07-24 11:44:59,Citigroup raised the price target for Cintas Corporation CTAS from $540 to $550. Citigroup analyst Leo Carrington downgraded the stock from Buy to Neutral. Cintas shares fell 0.8% to $503.43 in pre-market trading. Stifel raised Lam Research Corporation LRCX price target from $505 to $725.,JNJ,0.28664,0.325483,Somewhat-Bullish
J&J begins share exchange offer for consumer health spin-off Kenvue,https://www.reuters.com/business/healthcare-pharmaceuticals/jj-begins-share-exchange-offer-consumer-health-spin-off-kenvue-2023-07-24/,2023-07-24 10:39:00,J&J begins share exchange offer for consumer health ...,JNJ,0.666827,0.223,Somewhat-Bullish
ImmunoBiochem Announces Multi-Target License and Option Agreement with ImmunoGen to Develop Next-Generation Antibody-Drug Conjugates,https://www.prnewswire.com/news-releases/immunobiochem-announces-multi-target-license-and-option-agreement-with-immunogen-to-develop-next-generation-antibody-drug-conjugates-301883272.html,2023-07-24 10:30:00,ImmunoBiochem Announces Multi-Target License and Option Agreement with ImmunoGen to Develop Next ... PR ...,JNJ,0.058615,0.078582,Neutral
ImmunoBiochem Announces Multi-Target License and Option Agreement with ImmunoGen to Develop Next-Generation Antibody-Drug Conjugates - Immunogen  ( NASDAQ:IMGN ) ,https://www.benzinga.com/pressreleases/23/07/n33340750/immunobiochem-announces-multi-target-license-and-option-agreement-with-immunogen-to-develop-next-g,2023-07-24 10:30:00,"TORONTO, July 24, 2023 /PRNewswire/ - ImmunoBiochem Corporation, a privately-held biopharmaceutical company focused on the discovery of unique tumor targets and development of novel biological therapeutics, announced today a multi-target license and option agreement with ImmunoGen, Inc.",JNJ,0.056943,0.078443,Neutral
Allarity Therapeutics Strengthens Board of Directors with Appointment of Three Accomplished Biotechnology Executives,https://www.globenewswire.com/news-release/2023/07/24/2709344/0/en/Allarity-Therapeutics-Strengthens-Board-of-Directors-with-Appointment-of-Three-Accomplished-Biotechnology-Executives.html,2023-07-24 10:00:00,â€¢ New appointments bring therapeutic development expertise and proven leadership to support continued progress of Allarity's multiple oncology clinical programs,JNJ,0.022264,0.028324,Neutral
Teva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership,https://www.globenewswire.com/news-release/2023/07/24/2709266/0/en/Teva-Pharmaceuticals-and-Alvotech-Provide-Update-on-Strategic-Biosimilars-Partnership.html,2023-07-24 08:00:00,"Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. ( NYSE and TASE: TEVA ) , a global leader in generic and innovative medicines and Alvotech ( NASDAQ: ALVO ) , a global biotech company specializing in the development and manufacture of biosimilar medicines for ...",JNJ,0.016587,-0.043395,Neutral
Teva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership,https://www.globenewswire.com/news-release/2023/07/24/2709268/0/en/Teva-Pharmaceuticals-and-Alvotech-Provide-Update-on-Strategic-Biosimilars-Partnership.html,2023-07-24 08:00:00,"TEL AVIV, Israel and PARSIPPANY, N.J. and REYKJAVIK, Iceland, July 24, 2023 ( GLOBE NEWSWIRE ) -- Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. ( NYSE and TASE: TEVA ) , a global leader in generic and innovative medicines and Alvotech ( NASDAQ: ALVO ) , a ...",JNJ,0.016473,-0.043359,Neutral
Drugmakers Are 'Throwing the Kitchen Sink' to Halt Medicare Price Negotiations,https://www.nytimes.com/2023/07/23/us/politics/medicare-drug-price-negotiations-lawsuits.html,2023-07-23 07:00:17,The government will soon announce the first 10 medications that will be subject to price negotiations with Medicare under a new law. Drugmakers are fighting the measure in court.,JNJ,0.024053,-0.025632,Neutral
2 Revolutionary Stocks to Buy and Hold for 10 Years,https://www.fool.com/investing/2023/07/22/2-revolutionary-stocks-to-buy-and-hold-for-10-year/,2023-07-22 12:45:00,Breaking new ground can be highly lucrative.,JNJ,0.05833,0.023,Neutral
Kenvue CEO says consumers are spending on brand-name health products even as they pull back in other areas,https://www.cnbc.com/2023/07/21/kenvue-ceo-consumers-spend-on-health-products-as-they-pull-back-elsewhere.html,2023-07-21 20:47:51,"Thibaut Mongon's remarks follow Kenvue's second-quarter earnings beat, which was fueled by resilient demand for brands like Band-Aid, Tylenol and Aveeno.",JNJ,0.075516,0.117158,Neutral
Here's what Jim Cramer thinks about J&J stock after a pivotal talc case verdict,https://www.cnbc.com/2023/07/21/heres-what-jim-cramer-thinks-about-jj-stock-after-a-pivotal-talc-case-verdict-.html,2023-07-21 19:44:08,J&J was ordered to pay $18.8 million after jurors in California found in favor of a 24-year-old man who claimed the company's talc products caused his cancer.,JNJ,0.961451,-0.395752,Bearish
"The Last Two Times This Happened, Fortunes Were Made",https://moneymorning.com/2023/07/21/the-last-two-times-this-happened-fortunes-were-made/,2023-07-21 19:03:46,"Forget oil & gas... Set aside consumer staples or some farfetched belief that industrials are the place to be... Ignore financials, because not even the companies that control our cash can compete with what the tech sector rakes in.",JNJ,0.079524,0.155723,Somewhat-Bullish
"Johnson & Johnson Medtech Business Has Promising Momentum, Analysts Say After Good Q2 Performance - Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/analyst-ratings/analyst-color/23/07/33326095/johnson-johnson-medtech-business-has-promising-momentum-analysts-say-after-good-q2-,2023-07-21 17:32:15,"Credit Suisse analyst Trung Huynh increased the price for Johnson & Johnson JNJ to $175 from $170, with a Neutral rating. Thursday, Johnson & Johnson lifted FY23 guidance on the back of strong Medtech business sales growth.",JNJ,0.853391,0.606809,Bullish
AbbVie  ( ABBV )  to Report Q2 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2125606/abbvie-abbv-to-report-q2-earnings-whats-in-the-cards,2023-07-21 17:05:00,AbbVie's (ABBV) Q2 performance will likely reflect Skyrizi and Rinvoq sales trying to make up for the declining Humira sales following the loss of U.S. exclusivity.,JNJ,0.135347,0.037357,Neutral
ETFs to Tap Dow Jones' Longest Winning Streak Since 2017,https://www.zacks.com/stock/news/2125466/etfs-to-tap-dow-jones-longest-winning-streak-since-2017,2023-07-21 15:10:00,"Dow Jones climbed for nine consecutive sessions, marking the longest winning streak since Sep 20, 2017.",JNJ,0.088309,0.131307,Neutral
5 ETFs to Buy on JNJ's Q2 Earnings Strength,https://www.zacks.com/stock/news/2125412/5-etfs-to-buy-on-jnjs-q2-earnings-strength,2023-07-21 14:05:00,Johnson & Johnson (JNJ) continued with its long streak of earnings beat. It topped the revenue estimate as well as lifted the full-year outlook.,JNJ,0.431065,0.384854,Bullish
"Dow Leads As Tesla, Netflix, Taiwan Semi Hit Growth: Weekly Review",https://www.investors.com/news/dow-jones-leads-market-advance-as-tesla-netflix-taiwan-semiconductor-hit-growth-weekly-review/,2023-07-21 14:03:00,"The stock market rally saw the Dow Jones join the S&P 500 and Nasdaq composite in hitting 52-week highs, but then the Nasdaq sold off hard Thursday, wiping out weekly gains, amid earnings-related sell-offs from Tesla ( TSLA ) , Netflix ( NFLX ) and Taiwan Semiconductor ( TSM ) .",JNJ,0.077782,0.066829,Neutral
"Jim Cramer Says It's Time To Buy This Financial Services Stock Down 32% YTD - Compass Pathways  ( NASDAQ:CMPS ) , ASML Holding  ( NASDAQ:ASML ) ",https://www.benzinga.com/trading-ideas/long-ideas/23/07/33318106/jim-cramer-says-its-time-to-buy-this-financial-services-stock-down-32-ytd,2023-07-21 14:00:57,"On CNBC's ""Mad Money Lightning Round,"" Jim Cramer said Illumina, Inc. ILMN is not even as good as Danaher Corporation DHR. ""Be careful, that's too much Illumina,"" he added. When asked about COMPASS Pathways plc CMPS, he said, ""Treatment resistant depression is incredibly difficult, no one's ...",JNJ,0.18602,-0.188235,Somewhat-Bearish
The Investing Club's top 10 things to watch in the stock market Friday,https://www.cnbc.com/2023/07/21/the-investing-clubs-top-10-things-to-watch-in-the-stock-market-friday.html,2023-07-21 13:29:42,"Morgan Stanley now projects the global obesity market will reach $77 billion in 2030, with bullish implications for Club name Eli Lilly (LLY).",JNJ,0.135729,0.203409,Somewhat-Bullish
"Stock Market News for Jul 21, 2023",https://www.zacks.com/stock/news/2125300/stock-market-news-for-jul-21-2023,2023-07-21 13:22:00,Wall Street closed mixed on Thursday following mixed earnings results of second-quarter 2023.,JNJ,0.122581,0.011768,Neutral
Here's How Big Your Portfolio Can Get by Investing Just $50 a Week,https://www.fool.com/investing/2023/07/21/heres-how-big-your-portfolio-can-get-by-investing/,2023-07-21 12:10:00,Investing early and often can generate life-changing returns.,JNJ,0.236972,0.364016,Bullish
Stocks in Focus on Dow Jones ETF's First 9-Day Run Since 2017,https://www.zacks.com/stock/news/2125200/stocks-in-focus-on-dow-jones-etfs-first-9-day-run-since-2017,2023-07-21 12:00:00,"The Dow Jones index jumped more than 150 points on Jul 20, to log its first nine-day rally since ...",JNJ,0.107978,0.176843,Somewhat-Bullish
Futures inch up as megacaps recover after sharp decline,https://www.reuters.com/markets/us/futures-inch-up-megacaps-recover-after-sharp-decline-2023-07-21/,2023-07-21 10:07:00,"July 21 ( Reuters ) - U.S. stock index futures crept higher on Friday, setting the Dow on track for its tenth straight day of gains, while megacap growth and technology stocks recovered after sharp losses in the previous session.",JNJ,0.101582,0.378832,Bullish
"Morning Bid: Dollar flexes into Fed week, calm returns",https://www.reuters.com/markets/us/global-markets-view-usa-2023-07-21/,2023-07-21 10:02:00,"Dollar flexes into Fed week, calm returns ...",JNJ,0.059049,-0.001013,Neutral
"Tesla, Netflix pull Nasdaq and S&P lower, Dow ends higher",https://www.moneycontrol.com/news/business/markets/tesla-netflix-pull-nasdaq-and-sp-lower-dow-ends-higher-10998661.html,2023-07-21 00:32:20,"Tesla's ( TSLA.O ) shares tumbled 9.74%, its biggest one-day percentage drop since April 20, after the electric-vehicle maker reported a drop in its second-quarter gross margins to a four-year low and CEO Elon Musk hinted at more price cuts.",JNJ,0.142565,0.327205,Somewhat-Bullish
"Futures: Tesla Dives, But This Was The Key Market Loser",https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-tesla-tumbles-in-divided-market-but-this-was-the-key-loser/,2023-07-20 22:46:00,"Dow Jones futures were little changed after hours, along with S&P 500 futures and Nasdaq futures. The stock market rally was decidedly mixed Thursday. The Dow Jones rose for a ninth straight session while the Nasdaq suffered its worst loss in more than four months.",JNJ,0.051886,-0.056982,Neutral
Morning Bid: Fragile Friday as big tech finally falters,https://www.reuters.com/markets/asia/global-markets-view-asia-graphics-pix-2023-07-20/,2023-07-20 21:48:00,"July 21 ( Reuters ) - A look at the day ahead in Asian markets from Jamie McGeever, financial markets columnist. The bigger they are, the harder they fall.",JNJ,0.089797,0.173518,Somewhat-Bullish
Cidara Therapeutics Provides Update on Status of Ongoing CD388 Influenza Program,https://www.globenewswire.com/news-release/2023/07/20/2708627/0/en/Cidara-Therapeutics-Provides-Update-on-Status-of-Ongoing-CD388-Influenza-Program.html,2023-07-20 21:00:00,"SAN DIEGO, July 20, 2023 ( GLOBE NEWSWIRE ) -- Cidara Therapeutics, Inc. ( Nasdaq: CDTX ) , a biotechnology company developing long-acting therapeutics designed to help improve the standard of care for patients facing serious diseases, today provided an update on the status of its ongoing CD388 ...",JNJ,0.102231,0.140779,Neutral
"Stock Market Today: Nasdaq Spirals After Disappointing Netflix, Tesla Earnings",https://www.kiplinger.com/investing/stocks/stock-market-today-nasdaq-spirals-after-disappointing-netflix-tesla-earnings,2023-07-20 20:15:50,"Stock Market Today: Nasdaq Drops on Netflix, Tesla Earnings Kiplinger's Personal Finance ...",JNJ,0.273552,0.28916,Somewhat-Bullish
Johnson & Johnson investors can soon swap their shares for Kenvue stock - here's what you need to know,https://www.cnbc.com/2023/07/20/jj-investors-can-soon-swap-shares-for-kenvue-stock.html,2023-07-20 19:44:08,"J&J owns nearly 90% of Kenvue shares and plans to reduce its stake in the company through an exchange offer that could launch ""as early as the coming days."" ...",JNJ,0.101582,0.072464,Neutral
Moms First Convenes Business Leaders with Biden-Harris Administration Officials to Announce Bold Commitments to Expand Child Care,https://www.prnewswire.com/news-releases/moms-first-convenes-business-leaders-with-biden-harris-administration-officials-to-announce-bold-commitments-to-expand-child-care-301882494.html,2023-07-20 19:30:00,Moms First Convenes Business Leaders with Biden-Harris Administration Officials to Announce Bold Commitments to ... PR ...,JNJ,0.030602,0.140605,Neutral
Dow Jones Gains As Airline Stock Flies; Elon Musk Reveals This Supply Problem As Tesla Tumbles,https://www.investors.com/market-trend/stock-market-today/dow-jones-gains-as-airline-stock-flies-elon-musk-reveals-this-supply-problem-as-tesla-stock-tumbles-netflix-earnings/,2023-07-20 19:20:00,Dow Jones Gains As Airline Stock Flies. Elon Musk Reveals This Supply Problem As Tesla Tumbles Investor's Business Daily ...,JNJ,0.118452,0.227444,Somewhat-Bullish
Sales Of Johnson & Johnson Esketamine Drug Spravato Rise Nearly 100% Year Over Year - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/23/07/33310531/sales-of-johnson-johnson-esketamine-drug-spravato-rise-nearly-100-year-over-year,2023-07-20 19:14:57,"Global pharmaceutical behemoth Johnson & Johnson JNJ today announced results for their fiscal second quarter 2023. The company handily surpassed analyst forecasts by reporting adjusted earnings per share of $2.80 versus the consensus $2.62, and raised full year earnings guidance to boot.",JNJ,0.498188,0.270086,Somewhat-Bullish
These 2 Stocks Just Sent the Dow Jones Soaring,https://www.fool.com/investing/2023/07/20/these-2-stocks-just-sent-the-dow-jones-soaring/,2023-07-20 18:33:00,"Even as the Nasdaq takes a hit, part of the market is rising.",JNJ,0.390904,0.346604,Somewhat-Bullish
Johnson & Johnson  ( JNJ )  Q2 2023 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/07/20/johnson-johnson-jnj-q2-2023-earnings-call-transcri/,2023-07-20 18:30:22,"JNJ earnings call for the period ending June 30, 2023.",JNJ,0.130903,0.13055,Neutral
Infinant Health Hosts Screening of The Invisible Extinction and Q&A with the Film's Scientists,https://www.benzinga.com/pressreleases/23/07/n33309560/infinant-health-hosts-screening-of-the-invisible-extinction-and-q-a-with-the-films-scientists,2023-07-20 18:04:00,"ATLANTIC HIGHLANDS, N.J., July 20, 2023 /PRNewswire/ -- Infinant Health, a company committed to improving infant gut health and makers of EvivoÂ® Infant Probiotic, is hosting an exclusive screening of the award-winning documentary, The Invisible Extinction, on Sunday, July 30.",JNJ,0.088147,0.186432,Somewhat-Bullish
Kenvue  ( KVUE )  QEarnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/07/20/kenvue-kvue-qearnings-call-transcript/,2023-07-20 18:00:55,"KVUE earnings call for the period ending June 30, 2023.",JNJ,0.015252,0.032044,Neutral
IBD Stock Of The Day: Weight-Loss Kingpin Retakes 50-Day Line,https://www.investors.com/research/ibd-stock-of-the-day/novo-nordisk-stock-bounds-above-50-day-line-weight-loss-drugs-drive-enthusiasm/,2023-07-20 17:10:00,Novo Nordisk Stock Stock Bounds Above 50-Day Line. Weight-Loss Drugs Drive Enthusiasm Investor's Business Daily ...,JNJ,0.121037,0.154758,Somewhat-Bullish
What Stocks To Buy Today? 2 Dow Jones Industrial Average Stocks To Watch,https://stockmarket.com/featured/what-stocks-to-buy-today-2-dow-jones-industrial-average-stocks-to-watch-2023-07-20,2023-07-20 16:31:19,"The Dow Jones Industrial Average ( DJIA ) , often simply referred to as ""the Dow Jones"" is one of the most widely followed stock market indices in the world. Comprising 30 large, publicly-owned companies based in the United States.",JNJ,0.31482,0.328306,Somewhat-Bullish
"J&J  ( JNJ )  Q2 Earnings & Sales Top, '23 View Upped, Stock Jumps",https://www.zacks.com/stock/news/2124887/jj-jnj-q2-earnings-sales-top-23-view-upped-stock-jumps,2023-07-20 16:16:00,J&J (JNJ) beats estimates for second-quarter earnings and sales. It raises full-year sales and earnings guidance.,JNJ,0.080638,0.056916,Neutral
"Dow Surges 300 Points; Johnson & Johnson Posts Upbeat Earnings - Aspira Womens Health  ( NASDAQ:AWH ) , Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/news/earnings/23/07/33307846/dow-surges-300-points-johnson-johnson-posts-upbeat-earnings,2023-07-20 16:12:38,"U.S. stocks traded mixed midway through trading, with the Nasdaq Composite declining over 1% on Thursday. The Dow traded up 0.87% to 35,365.00 while the NASDAQ fell 1.11% to 14,198.86. The S&P 500, also fell, declining, 0.19% to 4,556.8. Health care shares climbed by 1.2% on Thursday.",JNJ,0.222327,0.104734,Neutral
"Win Streak Threatened: Tesla, Netflix Results Bring Pressure as Housing, Leading Indicators Data Awaited - American Express  ( NYSE:AXP ) , American Airlines Group  ( NASDAQ:AAL ) ",https://www.benzinga.com/news/earnings/23/07/33307492/win-streak-threatened-tesla-netflix-results-bring-pressure-as-housing-leading-indicators-data-await,2023-07-20 15:51:29,"( Thursday market open ) Pressure surfaced early Thursday as investors assessed yesterday's results from Tesla TSLA and Netflix NFLX. The Nasdaq ( COMP ) fell sharply in premarket trading, but the Dow Jones Industrial Average ( $DJI ) and its eight-session winning streak remained in the green.",JNJ,0.040899,0.22929,Somewhat-Bullish
"Stocks making the biggest moves midday: Netflix, American Airlines, Johnson & Johnson and more",https://www.cnbc.com/2023/07/20/stocks-making-the-biggest-moves-midday-netflix-american-airlines-johnson-johnson-and-more.html,2023-07-20 15:44:36,These are the stocks posting the largest moves in midday trading.,JNJ,0.1172,0.132476,Neutral
"'Don't be vulnerable, be ready,' Jim Cramer says on potential market pullback",https://www.cnbc.com/2023/07/20/dont-be-vulnerable-be-ready-jim-cramer-says-.html,2023-07-20 15:25:28,"The Investing Club holds its ""Morning Meeting"" every weekday at 10:20 a.m. ET.",JNJ,0.214304,0.12232,Neutral
Why Johnson & Johnson Stock Is Rising Today,https://www.fool.com/investing/2023/07/20/why-johnson-johnson-stock-is-rising-today/,2023-07-20 15:08:47,The healthcare giant posted better-than-expected 2023 Q2 financial results today.,JNJ,0.2872,0.331708,Somewhat-Bullish
2 Ultra-Safe Dividend Stocks Retirees May Want to Consider Buying,https://www.fool.com/investing/2023/07/20/2-ultra-safe-dividend-stocks-retirees-may-want-to/,2023-07-20 15:07:50,These two Dividend Kings sport top yields and high levels of safety.,JNJ,0.12645,0.155593,Somewhat-Bullish
"Stock Market Soft After Netflix, Tesla, Other Big Earnings; Discover Gives Awful News",https://www.investors.com/market-trend/stock-market-today/stock-market-soft-after-netflix-tesla-other-big-earnings-discover-gives-awful-news/,2023-07-20 14:46:00,"Stock Market Soft After Netflix, Tesla, Other Big Earnings. Discover Gives Awful News Investor's Business Daily ...",JNJ,0.129516,0.125479,Neutral
Weekly Jobless Claims Below Expectations,https://www.zacks.com/stock/news/2124760/weekly-jobless-claims-below-expectations,2023-07-20 14:31:00,"Today being Thursday, we see new Initial Jobless Claims for last week hitting the tape. These numbers continue to surprise to the downside, putting up 228K new claims. a range of 230-240K were expected by analysts. Today's headline is the lowest tally since cycle lows in mid-May of 225K.",JNJ,0.077593,0.148121,Neutral
"Top Stories Thursday, July 20: Tesla Recalls Over 17K EVs Over Camera & Seat Belt Issues, University Research Uncovers Unexpected Fluctuations In ChatGPT Capabilities, Juul Seeks FDA Nod For Next-Generation Vaporizer - Abbott Laboratories  ( NYSE:ABT ) , American Airlines Group  ( NASDAQ:AAL ) ",https://www.benzinga.com/news/23/07/33304679/tesla-recalls-over-17k-evs-over-camera-seat-belt-issues-university-research-uncovers-unexpected-fluc,2023-07-20 14:09:21,"Tesla Inc TSLA has issued a recall for over 1,300 Model S, X, and Y vehicles made in 2023, citing an issue with the forward-facing front camera, and over 15,000 Model S and X vehicles for problems related to front-row seat belts.",JNJ,0.103479,0.02749,Neutral
The Retail Army Is VERY Bullish - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/economics/macro-economic-events/23/07/33304748/the-retail-army-is-very-bullish,2023-07-20 14:02:47,"Do with this information as you see fit: Jim Cramer said this week he doesn't see a recession in the cards for the USâ€¦ The end of Fed hikes may be on the horizon but what about their effects on the economy? According to TD, the peak impact from a rate hike occurs ~4 quarters later for GDP and ~6 ...",JNJ,0.08183,0.0,Neutral
"Johnson & Johnson, Zions Bancorporation, Heritage-Crystal Clean And Other Big Stocks Moving Higher On Thursday - Heritage-Crystal Clean  ( NASDAQ:HCCI ) , Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/news/23/07/33304713/johnson-johnson-zions-bancorporation-heritage-crystal-clean-and-other-big-stocks-moving-higher-on-th,2023-07-20 14:02:28,"Tarsus Pharmaceuticals, Inc. TARS shares rose 12.3% to $22.59. Heritage-Crystal Clean, Inc HCCI surged 9.6% to $45.96 after the company announced it will be acquired by J.F. Lehman & Company for $1.2 billion.",JNJ,0.414559,0.643764,Bullish
"Q2 Beats for J&J, American; Jobless Claims, Philly Fed Lower",https://www.zacks.com/stock/news/2124566/q2-beats-for-jj-american-jobless-claims-philly-fed-lower,2023-07-20 14:02:00,"Both J&J and American Airlines put up solid beats on top and bottom lines, while the labor market remains buoyant.",JNJ,0.146916,0.132097,Neutral
Activist investor Elliott takes stake in drug manufacturer Catalent - source,https://www.reuters.com/markets/deals/activist-investor-elliott-takes-stake-drug-manufacturer-catalent-source-2023-07-20/,2023-07-20 13:44:00,"LONDON, July 20 ( Reuters ) - Activist investor Elliott Investment has taken a stake in contract drugmaker Catalent ( CTLT.N ) , a source familiar with the matter told Reuters on Thursday.",JNJ,0.101582,0.119647,Neutral
J&J Hurdles Over Litigation Woes On A 'Solid' Quarterly Beat,https://www.investors.com/news/technology/jnj-stock-johnson-johnson-earnings-q2-2023/,2023-07-20 13:41:00,JNJ Stock Hurdles Over Litigation Woes With A 'Solid' Beat And Raise Investor's Business Daily ...,JNJ,0.77688,0.226376,Somewhat-Bullish
J&J spinoff Kenvue forecasts upbeat annual profit on self-care boost,https://www.reuters.com/business/healthcare-pharmaceuticals/kenvue-quarterly-sales-rise-strong-demand-self-care-products-2023-07-20/,2023-07-20 13:34:00,"July 20 ( Reuters ) - Kenvue ( KVUE.N ) , the former consumer health unit of Johnson & Johnson ( JNJ.N ) , forecast full-year profit above Wall Street estimates on Thursday, betting on resilient demand for its skincare and self-care products such as Neutrogena and Tylenol.",JNJ,0.118064,0.125133,Neutral
Jim Cramer's top 10 things to watch in the stock market Thursday,https://www.cnbc.com/2023/07/20/jim-cramers-top-10-things-to-watch-in-the-stock-market-thursday.html,2023-07-20 13:06:53,Very confusing day. Quarterly releases from Tesla (TSLA) and Netflix (NFLX) were both very good but the market is overbought.,JNJ,0.109455,0.053477,Neutral
Surge in Heart Procedures Helps Drive Johnson & Johnson Revenue,https://www.wsj.com/articles/surge-in-heart-procedures-help-drive-johnson-johnson-revenue-1d49d5c2,2023-07-20 12:56:00,"Net earnings at the pharmaceutical company rose 6.9% to $5.14 billion, or $1.96 a share.",JNJ,0.682689,0.633668,Bullish
This Growth Stock Has Market-Beating Potential,https://www.fool.com/investing/2023/07/20/this-growth-stock-has-market-beating-potential/,2023-07-20 12:30:00,This exceptional growth stock has made investors rich before -- can it do it again?,JNJ,0.053153,0.190731,Somewhat-Bullish
Futures Split As Earnings Rush In; Tesla Falls On This 'Silly' Reason,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-rise-nasdaq-slides-in-earnings-rush-tesla-falls-for-silly-reason/,2023-07-20 12:13:00,Futures Split As Earnings Rush In. Tesla Falls On This 'Silly' Reason Investor's Business Daily ...,JNJ,0.152499,0.057527,Neutral
Why Johnson & Johnson  ( JNJ )  Shares Are Trading Higher Premarket Today? - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/general/biotech/23/07/33299598/johnson-johnson-q2-earnings-lifts-annual-outlook-on-strong-sales-growth-from-medtech-business,2023-07-20 12:12:06,"Johnson & Johnson JNJ has reported Q2 FY23 adjusted earnings of $2.80 per share, up 8.1% Y/Y and beating the consensus of $2.62. Sales increased 6.3% to $25.5 billion, beating the consensus of $24.63 billion, with operational growth of 7.5 and adjusted operational growth of 6.2%.",JNJ,0.685927,0.150222,Somewhat-Bullish
Stocks Split Amid Earnings Rush; Tesla Falls On 'Silly' Reason,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-rise-nasdaq-slides-in-earnings-rush-tesla-falls-for-silly-reason/,2023-07-20 12:07:00,Futures Divided As Earnings Rush In. Tesla Falls On This 'Silly' Reason' Investor's Business Daily ...,JNJ,0.147818,-0.054648,Neutral
"Stocks making the biggest moves premarket: Netflix, Tesla, United Airlines and more",https://www.cnbc.com/2023/07/20/stocks-making-the-biggest-moves-premarket-nflx-tsla-ual.html,2023-07-20 12:05:31,These are the stocks posting the largest moves in premarket trading.,JNJ,0.058047,0.15615,Somewhat-Bullish
Johnson & Johnson  ( JNJ )  Tops Q2 Earnings and Revenue Estimates,https://www.zacks.com/stock/news/2124299/johnson-johnson-jnj-tops-q2-earnings-and-revenue-estimates,2023-07-20 11:35:02,"Johnson & Johnson (JNJ) delivered earnings and revenue surprises of 7.28% and 3.43%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?",JNJ,0.393977,0.143973,Neutral
Kenvue earnings top estimates in J&J spinoff's first quarterly report since IPO,https://www.cnbc.com/2023/07/20/kenvue-kvue-q2-earnings-report-2023.html,2023-07-20 11:32:27,"J&J still owns a 90% stake in Kenvue, meaning it can generally control the direction of the consumer health spinoff's business for the time being.",JNJ,0.092213,0.0,Neutral
"The daily business briefing: July 20, 2023",https://theweek.com/briefing/business-briefing/1025156/the-daily-business-briefing-july-20-2023,2023-07-20 11:30:16,"Netflix reported Wednesday that it gained 5.9 million subscribers in the second quarter, an 8% increase that came after the streaming giant launched a global crackdown against password-sharing. But the streaming giant's revenue fell short of expectations and its shares plunged by 6.7%.",JNJ,0.071145,0.003069,Neutral
"J&J expects cancer drugs, medical devices to drive growth in 2023",https://www.reuters.com/business/healthcare-pharmaceuticals/jj-raises-annual-profit-forecast-medical-devices-cancer-drugs-strength-2023-07-20/,2023-07-20 11:22:00,"J&J expects cancer drugs, medical devices to drive growth in ...",JNJ,0.126119,0.052987,Neutral
"Nasdaq Futures Dragged Down By Tesla, Netflix After Q2 Prints: Analyst Sees Buying Spree Lasting Until Earnings 'Problems Show Up' - Discover Finl  ( NYSE:DFS ) , Netflix  ( NASDAQ:NFLX ) , Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , Tesla  ( NASDAQ:TSLA ) , D.R. Horton  ( NYSE:DHI ) , Johnson & Johnson  ( NYSE:JNJ ) , CSX  ( NASDAQ:CSX ) , Travelers Companies  ( NYSE:TRV ) , Capital One Finl  ( NYSE:COF ) , SPDR S&P 500  ( ARCA:SPY ) , Taiwan Semiconductor  ( NYSE:TSM ) ",https://www.benzinga.com/news/earnings/23/07/33300066/nasdaq-futures-dragged-down-by-tesla-netflix-after-q2-prints-analyst-sees-buying-spree-lasting-unti,2023-07-20 11:11:08,"The market mood has turned mixed, as blue chips and small-caps hold onto the upward momentum. However, negative reactions to earnings could test the tech sector's resilience and put brakes on the rally.",JNJ,0.103778,0.0,Neutral
OraSure Technologies Elects Robert McMahon to the Board of Directors,https://www.globenewswire.com/news-release/2023/07/20/2708070/11732/en/OraSure-Technologies-Elects-Robert-McMahon-to-the-Board-of-Directors.html,2023-07-20 11:05:00,"BETHLEHEM, Pa., July 20, 2023 ( GLOBE NEWSWIRE ) -- OraSure Technologies, Inc. ( NASDAQ: OSUR ) , a leader in point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, announced today the election of Robert W.",JNJ,0.028868,0.175451,Somewhat-Bullish
OraSure Technologies Elects Robert McMahon to the Board of Directors - OraSure Technologies  ( NASDAQ:OSUR ) ,https://www.benzinga.com/pressreleases/23/07/g33299862/orasure-technologies-elects-robert-mcmahon-to-the-board-of-directors,2023-07-20 11:05:00,"BETHLEHEM, Pa., July 20, 2023 ( GLOBE NEWSWIRE ) -- OraSure Technologies, Inc. OSUR, a leader in point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, announced today the election of Robert W.",JNJ,0.028456,0.175152,Somewhat-Bullish
"Johnson & Johnson beats on earnings, hikes full-year guidance as medtech sales surge",https://www.cnbc.com/2023/07/20/johnson-johnson-jnj-q2-earnings-report-2023.html,2023-07-20 10:24:49,The results come amid investor anxiety over the thousands of lawsuits claiming that J&J's talc-based baby powder and other products caused cancer.,JNJ,0.102449,0.075861,Neutral
Genmab Announces Net Sales of DARZALEXÂ®  ( daratumumab )  for Second Quarter of 2023,https://www.globenewswire.com/news-release/2023/07/20/2708002/0/en/Genmab-Announces-Net-Sales-of-DARZALEX-daratumumab-for-Second-Quarter-of-2023.html,2023-07-20 10:22:00,Company Announcement ...,JNJ,0.128135,0.011582,Neutral
Should Invesco S&P 500 Low Volatility ETF  ( SPLV )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2124246/should-invesco-sp-500-low-volatility-etf-splv-be-on-your-investing-radar,2023-07-20 10:20:07,Style Box ETF report for ...,JNJ,0.130926,0.070514,Neutral
"Morning Bid: Tesla, Netflix underwhelm",https://www.reuters.com/markets/us/global-markets-view-usa-2023-07-20/,2023-07-20 10:02:00,"Morning Bid: Tesla, ...",JNJ,0.067347,0.0,Neutral
Nasdaq futures slide as Tesla and Netflix results damp earnings optimism,https://www.marketwatch.com/story/nasdaq-futures-slide-as-tesla-and-netflix-results-damp-earnings-optimism-5380d936,2023-07-20 08:41:00,"Nasdaq futures were underperforming early Thursday, after results from Tesla and Netflix were not well received by traders.",JNJ,0.201523,0.062069,Neutral
"Johnson & Johnson, Tesla And 3 Stocks To Watch Heading Into Thursday - Abbott Laboratories  ( NYSE:ABT ) , American Airlines Group  ( NASDAQ:AAL ) ",https://www.benzinga.com/news/earnings/23/07/33297635/johnson-johnson-tesla-and-3-stocks-to-watch-heading-into-thursday,2023-07-20 08:17:03,Wall Street expects Johnson & Johnson JNJ to post quarterly earnings at $2.62 per share on revenue of $24.66 billion before the opening bell. Johnson & Johnson shares gained 0.2% to $159.09 in after-hours trading.,JNJ,0.570165,0.592483,Bullish
"Sosei Heptares Acquires Idorsia's Pharmaceuticals Business in Japan and APAC  ( ex-China ) , Accelerating its Transformation into a Fully Integrated Biopharmaceutical Company",https://www.benzinga.com/pressreleases/23/07/g33296896/sosei-heptares-acquires-idorsias-pharmaceuticals-business-in-japan-and-apac-ex-china-accelerating-,2023-07-20 06:30:00,"PIVLAZÂ® ( clazosentan; commercially available in Japan for cerebral vasospasm; NHI sales of ~JPY7.5 billion in FY22A launch year, with ~76% year-on-year growth expected for FY23E ) , and Daridorexant ( Japan filing expected 2H 2023 for insomnia, marketed in US/Europe as QUVIVIQÂ® )",JNJ,0.012584,0.096599,Neutral
"Sosei Heptares Acquires Idorsia's Pharmaceuticals Business in Japan and APAC  ( ex-China ) , Accelerating its Transformation into a Fully Integrated Biopharmaceutical Company",https://www.globenewswire.com/news-release/2023/07/20/2707901/0/en/Sosei-Heptares-Acquires-Idorsia-s-Pharmaceuticals-Business-in-Japan-and-APAC-ex-China-Accelerating-its-Transformation-into-a-Fully-Integrated-Biopharmaceutical-Company.html,2023-07-20 06:30:00,"Tokyo, Japan and Cambridge, UK, 20 July 2023 - Sosei Group Corporation ( ""the Company"". TSE: 4565 ) announces that it has resolved, at a meeting of the Board of Directors held on 20 July 2023, to acquire from Idorsia Ltd and Idorsia Pharmaceutical Ltd ( together ""Idorsia"" ) all shares of Idorsia ...",JNJ,0.012095,0.104171,Neutral
Stock market today: Early trading mixed but Dow appears primed to extend incredible streak,https://apnews.com/article/stock-market-shares-inflation-rates-05a13025875562a2b9779087b96cd9bd,2023-07-20 06:25:00,"Trading is mixed before the opening bell Thursday with more corporate earnings reports incoming and new data on jobs in the U.S. and housing. Futures for the S&P 500 slipped 0.2% before the bell, while the Dow Jones Industrial Average was up 0.1% and could extend its longest winning streak since ...",JNJ,0.060236,0.186043,Somewhat-Bullish
"Markets Remain Bullish After Dow Rises For Eighth Consecutive Session - Abbott Laboratories  ( NYSE:ABT ) , American Airlines Group  ( NASDAQ:AAL ) ",https://www.benzinga.com/news/earnings/23/07/33296853/markets-remain-bullish-after-dow-rises-for-eighth-consecutive-session,2023-07-20 06:23:57,"The CNN Money Fear and Greed index remained in the ""Extreme Greed"" zone on Wednesday. The Dow Jones gained recorded gains for the eighth straight session on Wednesday, its longest winning streak since Sept. 2019. The Goldman Sachs Group, Inc.",JNJ,0.275867,0.0,Neutral
"Perrigo  ( PRGO )  Beats on Q2 Earnings & Sales, Reiterates '23 View",https://www.zacks.com/stock/news/2133811/perrigo-prgo-beats-on-q2-earnings-sales-reiterates-23-view,2023-08-08 15:54:00,Perrigo (PRGO) reports encouraging second-quarter 2023 results. Management reaffirms the financial guidance for 2023.,JNJ,0.11123,0.049297,Neutral
Here's Why You Should Invest in Medtronic  ( MDT )  Stock Now,https://www.zacks.com/stock/news/2133796/heres-why-you-should-invest-in-medtronic-mdt-stock-now,2023-08-08 15:21:00,Investors are optimistic about Medtronic (MDT) on strong growth prospects within the Neurosurgery portfolio and upbeat 2024 guidance.,JNJ,0.040969,0.096299,Neutral
CRISPR Therapeutics  ( CRSP )  Q2 Loss Narrower Than Expected,https://www.zacks.com/stock/news/2133785/crispr-therapeutics-crsp-q2-loss-narrower-than-expected,2023-08-08 15:09:00,CRISPR Therapeutics' (CRSP) second-quarter results beat the mark for both earnings and sales.,JNJ,0.109956,0.052382,Neutral
Rubrik Acquires DSPM Leader Laminar to Accelerate Cloud Data Security,https://www.benzinga.com/pressreleases/23/08/g33632536/rubrik-acquires-dspm-leader-laminar-to-accelerate-cloud-data-security,2023-08-08 14:30:00,"Will unify data security posture across enterprise, cloud, and SaaS to deliver cyber resilience Announces intent to open new research and development ( R&D ) center in Israel to fuel cybersecurity innovation",JNJ,0.031364,0.100398,Neutral
"Just 5 Stocks Produce 10% Of $75.7 Trillion Global Stock Market Wealth, Study Shows",https://www.investors.com/research/just-5-stocks-produced-10-percent-of-75-7-trillion-global-wealth-in-three-decades-study-shows/,2023-08-08 14:12:00,"Buying stocks always involves a certain amount of risk, but investors accept it in hopes of higher rewards. But a study found that most stocks don't reward buyers, leaving a total $75.7 trillion global wealth created between 1990 and 2020 to a sliver of the stock market, just 2.4% of stocks.",JNJ,0.171485,0.427761,Bullish
Nyra Medical names Lori Chmura as Chief Executive Officer - PR Newswire,https://www.prnewswire.com/news-releases/nyra-medical-names-lori-chmura-as-chief-executive-officer-301895747.html,2023-08-08 13:45:00,Nyra Medical names Lori Chmura as Chief Executive Officer PR ...,JNJ,0.060848,0.200089,Somewhat-Bullish
Nyra Medical names Lori Chmura as Chief Executive Officer,https://markets.businessinsider.com/news/stocks/nyra-medical-names-lori-chmura-as-chief-executive-officer-1032529427,2023-08-08 13:45:00,"Health care executive brings more than 30 years of clinical, business, and operational expertise to company ATLANTA, Aug. 8, 2023 /PRNewswire/ -- Nyra Medical, an innovative medical device company developing a next generation transcatheter mitral valve repair technology, announced the appointment ...",JNJ,0.060848,0.200089,Somewhat-Bullish
Water for Injection Market to Exceed USD 53.8 Bn by 2031 with CAGR of 9.5%: TMR Study,https://www.benzinga.com/pressreleases/23/08/g33622695/water-for-injection-market-to-exceed-usd-53-8-bn-by-2031-with-cagr-of-9-5-tmr-study,2023-08-08 11:05:39,"Wilmington, Delaware, United States, Aug. 08, 2023 ( GLOBE NEWSWIRE ) -- The global water for injection market was valued at US$ 21.5 Bn in 2021. It is projected to expand at a CAGR of 9.5% from 2022 to 2031.",JNJ,0.050044,0.0,Neutral
Eli Lilly raises full-year guidance as drug pipeline drives second-quarter profit up 85%,https://www.cnbc.com/2023/08/08/eli-lilly-lly-q2-2023-earnings-report.html,2023-08-08 11:04:48,"Eli Lilly's stock has been on a tear, driven by positive trial results for its Alzheimer's drug and progress with its promising obesity drug pipeline.",JNJ,0.084127,0.132257,Neutral
Is Johnson & Johnson Stock a Buy Now?,https://www.fool.com/investing/2023/08/08/is-johnson-johnson-stock-a-buy-now/,2023-08-08 09:12:00,An old headwind is back for this pharmaceutical giant.,JNJ,0.625937,0.0,Neutral
"New Data May Push Insurers to Cover Novo, Lilly Obesity Drugs",https://www.barrons.com/amp/articles/novo-nordisk-wegovy-study-prevent-heart-attack-ae09e586,2023-08-07 15:55:00,Does Novo's Weight Loss Drug Prevent Heart Attacks? Investors Will Soon Know. ...,JNJ,0.089629,0.126477,Neutral
JNJ: 3 Pharma Stock Buys You Don't Want to Miss,https://stocknews.com/news/jnj-nvo-azn-3-pharma-stock-buys-you-dont-want-to-miss/,2023-08-07 14:15:53,"The pharmaceutical industry is expected to experience substantial growth in the coming years with expanding global medical needs. Also, the healthcare sector is relatively resilient during market downturns.",JNJ,0.281827,0.162493,Somewhat-Bullish
"NANOBIOTIX to Host Extraordinary General Meeting of Shareholders on September 1st, 2023",https://www.globenewswire.com/news-release/2023/08/04/2719271/0/en/NANOBIOTIX-to-Host-Extraordinary-General-Meeting-of-Shareholders-on-September-1st-2023.html,2023-08-04 20:15:00,"PARIS and CAMBRIDGE, Mass., Aug. 04, 2023 ( GLOBE NEWSWIRE ) -- NANOBIOTIX ( Euronext: NANO -- NASDAQ: NBTX - the ''Company'' ) , a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced that the ...",JNJ,0.107495,0.179872,Somewhat-Bullish
P/E Ratio Insights for Johnson & Johnson - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/news/23/08/33579873/pe-ratio-insights-for-johnson-johnson,2023-08-04 18:00:17,"In the current session, the stock is trading at $171.79, after a 0.67% increase. Over the past month, Johnson & Johnson Inc. JNJ stock increased by 7.87%, and in the past year, by 0.89%.",JNJ,0.405651,0.03593,Neutral
Karuna  ( KRTX )  Reports Narrower-Than-Expected Loss in Q2,https://www.zacks.com/stock/news/2132872/karuna-krtx-reports-narrower-than-expected-loss-in-q2,2023-08-04 16:40:00,Karuna (KRTX) reports mixed second-quarter 2023 results. The company beats estimates for earnings but misses the mark on sales.,JNJ,0.104683,0.047239,Neutral
Bioprocess Validation Market to grow at a CAGR of 11.39% from 2022 to 2027|Increasing demand for ... - PR Newswire,https://www.prnewswire.com/news-releases/bioprocess-validation-market-to-grow-at-a-cagr-of-11-39-from-2022-to-2027increasing-demand-for-biopharmaceuticals-to-boost-market-growth---technavio-301892736.html,2023-08-04 15:15:00,Bioprocess Validation Market to grow at a CAGR of 11.39% from 2022 to 2027|Increasing demand for ... PR ...,JNJ,0.031119,0.104281,Neutral
"Bruker  ( BRKR )  Q2 Earnings and Revenues Top, '23 Sales View Up",https://www.zacks.com/stock/news/2132699/bruker-brkr-q2-earnings-and-revenues-top-23-sales-view-up,2023-08-04 13:45:00,Bruker (BRKR) delivers better-than-expected earnings and revenues in the second quarter of 2023.,JNJ,0.154455,0.052515,Neutral
Better Buy: Johnson & Johnson vs. Proctor & Gamble,https://www.fool.com/investing/2023/08/04/better-buy-johnson-johnson-vs-proctor-gamble/,2023-08-04 12:25:00,"Both are excellent dividend stocks, but only one has better long-term prospects.",JNJ,0.178459,0.165822,Somewhat-Bullish
"The Zacks Analyst Blog Highlights Johnson & Johnson, General Dynamics, Pioneer Natural Resources, Alibaba Group and Autodesk",https://www.zacks.com/stock/news/2132595/the-zacks-analyst-blog-highlights-johnson-johnson-general-dynamics-pioneer-natural-resources-alibaba-group-and-autodesk,2023-08-04 12:08:00,"Johnson & Johnson, General Dynamics, Pioneer Natural Resources, Alibaba Group and Autodesk are part of the Zacks top Analyst Blog.",JNJ,0.219477,0.048085,Neutral
Biosense Webster Receives FDA Approval for Multiple Atrial Fibrillation Ablation Products to be Used in a Workflow Without Fluoroscopy,https://www.prnewswire.com/news-releases/biosense-webster-receives-fda-approval-for-multiple-atrial-fibrillation-ablation-products-to-be-used-in-a-workflow-without-fluoroscopy-301893319.html,2023-08-04 12:00:00,Biosense Webster Receives FDA Approval for Multiple Atrial Fibrillation Ablation Products to be Used in a Workflow ... PR ...,JNJ,0.269776,0.233945,Somewhat-Bullish
"Ralph Lauren To Rally 17%? Here Are 10 Other Analyst Forecasts For Friday - Apple  ( NASDAQ:AAPL ) , Alkami Technology  ( NASDAQ:ALKT ) ",https://www.benzinga.com/news/23/08/33571721/ralph-lauren-to-rally-17-here-are-10-other-analyst-forecasts-for-friday,2023-08-04 11:42:54,Atlantic Equities raised the price target for Johnson & Johnson JNJ from $167 to $170. Atlantic Equities analyst Steve Chesney maintained a Neutral rating. Johnson & Johnson shares rose 0.1% to $170.70 in pre-market trading. JP Morgan cut OUTFRONT Media Inc. OUT price target from $20 to $14..,JNJ,0.274834,0.135363,Neutral
Money Manager Shares Sage Advice For Picking Best ETFs,https://www.investors.com/etfs-and-funds/etfs/best-etf-picks-money-manager-sage-advice/,2023-08-04 11:00:00,"Thanks to the Federal Reserve's interest rate hikes, investors can earn 5% or more in some of the safest fixed income today. And as the stock rally broadens, investors get more choices of the best ETFs.",JNJ,0.084722,-0.012525,Neutral
The Pulmonary Embolism Therapeutics Market size to grow at a CAGR of 9.52% from 2022 to 2027|The advancement ... - PR Newswire,https://www.prnewswire.com/news-releases/the-pulmonary-embolism-therapeutics-market-size-to-grow-at-a-cagr-of-9-52-from-2022-to-2027the-advancement-in-the-healthcare-and-medical-sector-is-a-major-trend-technavio-301892623.html,2023-08-04 09:30:00,The Pulmonary Embolism Therapeutics Market size to grow at a CAGR of 9.52% from 2022 to 2027|The advancement ... PR ...,JNJ,0.045569,0.139204,Neutral
Stryker lifts annual profit forecast as demand for its devices picks up,https://www.reuters.com/business/healthcare-pharmaceuticals/stryker-lifts-annual-profit-forecast-demand-its-devices-picks-up-2023-08-03/,2023-08-03 20:59:00,"Aug 3 ( Reuters ) - Stryker ( SYK.N ) raised its annual profit forecast on Thursday as the medtech company sees strong demand for its medical and surgical devices, aided by a post-pandemic pickup in surgical procedure volumes at hospitals.",JNJ,0.16171,0.107801,Neutral
Looking to Bet On Perfect AAA Credit Ratings? Play These ETFs,https://www.zacks.com/stock/news/2132188/looking-to-bet-on-perfect-aaa-credit-ratings-play-these-etfs,2023-08-03 17:15:00,"In light of Fitch Ratings' downgrade of U.S. credit, investors might be interested in identifying companies and countries that still hold the desirable 'AAA' credit rating.",JNJ,0.130571,0.147308,Neutral
"Q2 Earnings Season Scorecard and Research Reports for JNJ, Pioneer Natural & Others",https://www.zacks.com/research-daily/2132025/q2-earnings-season-scorecard-and-research-reports-for-jnj-pioneer-natural-others,2023-08-03 16:59:00,"Today's Research Daily features a real-time Q2 scorecard and updated reports on JNJ (JNJ), General Dynamics (GD), Pioneer Natural Resources (PXD) and others.",JNJ,0.060388,0.162027,Somewhat-Bullish
"JNJ: 2 Must-Have Pharma Stocks to Buy in August, 1 to Sell",https://stocknews.com/news/jnj-nvs-sndl-cbmg-2-must-have-pharma-stocks-to-buy-in-august-1-to/,2023-08-03 15:51:03,"The healthcare and pharmaceutical industries experience consistent demand due to factors such as an aging population, rising incidence of chronic illnesses, and the overall growth in the global population.",JNJ,0.19857,0.158354,Somewhat-Bullish
"Sarepta  ( SRPT )  Q2 Loss Narrower Than Expected, Sales Miss",https://www.zacks.com/stock/news/2132152/sarepta-srpt-q2-loss-narrower-than-expected-sales-miss,2023-08-03 15:28:00,"Sarepta's (SRPT) second-quarter 2023 earnings beat estimates. Though total revenues register strong year-over-year growth during the quarter, the same misses the mark.",JNJ,0.09495,0.056501,Neutral
"Allogene's  ( ALLO )  Q2 Loss Narrower Than Expected, Sales Miss",https://www.zacks.com/stock/news/2132146/allogenes-allo-q2-loss-narrower-than-expected-sales-miss,2023-08-03 15:20:00,Allogene's (ALLO) second-quarter results beat estimates for earnings but misses the mark on sales. Management reiterated its previously-issued financial guidance for 2023.,JNJ,0.103778,0.047114,Neutral
"Moderna  ( MRNA )  Beats on Q2 Earnings & Sales, Raises '23 View",https://www.zacks.com/stock/news/2132136/moderna-mrna-beats-on-q2-earnings-sales-raises-23-view,2023-08-03 15:15:00,Moderna (MRNA) beats expectations for earnings and sales. Management raises its product revenue guidance based on potential U.S. demand for COVID vaccines during the upcoming fall season.,JNJ,0.090134,0.051723,Neutral
Genmab Announces Financial Results for the First Half of 2023,https://www.globenewswire.com/news-release/2023/08/03/2718313/0/en/Genmab-Announces-Financial-Results-for-the-First-Half-of-2023.html,2023-08-03 15:01:00,"August 3, 2023 Copenhagen, Denmark. Interim Report for the First Six Months Ended June ...",JNJ,0.03878,0.0,Neutral
GTECH Agency Takes the Lead on New Growth Strategy with WooRank,https://www.globenewswire.com/news-release/2023/08/03/2718021/9238/en/GTECH-Agency-Takes-the-Lead-on-New-Growth-Strategy-with-WooRank.html,2023-08-03 12:30:00,"WOBURN, Mass., Aug. 03, 2023 ( GLOBE NEWSWIRE ) -- Bridgeline Digital, Inc. ( NASDAQ: BLIN ) , a leading cloud-based marketing technology software provider, today announced that GTECH, a global full-service digital marketing company, has chosen, WooRank, its innovative SEO product to power their ...",JNJ,0.144275,0.302753,Somewhat-Bullish
GTECH Agency Takes the Lead on New Growth Strategy with WooRank - Bridgeline Digital  ( NASDAQ:BLIN ) ,https://www.benzinga.com/pressreleases/23/08/g33547388/gtech-agency-takes-the-lead-on-new-growth-strategy-with-woorank,2023-08-03 12:30:00,"WOBURN, Mass., Aug. 03, 2023 ( GLOBE NEWSWIRE ) -- Bridgeline Digital, Inc. BLIN, a leading cloud-based marketing technology software provider, today announced that GTECH, a global full-service digital marketing company, has chosen, WooRank, its innovative SEO product to power their revenue ...",JNJ,0.137671,0.295174,Somewhat-Bullish
Mobile health solutions market to grow at a CAGR of 27.09% from 2022 to 2027 | Increasing smartphone penetration will drive growth - Technavio,https://www.benzinga.com/pressreleases/23/08/n33534424/mobile-health-solutions-market-to-grow-at-a-cagr-of-27-09-from-2022-to-2027-increasing-smartphone-,2023-08-02 21:15:00,"NEW YORK, Aug. 2, 2023 /PRNewswire/ -- The mobile health solutions market size is estimated to grow by USD 256.69 billion from 2022 to 2027, at a CAGR of 27.09% according to Technavio. Download a Sample Report! Coverage: Parent market analysis. key drivers, major trends, and challenges.",JNJ,0.01441,0.091708,Neutral
This Is What Whales Are Betting On Johnson & Johnson - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/08/33530286/this-is-what-whales-are-betting-on-johnson-johnson,2023-08-02 19:31:32,"A whale with a lot of money to spend has taken a noticeably bullish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson JNJ we detected 16 strange trades. If we consider the specifics of each trade, it is accurate to state that 50% of the investors opened trades with ...",JNJ,0.797189,0.325741,Somewhat-Bullish
United Therapeutics  ( UTHR )  Q2 Earnings & Sales Beat Estimates,https://www.zacks.com/stock/news/2131296/united-therapeutics-uthr-q2-earnings-sales-beat-estimates,2023-08-02 16:29:00,United Therapeutics' (UTHR) second-quarter 2023 earnings and sales beat estimates. Tyvaso sales continue to drive the company's top line.,JNJ,0.100308,0.096756,Neutral
"Vertex  ( VRTX )  Beats on Q2 Earnings & Sales, Raises '23 View",https://www.zacks.com/stock/news/2131278/vertex-vrtx-beats-on-q2-earnings-sales-raises-23-view,2023-08-02 16:06:00,"Vertex Pharmaceuticals' (VRTX) second-quarter 2023 earnings and sales beat estimates. Based on strong Trikafta uptake, management raises its financial guidance for 2023.",JNJ,0.089629,0.053738,Neutral
Virtualware partners with AdvanSoft to introduce VIROO in Malaysia,https://www.globenewswire.com/news-release/2023/08/02/2717130/0/en/Virtualware-partners-with-AdvanSoft-to-introduce-VIROO-in-Malaysia.html,2023-08-02 16:00:00,"Bilbao, Spain, 18 August.- Spanish technology company Virtualware ( EPA: MLVIR ) , one of the European leaders in the virtual reality industry, has signed a partnership agreement with AdvanSoft Sdn Bhd to boost VIROO's presence in Malaysia.",JNJ,0.045396,0.097424,Neutral
"Health Canada Authorizes TECVAYLIâ„¢  ( teclistamab injection ) , a First-in-Class Bispecific Antibody for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma",https://www.newswire.ca/news-releases/health-canada-authorizes-tecvayli-tm-teclistamab-injection-a-first-in-class-bispecific-antibody-for-the-treatment-of-patients-with-relapsed-or-refractory-multiple-myeloma-809242836.html,2023-08-02 12:00:00,"Health Canada Authorizes TECVAYLIâ„¢ ( teclistamab injection ) , a First-in-Class Bispecific Antibody for the Treatment of ... Canada ...",JNJ,0.142686,-0.016784,Neutral
AI-Generated Data Could Be a Boon for Healthcare-If Only It Seemed More Real,https://www.wsj.com/articles/ai-generated-data-could-be-a-boon-for-healthcareif-only-it-seemed-more-real-5bfe52dd,2023-08-02 11:00:00,AI enables researchers to weave 'synthetic data' from sets of patient data. But CIOs question whether the generated data sufficiently captures the medical variables useful in research.,JNJ,0.443626,0.347469,Somewhat-Bullish
JNJ: Is Johnson & Johnson  ( JNJ )  a Must-Buy Stability Stock?,https://stocknews.com/news/jnj-nvo-abbv-bmy-is-johnson-johnson-jnj-a-must-buy-stability-stock/,2023-08-01 17:30:14,"Johnson & Johnson ( JNJ ) is one of the world's largest pharmaceutical and medical device manufacturers, making it appealing because of its safety. Being a well-established pharmaceutical company, it could resist unfavorable headwinds.",JNJ,0.521465,0.236065,Somewhat-Bullish
Zimmer Biomet's downbeat 2024 view hits shares after forecast raise,https://www.reuters.com/business/healthcare-pharmaceuticals/medical-device-maker-zimmer-biomet-lifts-profit-forecast-surgeries-rebound-2023-08-01/,2023-08-01 17:22:00,"An employee takes a glowing piece of metal from a furnace at the forge of medical implants maker Zimmer Biomet in Winterthur, Switzerland, January 23, 2017. REUTERS/Arnd Wiegmann/File Photo",JNJ,0.143415,0.182568,Somewhat-Bullish
"Merck  ( MRK )  Beats on Q2 Earnings and Sales, Ups 2023 View",https://www.zacks.com/stock/news/2130630/merck-mrk-beats-on-q2-earnings-and-sales-ups-2023-view,2023-08-01 16:28:00,Merck (MRK) beats Q2 estimates for earnings and sales. It raises its 2023 guidance. Stock rises in pre-market.,JNJ,0.059785,0.059996,Neutral
Merck swings to loss as it books charge on $10.8 billion acquisition of Prometheus Biosciences,https://www.marketwatch.com/story/merck-posts-narrower-than-expected-loss-and-sales-top-estimates-42c4e417,2023-08-01 15:15:00,Merck's earnings were also hit by lower sales of its COVID antiviral Lagevrio.,JNJ,0.128822,-0.234779,Somewhat-Bearish
"After Paying Lawyers, Trump's PAC Is Nearly Broke",https://www.nytimes.com/2023/07/31/us/politics/trump-pac-filing.html,2023-08-01 03:00:04,Trump PAC Down to $4 Million Cash on Hand After Legal Fees The New York Times ...,JNJ,0.030524,0.153184,Somewhat-Bullish
Drugmakers Want to Crush Medicare's Pricing Power,https://www.barrons.com/articles/drug-price-negotiation-lawsuits-medicare-ffd4cb95,2023-08-01 01:52:08,Pharma Companies Want to Crush Medicare's Ability to Negotiate Costs ...,JNJ,0.294093,-0.020378,Neutral
Wall Street finishes strong month on upbeat company earnings,https://www.moneycontrol.com/news/business/markets/wall-street-finishes-strong-month-on-upbeat-company-earnings-11069671.html,2023-08-01 00:42:44,"All three major stock indexes ended with gains for the month, ahead of a busy week of earnings reports from companies including Amazon.com ( AMZN.O ) and Apple ( AAPL.O ) , plus U.S. economic data including the jobs report.",JNJ,0.074001,0.033545,Neutral
Why Novavax Stock Zoomed 13% Higher on Monday,https://www.fool.com/investing/2023/07/31/why-novavax-stock-zoomed-13-higher-on-monday/,2023-07-31 22:24:41,A renewed fight against COVID-19 might be coming.,JNJ,0.141726,-0.004999,Neutral
"S&P 500: Entertainment Giants, AI Play Lead Monday's Winners",https://www.investors.com/news/sp-500-entertainment-giants-ai-play-adobe-lead-monday-5-best-medtech-firms-sicken/,2023-07-31 20:26:00,"S&P 500: Entertainment Giants, AI Play Lead Monday's 5 Best. Medtech Firms Sicken Investor's Business Daily ...",JNJ,0.214937,-0.338748,Somewhat-Bearish
J&J shares on track for biggest daily drop in 3 years on talc setback,https://www.reuters.com/business/healthcare-pharmaceuticals/jj-shares-track-biggest-daily-drop-3-years-talc-setback-2023-07-31/,2023-07-31 19:30:00,July 31 ( Reuters ) - Shares in Johnson & Johnson ( JNJ.N ) were down 4.1% on Monday and looked set for their biggest one-day percentage loss since June 2020 after a U.S. judge shot down its second attempt to resolve tens of thousands of talc-related lawsuits.,JNJ,0.282234,-0.234921,Somewhat-Bearish
Why Johnson & Johnson Stock Is Sinking Today,https://www.fool.com/investing/2023/07/31/why-johnson-johnson-stock-is-sinking-today/,2023-07-31 15:19:08,The healthcare giant struck out again in an attempt to resolve its talc-related woes.,JNJ,0.540042,-0.412903,Bearish
Orthopedic Fracture Repairing Implants for Osteoporosis Market anticipated to reach US$ 4.8 billion by 2031: TMR study,https://www.benzinga.com/pressreleases/23/07/g33471942/orthopedic-fracture-repairing-implants-for-osteoporosis-market-anticipated-to-reach-us-4-8-billion,2023-07-31 15:00:00,"Wilmington, Delaware, United States, July 31, 2023 ( GLOBE NEWSWIRE ) -- The global market for orthopedic fracture repairing implants for osteoporosis was estimated to have acquired a market valuation of around US$ 3 billion in 2021.",JNJ,0.041828,0.164856,Somewhat-Bullish
"Drug, Biotech Stocks' Q2 Earnings Due on Aug 1: PFE, MRK & More",https://www.zacks.com/stock/news/2129900/drug-biotech-stocks-q2-earnings-due-on-aug-1-pfe-mrk-more,2023-07-31 13:58:00,"Let's look at five big biotech, pharma companies, PFE, MRK, VRTX, EXEL and INCY, slated to release quarterly results on Aug 1.",JNJ,0.043658,0.134273,Neutral
Icertis Brings Generative AI to Enterprise Contracting with Delivery of First Contract Intelligence Copilots,https://www.prnewswire.com/news-releases/icertis-brings-generative-ai-to-enterprise-contracting-with-delivery-of-first-contract-intelligence-copilots-301888937.html,2023-07-31 13:00:00,"Global leaders pioneer secure use of generative AI in contracting through Icertis ExploreAI Early Adopter Program BELLEVUE, Wash., July 31, 2023 /PRNewswire/ -- Icertis has delivered Icertis Contract Intelligence ( ICI ) Copilots, the first generative AI applications for enterprise contract ...",JNJ,0.050786,0.092706,Neutral
We're exiting a health-care name - putting us on the hunt to buy a new stock for the portfolio,https://www.cnbc.com/2023/07/31/our-exit-of-a-health-care-name-puts-on-the-hunt-to-buy-a-new-stock.html,2023-07-31 12:50:01,We're taking a hard look at the Bullpen and the rest of the market for new opportunities.,JNJ,0.417995,0.104731,Neutral
"Forget Soft Landing for Economy, Think About a New Takeoff",https://www.zacks.com/stock/news/2129842/forget-soft-landing-for-economy-think-about-a-new-takeoff,2023-07-31 12:19:00,"At this stage, we have narrowed our search to five stocks. These are: META, GOOGL, KO, PEP, JNJ.",JNJ,0.08398,0.036767,Neutral
"Doozy of a Week, Central Bankers, Fed Funds Futures, Earnings Update, Markets",https://realmoney.thestreet.com/investing/doozy-of-a-week-central-bankers-fed-funds-futures-earnings-update-markets-16129896,2023-07-31 11:35:05,"The past week, to put it mildly, was a ""real doozy."" Markets withstood a week of key macroeconomic data, a week of high profile quarterly earnings, a week of less than dovish monetary policy decisions, a week of rising Treasury yields, and a suddenly rising US dollar relative to its reserve ...",JNJ,0.028626,-0.106813,Neutral
"Futures subdued ahead of more megacap earnings, employment data",https://www.reuters.com/markets/us/futures-subdued-ahead-more-megacap-earnings-employment-data-2023-07-31/,2023-07-31 10:13:00,July 31 ( Reuters ) - U.S. stock index futures were little changed on Monday as investors awaited earnings from more megacap companies and a key employment report later this week.,JNJ,0.102888,0.04169,Neutral
Legal-Bay Pre-Settlement Funding to Add Mesothelioma Cases for Funding Along with Talc After Large $18MM Verdict,https://www.prnewswire.com/news-releases/legal-bay-pre-settlement-funding-to-add-mesothelioma-cases-for-funding-along-with-talc-after-large-18mm-verdict-301888394.html,2023-07-31 10:05:00,"Johnson & Johnson faces additional pressure with another major loss as case is stayed in bankruptcy court awaiting next direction TRENTON, N.J., July 31, 2023 /PRNewswire/ -- Legal-Bay, The Pre Settlement Funding Company, announced today that they are now adding mesothelioma victims to their list ...",JNJ,0.279015,-0.152676,Somewhat-Bearish
Judge Rejects Johnson & Johnson's Effort to Limit Talc-Related Liabilities,https://www.nytimes.com/2023/07/30/business/johnson-johnson-talc-baby-powder-lawsuit.html,2023-07-30 16:58:44,"For the second time this year, a court has ruled against Johnson & Johnson's effort to use a bankruptcy case to limit its exposure to tens of thousands of lawsuits that claim its talcum powder products caused cancer.",JNJ,0.107495,-0.056853,Neutral
4 Top Stocks and 3 Top Cryptocurrencies for August,https://www.fool.com/investing/2023/07/30/4-top-stocks-and-3-top-cryptocurrencies-for-august/,2023-07-30 10:45:00,Investors looking for a portfolio checkup have come to the right place.,JNJ,0.227587,0.22964,Somewhat-Bullish
These 3 Dow Stocks Are Set to Soar in 2023 and Beyond,https://www.fool.com/investing/2023/07/30/these-3-dow-stocks-are-set-to-soar-in-2023-beyond/,2023-07-30 10:04:00,Three iconic Dow stocks are sitting on huge catalysts and preparing themselves for big things to come.,JNJ,0.257442,0.118104,Neutral
"Want $500 in Super Safe Annual Dividend Income? Invest $9,900 in the Following 3 Dividend Kings",https://www.fool.com/investing/2023/07/30/want-500-safe-annual-dividend-income-invest-9900/,2023-07-30 09:21:00,"These truly rock-solid income stocks, which sport an average yield of 5.07%, can pad patient investors' wallets.",JNJ,0.182782,0.181589,Somewhat-Bullish
Europe Approves Reduced Dosing For Johnson & Johnson's Cell Therapy For Multiple Myeloma - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/general/biotech/23/08/33917457/europe-approves-reduced-dosing-for-johnson-johnsons-cell-therapy-for-multiple-myeloma,2023-08-18 15:59:18,The Janssen Pharmaceutical Companies of Johnson & Johnson JNJ announced that the European Commission ( EC ) approved a Type II variation application for Tecvayli ( teclistamab ) .,JNJ,0.491878,0.344893,Somewhat-Bullish
Hair care market to grow by USD 19.6777 billion from 2022 to 2027; 34% of growth will originate from APAC - Technavio - PR Newswire,https://www.prnewswire.com/news-releases/hair-care-market-to-grow-by-usd-19-6777-billion-from-2022-to-2027-34-of-growth-will-originate-from-apac---technavio-301903952.html,2023-08-18 15:15:00,Hair care market to grow by USD 19.6777 billion from 2022 to 2027. 34% of growth will originate from APAC - Technavio PR ...,JNJ,0.04497,0.0,Neutral
's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet - Hawaiian Electric Indus  ( NYSE:HE ) ,https://www.benzinga.com/markets/cryptocurrency/23/08/33908140/benzingas-stock-whisper-index-5-stocks-investors-are-secretly-monitoring-but-not-talking-a,2023-08-18 12:45:08,"Investors are on the hunt for undervalued, underfollowed and emerging stocks, and retail traders have countless methods at their disposal to uncover new information.",JNJ,0.269181,0.260079,Somewhat-Bullish
"Acute Migraine Treatment Market Predicted to Reach USD 7 billion by 2031, Recording Over a 15% CAGR Says, Transparency Market Research",https://www.benzinga.com/pressreleases/23/08/g33911444/acute-migraine-treatment-market-predicted-to-reach-usd-7-billion-by-2031-recording-over-a-15-cagr-,2023-08-18 10:30:00,"Wilmington, Delaware, United States, Aug. 18, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global market for acute migraine treatment was estimated to be worth a market valuation of around US$ 2.1 billion in 2021.",JNJ,0.042571,0.059382,Neutral
Americans' Appetite for Weight-Loss Drugs is Feeding Denmark's Economy,https://www.thedailyupside.com/americans-appetite-for-weight-loss-drugs-is-feeding-denmarks-economy/,2023-08-17 23:00:57,"America's loss is Denmark's gain. Weight loss, that is. The US obsession with skinny-down pills Ozempic and Wegovy has turned Danish drugmaker...",JNJ,0.111488,0.093442,Neutral
Here's Why it is a Good Time to Buy J&J's  ( JNJ )  Stock Now,https://www.zacks.com/stock/news/2137657/heres-why-it-is-a-good-time-to-buy-jjs-jnj-stock-now,2023-08-17 15:47:00,J&J's (JNJ) Pharma sales are being driven by key drugs like Darzalex and new products. J&J's Pharma and MedTech units are likely to continue to drive sales growth in 2023.,JNJ,0.13873,0.107983,Neutral
AbbVie  ( ABBV )  Gets EU Approval for Migraine Prevention Drug,https://www.zacks.com/stock/news/2137725/abbvie-abbv-gets-eu-approval-for-migraine-prevention-drug,2023-08-17 15:43:00,"Following the approval, AbbVie's (ABBV) Aquipta is the first and the only oral CGRP receptor antagonist approved in the EU to prevent episodic and chronic migraines.",JNJ,0.172097,0.080245,Neutral
America's courts weigh in on how firms resolve liability claims,https://www.economist.com/business/2023/08/17/americas-courts-weigh-in-on-how-firms-resolve-liability-claims,2023-08-17 13:33:27,"T legal battle over America's opioid epidemic was reignited when, on August 10th, the country's Supreme Court said it would review an earlier settlement secured by Purdue Pharma, a main character in the saga.",JNJ,0.060541,-0.135376,Neutral
"Zarbee'sÂ® Brand Launches in Canada, Offering Parents a Range of Pediatric Cough and Immune Support Solutions - Canada NewsWire",https://www.newswire.ca/news-releases/zarbee-s-r-brand-launches-in-canada-offering-parents-a-range-of-pediatric-cough-and-immune-support-solutions-882026555.html,2023-08-17 11:45:00,"Zarbee'sÂ® Brand Launches in Canada, Offering Parents a Range of Pediatric Cough and Immune Support Solutions Canada ...",JNJ,0.034185,0.0,Neutral
Talvey Talquetamab Gets FDA Approval For Multiple Myeloma,https://www.benzinga.com/pressreleases/23/08/g33892466/talvey-talquetamab-gets-fda-approval-for-multiple-myeloma,2023-08-17 11:14:24,"Delhi, Aug. 17, 2023 ( GLOBE NEWSWIRE ) -- Johnson & Johnson's subsidiary Janssen made headlines again in August 2023 when the FDA approved its product talquetamab under the agency's accelerated approval program.",JNJ,0.046452,0.085186,Neutral
Virtualware partners with VRLOGIC to leverage its VR CAVEs business with VIROO.,https://www.globenewswire.com/news-release/2023/08/17/2727034/0/en/Virtualware-partners-with-VRLOGIC-to-leverage-its-VR-CAVEs-business-with-VIROO.html,2023-08-17 09:51:00,"Spanish technology company Virtualware ( EPA: MLVIR ) , one of the European leaders in the virtual reality industry, recently signed a partnership agreement with the German company VRLOGIC GmbH to leverage its VR CAVEs business with VIROO.",JNJ,0.049732,0.098234,Neutral
"Opinion: The Fed Is Losing the Battle Against Inflation, and There's No Easy Fix",https://www.fool.com/investing/2023/08/17/fed-is-losing-battle-against-inflation-no-easy-fix/,2023-08-17 09:06:00,"Wall Street may be forced to ""take its medicine"" to resolve stubbornly high core inflation.",JNJ,0.145583,-0.111702,Neutral
"Anticoagulants Market to Exceed USD 56.6 billion by 2031, Expanding at a CAGR of 6.2%: TMR Report",https://www.benzinga.com/pressreleases/23/08/g33890025/anticoagulants-market-to-exceed-usd-56-6-billion-by-2031-expanding-at-a-cagr-of-6-2-tmr-report,2023-08-17 08:35:08,"Wilmington, Delaware, United States, Aug. 17, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global anticoagulants market is projected to flourish at a CAGR of 6.2% from 2022 to 2031. As per the report published by TMR, a valuation of US$ 56.6 billion is anticipated for the ...",JNJ,0.041901,0.0,Neutral
Major shareholder announcement,https://www.globenewswire.com/news-release/2023/08/17/2726985/0/en/Major-shareholder-announcement.html,2023-08-17 08:30:00,ANNOUNCEMENT NO. ...,JNJ,0.29234,0.08587,Neutral
Meet The Man Who Revolutionized The Wine Industry,https://www.forbes.com/sites/bradjaphe/2023/08/17/meet-the-man-who-revolutionized-the-wine-industry/,2023-08-17 08:00:27,"Greg Lambrecht, the inventor of the Coravin, reveals what inspired him to change the way we drink wine.",JNJ,0.030799,0.012597,Neutral
"Federal Court Rules To Prohibit Access To Abortion Pill: Supreme Court To Weigh In - Johnson & Johnson  ( NYSE:JNJ ) , Merck & Co  ( NYSE:MRK ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/news/23/08/33881514/federal-court-rules-to-prohibit-access-to-abortion-pill-supreme-court-to-weigh-in,2023-08-16 19:23:07,"The 5th Circuit Court of Appeals ruled Wednesday to prohibit access to mifepristone, the drug known as the abortion pill, in a case filed against the Food and Drug Administration. The ruling will not take effect until the Supreme Court weighs in, which may not occur until next year, according to ...",JNJ,0.295867,-0.08874,Neutral
Looking Into Johnson & Johnson's Recent Short Interest - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/short-sellers/23/08/33878517/looking-into-johnson-johnsons-recent-short-interest,2023-08-16 16:00:28,"Johnson & Johnson's JNJ short percent of float has risen 115.22% since its last report. The company recently reported that it has 25.73 million shares sold short, which is 0.99% of all regular shares that are available for trading.",JNJ,0.221819,0.15378,Somewhat-Bullish
"Nicotine Replacement Therapy Market Revenue to Cross USD 52.1 billion by 2031, Expanding at a CAGR of 7.7% | Exclusive Report by Transparency Market Research",https://www.benzinga.com/pressreleases/23/08/g33877743/nicotine-replacement-therapy-market-revenue-to-cross-usd-52-1-billion-by-2031-expanding-at-a-cagr-,2023-08-16 15:19:26,"Wilmington, Delaware, United States, Aug. 16, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global nicotine replacement therapy market is projected to flourish at a CAGR of 7.7% from 2023 to 2031. As per the report published by TMR, a valuation of US$ 52.1 billion is ...",JNJ,0.04303,0.017827,Neutral
Nearing Retirement? These Stocks Are as Safe as They Come,https://www.fool.com/investing/2023/08/16/nearing-retirement-these-stocks-are-as-safe-as-the/,2023-08-16 15:19:00,These companies generate very durable earnings and have rock-solid balance sheets.,JNJ,0.341699,0.487129,Bullish
"Intracardiac Echocardiography Market to Surpass USD 979.5 million by 2031, Expanding at a CAGR of 5.3%: TMR Report",https://www.benzinga.com/pressreleases/23/08/g33877672/intracardiac-echocardiography-market-to-surpass-usd-979-5-million-by-2031-expanding-at-a-cagr-of-5,2023-08-16 15:16:53,"Wilmington, Delaware, United States, Aug. 16, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global intracardiac echocardiography market is projected to flourish at a CAGR of 5.3% from 2023 to 2031. As per the report published by TMR, a valuation of US$ 979.5 million is ...",JNJ,0.040899,0.0,Neutral
Johnson & Johnson  ( JNJ )  is Attracting Investor Attention: Here is What You Should Know,https://www.zacks.com/stock/news/2136885/johnson-johnson-jnj-is-attracting-investor-attention-here-is-what-you-should-know,2023-08-16 13:00:11,"Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",JNJ,0.47672,0.180521,Somewhat-Bullish
PaxMedica Appoints David Hough M.D. as Chief Medical Officer,https://www.globenewswire.com/news-release/2023/08/16/2726358/0/en/PaxMedica-Appoints-David-Hough-M-D-as-Chief-Medical-Officer.html,2023-08-16 12:30:00,Announces Additional Management Changes. Independent Directors Now Majority of Board ...,JNJ,0.039878,-0.034156,Neutral
PaxMedica Appoints David Hough M.D. as Chief Medical Officer - PaxMedica  ( NASDAQ:PXMD ) ,https://www.benzinga.com/pressreleases/23/08/g33874388/paxmedica-appoints-david-hough-m-d-as-chief-medical-officer,2023-08-16 12:30:00,"Announces Additional Management Changes; Independent Directors Now Majority of Board TARRYTOWN, NY, Aug. 16, 2023 ( GLOBE NEWSWIRE ) -- via NewMediaWire - PaxMedica, Inc.",JNJ,0.039096,-0.033094,Neutral
Elrexfio Gets Accelerated FDA Approval For Refractory Multiple Myeloma,https://www.benzinga.com/pressreleases/23/08/g33873434/elrexfio-gets-accelerated-fda-approval-for-refractory-multiple-myeloma,2023-08-16 11:36:49,"Delhi, Aug. 16, 2023 ( GLOBE NEWSWIRE ) -- US Bispecific Antibodies Market & Clinical Pipeline Insight 2028 Report Highlights: US Bispecific Antibodies Market Opportunity: > USD 15 Billion By 2028 FDA Approved Bispecific Antibodies: 11 Antibodies Approved Bispecific Antibodies Dosage, Price ...",JNJ,0.098862,0.128114,Neutral
Is iShares Core Dividend Growth ETF  ( DGRO )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2136792/is-ishares-core-dividend-growth-etf-dgro-a-strong-etf-right-now,2023-08-16 10:20:08,Smart Beta ETF report for ...,JNJ,0.114956,0.05992,Neutral
A New Stock Is About to Join the S&P 500. Does History Show That Buying It Now Could Pay Off?,https://www.fool.com/investing/2023/08/16/a-new-stock-is-about-to-join-the-sp-500-does-histo/,2023-08-16 09:50:00,History might not be reliable in this case.,JNJ,0.291644,0.061113,Neutral
Oklahoma declines to discuss a settlement of Tulsa Race Massacre survivors' lawsuit,https://apnews.com/article/tulsa-race-massacre-survivors-lawsuit-2731bcc20ef66decf564eb4918460327,2023-08-15 21:20:00,OKLAHOMA CITY ( AP ) - Oklahoma says it won't discuss a settlement with survivors who are seeking reparations for the 1921 Tulsa Race Massacre and have appealed a Tulsa County judge's last month.,JNJ,0.070725,-0.165968,Somewhat-Bearish
NANOBIOTIX Announces Expiration of HSR Waiting Period Regarding the Agreement for Worldwide Co-Development and Commercialization of Potential First-in-Class Radioenhancer NBTXR3,https://www.globenewswire.com/news-release/2023/08/15/2725912/0/en/NANOBIOTIX-Announces-Expiration-of-HSR-Waiting-Period-Regarding-the-Agreement-for-Worldwide-Co-Development-and-Commercialization-of-Potential-First-in-Class-Radioenhancer-NBTXR3.html,2023-08-15 20:15:00,"PARIS and CAMBRIDGE, Mass., Aug. 15, 2023 ( GLOBE NEWSWIRE ) -- NANOBIOTIX ( Euronext: NANO -- NASDAQ: NBTX - the ''Company'' ) , a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, announced today the ...",JNJ,0.053153,0.079995,Neutral
This Is What Whales Are Betting On Johnson & Johnson - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/08/33865153/this-is-what-whales-are-betting-on-johnson-johnson,2023-08-15 18:46:14,"Someone with a lot of money to spend has taken a bearish stance on Johnson & Johnson JNJ. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",JNJ,0.783009,0.228882,Somewhat-Bullish
VYM: Buy or Hold: Vanguard High Dividend Yield ETF  ( VYM ) ,https://stocknews.com/news/vym-vtv-iwd-schd-buy-or-hold-vanguard-high-dividend-yield-etf-vym/,2023-08-15 13:44:00,VYM: Buy or Hold: Vanguard High Dividend Yield ...,JNJ,0.088799,0.059849,Neutral
Boston Scientific's  ( BSX )  POLARx System Gets FDA Approval,https://www.zacks.com/stock/news/2136460/boston-scientifics-bsx-polarx-system-gets-fda-approval,2023-08-15 13:38:00,Boston Scientific's (BSX) POLARx enables doctors to expand and modify the new POLARx catheter to match a patient's unique anatomy during an ablation treatment.,JNJ,0.158868,0.0853,Neutral
"Investors Look at Apple, Amazon, and More",https://www.fool.com/investing/2023/08/14/investors-look-at-apple-amazon-and-more/,2023-08-15 01:24:00,"Wingstop, Uber, Disney... We've got a lot to talk about.",JNJ,0.005593,0.05438,Neutral
"Catalent, facing pressure from Elliott, had other activists in stock",https://www.reuters.com/business/healthcare-pharmaceuticals/catalent-facing-pressure-elliott-had-other-activists-stock-2023-08-14/,2023-08-14 22:42:00,"A general view of the drug product manufacturing laboratory in biologics and sterile injectables, Catalent, in Brussels, Belgium June 27, 2023. REUTERS/Yves Herman/file photo",JNJ,0.098659,0.096321,Neutral
"Biotechnology Market to Worth Around USD 3,995.22 Billion by 2032",https://www.benzinga.com/pressreleases/23/08/g33835844/biotechnology-market-to-worth-around-usd-3-995-22-billion-by-2032,2023-08-14 15:00:00,"Ottawa, Aug. 14, 2023 ( GLOBE NEWSWIRE ) -- The global biotechnology market size accounted for USD 1,224.31 billion in 2022, a study published by Towards Healthcare a sister firm of Precedence Research.",JNJ,0.013202,0.172021,Somewhat-Bullish
Johnson & Johnson Unusual Options Activity - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/08/33835558/johnson-johnson-unusual-options-activity,2023-08-14 14:46:06,"A whale with a lot of money to spend has taken a noticeably bullish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson JNJ we detected 17 strange trades. If we consider the specifics of each trade, it is accurate to state that 52% of the investors opened trades with ...",JNJ,0.825367,0.296763,Somewhat-Bullish
"Medicenna Establishes Boston Presence, Appoints Brent Meadows as Chief Business Officer, and Bolsters Management - Medicenna Therapeutics  ( NASDAQ:MDNA ) ",https://www.benzinga.com/pressreleases/23/08/g33825888/medicenna-establishes-boston-presence-appoints-brent-meadows-as-chief-business-officer-and-bolster,2023-08-14 11:00:25,"Company to grow business development, financing and clinical leadership in Boston by accessing top-biotech talent. Brent Meadows, MBA, joins as Chief Business Officer ( CBO ) , bringing over 25 years of large pharma and biotech experience and a track record of multiple high-value transactions in ...",JNJ,0.059415,0.022992,Neutral
"Medicenna Establishes Boston Presence, Appoints Brent Meadows as Chief Business Officer, and Bolsters Management",https://www.globenewswire.com/news-release/2023/08/14/2724250/0/en/Medicenna-Establishes-Boston-Presence-Appoints-Brent-Meadows-as-Chief-Business-Officer-and-Bolsters-Management.html,2023-08-14 11:00:00,"TORONTO and HOUSTON, Aug. 14, 2023 ( GLOBE NEWSWIRE ) -- Medicenna Therapeutics Corp. ( ""Medicenna"" or ""the Company"" ) ( NASDAQ: MDNA TSX: MDNA ) , a clinical-stage immunotherapy company, announced today the appointment of Brent Meadows, MBA, as its Chief Business Officer ( ""CBO"" ) , as part of ...",JNJ,0.071892,0.023106,Neutral
"Suspect In Tylenol Murders Dead At 76, Had Long-Time Tax Ties",https://www.forbes.com/sites/kellyphillipserb/2023/08/14/suspect-in-tylenol-murders-dead-at-76-had-long-time-tax-ties/,2023-08-14 10:00:00,The 1982 Tylenol poisonings captivated the country. A former tax preparer was suspected-but never charged-in the murders. He was convicted on related extortion charges ...,JNJ,0.092569,-0.07516,Neutral
Meet the Only 2 Publicly Traded Companies With a Higher Credit Rating Than the U.S. Government,https://www.fool.com/investing/2023/08/14/only-2-stocks-higher-credit-rating-us-government/,2023-08-14 09:21:00,"In 1980, more than 60 public companies possessed the highly coveted AAA credit rating from Standard & Poor's. Today, only two remain.",JNJ,0.241855,0.163341,Somewhat-Bullish
The Medical Aesthetics Market to grow at a CAGR of 8.6% from 2022 to 2027; Increasing global awareness about ... - PR Newswire,https://www.prnewswire.com/news-releases/the-medical-aesthetics-market-to-grow-at-a-cagr-of-8-6-from-2022-to-2027-increasing-global-awareness-about-medical-aesthetics-to-boost-market-growth---technavio-301898792.html,2023-08-14 09:00:00,The Medical Aesthetics Market to grow at a CAGR of 8.6% from 2022 to 2027. Increasing global awareness about ... PR ...,JNJ,0.056674,0.0,Neutral
"HD, MSFT, or JNJ: Which Blue Chip Stock Earns Wall Street's ""Strong Buy"" Rating?",https://markets.businessinsider.com/news/stocks/hd-msft-or-jnj-which-blue-chip-stock-earns-wall-street-s-strong-buy-rating-1032548261,2023-08-12 13:52:53,Investors looking for attractive investments amid the ongoing volatility in the stock market and persistent macro challenges could consider certain blue chip stocks for their portfolios.,JNJ,0.3,0.155597,Somewhat-Bullish
3 Unstoppable Dividend Stocks to Buy Right Now,https://www.fool.com/investing/2023/08/12/3-unstoppable-dividend-stocks-to-buy-right-now/,2023-08-12 10:15:00,These stocks' dividends are more dependable than most.,JNJ,0.262994,0.153418,Somewhat-Bullish
Boston Scientific's Farapulse Eyes Stronger US Market Position With Potential FDA Approval - Boston Scientific  ( NYSE:BSX ) ,https://www.benzinga.com/analyst-ratings/analyst-color/23/08/33754935/boston-scientifics-farapulse-eyes-stronger-us-market-position-with-potential-fda-ap,2023-08-11 16:53:18,Boston Scientific Corp BSX will present results from ADVENT pivotal trial for its Farapulse Pulsed Field Ablation ( PFA ) system at the 2023 European Society of Cardiology Congress on 27 August. ADVENT is a randomized clinical trial comparing Farapulse PFA to thermal ablation.,JNJ,0.265378,0.285094,Somewhat-Bullish
Pharma ETFs in Focus Post Q2 Earnings,https://www.zacks.com/stock/news/2135877/pharma-etfs-in-focus-post-q2-earnings,2023-08-11 16:15:00,Second-quarter earnings beat ratio of 86.6% and revenue beat ratio of 84.9% for the healthcare sector are impressive.,JNJ,0.115048,0.125234,Neutral
Johnson & Johnson  ( JNJ )  Could Be a Great Choice,https://www.zacks.com/stock/news/2135824/johnson-johnson-jnj-could-be-a-great-choice,2023-08-11 15:45:11,"Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.",JNJ,0.430088,0.484456,Bullish
Consider Bonds,https://www.nytimes.com/2023/08/11/business/bonds-investing-debt-downgrade.html,2023-08-11 13:00:15,"Stocks command most of the attention. But even after the latest U.S. debt downgrade, bonds are steady, essential investments, our columnist says.",JNJ,0.030254,0.133416,Neutral
Is Kenvue Stock a Buy After Earnings?,https://www.fool.com/investing/2023/08/11/is-kenvue-stock-a-buy-after-earnings/,2023-08-11 12:55:00,Kenvue is the consumer health company spun out of Johnson & Johnson.,JNJ,0.170475,0.040379,Neutral
IO Biotech Appoints Heidi Hunter to its Board of Directors,https://www.globenewswire.com/news-release/2023/08/11/2723515/0/en/IO-Biotech-Appoints-Heidi-Hunter-to-its-Board-of-Directors.html,2023-08-11 12:05:00,"NEW YORK, Aug. 11, 2023 ( GLOBE NEWSWIRE ) -- IO Biotech ( Nasdaq: IOBT ) , a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on its T-winÂ® technology platform, announced the appointment of Heidi Hunter to its board of directors.",JNJ,0.046452,0.045197,Neutral
IO Biotech Appoints Heidi Hunter to its Board of Directors - IO Biotech  ( NASDAQ:IOBT ) ,https://www.benzinga.com/pressreleases/23/08/g33746404/io-biotech-appoints-heidi-hunter-to-its-board-of-directors,2023-08-11 12:05:00,"NEW YORK, Aug. 11, 2023 ( GLOBE NEWSWIRE ) -- IO Biotech IOBT, a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on its T-winÂ® technology platform, announced the appointment of Heidi Hunter to its board of directors.",JNJ,0.045139,0.044061,Neutral
3 Glenmede Funds to Buy for Impressive Returns,https://www.zacks.com/stock/news/2135508/3-glenmede-funds-to-buy-for-impressive-returns,2023-08-11 10:17:00,"In the current market landscape, it's prudent for investors to delve into the opportunities presented by established Glenmede mutual funds like GQSCX, GTSOX and GEQIX.",JNJ,0.059636,0.050994,Neutral
"Supreme Court Halts Purdue Pharma's $6B Settlement: Sackler Family's Shield From Opioid Lawsuits Challenged - Johnson & Johnson  ( NYSE:JNJ ) , Teva Pharmaceutical Indus  ( NYSE:TEVA ) ",https://www.benzinga.com/news/23/08/33725158/supreme-court-halts-purdue-pharmas-6b-settlement-sackler-familys-shield-from-opioid-lawsuits-challen,2023-08-10 20:44:22,"On Thursday, the Supreme Court temporarily blocked a $6-billion bankruptcy settlement by Purdue Pharma, the maker of the opioid OxyContin, that would shield the Sackler family from civil lawsuits related to the opioid crisis.",JNJ,0.149656,0.038587,Neutral
These 10 medications are likely targets for Medicare price negotiations this fall,https://www.cnbc.com/2023/08/10/10-drugs-that-are-likely-targets-for-fall-medicare-price-negotiations.html,2023-08-10 17:21:52,"It's still unclear which drugs Medicare will select, but several companies have revealed in court filings that four of their medications are targets.",JNJ,0.140348,-0.089581,Neutral
Apex Labs announces the appointment of Chief Medical Officer & Chief Commercial Officer,https://www.newswire.ca/news-releases/apex-labs-announces-the-appointment-of-chief-medical-officer-amp-chief-commercial-officer-896912691.html,2023-08-10 14:35:00,Psychiatrist Dr. Mark Johnston as CMO and senior pharmaceutical commercialization expert Greg Rutherford as CCO accelerates APEX's ability to bring new drugs to market.,JNJ,0.032916,0.118592,Neutral
"NextEvo Announces Free CBD for Parents Dealing With Back to School Stress and Anxiety on National CBD Day, Plus Giveaway for a Year Supply of CBD",https://www.benzinga.com/pressreleases/23/08/g33703911/nextevo-announces-free-cbd-for-parents-dealing-with-back-to-school-stress-and-anxiety-on-national-,2023-08-10 12:00:00,"CONSHOHOCKEN, PA, Aug. 10, 2023 ( GLOBE NEWSWIRE ) -- via NewMediaWire - NextEvo Naturals ( ""NextEvo"" or the ""Company"" ) , a premium supplement brand focused on revolutionizing the delivery of nutritional compounds, announced today a philanthropic initiative to give away free doses of its ...",JNJ,0.057215,0.171021,Somewhat-Bullish
US FDA approves Johnson & Johnson's blood cancer therapy,https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-jjs-blood-cancer-therapy-2023-08-10/,2023-08-10 11:56:00,"Signage is seen outside of the Food and Drug Administration ( FDA ) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly Aug 10 ( Reuters ) - Johnson & Johnson ( JNJ.N ) said on Thursday the U.S.",JNJ,0.116914,-0.057286,Neutral
Should You Invest in the iShares U.S. Pharmaceuticals ETF  ( IHE ) ?,https://www.zacks.com/stock/news/2134781/should-you-invest-in-the-ishares-us-pharmaceuticals-etf-ihe,2023-08-10 10:20:09,Sector ETF report for ...,JNJ,0.130571,0.060993,Neutral
Should You Invest in the Fidelity MSCI Health Care Index ETF  ( FHLC ) ?,https://www.zacks.com/stock/news/2134783/should-you-invest-in-the-fidelity-msci-health-care-index-etf-fhlc,2023-08-10 10:20:08,Sector ETF report for ...,JNJ,0.127456,0.04982,Neutral
Is Vanguard High Dividend Yield ETF  ( VYM )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2134787/is-vanguard-high-dividend-yield-etf-vym-a-strong-etf-right-now,2023-08-10 10:20:08,Smart Beta ETF report for ...,JNJ,0.11894,0.067516,Neutral
Should iShares Core High Dividend ETF  ( HDV )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2134780/should-ishares-core-high-dividend-etf-hdv-be-on-your-investing-radar,2023-08-10 10:20:06,Style Box ETF report for ...,JNJ,0.123209,0.068541,Neutral
3 Top Biotech Stocks Defying the Bear Market,https://www.fool.com/investing/2023/08/10/3-top-biotech-stocks-defying-the-bear-market/,2023-08-10 09:21:00,"Biotech is still booming, if you pick the right biotech stocks.",JNJ,0.083541,0.146184,Neutral
"The Zacks Analyst Blog Highlights PepsiCo, Johnson & Johnson, Intuitive Surgical, Kimberly-Clark and Atmos Energy",https://www.zacks.com/stock/news/2134764/the-zacks-analyst-blog-highlights-pepsico-johnson-johnson-intuitive-surgical-kimberly-clark-and-atmos-energy,2023-08-10 09:21:00,"PepsiCo, Johnson & Johnson, Intuitive Surgical, Kimberly-Clark and Atmos Energy are included in this Analyst Blog.",JNJ,0.174335,0.110153,Neutral
"Walt Disney and Capri Holdings shares gain, among other movers",https://www.marketwatch.com/story/walt-disney-and-capri-holdings-shares-gain-among-other-movers-a5c1c121,2023-08-10 09:05:00,Plug Power stocks dives after revealing worse than expected losses.,JNJ,0.140076,0.140463,Neutral
"Kenvue, the J&J spinoff, will join the S&P 500 index",https://www.marketwatch.com/story/kenvue-the-j-j-spinoff-will-join-the-s-p-500-index-6d420f6c,2023-08-09 21:49:00,"Kenvue Inc., maker of Tylenol, Benadryl and other household names in health-care products, is joining the S&P 500 index, index provider S&P Dow Jones Indices said late Wednesday.",JNJ,0.837089,0.244741,Somewhat-Bullish
Looking At Johnson & Johnson's Recent Unusual Options Activity - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/08/33677721/looking-at-johnson-johnsons-recent-unusual-options-activity,2023-08-09 19:46:05,"Someone with a lot of money to spend has taken a bearish stance on Johnson & Johnson JNJ. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",JNJ,0.747404,0.130879,Neutral
Iovance  ( IOVA )  Posts Narrower-Than-Expected Loss in Q2,https://www.zacks.com/stock/news/2134444/iovance-iova-posts-narrower-than-expected-loss-in-q2,2023-08-09 15:14:00,Iovance (IOVA) reports mixed second-quarter results as earnings beat estimates but sales miss the mark.,JNJ,0.09239,0.046775,Neutral
"Novavax  ( NVAX )  Q2 Earnings Beat, Stock Down 4% on '23 Sales Cut",https://www.zacks.com/stock/news/2134415/novavax-nvax-q2-earnings-beat-stock-down-4-on-23-sales-cut,2023-08-09 14:37:00,"Novavax (NVAX) reports better-than-expected Q2 earnings results, as earnings and revenues beat estimates. Shares drop due to lowered 2023 product sales guidance.",JNJ,0.07104,0.045193,Neutral
PAN-TB Collaboration Announces the Start of a Phase 2 Clinical Trial to Evaluate Two Novel Tuberculosis Treatment Regimens,https://www.prnewswire.com/news-releases/pan-tb-collaboration-announces-the-start-of-a-phase-2-clinical-trial-to-evaluate-two-novel-tuberculosis-treatment-regimens-301896161.html,2023-08-09 14:00:00,PAN-TB Collaboration Announces the Start of a Phase 2 Clinical Trial to Evaluate Two Novel Tuberculosis Treatment ... PR ...,JNJ,0.071357,0.04343,Neutral
Johnson & Johnson's Talc Problems Aren't Going Away,https://www.fool.com/investing/2023/08/09/johnson-johnson-talc-problems-arent-going-away/,2023-08-09 12:45:00,The company's strategy to limit its talc-related liabilities isn't working.,JNJ,0.724105,-0.148346,Neutral
5 Defensive Stocks for Stable Returns Amid Recent Volatility,https://www.zacks.com/stock/news/2134256/5-defensive-stocks-for-stable-returns-amid-recent-volatility,2023-08-09 12:04:00,"We have narrowed our search to five stocks from defensive sectors. These are: JNJ, PEP, ISRG, KMB, ATO.",JNJ,0.146247,0.15633,Somewhat-Bullish
A Bull Market Is Coming: 2 Warren Buffett Stocks to Buy and Hold Forever,https://www.fool.com/investing/2023/08/09/a-bull-market-is-coming-2-warren-buffet-stocks-to/,2023-08-09 12:00:00,These two stocks have delivered outsize returns over the long run.,JNJ,0.47672,0.444243,Bullish
3 No-Brainer Stocks to Buy With $200 Right Now,https://www.fool.com/investing/2023/08/09/3-no-brainer-stocks-to-buy-with-200-right-now/,2023-08-09 09:21:00,A reasonably small amount of money can go a long way when it's invested in game-changing companies.,JNJ,0.18343,0.046536,Neutral
The Spinal Implants and Surgical Devices Market size to grow at a CAGR of 5.3% from 2022 to 2027; Technological ... - PR Newswire,https://www.prnewswire.com/news-releases/the-spinal-implants-and-surgical-devices-market-size-to-grow-at-a-cagr-of-5-3-from-2022-to-2027-technological-advancements-are-a-major-trend---technavio-301895596.html,2023-08-09 07:00:00,The Spinal Implants and Surgical Devices Market size to grow at a CAGR of 5.3% from 2022 to 2027. Technological ... PR ...,JNJ,0.042346,0.103516,Neutral
"Eli Lilly Clears Technical Benchmark, Hitting 90-Plus RS Rating",https://www.investors.com/ibd-data-stories/eli-lilly-clears-technical-benchmark-hitting-90-plus-rs-rating/,2023-08-09 07:00:00,"Eli Lilly ( LLY ) had its Relative Strength ( RS ) Rating upgraded from 89 to 95 Wednesday. When you're researching the best stocks to buy and watch, be sure to pay attention to relative price strength. This exclusive rating from Investor's Business Daily tracks price performance with a 1 ( ...",JNJ,0.323078,0.0,Neutral
Markets Up Second-Straight Day; Lots of Data On Deck,https://www.zacks.com/stock/news/2141612/markets-up-second-straight-day-lots-of-data-on-deck,2023-08-28 22:09:00,"All major indices are up over the past week of trading, though are still underwater for the past month.",JNJ,0.146916,0.066873,Neutral
"Viridian Chart Of The Week: How Capital Intensive Is Cannabis? - Brown Forman Inc Class B Common Stock  ( NYSE:BF/B ) , Ambev  ( NYSE:ABEV ) ",https://www.benzinga.com/markets/cannabis/23/08/34073822/viridian-chart-of-the-week-how-capital-intensive-is-cannabis,2023-08-28 17:10:39,"The chart explores the capital intensity of cannabis compared to four other industries thought to be likely suitors for cannabis companies upon federal legalization: Tobacco, Alcoholic Beverages, Pharmaceuticals, and Consumer Products. In the chart, the cannabis group comprises the nine MSOs with ...",JNJ,0.11123,0.0,Neutral
JNJ: Is Johnson & Johnson  ( JNJ )  a Buy Before September Begins?,https://stocknews.com/news/jnj-nvs-azn-snphy-is-johnson-johnson-jnj-a-buy-before-september-begins/,2023-08-28 16:36:10,"Global pharmaceutical powerhouse Johnson & Johnson ( JNJ ) experienced significant financial expansion in the second quarter, with its reported sales registering an impressive 6.3% year-on-year growth to $25.53 billion, exceeding the consensus estimate by 3.5%.",JNJ,0.665159,0.425622,Bullish
J&J  ( JNJ )  Seeks Full FDA Nod for Rybrevant in Lung Cancer,https://www.zacks.com/stock/news/2141532/jj-jnj-seeks-full-fda-nod-for-rybrevant-in-lung-cancer,2023-08-28 15:38:00,J&J's (JNJ) FDA filing is based on a late-stage study showing that treatment with Rybrevant plus chemotherapy improved progression-free survival in certain NSCLC patients.,JNJ,0.252332,0.019359,Neutral
Sinking Profits Means Layoffs To Follow.,https://www.forbes.com/sites/miltonezrati/2023/08/28/sinking-profits-means-layoffs-to-follow/,2023-08-28 13:54:34,"Earnings declines will force business to make layoffs. That will end the upbeat jobs market, which in any case is showing signs of retreat..",JNJ,0.053271,-0.050027,Neutral
"Medicenna Announces the Appointment of Jeff Caravella as Chief Financial Officer - Editas Medicine  ( NASDAQ:EDIT ) , Medicenna Therapeutics  ( NASDAQ:MDNA ) ",https://www.benzinga.com/pressreleases/23/08/g34064855/medicenna-announces-the-appointment-of-jeff-caravella-as-chief-financial-officer,2023-08-28 11:00:57,"Jeff Caravella brings over two decades of healthcare expertise steering strategic, financial and operational functions at leading public life-science corporations Mr. Caravella's appointment demonstrates Medicenna's continuing commitment to establish its presence in Boston, the leading ...",JNJ,0.07913,0.120375,Neutral
Medicenna Announces the Appointment of Jeff Caravella as Chief Financial Officer,https://www.globenewswire.com/news-release/2023/08/28/2732483/0/en/Medicenna-Announces-the-Appointment-of-Jeff-Caravella-as-Chief-Financial-Officer.html,2023-08-28 11:00:00,"Jeff Caravella brings over two decades of healthcare expertise steering strategic, financial and operational functions at leading public life-science corporations ...",JNJ,0.100308,0.126572,Neutral
Cytek Biosciences Appoints Dr. Philippe Busque Senior Vice President of Global Sales & Services,https://www.globenewswire.com/news-release/2023/08/28/2732394/0/en/Cytek-Biosciences-Appoints-Dr-Philippe-Busque-Senior-Vice-President-of-Global-Sales-Services.html,2023-08-28 09:30:00,"Sales Organization Enhanced, Platform Organization Created Sales Organization Enhanced, Platform Organization Created ...",JNJ,0.030292,0.131714,Neutral
3 Widely Owned Dow Stocks Prominent Billionaires Are Selling,https://www.fool.com/investing/2023/08/28/3-widely-owned-dow-stocks-billionaires-are-selling/,2023-08-28 09:21:00,Some of Wall Street's most-successful billionaire money managers are paring down or parting ways with a trio of top-tier companies.,JNJ,0.136499,0.036252,Neutral
"FATE THERAPEUTICS ALERT: Bragar Eagel & Squire, P.C. is Investigating Fate Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - Fate Therapeutics  ( NASDAQ:FATE ) ",https://www.benzinga.com/pressreleases/23/08/g34061249/fate-therapeutics-alert-bragar-eagel-squire-p-c-is-investigating-fate-therapeutics-inc-on-behalf-o,2023-08-28 01:00:00,"NEW YORK, Aug. 27, 2023 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Fate Therapeutics, Inc.",JNJ,0.107495,0.00342,Neutral
"30 dividend-paying stocks in solid sectors with upside outside the AI hype, according to a 30-year fund manager",https://www.businessinsider.com/30-dividend-paying-stocks-held-by-30-year-fund-manager-2023-8,2023-08-27 16:51:00,30 Dividend-Paying Stocks With Upside Held by 30-Year Fund Manager - Business Insider ...,JNJ,0.08183,-0.087669,Neutral
3 Stocks to Buy That Can Beat a Bear Market,https://www.fool.com/investing/2023/08/27/3-stocks-to-buy-that-can-beat-a-bear-market/,2023-08-27 13:45:00,Look for companies that can generate revenue -- and turn it into a profit -- regardless of the economic environment.,JNJ,0.149424,0.116822,Neutral
Multiple sclerosis market in the US to Grow by USD 3.95 billion from 2021 to 2026 | Rising prevalence of multiple ... - PR Newswire,https://www.prnewswire.com/news-releases/multiple-sclerosis-market-in-the-us-to-grow-by-usd-3-95-billion-from-2021-to-2026--rising-prevalence-of-multiple-sclerosis-will-drive-growth---technavio-301909378.html,2023-08-26 00:30:00,Multiple sclerosis market in the US to Grow by USD 3.95 billion from 2021 to 2026 | Rising prevalence of multiple ... PR ...,JNJ,0.059785,0.185027,Somewhat-Bullish
Cosmetics products market in France to grow by USD 2.48 billion from 2021 to 2026 | Growing population in the age ... - PR Newswire,https://www.prnewswire.com/news-releases/cosmetics-products-market-in-france-to-grow-by-usd-2-48-billion-from-2021-to-2026--growing-population-in-the-age-group-of-30-to-50-years-drives-growth---technavio-301909388.html,2023-08-25 20:45:00,Cosmetics products market in France to grow by USD 2.48 billion from 2021 to 2026 | Growing population in the age ... PR ...,JNJ,0.065866,0.015045,Neutral
"Instacart, Klaviyo Will Go Public-Should Be Two Of The Largest IPOs Since 2021",https://www.forbes.com/sites/dereksaul/2023/08/25/instacart-klaviyo-will-go-public-should-be-two-of-the-largest-ipos-since-2021/,2023-08-25 19:22:20,The grocery delivery and marketing startups will look to jolt the slumping U.S. IPO market.,JNJ,0.090816,0.040814,Neutral
Pharma Giants Unite Against Drug Price Negotiation: AstraZeneca Latest To Challenge The Government - AstraZeneca  ( NASDAQ:AZN ) ,https://www.benzinga.com/general/biotech/23/08/34045861/pharma-giants-unite-against-drug-price-negotiation-astrazeneca-latest-to-challenge-the-government,2023-08-25 17:49:45,AstraZeneca Plc AZN announced its legal challenge against the U.S. government's Inflation Reduction Act ( IRA ) that allows the Medicare health insurance system to negotiate more competitive drug prices.,JNJ,0.233556,0.0,Neutral
AstraZeneca sues US govt over Medicare drug price negotiation plans,https://www.business-standard.com/companies/news/astrazeneca-sues-us-govt-over-medicare-drug-price-negotiation-plans-123082501298_1.html,2023-08-25 16:18:42,AstraZeneca said on Friday it has sued the U.S. government to block parts of a program that gives the Medicare health insurance plan the power to negotiate lower drug prices.,JNJ,0.137671,0.146465,Neutral
Novo Nordisk's  ( NVO )  Shares Jump 17% in a Month: Here's Why,https://www.zacks.com/stock/news/2140987/novo-nordisks-nvo-shares-jump-17-in-a-month-heres-why,2023-08-25 15:41:00,"Novo Nordisk's (NVO) commercial and pipeline progress with its popular obesity drug, Wegovy, continues to drive the share price momentum.",JNJ,0.111488,0.062546,Neutral
Emergent BioSolutions  ( EBS )  Down 12% in a Week: Here's Why,https://www.zacks.com/stock/news/2140986/emergent-biosolutions-ebs-down-12-in-a-week-heres-why,2023-08-25 15:36:00,Shares of Emergent (EBS) are on a downward trajectory since the ticker was dropped from the S&P SmallCap 600 index.,JNJ,0.154951,-0.160879,Somewhat-Bearish
's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet - VCI Global  ( NASDAQ:VCIG ) ,https://www.benzinga.com/general/biotech/23/08/34043025/benzingas-stock-whisper-index-5-stocks-investors-are-secretly-monitoring-but-not-talking-about-ye,2023-08-25 14:47:58,"Investors are on the hunt for undervalued, underfollowed and emerging stocks, and retail traders have countless methods at their disposal to uncover new information.",JNJ,0.269033,0.278758,Somewhat-Bullish
What Is Dividend Investing?,https://www.forbes.com/sites/investor-hub/article/what-is-dividend-investing/,2023-08-25 14:42:44,"Dividend investing involves investing in stocks, but with a particular focus on the regular distribution of a company's income to shareholders, known as a ""dividend."" Find out the benefits and risks of dividend investing as well as investment strategies.",JNJ,0.02786,0.320531,Somewhat-Bullish
"Analysis of the Global AI in Clinical Trials Industry, 2023 to 2035 - Product/Technology Utilization and Integration Agreements Lead the Way in Partnerships",https://www.prnewswire.com/news-releases/analysis-of-the-global-ai-in-clinical-trials-industry-2023-to-2035---producttechnology-utilization-and-integration-agreements-lead-the-way-in-partnerships-301909941.html,2023-08-25 14:15:00,"Analysis of the Global AI in Clinical Trials Industry, 2023 to 2035 - Product/Technology Utilization and Integration ... PR ...",JNJ,0.017331,0.184568,Somewhat-Bullish
JNJ: 3 Pharma Stocks With Promising Pipelines,https://stocknews.com/news/jnj-nvs-rdy-3-pharma-stocks-with-promising-pipelines/,2023-08-25 13:02:52,"The pharmaceutical industry is poised to stay afloat because of consistent medical breakthroughs and escalating global demand for healthcare. Therefore, quality pharma stocks Johnson & Johnson ( JNJ ) , Novartis AG ( NVS ) , and Dr. Reddy's Laboratories Limited ( RDY ) , with promising pipelines, ...",JNJ,0.239541,0.195975,Somewhat-Bullish
Janssen Submits Supplemental Biologics License Application to the U.S. Food and Drug Administration Seeking Approval of RYBREVANTÂ®  ( amivantamab-vmjw )  in Combination with Chemotherapy for the First-line Treatment of Patients with Locally Advanced or Metastatic EGFR Exon 20 Insertion Mutation-Positive Non-Small Cell Lung Cancer,https://www.prnewswire.com/news-releases/janssen-submits-supplemental-biologics-license-application-to-the-us-food-and-drug-administration-seeking-approval-of-rybrevant-amivantamab-vmjw-in-combination-with-chemotherapy-for-the-first-line-treatment-of-patients-with-l-301910074.html,2023-08-25 12:04:00,Janssen Submits Supplemental Biologics License Application to the U.S. Food and Drug Administration Seeking ... PR ...,JNJ,0.079542,0.019688,Neutral
Childrens Cosmetics Market size to grow by USD 759.05 million from 2022-2027|The increased per capita income ... - PR Newswire,https://www.prnewswire.com/news-releases/childrens-cosmetics-market-size-to-grow-by-usd-759-05-million-from-2022-2027the-increased-per-capita-income-drives-market-growth---technavio-301908950.html,2023-08-25 04:30:00,Childrens Cosmetics Market size to grow by USD 759.05 million from 2022-2027|The increased per capita income ... PR ...,JNJ,0.050465,0.291578,Somewhat-Bullish
Mouthwash Market Size in India to grow by USD 158.15 million from 2021 to 2026 | The increase in awareness about ... - PR Newswire,https://www.prnewswire.com/news-releases/mouthwash-market-size-in-india-to-grow-by-usd-158-15-million-from-2021-to-2026--the-increase-in-awareness-about-oral-health-drives-the-market---technavio-301908951.html,2023-08-25 02:00:00,Mouthwash Market Size in India to grow by USD 158.15 million from 2021 to 2026 | The increase in awareness about ... PR ...,JNJ,0.052801,0.158645,Somewhat-Bullish
Stock buybacks spur wealth inequality and stifle innovation. Should they be banned?,https://www.marketwatch.com/story/stock-buybacks-spur-wealth-inequality-and-stifle-innovation-but-should-they-be-banned-13e963c0,2023-08-24 21:56:00,"Stock buybacks have become a major source of wealth inequality and have stifled innovation in the U.S., according to this academic.",JNJ,0.105295,0.087187,Neutral
Peripheral Artery Disease Global Market to Surpass USD 54 Billion Mark by 2027 | DelveInsight,https://www.prnewswire.com/news-releases/peripheral-artery-disease-global-market-to-surpass-usd-54-billion-mark-by-2027--delveinsight-301908812.html,2023-08-24 21:01:00,The global peripheral artery disease market is expanding rapidly due to reasons such as the growing geriatric population and the rising prevalence of peripheral artery disease and arteriosclerosis worldwide.,JNJ,0.0268,0.019428,Neutral
Elucida Oncology Appoints Ramzi Benamar as Chief Financial Officer,https://www.benzinga.com/pressreleases/23/08/g34026363/elucida-oncology-appoints-ramzi-benamar-as-chief-financial-officer,2023-08-24 15:00:00,"MONMOUTH JUNCTION, N.J., Aug. 24, 2023 ( GLOBE NEWSWIRE ) -- Elucida Oncology, a clinical-stage biotechnology company pioneering the next frontier in targeted cancer therapy, announced today that Ramzi Benamar, a seasoned financial leader with a proven track record in the life sciences industry, ...",JNJ,0.075161,0.049626,Neutral
"Major shareholder announcement - BlackRock, Inc.",https://www.globenewswire.com/news-release/2023/08/24/2731296/0/en/Major-shareholder-announcement-BlackRock-Inc.html,2023-08-24 13:40:00,ANNOUNCEMENT NO. ...,JNJ,0.261117,0.078327,Neutral
"Here are 16 stocks Jim Cramer is watching, including J&J split-off Kenvue, Petco, GM",https://www.cnbc.com/2023/08/24/16-stocks-jim-cramer-is-watching-including-jj-split-off-kenvue-petco-gm.html,2023-08-24 13:34:26,"Here are some of the tickers on my radar for Thursday, Aug. 24, taken directly from my reporter's notebook.",JNJ,0.199037,0.177078,Somewhat-Bullish
5 Defensive Stocks to Buy Amid Lingering Market Volatility,https://www.zacks.com/stock/news/2140273/5-defensive-stocks-to-buy-amid-lingering-market-volatility,2023-08-24 13:27:00,"Volatility has gripped Wall Street again. So, investing in defensive stocks like McKesson Corporation (MCK), Entergy Corporation (ETR), PepsiCo, Inc. (PEP), Johnson & Johnson (JNJ) and Atmos Energy Corporation (ATO) is a safe bet.",JNJ,0.273224,0.323273,Somewhat-Bullish
CARGO Therapeutics Appoints Biotech Life Sciences Leaders to Board of Directors,https://www.benzinga.com/pressreleases/23/08/g34023394/cargo-therapeutics-appoints-biotech-life-sciences-leaders-to-board-of-directors,2023-08-24 13:05:00,"- Board of Director appointments follow the Company's recent launch and $200 million Series A financing in March 2023 - - Appointments include industry veterans John Orwin as Chairman, David Lubner as Independent Director and Strategic Finance and Audit Committee Chair, and Dr. Krishnan ...",JNJ,0.043108,0.048696,Neutral
Is iShares Core High Dividend ETF  ( HDV )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2140013/is-ishares-core-high-dividend-etf-hdv-a-strong-etf-right-now,2023-08-24 10:20:06,Smart Beta ETF report for ...,JNJ,0.115509,0.060031,Neutral
Is WisdomTree U.S. Quality Dividend Growth ETF  ( DGRW )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2140017/is-wisdomtree-us-quality-dividend-growth-etf-dgrw-a-strong-etf-right-now,2023-08-24 10:20:05,Smart Beta ETF report for ...,JNJ,0.114682,0.059865,Neutral
J&J's Janssen to close part of its vaccine division -Telegraaf,https://www.reuters.com/business/healthcare-pharmaceuticals/jjs-janssen-close-part-its-vaccine-division-2023-08-23/,2023-08-23 16:32:00,J&J's Janssen to close part of its vaccine division ...,JNJ,0.485711,0.142736,Neutral
Check Out What Whales Are Doing With JNJ - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/08/34007584/check-out-what-whales-are-doing-with-jnj,2023-08-23 15:32:05,"Someone with a lot of money to spend has taken a bearish stance on Johnson & Johnson JNJ. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",JNJ,0.817578,0.236387,Somewhat-Bullish
VTV: 3 Large Cap ETFs Investors Are Watching Everyday,https://stocknews.com/news/vtv-iwd-vym-brk-b-unh-jpm-xom-avgo-3-large-cap-etfs-investors-are-watching-everyday/,2023-08-23 14:30:36,"Although inflation has significantly decreased from its peak in mid-2022, it remains notably higher than the Federal Reserve's desired 2% level. This continued high inflation makes interest rate cuts unlikely in the near future.",JNJ,0.19295,0.108006,Neutral
"Branded Merchandise Veteran Jill Albers Joins BDA As Senior Director, Business Development - PR Newswire",https://www.prnewswire.com/news-releases/branded-merchandise-veteran-jill-albers-joins-bda-as-senior-director-business-development-301908149.html,2023-08-23 14:00:00,"Branded Merchandise Veteran Jill Albers Joins BDA As Senior Director, Business Development PR ...",JNJ,0.163909,0.235631,Somewhat-Bullish
J&J Makes It Official: Kenvue Stock Swap Offer Was a Huge Hit With Shareholders,https://www.barrons.com/articles/jnj-kenvue-stock-price-swap-2c4014bd,2023-08-23 12:47:00,J&J Kenvue Stock Swap Offer Was a Huge Hit With Shareholders ...,JNJ,0.733479,0.401607,Bullish
Arm Listing May Boost Return To IPOs,https://www.barrons.com/news/arm-listing-may-boost-return-to-ipos-dd818abe,2023-08-23 10:24:00,Arm Listing May Boost Return To ...,JNJ,0.068896,0.192983,Somewhat-Bullish
Arm Listing May Boost Return To IPOs,https://www.barrons.com/news/arm-listing-may-boost-return-to-ipos-50f6f1a,2023-08-23 10:24:00,Arm Listing May Boost Return To ...,JNJ,0.068896,0.192983,Somewhat-Bullish
"Did Apple Shower Warren Buffett With $645M This Year? Yes, They Did: The Power Of Dividends - CVS Health  ( NYSE:CVS ) , NVIDIA  ( NASDAQ:NVDA ) , Johnson & Johnson  ( NYSE:JNJ ) , iShares Core S&P 500 ETF  ( ARCA:IVV ) , Star Bulk Carriers  ( NASDAQ:SBLK ) , Safe Bulkers  ( NYSE:SB ) , Signet Jewelers  ( NYSE:SIG ) , Hilton Worldwide Holdings  ( NYSE:HLT ) , Restaurant Brands Intl  ( NYSE:QSR ) , Tesla  ( NASDAQ:TSLA ) , iShares Core MSCI Emerging Markets ETF  ( ARCA:IEMG ) , Lowe's Companies  ( NYSE:LOW ) , Qualcomm  ( NASDAQ:QCOM ) , Procter & Gamble  ( NYSE:PG ) , PepsiCo  ( NASDAQ:PEP ) , FedEx  ( NYSE:FDX ) ",https://www.benzinga.com/news/large-cap/23/08/33994092/did-apple-shower-warren-buffett-with-645m-yes-they-did-the-power-of-dividends,2023-08-22 20:30:12,"Retail traders, the growing group of non professional investors who buy and sell stocks hoping to sell at a higher price than they bought, seem to have forgotten a very basic and initial rule of investing: Buy and Hold.",JNJ,0.074001,0.156036,Somewhat-Bullish
HHS awards $1.4 billion to drive development of new Covid-19 vaccines and therapies,https://www.cnn.com/2023/08/22/health/hhs-awards-usd1-4-billion-to-drive-development-of-new-covid-19-vaccines-and-therapies/index.html,2023-08-22 19:03:00,"The US government has awarded more than $1.4 billion to kick-start the development of new vaccines and therapies to fight Covid-19, the US Department of Health and Human Services announced Tuesday.",JNJ,0.074926,0.278873,Somewhat-Bullish
J&J  ( JNJ )  to Keep 9.5% Stake in Kenvue Post Share Exchange,https://www.zacks.com/stock/news/2139139/jj-jnj-to-keep-95-stake-in-kenvue-post-share-exchange,2023-08-22 14:26:00,"J&J's (JNJ) offer to exchange its shares for the shares of Kenvue, its recently-separated consumer healthcare business, gets oversubscribed. The exchange ratio is 8.0324 for every share of J&J.",JNJ,0.307924,0.0,Neutral
Axia Public Relations Hires Emmy Award-Winning Journalist,https://www.benzinga.com/pressreleases/23/08/n33982015/axia-public-relations-hires-emmy-award-winning-journalist,2023-08-22 12:45:00,"Bob Wiltfong will serve as a public relations account director JACKSONVILLE, Fla., Aug. 22, 2023 /PRNewswire/ -- Bob Wiltfong joined Axia Public Relations as a public relations account director. He directs and leads PR strategies, services, and measurement programs for Axia's national accounts.",JNJ,0.086556,0.149472,Neutral
Zimmer Biomet Announces Leadership Transition,https://www.prnewswire.com/news-releases/zimmer-biomet-announces-leadership-transition-301906636.html,2023-08-22 12:20:00,"Chief Operating Officer Ivan Tornos Appointed President and CEO; Elected to the Board of Directors Chief Financial Officer Suketu ( Suky ) Upadhyay's Role Expands to CFO and EVP, Finance, Operations & Supply Chain",JNJ,0.03478,-0.04209,Neutral
5 Blue-Chip Stocks for a Stable Portfolio Amid Volatility,https://www.zacks.com/stock/news/2139022/5-blue-chip-stocks-for-a-stable-portfolio-amid-volatility,2023-08-22 12:04:00,"We have narrowed our search to five blue-chip such stocks with strong growth potential for the rest of 2023. These are: WMT, JPM, JNJ, CAT, MCD.",JNJ,0.166169,0.230266,Somewhat-Bullish
"Zacks Industry Outlook Highlights Eli Lilly, J&J, Novo Nordisk, Novartis and AstraZeneca",https://www.zacks.com/stock/news/2139000/zacks-industry-outlook-highlights-eli-lilly-jj-novo-nordisk-novartis-and-astrazeneca,2023-08-22 11:38:00,"Eli Lilly, J&J, Novo Nordisk, Novartis and AstraZeneca are part of the Zacks Industry Outlook article ...",JNJ,0.047092,0.10432,Neutral
Verde Appoints Chief Marketing Officer,https://www.benzinga.com/pressreleases/23/08/g33979816/verde-appoints-chief-marketing-officer,2023-08-22 11:08:34,"SINGAPORE, Aug. 22, 2023 ( GLOBE NEWSWIRE ) -- Verde AgriTech Ltd NPK ( ""Verde"" or the ""Company"" ) is pleased to announce the appointment of marketing veteran Newton Nagumo to the position of Chief Marketing Officer ( ""CMO"" ) .",JNJ,0.018215,0.08519,Neutral
Verde Appoints Chief Marketing Officer,https://www.globenewswire.com/news-release/2023/08/22/2729351/0/en/Verde-Appoints-Chief-Marketing-Officer.html,2023-08-22 11:08:00,Newton Nagumo brings over two decades of successful communication and marketing planning expertise to boost Verde's market strategy Newton Nagumo brings over two decades of successful communication and marketing planning expertise to boost Verde's market strategy ...,JNJ,0.018757,0.088217,Neutral
Down 25% In A Year Will Pfizer Stock Rebound To Its Pre-Inflation Shock Level?,https://www.forbes.com/sites/greatspeculations/2023/08/22/down-25-in-a-year-will-pfizer-stock-rebound-to-its-pre-inflation-shock-level/,2023-08-22 11:00:22,"Returning to the pre-inflation shock level of over $60 means that PFE stock will have to gain more than 65% from here, and we don't think this will materialize anytime...",JNJ,0.045655,-0.031,Neutral
Virtualware nominated for 2023 Outstanding VR Company of the Year,https://www.globenewswire.com/news-release/2023/08/22/2729132/0/en/Virtualware-nominated-for-2023-Outstanding-VR-Company-of-the-Year.html,2023-08-22 06:00:00,"Bilbao, August 22, 2023. - The Academy of International Extended Reality ( AIXR ) has announced the finalists for the 7th International VR Awards, naming Virtualware finalist for ""Outstanding VR company of the Year"".",JNJ,0.038284,0.169288,Somewhat-Bullish
"Nasdaq rallies with Nvidia, tech shares; investors look toward Jackson Hole",https://www.moneycontrol.com/news/business/markets/nasdaq-rallies-with-nvidia-tech-shares-investors-look-toward-jackson-hole-11233351.html,2023-08-22 00:42:44,The yield on 10-year Treasury notes hit highs last seen during the Great Financial Crisis in 2007 as investors looked warily toward a meeting of central bankers who convene on Thursday at Jackson Hole in Wyoming. Federal Reserve Chair Jerome Powell is due to speak on Friday.,JNJ,0.081001,-0.02374,Neutral
Tech Shares Figure To Boost South Korea Shares,https://markets.businessinsider.com/news/stocks/tech-shares-figure-to-boost-south-korea-shares-1032571186,2023-08-21 23:00:05,"( RTTNews ) - The South Korea stock market on Monday halted the six-day losing streak in which it had tumbled almost 100 points or 4 percent. The KOSPI now rests just beneath the 2,510-point plateau and it may add to its winnings on Tuesday.",JNJ,0.17715,0.399271,Bullish
Stock Market Today: Tech Stocks Soar as Bargain Hunters Swoop In,https://www.kiplinger.com/investing/stocks/stock-market-today-tech-stocks-soar-as-bargain-hunters-swoop-in,2023-08-21 20:09:17,"The major indexes suffered notable losses last week, with the technology sector bearing the brunt of the selling. However, bulls were given a reprieve Monday, with tech stocks soaring as bargain hunters looked past spiking Treasury yields to scoop up some of Wall Street's favorite names at a ...",JNJ,0.204647,-0.072453,Neutral
"Adverum Biotechnologies Appoints Andrew Ramelmeier, Ph.D. as Chief Technology Officer",https://www.globenewswire.com/news-release/2023/08/21/2729011/32452/en/Adverum-Biotechnologies-Appoints-Andrew-Ramelmeier-Ph-D-as-Chief-Technology-Officer.html,2023-08-21 20:05:00,"Dr. Ramelmeier has more than 30 years of experience in drug development and clinical and commercial chemistry, manufacturing and controls ( CMC ) , including gene and cell therapies Dr. Ramelmeier has more than 30 years of experience in drug development and clinical and commercial chemistry, ...",JNJ,0.03792,0.003875,Neutral
"Adverum Biotechnologies Appoints Andrew Ramelmeier, Ph.D. as Chief Technology Officer - Adverum Biotechnologies  ( NASDAQ:ADVM ) ",https://www.benzinga.com/pressreleases/23/08/g33971253/adverum-biotechnologies-appoints-andrew-ramelmeier-ph-d-as-chief-technology-officer,2023-08-21 20:05:00,"REDWOOD CITY, Calif., Aug. 21, 2023 ( GLOBE NEWSWIRE ) -- Adverum Biotechnologies, Inc. ADVM, a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases, today announced that R.",JNJ,0.036869,0.003859,Neutral
Dow Jones Falls As Nvidia Surges On Wall Street Calls; These Warren Buffett Stocks Eye Entries,https://www.investors.com/market-trend/stock-market-today/dow-jones-falls-as-nvidia-stock-surges-on-these-wall-street-calls-these-warren-buffett-stocks-eye-entries/,2023-08-21 19:22:00,Dow Jones Falls As Nvidia Surges On Wall Street Calls. These ... Investor's Business Daily ...,JNJ,0.087824,-0.333681,Somewhat-Bearish
"Hidden investors took over Corizon Health, a leading prison healthcare company. Then they deployed the Texas Two-Step.",https://www.businessinsider.com/corizon-health-bankruptcy-yescare-texas-two-step-law-2023-8,2023-08-21 19:16:00,Corizon Health's Bankruptcy Could Rewrite Rules for Corporate America. - Business Insider ...,JNJ,0.004651,-0.084478,Neutral
Merck's  ( MRK )  Welireg Meets Renal Cell Carcinoma Study Goals,https://www.zacks.com/stock/news/2138866/mercks-mrk-welireg-meets-renal-cell-carcinoma-study-goals,2023-08-21 17:41:00,"Based on interim data from a late-stage study, Merck's (MRK) Welireg achieves statistically significant improvements in one of the study's dual endpoints of progression-free survival.",JNJ,0.110973,0.042671,Neutral
"Global equities rise as traders await US Fed meeting, eye earnings",https://www.business-standard.com/markets/news/global-equities-rise-as-traders-await-us-fed-meeting-eye-earnings-123082100804_1.html,2023-08-21 16:53:23,NEW YORK ( Reuters ) -Global equities rose and U.S. treasury yields touched a more than 12-year high on Monday as investors awaited a Federal Reserve meeting later this week. Crude futures climbed on fewer exports from Saudi Arabia and high heating oil prices. Wall Street opened higher.,JNJ,0.075397,-0.317907,Somewhat-Bearish
Arm Expected To Imminently File Paperwork To Go Public-What To Know About U.S.' Biggest IPO In 2 Years,https://www.forbes.com/sites/dereksaul/2023/08/21/arm-expected-to-imminently-file-paperwork-to-go-public-what-to-know-about-us-biggest-ipo-in-2-years/,2023-08-21 16:41:21,The British chip giant reportedly valued at $64 billion will be the biggest New York offering since Rivian's in late 2021.,JNJ,0.07423,0.053601,Neutral
Momentum Mondays: Stocks Setting up for an Epic Dip Buying Opportunity?,https://www.zacks.com/commentary/2138719/momentum-mondays-stocks-setting-up-for-an-epic-dip-buying-opportunity,2023-08-21 14:57:00,Want to start the week ahead of the pack? Check out Momentum Mondays!,JNJ,0.145672,0.146081,Neutral
"Lung Cancer Treatment Market Revenue to Cross USD 102 billion by 2031, Expanding at a CAGR of 9.8% Says, Transparency Market Research Inc.",https://www.benzinga.com/pressreleases/23/08/g33964549/lung-cancer-treatment-market-revenue-to-cross-usd-102-billion-by-2031-expanding-at-a-cagr-of-9-8-s,2023-08-21 14:30:00,"Wilmington, Delaware, United States, Aug. 21, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global lung cancer treatment market is projected to flourish at a CAGR of 9.8% from 2022 to 2031. As per the report published by TMR, a valuation of US$ 102 billion is anticipated for ...",JNJ,0.041323,0.052319,Neutral
5 Large Drug Stocks to Watch as New Drug Approvals & M&A Gain Pace,https://www.zacks.com/commentary/2138567/5-large-drug-stocks-to-watch-as-new-drug-approvals-ma-gain-pace,2023-08-21 13:51:00,"Drug, biotech companies are likely to see significant innovation. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), J&J (JNJ), Novo Nordisk (NVO), Novartis (NVS) and AstraZeneca (AZN) are worth retaining in your portfolio.",JNJ,0.072362,0.096477,Neutral
"VYM: Buy, Hold, or Sell: Vanguard High Dividend Yield ETF  ( VYM ) ",https://stocknews.com/news/vym-vtv-iwd-schd-buy-hold-or-sell-vanguard-high-dividend-yield-etf-vym/,2023-08-21 13:11:48,"VYM: Buy, Hold, or Sell: Vanguard High Dividend Yield ...",JNJ,0.084722,0.059367,Neutral
"'The sharks are still there.' Stock market's decline is just beginning, this top fund manager says",https://www.marketwatch.com/story/the-sharks-are-still-there-stock-markets-decline-is-just-beginning-this-top-fund-manager-says-12cb6ad3,2023-08-21 11:33:00,Neuberger Berman's Eli Salzmann is positioning his portfolio for a U.S. recession. Here's his investment strategy and what he's buying now.,JNJ,0.083638,0.099239,Neutral
HIV Drugs Market size to grow by USD 10.47 biilion from 2022 to 2027 | Expanding access to HIV treatment is a major ... - PR Newswire,https://www.prnewswire.com/news-releases/hiv-drugs-market-size-to-grow-by-usd-10-47-biilion-from-2022-to-2027--expanding-access-to-hiv-treatment-is-a-major-trend--technavio-301905076.html,2023-08-21 11:30:00,HIV Drugs Market size to grow by USD 10.47 biilion from 2022 to 2027 | Expanding access to HIV treatment is a major ... PR ...,JNJ,0.064973,0.102266,Neutral
"Titan Medical Signs License Agreement with Auris Health, Inc.",https://www.globenewswire.com/news-release/2023/08/21/2728576/0/en/Titan-Medical-Signs-License-Agreement-with-Auris-Health-Inc.html,2023-08-21 11:30:00,"TORONTO, Ontario, Aug. 21, 2023 ( GLOBE NEWSWIRE ) -- Titan Medical Inc. ( ""Titan"" or the ""Company"" ) ( TSX: TMD. OTC: TMDIF ) , a medical technology company, announced today that the Company has entered into a licensing agreement ( ""Agreement"" ) with Auris Health, Inc., ( ""Auris Health"" ) , a ...",JNJ,0.061315,0.248231,Somewhat-Bullish
"Treace Medical Concepts Appoints Nathan Minnich as Senior Vice President, Marketing",https://www.globenewswire.com/news-release/2023/08/21/2728536/0/en/Treace-Medical-Concepts-Appoints-Nathan-Minnich-as-Senior-Vice-President-Marketing.html,2023-08-21 11:00:00,"PONTE VEDRA, Fla., Aug. 21, 2023 ( GLOBE NEWSWIRE ) -- Treace Medical Concepts, Inc. ( ""Treace"" or the ""Company"" ) ( NasdaqGS: TMCI ) , a medical technology company driving a fundamental shift in the surgical treatment of hallux valgus ( commonly known as bunions ) through its LapiplastyÂ® 3D ...",JNJ,0.044634,0.030758,Neutral
J&J to hold 9.5% stake in Kenvue after share exchange offer,https://www.reuters.com/markets/deals/jj-hold-95-stake-kenvue-after-share-exchange-offer-2023-08-21/,2023-08-21 10:46:29,"The company logo for Kenvue Inc. Johnson & Johnson's consumer-health business, is displayed on during the company's IPO at the New York Stock Exchange ( NYSE ) in New York City, U.S., May 4, 2023. REUTERS/Brendan McDermid/File Photo Acquire Licensing Rights",JNJ,0.323078,0.149443,Neutral
Teleflex Announces Extension of Arrowâ„¢ ErgoPackâ„¢ Complete System to Hemodialysis and Large Bore Central Venous Catheters - Teleflex  ( NYSE:TFX ) ,https://www.benzinga.com/pressreleases/23/08/g33959016/teleflex-announces-extension-of-arrow-ergopack-complete-system-to-hemodialysis-and-large-bore-cent,2023-08-21 10:30:00,"WAYNE, Pa., Aug. 21, 2023 ( GLOBE NEWSWIRE ) -- Teleflex Incorporated TFX, a leading global provider of medical technologies, today announced the release of the Arrowâ„¢ ErgoPackâ„¢ Complete Kits with Hemodialysis and Large Bore catheters in the United States.",JNJ,0.061949,0.0,Neutral
Teleflex Announces Extension of Arrowâ„¢ ErgoPackâ„¢ Complete System to Hemodialysis and Large Bore Central Venous Catheters,https://www.globenewswire.com/news-release/2023/08/21/2728513/0/en/Teleflex-Announces-Extension-of-Arrow-ErgoPack-Complete-System-to-Hemodialysis-and-Large-Bore-Central-Venous-Catheters.html,2023-08-21 10:30:00,"WAYNE, Pa., Aug. 21, 2023 ( GLOBE NEWSWIRE ) -- Teleflex Incorporated ( NYSE: TFX ) , a leading global provider of medical technologies, today announced the release of the Arrowâ„¢ ErgoPackâ„¢ Complete Kits with Hemodialysis and Large Bore catheters in the United States.",JNJ,0.057352,0.0,Neutral
Should Schwab U.S. Large-Cap Value ETF  ( SCHV )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2138468/should-schwab-us-large-cap-value-etf-schv-be-on-your-investing-radar,2023-08-21 10:20:05,Style Box ETF report for ...,JNJ,0.121037,-0.025667,Neutral
"3 Stocks I Will ""Never"" Sell",https://www.fool.com/investing/2023/08/20/3-stocks-i-will-never-sell/,2023-08-20 10:15:00,These businesses can stand the test of time.,JNJ,0.273807,0.263554,Somewhat-Bullish
Pain Management Devices Market size to grow by USD 2.70 billion from 2022 to 2027 | Technological advances in ... - PR Newswire,https://www.prnewswire.com/news-releases/pain-management-devices-market-size-to-grow-by-usd-2-70-billion-from-2022-to-2027--technological-advances-in-ablation-devices-are-major-trends---technavio-301904152.html,2023-08-19 04:15:00,Pain Management Devices Market size to grow by USD 2.70 billion from 2022 to 2027 | Technological advances in ... PR ...,JNJ,0.048425,-0.103848,Neutral
Orthobiologics market to grow by USD 2.63 billion from 2022 to 2027; 41% of the market growth to originate from North ... - PR Newswire,https://www.prnewswire.com/news-releases/orthobiologics-market-to-grow-by-usd-2-63-billion-from-2022-to-2027--41-of-the-market-growth-to-originate-from-north-america---technavio-301904056.html,2023-08-19 02:00:00,Orthobiologics market to grow by USD 2.63 billion from 2022 to 2027. 41% of the market growth to originate from North ... PR ...,JNJ,0.056674,0.127006,Neutral
Johnson & Johnson  ( JNJ )  Gains As Market Dips: What You Should Know,https://www.zacks.com/stock/news/2146267/johnson-johnson-jnj-gains-as-market-dips-what-you-should-know,2023-09-07 21:45:20,"Johnson & Johnson (JNJ) closed the most recent trading day at $160.03, moving +1.28% from the previous trading session.",JNJ,0.596978,0.296113,Somewhat-Bullish
"U.S. Controlled Substance Market Size Worth USD 74.3 billion by 2031, Rising at a CAGR of 5.2% - Says Transparency Market Research",https://www.benzinga.com/pressreleases/23/09/g34333372/u-s-controlled-substance-market-size-worth-usd-74-3-billion-by-2031-rising-at-a-cagr-of-5-2-says-t,2023-09-07 19:30:00,"Wilmington, Delaware, United States, Sept. 08, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The U.S. controlled substance market is projected to flourish at a CAGR of 5.2% from 2022 to 2031. As per the report published by TMR, a valuation of US$ 74.3 billion is anticipated for ...",JNJ,0.046095,-0.015895,Neutral
 ( JNJ )  - Analyzing Johnson & Johnson's Short Interest - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/short-sellers/23/09/34321492/jnj-analyzing-johnson-johnsons-short-interest,2023-09-07 14:15:20,"Johnson & Johnson's JNJ short percent of float has risen 232.32% since its last report. The company recently reported that it has 85.50 million shares sold short, which is 3.29% of all regular shares that are available for trading.",JNJ,0.221819,0.15378,Somewhat-Bullish
"Here are the 13 stocks Jim Cramer is watching, including Eli Lilly, McDonald's",https://www.cnbc.com/2023/09/07/here-are-the-13-stocks-jim-cramer-is-watching-including-eli-lilly-mcdonalds.html,2023-09-07 13:50:57,"Here are some of the tickers on my radar for Thursday, Sept. 7, taken directly from my reporter's notebook.",JNJ,0.182506,0.0,Neutral
1 Brand-New Dividend Stock Income Investors Won't Want to Miss,https://www.fool.com/investing/2023/09/07/1-brand-new-dividend-stock-income-investors-wont-w/,2023-09-07 13:05:00,The recently spun-off Kenvue looks to be a high-quality dividend stock.,JNJ,0.236396,0.328144,Somewhat-Bullish
J&J  ( JNJ )  to End Pulmonary Hypertension Study on Opsumit,https://www.zacks.com/stock/news/2145863/jj-jnj-to-end-pulmonary-hypertension-study-on-opsumit,2023-09-07 12:43:00,"The decision to end the CTEPH study on J&J's (JNJ) Opsumit (macitentan) was made at the recommendation of the study's independent DMC, following a pre-planned interim analysis.",JNJ,0.204936,-0.119654,Neutral
J&J to pull the plug on hypertension drug study,https://www.reuters.com/business/healthcare-pharmaceuticals/jj-pull-plug-hypertension-drug-study-2023-09-06/,2023-09-06 22:01:00,"The company logo for Johnson & Johnson is displayed on a screen to celebrate the 75th anniversary of the company's listing at the New York Stock Exchange ( NYSE ) in New York, U.S., September 17, 2019. REUTERS/Brendan McDermid/File photo Acquire Licensing Rights",JNJ,0.451494,0.175947,Somewhat-Bullish
Johnson & Johnson Cancer Drug Rybrevant Shows Improvement In Broader Lung Cancer Population - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/general/biotech/23/09/34289484/johnson-johnson-cancer-drug-rybrevant-shows-improvement-in-broader-lung-cancer-population,2023-09-06 18:11:41,"Janssen, a unit of Johnson & Johnson JNJ, released topline results from the three-arm Phase 3 MARIPOSA-2 study evaluating Rybrevant ( amivantamab-vmjw ) regime versus chemotherapy alone, targeting epidermal growth factor receptor ( EGFR ) and mesenchymal-epithelial transition ( MET ) .",JNJ,0.504646,0.157912,Somewhat-Bullish
Stocks on the Mend: A Mean Reversion Duo,https://www.zacks.com/commentary/2145594/stocks-on-the-mend-a-mean-reversion-duo,2023-09-06 17:16:00,"September is starting in classic, historically weak form. However, if the market finds it's footing, two stocks have explosive, reversion to the mean potential.",JNJ,0.185306,0.054842,Neutral
Why Is Infectious Diseases Focused Cidara Therapeutics Stock Trading Higher Today? - Cidara Therapeutics  ( NASDAQ:CDTX ) ,https://www.benzinga.com/general/biotech/23/09/34281425/why-is-infectious-diseases-focused-cidara-therapeutics-stock-trading-higher-today,2023-09-06 15:26:31,"Cidara Therapeutics Inc CDTX shares are trading higher after the company announced that Janssen Pharmaceuticals Inc, a unit of Johnson & Johnson JNJ, decided to proceed with CD388 ( JNJ-0953 ) , which is being developed for the universal prevention of influenza A and B.",JNJ,0.514619,-0.022414,Neutral
J&J says drug combo contains lung cancer from spreading for longer duration,https://www.reuters.com/business/healthcare-pharmaceuticals/jj-says-drug-combo-contains-lung-cancer-spreading-longer-duration-2023-09-06/,2023-09-06 13:14:00,"The Johnson & Johnson logo is displayed on a screen on the floor of the New York Stock Exchange ( NYSE ) in New York, U.S., May 29, 2019. REUTERS/Brendan McDermid/File Photo Acquire Licensing Rights",JNJ,0.388879,-0.100101,Neutral
Jim Cramer's top 10 things to watch in the stock market Wednesday,https://www.cnbc.com/2023/09/06/jim-cramers-top-10-things-to-watch-in-the-stock-market-wednesday-.html,2023-09-06 13:08:22,"Equities are lower in premarket trading Wednesday, while Arm Holdings' roadshow ahead of a planned initial public offering is impressive.",JNJ,0.136113,0.0,Neutral
"South Africa 'held to ransom' by big pharma, overcharged for COVID vaccines",https://www.aljazeera.com/news/2023/9/6/south-africa-held-to-ransom-by-big-pharma-overcharged-for-covid-vaccines,2023-09-06 12:27:10,"Johannesburg, South Africa - Big pharmaceutical companies ""bullied"" South Africa into signing unfair agreements that forced the country to overpay for COVID-19 vaccines compared with Western nations, according to a nonprofit that lobbied for the details to be released.",JNJ,0.060694,-0.130014,Neutral
More Than A Third Of S&P 500 Stocks Get Kicked Out In Nine Years,https://www.investors.com/etfs-and-funds/sectors/sp-500-stocks-more-than-a-third-get-kicked-out-in-nine-years/,2023-09-06 12:00:00,"Think you know the world's most-popular index: The S&P 500? It's very different from what it was just nine years ago - and more changes are coming. Nearly 180 stocks in the S&P 500, or roughly a third of the index, have been replaced since 2015, says data from S&P Dow Jones Indices.",JNJ,0.169081,0.050492,Neutral
Cidara Therapeutics Announces Janssen's Election to Proceed Under its License Agreement Relating to Novel Drug-Fc Conjugates Targeting Influenza - Cidara Therapeutics  ( NASDAQ:CDTX ) ,https://www.benzinga.com/pressreleases/23/09/g34273802/cidara-therapeutics-announces-janssens-election-to-proceed-under-its-license-agreement-relating-to,2023-09-06 12:00:00,"Decision follows promising interim efficacy and safety data from ongoing Phase 1 and 2a trials Cidara to receive a $7 million milestone payment and is eligible to receive an additional $685 million in milestones, plus royalties SAN DIEGO, Sept. 06, 2023 ( GLOBE NEWSWIRE ) -- Cidara Therapeutics, ...",JNJ,0.125789,0.059176,Neutral
Is J&J a Buy After the Kenvue Separation?,https://www.fool.com/investing/2023/09/06/is-jj-a-buy-after-the-kenvue-separation/,2023-09-06 10:00:00,J&J shares have been on the decline.,JNJ,0.116914,0.121146,Neutral
Idorsia reacquires the world-wide rights to aprocitentan,https://www.globenewswire.com/news-release/2023/09/06/2737993/0/en/Idorsia-reacquires-the-world-wide-rights-to-aprocitentan.html,2023-09-06 05:00:00,Ad hoc announcement pursuant to Art. 53 LR ...,JNJ,0.016172,0.098222,Neutral
Check Out What Whales Are Doing With JNJ - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/09/34252783/check-out-what-whales-are-doing-with-jnj,2023-09-05 20:15:52,"Someone with a lot of money to spend has taken a bearish stance on Johnson & Johnson JNJ. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",JNJ,0.817578,0.288945,Somewhat-Bullish
Here's Why You Should Retain Boston Scientific  ( BSX )  Now,https://www.zacks.com/stock/news/2145006/heres-why-you-should-retain-boston-scientific-bsx-now,2023-09-05 15:59:00,Investors are optimistic about Boston Scientific (BSX) on growth in the legacy business and upbeat guidance.,JNJ,0.051111,0.077486,Neutral
"Top Stories Tuesday, Sep 5: Facebook News To Shut Down in Europe, Warner Bros. Discovery Revises Outlook As Strike Bites, Manchester United No Longer Up For Sale - Air France  ( OTC:AFLYY ) , AstraZeneca  ( NASDAQ:AZN ) ",https://www.benzinga.com/news/23/09/34237785/facebook-news-to-shut-down-in-europe-warner-bros-discovery-revises-outlook-as-strike-bites-mancheste,2023-09-05 14:19:30,"Meta Platforms Inc META announced a significant development regarding Facebook News in the U.K., France, and Germany. The dedicated news tab on Facebook, known as Facebook News, will cease to exist in early December.",JNJ,0.16144,0.079532,Neutral
Johnson & Johnson's Growth Strategy Post Tylenol Parent Kenvue Split: Paving the Way for Medical Innovation - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/general/biotech/23/09/34235802/johnson-johnsons-growth-strategy-post-tylenol-parent-kenvue-split-paving-the-way-for-medical-inno,2023-09-05 13:39:11,"Johnson & Johnson JNJ is gearing up to use the proceeds from the recent separation of its consumer-health segment Kenvue Inc KVUE to bolster its growth in pharmaceuticals and medical technology. This growth strategy could encompass new acquisitions, enhancement of product offerings, and a deeper ...",JNJ,0.426225,0.395761,Bullish
Arm Plans To Go Public At Up To $55 Billion Valuation-Biggest IPO Since Rivian's In 2021,https://www.forbes.com/sites/dereksaul/2023/09/05/arm-plans-to-go-public-at-up-to-55-billion-valuation-biggest-ipo-since-rivians-in-2021/,2023-09-05 13:38:50,The valuation comes in far below the reported $64 billion internal valuation for the SoftBank-owned chip designer.,JNJ,0.086245,0.126603,Neutral
"Legal Twist In Drug Price Negotiation: Federal Judge Quits Case Amid Allegations Of Stock Ownership - AstraZeneca  ( NASDAQ:AZN ) , Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/general/biotech/23/09/34228654/legal-twist-in-drug-price-negotiation-federal-judge-quits-case-amid-allegations-of-stock-ownershi,2023-09-05 12:38:32,"On Friday, Judge Thomas Rose, serving in the U.S. District Court for the Southern District of Ohio, opted to step down from the case on the same day the Revolving Door Project, a nonprofit organization, revealed his ownership of stocks in Johnson & Johnson JNJ and AstraZeneca Plc AZN.",JNJ,0.345674,-0.017137,Neutral
Eterna Therapeutics Appoints Biopharma Industry Veteran Dorothy Clarke to Board of Directors - Eterna Therapeutics  ( NASDAQ:ERNA ) ,https://www.benzinga.com/pressreleases/23/09/g34233101/eterna-therapeutics-appoints-biopharma-industry-veteran-dorothy-clarke-to-board-of-directors,2023-09-05 12:30:49,"CAMBRIDGE, Mass., Sept. 05, 2023 ( GLOBE NEWSWIRE ) -- Eterna Therapeutics Inc. ERNA ( ""Eterna"" or the ""Company"" ) , a life science company committed to realizing the potential of mRNA cell engineering to provide patients with transformational new medicines, today announced the appointment of ...",JNJ,0.253866,0.050322,Neutral
Eterna Therapeutics Appoints Biopharma Industry Veteran Dorothy Clarke to Board of Directors,https://www.globenewswire.com/news-release/2023/09/05/2737383/0/en/Eterna-Therapeutics-Appoints-Biopharma-Industry-Veteran-Dorothy-Clarke-to-Board-of-Directors.html,2023-09-05 12:30:00,"CAMBRIDGE, Mass., Sept. 05, 2023 ( GLOBE NEWSWIRE ) -- Eterna Therapeutics Inc. ( Nasdaq: ERNA ) ( ""Eterna"" or the ""Company"" ) , a life science company committed to realizing the potential of mRNA cell engineering to provide patients with transformational new medicines, today announced the ...",JNJ,0.144853,0.03332,Neutral
Addex ADX71149 Phase 2 Epilepsy Study Expected to Readout Data in Q2 2024,https://www.globenewswire.com/news-release/2023/09/05/2736936/0/en/Addex-ADX71149-Phase-2-Epilepsy-Study-Expected-to-Readout-Data-in-Q2-2024.html,2023-09-05 05:00:00,Ad Hoc Announcement Pursuant to Art. 53 LR ...,JNJ,0.072326,0.086543,Neutral
JNJ: 3 Pharma Stocks to Consider Prescribing to for Quality,https://stocknews.com/news/jnj-azn-rdy-3-pharma-stocks-to-consider-prescribing-to-for-quality/,2023-09-04 16:18:32,"The pharmaceutical industry is expected to grow significantly as a result of global medical demands, aging population, technological advancements, and government investments in healthcare infrastructure, which will drive demand for pharmaceutical products and services.",JNJ,0.274705,0.11876,Neutral
"Decoding the Global Vasectomy Market 2023: Trends, Strategies, and Regulatory Insights",https://www.prnewswire.com/news-releases/decoding-the-global-vasectomy-market-2023-trends-strategies-and-regulatory-insights-301916835.html,2023-09-04 16:00:00,"DUBLIN, Sept. 4, 2023 /PRNewswire/ -- The ""Global Vasectomy Market ( 2023-2028 ) by Drug, Type, Patients, End Users, and Geography, Competitive Analysis, Impact of Covid-19 and Ansoff Analysis"" report has been added to ResearchAndMarkets.com's offering.",JNJ,0.088147,0.211476,Somewhat-Bullish
Binge-eating Disorder Treatment Market size is set to grow by USD 578.04 million from 2022 to 2027 | The increasing ... - PR Newswire,https://www.prnewswire.com/news-releases/binge-eating-disorder-treatment-market-size-is-set-to-grow-by-usd-578-04-million-from-2022-to-2027--the-increasing-prevalence-of-binge-eating-disorder-drives-the-market---technavio-301916031.html,2023-09-04 15:15:00,Binge-eating Disorder Treatment Market size is set to grow by USD 578.04 million from 2022 to 2027 | The increasing ... PR ...,JNJ,0.046095,0.057979,Neutral
Absorbable Sutures Market size to grow by USD 622.72 million from 2022 to 2027 | The number of surgical procedures ... - PR Newswire,https://www.prnewswire.com/news-releases/absorbable-sutures-market-size-to-grow-by-usd-622-72-million-from-2022-to-2027--the-number-of-surgical-procedures-globally-drives-market-growth---technavio-301916016.html,2023-09-04 11:00:00,Absorbable Sutures Market size to grow by USD 622.72 million from 2022 to 2027 | The number of surgical procedures ... PR ...,JNJ,0.05387,0.0,Neutral
"J&J's $40 Billion Split-Off Sets Stage for Pharma, Medical Tech Expansion ï»¿",https://www.wsj.com/articles/j-js-40-billion-split-off-sets-stage-for-pharma-medical-tech-expansion-817701c1,2023-09-04 09:30:00,The healthcare giant's separation of its consumer-health business arms it with billions in cash for allocating capital in the remaining businesses.,JNJ,0.546745,0.213927,Somewhat-Bullish
4 Warren Buffett Stocks That Could Join the Trillion-Dollar Club by 2032,https://www.fool.com/investing/2023/09/03/4-buffett-stocks-that-could-join-the-trillion/,2023-09-03 13:45:00,These companies all offer goods or services most of us use regularly.,JNJ,0.278486,0.328313,Somewhat-Bullish
Is It Too Late to Buy Veeva Systems Stock?,https://www.fool.com/investing/2023/09/03/is-it-too-late-to-buy-veeva-systems-stock/,2023-09-03 11:40:00,This niche cloud software company's growth is accelerating again.,JNJ,0.067347,0.089204,Neutral
"Sen. Tommy Tuberville is worth at least $4.5 million, according to his financial disclosures",https://www.businessinsider.com/tommy-tuberville-net-worth-financial-disclosures-2023-8,2023-09-02 15:00:00,Tommy Tuberville net worth is at least $4.5 million: disclosures - Business Insider ...,JNJ,0.056275,0.0,Neutral
Is This Incredible Dividend Stock Still a Buy Following Its Recent Split?,https://www.fool.com/investing/2023/09/02/is-this-incredible-dividend-stock-still-a-buy-foll/,2023-09-02 11:30:00,Johnson & Johnson has completed its separation of Kenvue.,JNJ,0.455525,0.401015,Bullish
8 Pharma Stocks Affected by New Drug Price Negotiation Rules,https://www.fool.com/investing/2023/09/02/8-pharma-stocks-affected-by-new-drug-price-negotia/,2023-09-02 10:51:00,Which companies have the most to lose now that Medicare can negotiate directly with them on the prices of some of the most widely used drugs?,JNJ,0.141726,0.040275,Neutral
Bone Replacement Market to grow by USD 5.611 billion from 2022 to 2027 | North America to contribute 38% of the ... - PR Newswire,https://www.prnewswire.com/news-releases/bone-replacement-market-to-grow-by-usd-5-611-billion-from-2022-to-2027--north-america-to-contribute-38-of-the-market-growth---technavio-301915487.html,2023-09-02 01:00:00,Bone Replacement Market to grow by USD 5.611 billion from 2022 to 2027 | North America to contribute 38% of the ... PR ...,JNJ,0.04531,0.065755,Neutral
Johnson & Johnson  ( JNJ )  Stock Sinks As Market Gains: What You Should Know,https://www.zacks.com/stock/news/2143952/johnson-johnson-jnj-stock-sinks-as-market-gains-what-you-should-know,2023-09-01 21:45:15,"In the latest trading session, Johnson & Johnson (JNJ) closed at $160.48, marking a -0.74% move from the previous day.",JNJ,0.608634,0.353132,Bullish
Prison healthcare giant Corizon reaches tentative bankruptcy deal that could shortchange prisoners; Sen. Elizabeth Warren pledges oversight,https://www.businessinsider.com/corizon-health-bankruptcy-could-lowball-malpractice-claims-2023-8,2023-09-01 16:51:00,"Corizon reaches bankruptcy deal that may allow it to ""profit at the expense of creditors"" - Business Insider ...",JNJ,0.031405,-0.193802,Somewhat-Bearish
Orthopedic implants market to grow by USD 14.0616 billion from 2022 to 2027 | The increasing incidence of knee ... - PR Newswire,https://www.prnewswire.com/news-releases/orthopedic-implants-market-to-grow-by-usd-14-0616-billion-from-2022-to-2027--the-increasing-incidence-of-knee-injuries-to-boost-market-growth---technavio-301915326.html,2023-09-01 15:15:00,Orthopedic implants market to grow by USD 14.0616 billion from 2022 to 2027 | The increasing incidence of knee ... PR ...,JNJ,0.044141,0.0,Neutral
Amgen's $27.8 Billion Purchase Of Horizon Therapeutics On After FTC Settlement,https://www.forbes.com/sites/tylerroush/2023/09/01/amgens-278-billion-purchase-of-horizon-therapeutics-on-after-ftc-settlement/,2023-09-01 14:53:09,The agency previously argued the merger could harm patients who are prescribed Horizon's two fastest-growing drugs.,JNJ,0.103331,-0.078932,Neutral
Former Best Buy CEO Hubert Joly On How To 'Refound' A Company,https://www.forbes.com/sites/petercohan/2023/09/01/former-best-buy-ceo-hubert-joly-on-how-to-refound-a-company/,2023-09-01 13:22:23,"Invest in companies whose leaders are curious, have intellectual humility, create meaning for workers, and capture short- and long-term growth opportunities ...",JNJ,0.021106,0.087758,Neutral
Nvidia's market cap climbs amid tech turbulence in August,https://www.reuters.com/business/global-markets-marketcap-2023-09-01/,2023-09-01 12:03:09,"A smartphone with a displayed NVIDIA logo is placed on a computer motherboard in this illustration taken March 6, 2023. REUTERS/Dado Ruvic/Illustration/File Photo Acquire Licensing Rights",JNJ,0.123526,-0.035067,Neutral
What's Happening With Johnson & Johnson Stock?,https://www.forbes.com/sites/greatspeculations/2023/09/01/whats-happening-with-johnson--johnson-stock/,2023-09-01 12:00:46,"Johnson & Johnson stock (NYSE: JNJ) has seen a 3% fall in a month, compared to a 2% fall for the broader S&P500 index.",JNJ,0.672533,0.133516,Neutral
Should Franklin U.S. Low Volatility High Dividend Index ETF  ( LVHD )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2143387/should-franklin-us-low-volatility-high-dividend-index-etf-lvhd-be-on-your-investing-radar,2023-09-01 10:20:06,Style Box ETF report for ...,JNJ,0.118354,0.067379,Neutral
Artificial Bone Marrow Market to grow by USD 170.77 million from 2022 to 2027 | The increasing prevalence of bone ... - PR Newswire,https://www.prnewswire.com/news-releases/artificial-bone-marrow-market-to-grow-by-usd-170-77-million-from-2022-to-2027--the-increasing-prevalence-of-bone-disorders-and-injuries-drives-the-market---technavio-301915130.html,2023-09-01 08:30:00,Artificial Bone Marrow Market to grow by USD 170.77 million from 2022 to 2027 | The increasing prevalence of bone ... PR ...,JNJ,0.040969,0.016619,Neutral
How To Earn $500 A Month From Dollar General After Sour Earnings Print - Dollar Gen  ( NYSE:DG ) ,https://www.benzinga.com/news/earnings/23/08/34154284/how-to-earn-500-a-month-from-dollar-general-after-sour-earnings-print,2023-08-31 18:23:25,"Shares of Dollar General Corp DG fell more than 13% Thursday following the company's less-than-stellar second-quarter earnings report. Here's what you need to know about the print, and how to earn $500 a month from the stock - equity appreciation aside.",JNJ,0.112008,0.0,Neutral
This Is What Whales Are Betting On Johnson & Johnson - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/08/34149480/this-is-what-whales-are-betting-on-johnson-johnson,2023-08-31 15:48:00,"A whale with a lot of money to spend has taken a noticeably bearish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson JNJ we detected 12 strange trades. If we consider the specifics of each trade, it is accurate to state that 16% of the investors opened trades with ...",JNJ,0.799321,-0.024015,Neutral
A New Era for Ledge Lounger: Chris Scherzinger Succeeds Founder Christopher Anderson,https://www.prnewswire.com/news-releases/a-new-era-for-ledge-lounger-chris-scherzinger-succeeds-founder-christopher-anderson-301914932.html,2023-08-31 13:46:00,"KATY, Texas, Aug. 31, 2023 /PRNewswire/ -- Ledge Lounger Inc. ( ""Ledge"" or the ""Company"" ) , an industry leader in outdoor & in-pool furniture, is excited to announce a significant leadership transition, as Chris Scherzinger takes the reins as the incoming CEO, succeeding the Founder and ...",JNJ,0.085936,0.167015,Somewhat-Bullish
J&J  ( JNJ )  Updates 2023 Guidance After Final Kenvue Separation,https://www.zacks.com/stock/news/2142863/jj-jnj-updates-2023-guidance-after-final-kenvue-separation,2023-08-31 12:59:00,"With the complete separation of the Consumer Health segment, J&J (JNJ) is now a two-sector company focused on the Pharmaceutical and MedTech fields.",JNJ,0.199859,0.066313,Neutral
"Biomea Fusion Announces Appointment of Juan Pablo FrÃ­as, M.D. as Chief Medical Officer",https://www.globenewswire.com/news-release/2023/08/31/2735267/0/en/Biomea-Fusion-Announces-Appointment-of-Juan-Pablo-Fr%C3%ADas-M-D-as-Chief-Medical-Officer.html,2023-08-31 12:30:00,"REDWOOD CITY, Calif., Aug. 31, 2023 ( GLOBE NEWSWIRE ) -- Biomea Fusion, Inc. ( ""Biomea"" ) ( Nasdaq: BMEA ) , a clinical-stage biopharmaceutical company dedicated to discovering and developing novel covalent small molecules to treat and improve the lives of patients with genetically defined ...",JNJ,0.025624,0.079697,Neutral
"J&J, India's Lupin slash prices for tuberculosis drug in lower-income countries",https://www.financialexpress.com/healthcare/pharma-healthcare/jj-indias-lupin-slash-prices-for-tuberculosis-drug-in-lower-income-countries/3228836/,2023-08-31 11:10:08,Johnson & Johnson and India's Lupin will supply their versions of the tuberculosis drug bedaquiline at a significantly cheaper price in low- and middle-income countries.,JNJ,0.12165,-0.004731,Neutral
Johnson & Johnson Just Cut an Entire Division. Is It Still a Buy?,https://www.fool.com/investing/2023/08/31/johnson-johnson-cut-entire-division-still-buy/,2023-08-31 10:12:00,The change won't have much of an immediate impact for investors either way.,JNJ,0.165788,-0.050042,Neutral
2 Dividend Kings That Face Massive Legal Risks,https://www.fool.com/investing/2023/08/31/2-dividend-kings-face-massive-legal-risks/,2023-08-31 09:37:00,Are the payouts for these two dividend stocks still safe?,JNJ,0.33433,-0.082325,Neutral
Medicare Will Soon Negotiate Some Drug Prices. Is This a Threat to Johnson & Johnson's Earnings?,https://www.fool.com/investing/2023/08/31/medicare-will-soon-negotiate-some-drug-prices-is-t/,2023-08-31 09:30:00,The healthcare giant's immunology drug Stelara brought in more than $9 billion in revenue last year.,JNJ,0.425925,-0.025866,Neutral
"J&J, India's Lupin cut prices for tuberculosis drug in lower-income countries",https://www.business-standard.com/companies/news/j-j-india-s-lupin-cut-prices-for-tuberculosis-drug-in-lower-income-countries-123083000984_1.html,2023-08-31 01:29:05,"J&J, Lupin cut prices for tuberculosis drug in lower-income countries Business Standard ...",JNJ,0.122894,-0.003518,Neutral
Alvotech Reports Financial Results for First Six Months of 2023 and Provides Business Update,https://www.globenewswire.com/news-release/2023/08/30/2734798/0/en/Alvotech-Reports-Financial-Results-for-First-Six-Months-of-2023-and-Provides-Business-Update.html,2023-08-30 20:15:00,"Alvotech ( NASDAQ: ALVO, or the ""Company"" ) , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today reported unaudited financial results for the first six months of 2023 and provided a summary of recent corporate highlights.",JNJ,0.041586,0.027392,Neutral
Alvotech Reports Financial Results for First Six Months of 2023 and Provides Business Update,https://www.globenewswire.com/news-release/2023/08/30/2734797/0/en/Alvotech-Reports-Financial-Results-for-First-Six-Months-of-2023-and-Provides-Business-Update.html,2023-08-30 20:15:00,"REYKJAVIK, Iceland, Aug. 30, 2023 ( GLOBE NEWSWIRE ) -- Alvotech ( NASDAQ: ALVO, or the ""Company"" ) , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today reported unaudited financial results for the first six months of ...",JNJ,0.041442,0.02738,Neutral
New Jersey Innovation Institute Names Michael Johnson as Next President,https://www.benzinga.com/pressreleases/23/08/g34123446/new-jersey-innovation-institute-names-michael-johnson-as-next-president,2023-08-30 19:04:54,"Newark, N.J., Aug. 30, 2023 ( GLOBE NEWSWIRE ) -- The New Jersey Innovation Institute ( NJII ) , a corporation of New Jersey Institute of Technology ( NJIT ) , is pleased to announce the appointment of Dr. Michael Johnson as NJII President.",JNJ,0.043264,0.060485,Neutral
Medicare wants to cut the price on an Eli Lilly drug. What is means for LLY shares,https://www.cnbc.com/2023/08/30/medicare-wants-to-cut-the-price-on-an-eli-lilly-drug-what-is-means-for-lly-shares.html,2023-08-30 18:23:19,"Lilly's Jardiance is among the first 10 prescription drugs subject a new, contentious negotiation process between Medicare and drugmakers.",JNJ,0.064797,0.027117,Neutral
Medicare drug price negotiations may have a muted impact on drugmakers in the near term,https://www.cnbc.com/2023/08/30/medicare-drug-price-negotiations-may-have-muted-impact-on-drugmakers.html,2023-08-30 17:48:18,Many of the drugs are already facing strong competition from other branded medications or patent expirations that will open the market to generic alternatives.,JNJ,0.069697,-0.034149,Neutral
"Pharma Giant Johnson & Johnson, Lupin Offer Significant Price Cuts On Tuberculosis Drug - Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/general/biotech/23/08/34120364/pharma-giant-johnson-johnson-lupin-offer-significant-price-cuts-on-tuberculosis-drug,2023-08-30 17:23:40,"U.S. pharma giant Johnson & Johnson JNJ and India-based Lupin Limited announced substantial price reductions for their versions of the tuberculosis drug, bedaquiline, to tackle the spread of tuberculosis in low- and middle-income nations.",JNJ,0.485711,0.044451,Neutral
Merck's  ( MRK )  Keytruda Receives EU Nod in Gastric Cancer,https://www.zacks.com/stock/news/2142587/mercks-mrk-keytruda-receives-eu-nod-in-gastric-cancer,2023-08-30 15:51:00,"Following the approval, Merck's (MRK) Keytruda is the first immunotherapy approved in the EU for first-line treatment for HER2-positive advanced gastric cancer in adults whose tumors express PD-L1.",JNJ,0.102013,0.041538,Neutral
Johnson & Johnson Reveals Updated 2023 Projections After Finalizing Biggest Shake Up In 135 Years - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/general/biotech/23/08/34117196/johnson-johnson-reveals-updated-2023-projections-after-finalizing-biggest-shake-up-in-135-years,2023-08-30 15:42:19,"Johnson & Johnson JNJ has unveiled 2023 projections, predicting double-digit profit growth after its recent spinoff of consumer health company Kenvue Inc KVUE. The company's outlook provides an early glimpse into the performance of its standalone drugs and medical device businesses.",JNJ,0.967875,0.513167,Bullish
"J&J, India's Lupin cut prices for tuberculosis drug in lower-income countries",https://www.reuters.com/business/healthcare-pharmaceuticals/jj-indias-lupin-cut-prices-tuberculosis-drug-lower-income-countries-2023-08-30/,2023-08-30 14:15:00,"FILE PHOTO-The Johnson & Johnson logo is displayed on a screen on the floor of the New York Stock Exchange ( NYSE ) in New York, U.S., May 29, 2019. REUTERS/Brendan McDermid/File Photo Acquire Licensing Rights",JNJ,0.214937,-0.001659,Neutral
The Investing Club's top 10 things to watch in the stock market Wednesday,https://www.cnbc.com/2023/08/30/the-investing-clubs-top-10-things-to-watch-in-the-market-wednesday-.html,2023-08-30 13:19:44,"Stocks are poised to open slightly higher Wednesday, while Citigroup maintains a buy rating on Club name Apple (AAPL) ahead of its Sept. 12 product event.",JNJ,0.113866,0.118636,Neutral
1 Top Dividend Stock to Buy Hand Over Fist Right Now,https://www.fool.com/investing/2023/08/30/1-top-dividend-stock-to-buy-hand-over-fist-right-n/,2023-08-30 12:45:00,Kenvue stands out as a leading dividend provider.,JNJ,0.131643,0.310755,Somewhat-Bullish
"Surgical Kits Market Surpass USD 40 billion by 2031, Expanding at a CAGR of 7% - Exclusive Report by Transparency Market Research",https://www.benzinga.com/pressreleases/23/08/g34111111/surgical-kits-market-surpass-usd-40-billion-by-2031-expanding-at-a-cagr-of-7-exclusive-report-by-t,2023-08-30 11:30:00,"Wilmington, Delaware, United States, Aug. 30, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global surgical kits market is projected to flourish at a CAGR of 7% from 2023 to 2031. As per the report published by TMR, a valuation of US$ 40 billion is anticipated for the market ...",JNJ,0.041323,0.261581,Somewhat-Bullish
J&J forecasts 12.5% growth in 2023 profit after Kenvue spinoff,https://www.reuters.com/business/retail-consumer/jj-forecasts-125-growth-2023-profit-after-kenvue-spinoff-2023-08-30/,2023-08-30 10:41:49,"Johnson & Johnson company offices are shown in Irvine, California, U.S., October 14, 2020. REUTERS/Mike Blake Acquire Licensing Rights Aug 30 ( Reuters ) - Johnson & Johnson ( JNJ.N ) on Wednesday forecast 12.5% growth in its annual adjusted profit after completing the separation of consumer ...",JNJ,0.417995,0.332111,Somewhat-Bullish
4 Big Tech giants have plowed over $1 trillion into stock buybacks in 10 years - more than Tesla or Meta's entire market value,https://markets.businessinsider.com/news/stocks/big-tech-stock-buybacks-apple-google-meta-microsoft-tesla-buffett-2023-8,2023-08-30 10:39:00,4 Big Tech Giants Spent Over $1 Trillion on Stock Buybacks in 10 Years - Markets Insider ...,JNJ,0.092927,0.041619,Neutral
3 PIMCO Mutual Funds for Stellar Returns,https://www.zacks.com/stock/news/2142216/3-pimco-mutual-funds-for-stellar-returns,2023-08-30 08:30:00,"Below, we share with you three top-ranked PIMCO mutual funds. Each has earned a Zacks Mutual Fund Rank #1.",JNJ,0.093653,0.05768,Neutral
Laparoscopy Devices Market is Projected to Hit USD 16.4 Billion at a Healthy CAGR of 6.5% by 2030 - Report by Transparency Market Research,https://www.benzinga.com/pressreleases/23/08/g34108095/laparoscopy-devices-market-is-projected-to-hit-usd-16-4-billion-at-a-healthy-cagr-of-6-5-by-2030-r,2023-08-30 07:42:36,"Wilmington, Delaware, United States, Aug. 30, 2023 ( GLOBE NEWSWIRE ) -- The global laparoscopy devices market is projected to flourish at a CAGR of 6.5% from 2020 to 2030. As per the report published by TMR, a valuation of US$ 16.4 billion is anticipated for the market in 2031.",JNJ,0.0428,-0.171195,Somewhat-Bearish
"Albert Maasland, Former CAB and Saxo Bank UK CEO, joins Virtualware's International Advisory Board",https://www.globenewswire.com/news-release/2023/08/30/2734030/0/en/Albert-Maasland-Former-CAB-and-Saxo-Bank-UK-CEO-joins-Virtualware-s-International-Advisory-Board.html,2023-08-30 06:00:00,"London and Bilbao, Spain, August 30, 2023.- Spanish Virtual Reality company Virtualware ( MLVIR.PA ) has appointed Albert C. Maasland, former CEO of Crown Agents Bank and former CEO of Saxo Bank UK, to its International Advisory Board, in a decision that will reinforce the company's position as a ...",JNJ,0.051774,0.114497,Neutral
How To Earn $500 A Month From Johnson & Johnson Stock - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/government/23/08/34104307/how-to-earn-500-a-month-from-johnson-johnson-stock,2023-08-29 21:59:53,"Johnson & Johnson JNJ investors on Tuesday reacted negatively to the Centers for Medicare and Medicaid Services ( CMS ) announcement of a price negotiation list that included multiple drugs from the New Brunswick, New Jersey-based company.",JNJ,0.459624,-0.203717,Somewhat-Bearish
What Impact Will Medicare Price Negotiations Have on Big Pharma Stocks?,https://www.fool.com/investing/2023/08/29/medicare-price-negotiations-big-pharma-stocks/,2023-08-29 21:00:00,Investors appear to be yawning for the most part at the latest news on Medicare drug price negotiations.,JNJ,0.308891,0.104613,Neutral
"Cannabis Industry's Capital Crunch: Why It Needs More Funds Than Other Industries, Will Fed Legalization Change This? - Colgate-Palmolive  ( NYSE:CL ) , Diageo  ( NYSE:DEO ) ",https://www.benzinga.com/markets/cannabis/23/08/34100550/cannabis-industrys-capital-crunch-why-it-needs-more-funds-than-other-industries-will-fed-legaliz,2023-08-29 19:46:58,Recent research conducted by Viridian Capital Advisors reveals that the cannabis sector requires more capital as compared to other similar industries.,JNJ,0.125789,0.0,Neutral
America's plan to cut drug prices comes with unpleasant side-effects,https://www.economist.com/business/2023/08/29/americas-plan-to-cut-drug-prices-comes-with-unpleasant-side-effects,2023-08-29 19:28:58,"""A piggy-bank of the pharma world,"" gripes David Mitchell of Patients for Affordable Drugs, a consumer lobbying group. There is some truth to this. America is the world's largest pharmaceutical market, with $630bn in sales in 2022, or 42% of the worldwide total.",JNJ,0.045918,-0.038835,Neutral
"Eliquis, Jardiance among first 10 drugs selected for Medicare price negotiations",https://www.marketwatch.com/story/merck-amgen-abbvie-products-among-first-10-drugs-selected-for-medicare-price-negotiations-556c2484,2023-08-29 19:22:00,"Merck, Johnson & Johnson and Amgen are among the first drugmakers to have products chosen for a contentious initiative to rein in prescription-drug costs.",JNJ,0.058188,0.049067,Neutral
J&J  ( JNJ )  Seeks Full FDA Nod for Balversa in Urothelial Cancer,https://www.zacks.com/stock/news/2142126/jj-jnj-seeks-full-fda-nod-for-balversa-in-urothelial-cancer,2023-08-29 17:14:00,J&J (JNJ) submits a supplemental new drug application to the FDA for full approval of Balversa to treat urothelial carcinoma.,JNJ,0.454174,-0.399874,Bearish
Why Johnson & Johnson  ( JNJ )  is a Great Dividend Stock Right Now,https://www.zacks.com/stock/news/2142005/why-johnson-johnson-jnj-is-a-great-dividend-stock-right-now,2023-08-29 15:45:10,"Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.",JNJ,0.445179,0.480354,Bullish
10 Drugs Selected for Medicare Price Reduction,https://www.zacks.com/stock/news/2141961/10-drugs-selected-for-medicare-price-reduction,2023-08-29 14:55:00,"We're getting Case-Shiller home price numbers ahead of the opening bell this morning, but there's not enough time to dig into it. Give us till this afternoon to speak about these. Pre-market indices are in the red currently, albeit marginally. Investors cool their heels early after back-to-back ...",JNJ,0.160633,0.041728,Neutral
Biden admin names first 10 drugs subject to Medicare price negotiation,https://www.foxbusiness.com/economy/biden-administration-names-first-10-drugs-subject-medicare-price-negotiation,2023-08-29 14:53:52,"The Biden administration on Tuesday released a list of the first 10 prescription medications that will be subject to price negotiations with Medicare, in an effort to lower the cost of pharmaceutical drugs for older Americans.",JNJ,0.105604,0.0,Neutral
Medicare Drugs Targeted Under Inflation Reduction Act,https://www.zacks.com/stock/news/2141940/medicare-drugs-targeted-under-inflation-reduction-act,2023-08-29 14:21:00,"Last year, these 10 drugs made up $50 billion, about 20%, of Medicare part D costs.",JNJ,0.15347,0.041855,Neutral
Arm IPO Thought To Raise $6 Billion; Instacart On Tap Too,https://www.investors.com/research/arm-ipo-could-raise-6-billion-instacart-on-tap-too/,2023-08-29 13:47:00,Arm IPO Thought To Raise $6 Billion. Instacart On Tap Too Investor's Business Daily ...,JNJ,0.124486,0.101187,Neutral
Is Most-Watched Stock Johnson & Johnson  ( JNJ )  Worth Betting on Now?,https://www.zacks.com/stock/news/2141784/is-most-watched-stock-johnson-johnson-jnj-worth-betting-on-now,2023-08-29 13:00:11,"Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",JNJ,0.474082,0.159554,Somewhat-Bullish
US names 10 prescription drugs subject to price negotiations,https://www.aljazeera.com/news/2023/8/29/us-names-10-prescription-drugs-subject-to-price-negotiations,2023-08-29 12:55:17,Move is expected to cut costs for some patients but faces lawsuits from drugmakers and heavy criticism from Republicans.,JNJ,0.067919,-0.067157,Neutral
"Beaten Down COVID-19 Vaccine Partner Stock Catalent Finalizes Deal With Activist Investor, Reports Mixed Q4 Earnings - Catalent  ( NYSE:CTLT ) ",https://www.benzinga.com/general/biotech/23/08/34086113/beaten-down-covid-19-vaccine-partner-stock-catalent-finalizes-deal-with-activist-investor-reports,2023-08-29 12:17:43,"Catalent Inc CTLT, valued at around $8 billion, has finalized a deal with activist investor Elliott Investment Management. The board has recommended and approved the appointment of four new independent directors. With these appointments, Catalent's Board of Directors will consist of 16 directors, ...",JNJ,0.202366,0.364349,Bullish
U.S. Announces First Drugs Picked for Medicare Price Negotiations,https://www.nytimes.com/2023/08/29/us/politics/medicare-drug-pricing-negotiations.html,2023-08-29 11:39:43,"The Biden administration's announcement was an important moment for Democrats, who have campaigned on a promise to lower the cost of prescription drugs.",JNJ,0.214462,-0.091298,Neutral
Biden administration unveils first 10 drugs subject to Medicare price negotiations,https://www.cnbc.com/2023/08/29/10-drugs-to-face-medicare-price-negotiations-see-the-list.html,2023-08-29 11:37:25,The announcement of the 10 drugs kicks off a Medicare negotiation process that aims to make costly medications more affordable for older Americans.,JNJ,0.112709,-0.056086,Neutral
3 Best TIAA Mutual Funds to Strengthen Your Portfolio,https://www.zacks.com/stock/news/2141706/3-best-tiaa-mutual-funds-to-strengthen-your-portfolio,2023-08-29 10:37:00,"Consider investing in TIAA mutual funds like TRLCX, TSRPX and TICRX to secure appealing gains.",JNJ,0.06623,0.050062,Neutral
US to name first 10 drugs for Medicare price negotiation,https://www.reuters.com/business/healthcare-pharmaceuticals/us-name-first-10-drugs-medicare-price-negotiation-2023-08-29/,2023-08-29 10:20:00,"[1/3] U.S. President Joe Biden delivers remarks on Social Security and Medicare at the University of Tampa in Tampa, Florida, U.S. February 9, 2023. REUTERS/Jonathan Ernst Acquire Licensing Rights",JNJ,0.068306,-0.066523,Neutral
3 High-Quality Dividend Stocks Yielding 3%-Plus to Buy for Decades of Rising Income,https://www.fool.com/investing/2023/09/17/3-high-quality-dividend-stocks-yeilding-3-to-buy-f/,2023-09-17 15:09:00,These companies generate durable and growing cash flows.,JNJ,0.121343,0.089341,Neutral
Activist Elliott makes inroads at Catalent to build value. Here's what could happen next,https://www.cnbc.com/2023/09/16/activist-elliott-makes-inroads-at-catalent-to-build-value-heres-what-could-happen-next.html,2023-09-16 12:35:55,Elliott recently entered a cooperation agreement with Catalent. This could pave the way for some major changes at the pharmaceutical company.,JNJ,0.036812,0.089875,Neutral
A top-12% portfolio manager over the last 5 years shares how he finds unloved stocks trading at massive discounts - and 6 of the top opportunities in markets right now,https://www.businessinsider.com/how-to-invest-value-stocks-to-buy-top-fund-manager-2023-9,2023-09-16 10:00:00,6 Undervalued Investments to Make Right Now: Top-12% Fund Manager - Business Insider ...,JNJ,0.067727,0.131897,Neutral
Warren Buffett poured $3 billion into Dow Chemical during the financial crisis. Here's the story of how he helped the manufacturing titan - and doubled his money.,https://africa.businessinsider.com/markets/warren-buffett-poured-dollar3-billion-into-dow-chemical-during-the-financial-crisis/t5nwqfx,2023-09-16 09:39:27,"Dow agreed to buy Rohm and Haas for nearly $19 billion including debt in July 2008, and roped in Warren Buffett's Berkshire Hathaway to help with the financing. The acquisition was part of Dow's strategy to shift its focus away from bulk chemicals toward higher-margin, specialty chemicals.",JNJ,0.095138,0.09814,Neutral
Warren Buffett poured $3 billion into Dow Chemical during the financial crisis. Here's the story of how he helped the manufacturing titan - and doubled his money.,https://markets.businessinsider.com/news/stocks/warren-buffett-berkshire-hathaway-dow-chemical-stock-deal-financial-crisis-2023-9,2023-09-16 09:39:00,"How Warren Buffett Bet $3 Billion on Dow Chemical, Doubled His Money - Markets Insider ...",JNJ,0.049322,0.091826,Neutral
Why the F.D.A. Took So Long to Tackle a Disputed Cold Remedy,https://www.nytimes.com/2023/09/15/health/fda-cold-medicine-decongestant.html,2023-09-15 20:24:29,Pharmacists affiliated with the University of Florida have spent decades nudging the agency to pull a decongestant from over-the-counter medicines.,JNJ,0.024775,-0.020373,Neutral
"Top Analyst Reports for Meta Platforms, Walmart & Johnson & Johnson",https://www.zacks.com/research-daily/2149578/top-analyst-reports-for-meta-platforms-walmart-johnson-johnson,2023-09-15 16:59:00,"Today's Research Daily features new research reports on 16 major stocks, including Meta Platforms, Inc. (META), Walmart Inc. (WMT) and Johnson & Johnson (JNJ).",JNJ,0.104228,0.252141,Somewhat-Bullish
Jets owner Woody Johnson is privately lobbying GOP megadonors to donate to Trump's campaign,https://www.cnbc.com/2023/09/15/jets-owner-woody-johnson-helps-trump-2024-campaign.html,2023-09-15 16:45:46,"New York Jets owner Woody Johnson is privately lobbying fellow Republican megadonors to donate to Donald Trump, making him a rare figure in the GOP.",JNJ,0.043499,0.278581,Somewhat-Bullish
The Orthopedic Devices Market Is Expected To Grow At A CAGR Of 5% With Rising Geriatric Population As Per The Business Research Company's Orthopedic Devices Global Market Report 2023,https://www.benzinga.com/pressreleases/23/09/g34619983/the-orthopedic-devices-market-is-expected-to-grow-at-a-cagr-of-5-with-rising-geriatric-population-,2023-09-15 15:30:00,"LONDON, Sept. 15, 2023 ( GLOBE NEWSWIRE ) -- The Business Research Company's Orthopedic Devices Global Market Report 2023, the global orthopedic devices market has demonstrated remarkable growth, increasing from $43 billion in 2022 to $45.79 billion in 2023, reflecting a robust compound annual ...",JNJ,0.053509,-0.013,Neutral
"JNJ: Which of these 3 Pharma Stocks Should You Buy, Hold or Sell?",https://stocknews.com/news/jnj-calt-acb-kvue-which-of-these-3-pharma-stocks-should-you-buy-hold/,2023-09-15 14:05:23,"The pharmaceutical sector is popular amongst investors because of its ability to maintain profit margins irrespective of the economic climate. Moreover, the industry is well-positioned for growth thanks to the growing incidence of chronic diseases and the development of drugs for treating rare ...",JNJ,0.318439,0.230508,Somewhat-Bullish
Instacart Raises IPO Price Nearly 10% After Arm's Splashy Start,https://www.forbes.com/sites/dereksaul/2023/09/15/instacart-raises-ipo-price-nearly-10-after-arms-splashy-start/,2023-09-15 13:30:57,Instacart will begin trading Tuesday at a projected valuation between $9.3 billion to $9.9 billion.,JNJ,0.103778,0.0,Neutral
3 Great Dividend Stocks You Can Buy for Less Than $50,https://www.fool.com/investing/2023/09/15/3-great-dividend-stocks-you-can-buy-for-less-than/,2023-09-15 12:10:00,These steady-Eddie operators are perfect bedrock stocks for investors despite trading for less than $50.,JNJ,0.078482,0.005112,Neutral
Should iShares Russell Top 200 Value ETF  ( IWX )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2149290/should-ishares-russell-top-200-value-etf-iwx-be-on-your-investing-radar,2023-09-15 10:20:05,Style Box ETF report for ...,JNJ,0.123209,-0.022289,Neutral
"Arm debut will help jump-start IPO market, early Airbnb investor Rick Heitzmann suggests",https://www.cnbc.com/2023/09/14/arm-ipo-to-help-jump-start-ipo-market-airbnb-investor-rick-heitzmann.html,2023-09-14 23:28:45,"""People are looking for the new toy,"" FirstMark Capital's Rick Heitzmann says after Arm Holdings stock jumps 25% in its first trading day.",JNJ,0.106541,0.037761,Neutral
Johnson & Johnson ditching script logo after 130 years,https://www.foxbusiness.com/markets/johnson-johnson-ditching-script-logo-after-130-years,2023-09-14 20:12:57,on Thursday announced that the company is updating its logo as part of a brand realignment that will unite its medical technology and pharmaceutical segments under its brand name.,JNJ,0.459624,0.474228,Bullish
"Lawsuit Against Dummy Pills For Allergy, Cold: Johnson & Johnson And Procter & Gamble Face Allegations - Johnson & Johnson  ( NYSE:JNJ ) , Procter & Gamble  ( NYSE:PG ) ",https://www.benzinga.com/news/large-cap/23/09/34589803/lawsuit-against-dummy-pills-for-allergy-cold-johnson-johnson-and-procter-gamble-face-allegations,2023-09-14 19:10:07,"In a recent lawsuit, Johnson & Johnson JNJ and Procter & Gamble Co PG are facing allegations of misleading consumers regarding decongestant cold medicines containing an ingredient that a unanimous FDA advisory panel declared ineffective this week.",JNJ,0.388879,-0.24671,Somewhat-Bearish
Johnson & Johnson is replacing its iconic logo | Business,https://www.cnn.com/2023/09/14/business/johnson-and-johnson-new-logo/index.html,2023-09-14 18:42:00,Johnson & Johnson is replacing its iconic logo ...,JNJ,0.288893,0.076011,Neutral
Notification of managers' transactions,https://www.globenewswire.com/news-release/2023/09/14/2743487/0/en/Notification-of-managers-transactions.html,2023-09-14 15:20:00,ANNOUNCEMENT NO. ...,JNJ,0.282234,0.124107,Neutral
"IoT Medical Devices Market Size is projected to reach USD 112 billion by 2031, growing at a CAGR of 27.6%: Straits Research",https://www.benzinga.com/pressreleases/23/09/g34583244/iot-medical-devices-market-size-is-projected-to-reach-usd-112-billion-by-2031-growing-at-a-cagr-of,2023-09-14 14:15:00,"New York, United States, Sept. 14, 2023 ( GLOBE NEWSWIRE ) -- IoT medical devices manage mechanical ventilation systems and artificial airways, disperse aerosol-based medications, and identify and treat cardiopulmonary diseases.",JNJ,0.02671,-0.025173,Neutral
Johnson & Johnson is getting rid of its script logo after more than 130 years,https://apnews.com/article/johnson-logo-change-cursive-7236463751d2ba89a7a8858c3accf162,2023-09-14 14:03:17,Johnson & Johnson is signing off on a new logo. The health care giant said Thursday that it will replace the well-known signature script it has used since 1887 with a modern look that reflects its sharpened focus on pharmaceuticals and medical devices.,JNJ,0.453099,0.233741,Somewhat-Bullish
"Percutaneous Coronary Intervention Guidance Devices Market Revenue to Cross USD 23.5 billion by 2031, Expanding at a 6.1% CAGR: TMR Report",https://www.benzinga.com/pressreleases/23/09/g34578437/percutaneous-coronary-intervention-guidance-devices-market-revenue-to-cross-usd-23-5-billion-by-20,2023-09-14 12:30:00,"Wilmington, Delaware, United States, Sept. 14, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The percutaneous coronary intervention guidance devices market was estimated to have acquired US$ 12.2 billion in 2021.",JNJ,0.04076,0.0,Neutral
"Arm Holdings IPO shares expected to begin trading today: Check stock price, valuation, ticker symbol",https://www.financialexpress.com/business/investing-abroad-arm-holdings-ipo-shares-expected-to-begin-trading-today-check-stock-price-valuation-ticker-symbol-3243273/,2023-09-14 10:37:00,"The chip designer, which is owned by SoftBank Group Corp., sold 95.5 million American depositary shares for $51 apiece, according to a statement Wednesday confirming an earlier Bloomberg News report. Arm had marketed the shares for $47 to $51 each.",JNJ,0.045224,-0.095404,Neutral
3 Warren Buffett Stocks That Are Near Their 52-Week Lows,https://www.fool.com/investing/2023/09/14/warren-buffett-stocks-near-their-52-week-low/,2023-09-14 09:20:00,Should you consider loading up on these stocks?,JNJ,0.249958,0.13399,Neutral
Innovations and Opportunities in European Healthcare Technologies,https://investingnews.com/innovations-and-opportunities-in-european-healthcare-technologies/,2023-09-14 04:19:26,These advanced European technologies are often only distributed and implemented exclusively within the European Union. The good news is that it doesn't need to stay this way.,JNJ,0.021718,0.131751,Neutral
SoftBank-backed Arm raises $4.87 billion in biggest IPO of the year,https://www.business-standard.com/world-news/softbank-backed-arm-raises-4-87-billion-in-biggest-ipo-of-the-year-123091400129_1.html,2023-09-14 03:05:38,"By Gillian Tan, Ian King, Ryan Gould and Amy Or Arm Holdings Plc priced its initial public offering at the top end of its range to raise $4.87 billion in the largest listing of the year, one that could give a major lift to long-suffering equity markets.",JNJ,0.042723,-0.094807,Neutral
Johnson & Johnson  ( JNJ )  Outpaces Stock Market Gains: What You Should Know,https://www.zacks.com/stock/news/2148591/johnson-johnson-jnj-outpaces-stock-market-gains-what-you-should-know,2023-09-13 21:45:17,"In the latest trading session, Johnson & Johnson (JNJ) closed at $163.99, marking a +0.25% move from the previous day.",JNJ,0.5633,0.193809,Somewhat-Bullish
Kimberly-Clark Elects Deeptha Khanna to its Board of Directors,https://www.prnewswire.com/news-releases/kimberly-clark-elects-deeptha-khanna-to-its-board-of-directors-301926867.html,2023-09-13 20:19:00,"DALLAS, Sept. 13, 2023 /PRNewswire/ -- Kimberly-Clark Corporation ( NYSE: KMB ) today announced that Deeptha Khanna has been elected to its board of directors effective immediately.",JNJ,0.214937,0.076385,Neutral
"Buy Birkenstock? What to know about Crocs, Allbirds and the uneven history of the footwear IPO market",https://www.cnbc.com/2023/09/13/buy-birkenstock-ipo-crocs-allbirds-and-an-uneven-footwear-market.html,2023-09-13 18:51:39,Iconic footwear brand Birkenstock is planning to go public at a time when tech IPOs including Arm and Instacart are hoping to give the IPO market a jolt.,JNJ,0.021124,-0.005732,Neutral
"Annual Report 2022/23 - Continued solid earnings, but weaker growth amid challenging market conditions",https://www.globenewswire.com/news-release/2023/09/13/2742833/0/en/Annual-Report-2022-23-Continued-solid-earnings-but-weaker-growth-amid-challenging-market-conditions.html,2023-09-13 17:50:00,ANNOUNCEMENT NO. ...,JNJ,0.065685,0.061067,Neutral
Guidance for the 2023/24 financial year,https://www.globenewswire.com/news-release/2023/09/13/2742832/0/en/Guidance-for-the-2023-24-financial-year.html,2023-09-13 17:45:00,ANNOUNCEMENT NO. ...,JNJ,0.299478,0.130157,Neutral
"The latest Covid-19 vaccine is here. Here's where and when to get it - and RSV and flu shots, too",https://www.cnn.com/2023/09/13/health/updated-covid-vaccine-where-when-flu-rsv-wellness/index.html,2023-09-13 16:38:00,"Now that the US Food and Drug Administration and Centers for Disease Control and Prevention have signed off, you won't have to wait long to get your updated Covid-19 shot. Major pharmacy chains have already started rolling out vaccine appointments.",JNJ,0.027072,0.075894,Neutral
"Internal Hiring Boosts Retention and Saves Money, Yet Has Slumped Post Pandemic, The Josh Bersin Company Finds",https://www.prnewswire.com/news-releases/internal-hiring-boosts-retention-and-saves-money-yet-has-slumped-post-pandemic-the-josh-bersin-company-finds-301926233.html,2023-09-13 13:00:00,"â€¢ Internal mobility initiatives and hiring processes rose in popularity during the pandemic to become a source of innovation, employee retention, a core driver of company culture, and broad savings â€¢ But the focus on internal recruitment has waned-slumping to represent just 24% of all hires from ...",JNJ,0.032035,0.076029,Neutral
How We'll Tap This Spinoff For 200%+ Dividend Growth,https://www.forbes.com/sites/brettowens/2023/09/13/how-well-tap-this-spinoff-for-200-dividend-growth/,2023-09-13 12:21:00,"Let's dive into this Johnson & Johnson (JNJ) spinoff-because it shows exactly how we can tap ""splits"" like these to grab not one but TWO income streams.",JNJ,0.264351,0.426032,Bullish
Here's My Top Growth Stock to Buy in 2023,https://www.fool.com/investing/2023/09/13/heres-my-top-growth-stock-to-buy-in-2023/,2023-09-13 11:41:00,The growth train is leaving the station and you don't want to miss it. Find out why this stock remains a strong buy even after doubling in 2023.,JNJ,0.123844,0.171986,Somewhat-Bullish
Better Buy: J&J vs. Kenvue,https://www.fool.com/investing/2023/09/13/better-buy-jj-vs-kenvue/,2023-09-13 09:30:00,"You can count on both of these companies for passive income, too.",JNJ,0.148426,0.170505,Somewhat-Bullish
Johnson & Johnson Unusual Options Activity - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/09/34502706/johnson-johnson-unusual-options-activity,2023-09-12 19:15:45,"Someone with a lot of money to spend has taken a bullish stance on Johnson & Johnson JNJ. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",JNJ,0.75957,0.283185,Somewhat-Bullish
Your cold pills could be yanked off the shelf. An FDA panel just ruled some of them don't work.,https://www.businessinsider.com/cold-medicine-fda-phenylephrine-congestion-does-not-work-2023-9,2023-09-12 17:39:00,Your cold medicine may soon be pulled from shelves - Business Insider ...,JNJ,0.052918,0.035795,Neutral
"Decongestant found in many cold, allergy medicines doesn't actually work, FDA advisors say",https://www.cnbc.com/2023/09/12/decongestant-phenylephrine-ineffective.html,2023-09-12 16:48:33,"In a unanimous vote, advisors said oral versions of phenylephrine - a nasal decongestant found in versions of drugs like Nyquil and Benadryl - isn't effective.",JNJ,0.107978,0.0,Neutral
NVS: 3 Pharma Stocks Surpassing Johnson & Johnson  ( JNJ ) ,https://stocknews.com/news/nvs-hznp-rdy-jnj-amgn-3-pharma-stocks-surpassing-johnson-johnson-jnj/,2023-09-12 16:38:07,NVS: 3 Pharma Stocks Surpassing Johnson & Johnson ...,JNJ,0.058615,0.11319,Neutral
AstraZeneca  ( AZN )  Posts Upbeat Data on Lung Cancer Drug Combo,https://www.zacks.com/stock/news/2147960/astrazeneca-azn-posts-upbeat-data-on-lung-cancer-drug-combo,2023-09-12 15:49:00,Data from a late-stage study shows that AstraZeneca's (AZN) Tagrisso combined with chemotherapy cut the risk of disease progression or death by 38% in certain lung cancer patients.,JNJ,0.12645,-0.05543,Neutral
"Popular nasal decongestant doesn't actually relieve congestion, FDA advisers say",https://apnews.com/article/sudafed-decongestants-phenylephrine-pseudoephedrine-fda-0f140bafae9a500c5fba05fe764ecb66,2023-09-12 15:14:00,"Popular nasal decongestant doesn't actually relieve congestion, FDA experts say The Associated Press ...",JNJ,0.085476,-0.025989,Neutral
Should Vanguard High Dividend Yield ETF  ( VYM )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2147555/should-vanguard-high-dividend-yield-etf-vym-be-on-your-investing-radar,2023-09-12 10:20:07,Style Box ETF report for ...,JNJ,0.12546,0.069101,Neutral
J&J  ( JNJ )  Seeks Approval for Bladder Cancer Drug in Europe,https://www.zacks.com/stock/news/2147378/jj-jnj-seeks-approval-for-bladder-cancer-drug-in-europe,2023-09-11 16:31:00,J&J's (JNJ) erdafitinib is already marketed as Balversa in the United States for FGFR-altered metastatic UC. Balversa is approved by the FDA under the accelerated pathway.,JNJ,0.279015,-0.054565,Neutral
The Prostate Cancer Drugs Market Is Expected To Reach A Value Of $23 Billion By 2027 At A CAGR Of More Than 5 % As Per The Business Research Company's Prostate Cancer Drugs Global Market Report 2023,https://www.benzinga.com/pressreleases/23/09/g34446203/the-prostate-cancer-drugs-market-is-expected-to-reach-a-value-of-23-billion-by-2027-at-a-cagr-of-m,2023-09-11 15:30:00,"LONDON, Sept. 11, 2023 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Prostate Cancer Drugs Global Market Report 2023, the global prostate cancer drugs market is making strides worth noting.",JNJ,0.059341,0.012045,Neutral
Stock Market Fades; Twinkie Maker Rallies On Deal News,https://www.investors.com/market-trend/stock-market-today/stock-market-fased-from-strong-start-twinkie-maker-rallies-on-deal-news/,2023-09-11 14:49:00,Stock Market Fades. Twinkie Maker Rallies On Deal News Investor's Business Daily ...,JNJ,0.122894,0.311676,Somewhat-Bullish
Here's an easy way to make a more concentrated play on the 'Magnificent Seven' stocks,https://www.marketwatch.com/story/heres-an-easy-way-to-make-a-more-concentrated-play-on-the-magnificent-seven-stocks-b4fd8c1e,2023-09-11 14:32:00,The S&P 500 is highly concentrated on the largest tech stocks. But there are other broad indexes with even heavier concentration to tech giants.,JNJ,0.098862,0.0,Neutral
"Here are the 16 stocks Jim Cramer is watching, including Twinkie deal, auto strike risk",https://www.cnbc.com/2023/09/11/here-are-the-16-stocks-jim-cramer-is-watching-including-twinkie-deal-auto-strike-risk.html,2023-09-11 13:45:51,"Here are some of the tickers on my radar for Monday, Sept. 11, taken directly from my reporter's notebook.",JNJ,0.145145,-0.033649,Neutral
Another Arthritis Blockbuster Drug Faces Generic Competition: Novartis' Sandoz Inks Pact With Samsung Bioepis - Novartis  ( NYSE:NVS ) ,https://www.benzinga.com/general/biotech/23/09/34440622/another-arthritis-blockbuster-drug-faces-generic-competition-novartis-sandoz-inks-pact-with-samsu,2023-09-11 13:32:00,"Sandoz, a generic and biosimilar medicines unit of Novartis AG NVS, has entered a development and commercialization agreement with Samsung Bioepis. The agreement provides Sandoz exclusive rights to commercialize the biosimilar SB17 ustekinumab in the US, Canada, EEA, Switzerland, and the U.K.",JNJ,0.371523,-0.101034,Neutral
Is Trending Stock Johnson & Johnson  ( JNJ )  a Buy Now?,https://www.zacks.com/stock/news/2147101/is-trending-stock-johnson-johnson-jnj-a-buy-now,2023-09-11 13:00:10,"Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",JNJ,0.481177,0.16653,Somewhat-Bullish
AstraZeneca's Tagrisso-chemo combo results raise bar for J&J cancer drug-analysts,https://www.reuters.com/business/healthcare-pharmaceuticals/astrazenecas-tagrisso-chemo-combo-results-raise-bar-jj-cancer-drug-analysts-2023-09-11/,2023-09-11 12:15:00,AstraZeneca's Tagrisso-chemo combo results raise bar for J&J cancer ...,JNJ,0.094762,0.079645,Neutral
Treatment with RYBREVANTÂ®  ( amivantamab-vmjw )  and Lazertinib Plus Chemotherapy Showed Durable Progression-Free Survival in Patients with Previously Treated EGFR-Mutated Advanced Non-Small Cell Lung Cancer,https://www.prnewswire.com/news-releases/treatment-with-rybrevant-amivantamab-vmjw-and-lazertinib-plus-chemotherapy-showed-durable-progression-free-survival-in-patients-with-previously-treated-egfr-mutated-advanced-non-small-cell-lung-cancer-301923248.html,2023-09-11 11:30:00,Treatment with RYBREVANTÂ® ( amivantamab-vmjw ) and Lazertinib Plus Chemotherapy Showed Durable Progression ... PR ...,JNJ,0.082231,-0.003137,Neutral
"Major shareholder announcement - BlackRock, Inc.",https://www.globenewswire.com/news-release/2023/09/11/2740670/0/en/Major-shareholder-announcement-BlackRock-Inc.html,2023-09-11 11:15:00,ANNOUNCEMENT NO. ...,JNJ,0.252987,0.076328,Neutral
Could This Issue Sink Johnson & Johnson's Stock Price?,https://www.fool.com/investing/2023/09/11/could-this-issue-sink-johnson-johnson-stock/,2023-09-11 10:49:00,Don't be too quick to press the sell button.,JNJ,0.628304,-0.047867,Neutral
Should You Invest in the Vanguard Health Care ETF  ( VHT ) ?,https://www.zacks.com/stock/news/2147010/should-you-invest-in-the-vanguard-health-care-etf-vht,2023-09-11 10:20:06,Sector ETF report for ...,JNJ,0.136499,0.064794,Neutral
"Visgenx Presents Poster at the Cell and Gene Therapy: Advancing Next Generation Therapies, West Coast Symposium",https://www.prnewswire.com/news-releases/visgenx-presents-poster-at-the-cell-and-gene-therapy-advancing-next-generation-therapies-west-coast-symposium-301922818.html,2023-09-11 10:00:00,Poster presentation covered the Company's platform on synthetic AAV genomes for gene delivery Symposium Program was Presented by Johnson & Johnson and California Life Sciences,JNJ,0.085936,0.0,Neutral
Warren Buffett's Highest-Yielding Stock Isn't Citigroup at 5%. He's Netting Almost 57% Annually From Another Top Holding.,https://www.fool.com/investing/2023/09/11/warren-buffett-highest-yielding-stock-57-annually/,2023-09-11 09:21:00,"Relative to Berkshire's cost basis in the company, this longtime Buffett holding is generating more than 11 times the nominal yield of Citigroup.",JNJ,0.160099,0.094183,Neutral
Smart Healthcare Market to grow by USD 115.39 billion from 2022-2027; North America to account for 43% of market ... - PR Newswire,https://www.prnewswire.com/news-releases/smart-healthcare-market-to-grow-by-usd-115-39-billion-from-2022-2027-north-america-to-account-for-43-of-market-growth---technavio-301922137.html,2023-09-11 07:15:00,Smart Healthcare Market to grow by USD 115.39 billion from 2022-2027. North America to account for 43% of market ... PR ...,JNJ,0.05234,0.0,Neutral
"Autoclave Market to grow by USD 571.78 million from 2022 to 2027, North America to account for 34% of market growth ... - PR Newswire",https://www.prnewswire.com/news-releases/autoclave-market-to-grow-by-usd-571-78-million-from-2022-to-2027--north-america-to-account-for-34-of-market-growth--technavio-301921875.html,2023-09-11 01:15:00,"Autoclave Market to grow by USD 571.78 million from 2022 to 2027, North America to account for 34% of market growth ... PR ...",JNJ,0.047092,0.0,Neutral
Bargain Hunting With $100? This New S&P 500 Dividend Stock Is a No-Brainer to Buy on the Dip,https://www.fool.com/investing/2023/09/10/bargain-hunting-with-100-this-new-sp-500-dividend/,2023-09-10 10:00:00,"The market may be sleeping on this dividend stock, down 19% in its short history as a stand-alone business.",JNJ,0.051886,-0.002998,Neutral
New to Investing? Here's How You Can Get Started With $500.,https://www.fool.com/investing/2023/09/10/new-to-investing-heres-how-you-can-get-started-wit/,2023-09-10 09:00:00,You don't have to invest a lot to start building a winning portfolio.,JNJ,0.054483,0.15606,Somewhat-Bullish
StockNews.com Downgrades Johnson & Johnson  ( NYSE:JNJ )  to Buy,https://www.defenseworld.net/2023/09/10/stocknews-com-downgrades-johnson-johnson-nysejnj-to-buy.html,2023-09-10 06:14:42,"Johnson & Johnson ( NYSE:JNJ - Get Free Report ) was downgraded by investment analysts at StockNews.com from a ""strong-buy"" rating to a ""buy"" rating in a research note issued on Friday.",JNJ,0.686097,0.431784,Bullish
"Johnson & Johnson Stock Downgraded to ""Buy"" Rating by StockNews.com",https://www.claytoncountyregister.com/news2/johnson-johnson-nysejnj-downgraded-by-stocknews-com/346086/,2023-09-09 12:40:29,"Johnson & Johnson Stock Downgraded to ""Buy"" Rating by ... Clayton County Register ...",JNJ,0.653656,0.1809,Somewhat-Bullish
3 Pharmaceutical Stocks That Are Too Cheap to Ignore,https://www.fool.com/investing/2023/09/09/pharmaceutical-stocks-that-are-too-cheap-to-ignore/,2023-09-09 11:20:00,"Viatris, GSK, and Organon are all trading at less than 7 times earnings.",JNJ,0.049424,0.160093,Somewhat-Bullish
3 No-Brainer Dividend Stocks to Buy No Matter What the Market Is Doing,https://www.fool.com/investing/2023/09/09/3-no-brainer-dividend-stocks-to-buy-no-matter-what/,2023-09-09 09:00:00,You'll want to hold on to these players for the long term.,JNJ,0.107978,0.177943,Somewhat-Bullish
Oral Antiviral Market Report 2023: Demand for Novel Therapeutics Boosts Opportunities,https://www.prnewswire.com/news-releases/oral-antiviral-market-report-2023-demand-for-novel-therapeutics-boosts-opportunities-301921979.html,2023-09-09 01:15:00,"DUBLIN, Sept. 8, 2023 /PRNewswire/ -- The ""Oral Antiviral Market by Indication, Drug Class, Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031"" report has been added to ResearchAndMarkets.com's offering.",JNJ,0.085022,0.079948,Neutral
University Lab Partners announces CytoRecovery and Vena Vitals as the winners of Orange County's 2023 Pitch ... - PR Newswire,https://www.prnewswire.com/news-releases/university-lab-partners-announces-cytorecovery-and-vena-vitals-as-the-winners-of-orange-countys-2023-pitch-launch-grow-competition-301922246.html,2023-09-08 17:20:00,University Lab Partners announces CytoRecovery and Vena Vitals as the winners of Orange County's 2023 Pitch ... PR ...,JNJ,0.07887,0.081153,Neutral
Kroger Agrees To Pay $1.2 Billion In Opioid Settlements,https://www.forbes.com/sites/dereksaul/2023/09/08/kroger-agrees-to-pay-12-billion-in-opioid-settlements/,2023-09-08 13:13:22,"Kroger joins fellow corporations CVS, Walgreens, Walmart and Johnson & Johnson in ponying up billions to opioid settlement funds.",JNJ,0.116914,0.052986,Neutral
"Perimeter Medical Imaging AI Strengthens Leadership Team with Appointment of Experienced MedTech Executive, Adam Hodges, as Vice President, Sales and Marketing",https://www.prnewswire.com/news-releases/perimeter-medical-imaging-ai-strengthens-leadership-team-with-appointment-of-experienced-medtech-executive-adam-hodges-as-vice-president-sales-and-marketing-301921418.html,2023-09-08 12:30:00,Perimeter Medical Imaging AI Strengthens Leadership Team with Appointment of Experienced MedTech Executive ... PR ...,JNJ,0.066047,0.033107,Neutral
"Perimeter Medical Imaging AI Strengthens Leadership Team with Appointment of Experienced MedTech Executive, Adam Hodges, as Vice President, Sales and Marketing",https://www.newswire.ca/news-releases/perimeter-medical-imaging-ai-strengthens-leadership-team-with-appointment-of-experienced-medtech-executive-adam-hodges-as-vice-president-sales-and-marketing-813757976.html,2023-09-08 12:30:00,Perimeter Medical Imaging AI Strengthens Leadership Team with Appointment of Experienced MedTech Executive ... Canada ...,JNJ,0.061315,0.033022,Neutral
"AstraZeneca, Boehringer Ingelheim to participate in Medicare drug price negotiations",https://www.cnbc.com/2023/09/27/diabetes-medicare-drug-price-negotiations.html,2023-09-27 19:55:22,"AstraZeneca, Boehringer Ingelheim and other drugmakers have filed at least eight lawsuits seeking to declare the Medicare price talks unconstitutional.",JNJ,0.088799,-0.182524,Somewhat-Bearish
"Almost 1,500 high-grade corporate bonds are on sale. Here's how you could add cheap Apple bonds to your portfolio.",https://www.marketwatch.com/story/almost-1-500-high-grade-corporate-bonds-are-on-sale-heres-how-you-could-add-cheap-apple-bonds-to-your-portfolio-11cee2f6,2023-09-27 18:33:00,"Almost 1,500 high-grade corporate bonds issued by some household names are currently trading between 50 and 80 cents on the dollar.",JNJ,0.087824,0.0,Neutral
Why Immunovant Stock Is Bolting Higher Today,https://www.fool.com/investing/2023/09/27/why-immunovant-stock-is-bolting-higher-today/,2023-09-27 16:21:54,The company may have best-in-class autoimmune disease therapy under its roof.,JNJ,0.108958,0.102277,Neutral
Looking At Johnson & Johnson's Recent Unusual Options Activity - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/09/34953236/looking-at-johnson-johnsons-recent-unusual-options-activity,2023-09-27 15:32:08,"Someone with a lot of money to spend has taken a bullish stance on Johnson & Johnson JNJ. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",JNJ,0.784902,0.210033,Somewhat-Bullish
The Kellogg Split,https://www.fool.com/investing/2023/09/27/the-kellogg-split/,2023-09-27 13:12:00,Kellogg is spinning off its core cereal business to focus on the fast-growing snacks market.,JNJ,0.017723,0.021669,Neutral
Evergreening: Big Pharma's big con,https://theweek.com/health/evergreening-big-pharmas-big-con,2023-09-27 10:13:24,A free daily digest of the biggest news stories of the day - and the best features from our website Thank you for signing up to TheWeek. You will receive a verification email shortly. There was a problem. Please refresh the page and try again.,JNJ,0.037446,-0.002905,Neutral
3 Things About Johnson & Johnson That Smart Investors Know,https://www.fool.com/investing/2023/09/27/3-things-about-j-and-j-that-smart-investors-know/,2023-09-27 09:30:00,J&J shares have missed out on the market rally so far this year.,JNJ,0.110717,0.146246,Neutral
Johnson & Johnson  ( JNJ )  Stock Moves -0.77%: What You Should Know,https://www.zacks.com/stock/news/2155700/johnson-johnson-jnj-stock-moves--077-what-you-should-know,2023-09-26 21:45:19,"Johnson & Johnson (JNJ) closed the most recent trading day at $159.02, moving -0.77% from the previous trading session.",JNJ,0.48268,0.04361,Neutral
NANOBIOTIX Provides Business Update and Financial Results for the First Half of 2023,https://www.globenewswire.com/news-release/2023/09/26/2749941/0/en/NANOBIOTIX-Provides-Business-Update-and-Financial-Results-for-the-First-Half-of-2023.html,2023-09-26 20:15:00,"Conference call and webcast scheduled for Wednesday, September 27, 2023, at 2:00 pm CEST / 8:00 am ...",JNJ,0.055078,0.083017,Neutral
"Cataract Surgery Devices And Equipment Market Analysis 2023-2027: Projected Market Size, Key Drivers, And Major Segments As Per The Business Research Company's Cataract Surgery Devices And Equipment Global Market Report 2023",https://www.benzinga.com/pressreleases/23/09/g34915104/cataract-surgery-devices-and-equipment-market-analysis-2023-2027-projected-market-size-key-drivers,2023-09-26 15:30:00,"LONDON, Sept. 26, 2023 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Cataract Surgery Devices And Equipment Global Market Report 2023, the global cataract surgery devices and equipment market is on a remarkable growth trajectory, with a projected market size of $7.11 billion in ...",JNJ,0.059194,0.106999,Neutral
"Endoscopy Procedures Market Size worth $53.19 Billion, Globally, by 2030 - Exclusive Report by The Insight Partners",https://www.benzinga.com/pressreleases/23/09/g34912197/endoscopy-procedures-market-size-worth-53-19-billion-globally-by-2030-exclusive-report-by-the-insi,2023-09-26 14:35:28,"Pune, India, Sept. 26, 2023 ( GLOBE NEWSWIRE ) -- Endoscopy is a minimally invasive procedure used to examine a person's digestive tract through the mouth, anus, or in small incisions. The procedure uses an endoscope, a flexible tube with a light and camera attached.",JNJ,0.032825,0.143827,Neutral
2 Monster Stocks to Buy Without Any Hesitation,https://www.fool.com/investing/2023/09/26/2-monster-stocks-to-buy-without-any-hesitation/,2023-09-26 11:41:00,Recent bumps in the road won't deter these companies.,JNJ,0.478692,0.313658,Somewhat-Bullish
"Avalo Therapeutics Successfully Eliminates $35 Million Debt Paving the Way for Future Growth and Innovation - Avalo Therapeutics  ( NASDAQ:AVTX ) , Horizon Tech Finance  ( NASDAQ:HRZN ) ",https://www.benzinga.com/pressreleases/23/09/g34899423/avalo-therapeutics-successfully-eliminates-35-million-debt-paving-the-way-for-future-growth-and-in,2023-09-26 11:00:00,"WAYNE, Pa. and ROCKVILLE, Md., Sept. 26, 2023 ( GLOBE NEWSWIRE ) -- In a major achievement, Avalo Therapeutics AVTX proudly announces the payoff of the remainder of its $35 million debt owed to Horizon Technology Finance Corporation HRZN. This significant milestone not only signifies the ...",JNJ,0.037387,0.119603,Neutral
Avalo Therapeutics Successfully Eliminates $35 Million Debt Paving the Way for Future Growth and Innovation,https://www.globenewswire.com/news-release/2023/09/26/2749320/0/en/Avalo-Therapeutics-Successfully-Eliminates-35-Million-Debt-Paving-the-Way-for-Future-Growth-and-Innovation.html,2023-09-26 11:00:00,"WAYNE, Pa. and ROCKVILLE, Md., Sept. 26, 2023 ( GLOBE NEWSWIRE ) -- In a major achievement, Avalo Therapeutics ( Nasdaq: AVTX ) proudly announces the payoff of the remainder of its $35 million debt owed to Horizon Technology Finance Corporation ( Nasdaq: HRZN ) .",JNJ,0.028695,0.115436,Neutral
Johnson & Johnson Innovation Announces Collaboration with Singapore Economic Development Board to Help Transform Singapore's Life Science Innovation Ecosystem,https://www.prnewswire.com/apac/news-releases/johnson--johnson-innovation-announces-collaboration-with-singapore-economic-development-board-to-help-transform-singapores-life-science-innovation-ecosystem-301938094.html,2023-09-25 22:30:00,Johnson & Johnson Innovation Announces Collaboration with Singapore Economic Development Board to Help ... PR ...,JNJ,0.683587,0.458931,Bullish
"Electrophysiology Catheters Market size to grow by USD 2.24 billion from 2022-2027| Abbott Laboratories, Acutus ... - PR Newswire",https://www.prnewswire.com/news-releases/electrophysiology-catheters-market-size-to-grow-by-usd-2-24-billion-from-2022-2027-abbott-laboratories-acutus-medical-inc-and-johnson-and-johnson-are-some-of-the-major-companies-in-the-market---technavio-301936344.html,2023-09-25 21:15:00,"Electrophysiology Catheters Market size to grow by USD 2.24 billion from 2022-2027| Abbott Laboratories, Acutus ... PR ...",JNJ,0.063933,0.070037,Neutral
"CAR T-cell Therapy for Multiple Myeloma Market to Observe Stunning Growth by 2032, Evaluates DelveInsight | Key Companies - Cartesian, Arcellx, Novartis, Bristol-Myers Squibb, CARsgen, Poseida, Juno, CRISPR, bluebird bio",https://www.prnewswire.com/news-releases/car-t-cell-therapy-for-multiple-myeloma-market-to-observe-stunning-growth-by-2032-evaluates-delveinsight--key-companies---cartesian-arcellx-novartis-bristol-myers-squibb-carsgen-poseida-juno-crispr-bluebird-bio-301937157.html,2023-09-25 21:01:00,"CAR T-cell Therapy for Multiple Myeloma Market to Observe Stunning Growth by 2032, Evaluates DelveInsight | Key ... PR ...",JNJ,0.018757,0.026387,Neutral
18 top public-relations experts CEOs scramble to hire in a crisis,https://www.businessinsider.com/meet-the-top-pr-people-in-crisis-communications-2023-9,2023-09-25 18:13:00,Meet the Top PR People in Crisis Communications - Business Insider ...,JNJ,0.022431,-0.156203,Somewhat-Bearish
 ( JNJ )  - Analyzing Johnson & Johnson's Short Interest - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/short-sellers/23/09/34870469/jnj-analyzing-johnson-johnsons-short-interest,2023-09-25 15:30:24,"Johnson & Johnson's JNJ short percent of float has fallen 58.36% since its last report. The company recently reported that it has 32.86 million shares sold short, which is 1.37% of all regular shares that are available for trading.",JNJ,0.221819,0.081322,Neutral
Should You Invest in the Invesco Pharmaceuticals ETF  ( PJP ) ?,https://www.zacks.com/stock/news/2154633/should-you-invest-in-the-invesco-pharmaceuticals-etf-pjp,2023-09-25 10:20:06,Sector ETF report for ...,JNJ,0.132004,0.063692,Neutral
"Consumer Healthcare Market to grow by USD 189.13 billion from 2022 to 2027, North America to account for 33% of ... - PR Newswire",https://www.prnewswire.com/news-releases/consumer-healthcare-market-to-grow-by-usd-189-13-billion-from-2022-to-2027--north-america-to-account-for-33-of-market-growth--technavio-301935802.html,2023-09-24 20:35:00,"Consumer Healthcare Market to grow by USD 189.13 billion from 2022 to 2027, North America to account for 33% of ... PR ...",JNJ,0.052918,0.0,Neutral
"Once reputation is at risk, so is money. That's when companies turn to crisis PR | Business",https://www.cnn.com/2023/09/24/business/crisis-public-relations-companies/index.html,2023-09-24 17:37:00,"Once reputation is at risk, so is money. That's when companies turn to crisis PR ...",JNJ,0.022452,-0.045261,Neutral
3 Best Stocks to Buy in September and Hold Forever,https://www.fool.com/investing/2023/09/24/3-best-stocks-to-buy-in-september-and-hold-forever/,2023-09-24 11:41:00,Healthcare blue chip stocks with proven track records can be excellent long-term investments.,JNJ,0.164656,0.017636,Neutral
"Laparoscopic Devices Market to grow by USD 4.39 billion from 2022-2027, North America to account for 36% of market ... - PR Newswire",https://www.prnewswire.com/news-releases/laparoscopic-devices-market-to-grow-by-usd-4-39-billion-from-2022-2027--north-america-to-account-for-36-of-market-growth---technavio-301935797.html,2023-09-24 10:35:00,"Laparoscopic Devices Market to grow by USD 4.39 billion from 2022-2027, North America to account for 36% of market ... PR ...",JNJ,0.108466,0.132623,Neutral
"Flow Diversion Aneurysm Treatment Market to grow by USD 2.11 billion from 2022 to 2027, North America to account ... - PR Newswire",https://www.prnewswire.com/news-releases/flow-diversion-aneurysm-treatment-market-to-grow-by-usd-2-11-billion-from-2022-to-2027--north-america-to-account-for-38-of-market-growth---technavio-301935772.html,2023-09-24 01:45:00,"Flow Diversion Aneurysm Treatment Market to grow by USD 2.11 billion from 2022 to 2027, North America to account ... PR ...",JNJ,0.051003,0.112393,Neutral
Global LASIK Eye Surgery Devices Market Analysis Report 2023-2028: Medical Tourism and LASIK Surgery as the Preferred Treatment for Refractive Errors Bolsters Growth,https://www.prnewswire.com/news-releases/global-lasik-eye-surgery-devices-market-analysis-report-2023-2028-medical-tourism-and-lasik-surgery-as-the-preferred-treatment-for-refractive-errors-bolsters-growth-301936095.html,2023-09-22 23:00:00,Global LASIK Eye Surgery Devices Market Analysis Report 2023-2028: Medical Tourism and LASIK Surgery as the ... PR ...,JNJ,0.143415,0.093836,Neutral
Innovative Gelatin Capsules Transforming Pharmaceutical Industry: A Look into the Future,https://www.prnewswire.com/news-releases/innovative-gelatin-capsules-transforming-pharmaceutical-industry-a-look-into-the-future-301936082.html,2023-09-22 21:45:00,"DUBLIN, Sept. 22, 2023 /PRNewswire/ -- The ""Pharmaceutical Gelatin Market Share, Size, Trends, Industry Analysis Report, By Source, By Function, By End Use, By Regions, Segment Forecast, 2023-2032"" report has been added to ResearchAndMarkets.com's offering.",JNJ,0.060236,-0.055999,Neutral
"Global Dermatology Drugs Market Set to Skyrocket, Anticipated Valuation of $50.47 Billion by 2032",https://www.prnewswire.com/news-releases/global-dermatology-drugs-market-set-to-skyrocket-anticipated-valuation-of-50-47-billion-by-2032--301936081.html,2023-09-22 21:30:00,"DUBLIN, Sept. 22, 2023 /PRNewswire/ -- The ""Dermatology Drugs Market Share, Size, Trends, Industry Analysis Report, By Therapeutic Area, By Drug Class, By Route of Administration, By Distribution Channel, By Region, Segment Forecast, 2023-2032"" report has been added to ResearchAndMarkets.com's ...",JNJ,0.060541,-0.056,Neutral
The Executive Leadership Council to Award More Than $3M in Scholarships During its Annual Recognition and Fundraising Gala,https://www.prnewswire.com/news-releases/the-executive-leadership-council-to-award-more-than-3m-in-scholarships-during-its-annual-recognition-and-fundraising-gala-301936374.html,2023-09-22 16:05:00,The Executive Leadership Council to Award More Than $3M in Scholarships During its Annual Recognition and ... PR ...,JNJ,0.053992,0.043822,Neutral
Asha Therapeutics Selected as a BLUE KNIGHTâ„¢ Company by Johnson & Johnson Innovation and the Biomedical Advanced Research and Development Authority  ( BARDA ) ,https://www.prnewswire.com/news-releases/asha-therapeutics-selected-as-a-blue-knight-company-by-johnson--johnson-innovation-and-the-biomedical-advanced-research-and-development-authority-barda-301936211.html,2023-09-22 14:03:00,Asha Therapeutics Selected as a BLUE KNIGHTâ„¢ Company by Johnson & Johnson Innovation and the Biomedical ... PR ...,JNJ,0.179343,0.230915,Somewhat-Bullish
"FORTUNE CEO INITIATIVE RETURNS TO WASHINGTON, D.C. OCTOBER 3, 2023",https://www.prnewswire.com/news-releases/fortune-ceo-initiative-returns-to-washington-dc-october-3-2023-301936220.html,2023-09-22 14:00:00,"Navigating the New Frontier of Leadership: Fortune's annual meeting of the CEO Initiative will assemble top leaders in business, public affairs and government to examine crucial issues of AI, ESG, culture wars, geopolitical tensions, and other industry headwinds Confirmed speakers include U.S.",JNJ,0.073098,0.128025,Neutral
Here is What to Know Beyond Why Johnson & Johnson  ( JNJ )  is a Trending Stock,https://www.zacks.com/stock/news/2154107/here-is-what-to-know-beyond-why-johnson-johnson-jnj-is-a-trending-stock,2023-09-22 13:00:12,"Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",JNJ,0.477606,0.138942,Neutral
The 'Great IPO Reopening' may be on hold: rising rates and weaker stocks are a killer,https://www.cnbc.com/2023/09/22/ipo-reopening-is-on-hold-rising-rates-and-lower-stocks-are-a-killer.html,2023-09-22 12:39:21,"Cash-strapped unicorns have three choices: raise additional capital in the private markets, merge or be bought out. move into the public markets.",JNJ,0.064104,-0.10008,Neutral
StockNews.com Downgrades Johnson & Johnson  ( NYSE:JNJ )  to Buy,https://www.defenseworld.net/2023/09/22/stocknews-com-downgrades-johnson-johnson-nysejnj-to-buy-2.html,2023-09-22 06:26:42,"Johnson & Johnson ( NYSE:JNJ - Get Free Report ) was downgraded by equities research analysts at StockNews.com from a ""strong-buy"" rating to a ""buy"" rating in a research note issued to investors on Wednesday. Other analysts also recently issued reports about the company.",JNJ,0.74896,0.407233,Bullish
Osteal Therapeutics Closes $23M Series C Financing,https://www.benzinga.com/pressreleases/23/09/g34790133/osteal-therapeutics-closes-23m-series-c-financing,2023-09-21 12:23:26,"Financing led by Asteroid Partners with new investor Gideon Strategic Partners and returning investors Johnson and Johnson Development Corp., HM Capital, Prism Ventures and Medvest Capital.",JNJ,0.080055,0.149718,Neutral
"This Cancer Therapy is Lifesaving, but There Isn't Enough of It",https://www.wsj.com/health/pharma/blockbuster-cancer-treatment-stymied-by-supply-chainfor-now-92723823,2023-09-21 12:00:00,"A cell therapy for multiple myeloma promises to be a major blockbuster for J&J and partner Legend, if they can increase manufacturing.",JNJ,0.716023,-0.37182,Bearish
"Global Soft Tissue Repair Market size to grow by USD 3.42 billion from 2022-2027 | 3M Co., Acera Surgical Inc., and ... - PR Newswire",https://www.prnewswire.com/news-releases/global-soft-tissue-repair-market-size-to-grow-by-usd-3-42-billion-from-2022-2027--3m-co-acera-surgical-inc-and-allosource-are-some-leading-market-companies---technavio-301934252.html,2023-09-21 08:35:00,"Global Soft Tissue Repair Market size to grow by USD 3.42 billion from 2022-2027 | 3M Co., Acera Surgical Inc., and ... PR ...",JNJ,0.053035,0.117649,Neutral
"Faron Appoints Dr. Birge Berns, MD as Interim Chief Medical Officer",https://www.globenewswire.com/news-release/2023/09/21/2746967/0/en/Faron-Appoints-Dr-Birge-Berns-MD-as-Interim-Chief-Medical-Officer.html,2023-09-21 06:00:00,"â€¢ Dr. Marie-Louise FjÃ¤llskog, outgoing CMO, is proposed to continue key role in bexmarilimab's development as a Board member ...",JNJ,0.072,0.021214,Neutral
"Faron Appoints Dr. Birge Berns, MD as Interim Chief Medical Officer",https://www.benzinga.com/pressreleases/23/09/g34778753/faron-appoints-dr-birge-berns-md-as-interim-chief-medical-officer,2023-09-21 06:00:00,"â€¢ Dr. Marie-Louise FjÃ¤llskog, outgoing CMO, is proposed to continue key role in bexmarilimab's development as a Board member TURKU, Finland and BOSTON, Sept. 21, 2023 ( GLOBE NEWSWIRE ) -- Faron Pharmaceuticals Ltd.",JNJ,0.071892,0.021211,Neutral
Johnson & Johnson Unusual Options Activity - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/09/34772994/johnson-johnson-unusual-options-activity,2023-09-20 20:15:41,"Someone with a lot of money to spend has taken a bearish stance on Johnson & Johnson JNJ. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",JNJ,0.822,0.263241,Somewhat-Bullish
"SHAREHOLDER ALERT: Morris Kandinov Investigating EBS, JRVR, EGIO, and HAFC; Shareholders are Encouraged to Contact the Firm",https://www.benzinga.com/pressreleases/23/09/g34771758/shareholder-alert-morris-kandinov-investigating-ebs-jrvr-egio-and-hafc-shareholders-are-encouraged,2023-09-20 19:09:55,"SAN DIEGO, Sept. 20, 2023 ( GLOBE NEWSWIRE ) -- National law firm Morris Kandinov is investigating the actions of the officers and board of directors of Emergent BioSolutions Inc., James River Group Holdings, Ltd., Edgio, Inc., and Hanmi Financial Corporation.",JNJ,0.094576,-0.072926,Neutral
Nulogy and OMP Expand Partnership to Deliver Digital Transformation Experience to Life Sciences and Chemical ... - PR Newswire,https://www.prnewswire.com/news-releases/nulogy-and-omp-expand-partnership-to-deliver-digital-transformation-experience-to-life-sciences-and-chemical-supply-chains-301932200.html,2023-09-20 14:30:00,Nulogy and OMP Expand Partnership to Deliver Digital Transformation Experience to Life Sciences and Chemical ... PR ...,JNJ,0.053629,0.334982,Somewhat-Bullish
Nulogy and OMP Expand Partnership to Deliver Digital Transformation Experience to Life Sciences and Chemical Supply Chains,https://www.benzinga.com/pressreleases/23/09/n34765517/nulogy-and-omp-expand-partnership-to-deliver-digital-transformation-experience-to-life-sciences-an,2023-09-20 14:30:00,"The companies are expanding their collaboration, offering their combined solutions and services to additional industries to fulfill their growing need for digital transformation of internal planning and external supplier network collaboration.",JNJ,0.05257,0.334926,Somewhat-Bullish
Nulogy and OMP Expand Partnership to Deliver Digital Transformation Experience to Life Sciences and Chemical ... - Canada NewsWire,https://www.newswire.ca/news-releases/nulogy-and-omp-expand-partnership-to-deliver-digital-transformation-experience-to-life-sciences-and-chemical-supply-chains-834338237.html,2023-09-20 14:30:00,Nulogy and OMP Expand Partnership to Deliver Digital Transformation Experience to Life Sciences and Chemical ... Canada ...,JNJ,0.049526,0.334553,Somewhat-Bullish
"Here are the 14 stocks Jim Cramer is watching, including Apple, Goldman Sachs, Amazon",https://www.cnbc.com/2023/09/20/here-are-the-14-stocks-jim-cramer-is-watching-including-apple-goldman-sachs-amazon.html,2023-09-20 13:41:14,"Here are some of the tickers on my radar for Wednesday, Sept. 20, taken directly from my reporter's notebook.",JNJ,0.19117,0.292977,Somewhat-Bullish
Thrombectomy Devices Market worth $2.1 Billion by 2027 - Exclusive Report by The Insight Partners,https://www.benzinga.com/pressreleases/23/09/g34761070/thrombectomy-devices-market-worth-2-1-billion-by-2027-exclusive-report-by-the-insight-partners,2023-09-20 13:09:29,"Pune, India., Sept. 20, 2023 ( GLOBE NEWSWIRE ) -- The thrombectomy devices market growth is propelled by elevating incidences of CVDs and neurological diseases, technological advancements, government initiatives towards prevention of diseases and favorable medical reimbursement scenario.",JNJ,0.088472,0.110876,Neutral
BDA Bolsters Leadership Bench with Appointment of Divisional Vice President of Global Marketing and Creative Services - PR Newswire,https://www.prnewswire.com/news-releases/bda-bolsters-leadership-bench-with-appointment-of-divisional-vice-president-of-global-marketing-and-creative-services-301933088.html,2023-09-20 13:00:00,BDA Bolsters Leadership Bench with Appointment of Divisional Vice President of Global Marketing and Creative Services PR ...,JNJ,0.148273,0.217254,Somewhat-Bullish
2 Incredibly Cheap Dividend Stocks to Buy Now,https://www.fool.com/investing/2023/09/20/2-incredibly-cheap-dividend-stocks-to-buy-now/,2023-09-20 12:30:00,High-quality dividend stocks are rarely cheap. These two names are an exception.,JNJ,0.141726,0.3333,Somewhat-Bullish
Should You Invest in the iShares U.S. Healthcare ETF  ( IYH ) ?,https://www.zacks.com/stock/news/2152866/should-you-invest-in-the-ishares-us-healthcare-etf-iyh,2023-09-20 10:20:07,Sector ETF report for ...,JNJ,0.132368,0.069712,Neutral
Buying These 2 Stocks Is a Good Way to Hedge Against a Market Crash,https://www.fool.com/investing/2023/09/20/these-2-stocks-good-hedge-against-crash/,2023-09-20 10:00:00,"Market crashes are inevitable, but certain stocks could limit potential damage.",JNJ,0.120431,0.135952,Neutral
3 No-Brainer Stocks to Buy With $500 Right Now,https://www.fool.com/investing/2023/09/20/3-no-brainer-stocks-to-buy-with-500-right-now/,2023-09-20 09:21:00,A modest amount of money can go a long way when it's invested in industry-leading businesses.,JNJ,0.154852,0.159817,Somewhat-Bullish
Johnson & Johnson  ( JNJ )  Stock Moves -0.17%: What You Should Know,https://www.zacks.com/stock/news/2152751/johnson-johnson-jnj-stock-moves--017-what-you-should-know,2023-09-19 21:45:20,"Johnson & Johnson (JNJ) closed the most recent trading day at $162.20, moving -0.17% from the previous trading session.",JNJ,0.658245,0.121668,Neutral
Danaher Lowers Price Of Tuberculosis Test After Pressure Campaign,https://www.forbes.com/sites/willskipworth/2023/09/19/danaher-lowers-price-of-tuberculosis-test-after-pressure-campaign/,2023-09-19 19:53:41,Popular novelist and YouTuber John Green as well as international health nonprofits had been running a weeklong pressure campaign against the company.,JNJ,0.11894,0.052364,Neutral
An Update On The Foreign Tax Credit Rules And IRS Relief,https://www.forbes.com/sites/taxnotes/2023/09/19/an-update-on-the-foreign-tax-credit-rules-and-irs-relief/,2023-09-19 19:46:40,"Tax Notes reporter Andrew Velarde discusses the latest developments on the final regulations for claiming foreign tax credits, including the IRS's decision to delay implementation and the tax community's response.",JNJ,0.025008,0.088376,Neutral
OXOS Medical taps medtech transformational leader Jeff Brown as COO,https://www.benzinga.com/pressreleases/23/09/g34729402/oxos-medical-taps-medtech-transformational-leader-jeff-brown-as-coo,2023-09-19 13:30:43,"ATLANTA, Sept. 19, 2023 ( GLOBE NEWSWIRE ) -- OXOS MedicalÂ®, a leader in the portable x-ray solutions market, today announced that it has appointed Jeff Brown as the company's new Chief Operations Officer.",JNJ,0.090474,0.064221,Neutral
Anixa Biosciences Establishes Cancer Business Advisory Board,https://www.prnewswire.com/news-releases/anixa-biosciences-establishes-cancer-business-advisory-board-301931654.html,2023-09-19 12:30:00,"SAN JOSE, Calif., Sept. 19, 2023 /PRNewswire/ -- Anixa Biosciences, Inc. ( ""Anixa"" or the ""Company"" ) ( NASDAQ: ANIX ) , a biotechnology company focused on the treatment and prevention of cancer, today announced that it has established a Cancer Business Advisory Board ( CBAB ) , whose purpose is ...",JNJ,0.020456,0.026359,Neutral
5 Investors Make $1 Billion A Year From Dividends Alone,https://www.investors.com/etfs-and-funds/sectors/sp500-investors-found-a-way-to-make-billion-a-year-from-dividends/,2023-09-19 12:00:00,Looking to score some supersize dividends as the S&P 500 goes sideways? There's a billion lessons to be learned from investors turning dividends into serious cashflow.,JNJ,0.079524,0.037518,Neutral
Impulse Dynamics Announces Leadership Changes,https://www.benzinga.com/pressreleases/23/09/g34722638/impulse-dynamics-announces-leadership-changes,2023-09-19 11:17:08,"MARLTON, N.J., Sept. 19, 2023 ( GLOBE NEWSWIRE ) -- Impulse Dynamics plc, a global medical device company dedicated to improving the lives of people with heart failure, announced new leadership appointments, including Jason Spees to Chief Executive Officer, Shlomi Nachman to Chairman of the ...",JNJ,0.04677,0.123094,Neutral
3 Stocks That Could Be Kicked Out of the Dow -- and the Companies That May Replace Them,https://www.fool.com/investing/2023/09/19/3-stocks-that-could-be-kicked-out-of-the-dow/,2023-09-19 09:06:00,Three time-tested yet poor-performing Dow components are at risk of being removed from the index.,JNJ,0.032425,0.185748,Somewhat-Bullish
ONWARDÂ® Reports 2023 Half Year Results and Business Update,https://www.globenewswire.com/news-release/2023/09/19/2745268/0/en/ONWARD-Reports-2023-Half-Year-Results-and-Business-Update.html,2023-09-19 04:30:00,"Eindhoven, Sept. 19, 2023 ( GLOBE NEWSWIRE ) -- THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7 ( 1 ) OF THE EUROPEAN MARKET ABUSE REGULATION ...",JNJ,0.020096,0.085159,Neutral
AnaptysBio Announces Appointment of John Orwin as Chairman of the Board of Directors,https://www.globenewswire.com/news-release/2023/09/18/2745192/0/en/AnaptysBio-Announces-Appointment-of-John-Orwin-as-Chairman-of-the-Board-of-Directors.html,2023-09-18 20:15:00,"SAN DIEGO, Sept. 18, 2023 ( GLOBE NEWSWIRE ) -- AnaptysBio, Inc. ( Nasdaq: ANAB ) , a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced it has appointed John Orwin chairman of the AnaptysBio Board of Directors.",JNJ,0.04028,0.060892,Neutral
Dwayne 'The Rock' Johnson makes WWE return,https://www.cnn.com/2023/09/18/entertainment/dwayne-johnson-wwe/index.html,2023-09-18 17:27:00,"Dwayne ""The Rock"" Johnson made a surprise return to the WWE. The WWE's official account on X ( formerly known as Twitter ) , showed a clip of Johnson facing off with John Cena during the WWE SmackDown! Friday night at Ball Arena in Denver.",JNJ,0.279015,0.469476,Bullish
Dwayne 'The Rock' Johnson makes WWE return,https://edition.cnn.com/2023/09/18/entertainment/dwayne-johnson-wwe/index.html,2023-09-18 17:27:00,"Dwayne ""The Rock"" Johnson made a surprise return to the WWE. The WWE's official account on X ( formerly known as Twitter ) , showed a clip of Johnson facing off with John Cena during the WWE SmackDown! Friday night at Ball Arena in Denver.",JNJ,0.279015,0.469476,Bullish
JNJ: 3 Healthcare Stocks to Buy Today,https://stocknews.com/news/jnj-abbv-amgn-3-healthcare-stocks-to-buy-today/,2023-09-18 16:18:05,"Johnson & Johnson ( JNJ ) , Amgen ( AMGN ) and AbbVie ( ABBV ) are healthcare sector leaders with their company specific transformative catalysts in the fray. All three stocks are rated a strong buy by the propriety POWR Rating, ranking above the 95th percentile.",JNJ,0.396147,0.21806,Somewhat-Bullish
"Personal Hygiene Market Size is projected to reach USD 720 Billion by 2030, growing at a CAGR of 3.6%: Straits Research",https://www.benzinga.com/pressreleases/23/09/g34696357/personal-hygiene-market-size-is-projected-to-reach-usd-720-billion-by-2030-growing-at-a-cagr-of-3-,2023-09-18 15:40:00,"New York, United States, Sept. 18, 2023 ( GLOBE NEWSWIRE ) -- Personal hygiene is maintaining one's health and hygiene to prevent infectious diseases, fungi, and other illnesses. Regular hand washing, bathing, brushing your teeth after each meal, trimming and cleaning your nails, and other ...",JNJ,0.027164,-0.090929,Neutral
"Cold Chain Packaging Market Size is projected to reach USD 55.97 Billion by 2030, growing at a CAGR of 10.70%: Straits Research",https://www.benzinga.com/pressreleases/23/09/g34694957/cold-chain-packaging-market-size-is-projected-to-reach-usd-55-97-billion-by-2030-growing-at-a-cagr,2023-09-18 15:10:00,"New York, United States, Sept. 18, 2023 ( GLOBE NEWSWIRE ) -- The shipment and packaging of products that need to be kept at a specific temperature to operate correctly are known as ""cold chain packing."" Cold chain packaging solutions are necessary for the growth of the worldwide market for ...",JNJ,0.032078,-0.066034,Neutral
"The Zacks Analyst Blog Highlights Meta Platforms, Walmart, Johnson & Johnson, Pfizer and Morgan Stanley",https://www.zacks.com/stock/news/2151790/the-zacks-analyst-blog-highlights-meta-platforms-walmart-johnson-johnson-pfizer-and-morgan-stanley,2023-09-18 12:03:00,"Meta Platforms, Walmart, Johnson & Johnson, Pfizer and Morgan Stanley are part of the Zacks top Analyst Blog.",JNJ,0.289748,0.153621,Somewhat-Bullish
Should You Invest in the Health Care Select Sector SPDR ETF  ( XLV ) ?,https://www.zacks.com/stock/news/2151652/should-you-invest-in-the-health-care-select-sector-spdr-etf-xlv,2023-09-18 10:20:06,Sector ETF report for ...,JNJ,0.12645,0.063548,Neutral
Is Franklin U.S. Low Volatility High Dividend Index ETF  ( LVHD )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2151659/is-franklin-us-low-volatility-high-dividend-index-etf-lvhd-a-strong-etf-right-now,2023-09-18 10:20:05,Smart Beta ETF report for ...,JNJ,0.113329,0.059598,Neutral
"Breast Cancer Monoclonal Antibodies Market to grow by USD 15 billion from 2022 to 2027, North America to account ... - PR Newswire",https://www.prnewswire.com/news-releases/breast-cancer-monoclonal-antibodies-market-to-grow-by-usd-15-billion-from-2022-to-2027-north-america-to-account-for-42-of-market-growth---technavio-301929309.html,2023-09-18 09:15:00,"Breast Cancer Monoclonal Antibodies Market to grow by USD 15 billion from 2022 to 2027, North America to account ... PR ...",JNJ,0.043108,0.0,Neutral
Large Molecule Injectable Drugs Market to grow by USD 191.45 billion from 2022-2027 | North America to account for ... - PR Newswire,https://www.prnewswire.com/news-releases/large-molecule-injectable-drugs-market-to-grow-by-usd-191-45-billion-from-2022-2027--north-america-to-account-for-45-of-market-growth---technavio-301929312.html,2023-09-18 08:35:00,Large Molecule Injectable Drugs Market to grow by USD 191.45 billion from 2022-2027 | North America to account for ... PR ...,JNJ,0.052685,0.0,Neutral
Myopia and presbyopia treatment market to grow by USD 7.94 billion from 2022 to 2027 | Asia to account for 37% of ... - PR Newswire,https://www.prnewswire.com/news-releases/myopia-and-presbyopia-treatment-market-to-grow-by-usd-7-94-billion-from-2022-to-2027--asia-to-account-for-37-of-market-growth--technavio-301929564.html,2023-09-18 04:15:00,Myopia and presbyopia treatment market to grow by USD 7.94 billion from 2022 to 2027 | Asia to account for 37% of ... PR ...,JNJ,0.052801,0.184679,Somewhat-Bullish
Weight Management Devices Market to grow by USD 4.57 billion between 2022 - 2027 | Growth Driven by Growing ... - PR Newswire,https://www.prnewswire.com/news-releases/weight-management-devices-market-to-grow-by-usd-4-57-billion-between-2022---2027--growth-driven-by-growing-obese-population---technavio-301929563.html,2023-09-18 03:15:00,Weight Management Devices Market to grow by USD 4.57 billion between 2022 - 2027 | Growth Driven by Growing ... PR ...,JNJ,0.047559,0.159676,Somewhat-Bullish
Could The Next Tech Unicorn Be Hiding In A Forest Of Patents?,https://www.forbes.com/sites/carolynschwaar/2023/10/07/could-the-next-tech-unicorn-be-hiding-in-a-forest-of-patents/,2023-10-07 13:43:46,"As 3D printing continues to evolve as a manufacturing method, patent data provides valuable insight into the technological landscape and areas of innovation.",JNJ,0.037329,0.049634,Neutral
"Malinda Williams, Founder of The Arise And Shine Women's Empowerment Brunch, celebrated 5 years of uplifting, uniting and inspiring black women",https://www.benzinga.com/pressreleases/23/10/n35134983/malinda-williams-founder-of-the-arise-and-shine-womens-empowerment-brunch-celebrated-5-years-of-up,2023-10-07 00:45:00,"Williams also announced the launch of the Arise And Shine Foundation, a 501 ( c ) ( 3 ) that aims to advance the professional development of underserved and underrepresented women and girls. The E.S.T.E.A.M Project will be the pilot program under the new nonprofit.",JNJ,0.044634,0.267963,Somewhat-Bullish
Kansas City Chiefs' Travis Kelce laughs off Aaron Rodgers' 'Mr. Pfizer' quip,https://www.cnn.com/2023/10/06/sport/travis-kelce-aaron-rodgers-nickname-swift-spt-intl/index.html,2023-10-06 21:58:00,"Travis Kelce has laughed off Aaron Rodgers' new nickname for the Kansas City Chiefs tight end after the injured New York Jets quarterback called him ""Mr. Pfizer"" during his weekly appearance on ESPN's ""The Pat McAfee Show.""",JNJ,0.147818,-0.080342,Neutral
The Executive Leadership Council's Symposium and Recognition Gala Week Wraps Up with $1M Community Impact ... - PR Newswire,https://www.prnewswire.com/news-releases/the-executive-leadership-councils-symposium-and-recognition-gala-week-wraps-up-with-1m-community-impact-investment-301949944.html,2023-10-06 20:40:00,The Executive Leadership Council's Symposium and Recognition Gala Week Wraps Up with $1M Community Impact ... PR ...,JNJ,0.07157,0.055272,Neutral
Will Johnson & Johnson  ( JNJ )  Beat Estimates Again in Its Next Earnings Report?,https://www.zacks.com/stock/news/2161719/will-johnson-johnson-jnj-beat-estimates-again-in-its-next-earnings-report,2023-10-06 16:10:11,Johnson & Johnson (JNJ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.,JNJ,0.396261,0.474656,Bullish
"Johnson & Johnson Has Potential To Drive Its Pharma And MedTech Franchises, Says Bullish Analyst - Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/analyst-ratings/analyst-color/23/10/35111380/johnson-johnson-has-potential-to-drive-its-pharma-and-medtech-franchises-says-bulli,2023-10-05 16:40:11,"Shares of Johnson & Johnson JNJ recovered slightly in early trading on Thursday, after tanking in the previous session. The company is ""uniquely positioned with Pharma and MedTech under one umbrella,"" according to RBC Capital Markets.",JNJ,0.973732,0.286539,Somewhat-Bullish
"Stocks making the biggest moves midday: Rivian, Orchard Therapeutics, Lamb Weston and more",https://www.cnbc.com/2023/10/05/stocks-making-the-biggest-moves-midday-rivian-orchard-therapeutics-lamb-weston-and-more.html,2023-10-05 16:34:26,These are the stocks posting the largest moves in midday trading.,JNJ,0.060848,0.120012,Neutral
3 Ways AI Can Help Healthcare Companies Grow,https://www.fool.com/investing/2023/10/05/3-ways-ai-can-help-healthcare-companies-grow/,2023-10-05 12:00:00,"The hottest AI stocks are in tech right now, but the best opportunities ahead may be in healthcare.",JNJ,0.154785,0.16921,Somewhat-Bullish
2 Magnificent Dividend Kings to Buy Now,https://www.fool.com/investing/2023/10/05/2-magnificent-dividend-kings-to-buy-now/,2023-10-05 10:00:00,These stocks offer you income no matter what the market is doing.,JNJ,0.124809,-0.032715,Neutral
"Phase III studies to investigate survodutide for people living with obesity and overweight, with and without diabetes, cardiovascular disease and chronic kidney disease",https://www.globenewswire.com/news-release/2023/10/05/2755164/0/en/Phase-III-studies-to-investigate-survodutide-for-people-living-with-obesity-and-overweight-with-and-without-diabetes-cardiovascular-disease-and-chronic-kidney-disease.html,2023-10-05 09:53:00,"Phase III studies to investigate survodutide for people living with obesity and overweight, with and without diabetes, cardiovascular disease and chronic kidney disease â€¢ SYNCHRONIZE-1 and SYNCHRONIZE-2 are global Phase III studies of survodutide ( BI 456906 ) in people living with obesity and ...",JNJ,0.027164,0.05734,Neutral
3 Historically Cheap Dow Stocks to Buy Hand Over Fist in October,https://www.fool.com/investing/2023/10/05/3-historically-cheap-dow-stocks-to-buy-in-october/,2023-10-05 09:21:00,"These profitable, time-tested Dow Jones stocks are cheaper than they've been in at least a decade, if not well beyond.",JNJ,0.188193,0.20772,Somewhat-Bullish
India Baby Care Products Market size to grow by USD 15.69 billion from 2022 to 2027 | Market is fragmented due to the ... - PR Newswire,https://www.prnewswire.com/news-releases/india-baby-care-products-market-size-to-grow-by-usd-15-69-billion-from-2022-to-2027--market-is-fragmented-due-to-the-presence-of-prominent-companies-like-abbott-laboratories-artsana-spa-bio-veda-action-research-co-and-many-mo-301944281.html,2023-10-04 23:00:00,India Baby Care Products Market size to grow by USD 15.69 billion from 2022 to 2027 | Market is fragmented due to the ... PR ...,JNJ,0.07446,0.089055,Neutral
Promaxo Receives Direct Investment from Surgical Robotics Industry Pioneer Fred Moll and Announces Appointment as Strategic Advisor,https://www.benzinga.com/pressreleases/23/10/g35092941/promaxo-receives-direct-investment-from-surgical-robotics-industry-pioneer-fred-moll-and-announces,2023-10-04 16:00:00,"OAKLAND, Calif., Oct. 04, 2023 ( GLOBE NEWSWIRE ) -- Promaxo, Inc. ( ""Promaxo"" or the ""Company"" ) , a medical imaging, robotics, and AI technology company, announced today that it has received a direct investment from Fred Moll, M.D., industry pioneer and leader in surgical robotics and ...",JNJ,0.172713,0.0,Neutral
"Medical Supplies Market Size is Projected to Hit USD 185.21 Billion, at a 4.5% CAGR by 2028 | Brandessence Market Research",https://www.prnewswire.com/news-releases/medical-supplies-market-size-is-projected-to-hit-usd-185-21-billion-at-a-4-5-cagr-by-2028--brandessence-market-research-301947208.html,2023-10-04 15:15:00,"Medical Supplies Market Size is Projected to Hit USD 185.21 Billion, at a 4.5% CAGR by 2028 | Brandessence Market ... PR ...",JNJ,0.067536,-0.16357,Somewhat-Bearish
Showpad Recognized as a Leader in Sales Readiness Solutions,https://www.benzinga.com/pressreleases/23/10/g35091831/showpad-recognized-as-a-leader-in-sales-readiness-solutions,2023-10-04 15:05:09,"Top-tier industry analyst firm recognizes Showpad as it:""paves the way with a comprehensive solution and a focused market approach"" CHICAGO, Oct. 04, 2023 ( GLOBE NEWSWIRE ) -- Showpad, a global leader in sales enablement, has secured a coveted spot as a recognized leader in The Forrester Waveâ„¢: ...",JNJ,0.058759,0.068072,Neutral
Jim Cramer's top 10 things to watch in the stock market Wednesday,https://www.cnbc.com/2023/10/04/jim-cramers-top-10-things-to-watch-in-the-stock-market-wednesday.html,2023-10-04 13:12:12,"Stock futures are up on light jobs data, but several headwinds keeping a lid on prices.",JNJ,0.122269,-0.06858,Neutral
Investors Heavily Search Johnson & Johnson  ( JNJ ) : Here is What You Need to Know,https://www.zacks.com/stock/news/2159912/investors-heavily-search-johnson-johnson-jnj-here-is-what-you-need-to-know,2023-10-04 13:00:10,"Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",JNJ,0.475838,0.129986,Neutral
Here's Why Kenvue Stock Is  ( Slightly )  Riskier Than It Seems,https://www.fool.com/investing/2023/10/04/heres-why-kenvue-stock-is-slightly-riskier-than-it/,2023-10-04 12:36:00,"It's not about to crash, but eventually, it might struggle to thrive.",JNJ,0.056808,0.006,Neutral
"Esteemed Leader, Robert Pemberton, Joins Forces with Co-Founders Anthony Uzzo and Jim Gregory to Accelerate ... - PR Newswire",https://www.prnewswire.com/news-releases/esteemed-leader-robert-pemberton-joins-forces-with-co-founders-anthony-uzzo-and-jim-gregory-to-accelerate-service-insights-path-to-enable-digital-transformation-across-diverse-industries-301946103.html,2023-10-04 12:00:00,"Esteemed Leader, Robert Pemberton, Joins Forces with Co-Founders Anthony Uzzo and Jim Gregory to Accelerate ... PR ...",JNJ,0.045396,0.256005,Somewhat-Bullish
"You Can't Control Recessions, but You Can Control What You Do About Them",https://www.fool.com/investing/2023/10/04/you-cant-control-recessions-but-you-can-control-wh/,2023-10-04 09:32:00,These strategies can help you weather the storms to come ... and they will come.,JNJ,0.057079,0.160979,Somewhat-Bullish
Global South should learn from Big Pharma's bullying of South Africa,https://www.aljazeera.com/opinions/2023/10/4/global-south-should-learn-from-big-pharmas-bullying-of-south-africa,2023-10-04 08:42:41,The extortionate vaccine contracts Pretoria signed during the pandemic demonstrate why achieving pharmaceutical sovereignty should be a priority for all developing nations.,JNJ,0.03798,0.000994,Neutral
Drugmakers Agree To Participate For Medicare Drug Price Negotiation With Biden Administration - Novo Nordisk  ( NYSE:NVO ) ,https://www.benzinga.com/general/biotech/23/10/35068559/drugmakers-agree-to-participate-for-medicare-drug-price-negotiation-with-biden-administration,2023-10-03 17:35:19,"All ten manufacturers of the first drugs selected for Medicare price negotiations will be participating, the White House said, even though many of them are suing the administration to halt the process.",JNJ,0.262522,0.0,Neutral
Drugmakers Agree To US Govt Price Talks Amid Pushback,https://www.barrons.com/news/drugmakers-agree-to-us-govt-price-talks-amid-pushback-c7eb4567,2023-10-03 15:48:00,Drugmakers Agree To US Govt Price Talks Amid ...,JNJ,0.070725,-0.029698,Neutral
Court tosses $223.8 million verdict against J&J in talc cancer case,https://www.reuters.com/markets/us/court-tosses-2238-million-verdict-against-jj-talc-cancer-case-2023-10-03/,2023-10-03 14:57:00,Oct 3 ( Reuters ) - A New Jersey appeals court on Tuesday threw out a $223.8 million verdict against Johnson & Johnson ( JNJ.N ) that a jury had awarded to four plaintiffs who claimed they developed cancer from being exposed to asbestos in the company's talc powder products.,JNJ,0.118647,-0.032967,Neutral
Sanofi  ( SNY )  Inks Deal With J&J to Develop E. coli Vaccine,https://www.zacks.com/stock/news/2159363/sanofi-sny-inks-deal-with-jj-to-develop-e-coli-vaccine,2023-10-03 14:45:00,"Per the terms of the deal, Sanofi (SNY) and J&J will co-fund current and future R&D costs to develop a potential first-in-class vaccine against extraintestinal pathogenic E. coli.",JNJ,0.153961,0.220831,Somewhat-Bullish
"Top Stories Tuesday, Oct 3: 'Airbnb Has Foundational Cracks', Disney+ Follows Netflix On Subscription Sharing Crackdown, Microsoft's Nadella Criticizes Google's Exclusive Content Deals - Apple  ( NASDAQ:AAPL ) , ALX Oncology Holdings  ( NASDAQ:ALXO ) ",https://www.benzinga.com/news/23/10/35064552/airbnb-has-foundational-cracks-disney-follows-netflix-on-subscription-sharing-crackdown-microsofts-n,2023-10-03 14:11:20,"In a significant development, Microsoft Corp's MSFT CEO, Satya Nadella, has voiced concerns over the competitive landscape of content acquisition essential for training artificial intelligence ( AI ) .",JNJ,0.076236,-0.067693,Neutral
3 Healthcare Stocks to Keep an Eye On,https://www.fool.com/investing/2023/10/03/3-healthcare-stocks-to-keep-an-eye-on/,2023-10-03 13:45:00,These three lesser-known healthcare companies have strong growth potential.,JNJ,0.040078,0.0,Neutral
"Pharma Giants Sanofi, Johnson & Johnson Join Forces To Develop E.coli Vaccine - Johnson & Johnson  ( NYSE:JNJ ) , Sanofi  ( NASDAQ:SNY ) ",https://www.benzinga.com/general/biotech/23/10/35054080/pharma-giants-sanofi-johnson-johnson-join-forces-to-develop-e-coli-vaccine,2023-10-03 12:25:42,"Sanofi SA SNY struck a deal with Janssen Pharmaceuticals, a unit of Johnson & Johnson JNJ, to develop and commercialize the vaccine candidate for extraintestinal pathogenic E. coli ( 9-valent ) .",JNJ,0.504646,0.129704,Neutral
"Medicare drug price negotiations move forward with all drugmakers participating, White House says",https://www.marketwatch.com/story/medicare-drug-price-negotiations-move-forward-with-all-drugmakers-participating-white-house-says-45b891dc,2023-10-03 12:00:00,Novo Nordisk is latest drugmaker to challenge negotiation program in court.,JNJ,0.11983,-0.018592,Neutral
Johnson & Johnson Vision's ACUVUE onboards Ranveer Singh; launches campaign #AcuvueSePoochho,https://www.financialexpress.com/business/brandwagon-johnson-amp-johnson-visions-acuvue-onboards-ranveer-singh-launches-campaign-acuvuesepoochho-3261578/,2023-10-03 10:57:00,Johnson & Johnson Vision's ACUVUE onboards Ranveer Singh. launches campaign #AcuvueSePoochho The Financial Express ...,JNJ,0.241684,0.367067,Bullish
Sanofi clinches vaccine deal with J&J to battle E. coli,https://www.financialexpress.com/healthcare/pharma-healthcare/sanofi-clinches-vaccine-deal-with-jj-to-battle-e-coli/3261648/,2023-10-03 10:27:40,"Sanofi struck a deal to help fund and sell an experimental vaccine developed by Johnson & Johnson against an invasive form of the digestive pathogen E. coli. Sanofi will pay J&J's Janssen unit $175 million upfront, as well as development and commercial milestones, the French drugmaker said in a ...",JNJ,0.269776,-0.159895,Somewhat-Bearish
Sanofi in agreement with Janssen to develop E. coli the vaccine candidate,https://www.reuters.com/business/healthcare-pharmaceuticals/sanofi-agreement-with-janssen-develop-e-coli-vaccine-candidate-2023-10-03/,2023-10-03 05:44:00,"[1/2] The logo of French drugmaker Sanofi is seen a the Sanofi Genzyme Polyclonals in Lyon, France, September 30, 2023. REUTERS/Gonzalo Fuentes/File Photo Acquire Licensing Rights",JNJ,0.401331,0.354898,Bullish
Press Release: Sanofi announces agreement for potential first-in-class vaccine against extraintestinal pathogenic E. coli,https://www.globenewswire.com/news-release/2023/10/03/2753274/0/en/Press-Release-Sanofi-announces-agreement-for-potential-first-in-class-vaccine-against-extraintestinal-pathogenic-E-coli.html,2023-10-03 05:30:00,"â€¢ Extraintestinal pathogenic E. coli ( ExPEC ) is a leading bacterial cause of sepsis, causing approximately 10 million cases of invasive ExPEC disease ( IED ) annually, worldwide1,2 â€¢ Phase 3 clinical trial of vaccine candidate ongoing. Novel ExPEC vaccine expected to complement existing older ...",JNJ,0.036091,0.195905,Somewhat-Bullish
Press Release Biocartis Group NV: Disclosure of transparency notification,https://www.globenewswire.com/news-release/2023/10/03/2753267/0/en/Press-Release-Biocartis-Group-NV-Disclosure-of-transparency-notification.html,2023-10-03 05:00:00,"PRESS RELEASE: REGULATED INFORMATION 3 October 2023, 7:00 CEST ...",JNJ,0.428632,0.23394,Somewhat-Bullish
Johnson & Johnson  ( JNJ )  Stock Sinks As Market Gains: What You Should Know,https://www.zacks.com/stock/news/2158852/johnson-johnson-jnj-stock-sinks-as-market-gains-what-you-should-know,2023-10-02 21:45:18,"Johnson & Johnson (JNJ) closed at $155.15 in the latest trading session, marking a -0.39% move from the prior day.",JNJ,0.540358,0.277964,Somewhat-Bullish
Experts are worried about tuberculosis again,https://theweek.com/health/experts-are-worried-about-tuberculosis-again,2023-10-02 21:13:22,Tuberculosis is once again causing concern The Week ...,JNJ,0.05234,0.076018,Neutral
Drugmakers opt in to Medicare drug price negotiations - here's what happens next,https://www.cnbc.com/2023/10/02/drugmakers-agree-to-medicare-price-negotiations-whats-next.html,2023-10-02 19:34:02,"The lengthy negotiation process with Medicare won't end until August 2024, with reduced prices going into effect in January 2026.",JNJ,0.051221,-0.057993,Neutral
Drugmakers sign on to negotiate Medicare prices under protest,https://www.reuters.com/business/healthcare-pharmaceuticals/drugmakers-sign-negotiate-medicare-prices-under-protest-2023-10-02/,2023-10-02 17:12:00,"U.S. President Joe Biden delivers remarks on Social Security and Medicare at the University of Tampa in Tampa, Florida, U.S. February 9, 2023. REUTERS/Jonathan Ernst/File Photo Acquire Licensing Rights",JNJ,0.085022,0.033017,Neutral
Johnson & Johnson Urged To Expand Access To Tuberculosis Medication - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/general/biotech/23/10/35030857/johnson-johnson-urged-to-expand-access-tuberculosis-medication,2023-10-02 16:28:51,"Global health aid agency Unitaid is advocating for expanded access to tuberculosis ( TB ) drug, bedaquiline, produced by Johnson & Johnson JNJ. The push comes as countries like South Africa, Belarus, and Ukraine grapple with high TB cases but limited access to the medication.",JNJ,0.517168,-0.176073,Somewhat-Bearish
J&J's  ( JNJ )  Rybrevant Combo Meets Primary Goal in NSCLC Study,https://www.zacks.com/stock/news/2158753/jjs-jnj-rybrevant-combo-meets-primary-goal-in-nsclc-study,2023-10-02 14:45:00,J&J (JNJ) meets the primary goal in the late-stage study of the combination therapy of Rybrevant and lazertinib against Tagrisso for EGFR-mutated first-line NSCLC.,JNJ,0.302243,-0.022095,Neutral
Capital Product Partners L.P. Announces the Appointment of Director by Capital GP L.L.C.,https://www.globenewswire.com/news-release/2023/10/02/2752834/20327/en/Capital-Product-Partners-L-P-Announces-the-Appointment-of-Director-by-Capital-GP-L-L-C.html,2023-10-02 13:10:00,"ATHENS, Greece, Oct. 02, 2023 ( GLOBE NEWSWIRE ) -- Capital Product Partners L.P. ( NASDAQ: CPLP ) ( the ""Partnership"" ) today announced that Capital GP L.L.C., its general partner ( the ""General Partner"" ) , has appointed Mr. Atsunori Kozuki to act as a member of the Board of Directors of the ...",JNJ,0.089129,0.0,Neutral
Capital Product Partners L.P. Announces the Appointment of Director by Capital GP L.L.C. - Capital Product Partners  ( NASDAQ:CPLP ) ,https://www.benzinga.com/pressreleases/23/10/g35031145/capital-product-partners-l-p-announces-the-appointment-of-director-by-capital-gp-l-l-c,2023-10-02 13:10:00,"ATHENS, Greece, Oct. 02, 2023 ( GLOBE NEWSWIRE ) -- Capital Product Partners L.P.",JNJ,0.080458,0.0,Neutral
2 Exceptional Dividend Stocks to Buy in October and Hold Forever,https://www.fool.com/investing/2023/10/01/x-dividend-stocks-to-buy-in-october-and-hold-forev/,2023-10-01 10:47:00,Temporary challenges are creating bargain opportunities for investors with a long-term mindset.,JNJ,0.180685,0.044748,Neutral
Could Kenvue Follow in the Footsteps of Johnson & Johnson and Become a Top Dividend Stock?,https://www.fool.com/investing/2023/10/01/could-kenvue-become-top-dividend-stock/,2023-10-01 10:00:00,Kenvue says rewarding shareholders is an important part of its strategy.,JNJ,0.058472,0.089984,Neutral
"StockNews.com Upgrades Johnson & Johnson  ( NYSE:JNJ )  to ""Strong-Buy""",https://www.defenseworld.net/2023/10/01/stocknews-com-upgrades-johnson-johnson-nysejnj-to-strong-buy.html,2023-10-01 07:28:43,StockNews.com Upgrades Johnson & Johnson ( NYSE:JNJ ) to ... Defense World ...,JNJ,0.734323,0.398835,Bullish
Is Kenvue Stock Too Pricey to Buy?,https://www.fool.com/investing/2023/09/30/is-kenvue-stock-too-pricey-to-buy/,2023-09-30 13:22:00,Its valuation depends on its brands being highly valuable indefinitely.,JNJ,0.069697,0.087708,Neutral
3 Magnificent Dividend Stocks to Buy in October,https://www.fool.com/investing/2023/09/30/3-magnificent-dividend-stocks-to-buy-in-october/,2023-09-30 10:55:00,These stocks come with great dividends and more.,JNJ,0.266828,0.205411,Somewhat-Bullish
"Here's Why You Should Consider Moderna Stock, and No, It's Not the COVID Vaccine",https://www.fool.com/investing/2023/09/30/heres-why-you-should-consider-moderna-stock-and-no/,2023-09-30 09:30:00,"The COVID-19 vaccine put Moderna on the map, but its pipeline is going to be what keeps it there.",JNJ,0.06515,0.114691,Neutral
Federal judge declines to block Medicare price negotiations,https://www.cnbc.com/2023/09/29/medicare-price-negotiations-federal-judge-denies-injunction-request.html,2023-09-29 21:39:58,Judge Michael Newman of the Southern District of Ohio issued a ruling denying a preliminary injunction sought by the Chamber of Commerce.,JNJ,0.057907,-0.102975,Neutral
Announcing the 2023 Most Powerful Latina Summit at L'attitude: Elevating Latina Leaders and Charting the Future of Global Economy,https://www.prnewswire.com/news-releases/announcing-the-2023-most-powerful-latina-summit-at-lattitude-elevating-latina-leaders-and-charting-the-future-of-global-economy-301942564.html,2023-09-29 15:00:00,Announcing the 2023 Most Powerful Latina Summit at L'attitude: Elevating Latina Leaders and Charting the Future of ... PR ...,JNJ,0.049322,0.096311,Neutral
Third Quarter 2023: CINDE Announces 28 New Multinationals Confirm Arrival to Costa Rica,https://www.prnewswire.com/news-releases/third-quarter-2023-cinde-announces-28-new-multinationals-confirm-arrival-to-costa-rica-301943060.html,2023-09-29 14:38:00,"â€¢ The companies that have chosen to set up new operations in this country are from , , , , and . â€¢ Nine of the companies will be setting up outside the greater metropolitan area, some of the selected regions being Orotina, Turrialba, Puntarenas, Grecia, Puerto Viejo de SarapiquÃ­, Bagaces, and ...",JNJ,0.071145,0.18229,Somewhat-Bullish
"As Merck, AstraZeneca and other drugmakers sign on, Medicare price negotiations face critical moment",https://www.marketwatch.com/story/as-merck-astrazeneca-and-other-drugmakers-sign-on-medicare-price-negotiations-face-critical-moment-9d85879f,2023-09-29 14:20:00,A deadline looms to sign drug-price negotiation agreements as industry watches for legal reprieve.,JNJ,0.100099,0.0,Neutral
Artwork Management Software Market worth $1.12 Billion by 2030 - Exclusive Report by The Insight Partners,https://www.benzinga.com/pressreleases/23/09/g35002288/artwork-management-software-market-worth-1-12-billion-by-2030-exclusive-report-by-the-insight-part,2023-09-29 13:26:58,"Pune, India., Sept. 29, 2023 ( GLOBE NEWSWIRE ) -- According to a new report on ""Artwork Management Software Market Size and Forecasts ( 2020 - 2030 ) , Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Deployment ( Cloud and On-Premise ) , Application ( Life ...",JNJ,0.031822,0.171305,Somewhat-Bullish
A Bull Market Is Coming: 3 Top Dividend Stocks to Buy Now,https://www.fool.com/investing/2023/09/29/bull-market-top-dividend-stocks-to-buy-now/,2023-09-29 09:23:00,These steadfast investments can help you earn more passive income.,JNJ,0.05749,0.144983,Neutral
"These 7 Dividend Stocks Pay $98 Billion Annually, Combined, to Their Shareholders",https://www.fool.com/investing/2023/09/29/7-dividend-stocks-pay-98-billion-year-shareholders/,2023-09-29 09:21:00,"Seven brand-name, time-tested businesses are doling out between $11.2 billion and $22.3 billion to their shareholders each year.",JNJ,0.089573,0.085197,Neutral
Unitaid urges Johnson & Johnson to improve access to TB drug bedaquiline,https://www.reuters.com/business/healthcare-pharmaceuticals/unitaid-urges-johnson-johnson-improve-access-tb-drug-bedaquiline-2023-09-29/,2023-09-29 08:44:00,Unitaid urges Johnson & Johnson to improve access to TB drug ...,JNJ,0.334008,-0.07906,Neutral
Virtualware's VIROO capabilities shown at NATO Exercise,https://www.globenewswire.com/news-release/2023/09/29/2751745/0/en/Virtualware-s-VIROO-capabilities-shown-at-NATO-Exercise.html,2023-09-29 05:39:00,"Bilbao, Spain, September 29.- Virtualware ( EPA: MLVIR ) , the European leader in the virtual reality industry, has participated at the NATO Air Operation exercise focused on chemical, biological, radiological, and nuclear ( CBRN ) Def interoperability to present the VR training project for the ...",JNJ,0.045396,0.113299,Neutral
The Office Real Estate Depression,https://www.fool.com/investing/2023/09/28/the-office-real-estate-depression/,2023-09-28 23:49:00,We've also got a look at two stocks worth watching and a discussion about the AI future.,JNJ,0.006019,0.076661,Neutral
NANOBIOTIX Announces Presentation of First Data From Phase 1 Study Evaluating NBTXR3 for Patients With Locally Advanced Pancreatic Cancer - Nanobiotix  ( NASDAQ:NBTX ) ,https://www.benzinga.com/pressreleases/23/09/g34987056/nanobiotix-announces-presentation-of-first-data-from-phase-1-study-evaluating-nbtxr3-for-patients-,2023-09-28 20:15:00,"Preliminary data show local endoscopic injection of NBTXR3 followed by radiotherapy activation remains feasible with a tolerable safety profile in 15 patients As of the data cutoff, in 13 patients evaluable for efficacy, the study showed an injected tumor disease control rate of 92.3% ( 12/13 )",JNJ,0.024749,0.015093,Neutral
NANOBIOTIX Announces Presentation of First Data From Phase 1 Study Evaluating NBTXR3 for Patients With Locally Advanced Pancreatic Cancer,https://www.globenewswire.com/news-release/2023/09/28/2751640/0/en/NANOBIOTIX-Announces-Presentation-of-First-Data-From-Phase-1-Study-Evaluating-NBTXR3-for-Patients-With-Locally-Advanced-Pancreatic-Cancer.html,2023-09-28 20:15:00,Data presented at the 2023 Special Meeting on Pancreatic Cancer of the American Association for Cancer Research ...,JNJ,0.023696,0.020646,Neutral
The Anti-obesity Drug Market Is About to Get More Crowded,https://www.thedailyupside.com/industries/the-anti-obesity-drug-market-is-about-to-get-more-crowded/,2023-09-28 14:31:33,"Obesity is an epidemic that affects more than 40% of all American adults, and it's creating a feeding frenzy for investors. With the rise of...",JNJ,0.091162,-0.078458,Neutral
"Pharma Giants Shift Stance, Embrace Medicare Negotiations Amid Rising Drug Costs - AstraZeneca  ( NASDAQ:AZN ) ",https://www.benzinga.com/general/biotech/23/09/34977352/pharma-giants-shift-stance-embrace-medicare-negotiations-amid-rising-drug-costs,2023-09-28 14:19:56,"AstraZeneca Plc AZN, Bristol Myers Squibb & Co BMY, and Boehringer Ingelheim are willing to participate in the initial round of Medicare drug price negotiations despite having previously sued to halt the process.",JNJ,0.303175,0.0,Neutral
3 Dividend Kings With Recession-Proof Payouts,https://realmoney.thestreet.com/investing/stocks/3-dividend-kings-with-recession-proof-payouts-16134258,2023-09-28 14:15:00,3 Dividend Kings With ...,JNJ,0.21686,0.018532,Neutral
Here's Why You Should Retain Medtronic  ( MDT )  Stock for Now,https://www.zacks.com/stock/news/2157159/heres-why-you-should-retain-medtronic-mdt-stock-for-now,2023-09-28 13:49:00,Investors are optimistic about Medtronic (MDT) on strong global expansion.,JNJ,0.049221,0.085209,Neutral
J&J's lung cancer therapy succeeds in head-to-head study with AstraZeneca's drug,https://www.reuters.com/business/healthcare-pharmaceuticals/jjs-lung-cancer-therapy-combo-succeeds-late-stage-study-2023-09-28/,2023-09-28 13:32:00,"The logo of Johnson & Johnson is seen on the top of a Brussels' office of the company in Diegem, Belgium September 21, 2023. REUTERS/Yves Herman/File photo Acquire Licensing Rights",JNJ,0.232439,-0.070062,Neutral
Landmark Phase 3 MARIPOSA Study Meets Primary Endpoint Resulting in Statistically Significant and Clinically Meaningful Improvement in Progression-Free Survival for RYBREVANTÂ®  ( amivantamab-vmjw )  plus Lazertinib Versus Osimertinib in Patients with EGFR-Mutated Non-Small Cell Lung Cancer,https://www.prnewswire.com/news-releases/landmark-phase-3-mariposa-study-meets-primary-endpoint-resulting-in-statistically-significant-and-clinically-meaningful-improvement-in-progression-free-survival-for-rybrevant-amivantamab-vmjw-plus-lazertinib-versus-osimertinib--301941646.html,2023-09-28 11:30:00,Landmark Phase 3 MARIPOSA Study Meets Primary Endpoint Resulting in Statistically Significant and Clinically ... PR ...,JNJ,0.082272,0.01986,Neutral
Johnson & Johnson's Sharper Focus Is Already Paying Dividends for Investors,https://www.fool.com/investing/2023/10/17/johnson-johnsons-sharper-focus-is-already-paying-d/,2023-10-17 20:00:00,The healthcare behemoth reported strong earnings after separating its consumer health division.,JNJ,0.366061,0.528137,Bullish
"Back for Another Round: Rate Hike Fears Grow After Strong Retail Sales Sends Yields Spinning Higher - Bank of America  ( NYSE:BAC ) , American Airlines Group  ( NASDAQ:AAL ) ",https://www.benzinga.com/markets/23/10/35295882/back-for-another-round-rate-hike-fears-grow-after-strong-retail-sales-sends-yields-spinning-higher,2023-10-17 18:38:03,( Tuesday market open ) Early earnings results continued to impress but major indexes flagged in premarket trading Tuesday as Treasury yields swung higher after unexpectedly strong September U.S. Retail Sales raised concerns about another possible rate hike.,JNJ,0.055025,0.056,Neutral
"Johnson & Johnson's Q3 2023: $21.3B Rise In Sales, 'Sharpened Focus' On Innovation & Biotech Solutions - Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/markets/cannabis/23/10/35295397/johnson-johnsons-q3-2023-21-3b-rise-in-sales-sharpened-focus-on-innovation-biotech-solutions,2023-10-17 18:28:46,"Healthcare company Johnson & Johnson ( J&J ) JNJ shared its financial outcomes for the third quarter of 2023, reflecting: Total reported sales of $21,351 million, a 6.8% increase compared to the same period in 2022.",JNJ,0.252987,0.424436,Bullish
"Johnson & Johnson's Q3 2023: $21.3B Rise In Sales, 'Sharpened Focus' On Innovation & Biotech Solutions - Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/markets/cannabis/23/10/35295397/johnson-johnsons-q3-2023-21-3b-in-sales-sharpened-focus-on-innovation-biotech-solutions,2023-10-17 18:28:44,"Healthcare company Johnson & Johnson ( J&J ) JNJ shared its financial outcomes for the third quarter of 2023, reflecting: Total reported sales of $21,351 million, a 6.8% increase compared to the same period in 2022.",JNJ,0.252987,0.424436,Bullish
"US Stock Futures Slide As Traders Look Past Positive Earnings News Flow; Analysts Predict Year-End Rally And Strong 2024 Ahead - Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , United Airlines Holdings  ( NASDAQ:UAL ) , Lockheed Martin  ( NYSE:LMT ) , Bank of America  ( NYSE:BAC ) ",https://www.benzinga.com/23/10/35284350/us-stock-futures-slide-as-traders-look-past-positive-earnings-news-flow-analysts-predict-year-end-ra,2023-10-17 17:46:27,"The market mood has turned somber on Tuesday, signaling that stocks could reverse some of the upside seen in the previous session. The bond yields have resumed their climb, with the 10-year U.S. Treasury note yield back above 4.7%, reflecting investor fears concerning further rate hikes.",JNJ,0.091684,0.022606,Neutral
Johnson & Johnson  ( JNJ )  Q3 2023 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/10/17/johnson-johnson-jnj-q3-2023-earnings-call-transcri/,2023-10-17 17:30:22,"JNJ earnings call for the period ending September 30, 2023.",JNJ,0.057724,0.126025,Neutral
Johnson & Johnson Was Saved By Its Focus On MedTech And Innovative Medicine - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/23/10/35294426/johnson-johnson-was-saved-by-its-focus-on-medtech-and-innovative-medicine,2023-10-17 17:16:16,Johnson & Johnson JNJ reported its third quarter results that topped Wall Street's expectations while also lifting its full year guidance fueled by a strong performance of its pharmaceutical and medical devices businesses.,JNJ,0.342093,-0.007579,Neutral
J&J  ( JNJ )  Beats Q3 Earnings & Sales Estimates Post Spin-Off,https://www.zacks.com/stock/news/2167442/jj-jnj-beats-q3-earnings-sales-estimates-post-spin-off,2023-10-17 16:32:00,J&J (JNJ) beats estimates for third-quarter earnings and sales. It raises full-year sales and earnings guidance.,JNJ,0.090021,0.057932,Neutral
"Baby Care Products Market to Touch USD 163.4 billion by 2031, Recording a CAGR of 6.2% | Report by Transparency Market Research",https://www.benzinga.com/pressreleases/23/10/g35291856/baby-care-products-market-to-touch-usd-163-4-billion-by-2031-recording-a-cagr-of-6-2-report-by-tra,2023-10-17 15:30:00,"Wilmington, Delaware, United States, Oct. 17, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global baby care products market is projected to flourish at a CAGR of 6.2% from 2021 to 2031. As per the report published by TMR, a valuation of US$ 163.4 billion is anticipated for ...",JNJ,0.047465,0.231866,Somewhat-Bullish
"STERIS'  ( STE )  Improved Volume, New Buyouts Drive Growth",https://www.zacks.com/stock/news/2167341/steris-ste-improved-volume-new-buyouts-drive-growth,2023-10-17 15:17:00,"On the capital equipment side for STERIS (STE), the easing of supply-chain issues and reduced lead times are boosting shipments.",JNJ,0.060694,0.074052,Neutral
"Dow Jones Flat As Hot Data, Yields Weigh In; Tesla Falls On Fresh Recall",https://www.investors.com/market-trend/stock-market-today/dow-jones-falls-as-hot-data-yields-spook-stocks-tesla-falls-on-fresh-recall/,2023-10-17 15:16:00,"Dow Jones Flat As Hot Data, Yields Weigh In. Tesla Falls On Fresh ... Investor's Business Daily ...",JNJ,0.104683,0.131785,Neutral
Economic News Is More Important Than Earnings Right Now,https://realmoney.thestreet.com/investing/economic-news-is-more-important-than-earnings-right-now-16135714,2023-10-17 15:10:00,"Retail sales numbers were much higher than expected, and all six of the major earnings reports this morning beat on both revenues and EPS. That sounds like a catalyst for a positive market reaction, but what we are seeing is some very strong rotation out of the big-cap technology names and into ...",JNJ,0.279015,0.481203,Bullish
Retail Sales Increased More Than Expected,https://www.zacks.com/stock/news/2167321/retail-sales-increased-more-than-expected,2023-10-17 14:54:00,"This morning we see new Retail Sales numbers for September, and they have come in hotter than expected: headline +0.7% month over month is 50 basis points ( bps ) higher than expected, though down 10 bps from the upwardly revised +0.8% in August.",JNJ,0.156461,0.155728,Somewhat-Bullish
This 'Boring' Market Is Our Key To 10% Dividend Payouts,https://www.forbes.com/sites/michaelfoster/2023/10/17/this-boring-market-is-our-key-to-10-dividend-payouts/,2023-10-17 14:35:00,"The ""boring"" truth is that what we've been seeing is nothing more than a transition from a panicked market to a more normal one.",JNJ,0.085476,0.073844,Neutral
"Retail Sales Hotter at +0.7%; JNJ, BAC, GS All Beat in Q3",https://www.zacks.com/stock/news/2167302/retail-sales-hotter-at-07-jnj-bac-gs-all-beat-in-q3,2023-10-17 14:32:00,"Retail Sales infer a consumer willing to spend, and the outlook for Q3 GDP is likely up somewhat on this news.",JNJ,0.147818,0.149788,Neutral
Johnson & Johnson lifts profit outlook on strong demand for top-seller Stelara,https://www.foxbusiness.com/markets/johnson-johnson-lifts-profit-outlook-strong-demand-top-seller-stelara,2023-10-17 14:04:50,"Johnson & Johnson raised its 2023 profit forecast in its first earnings report since spinning off its consumer health business, with the company's fortunes now tied more closely to sales of blockbusters like its arthritis drug Stelara. The company's shares were up about 2% in premarket trading on ...",JNJ,0.234307,0.137139,Neutral
"Johnson & Johnson Is Falling, but This Tech Stock Is Really Getting Hit Hard",https://www.fool.com/investing/2023/10/17/johnson-johnson-is-falling-but-this-tech-stock-is/,2023-10-17 14:00:22,Earnings season is starting to ramp up.,JNJ,0.399204,0.251898,Somewhat-Bullish
Top 10 things to watch in the stock market Tuesday,https://www.cnbc.com/2023/10/17/top-10-things-to-watch-in-the-stock-market-tuesday.html,2023-10-17 13:11:08,U.S. stocks are set to open lower on Tuesday as bond yields rise.,JNJ,0.121037,0.0,Neutral
J&J Raises Outlook As Health Bellwether Tries To Reinvent Itself,https://www.investors.com/news/technology/jnj-stock-johnson-johnson-earnings-q3-2023/,2023-10-17 13:05:00,JNJ Stock: Health Care Bellwether Boosts Outlook As It Refocuses ... Investor's Business Daily ...,JNJ,0.880871,0.573042,Bullish
Stock market today: Wall Street inches back as war in the Middle East hangs over markets,https://apnews.com/article/stock-markets-earnings-china-war-69e60cda4b5adde06417e5822870837d,2023-10-17 12:14:00,"Wall Street pointed toward losses early Tuesday as corporate earnings roll in and worries about war in the Middle East hang over markets. Futures for the S&P 500 and Dow industrials slipped 0.2% before the bell. In addition to another heavy slate of quarterly earnings, the U.S. will release ...",JNJ,0.06211,0.164097,Somewhat-Bullish
"The daily business briefing: October 17, 2023",https://theweek.com/business/the-daily-business-briefing-october-17-2023,2023-10-17 11:56:16,2. Lululemon shares jump after joining S&P 500 3. Stock futures struggle as earnings season picks up 4. China tells banks to ease municipal debt burdens 5. Survey says shoppers expect to spend more this year,JNJ,0.033236,0.028903,Neutral
"New Johnson & Johnson's Q3 Earnings Beat Street View, Raises Annual Outlook - Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/general/biotech/23/10/35283724/new-johnson-johnsons-q3-earnings-beat-street-view-raises-annual-outlook,2023-10-17 11:53:26,"Johnson & Johnson JNJ has reported Q3 FY23 adjusted earnings of $2.66 per share, up 19.3% Y/Y and beating the consensus of $2.51. Sales increased 6.8% to $21.35 billion, beating the consensus of $21.04 billion, with operational growth of 7.5 and adjusted operational growth of 6.4%.",JNJ,0.82082,0.504831,Bullish
Johnson & Johnson  ( JNJ )  Q3 Earnings and Revenues Surpass Estimates,https://www.zacks.com/stock/news/2166934/johnson-johnson-jnj-q3-earnings-and-revenues-surpass-estimates,2023-10-17 11:40:02,"Johnson & Johnson (JNJ) delivered earnings and revenue surprises of 5.56% and 1.67%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?",JNJ,0.395012,0.1105,Neutral
Tupperware Brands Announces CEO Transition and Board Refreshment - PR Newswire,https://www.prnewswire.com/news-releases/tupperware-brands-announces-ceo-transition-and-board-refreshment-301958827.html,2023-10-17 11:30:00,Tupperware Brands Announces CEO Transition and Board Refreshment PR ...,JNJ,0.028937,0.023681,Neutral
"Invest in millennials and these 'one-in-a-lifetime opportunity' stocks, says this fund manager",https://www.marketwatch.com/story/invest-in-millennials-and-these-one-in-a-lifetime-opportunity-stocks-says-this-fund-manager-cc5420c4,2023-10-17 10:52:00,Our call of the day offers bargains among energy and stocks catering to future millennial spending.,JNJ,0.082111,0.043497,Neutral
"Johnson & Johnson beats on earnings and hikes outlook as medtech, pharmaceutical sales surge",https://www.cnbc.com/2023/10/17/johnson-johnson-jnj-q3-earnings-report-2023.html,2023-10-17 10:25:15,It marks J&J's first quarterly results since the company completed the separation from its consumer health spinoff Kenvue in August.,JNJ,0.129516,0.0,Neutral
J&J raises annual profit forecast on anti-inflammatory drug demand,https://www.reuters.com/business/healthcare-pharmaceuticals/jj-raises-annual-profit-forecast-strong-cancer-drug-demand-2023-10-17/,2023-10-17 10:24:57,"The logo of Johnson & Johnson is seen on a Brussels' office of the company in Diegem, Belgium September 21, 2023. REUTERS/Yves Herman/File Photo Acquire Licensing Rights",JNJ,0.591019,0.385262,Bullish
Genmab Announces Net Sales of DARZALEXÂ®  ( daratumumab )  for Third Quarter of 2023,https://www.globenewswire.com/news-release/2023/10/17/2761310/0/en/Genmab-Announces-Net-Sales-of-DARZALEX-daratumumab-for-Third-Quarter-of-2023.html,2023-10-17 10:22:00,Company Announcement ...,JNJ,0.127795,0.011568,Neutral
"Morning Bid: Banks, Biden visit buoy markets",https://www.reuters.com/markets/us/global-markets-view-usa-2023-10-17/,2023-10-17 10:01:00,"Traders work on the floor of the New York Stock Exchange ( NYSE ) in New York City, U.S., August 15, 2023. REUTERS/Brendan McDermid/File Photo Acquire Licensing Rights A look at the day ahead in U.S. and global markets from Mike Dolan",JNJ,0.04794,0.0,Neutral
S&P 500 futures drift as Goldman Sachs and Bank of America earnings awaited,https://www.marketwatch.com/story/s-p-500-futures-drift-as-goldman-sachs-and-bank-of-america-earnings-awaited-dfd86d7b,2023-10-17 08:51:00,U.S. stock futures show Wall Street holding most of the rally from the start of the week as investors display less anxiety about geopolitical risk.,JNJ,0.154951,0.0,Neutral
"Bank of America, Johnson & Johnson And 3 Stocks To Watch Heading Into Tuesday - Bank of America  ( NYSE:BAC ) , Goldman Sachs Gr  ( NYSE:GS ) ",https://www.benzinga.com/news/earnings/23/10/35280111/bank-of-america-johnson-johnson-and-3-stocks-to-watch-heading-into-tuesday,2023-10-17 07:45:54,"With U.S. stock futures trading lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Johnson & Johnson JNJ to report quarterly earnings at $2.51 per share on revenue of $21.04 billion before the opening bell.",JNJ,0.501398,0.559502,Bullish
Johnson & Johnson earnings: What to expect,https://www.marketwatch.com/story/johnson-johnson-earnings-what-to-expect-ee9e4a13,2023-10-17 07:13:00,Drug and medtech company is posting third-quarter earnings before the bell on Tuesday.,JNJ,0.357293,0.303784,Somewhat-Bullish
Asia stocks rise on earnings hopes; keep wary eye on Middle east tensions,https://www.moneycontrol.com/news/business/markets/asia-stocks-rise-on-earnings-hopes-keep-wary-eye-on-middle-east-tensions-11544961.html,2023-10-17 04:12:26,MSCI's broadest index of Asia-Pacific shares outside Japan advanced 0.4%. Tokyo's Nikkei rose 1%.,JNJ,0.075635,0.0,Neutral
Asia stocks rise on earnings hopes; keep wary eye on Mideast tensions,https://www.reuters.com/markets/global-markets-wrapup-1-2023-10-17/,2023-10-17 03:32:39,Asia stocks rise on earnings hopes. keep wary eye on Mideast tensions ...,JNJ,0.068306,0.0,Neutral
"Bitcoin, Ethereum, Dogecoin Spike As False BlackRock ETF Rumor Sparks $104M Shorts Liquidation: Analyst Says 'Real Tweet Would Do So Much More' - BlackRock  ( NYSE:BLK ) ",https://www.benzinga.com/markets/cryptocurrency/23/10/35279325/bitcoin-ethereum-dogecoin-spike-as-false-blackrock-etf-rumor-sparks-104m-shorts-liquidatio,2023-10-17 02:39:52,"Major cryptocurrencies experienced a significant surge on Monday evening, triggered by a false rumor on X, claiming that the Securities and Exchange Commission ( SEC ) had approved BlackRock's BLK spot bitcoin ETF application.",JNJ,0.066047,0.079114,Neutral
Wall Street ends up on earnings optimism; eyes remain on Middle East,https://www.moneycontrol.com/news/business/markets/wall-street-ends-up-on-earnings-optimism-eyes-remain-on-middle-east-11543891.html,2023-10-17 00:48:45,"Market participants were monitoring the Israeli war in Gaza, but appeared to be taking more of a risk-on stance on Monday, with safe-haven gold prices down.",JNJ,0.078354,0.0,Neutral
"Markets Pop on Bargain Hunting, Stronger Economy",https://www.zacks.com/stock/news/2166817/markets-pop-on-bargain-hunting-stronger-economy,2023-10-16 22:42:00,"The small-cap Russell 2000, still under water over the past month, led the way higher today.",JNJ,0.174587,0.036241,Neutral
Futures: Market Rally Snaps Back With Big Gains,https://www.investors.com/market-trend/stock-market-today/dow-jones-rallies-market-rally-snaps-back-netflix-nvidia-tesla-in-focus/,2023-10-16 21:11:00,Dow Jones Rallies 300 Points As Market Rally Snaps Back. Netflix ... Investor's Business Daily ...,JNJ,0.069194,0.0,Neutral
"Large Granular Lymphocyte Leukemia Market is Projected to Grow During the Study Period  ( 2019-2032 ) , Assesses DelveInsight | Key Companies - Bristol Myers Squibb, Innate Pharma, Kymera Therapeutics, EUSA Pharma, Abcuro, Dren Bio, Novotech",https://www.prnewswire.com/news-releases/large-granular-lymphocyte-leukemia-market-is-projected-to-grow-during-the-study-period-20192032-assesses-delveinsight--key-companies---bristol-myers-squibb-innate-pharma-kymera-therapeutics-eusa-pharma-abcuro-dren-bio-n-301957023.html,2023-10-16 21:01:00,"Large Granular Lymphocyte Leukemia Market is Projected to Grow During the Study Period ( 2019-2032 ) , Assesses ... PR ...",JNJ,0.025845,-0.032245,Neutral
Johnson & Johnson's Earnings Will Offer a Look at the Company Without Kenvue,https://www.barrons.com/articles/johnson-jnj-earnings-stock-price-20d516cc,2023-10-16 21:00:00,Johnson & Johnson's Earnings Are Coming. They'll Be the First ... ...,JNJ,0.769861,0.0,Neutral
4 Hot Penny Stocks To Watch With The Stock Market Up Today,https://pennystocks.com/featured/2023/10/16/4-hot-penny-stocks-to-watch-with-the-stock-market-up-today/,2023-10-16 17:43:27,"Whether you're trading penny stocks or stocks over $100, it's hard to miss that the stock market is up today. That's in stark contrast to last week, when markets appeared to be heading toward another downtrend.",JNJ,0.039811,0.14224,Neutral
"Pendulum Swings: Markets Recover Slightly After Friday's Anxious Trading, but Middle East Worries Dominate - Apple  ( NASDAQ:AAPL ) , American Airlines Group  ( NASDAQ:AAL ) ",https://www.benzinga.com/markets/23/10/35272437/pendulum-swings-markets-recover-slightly-after-fridays-anxious-trading-but-middle-east-worries-domin,2023-10-16 17:07:15,"( Monday market open ) Last week gave us a taste of earnings. The meal starts tomorrow and picks up steam as banks, airlines, and health care companies report. And the main course might be Wednesday afternoon when Netflix NFLX and Tesla TSLA open their books.",JNJ,0.0726,0.0,Neutral
"Monday's Market Minute: This Week's Focus: Earnings & Consumer Spending - Bank of America  ( NYSE:BAC ) , American Express  ( NYSE:AXP ) ",https://www.benzinga.com/news/earnings/23/10/35272066/mondays-market-minute-this-weeks-focus-earnings-consumer-spending,2023-10-16 16:46:05,The focus for investors and traders will shift from inflation after the higher-than-expected figures last week to earnings and consumer spending habits.,JNJ,0.246582,0.172999,Somewhat-Bullish
Wall Street Waits for Big Earnings Results,https://www.zacks.com/stock/news/2166555/wall-street-waits-for-big-earnings-results,2023-10-16 14:57:00,"It's a busy trading week ahead, with Q3 earnings season heating up and more economic data being released a couple weeks ahead of the next Federal Open Market Committee ( FOMC ) meeting, which decides on interest rates.",JNJ,0.210274,0.043266,Neutral
Empire State Less Bad than Expected; SCHW Mixed in Q3,https://www.zacks.com/stock/news/2166539/empire-state-less-bad-than-expected-schw-mixed-in-q3,2023-10-16 14:27:00,"We've only seen four months in positive territory on Empire State manufacturing year to date, the highest being +10.8 in April.",JNJ,0.204936,0.042404,Neutral
"White River Bancshares Co. Earns $639,000, or $0.64 Per Diluted Share, in Third Quarter 2023; Highlighted by Double Digit Loan and Deposit Growth Year-Over-year",https://www.globenewswire.com/news-release/2023/10/16/2760706/0/en/White-River-Bancshares-Co-Earns-639-000-or-0-64-Per-Diluted-Share-in-Third-Quarter-2023-Highlighted-by-Double-Digit-Loan-and-Deposit-Growth-Year-Over-year.html,2023-10-16 13:00:00,"FAYETTEVILLE, Ark., Oct. 16, 2023 ( GLOBE NEWSWIRE ) -- White River Bancshares Company ( OTCQX: WRIV ) , ( the ""Company"" ) the holding company for Signature Bank of Arkansas ( the ""Bank"" ) , today reported net income of $639,000, or $0.64 per diluted share, in the third quarter of 2023, compared ...",JNJ,0.016271,0.116446,Neutral
Innovation Takes Center Stage: Florida's Life Sciences Leaders Shine at BioFlorida Conference,https://www.prnewswire.com/news-releases/innovation-takes-center-stage-floridas-life-sciences-leaders-shine-at-bioflorida-conference-301957464.html,2023-10-16 12:38:00,The Annual Conference Fuels Growth with a Focus on Elevating Florida's Position on the Global Stage,JNJ,0.028592,0.198867,Somewhat-Bullish
4 Dividend Stocks Yielding 4% or More to Buy Without Hesitation,https://www.fool.com/investing/2023/10/16/4-dividend-stocks-yield-4-buy-without-hesitation/,2023-10-16 12:12:00,These stocks offer attractive payouts that should rise in the future.,JNJ,0.089797,0.199687,Somewhat-Bullish
"The daily business briefing: October 16, 2023",https://theweek.com/business/the-daily-business-briefing-october-16-2023,2023-10-16 12:09:57,"2. Taylor Swift's concert movie breaks records 3. Dow, S&P edge higher ahead of wave of earnings 5. Pfizer cuts forecast for Covid vaccine, therapy sales A free daily digest of the biggest news stories of the day - and the best features from our website Thank you for signing up to TheWeek.",JNJ,0.033282,0.008567,Neutral
TREMFYAÂ®  ( guselkumab )  Maintains Key Efficacy Endpoints Through Three Years for Adults with Moderately to Severely Active Crohn's Disease in a Phase 2 Study,https://markets.businessinsider.com/news/stocks/tremfya-guselkumab-maintains-key-efficacy-endpoints-through-three-years-for-adults-with-moderately-to-severely-active-crohn-s-disease-in-a-phase-2-study-1032708159,2023-10-16 12:01:00,TREMFYAÂ® (guselkumab) Maintains Key Efficacy Endpoints Through Three Years for Adults with Moderately to Severely Active Crohn's Disease in a Phase 2 Study ...,JNJ,0.130217,0.10974,Neutral
Janssen Aims to Define New Standards of Care in the Treatment of Solid Tumor Cancers with Transformative Data Planned for Presentation at ESMO,https://markets.businessinsider.com/news/stocks/janssen-aims-to-define-new-standards-of-care-in-the-treatment-of-solid-tumor-cancers-with-transformative-data-planned-for-presentation-at-esmo-1032708126,2023-10-16 12:00:00,Janssen Aims to Define New Standards of Care in the Treatment of Solid Tumor Cancers with Transformative Data Planned for Presentation at ...,JNJ,0.028109,-0.050847,Neutral
Janssen to Highlight Latest Research from Nipocalimab Clinical Development Program to Address Unmet Need in Myasthenia Gravis at AANEM 2023 Meeting,https://www.prnewswire.com/news-releases/janssen-to-highlight-latest-research-from-nipocalimab-clinical-development-program-to-address-unmet-need-in-myasthenia-gravis-at-aanem-2023-meeting-301957084.html,2023-10-16 12:00:00,Janssen to Highlight Latest Research from Nipocalimab Clinical Development Program to Address Unmet Need in ... PR ...,JNJ,0.185917,-0.009305,Neutral
"TSX futures kick off week on copper boost, Middle East conflict weighs",https://www.reuters.com/markets/tsx-futures-kick-off-week-copper-boost-middle-east-conflict-weighs-2023-10-16/,2023-10-16 11:49:00,"The Art Deco facade of the original Toronto Stock Exchange building is seen on Bay Street in Toronto, Ontario, Canada January 23, 2019. REUTERS/Chris Helgren/File Photo Acquire Licensing Rights",JNJ,0.110973,0.0,Neutral
"US Stocks On Track For A Strong Start To Week, Buoyed By Earnings Optimism: Analyst Flags 13-14% Upside As Bull Market Enters Its Second Year - Netflix  ( NASDAQ:NFLX ) , Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , NVIDIA  ( NASDAQ:NVDA ) , Tesla  ( NASDAQ:TSLA ) ",https://www.benzinga.com/news/earnings/23/10/35263899/us-stocks-on-track-for-a-strong-start-to-week-buoyed-by-earnings-optimism-analyst-flags-13-14-upsid,2023-10-16 11:34:07,"Earnings optimism has kept sentiment buoyant, with the stock futures pointing to a higher opening on Monday. The third-quarter earnings season starts in earnest this week, with some blue chip companies, including Tesla, Inc. TSLA, Netflix, Inc.",JNJ,0.100308,0.179311,Somewhat-Bullish
Is iShares Core Dividend Growth ETF  ( DGRO )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2166224/is-ishares-core-dividend-growth-etf-dgro-a-strong-etf-right-now,2023-10-16 10:20:06,Smart Beta ETF report for ...,JNJ,0.115232,0.06109,Neutral
Infinium Global Research Forecasts Robust Growth in Ophthalmic Surgical Technologies Market: Anticipates USD 2487.63 Million Value by 2030 with a Notable CAGR of 5.25%,https://www.prnewswire.com/news-releases/infinium-global-research-forecasts-robust-growth-in-ophthalmic-surgical-technologies-market-anticipates-usd-2487-63-million-value-by-2030-with-a-notable-cagr-of-5-25-301957269.html,2023-10-16 10:00:00,Infinium Global Research Forecasts Robust Growth in Ophthalmic Surgical Technologies Market: Anticipates USD ... PR ...,JNJ,0.04882,0.092574,Neutral
"Futures up ahead of earnings and data, Middle East tensions weigh",https://www.reuters.com/markets/us/futures-up-ahead-earnings-data-middle-east-tensions-weigh-2023-10-16/,2023-10-16 09:56:00,"Traders work on the floor of the New York Stock Exchange ( NYSE ) in New York City, U.S., September 28, 2023. REUTERS/Brendan McDermid/File Photo Acquire Licensing Rights",JNJ,0.085324,0.0,Neutral
TECHNICOLOR CREATIVE STUDIOS STRENGTHENS ITS LEADERSHIP STRUCTURE,https://www.benzinga.com/pressreleases/23/10/g35258709/technicolor-creative-studios-strengthens-its-leadership-structure,2023-10-16 06:04:26,"Paris ( France ) , October 16, 2023 - Technicolor Creative Studios ( TCS ) announces the evolution of its Executive Committee with: The appointment of Michael Masset as Chief People Officer The extension of StÃ©phanie Fougou's portfolio of responsibilities with the inclusion of the ...",JNJ,0.033751,0.106387,Neutral
TECHNICOLOR CREATIVE STUDIOS STRENGTHENS ITS LEADERSHIP STRUCTURE,https://www.globenewswire.com/news-release/2023/10/16/2760308/0/en/TECHNICOLOR-CREATIVE-STUDIOS-STRENGTHENS-ITS-LEADERSHIP-STRUCTURE.html,2023-10-16 06:04:00,PRESS RELEASE ...,JNJ,0.033656,0.106346,Neutral
"Wall Street's Q3 expectations have been all over the place. Now, a swing to profit growth is 'likely' - with a bigger rebound next year",https://www.marketwatch.com/story/wall-streets-q3-expectations-have-been-all-over-the-place-now-a-swing-to-profit-growth-is-likely-with-a-bigger-rebound-next-year-d12282de,2023-10-15 14:31:00,One analyst who tracks the ebbs and flows of earnings data says at least a slight profit gain for the third quarter is more likely.,JNJ,0.102888,-0.066278,Neutral
Why You Should Invest In Healthcare Stocks,https://www.kiplinger.com/investing/healthcare-stocks/why-you-should-invest-in-healthcare-stocks,2023-10-15 14:00:59,"Healthcare stocks have had a rough few years. So why invest in them? First, I'm a contrarian. I like what's down. Second, healthcare is a booming industry, accounting for 18% of gross domestic product ( GDP ) in 2021, up from 12% in 1991. Third, the sector adds stability to any portfolio.",JNJ,0.066598,0.0641,Neutral
3 Dividend Growth Stocks You Can Buy and Hold Forever,https://www.fool.com/investing/2023/10/14/3-dividend-growth-stocks-you-can-buy-and-hold-fore/,2023-10-14 10:52:00,Investors can sit back and let the dividends flow in with these great stocks.,JNJ,0.316337,0.229411,Somewhat-Bullish
"Kenvue Inc.: Please contact the Portnoy Law Firm to recover your losses; December 8, 2023 deadline - Kenvue  ( NYSE:KVUE ) ",https://www.benzinga.com/pressreleases/23/10/g35251596/kenvue-inc-please-contact-the-portnoy-law-firm-to-recover-your-losses-december-8-2023-deadline,2023-10-14 01:42:46,Investors can contact the law firm at no cost to learn more about recovering their losses,JNJ,0.079392,0.128105,Neutral
Brazil - Cosmetics Market size to increase by USD 4.72 billion between 2022 to 2027| Rise in sales of cosmetics ... - PR Newswire,https://www.prnewswire.com/news-releases/brazil---cosmetics-market-size-to-increase-by-usd-4-72-billion-between-2022-to-2027-rise-in-sales-of-cosmetics-through-e-commerce-channels-drives-the-market-growth---technavio-301955600.html,2023-10-13 23:35:00,Brazil - Cosmetics Market size to increase by USD 4.72 billion between 2022 to 2027| Rise in sales of cosmetics ... PR ...,JNJ,0.056674,0.0,Neutral
ENT Devices Market size to grow by USD 8.83 billion from 2022-2027| Market is fragmented by major companies like ... - PR Newswire,https://www.prnewswire.com/news-releases/ent-devices-market-size-to-grow-by-usd-8-83-billion-from-2022-2027-market-is-fragmented-by-major-companies-like-baxter-international-inc-siemens-healthineers-ag-johnson-and-johnson-and-much-more---technavio-301955602.html,2023-10-13 23:15:00,ENT Devices Market size to grow by USD 8.83 billion from 2022-2027| Market is fragmented by major companies like ... PR ...,JNJ,0.076358,0.059606,Neutral
Weekly Roundup,https://aap.thestreet.com/story/16135510/1/weekly-roundup.html,2023-10-13 22:56:00,"Before the week even started, we knew it had the potential to be volatile. We had just come off the September jobs report that surprised with its stunning strength, and we had the consumer and producer price index reports that would land, filling out the picture on inflation.",JNJ,0.007213,-0.057441,Neutral
Cramer's week ahead: Keep an eye on banks as earnings season kicks off,https://www.cnbc.com/2023/10/13/cramers-week-ahead-keep-an-eye-on-banks-as-earnings-season-kicks-off.html,2023-10-13 22:21:51,"CNBC's Jim Cramer on Friday told investors what to look out for next week, with numerous major names reporting earnings.",JNJ,0.097457,0.111927,Neutral
Facial Serum Market size is to grow by USD 466.23 million from 2022 to 2027 | The introduction of brands owned or ... - PR Newswire,https://www.prnewswire.com/news-releases/facial-serum-market-size-is-to-grow-by-usd-466-23-million-from-2022-to-2027--the-introduction-of-brands-owned-or-endorsed-by-celebrities-to-boost-market-growth---technavio-301955571.html,2023-10-13 22:00:00,Facial Serum Market size is to grow by USD 466.23 million from 2022 to 2027 | The introduction of brands owned or ... PR ...,JNJ,0.064623,0.117452,Neutral
"Investing Action Plan: A Change Of Season As Netflix, Tesla Face Tests",https://www.investors.com/research/investing-action-plan/investing-action-plan-a-change-of-season-as-netflix-tesla-face-tests/,2023-10-13 21:45:00,"Investing Action Plan: A Change Of Season As Netflix, Tesla Face ... Investor's Business Daily ...",JNJ,0.045874,0.016984,Neutral
"Israel-Hamas War Shakes Middle East, Inflation Reawakens, Oil Surges: The Week In The Markets - United Airlines Holdings  ( NASDAQ:UAL ) , Johnson & Johnson  ( NYSE:JNJ ) , SLB  ( NYSE:SLB ) , Bank of New York Mellon  ( NYSE:BK ) ",https://www.benzinga.com/markets/equities/23/10/35248880/israel-hamas-war-shakes-middle-east-inflation-reawakens-oil-surges-the-week-in-the-markets,2023-10-13 20:33:31,"Global geopolitical developments and domestic economic data shaped investor sentiment throughout the week, sparking fresh concerns regarding the outlook for growth and inflation. The week commenced with the eruption of conflict in the Middle East involving Israel and the Palestinian militant ...",JNJ,0.095517,0.0,Neutral
"Over Delivering: Big Banks Beat Expectations After Tough Quarter, but Market Eyes Middle East Warily - Abbott Laboratories  ( NYSE:ABT ) , American Airlines Group  ( NASDAQ:AAL ) ",https://www.benzinga.com/markets/23/10/35244544/over-delivering-big-banks-beat-expectations-after-tough-quarter-but-market-eyes-middle-east-warily,2023-10-13 16:19:33,( Friday market open ) Big bank earnings this morning threatened to take a back seat as geopolitical worries helped spark a rally in crude oil and sent more investors fleeing toward the perceived safety of fixed income. The benchmark 10-year U.S.,JNJ,0.075635,0.0,Neutral
Growing Geriatric Population Fuels Ankylosing Spondylitis Market: Management of Pain and Mobility Gains Importance in Aging Demographics,https://www.prnewswire.com/news-releases/growing-geriatric-population-fuels-ankylosing-spondylitis-market-management-of-pain-and-mobility-gains-importance-in-aging-demographics-301956060.html,2023-10-13 15:45:00,Growing Geriatric Population Fuels Ankylosing Spondylitis Market: Management of Pain and Mobility Gains Importance ... PR ...,JNJ,0.036643,0.067285,Neutral
"J&J  ( JNJ )  to Report Q3 Earnings, Its First After Unit Spin-Off",https://www.zacks.com/stock/news/2165582/jj-jnj-to-report-q3-earnings-its-first-after-unit-spin-off,2023-10-13 13:49:00,J&J's (JNJ) third-quarter results are the first quarterly update for the new company after the Consumer Health spin-off.,JNJ,0.173333,0.080645,Neutral
"UM Commerce Hosts Grand Opening of ""Marva's,"" Industry-First 360 Commerce Experience - PR Newswire",https://www.prnewswire.com/news-releases/um-commerce-hosts-grand-opening-of-marvas-industry-first-360-commerce-experience-301956034.html,2023-10-13 11:03:00,"UM Commerce Hosts Grand Opening of ""Marva's,"" Industry-First 360 Commerce Experience PR ...",JNJ,0.052226,0.187607,Somewhat-Bullish
"Ophthalmology Devices Market size to grow by USD 19.93 billion from 2022 to 2027, North America to account for 41 ... - PR Newswire",https://www.prnewswire.com/news-releases/ophthalmology-devices-market-size-to-grow-by-usd-19-93-billion-from-2022-to-2027--north-america-to-account-for-41-of-market-growth--technavio-301955503.html,2023-10-13 08:35:00,"Ophthalmology Devices Market size to grow by USD 19.93 billion from 2022 to 2027, North America to account for 41 ... PR ...",JNJ,0.06179,0.0,Neutral
Take Five: War and peace of mind,https://www.reuters.com/business/take-five/global-markets-themes-graphic-pix-2023-10-13/,2023-10-13 07:20:00,"LONDON Oct 13 ( Reuters ) - Geopolitics are at the forefront of everyone's minds after war broke out between Israel and Palestinian militant group Hamas, and the mood in markets is jittery at best.",JNJ,0.048425,0.0,Neutral
Peering Into Johnson & Johnson's Recent Short Interest - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/short-sellers/23/10/35228760/peering-into-johnson-johnsons-recent-short-interest,2023-10-12 19:45:30,"Johnson & Johnson's JNJ short percent of float has fallen 32.85% since its last report. The company recently reported that it has 22.26 million shares sold short, which is 0.92% of all regular shares that are available for trading.",JNJ,0.221819,0.081322,Neutral
"Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Kenvue Inc.  ( KVUE )  Investors and Encourages Investors to Contact the Firm Before December 8, 2023 - Kenvue  ( NYSE:KVUE ) ",https://www.benzinga.com/pressreleases/23/10/g35228334/kirby-mcinerney-llp-reminds-investors-that-a-class-action-lawsuit-has-been-filed-on-behalf-of-kenv,2023-10-12 19:22:02,"NEW YORK, Oct. 12, 2023 ( GLOBE NEWSWIRE ) -- The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S.",JNJ,0.16171,0.052379,Neutral
Stellar Ventures and Cypress Growth Capital Commit to Fueling the Future of Robotics Software,https://www.prnewswire.com/news-releases/stellar-ventures-and-cypress-growth-capital-commit-to-fueling-the-future-of-robotics-software-301955366.html,2023-10-12 18:35:00,"BOULDER, Colo., Oct. 12, 2023 /PRNewswire/ -- PickNik Robotics, ""The Unstructured Robotics Company,"" proudly announces a major milestone in its mission to bring robot arms out of factories and into our everyday lives.",JNJ,0.043658,0.235082,Somewhat-Bullish
"CPI Data Generates Calm Initial Reaction, But Some Troubling Trends Under the Surface - Citigroup  ( NYSE:C ) , Delta Air Lines  ( NYSE:DAL ) ",https://www.benzinga.com/markets/23/10/35223366/cpi-data-generates-calm-initial-reaction-but-some-troubling-trends-under-the-surface,2023-10-12 15:26:01,"( Thursday market open ) An eagerly awaited report on U.S. consumer inflation didn't appear too frightening early Thursday, and major indexes initially appeared unhindered as the October rally rolled on.",JNJ,0.041682,0.0,Neutral
Dow ETF in Focus Ahead of Q3 Earnings,https://www.zacks.com/stock/news/2165006/dow-etf-in-focus-ahead-of-q3-earnings,2023-10-12 15:10:00,"With some of the blue-chip companies having reasonable chances of coming up with an earnings surprise, investors should closely monitor the movement of the Dow ETF and grab any opportunity that arises from a surge in any of the 30 stocks.",JNJ,0.136113,0.031511,Neutral
JNJ: Johnson & Johnson  ( JNJ )  vs. Madrigal Pharmaceuticals  ( MDGL ) : Which Pharma Stock Is a Worthier October Investment?,https://stocknews.com/news/jnj-mdgl-johnson-johnson-jnj-vs-madrigal-pharmaceuticals-mdgl-which-pharma/,2023-10-12 11:49:52,JNJ: Johnson & Johnson ( JNJ ) vs. Madrigal Pharmaceuticals ... ...,JNJ,0.632922,0.16808,Somewhat-Bullish
Attention Medicare Recipients: You Could See Lower Costs for These 10 Drugs in the Not-Too-Distant Future,https://www.fool.com/retirement/2023/10/12/medicare-recipients-could-see-lower-costs-for-thes/,2023-10-12 09:15:00,Medicare will soon begin negotiations with drugmakers for the first time ever.,JNJ,0.08687,-0.129312,Neutral
"Where can you find entertainment, beaches, jobs, low cost of living and more? Here are some of the best places to live in Florida.",https://www.marketwatch.com/story/where-can-you-find-entertainment-beaches-jobs-low-cost-of-living-and-more-here-are-some-of-the-best-places-to-live-in-florida-2638454c,2023-10-12 09:02:00,"You're never far from the water, blue skies and sunshine in Florida. These cities offer thriving economies, low cost of living and a healthy active lifestyle.",JNJ,0.029025,0.149857,Neutral
Alvotech Provides Update on Status of U.S. Biologics License Application for AVT04,https://www.globenewswire.com/news-release/2023/10/12/2758971/0/en/Alvotech-Provides-Update-on-Status-of-U-S-Biologics-License-Application-for-AVT04.html,2023-10-12 08:00:00,"Alvotech ( NASDAQ: ALVO ) , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that the US Food and Drug Administration ( FDA ) has issued a complete response letter ( CRL ) for Alvotech's Biologics License ...",JNJ,0.028695,0.032211,Neutral
Alvotech Provides Update on Status of U.S. Biologics License Application for AVT04,https://www.globenewswire.com/news-release/2023/10/12/2758972/0/en/Alvotech-Provides-Update-on-Status-of-U-S-Biologics-License-Application-for-AVT04.html,2023-10-12 08:00:00,"REYKJAVIK, Iceland, Oct. 12, 2023 ( GLOBE NEWSWIRE ) -- Alvotech ( NASDAQ: ALVO ) , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that the US Food and Drug Administration ( FDA ) has issued a complete ...",JNJ,0.028388,0.125175,Neutral
Healthcare Education Solutions Market size to grow by USD 5.30 billion from 2022 to 2027 | Market is fragmented due ... - PR Newswire,https://www.prnewswire.com/news-releases/healthcare-education-solutions-market-size-to-grow-by-usd-5-30-billion-from-2022-to-2027--market-is-fragmented-due-to-the-presence-of-prominent-companies-like-3m-co-bbraun-se-and-becton-dickinson-and-co-and-many-more-301952875.html,2023-10-11 23:15:00,Healthcare Education Solutions Market size to grow by USD 5.30 billion from 2022 to 2027 | Market is fragmented due ... PR ...,JNJ,0.070725,0.086725,Neutral
Birkenstock slides about 10% in stock market debut after opening at $41 per share,https://www.cnbc.com/2023/10/11/birkenstock-ipo-birk-starts-trading-on-the-nyse.html,2023-10-11 17:34:11,German shoe brand Birkenstock made its market debut Wednesday after pricing its IPO at $46.,JNJ,0.062434,0.0,Neutral
Here's Why You Should Invest in Boston Scientific  ( BSX )  Now,https://www.zacks.com/stock/news/2164426/heres-why-you-should-invest-in-boston-scientific-bsx-now,2023-10-11 14:47:00,Investors are optimistic about Boston Scientific (BSX) on consistent growth and upbeat guidance.,JNJ,0.050044,0.070392,Neutral
The 20 companies engineering students around the world most want to work for,https://africa.businessinsider.com/careers/the-20-companies-engineering-students-around-the-world-most-want-to-work-for/yr5x4mp,2023-10-11 14:03:20,"That's based on the World's Most Attractive Employers report for this year from employer-branding company Universum. The newly published engineering-student ranking from the report, along with the other global rankings part of it, are based on how students of different college and university ...",JNJ,0.299478,0.106751,Neutral
The 20 companies engineering students around the world most want to work for,https://www.businessinsider.com/companies-engineering-students-around-world-want-to-work-for-2023-10,2023-10-11 14:03:00,Companies engineering students around the world want to work for - Business Insider ...,JNJ,0.195814,0.075947,Neutral
2 No-Brainer Dividend King Stocks to Buy Right Now,https://www.fool.com/investing/2023/10/11/2-no-brainer-dividend-king-stocks-to-buy-right-now/,2023-10-11 12:45:00,These two blue-chip stocks should hold up well in a choppy market.,JNJ,0.195287,0.282736,Somewhat-Bullish
3 Delaware Investments Mutual Funds for Solid Returns,https://www.zacks.com/stock/news/2164054/3-delaware-investments-mutual-funds-for-solid-returns,2023-10-11 09:09:00,"Invest in Delaware Investments mutual funds such as WLGYX, IDAAX and DDFAX for the opportunity to maximize your investment returns.",JNJ,0.069094,0.0,Neutral
Johnson & Johnson  ( NYSE:JNJ )  Upgraded by StockNews.com to Strong-Buy,https://www.defenseworld.net/2023/10/11/johnson-johnson-nysejnj-upgraded-by-stocknews-com-to-strong-buy.html,2023-10-11 08:02:44,Johnson & Johnson ( NYSE:JNJ ) Upgraded by StockNews.com to ... Defense World ...,JNJ,0.717663,0.495744,Bullish
"Sinus Dilation Devices Market Revenue to Cross USD 4.7 billion in 2031, Securing a 7.2% CAGR Says, Transparency Market Research",https://www.benzinga.com/pressreleases/23/10/g35183414/sinus-dilation-devices-market-revenue-to-cross-usd-4-7-billion-in-2031-securing-a-7-2-cagr-says-tr,2023-10-11 07:25:54,"Wilmington, Delaware, United States, Oct. 11, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global sinus dilation devices market is anticipated to expand at a 7.2% CAGR from 2021 to 2031. The market for sinus dilation devices is expected to reach US$ 4.7 billion by 2031.",JNJ,0.045054,0.049951,Neutral
"Johnson & Johnson Upgraded to ""Strong-Buy"" Rating by StockNews.com",https://www.claytoncountyregister.com/news2/johnson-johnson-nysejnj-stock-rating-upgraded-by-stocknews-com/564546/,2023-10-11 05:12:09,"Johnson & Johnson Upgraded to ""Strong-Buy"" Rating by StockNews ... Clayton County Register ...",JNJ,0.870696,0.434441,Bullish
"Birkenstock expects to price IPO at $46 per share, toward midpoint of stated range",https://www.cnbc.com/2023/10/10/birkenstock-expects-to-price-ipo-at-46-per-share.html,2023-10-10 20:59:39,German shoemaker Birkenstock is expected to price its IPO at $46 per share on Tuesday.,JNJ,0.101582,0.185764,Somewhat-Bullish
Johnson & Johnson Unusual Options Activity - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/10/35170396/johnson-johnson-unusual-options-activity,2023-10-10 20:00:53,"Someone with a lot of money to spend has taken a bearish stance on Johnson & Johnson JNJ. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",JNJ,0.749166,0.279992,Somewhat-Bullish
"As Middle East Conflict Continues, Yields Recede, Giving Stocks A Light Tailwind - Citigroup  ( NYSE:C ) , Delta Air Lines  ( NYSE:DAL ) ",https://www.benzinga.com/markets/23/10/35168047/as-middle-east-conflict-continues-yields-recede-giving-stocks-a-light-tailwind,2023-10-10 17:21:06,"( Tuesday market open ) Back from their three-day holiday weekend, U.S. Treasury note yields slipped early Tuesday, initially providing traction for stocks in premarket trading before the market flattened ahead of the open.",JNJ,0.042159,0.0,Neutral
Earnings Preview: Johnson & Johnson  ( JNJ )  Q3 Earnings Expected to Decline,https://www.zacks.com/stock/news/2163470/earnings-preview-johnson-johnson-jnj-q3-earnings-expected-to-decline,2023-10-10 14:00:16,Johnson & Johnson (JNJ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,JNJ,0.295273,0.083135,Neutral
"Russell Reynolds Associates, World 50 Group To Help Accelerate Executive Diversity With Third Cohort of ""Next Generation Director"" Development Program",https://www.prnewswire.com/news-releases/russell-reynolds-associates-world-50-group-to-help-accelerate-executive-diversity-with-third-cohort-of-next-generation-director-development-program-301951425.html,2023-10-10 13:00:00,"Russell Reynolds Associates, World 50 Group To Help Accelerate Executive Diversity With Third Cohort of ""Next ... PR ...",JNJ,0.04161,0.089247,Neutral
Society Pass Inc.  ( Nasdaq: SOPA )  Announces Plans to Spinout Two Profitable Business Units Into New Publicly-Traded Companies via Nasdaq IPOs in 2024,https://www.globenewswire.com/news-release/2023/10/10/2757479/0/en/Society-Pass-Inc-Nasdaq-SOPA-Announces-Plans-to-Spinout-Two-Profitable-Business-Units-Into-New-Publicly-Traded-Companies-via-Nasdaq-IPOs-in-2024.html,2023-10-10 12:30:00,"NEW YORK, NY, Oct. 10, 2023 ( GLOBE NEWSWIRE ) -- via NewMediaWire - Society Pass Inc. ( Nasdaq: SOPA ) ( ""SoPa"" or the ""Company"" ) , Southeast Asia's ( ""SEA"" ) next generation, data-driven, loyalty, fintech and e-commerce ecosystem, announces that its Board of Directors, together with its ...",JNJ,0.057559,0.070955,Neutral
"IBN Announces Latest Episode of The Bell2Bell Podcast featuring Rob Etherington, CEO of Clene Inc.",https://www.benzinga.com/pressreleases/23/10/g35160236/ibn-announces-latest-episode-of-the-bell2bell-podcast-featuring-rob-etherington-ceo-of-clene-inc,2023-10-10 12:17:00,"LOS ANGELES, Oct. 10, 2023 ( GLOBE NEWSWIRE ) -- via IBN -- IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The Bell2Bell Podcast as part of its sustained effort to ...",JNJ,0.028695,0.182241,Somewhat-Bullish
Should You Invest in the Fidelity MSCI Health Care Index ETF  ( FHLC ) ?,https://www.zacks.com/stock/news/2163168/should-you-invest-in-the-fidelity-msci-health-care-index-etf-fhlc,2023-10-10 10:20:06,Sector ETF report for ...,JNJ,0.12546,0.049458,Neutral
Should You Invest in the iShares U.S. Pharmaceuticals ETF  ( IHE ) ?,https://www.zacks.com/stock/news/2163169/should-you-invest-in-the-ishares-us-pharmaceuticals-etf-ihe,2023-10-10 10:20:05,Sector ETF report for ...,JNJ,0.132004,0.063692,Neutral
Should iShares Core High Dividend ETF  ( HDV )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2163163/should-ishares-core-high-dividend-etf-hdv-be-on-your-investing-radar,2023-10-10 10:20:05,Style Box ETF report for ...,JNJ,0.122894,0.068464,Neutral
Is Vanguard High Dividend Yield ETF  ( VYM )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2163174/is-vanguard-high-dividend-yield-etf-vym-a-strong-etf-right-now,2023-10-10 10:20:05,Smart Beta ETF report for ...,JNJ,0.121037,0.061185,Neutral
"Shake it off: Travis Kelce hip to Taylor Swift's lyrics as he slips free from injury, Rodgers insult",https://apnews.com/article/behind-call-kelce-rodgers-2f0725e098511f88ba36a25faa760503,2023-10-10 10:00:00,"Need another sign that Travis Kelce and Taylor Swift are simply meant to be together or ""Tayvis"" or besties or whatever it is they are? How about this: the Kansas City Chiefs star tight end just spent Week 5 dealing with both a gnarly-looking sprained ankle and a needless dig from Aaron Rodgers ...",JNJ,0.100941,-0.027953,Neutral
New Equity Research Report Recommends 'Buy' Rating for Virtualware  ( EPA:MLVIR )  with â‚¬10 Price Target,https://www.globenewswire.com/news-release/2023/10/10/2757117/0/en/New-Equity-Research-Report-Recommends-Buy-Rating-for-Virtualware-EPA-MLVIR-with-10-Price-Target.html,2023-10-10 05:45:00,"New York and Bilbao, Spain, 10, October.- Litchfield Hills Research initiated coverage of Virtualware ( ENXTPA: MLVIR ) with a 'Buy' rating and â‚¬10 ( $10.56 ) price target, according to an equity research report published and distributed Monday.",JNJ,0.047278,0.097811,Neutral
"The Evolving Market Dynamics of Factor-based Bleeding Disorders: Hemophilia A, Hemophilia B, and Von Willebrand Disease | Key Analysis by DelveInsight",https://www.prnewswire.com/news-releases/the-evolving-market-dynamics-of-factor-based-bleeding-disorders-hemophilia-a-hemophilia-b-and-von-willebrand-disease--key-analysis-by-delveinsight-301950491.html,2023-10-09 21:01:00,"The Evolving Market Dynamics of Factor-based Bleeding Disorders: Hemophilia A, Hemophilia B, and Von Willebrand ... PR ...",JNJ,0.036338,0.033442,Neutral
Penny Stocks To Buy This Week? Analysts Like These 3,https://pennystocks.com/featured/2023/10/09/penny-stocks-to-buy-this-week-analysts-like-these-3/,2023-10-09 20:06:08,"Penny Stocks: Using Analyst Sentiment and Research for Smart Trading Penny stocks are shares of small companies priced under $5 per share. While the potential returns can be alluring, penny stocks carry high risk. Thorough research is essential before trading.",JNJ,0.031446,-0.001896,Neutral
Looking At Johnson & Johnson's Recent Unusual Options Activity - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/10/35150435/looking-at-johnson-johnsons-recent-unusual-options-activity,2023-10-09 19:01:14,"A whale with a lot of money to spend has taken a noticeably bearish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson JNJ we detected 16 strange trades. If we consider the specifics of each trade, it is accurate to state that 37% of the investors opened trades with ...",JNJ,0.677342,0.056099,Neutral
J&J  ( JNJ )  Seeks EU Nod for Rybrevant for First-Line NSCLC,https://www.zacks.com/stock/news/2162746/jj-jnj-seeks-eu-nod-for-rybrevant-for-first-line-nsclc,2023-10-09 15:10:00,J&J (JNJ) files an application in Europe seeking expanded approval for Rybrevant as a first-line combination treatment in patients with advanced or metastatic EGFR exon 20 insertion mutation-positive NSCLC.,JNJ,0.245959,-0.059285,Neutral
Janssen Highlights Latest Research for TREMFYAÂ®  ( guselkumab )  and Investigational Targeted Oral Peptide JNJ-2113 in Moderate to Severe Plaque Psoriasis at the European Academy of Dermatology and Venereology  ( EADV )  Congress,https://www.prnewswire.com/news-releases/janssen-highlights-latest-research-for-tremfya-guselkumab-and-investigational-targeted-oral-peptide-jnj-2113-in-moderate-to-severe-plaque-psoriasis-at-the-european-academy-of-dermatology-and-venereology-eadv-congress-301949936.html,2023-10-09 11:31:00,Janssen Highlights Latest Research for TREMFYAÂ® ( guselkumab ) and Investigational Targeted Oral Peptide JNJ-2113 ... PR ...,JNJ,0.335845,0.046641,Neutral
Meet the 3 Dividend Kings Warren Buffett Is Betting $21 Billion On,https://www.fool.com/investing/2023/10/09/3-dividend-kings-warren-buffett-bet-21-billion-on/,2023-10-09 09:21:00,Three dividend stocks that have each increased their base annual payout for more than 60 years account for $21 billion of Berkshire Hathaway's $337 billion of invested assets.,JNJ,0.157278,0.22646,Somewhat-Bullish
J&J : Data Suggest Esketamine More Effective Than Typical Treatments In Major Depressive Disorder,https://markets.businessinsider.com/news/stocks/j-j-data-suggest-esketamine-more-effective-than-typical-treatments-in-major-depressive-disorder-1032686618,2023-10-08 17:18:42,( RTTNews ) - The new safety data from the ESCAPE-TRD Phase 3b study suggested Johnson & Johnson's Spravato or esketamine nasal spray was more tolerable and effective compared to quetiapine extended-release in adults with treatment-resistant major depressive disorder.,JNJ,0.181137,-0.143264,Neutral
My Top Under-Appreciated Dividend King to Buy in October,https://www.fool.com/investing/2023/10/08/my-top-under-appreciated-dividend-king-buy-october/,2023-10-08 09:57:00,This company is putting on a clinic on how to operate as a successful industrial conglomerate.,JNJ,0.039224,0.094794,Neutral
Johnson & Johnson produces documents in DoJ civil investigation of eye products,https://www.reuters.com/business/healthcare-pharmaceuticals/johnson-johnson-produces-documents-doj-civil-investigation-eye-products-2023-10-27/,2023-10-27 21:23:00,"The logo of Johnson & Johnson is seen on a Brussels' office of the company in Diegem, Belgium September 21, 2023. REUTERS/Yves Herman/File Photo Acquire Licensing Rights Oct 27 ( Reuters ) - Johnson & Johnson ( JNJ.N ) has begun providing documents and information in response to a civil ...",JNJ,0.760593,0.420122,Bullish
"Kessler Topaz Meltzer & Check, LLP ANNOUNCES A SECURITIES FRAUD CLASS ACTION FILED AGAINST KENVUE INC. - Kenvue  ( NYSE:KVUE ) ",https://www.benzinga.com/pressreleases/23/10/g35474631/kessler-topaz-meltzer-check-llp-announces-a-securities-fraud-class-action-filed-against-kenvue-inc,2023-10-27 21:01:59,"RADNOR, Pa., Oct. 27, 2023 ( GLOBE NEWSWIRE ) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the District of New Jersey against Kenvue Inc. ( ""Kenvue"" ) KVUE. ...",JNJ,0.057079,0.129961,Neutral
Is Ozempic Killing Liposuction? A Stock That Could Get Hit Hard From New Weight-Loss Drugs - Novo Nordisk  ( NYSE:NVO ) ,https://www.benzinga.com/general/health-care/23/10/35469218/is-ozempic-killing-liposuction-a-stock-that-could-get-hit-hard-from-new-weight-loss-drugs,2023-10-27 19:15:55,"Ozempic, Novo Nordisk's NVO diabetes drug, is now popular for weight loss. The rise of the drug could become a major headwind for other companies that provide weight-loss services such as liposuction and bariatric surgeries. Some companies are already seeing the impact of widespread Ozempic use.",JNJ,0.316846,-0.31328,Somewhat-Bearish
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Kenvue Inc. - KVUE - Kenvue  ( NYSE:KVUE ) ,https://www.benzinga.com/pressreleases/23/10/g35470371/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-kenvue-inc-kvue,2023-10-27 17:42:47,"NEW YORK, Oct. 27, 2023 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Kenvue Inc. ( ""Kenvue"" or the ""Company"" ) KVUE. Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.",JNJ,0.115787,0.021477,Neutral
"AbbVie  ( ABBV )  Q3 Earnings Beat, Shares Down Despite Raised View",https://www.zacks.com/stock/news/2173886/abbvie-abbv-q3-earnings-beat-shares-down-despite-raised-view,2023-10-27 14:51:00,"AbbVie's (ABBV) third-quarter 2023 earnings and sales beat estimates. Though the company raised its EPS outlook for both 2023 and 2024, share price dives as some key drugs misses out on estimates.",JNJ,0.074345,0.131252,Neutral
"FDA Gives Nod To Eli Lilly's First Treatment For Type Of Inflammatory Bowel Disease, To Compete With JNJ, Pfizer, AbbVie - Eli Lilly  ( NYSE:LLY ) ",https://www.benzinga.com/general/biotech/23/10/35465199/fda-gives-nod-to-eli-lillys-first-treatment-for-type-of-inflammatory-bowel-disease-to-compete-wit,2023-10-27 14:28:19,"The FDA approved Eli Lilly And Co's LLY Omvoh ( mirikizumab-mrkz ) for moderately to severely active ulcerative colitis ( UC ) in adults, marking Lilly's first approved treatment for a type of inflammatory bowel disease.",JNJ,0.2872,0.447515,Bullish
Sanofi loses $21 bn in market value after dropping 2025 profit target,https://www.business-standard.com/companies/news/sanofi-loses-21-bn-in-market-value-after-dropping-2025-profit-target-123102701074_1.html,2023-10-27 14:18:23,"Sanofi stock plunged on Friday, wiping 20 billion euros ( $21 billion ) off its market value, after it abandoned its 2025 profit target under a plan to list its consumer healthcare business to focus on its core innovative drugs business.",JNJ,0.049526,0.001999,Neutral
Is iShares Core High Dividend ETF  ( HDV )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2173449/is-ishares-core-high-dividend-etf-hdv-a-strong-etf-right-now,2023-10-27 10:20:07,Smart Beta ETF report for ...,JNJ,0.113329,0.060706,Neutral
Global Medical Robotics Market is Forecast to Reach a Value of USD 28.77 Billion By 2030 with a Growing CAGR of 14.94% | Infinium Global Research,https://www.prnewswire.com/news-releases/global-medical-robotics-market-is-forecast-to-reach-a-value-of-usd-28-77-billion-by-2030-with-a-growing-cagr-of-14-94--infinium-global-research-301970015.html,2023-10-27 10:03:00,Global Medical Robotics Market is Forecast to Reach a Value of USD 28.77 Billion By 2030 with a Growing CAGR of ... PR ...,JNJ,0.038101,0.066226,Neutral
"Sanofi shares plunge after 2025 target dropped, consumer unit marked for spin-off",https://www.reuters.com/business/healthcare-pharmaceuticals/sanofi-considering-consumer-unit-listing-late-next-year-2023-10-27/,2023-10-27 08:00:00,"Sanofi shares plunge after 2025 target dropped, consumer unit marked for ...",JNJ,0.056943,0.002002,Neutral
Sanofi takes page from rivals' separation playbook,https://www.reuters.com/business/healthcare-pharmaceuticals/sanofi-takes-page-rivals-separation-playbook-2023-10-27/,2023-10-27 07:36:00,"FILE PHTOO: The logo of French drugmaker Sanofi is seen a the Sanofi Genzyme Polyclonals in Lyon, France, September 30, 2023. REUTERS/Gonzalo Fuentes/File photo Acquire Licensing Rights",JNJ,0.100729,-0.018451,Neutral
Analysis: Healthcare companies counter investor worries over Wegovy effect,https://www.reuters.com/business/healthcare-pharmaceuticals/healthcare-companies-counter-investor-worries-over-wegovy-effect-2023-10-27/,2023-10-27 05:00:20,"A selection of injector pens for the Wegovy weight loss drug are shown in this photo illustration in Chicago, Illinois, U.S., March 31, 2023. REUTERS/Jim Vondruska/Illustration/File Photo Acquire Licensing Rights",JNJ,0.049221,-0.129072,Neutral
"Wound Care Market to grow by USD 6.83 billion from 2022 to 2027|3M Co., Advancis Medical, Avery Dennison Corp ... - PR Newswire",https://www.prnewswire.com/news-releases/wound-care-market-to-grow-by-usd-6-83-billion-from-2022-to-20273m-co-advancis-medical-avery-dennison-corp-axio-biosolutions-pvt-ltd-and-more-among-the-key-companies-in-the-market---technavio-301969520.html,2023-10-27 03:00:00,"Wound Care Market to grow by USD 6.83 billion from 2022 to 2027|3M Co., Advancis Medical, Avery Dennison Corp ... PR ...",JNJ,0.04872,0.082671,Neutral
Kenvue  ( KVUE )  Q3 2023 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/10/26/kenvue-kvue-q3-2023-earnings-call-transcript/,2023-10-26 18:30:24,"KVUE earnings call for the period ending September 30, 2023.",JNJ,0.009953,0.185623,Somewhat-Bullish
JNJ: 3 Pharma Stocks on the Rise - Buy Now,https://stocknews.com/news/jnj-azn-sny-3-pharma-stocks-on-the-rise-buy-now/,2023-10-26 15:48:43,"The pharmaceutical industry is set to grow in the coming years thanks to an aging population, chronic diseases, and new technologies. In this article, we'll look at the fundamentals of three pharma stocks, Sanofi ( SNY ) , Johnson & Johnson ( JNJ ) and AstraZeneca PLC ( AZN ) , which can boost ...",JNJ,0.202648,0.136799,Neutral
"Scleroderma Market Outlook 2023-2027: Expected Market Size, Growth Drivers, And Key Trends As Per The Business Research Company's Scleroderma Global Market Report 2023",https://www.benzinga.com/pressreleases/23/10/g35444019/scleroderma-market-outlook-2023-2027-expected-market-size-growth-drivers-and-key-trends-as-per-the,2023-10-26 15:30:00,"LONDON, Oct. 26, 2023 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Scleroderma Global Market Report 2023, the global scleroderma market is on an upward trajectory, with expectations of reaching $2.15 billion in 2023, signifying a compound annual growth rate ( CAGR ) of 7.5%.",JNJ,0.068698,0.071658,Neutral
"Fatty Liver Treatment Market Is Set To Grow At A CAGR Of 6%, Driven By Rise In Alcohol Consumption As Per The Business Research Company's Fatty Liver Treatment Global Market Report 2023",https://www.benzinga.com/pressreleases/23/10/g35444012/fatty-liver-treatment-market-is-set-to-grow-at-a-cagr-of-6-driven-by-rise-in-alcohol-consumption-a,2023-10-26 15:30:00,"LONDON, Oct. 26, 2023 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Fatty Liver Treatment Global Market Report 2023, the global fatty liver treatment market is gearing up for substantial growth, expected to rise from $20.83 billion in 2022 to $22.17 billion in 2023, with a ...",JNJ,0.05749,0.06602,Neutral
"Build Relationships that Drive Revenue at Transform 2023, Hosted by Showpad",https://www.benzinga.com/pressreleases/23/10/g35441300/build-relationships-that-drive-revenue-at-transform-2023-hosted-by-showpad,2023-10-26 14:13:24,"Discover the trends shaping the industry and hear first-hand from sales enablement experts at Stanley Black & Decker, Kaiser Permanente, Regal Rexnord, and LastPass, on how to unlock sales potential at Showpad's Transform 2023",JNJ,0.043818,0.067432,Neutral
"Kenvue tempers annual profit view on soft demand for cold, flu medicines",https://www.reuters.com/business/healthcare-pharmaceuticals/kenvue-reports-higher-q3-revenue-self-care-products-strength-2023-10-26/,2023-10-26 14:11:00,"[1/2] The company logo for Kenvue Inc. Johnson & Johnson's consumer-health business, is displayed on a screen during the company's IPO at the New York Stock Exchange ( NYSE ) in New York City, U.S., May 4, 2023. REUTERS/Brendan McDermid/File Photo Acquire Licensing Rights",JNJ,0.105604,-0.045208,Neutral
2 Magnificent Dividend Stocks That Could Deliver a Lifetime of Passive Income,https://www.fool.com/investing/2023/10/26/2-magnifient-dividend-stocks-that-could-deliver-a/,2023-10-26 11:45:00,These two healthcare stocks are proven passive income vehicles.,JNJ,0.1331,0.090457,Neutral
3 Pharma Stocks That Are Screaming Buys in October,https://www.fool.com/investing/2023/10/26/3-pharma-stocks-that-are-screaming-buys-in-october/,2023-10-26 11:30:00,Each company delivers an above-average dividend and revenue growth.,JNJ,0.188781,0.100446,Neutral
Johnson & Johnson  ( NYSE:JNJ )  Upgraded to Strong-Buy at StockNews.com,https://www.defenseworld.net/2023/10/26/johnson-johnson-nysejnj-upgraded-to-strong-buy-at-stocknews-com.html,2023-10-26 07:22:46,Johnson & Johnson ( NYSE:JNJ ) Upgraded to Strong-Buy at ... Defense World ...,JNJ,0.806749,0.538381,Bullish
InnovationRx: Ransomware Attacks On U.S. Health Systems Have Cost The Economy Nearly $80 Billion,https://www.forbes.com/sites/alexknapp/2023/10/25/innovationrx-ransomware-attacks-on-us-health-systems-have-cost-the-economy-nearly-8-billion/,2023-10-26 00:42:47,"InnovationRx is your weekly digest of healthcare news. To get it in your inbox, subscribe here.",JNJ,0.05339,-0.292031,Somewhat-Bearish
Icertis Named a Leader in 2023 GartnerÂ® Magic Quadrantâ„¢ for Contract Life Cycle Management,https://www.prnewswire.com/news-releases/icertis-named-a-leader-in-2023-gartner-magic-quadrant-for-contract-life-cycle-management-301966992.html,2023-10-25 16:30:00,"BELLEVUE, Wash., Oct. 25, 2023 /PRNewswire/ -- Icertis announced today that it has been named a Leader in the 2023 Gartner Magic Quadrant for Contract Life Cycle Management ( CLM ) 1.",JNJ,0.047278,0.095863,Neutral
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Kenvue Inc.  ( KVUE )  - Kenvue  ( NYSE:KVUE ) ,https://www.benzinga.com/pressreleases/23/10/g35418916/glancy-prongay-murray-llp-reminds-investors-of-looming-deadline-in-the-class-action-lawsuit-agains,2023-10-25 15:23:00,"LOS ANGELES, Oct. 25, 2023 ( GLOBE NEWSWIRE ) -- Glancy Prongay & Murray LLP ( ""GPM"" ) reminds investors of the upcoming December 8, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Kenvue Inc. ( ""Kenvue"" or the ...",JNJ,0.062597,0.086023,Neutral
Transdermal Drug Delivery System Market to Hit 4.3% CAGR with Transdermal Gels Segment Driving Growth During 2022-2030 | The Insight Partners,https://www.benzinga.com/pressreleases/23/10/g35417362/transdermal-drug-delivery-system-market-to-hit-4-3-cagr-with-transdermal-gels-segment-driving-grow,2023-10-25 14:40:15,"Pune, India, Oct. 25, 2023 ( GLOBE NEWSWIRE ) -- Transdermal drug delivery systems are dosage forms actively used to deliver a therapeutically effective amount of drug across a patient's skin.",JNJ,0.025817,0.061488,Neutral
"Drug, Biotech Stocks' Q3 Earnings Due on Oct 26: BMY, MRK, BPMC",https://www.zacks.com/stock/news/2171776/drug-biotech-stocks-q3-earnings-due-on-oct-26-bmy-mrk-bpmc,2023-10-25 14:15:00,"Let's look at three biotech/drug companies, BMY, MRK and BPMC, slated to release quarterly results on Oct 26.",JNJ,0.101582,0.131226,Neutral
"Surgical Robots Market to Hit 14.8% CAGR, Globally Driven by Increase in Surgical Procedures During 2022-2028 | The Insight Partners",https://www.benzinga.com/pressreleases/23/10/g35416590/surgical-robots-market-to-hit-14-8-cagr-globally-driven-by-increase-in-surgical-procedures-during-,2023-10-25 14:09:19,"Pune, India, Oct. 25, 2023 ( GLOBE NEWSWIRE ) -- Surgical Robots are robotic systems operated by surgeons consisting of miniaturized surgical instruments mounted on robotic arms. These are controlled by the surgeons on a computer console that offers HD and a magnified 3-D view of the surgical ...",JNJ,0.034185,0.097864,Neutral
Powerful senators fire off letter decrying 'abusive' tactics in Corizon bankruptcy,https://www.businessinsider.com/senator-warren-oversight-letter-on-corizon-tehum-yescare-bankruptcy-deal-2023-10,2023-10-25 12:00:00,Senators press for answers from executives of Corizon successor companies - Business Insider ...,JNJ,0.029113,-0.073979,Neutral
"Self-Diagnostic Medical Devices Market Size Worth $39.88 Billion, Globally, by 2030- Exclusive Report by The Insight Partners",https://www.benzinga.com/pressreleases/23/10/g35410523/self-diagnostic-medical-devices-market-size-worth-39-88-billion-globally-by-2030-exclusive-report-,2023-10-25 09:30:22,"Pune, India, Oct. 25, 2023 ( GLOBE NEWSWIRE ) -- According to our new research study on ""Self-Diagnostic Medical Devices Market covers analysis By Product Type ( Wearable Devices, Implantable Devices, Handheld/Portable Devices, Stationary Devices, and Others ) , Component ( Software, Devices, ...",JNJ,0.040553,0.095195,Neutral
2 Exceptional Dividend Stocks Near 52-Week Lows. Are They Bargains Now?,https://www.fool.com/investing/2023/10/25/2-exceptional-dividend-stocks-near-52-week-lows-ar/,2023-10-25 09:19:00,Attractive valuation metrics don't always tell the whole story.,JNJ,0.122581,0.240911,Somewhat-Bullish
"The Global AI In Healthcare Diagnosis Market Set For Explosive Growth, Projected To Reach $71.24 Billion By 2027 As Per The Business Research Company's Artificial Intelligence In Healthcare Diagnosis Global Market Report 2023",https://www.benzinga.com/pressreleases/23/10/g35397852/the-global-ai-in-healthcare-diagnosis-market-set-for-explosive-growth-projected-to-reach-71-24-bil,2023-10-24 15:35:00,"LONDON, Oct. 24, 2023 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Artificial Intelligence In Healthcare Diagnosis Global Market Report 2023, the global Artificial Intelligence ( AI ) in healthcare diagnosis market is poised for a remarkable surge, with a projected growth from ...",JNJ,0.055621,0.240059,Somewhat-Bullish
JNJ: Should You Invest in Johnson & Johnson  ( JNJ )  Following Q3 Results,https://stocknews.com/news/jnj-nvs-abbv-nvo-should-you-invest-in-johnson-johnson-jnj-following-q3/,2023-10-24 14:44:18,JNJ: Should You Invest in Johnson & Johnson ( JNJ ) Following Q3 ... ...,JNJ,0.628234,0.331411,Somewhat-Bullish
3 High-Yielding Dividend Stocks Near Their 52-Week Lows,https://www.fool.com/investing/2023/10/24/3-high-yielding-dividend-stocks-near-their-52-week/,2023-10-24 11:45:00,"Due to their declining share prices, Johnson & Johnson, Bank of America, and Target all yield more than 3% right now.",JNJ,0.321673,0.209912,Somewhat-Bullish
"The Best Stocks to Invest $5,000 In Right Now",https://www.fool.com/investing/2023/10/24/the-best-stocks-to-invest-5000-in-right-now/,2023-10-24 09:30:00,"Today, the following three healthcare players look like fantastic bargains.",JNJ,0.102668,0.175114,Somewhat-Bullish
2 Historically Cheap Dow Dividend Kings That Are Ripe for the Picking,https://www.fool.com/investing/2023/10/24/2-cheap-dow-dividend-kings-are-ripe-for-picking/,2023-10-24 09:21:00,These inexpensive Dow components have achieved royalty status among income stocks -- more than 60 consecutive years of dividend increases.,JNJ,0.298567,0.116827,Neutral
Idorsia announces financial results for the first nine months of 2023 - adapting the company to create sustainable value,https://www.globenewswire.com/news-release/2023/10/24/2765251/0/en/Idorsia-announces-financial-results-for-the-first-nine-months-of-2023-adapting-the-company-to-create-sustainable-value.html,2023-10-24 05:00:00,Ad hoc announcement pursuant to Art. 53 LR ...,JNJ,0.011574,0.0,Neutral
Phase 3 MARIPOSA-2 Study Shows RYBREVANTÂ®  ( amivantamab-vmjw )  Plus Chemotherapy Given with or without Lazertinib Reduced Risk of Disease Progression or Death by 56 and 52 Percent Respectively in Patients with EGFR-Mutated Non-Small Cell Lung Cancer who Progressed on or after Osimertinib,https://www.prnewswire.com/news-releases/phase-3-mariposa-2-study-shows-rybrevant-amivantamab-vmjw-plus-chemotherapy-given-with-or-without-lazertinib-reduced-risk-of-disease-progression-or-death-by-56-and-52-percent-respectively-in-patients-with-egfr-mutated-non-small-301964621.html,2023-10-23 14:44:00,Phase 3 MARIPOSA-2 Study Shows RYBREVANTÂ® ( amivantamab-vmjw ) Plus Chemotherapy Given with or without ... PR ...,JNJ,0.058,0.020062,Neutral
Charles River  ( CRL )  Offers Access to Preclinical Cancer Research,https://www.zacks.com/stock/news/2170290/charles-river-crl-offers-access-to-preclinical-cancer-research,2023-10-23 14:10:00,Charles River (CRL) contributes to 84 percent of the FDA-approved cancer medicines and provides partners with 16 oncology prospects.,JNJ,0.172097,0.118379,Neutral
Johnson & Johnson  ( JNJ )  Is a Trending Stock: Facts to Know Before Betting on It,https://www.zacks.com/stock/news/2170161/johnson-johnson-jnj-is-a-trending-stock-facts-to-know-before-betting-on-it,2023-10-23 13:00:10,"Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",JNJ,0.47672,0.133307,Neutral
New Phase 3 TREMFYAÂ®  ( guselkumab )  Results in Ulcerative Colitis Show a 77 Percent Overall Clinical Response Rate and Early Symptom Improvement,https://www.prnewswire.com/news-releases/new-phase-3-tremfya-guselkumab-results-in-ulcerative-colitis-show-a-77-percent-overall-clinical-response-rate-and-early-symptom-improvement-301963553.html,2023-10-23 11:31:00,New Phase 3 TREMFYAÂ® ( guselkumab ) Results in Ulcerative Colitis Show a 77 Percent Overall Clinical Response ... PR ...,JNJ,0.215149,0.01562,Neutral
The 3 Safest Warren Buffett Stocks to Buy and Hold for the Next 20 Years,https://www.fool.com/investing/2023/10/23/the-3-safest-warren-buffett-stocks-to-buy-and-hold/,2023-10-23 10:50:00,These stocks are less risky than most.,JNJ,0.06623,0.105469,Neutral
AbbVie  ( ABBV )  to Report Q3 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2170056/abbvie-abbv-to-report-q3-earnings-whats-in-the-cards,2023-10-23 08:32:00,AbbVie's (ABBV) Q3 performance will likely reflect its newer immunotherapy drugs trying to compensate for declining Humira sales following the loss of U.S. exclusivity.,JNJ,0.043264,0.115711,Neutral
"Down in the Double Digits, These 2 Classic Warren Buffett Stocks Make Great Buys Now",https://www.fool.com/investing/2023/10/22/down-double-digits-these-buffett-stocks-are-buys/,2023-10-22 10:50:00,These players could deliver top returns over the long haul.,JNJ,0.106305,0.015372,Neutral
3 Foundational Blue Chip Dow Dividend Stocks for Building Generational Wealth,https://www.fool.com/investing/2023/10/22/3-foundational-blue-chip-dow-dividend-stocks/,2023-10-22 09:03:00,Dow stocks can provide the confidence needed to hold through periods of volatility.,JNJ,0.157227,0.098489,Neutral
Final Multivariate Analysis from the Phase 3 MAGNITUDE Study Shows Trend Toward Improvement in Overall Survival in Patients with Metastatic Castration-Resistant Prostate Cancer with BRCA Alterations Treated with Niraparib and Abiraterone Acetate Plus Prednisone,https://www.prnewswire.com/news-releases/final-multivariate-analysis-from-the-phase-3-magnitude-study-shows-trend-toward-improvement-in-overall-survival-in-patients-with-metastatic-castration-resistant-prostate-cancer-with-brca-alterations-treated-with-niraparib-and-abir-301963785.html,2023-10-22 06:30:00,Final Multivariate Analysis from the Phase 3 MAGNITUDE Study Shows Trend Toward Improvement in Overall Survival ... PR ...,JNJ,0.085411,0.023147,Neutral
New Data from Phase 3 PAPILLON Study Show RYBREVANTÂ®  ( amivantamab-vmjw )  Plus Chemotherapy Resulted in 60 Percent Reduction in Risk of Disease Progression or Death in Patients with Previously Untreated EGFR Exon 20 Insertion Mutation-Positive Non-Small Cell Lung Cancer,https://www.prnewswire.com/news-releases/new-data-from-phase-3-papillon-study-show-rybrevant-amivantamab-vmjw-plus-chemotherapy-resulted-in-60-percent-reduction-in-risk-of-disease-progression-or-death-in-patients-with-previously-untreated-egfr-exon-20-insertion-mutati-301963753.html,2023-10-21 14:30:00,New Data from Phase 3 PAPILLON Study Show RYBREVANTÂ® ( amivantamab-vmjw ) Plus Chemotherapy Resulted in ... PR ...,JNJ,0.073418,0.020485,Neutral
2 Warren Buffett Dividend Stocks to Buy and Hold Forever,https://www.fool.com/investing/2023/10/21/2-warren-buffett-dividend-stocks-to-buy-and-hold/,2023-10-21 14:07:00,Most people have come across these companies' services.,JNJ,0.417995,0.316087,Somewhat-Bullish
Bull Market or Recession? 2 Resilient Index Funds That Are Proven Moneymakers to Buy Now and Hold Forever  ( No Matter What Comes Next ) ,https://www.fool.com/investing/2023/10/21/bull-market-or-recession-2-index-funds-to-buy-now/,2023-10-21 11:07:00,"Through economic booms and recessions, bull markets and bear markets, these resilient index funds have consistently made money for patient investors.",JNJ,0.044222,-0.181439,Somewhat-Bearish
These 2 Dow Stocks Moved Markets This Week,https://www.fool.com/investing/2023/10/21/these-2-dow-stocks-moved-markets-this-week/,2023-10-21 10:27:00,Bulls and bears alike looked closely at these two companies.,JNJ,0.436947,0.298936,Somewhat-Bullish
Intuitive Surgical's Revenue Dipped: Is It Time to Sell?,https://www.fool.com/investing/2023/10/21/intuitive-surgicals-revenue-dipped-is-it-time-to-s/,2023-10-21 09:27:00,"A stagnating top line isn't what investors want to see, but things might not be as bad as the surgical robot specialist's stock price performance would suggest.",JNJ,0.111747,0.027716,Neutral
Results from Phase 2 THOR-2 Study Show Improved Rates of Recurrence-Free Survival in Patients with High-Risk Non-Muscle-Invasive Bladder Cancer with Select Fibroblast Growth Factor Receptor Alterations Treated with BALVERSAÂ®  ( erdafitinib )  Versus Chemotherapy,https://www.prnewswire.com/news-releases/results-from-phase-2-thor-2-study-show-improved-rates-of-recurrence-free-survival-in-patients-with-high-risk-non-muscle-invasive-bladder-cancer-with-select-fibroblast-growth-factor-receptor-alterations-treated-with-balversa-erda-301963725.html,2023-10-21 06:58:00,Results from Phase 2 THOR-2 Study Show Improved Rates of Recurrence-Free Survival in Patients with High-Risk Non ... PR ...,JNJ,0.099418,0.010968,Neutral
Stocks Struggle As Yields Soar; Tesla Tumbles: Weekly Review,https://www.investors.com/news/stock-market-struggles-as-treasury-yields-soar-tesla-nvidia-among-notable-losers/,2023-10-20 15:49:00,"Stock Market Struggles As Treasury Yields Soar. Tesla, Nvidia ... Investor's Business Daily ...",JNJ,0.044469,-0.064247,Neutral
"Janssen Announces TREMFYAÂ®  ( guselkumab )  Demonstrates Significant Skin Clearance in First-of-its-Kind Prospective, Large-Scale Study Dedicated to People of Color Living with Moderate to Severe Plaque Psoriasis",https://www.prnewswire.com/news-releases/janssen-announces-tremfya-guselkumab-demonstrates-significant-skin-clearance-in-first-of-its-kind-prospective-large-scale-study-dedicated-to-people-of-color-living-with-moderate-to-severe-plaque-psoriasis-301963282.html,2023-10-20 14:25:00,Janssen Announces TREMFYAÂ® ( guselkumab ) Demonstrates Significant Skin Clearance in First-of-its-Kind ... PR ...,JNJ,0.108222,0.006817,Neutral
CVS Health pulls some cough-and-cold treatments with ingredient deemed ineffective by doctors,https://apnews.com/article/cvs-health-cold-medications-phenylephrine-c8953a17b8e404cfe9e4a37d76993dc4,2023-10-20 14:24:00,"CVS pulls some cough, cold medicines containing phenylephrine off shelves The Associated Press ...",JNJ,0.117486,-0.078822,Neutral
Medical device makers see limited hit from weight-loss drugs,https://www.reuters.com/business/healthcare-pharmaceuticals/medical-device-makers-see-limited-hit-weight-loss-drugs-2023-10-20/,2023-10-20 14:18:00,"[1/2] Boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, is seen at a Rock Canyon Pharmacy in Provo, Utah, U.S. March 29, 2023. REUTERS/George Frey/File Photo Acquire Licensing Rights",JNJ,0.156461,-0.029172,Neutral
First pill for dengue shows promise in human challenge trial,https://www.reuters.com/business/healthcare-pharmaceuticals/first-pill-dengue-shows-promise-human-challenge-trial-2023-10-20/,2023-10-20 08:11:00,"[1/2] An assistant holds a test tube with an Aedes aegypti mosquito at the CNEA ( National Atomic Energy Commission ) , in Ezeiza, in the outskirts of Buenos Aires, Argentina April 12, 2023. REUTERS/Agustin Marcarian/File Photo Acquire Licensing Rights",JNJ,0.078354,0.013549,Neutral
"Striving Together For A Thriving Industry, International Biopharma Industry Week Shanghai 2023 Opens",https://www.prnewswire.com/apac/news-releases/striving-together-for-a-thriving-industry-international-biopharma-industry-week-shanghai-2023-opens-301962953.html,2023-10-20 07:29:00,"SHANGHAI, Oct. 20, 2023 /PRNewswire/ -- On October 16th, the inaugural ceremony of the 2023 International Biopharma Industry Week Shanghai ( IBIWS 2023 ) unfolded at the Zhangjiang Science Hall in Shanghai.",JNJ,0.019364,0.190474,Somewhat-Bullish
StockNews.com Downgrades Johnson & Johnson  ( NYSE:JNJ )  to Buy,https://www.defenseworld.net/2023/10/20/stocknews-com-downgrades-johnson-johnson-nysejnj-to-buy.html,2023-10-20 07:10:42,"Johnson & Johnson ( NYSE:JNJ - Get Free Report ) was downgraded by equities research analysts at StockNews.com from a ""strong-buy"" rating to a ""buy"" rating in a research note issued on Wednesday.",JNJ,0.722944,0.433559,Bullish
KENVUE DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered ... - PR Newswire,https://www.prnewswire.com/news-releases/kenvue-deadline-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-in-kenvue-to-contact-him-directly-to-discuss-their-options-301962696.html,2023-10-20 00:45:00,KENVUE DEADLINE ALERT: Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered ... PR ...,JNJ,0.061003,0.093005,Neutral
"Myopia Market to Grow at a Substantial Growth Rate During the Study Period  ( 2019-2032 ) , Predicts DelveInsight | Leading Companies - Nevakar, Vyluma, Bausch & Lomb, Sydnexis, Ocumension, ORA, LENZ Therapeutics",https://www.prnewswire.com/news-releases/myopia-market-to-grow-at-a-substantial-growth-rate-during-the-study-period-20192032-predicts-delveinsight--leading-companies---nevakar-vyluma-bausch--lomb-sydnexis-ocumension-ora-lenz-therapeutics-301961706.html,2023-10-19 21:01:00,"Myopia Market to Grow at a Substantial Growth Rate During the Study Period ( 2019-2032 ) , Predicts DelveInsight ... PR ...",JNJ,0.050786,0.160348,Somewhat-Bullish
Invitae Appoints Dr. David Sholehvar as Chief Operating Officer,https://www.prnewswire.com/news-releases/invitae-appoints-dr-david-sholehvar-as-chief-operating-officer-301962415.html,2023-10-19 20:30:00,"SAN FRANCISCO, Oct. 19, 2023 /PRNewswire/ -- ( NYSE: NVTA ) , a leading medical genetics company, today announced the appointment of veteran healthcare leader David Sholehvar, M.D., as chief operating officer, effective November 13, 2023.",JNJ,0.140076,0.008823,Neutral
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Kenvue Inc. - KVUE - Kenvue  ( NYSE:KVUE ) ,https://www.benzinga.com/pressreleases/23/10/g35338096/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-kenvue-inc-kvue,2023-10-19 19:20:06,"NEW YORK, Oct. 19, 2023 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Kenvue Inc. ( ""Kenvue"" or the ""Company"" ) KVUE. Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.",JNJ,0.115787,0.021477,Neutral
Check Out What Whales Are Doing With JNJ - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/10/35336744/check-out-what-whales-are-doing-with-jnj,2023-10-19 18:01:41,"A whale with a lot of money to spend has taken a noticeably bearish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson JNJ we detected 13 strange trades. If we consider the specifics of each trade, it is accurate to state that 38% of the investors opened trades with ...",JNJ,0.800656,0.201565,Somewhat-Bullish
Global Atherosclerosis Drugs Market Is Projected To Reach $54.8 Billion In 2027 With A CAGR Of 3% As Per The Business Research Company's Atherosclerosis Drugs Global Market Report 2023,https://www.benzinga.com/pressreleases/23/10/g35333824/global-atherosclerosis-drugs-market-is-projected-to-reach-54-8-billion-in-2027-with-a-cagr-of-3-as,2023-10-19 15:45:00,"LONDON, Oct. 19, 2023 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Atherosclerosis Drugs Global Market Report 2023, the global atherosclerosis drugs market is poised for significant growth in 2023, with a projected value of $48.72 billion, marking a steady Compound Annual Growth ...",JNJ,0.062271,0.072345,Neutral
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Kenvue Inc.  ( KVUE )  - Kenvue  ( NYSE:KVUE ) ,https://www.benzinga.com/pressreleases/23/10/g35332113/glancy-prongay-murray-llp-reminds-investors-of-looming-deadline-in-the-class-action-lawsuit-agains,2023-10-19 15:00:00,"LOS ANGELES, Oct. 19, 2023 ( GLOBE NEWSWIRE ) -- Glancy Prongay & Murray LLP ( ""GPM"" ) reminds investors of the upcoming December 8, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Kenvue Inc. ( ""Kenvue"" or the ...",JNJ,0.062597,0.086023,Neutral
Stock Market Erases Gains And Here Comes Powell; Tesla Stock Has This Problem,https://www.investors.com/market-trend/stock-market-today/stock-market-erases-gains-here-comes-powell-teslas-chart-becomes-deformed/,2023-10-19 14:47:00,Stock Market Erases Gains And Here Comes Powell. Tesla Stock ... Investor's Business Daily ...,JNJ,0.1172,-0.089813,Neutral
Is Johnson & Johnson Still a Good Dividend Stock to Buy?,https://www.fool.com/investing/2023/10/19/is-johnson-johnson-still-a-good-dividend-stock-to/,2023-10-19 10:53:00,Investors wonder if the healthcare giant can keep raising its payout now that it no longer sells the consumer health brands that made it famous.,JNJ,0.365166,0.307675,Somewhat-Bullish
Legal tech teams turn to AI to advance business goals,https://www.ft.com/content/9a117ac7-29ae-43fe-b840-a04005b98799,2023-10-19 03:00:41,Our case studies highlight how the latest tools are helping speed up legal work ...,JNJ,0.021369,0.072416,Neutral
Why Johnson & Johnson Stock Flopped Today,https://www.fool.com/investing/2023/10/18/why-johnson-johnson-stock-flopped-today/,2023-10-18 21:46:46,Perhaps those third-quarter results weren't as impressive as they first appeared to be.,JNJ,0.76191,0.302456,Somewhat-Bullish
Positive Outlook On Johnson & Johnson's Partner Legend Biotech: Analyst Confident On Blood Cancer Drug - Legend Biotech  ( NASDAQ:LEGN ) ,https://www.benzinga.com/analyst-ratings/analyst-color/23/10/35314510/positive-outlook-on-johnson-johnsons-partner-legend-biotech-analyst-confident-on-bl,2023-10-18 18:44:06,"Legend Biotech Corporation's LEGN partner, Johnson & Johnson JNJ, reported Q3 Carvykti revenues of $152 million, up 30% sequentially.",JNJ,0.288893,0.0,Neutral
The Virology Testing Market Is Expected To Grow At A CAGR Of More Than 9% With Growing Viral Infections Cases As Per The Business Research Company's Virology Testing Global Market Report 2023,https://www.benzinga.com/pressreleases/23/10/g35312142/the-virology-testing-market-is-expected-to-grow-at-a-cagr-of-more-than-9-with-growing-viral-infect,2023-10-18 15:30:00,"LONDON, Oct. 18, 2023 ( GLOBE NEWSWIRE ) -- The global virology testing market is experiencing significant growth, and the latest market report for 2023 by The Business Research Company reveals an industry poised for substantial expansion.",JNJ,0.065327,0.115639,Neutral
"JNJ Beats Q3 Earnings Estimates, Raises View: ETFs in Focus",https://www.zacks.com/stock/news/2168098/jnj-beats-q3-earnings-estimates-raises-view-etfs-in-focus,2023-10-18 14:05:00,The world's biggest healthcare products maker continued with its long streak of earnings beat and lifted the full year outlook.,JNJ,0.454714,0.370588,Bullish
1 Warren Buffett Stock to Buy Hand Over Fist Right Now,https://www.fool.com/investing/2023/10/18/1-warren-buffett-stock-to-buy-hand-over-fist-right/,2023-10-18 13:30:00,This blue-chip healthcare stock is a solid pick for investors in uncertain times.,JNJ,0.130926,-0.010115,Neutral
Is American Century U.S. Quality Value ETF  ( VALQ )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2167684/is-american-century-us-quality-value-etf-valq-a-strong-etf-right-now,2023-10-18 10:20:06,Smart Beta ETF report for ...,JNJ,0.114682,0.04541,Neutral
"Is the ""New"" Johnson & Johnson Stock a Buy With Its Improved Profit Outlook?",https://www.fool.com/investing/2023/10/18/is-the-new-johnson-johnson-stock-a-buy-with-its-im/,2023-10-18 09:51:00,Some things are different about J&J. But other things remain the same as they've been for a long time.,JNJ,0.569063,0.373567,Bullish
"The doctor lowering drug prices for 1 million patients, with help from Mark Cuban, Sam Altman - and Martin Shkreli",https://www.marketwatch.com/story/the-doctor-lowering-drug-prices-for-1-million-patients-with-help-from-mark-cuban-sam-altman-and-martin-shkreli-5e72d77a,2023-11-06 20:32:00,Kristopher Koeller relies on two daily medications to keep his blood pressure under control. They're both generics that have been on the market for decades-the kind of drugs that should be cheap.,JNJ,0.027941,0.024774,Neutral
Eli Lilly chief scientific officer 'extremely optimistic' that major new Alzheimer's breakthrough is coming,https://www.marketwatch.com/story/eli-lilly-chief-scientific-officer-extremely-optimistic-that-major-new-alzheimers-breakthrough-is-coming-79003fcc,2023-11-06 16:05:00,"Dr. Daniel Skovronsky believes a big leap in Alzheimer's disease treatment may be just around the corner-and that an overlooked class of medicines could become the GLP-1 drugs of the future. If he's right, Eli Lilly & Co.'s LLY, remarkable winning streak won't fizzle any time soon.",JNJ,0.075754,0.154848,Somewhat-Bullish
"Kohler Co. to Establish Energy Division as Independent Business with Platinum Equity as Majority Investment Partner, Accelerating Long-Term Growth Strategies for Both Organizations",https://www.prnewswire.com/news-releases/kohler-co-to-establish-energy-division-as-independent-business-with-platinum-equity-as-majority-investment-partner-accelerating-long-term-growth-strategies-for-both-organizations-301978609.html,2023-11-06 16:00:00,Kohler Co. to Establish Energy Division as Independent Business with Platinum Equity as Majority Investment Partner ... PR ...,JNJ,0.035397,0.0,Neutral
"Kohler Co. to Establish Energy Division as Independent Business with Platinum Equity as Majority Investment Partner, Accelerating Long-Term Growth Strategies for Both Organizations",https://www.prnewswire.com/in/news-releases/kohler-co-to-establish-energy-division-as-independent-business-with-platinum-equity-as-majority-investment-partner-accelerating-long-term-growth-strategies-for-both-organizations-301978615.html,2023-11-06 16:00:00,Kohler Co. to Establish Energy Division as Independent Business with Platinum Equity as Majority Investment Partner ... PR ...,JNJ,0.035397,0.0,Neutral
"Kohler Co. to Establish Energy Division as Independent Business with Platinum Equity as Majority Investment Partner, Accelerating Long-Term Growth Strategies for Both Organizations",https://www.newswire.ca/news-releases/kohler-co-to-establish-energy-division-as-independent-business-with-platinum-equity-as-majority-investment-partner-accelerating-long-term-growth-strategies-for-both-organizations-871976866.html,2023-11-06 16:00:00,Kohler Co. to Establish Energy Division as Independent Business with Platinum Equity as Majority Investment Partner ... Canada ...,JNJ,0.035397,0.0,Neutral
"Mind-altering ketamine becomes new pain treatment, despite little research or regulation",https://apnews.com/article/ketamine-pain-drugs-psychedelic-fda-2c67eeac1932962a7b0affc07d24c09a,2023-11-06 13:57:00,"WASHINGTON ( AP ) - As U.S. doctors scale back their use of , a new option for hard-to-treat pain is taking root: ketamine, the decades-old surgical drug that is now a .",JNJ,0.028695,-0.163383,Somewhat-Bearish
Anavex Life Sciences Appoints Senior VP of Regulatory Affairs,https://www.globenewswire.com/news-release/2023/11/06/2774022/29248/en/Anavex-Life-Sciences-Appoints-Senior-VP-of-Regulatory-Affairs.html,2023-11-06 13:00:00,"NEW YORK, Nov. 06, 2023 ( GLOBE NEWSWIRE ) -- Anavex Life Sciences Corp. ( ""Anavex"" or the ""Company"" ) ( Nasdaq: AVXL ) , a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders, including ...",JNJ,0.04583,0.101487,Neutral
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Kenvue Inc. - KVUE - Kenvue  ( NYSE:KVUE ) ,https://www.benzinga.com/pressreleases/23/11/g35611321/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-kenvue-inc-kvue,2023-11-05 21:31:27,"NEW YORK, Nov. 05, 2023 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Kenvue Inc. ( ""Kenvue"" or the ""Company"" ) KVUE. Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.",JNJ,0.115787,0.021477,Neutral
"Pharmacy Workers Strike At CVS and Walgreens, Echoing Wider Pharma Sector Unrest - CVS Health  ( NYSE:CVS ) , SPDR Select Sector Fund - Health Care  ( ARCA:XLV ) , Johnson & Johnson  ( NYSE:JNJ ) , Walgreens Boots Alliance  ( NASDAQ:WBA ) ",https://www.benzinga.com/news/23/11/35610842/pharmacy-workers-strike-at-cvs-and-walgreens-echoing-wider-pharma-sector-unrest,2023-11-05 20:48:48,"In a recent surge of labor unrest, pharmacy employees from CVS Health Corporation CVS and Walgreens Boots Alliance, Inc. WBA raised their voices by calling out sick or walking out entirely last week.",JNJ,0.14131,-0.093063,Neutral
"KVUE Class Action Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Kenvue Inc.  ( KVUE )  Investors of Securities Fraud Class Action Lawsuit - Kenvue  ( NYSE:KVUE ) ",https://www.benzinga.com/pressreleases/23/11/g35606416/kvue-class-action-reminder-kessler-topaz-meltzer-check-llp-reminds-kenvue-inc-kvue-investors-of-se,2023-11-04 14:46:00,"RADNOR, Pa., Nov. 04, 2023 ( GLOBE NEWSWIRE ) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the District of New Jersey against Kenvue Inc. ( ""Kenvue"" ) KVUE. ...",JNJ,0.057079,0.129961,Neutral
KENVUE SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi Securities Litigation Partner James  ( Josh )  Wilson Encourages Investors Who Suffered Losses In Kenvue To Contact Him Directly To Discuss Their Options - Kenvue  ( NYSE:KVUE ) ,https://www.benzinga.com/pressreleases/23/11/g35605845/kenvue-shareholder-action-reminder-faruqi-faruqi-securities-litigation-partner-james-josh-wilson-e,2023-11-04 12:00:00,"If you purchased or acquired securities in Kenvue securities pursuant and/or traceable to the registration statement and related prospectus ( collectively, the ""Registration Statement"" ) issued in connection with the Company's May 2023 initial public offering ( the ""IPO"" or ""Offering"" ) and ...",JNJ,0.064104,0.09307,Neutral
Looking for a Lifetime of Passive Income? 2 Top Dividend Stocks to Buy and Hold Forever,https://www.fool.com/investing/2023/11/04/want-passive-income-top-dividend-stocks-to-buy/,2023-11-04 09:30:00,Dividend stocks can cushion your portfolio in times of market trouble.,JNJ,0.108712,0.104043,Neutral
KENVUE SHAREHOLDER ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who ... - PR Newswire,https://www.prnewswire.com/news-releases/kenvue-shareholder-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-in-kenvue-to-contact-him-directly-to-discuss-their-options-301976714.html,2023-11-04 00:45:00,KENVUE SHAREHOLDER ALERT: Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who ... PR ...,JNJ,0.061003,0.093005,Neutral
Weekly Roundup,https://aap.thestreet.com/story/16137219/1/weekly-roundup.html,2023-11-03 22:29:00,"All four major market indexes climbed higher in the first days of November, putting each except for the Russell 2000 in positive territory quarter-to date. A less-hawkish-than-expected Fed, retreating Treasury yields and slower job growth spurred the buying.",JNJ,0.007738,0.154498,Somewhat-Bullish
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Kenvue Inc. - KVUE,https://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-kenvue-inc---kvue-301977470.html,2023-11-03 20:36:00,"NEW YORK, Nov. 3, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Kenvue Inc. ( ""Kenvue"" or the ""Company"" ) ( NYSE: KVUE ) . Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.",JNJ,0.124164,0.023342,Neutral
"Medela Announces Transition of Wound Care Business, Creating a New Company Dedicated to Wound Therapy Solutions",https://www.benzinga.com/pressreleases/23/11/g35597861/medela-announces-transition-of-wound-care-business-creating-a-new-company-dedicated-to-wound-thera,2023-11-03 17:42:42,"Baar, Switzerland, Nov. 03, 2023 ( GLOBE NEWSWIRE ) -- Medela, a global healthcare company known for being the most trusted breastfeeding brand in North America*, announced it will transition its wound care business into a separate global company.",JNJ,0.055492,0.140718,Neutral
Council Post: What Startups Can Learn From Titans About Treasury Management,https://www.forbes.com/sites/forbesbusinesscouncil/2023/11/03/what-startups-can-learn-from-titans-about-treasury-management/,2023-11-03 14:30:00,What Startups Can Learn From Titans About Treasury Management Forbes ...,JNJ,0.035035,0.067637,Neutral
This Stock Just Dropped By 15%: Is It a Buy?,https://www.fool.com/investing/2023/11/03/this-stock-just-dropped-by-15-is-it-a-buy/,2023-11-03 14:07:00,Now could be a great opportunity to buy low.,JNJ,0.061315,0.047,Neutral
Johnson & Johnson  ( JNJ )  is Attracting Investor Attention: Here is What You Should Know,https://www.zacks.com/stock/news/2177963/johnson-johnson-jnj-is-attracting-investor-attention-here-is-what-you-should-know,2023-11-03 13:00:10,"Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",JNJ,0.478494,0.159977,Somewhat-Bullish
3 Top-Ranked PIMCO Mutual Funds for 2023 & Beyond,https://www.zacks.com/stock/news/2177867/3-top-ranked-pimco-mutual-funds-for-2023-beyond,2023-11-03 10:53:00,"Invest in PIMCO mutual funds like PMJPX, PKAAX and PQIPX that have given positive returns amid uncertain market conditions and are expected to perform well in the future.",JNJ,0.057079,0.05394,Neutral
3 Healthcare Stocks to Buy Hand Over Fist in November,https://www.fool.com/investing/2023/11/03/3-health-stocks-to-buy-hand-over-fist-in-november/,2023-11-03 09:00:00,Get these stocks while they're cheap.,JNJ,0.162073,0.183261,Somewhat-Bullish
"Wound Care Market to grow by USD 6.83 billion from 2022 to 2027|3M Co., Advancis Medical, Avery Dennison Corp ... - PR Newswire",https://www.prnewswire.com/news-releases/wound-care-market-to-grow-by-usd-6-83-billion-from-2022-to-20273m-co-advancis-medical-avery-dennison-corp-axio-biosolutions-pvt-ltd-and-more-among-the-key-companies-in-the-market---technavio-301976551.html,2023-11-03 07:35:00,"Wound Care Market to grow by USD 6.83 billion from 2022 to 2027|3M Co., Advancis Medical, Avery Dennison Corp ... PR ...",JNJ,0.049939,0.082775,Neutral
Montana GOP Senate candidate would be in the top 10 richest lawmakers - and his investments are sure to irk some conservatives,https://www.businessinsider.com/tim-sheehy-montana-wealthy-republican-climate-change-china-investments-2023-11,2023-11-02 20:35:00,"GOP hopeful Sheehy is super rich, invested in things conservatives hate - Business Insider ...",JNJ,0.058472,0.041013,Neutral
Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results,https://www.globenewswire.com/news-release/2023/11/02/2772866/0/en/Cidara-Therapeutics-Provides-Corporate-Update-and-Reports-Third-Quarter-2023-Financial-Results.html,2023-11-02 20:15:00,"SAN DIEGO, Nov. 02, 2023 ( GLOBE NEWSWIRE ) -- Cidara Therapeutics, Inc. ( Nasdaq: CDTX ) , a biotechnology company focused on developing targeted therapies designed to save lives and improve the standard of care for patients facing serious diseases, today reported financial results for the ...",JNJ,0.024546,0.061222,Neutral
"EXCLUSIVE: Roundhill Launches Dividend Kings ETF With 'The Gold Standard Of Dividend Growers,' Companies With 'Incredible Resilience' - Target  ( NYSE:TGT ) , Kimberly-Clark  ( NYSE:KMB ) , Coca-Cola  ( NYSE:KO ) , Listed Funds Trust Roundhill Cannabis ETF  ( BATS:WEED ) ",https://www.benzinga.com/trading-ideas/dividends/23/11/35572980/exclusive-roundhill-launches-dividend-kings-etf-with-the-gold-standard-of-dividend-grower,2023-11-02 18:25:38,"The company behind pure-play ETFs that cover sectors such as cannabis stocks, the metaverse, sports betting and meme stocks is back with a new fund that covers a popular investment strategy. What Happened: Roundhill Investments launched the Roundhill S&P Dividend Monarchs ETF KNGS on Thursday.",JNJ,0.12645,-0.038107,Neutral
JNJ: 3 Pharma Stocks to Capitalize on With Potential Upside,https://stocknews.com/news/jnj-bmy-gsk-me-3-pharma-stocks-to-capitalize-on-with-potential-upside/,2023-11-02 18:05:15,"The pharmaceutical sector is poised for robust growth, propelled by the rapidly expanding market for medications and vaccines. Moreover, the consistent demand for its products upholds the industry's resilience, rendering it less vulnerable to economic fluctuations.",JNJ,0.23008,0.168599,Somewhat-Bullish
"Novo Nordisk, Lilly see insatiable demand for weight-loss drugs",https://www.reuters.com/business/healthcare-pharmaceuticals/novo-nordisk-lilly-see-insatiable-demand-weight-loss-drugs-2023-11-02/,2023-11-02 17:15:00,Nov 2 ( Reuters ) - Novo Nordisk ( NOVOb.CO ) and Eli Lilly ( LLY.N ) both expect juggernaut sales for their diabetes and weight-loss drugs to extend into coming years - limited only by their availability.,JNJ,0.063425,-0.07403,Neutral
Looking Into Johnson & Johnson's Recent Short Interest - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/short-sellers/23/11/35569909/looking-into-johnson-johnsons-recent-short-interest,2023-11-02 16:45:22,"Johnson & Johnson's JNJ short percent of float has fallen 12.16% since its last report. The company recently reported that it has 15.68 million shares sold short, which is 0.65% of all regular shares that are available for trading.",JNJ,0.221819,0.081322,Neutral
Why Nanobiotix  ( NBTX )  Stock Is Plunging Thursday - Nanobiotix  ( NASDAQ:NBTX ) ,https://www.benzinga.com/news/23/11/35566629/why-nanobiotix-nbtx-stock-is-plunging-thursday,2023-11-02 15:06:40,"Nanobiotix SA - ADR NBTX shares are trading lower by 16.4% to $5.14 Thursday morning after the company priced its global follow-on offering. The offering includes 3,106,907 ADSs in the U.S. at $5.36 per ADS and 2,492,223 Ordinary Shares in Europe at â‚¬5.07 per share.",JNJ,0.266828,-0.028581,Neutral
NANOBIOTIX Announces Pricing of a Capital Increase Raising Total Gross Proceeds of $55M,https://www.benzinga.com/pressreleases/23/11/g35566174/nanobiotix-announces-pricing-of-a-capital-increase-raising-total-gross-proceeds-of-55m,2023-11-02 14:49:49,"PARIS and CAMBRIDGE, Mass., Nov. 02, 2023 ( GLOBE NEWSWIRE ) -- NANOBIOTIX ( Euronext: NANO - NASDAQ: NBTX - ""Nanobiotix"" or the ""Company"" ) , a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, announces the ...",JNJ,0.012294,0.062192,Neutral
NANOBIOTIX Announces Pricing of a Capital Increase Raising Total Gross Proceeds of $55M,https://www.globenewswire.com/news-release/2023/11/02/2772565/0/en/NANOBIOTIX-Announces-Pricing-of-a-Capital-Increase-Raising-Total-Gross-Proceeds-of-55M.html,2023-11-02 14:49:00,"PARIS and CAMBRIDGE, Mass., Nov. 02, 2023 ( GLOBE NEWSWIRE ) -- NANOBIOTIX ( Euronext: NANO - NASDAQ: NBTX - ""Nanobiotix"" or the ""Company"" ) , a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, announces the ...",JNJ,0.0123,0.067647,Neutral
NANOBIOTIX Announces Pricing of a Capital Increase Raising Total Gross Proceeds of $55M,https://www.globenewswire.com/news-release/2023/11/02/2772563/0/en/NANOBIOTIX-Announces-Pricing-of-a-Capital-Increase-Raising-Total-Gross-Proceeds-of-55M.html,2023-11-02 14:49:00,"PARIS and CAMBRIDGE, Mass., Nov. 02, 2023 ( GLOBE NEWSWIRE ) -- NANOBIOTIX ( Euronext: NANO - NASDAQ: NBTX - ""Nanobiotix"" or the ""Company"" ) , a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, announces the ...",JNJ,0.011513,0.067248,Neutral
NANOBIOTIX Announces Launch of Global Follow-On Offering and a Concurrent Private Placement Along with the Removal of the EIB Cash Covenant,https://www.globenewswire.com/news-release/2023/11/01/2771818/0/en/NANOBIOTIX-Announces-Launch-of-Global-Follow-On-Offering-and-a-Concurrent-Private-Placement-Along-with-the-Removal-of-the-EIB-Cash-Covenant.html,2023-11-01 22:32:00,"PARIS and CAMBRIDGE, Mass., Nov. 01, 2023 ( GLOBE NEWSWIRE ) -- NANOBIOTIX ( Euronext: NANO - NASDAQ: NBTX - ""Nanobiotix"" or the ""Company"" ) , a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, announces the ...",JNJ,0.011762,0.06556,Neutral
NANOBIOTIX Announces Launch of Global Follow-On Offering and a Concurrent Private Placement Along with the Removal of the EIB Cash Covenant,https://www.globenewswire.com/news-release/2023/11/01/2771817/0/en/NANOBIOTIX-Announces-Launch-of-Global-Follow-On-Offering-and-a-Concurrent-Private-Placement-Along-with-the-Removal-of-the-EIB-Cash-Covenant.html,2023-11-01 22:30:00,"PARIS and CAMBRIDGE, Mass., Nov. 01, 2023 ( GLOBE NEWSWIRE ) -- NANOBIOTIX ( Euronext: NANO - NASDAQ: NBTX - ""Nanobiotix"" or the ""Company"" ) , a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, announces the ...",JNJ,0.012624,0.065986,Neutral
Prostate Cancer Minimally Invasive Surgery Market Size is Envisioned to Grow at a CAGR of 3.6% and reach USD 3.9 billion by 2031|Report by TMR,https://www.benzinga.com/pressreleases/23/11/g35543727/prostate-cancer-minimally-invasive-surgery-market-size-is-envisioned-to-grow-at-a-cagr-of-3-6-and-,2023-11-01 17:00:00,"Wilmington, Delaware, United States, Nov. 01, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. The global prostate cancer minimally invasive surgery market stood at US$ 2.9 billion in 2022 and is projected to reach US$ 3.9 billion in 2031.",JNJ,0.040484,0.0,Neutral
"Sanitary Napkin Market to hit USD 41 billion by 2031, says Transparency Market Research Inc.",https://www.benzinga.com/pressreleases/23/11/g35539142/sanitary-napkin-market-to-hit-usd-41-billion-by-2031-says-transparency-market-research-inc,2023-11-01 14:30:00,"Wilmington, Delaware, United States, Nov. 01, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc- The global sanitary napkin market was estimated to have acquired US$ 24.5 billion in 2021. It is anticipated to register a 5.0% CAGR from 2022 to 2031 and by 2031, the market is likely to ...",JNJ,0.046452,0.101757,Neutral
3 Dividend Kings Whose Growth Streaks Could Break Before 2030,https://www.fool.com/investing/2023/11/01/3-dividend-kings-whose-growth-streaks-could-break/,2023-11-01 14:12:00,"Investors should be careful with these high-yielding dividend stocks, as they aren't as safe as they may have been even a few years ago.",JNJ,0.267804,0.028821,Neutral
Johnson & Johnson Innovation Launches Singapore QuickFire Challenge with the Singapore Economic Development Board,https://www.prnewswire.com/apac/news-releases/johnson--johnson-innovation-launches-singapore-quickfire-challenge-with-the-singapore-economic-development-board-301974279.html,2023-11-01 14:05:00,Johnson & Johnson Innovation Launches Singapore QuickFire Challenge with the Singapore Economic Development ... PR ...,JNJ,0.539522,0.489524,Bullish
The Mullings Group Acquires M. J. Moore & Associates and Names Michael Moore Partner,https://www.prnewswire.com/news-releases/the-mullings-group-acquires-m-j-moore--associates-and-names-michael-moore-partner-301974041.html,2023-11-01 13:00:00,"DELRAY BEACH, Fla., Nov. 1, 2023 /PRNewswire/ -- The Mullings Group, a leading talent acquisition firm headquartered in the U.S. specializing in medical & health technology, life sciences, and emerging high-tech industries, announces the acquisition of M. J. Moore & Associates. The founder of M.",JNJ,0.062926,0.170157,Somewhat-Bullish
Can Kenvue Be a Reliable Dividend Stock to Hold for the Long Haul?,https://www.fool.com/investing/2023/11/01/can-kenvue-be-a-reliable-dividend-stock-to-hold-fo/,2023-11-01 11:44:00,"Kenvue's operations are diverse, boasting many strong brands. Is that enough to make this a solid dividend stock to own?",JNJ,0.261818,0.026237,Neutral
Acquisition of Industrial Vision Systems Ltd and Issue of Equity,https://www.globenewswire.com/news-release/2023/11/01/2770854/0/en/Acquisition-of-Industrial-Vision-Systems-Ltd-and-Issue-of-Equity.html,2023-11-01 09:00:00,1 November ...,JNJ,0.02799,0.243977,Somewhat-Bullish
Agriculture Stock News - MustGrow  ( TSXV: MGRO )   ( OTCQB: MGROF )  Receives USDA Organic Approval for Biological Fertilizer and Soil Amendment Technology,https://www.investorideas.com/news/2023/agriculture/10311TSXV-MGRO.asp,2023-10-31 19:40:30,Agriculture Stock News - MustGrow ( TSXV: MGRO ) ( OTCQB ... ...,JNJ,0.023304,0.144156,Neutral
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Kenvue Inc.  ( KVUE )  - Kenvue  ( NYSE:KVUE ) ,https://www.benzinga.com/pressreleases/23/10/g35519632/glancy-prongay-murray-llp-reminds-investors-of-looming-deadline-in-the-class-action-lawsuit-agains,2023-10-31 16:43:14,"LOS ANGELES, Oct. 31, 2023 ( GLOBE NEWSWIRE ) -- Glancy Prongay & Murray LLP ( ""GPM"" ) reminds investors of the upcoming December 8, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Kenvue Inc. ( ""Kenvue"" or the ...",JNJ,0.062597,0.086023,Neutral
"Johnson & Johnson Offloads Rights For Hepatitis B Candidate To GSK - Johnson & Johnson  ( NYSE:JNJ ) , GSK  ( NYSE:GSK ) ",https://www.benzinga.com/general/biotech/23/10/35515126/johnson-johnson-offloads-rights-for-hepatitis-b-candidate-to-gsk,2023-10-31 15:05:14,"GSK plc GSK and Arrowhead Pharmaceuticals Inc ARWR have reached an agreement with Janssen Pharmaceuticals Inc, a Johnson & Johnson company JNJ, to transfer exclusive worldwide rights to further develop and commercialize JNJ-3989 to GSK.",JNJ,0.772194,0.292504,Somewhat-Bullish
Cybin Announces Unprecedented Positive Interim Phase 2 Data for CYB003 in Major Depressive Disorder Meeting ... - Canada NewsWire,https://www.newswire.ca/news-releases/cybin-announces-unprecedented-positive-interim-phase-2-data-for-cyb003-in-major-depressive-disorder-meeting-primary-efficacy-endpoint-with-rapid-and-significant-improvements-in-depression-symptoms-after-single-dose-full-topline-data-on-trac-810755830.html,2023-10-31 13:00:00,Cybin Announces Unprecedented Positive Interim Phase 2 Data for CYB003 in Major Depressive Disorder Meeting ... Canada ...,JNJ,0.018568,0.031183,Neutral
GSK to pay $1 bln for exclusive license to J&J's hepatitis B therapy,https://www.reuters.com/markets/deals/gsk-signs-1-bln-deal-exclusive-license-jjs-hepatitis-b-therapy-2023-10-31/,2023-10-31 12:38:00,"[1/2] GSK ( GlaxoSmithKline ) logo is seen in this illustration, August 10, 2022. REUTERS/Dado Ruvic/Illustration/File Photo Acquire Licensing Rights",JNJ,0.499789,0.0,Neutral
Coalition calls on Congress to repeal Biden's prescription drug price controls,https://www.foxbusiness.com/politics/coalition-calls-congress-repeal-bidens-prescription-drug-price-controls,2023-10-31 09:00:50,"EXCLUSIVE - A coalition of more than 40 groups is calling on Congress to repeal the Drug Price Negotiation Program included in the Inflation Reduction Act ( IRA ) that passed last year, arguing that the price control scheme run by the Biden administration will ultimately lead to shortages of ...",JNJ,0.064797,0.0,Neutral
"Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Kenvue Inc.  ( KVUE )  Investors and Encourages Investors to Contact the Firm Before December 8, 2023 - Kenvue  ( NYSE:KVUE ) ",https://www.benzinga.com/pressreleases/23/10/g35491796/kirby-mcinerney-llp-reminds-investors-that-a-class-action-lawsuit-has-been-filed-on-behalf-of-kenv,2023-10-30 14:21:46,"NEW YORK, Oct. 30, 2023 ( GLOBE NEWSWIRE ) -- The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S.",JNJ,0.16171,0.052379,Neutral
Nearly 70% of Warren Buffett's $326 Billion Portfolio Is Invested in These 9 Megacap Stocks,https://www.fool.com/investing/2023/10/30/nearly-70-of-warren-buffetts-326-billion-portfolio/,2023-10-30 09:50:00,The Oracle of Omaha likes big stocks.,JNJ,0.112008,0.0,Neutral
"Smoke Evacuation Systems Market Revenue to Cross USD 298.8 million by 2031, Garnering 6.6% CAGR: TMR Report",https://www.benzinga.com/pressreleases/23/10/g35484877/smoke-evacuation-systems-market-revenue-to-cross-usd-298-8-million-by-2031-garnering-6-6-cagr-tmr-,2023-10-30 09:30:00,"Wilmington, Delaware, United States, Oct. 30, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The smoke evacuation systems market was estimated to have acquired US$ 158.5 million in 2021. It is anticipated to register a 6.6% CAGR from 2022 to 2031, and by 2031, the market is likely ...",JNJ,0.03798,0.051531,Neutral
Warren Buffett's $690 Million Secret Portfolio Is Buying 3 Historically Cheap Stocks,https://www.fool.com/investing/2023/10/30/warren-buffett-secret-portfolio-buy-3-cheap-stocks/,2023-10-30 09:06:00,The Oracle of Omaha's under-the-radar investment portfolio is buying shares of three industry-leading businesses.,JNJ,0.155652,0.146779,Neutral
KENVUE ONGOING DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who ... - PR Newswire,https://www.prnewswire.com/news-releases/kenvue-ongoing-deadline-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-in-kenvue-to-contact-him-directly-to-discuss-their-options-301970622.html,2023-10-30 00:45:00,KENVUE ONGOING DEADLINE ALERT: Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who ... PR ...,JNJ,0.061003,0.093005,Neutral
"Kessler Topaz Meltzer & Check, LLP Announces Investor Securities Fraud Class Action Lawsuit Filed Against Kenvue Inc.",https://www.prnewswire.com/news-releases/kessler-topaz-meltzer--check-llp-announces-investor-securities-fraud-class-action-lawsuit-filed-against-kenvue-inc-301970546.html,2023-10-29 14:20:00,"Kessler Topaz Meltzer & Check, LLP Announces Investor Securities Fraud Class Action Lawsuit Filed Against Kenvue ... PR ...",JNJ,0.059785,0.135003,Neutral
"Dermatitis is not just skin-deep: A common skin condition, it can be irritating and painful",https://www.financialexpress.com/healthcare/dermatitis-is-not-just-skin-deep-a-common-skin-condition-it-can-be-irritating-and-painful/3289895/,2023-10-28 22:15:00,"What do Jessica Simpson, Kerry Washington, Elle Fanning, Tia Mowry, Kristen Bell and Seonghwa have in common? Well, apart from being well-known celebrities, they have all battled with skin conditions and have either announced or discussed them on social media.",JNJ,0.024852,0.012074,Neutral
"Meta's Plans, Cyberattacks, and the EV Race",https://www.fool.com/investing/2023/10/28/metas-plans-cyberattacks-and-the-ev-race/,2023-10-28 13:45:00,And we've got a look at two stocks worth watching: Chevron and Burford Capital.,JNJ,0.006416,0.080732,Neutral
"Got $2,500? 2 Top Stocks That You Can Buy and Hold for a Lifetime",https://www.fool.com/investing/2023/10/28/got-2500-2-top-stocks-that-you-can-buy-and-hold-fo/,2023-10-28 09:03:00,These elite companies make exceptional foundational investments for any portfolio.,JNJ,0.318211,0.470206,Bullish
Have $500? 2 Absurdly Cheap Stocks Long-Term Investors Should Buy Right Now,https://www.fool.com/investing/2023/10/28/have-500-dollars-2-absurdly-cheap-stocks-to-buy/,2023-10-28 09:00:00,A few hundred dollars invested today could go a long way over time.,JNJ,0.123844,0.124049,Neutral
"Unraveling the Shifting Rare Eye Diseases Market Landscape: Analysis of Retinoblastoma Market, Retinitis Pigmentosa Market, Limbal Stem Cell Deficiency Market, Leber Hereditary Optic Neuropathy Market, and Stargardt Disease Market | DelveInsight",https://www.prnewswire.com/news-releases/unraveling-the-shifting-rare-eye-diseases-market-landscape-analysis-of-retinoblastoma-market-retinitis-pigmentosa-market-limbal-stem-cell-deficiency-market-leber-hereditary-optic-neuropathy-market-and-stargardt-disease-market-301991311.html,2023-11-16 22:01:00,"Unraveling the Shifting Rare Eye Diseases Market Landscape: Analysis of Retinoblastoma Market, Retinitis ... PR ...",JNJ,0.01645,0.006093,Neutral
Charlie Munger blasts 'ridiculous' idea that Warren Buffett enriched himself at his shareholders' expense,https://africa.businessinsider.com/markets/charlie-munger-blasts-ridiculous-idea-that-warren-buffett-enriched-himself-at-his/80gbstd,2023-11-16 17:06:12,"""I don't think there's the slightest chance that Warren Buffett is doing something that's deeply evil to make money for himself,"" said the 99-year-old vice-chairman of Buffett's Berkshire Hathaway conglomerate.",JNJ,0.146025,-0.111994,Neutral
Charlie Munger blasts 'ridiculous' idea that Warren Buffett enriched himself at his shareholders' expense,https://markets.businessinsider.com/news/stocks/charlie-munger-warren-buffett-propublica-personal-stock-portfolio-berkshire-trades-2023-11,2023-11-16 17:06:00,Munger Blasts Idea Buffett Enriched Himself Over Berkshire Shareholders - Markets Insider ...,JNJ,0.105141,-0.095301,Neutral
"No chance Warren Buffett is doing something 'deeply evil,' says Charlie Munger",https://www.marketwatch.com/story/no-chance-warren-buffett-is-doing-something-deeply-evil-says-charlie-munger-8803fd52,2023-11-16 16:49:00,"Buffett reportedly traded stocks that Berkshire Hathaway was buying and selling, according to a recent ProPublica story ...",JNJ,0.113597,-0.038609,Neutral
Johnson & Johnson  ( JNJ )  Down 2.6% Since Last Earnings Report: Can It Rebound?,https://www.zacks.com/stock/news/2185490/johnson-johnson-jnj-down-26-since-last-earnings-report-can-it-rebound,2023-11-16 16:30:09,Johnson & Johnson (JNJ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,JNJ,0.104002,0.046419,Neutral
Better Being announces leadership transition for next phase of growth - PR Newswire,https://www.prnewswire.com/news-releases/better-being-announces-leadership-transition-for-next-phase-of-growth-301990736.html,2023-11-16 15:00:00,Better Being announces leadership transition for next phase of growth PR ...,JNJ,0.051111,0.149949,Neutral
Digital Health Market is Expected to Reach $549.7 billion | MarketsandMarkets.,https://www.benzinga.com/pressreleases/23/11/g35824455/digital-health-market-is-expected-to-reach-549-7-billion-marketsandmarkets,2023-11-16 12:30:00,"Chicago, Nov. 16, 2023 ( GLOBE NEWSWIRE ) -- Digital Health market in terms of revenue was estimated to be worth $180.2 billion in 2023 and is poised to reach $549.7 billion by 2028, growing at a CAGR of 25.0% from 2023 to 2028 according to a latest report published by MarketsandMarketsâ„¢.",JNJ,0.040484,-0.0347,Neutral
Major Buyout Firms Eye Sanofi's Consumer Health Division Spinoff Valued Over $20B - Sanofi  ( NASDAQ:SNY ) ,https://www.benzinga.com/markets/equities/23/11/35823034/major-buyout-firms-eye-sanofis-consumer-health-division-spinoff-valued-over-20b,2023-11-16 11:58:11,"Sanofi SA SNY has reportedly initiated talks with Rothschild & Co. to explore the possibility of spinning off its consumer health division, which could potentially value the business at over $20 billion.",JNJ,0.297661,-0.170933,Somewhat-Bearish
Looking for Stocks to Buy? Here Are the Companies Johnson & Johnson Is Betting the Most On,https://www.fool.com/investing/2023/11/16/looking-for-stocks-to-buy-heres-who-johnson-johnso/,2023-11-16 10:50:00,"Unsurprisingly, Johnson & Johnson's top investments are all in the healthcare sector.",JNJ,0.460544,0.159224,Somewhat-Bullish
Pharma Is Out of Favor. 5 Drug Stocks With Room to Grow.,https://www.barrons.com/articles/eli-lilly-pfizer-astrazeneca-drug-pharma-stocks-de1d4c9d,2023-11-16 07:00:00,"Most drug stocks have been out of favor in 2023. Pfizer was down 43.4% as of the market close Monday, while Johnson & Johnson is down 16.4%. Despite Eli Lilly's monster 66.8% gain on the year, amid investor frenzy over its weight-loss drugs, the S&P 500 Pharmaceuticals index is down 2.3%.",JNJ,0.716023,0.410039,Bullish
"Berkshire sheds GM, Johnson & Johnson, Procter & Gamble as it amasses cash",https://www.foxbusiness.com/markets/berkshire-sheds-gm-johnson-johnson-procter-gamble-amasses-cash,2023-11-16 00:25:00,"Berkshire Hathaway said it has shed its holdings in General Motors, Johnson & Johnson and Procter & Gamble, and trimmed its stake in Amazon.com, as the conglomerate controlled by Warren Buffett boosted its cash pile to a record $157.2 billion.",JNJ,0.077593,0.070857,Neutral
Warren Buffett's Berkshire Hathaway sold all of its GM stock | Business,https://www.cnn.com/2023/11/15/investing/warren-buffett-berkshire-hathaway-gm-stock/index.html,2023-11-15 21:35:00,Warren Buffett's Berkshire Hathaway sold all of its GM stock ...,JNJ,0.080458,0.067083,Neutral
"JNJ: Analyzing Pharma Stock Giants: JNJ, MRK, and ABBV",https://stocknews.com/news/jnj-mrk-abbv-kvue-analyzing-pharma-stock-giants-jnj-mrk-and-abbv/,2023-11-15 16:30:13,"JNJ: Analyzing Pharma Stock Giants: JNJ, MRK, and ...",JNJ,0.204072,0.124423,Neutral
2 Dividend Stocks Near Their 52-Week Lows to Buy and Hold Forever,https://www.fool.com/investing/2023/11/15/2-dividend-stocks-near-their-52-week-lows-to-buy-a/,2023-11-15 15:07:00,These longtime healthcare leaders have faced -- and overcome -- plenty of obstacles before.,JNJ,0.386626,0.323064,Somewhat-Bullish
Investors Heavily Search Johnson & Johnson  ( JNJ ) : Here is What You Need to Know,https://www.zacks.com/stock/news/2184526/investors-heavily-search-johnson-johnson-jnj-here-is-what-you-need-to-know,2023-11-15 14:00:09,"Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",JNJ,0.477606,0.106521,Neutral
Alcon stock falls as third-quarter sales miss estimates,https://www.marketwatch.com/story/alcons-stock-falls-as-third-quarter-sales-miss-estimates-96cebc74,2023-11-15 13:49:00,Eye care company reins in full-year sales and profit outlook ...,JNJ,0.290607,0.154617,Somewhat-Bullish
"Noema Pharma Appoints Robert Lasser, M.D., as Chief Medical Officer",https://www.benzinga.com/pressreleases/23/11/g35802163/noema-pharma-appoints-robert-lasser-m-d-as-chief-medical-officer,2023-11-15 13:00:00,"BASEL, Switzerland, Nov. 15, 2023 ( GLOBE NEWSWIRE ) -- Noema Pharma, a clinical-stage biotech company targeting debilitating central nervous system ( CNS ) disorders, today announced Robert Lasser, M.D., M.B.A has joined the Company as Chief Medical Officer ( CMO ) .",JNJ,0.066598,-0.006014,Neutral
"Warren Buffett's Berkshire Hathaway sheds investments in GM, J&J and P&G",https://www.fnlondon.com/articles/warren-buffetts-berkshire-hathaway-sheds-investments-in-gm-jj-and-pg-20231115,2023-11-15 10:56:00,"Warren Buffett's Berkshire Hathaway eliminated its stake in a handful of American blue chips, including General Motors and Johnson & Johnson, while the stock market's rally sputtered in the third quarter.",JNJ,0.546745,0.0,Neutral
3 Moves to Make if the Stock Market Plummets Tomorrow,https://www.fool.com/investing/2023/11/15/3-moves-to-make-if-the-stock-market-plummets/,2023-11-15 10:30:00,These steps could boost your long-term performance.,JNJ,0.111488,0.07066,Neutral
Warren Buffett's Berkshire Hathaway reveals it sold a bunch of long-held stocks - and made at least one secret bet,https://markets.businessinsider.com/news/stocks/warren-buffett-berkshire-hathaway-secret-stock-sales-gm-q3-portfolio-2023-11,2023-11-15 09:55:00,"Buffett's Berkshire Sold Long-Held Stocks, Made Secret Bet: Q3 Update - Markets Insider ...",JNJ,0.115787,0.095902,Neutral
"Buffett's Berkshire Trimmed Chevron Stake While Cashing Out Of GM And This COVID Stock: Here's How The Sage Of Omaha Adjusted His Portfolio In Q3 - Apple  ( NASDAQ:AAPL ) , Amazon.com  ( NASDAQ:AMZN ) ",https://www.benzinga.com/markets/equities/23/11/35797715/buffetts-berkshire-trimmed-chevron-stake-while-cashing-out-of-gm-and-this-covid-stock-heres-how-,2023-11-15 07:47:53,"Billionaire investor Warren Buffett-run Berkshire Hathaway, Inc. BRK BRK maintained its core portfolio stocks largely unchanged in the third quarter but divested a slew of stocks including legacy automaker General Motors Corp. GM.",JNJ,0.113866,0.107548,Neutral
"Warren Buffett's Berkshire Hathaway Sheds Investments in GM, J&J and P&G",https://www.wsj.com/finance/stocks/warren-buffetts-berkshire-hathaway-sheds-investments-in-gm-j-j-and-p-g-5529f8f5,2023-11-15 02:51:00,"Berkshire's stock portfolio is concentrated in five companies: Apple, Bank of America, American Express, Coca-Cola and Chevron.",JNJ,0.535653,0.0,Neutral
Why a derailed $11 trillion corporate bond market looks ripe for a comeback as U.S. inflation slows,https://www.marketwatch.com/story/why-a-derailed-11-trillion-corporate-bond-market-looks-ripe-for-a-comeback-as-u-s-inflation-slows-a682a46c,2023-11-14 21:17:00,Bonds issued by America's most valuable companies are steaming ahead after sinking to their lowest prices in about 20 years.,JNJ,0.121037,0.008397,Neutral
"Medical Component Manufacturing Market Analysis 2023-2027: Estimated Market Size, Key Drivers And Lucrative Segments As Per The Business Research Company's Medical Component Manufacturing Global Market Report 2023",https://www.benzinga.com/pressreleases/23/11/g35781916/medical-component-manufacturing-market-analysis-2023-2027-estimated-market-size-key-drivers-and-lu,2023-11-14 16:30:00,"LONDON, Nov. 14, 2023 ( GLOBE NEWSWIRE ) -- The Business Research Company's Medical Component Manufacturing Global Market Report 2023 unveils a robust trajectory, forecasting growth from $12.44 billion in 2022 to $13.29 billion in 2023, reflecting a commendable compound annual growth rate ( CAGR ...",JNJ,0.054359,0.211882,Somewhat-Bullish
Dow Gains 500 Points On Cooling Inflation; Tesla Rises On China Price Hikes,https://www.investors.com/market-trend/stock-market-today/dow-jones-gains-500-points-on-cooling-inflation-tesla-rises-on-china-price-hikes/,2023-11-14 16:21:00,Dow Gains 500 Points On Cooling Inflation. Tesla Rises On China ... Investor's Business Daily ...,JNJ,0.090134,-0.058687,Neutral
"Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, J&J and AbbVie",https://www.zacks.com/stock/news/2183791/zacks-industry-outlook-highlights-eli-lilly-novo-nordisk-jj-and-abbvie,2023-11-14 12:42:00,"Eli Lilly, Novo Nordisk, J&J and AbbVie are part of the Zacks Industry Outlook article.",JNJ,0.047092,0.030471,Neutral
"Alvotech and JAMP Pharma Announce Receipt of Marketing Authorization for Jamteki  ( AVT04 ) , the First Biosimilar of StelaraÂ®  ( ustekinumab ) ",https://www.globenewswire.com/news-release/2023/11/14/2779894/0/en/Alvotech-and-JAMP-Pharma-Announce-Receipt-of-Marketing-Authorization-for-Jamteki-AVT04-the-First-Biosimilar-of-Stelara-ustekinumab.html,2023-11-14 12:00:00,"Alvotech ( NASDAQ: ALVO ) , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and JAMP Pharma Group ( ""JAMP Pharma"" ) , a Canadian owned pharmaceutical organization headquartered in the Greater Montreal area, announced today ...",JNJ,0.020885,0.0,Neutral
"Alvotech and JAMP Pharma Announce Receipt of Marketing Authorization for Jamtekiâ„¢  ( AVT04 ) , the First Biosimilar of StelaraÂ®  ( ustekinumab ) ",https://www.globenewswire.com/news-release/2023/11/14/2779896/0/en/Alvotech-and-JAMP-Pharma-Announce-Receipt-of-Marketing-Authorization-for-Jamteki-AVT04-the-First-Biosimilar-of-Stelara-ustekinumab.html,2023-11-14 12:00:00,PrJamtekiTM is the second biosimilar developed under this partnership that receives marketing authorization in Canada.,JNJ,0.02074,0.0,Neutral
"Alvotech and JAMP Pharma announce receipt of marketing authorization for PrJamtekiTM (AVT04), the first biosimilar ... - Canada NewsWire",https://www.newswire.ca/news-releases/alvotech-and-jamp-pharma-announce-receipt-of-marketing-authorization-for-prjamtekitm-avt04-the-first-biosimilar-of-stelara-r-ustekinumab--858287722.html,2023-11-14 12:00:00,"Alvotech and JAMP Pharma announce receipt of marketing authorization for PrJamtekiTM ( AVT04 ) , the first biosimilar ... Canada ...",JNJ,0.020579,0.0,Neutral
3 Dividend Giants to Grow Wealth no Matter What the Market Is Doing,https://www.fool.com/investing/2023/11/14/3-dividend-giants-to-grow-wealth-in-any-market/,2023-11-14 10:30:00,You'll be happy to own these top companies in any market environment.,JNJ,0.122894,0.290972,Somewhat-Bullish
Addex ADX71149 Epilepsy Phase 2 Study Completes Recruitment of Patients,https://www.globenewswire.com/news-release/2023/11/14/2779698/0/en/Addex-ADX71149-Epilepsy-Phase-2-Study-Completes-Recruitment-of-Patients.html,2023-11-14 06:00:00,Ad Hoc Announcement Pursuant to Art. 53 LR ...,JNJ,0.072,0.083491,Neutral
DRI Healthcare Trust Reports Third Quarter 2023 Results,https://www.newswire.ca/news-releases/dri-healthcare-trust-reports-third-quarter-2023-results-855892981.html,2023-11-13 22:00:00,- 36% royalty income growth over prior year period highlights successful portfolio growth strategy - - Significant deployment capacity available after follow-on offerings and credit facility increase -,JNJ,0.011005,0.0,Neutral
NANOBIOTIX Provides Third Quarter 2023 Operational and Financial Update,https://www.globenewswire.com/news-release/2023/11/13/2779491/0/en/NANOBIOTIX-Provides-Third-Quarter-2023-Operational-and-Financial-Update.html,2023-11-13 21:15:00,"Conference call and webcast scheduled for Tuesday, November 14, 2023, at 2:00 pm CET / 8:00 am ET ...",JNJ,0.056055,0.086984,Neutral
Pfizer Stock Hits 3-Year Low-Down 50% From 2021 Peak,https://www.forbes.com/sites/dereksaul/2023/11/13/pfizer-stock-hits-3-year-low-down-50-from-2021-peak/,2023-11-13 21:08:53,"Pfizer shares tumbled again Monday, continuing the pharmaceutical giant's struggles tied to declining demand for its Covid-19 products and essentially wiping out the entirety of the firm's peak pandemic gains. Pfizer stock slipped 1.6% to $28.96, closing at its lowest share price since March 26, ...",JNJ,0.110462,-0.007782,Neutral
Asset manager GMO's first ETF will focus on 'quality' companies,https://www.reuters.com/business/finance/asset-manager-gmos-first-etf-will-focus-quality-companies-2023-11-13/,2023-11-13 20:01:00,"Jeremy Grantham, co-founder and chief investment strategist of GMO, takes notes during an Oxford-style debate on financial innovation hosted by ""The Economist"" magazine at Pace University in New York October 16, 2009. REUTERS/Nicholas Roberts/File Photo Acquire Licensing Rights",JNJ,0.114137,0.273544,Somewhat-Bullish
Investors seeking triple-A rated U.S. corporate debt only have these two choices - for now,https://www.marketwatch.com/story/investors-seeking-triple-a-rated-u-s-corporate-debt-only-have-these-two-choices-for-now-f2c4f9f6,2023-11-13 16:24:00,"If Moody's downgrades the U.S. rating, it may not bode well for the two remaining triple-A corporate credits.",JNJ,0.18046,0.125617,Neutral
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Kenvue Inc. - KVUE - Kenvue  ( NYSE:KVUE ) ,https://www.benzinga.com/pressreleases/23/11/g35755047/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-kenvue-inc-kvue,2023-11-13 16:20:15,"NEW YORK, Nov. 13, 2023 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Kenvue Inc. ( ""Kenvue"" or the ""Company"" ) KVUE. Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.",JNJ,0.115787,0.021477,Neutral
4 Large Drug Stocks Likely to Sail Through Industry Woes,https://www.zacks.com/commentary/2183148/4-large-drug-stocks-likely-to-sail-through-industry-woes,2023-11-13 15:03:00,"Drug, biotech companies are likely to see significant innovation. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), Novo Nordisk (NVO), J&J (JNJ) and AbbVie (ABBV) are worth retaining in your portfolio.",JNJ,0.04907,0.092705,Neutral
KENVUE INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James (Josh) Wilson Encourages ... - PR Newswire,https://www.prnewswire.com/news-releases/kenvue-investor-deadline-approaching-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-in-kenvue-to-contact-him-directly-to-discuss-their-options-301985405.html,2023-11-13 13:45:00,KENVUE INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James ( Josh ) Wilson Encourages ... PR ...,JNJ,0.061003,0.093005,Neutral
Comera Life Sciences Appoints Dorothy Clarke to Board of Directors - Comera Life Sciences  ( NASDAQ:CMRA ) ,https://www.benzinga.com/pressreleases/23/11/g35746556/comera-life-sciences-appoints-dorothy-clarke-to-board-of-directors,2023-11-13 13:00:19,"WOBURN, Mass., Nov. 13, 2023 ( GLOBE NEWSWIRE ) -- Comera Life Sciences Holdings, Inc. CMRA, a life sciences company developing a new generation of biologic medicines to improve patient access, safety, and convenience, today announced it appointed Dorothy Clarke to its board of directors.",JNJ,0.05257,0.058687,Neutral
Comera Life Sciences Appoints Dorothy Clarke to Board of Directors,https://www.globenewswire.com/news-release/2023/11/13/2779029/0/en/Comera-Life-Sciences-Appoints-Dorothy-Clarke-to-Board-of-Directors.html,2023-11-13 13:00:00,"WOBURN, Mass., Nov. 13, 2023 ( GLOBE NEWSWIRE ) -- Comera Life Sciences Holdings, Inc. ( Nasdaq: CMRA ) , a life sciences company developing a new generation of biologic medicines to improve patient access, safety, and convenience, today announced it appointed Dorothy Clarke to its board of ...",JNJ,0.053509,0.058756,Neutral
Should You Invest in the Vanguard Health Care ETF  ( VHT ) ?,https://www.zacks.com/stock/news/2183064/should-you-invest-in-the-vanguard-health-care-etf-vht,2023-11-13 11:20:05,Sector ETF report for ...,JNJ,0.13459,0.064321,Neutral
Better Buy Now: Novo Nordisk vs. Eli Lilly,https://www.fool.com/investing/2023/11/13/better-buy-now-novo-nordisk-vs-eli-lilly/,2023-11-13 11:17:00,"Both of these companies are reporting positive news for their competing weight-loss drugs, but which is the better stock to buy now?",JNJ,0.045743,0.029926,Neutral
Sports medicine market size to grow by USD 2.64 billion from 2022 to 2027|The increasing incidence of sports injuries ... - PR Newswire,https://www.prnewswire.com/news-releases/sports-medicine-market-size-to-grow-by-usd-2-64-billion-from-2022-to-2027the-increasing-incidence-of-sports-injuries-drives-the-market-growth---technavio-301984318.html,2023-11-13 03:35:00,Sports medicine market size to grow by USD 2.64 billion from 2022 to 2027|The increasing incidence of sports injuries ... PR ...,JNJ,0.056143,0.0,Neutral
"KVUE ALERT: Kessler Topaz Meltzer & Check, LLP Reminds Kenvue Inc.  ( KVUE )  Shareholders of Securities Fraud Class Action Lawsuit and Encourages Investors with Substantial Losses to Contact the Firm - Kenvue  ( NYSE:KVUE ) ",https://www.benzinga.com/pressreleases/23/11/g35740511/kvue-alert-kessler-topaz-meltzer-check-llp-reminds-kenvue-inc-kvue-shareholders-of-securities-frau,2023-11-12 15:59:00,"RADNOR, Pa., Nov. 12, 2023 ( GLOBE NEWSWIRE ) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the District of New Jersey against Kenvue Inc. ( ""Kenvue"" ) KVUE. ...",JNJ,0.057079,0.129961,Neutral
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Kenvue Inc. - KVUE,https://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-kenvue-inc---kvue-301985117.html,2023-11-11 15:10:00,"NEW YORK, Nov. 11, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Kenvue Inc. ( ""Kenvue"" or the ""Company"" ) ( NYSE: KVUE ) . Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.",JNJ,0.124164,0.023342,Neutral
Cautious Investor? 2 Safe Stocks You Also Can Count on For Growth,https://www.fool.com/investing/2023/11/11/cautious-investor-2-safe-stocks-you-also-can-count/,2023-11-11 10:00:00,These stocks offer the best of both worlds.,JNJ,0.115787,0.207342,Somewhat-Bullish
Big Players' Recent Trades in JNJ Options - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/11/35729474/big-players-recent-trades-in-jnj-options,2023-11-10 16:47:37,"Whales with a lot of money to spend have taken a noticeably bullish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson JNJ we detected 10 trades. If we consider the specifics of each trade, it is accurate to state that 70% of the investors opened trades with bullish ...",JNJ,0.679765,0.363878,Bullish
Warren Buffett's followers just got a rare peek inside his personal stock portfolio. Here's what they learned from a new report.,https://markets.businessinsider.com/news/stocks/warren-buffett-personal-portfolio-stocks-size-berkshire-hathaway-propublica-billionaires-2023-11,2023-11-10 16:10:00,"Warren Buffett's Personal Portfolio: New Report Hints at Size, Stocks - Markets Insider ...",JNJ,0.262522,0.025227,Neutral
2 Top Biotech Stocks to Buy Right Now,https://www.fool.com/investing/2023/11/10/2-top-biotech-stocks-to-buy-right-now/,2023-11-10 15:15:00,Don't give up on these stocks too fast.,JNJ,0.05654,0.084917,Neutral
Oncology Drugs Market worth $520 billion by 2033 - Exclusive Report by We Market Research,https://www.prnewswire.com/news-releases/oncology-drugs-market-worth-520-billion-by-2033---exclusive-report-by-we-market-research-301984776.html,2023-11-10 15:01:00,"CHICAGO, Nov. 10, 2023 /PRNewswire/ -- According to the latest findings from We Market Research, the oncology drug market is on track to achieve a value of USD 205 billion by the year 2023.",JNJ,0.040622,0.059987,Neutral
Baby Diaper Market is Estimated to Attain a Size of $73Bn Globally by 2030 - Exclusive Report by The Insight Partners,https://www.benzinga.com/pressreleases/23/11/g35725140/baby-diaper-market-is-estimated-to-attain-a-size-of-73bn-globally-by-2030-exclusive-report-by-the-,2023-11-10 14:06:02,"Pune, India, Nov. 10, 2023 ( GLOBE NEWSWIRE ) -- According to our latest study on ""Baby Diaper Market Size Report, Forecast to 2030 - COVID-19 Impact and Global Analysis - by Type, Distribution Channel, and Geography,"" the baby diaper market is expected to grow from $47 billion in 2022 to $73 ...",JNJ,0.02689,0.114135,Neutral
KENVUE INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi Securities Litigation Partner James  ( Josh )  Wilson Encourages Investors Who Suffered Losses In Kenvue To Contact Him Directly To Discuss Their Options - Kenvue  ( NYSE:KVUE ) ,https://www.benzinga.com/pressreleases/23/11/g35716673/kenvue-investor-deadline-approaching-faruqi-faruqi-securities-litigation-partner-james-josh-wilson,2023-11-09 22:30:00,"If you purchased or acquired securities in Kenvue securities pursuant and/or traceable to the registration statement and related prospectus ( collectively, the ""Registration Statement"" ) issued in connection with the Company's May 2023 initial public offering ( the ""IPO"" or ""Offering"" ) and ...",JNJ,0.064104,0.09307,Neutral
How To Build An Investment Portfolio For Retirement,https://www.forbes.com/sites/investor-hub/article/how-to-build-an-investment-portfolio-for-retirement/,2023-11-09 21:40:38,"When is the best time to start investing for retirement? Right now. As a rule of thumb, you need to amass about 10 times your annual salary by the time you retire. Fall short of that mark and you face a lifestyle downgrade in your senior years.",JNJ,0.013892,0.196938,Somewhat-Bullish
Here's Why You Should Retain Boston Scientific  ( BSX )  Now,https://www.zacks.com/stock/news/2181886/heres-why-you-should-retain-boston-scientific-bsx-now,2023-11-09 18:18:00,"Investors are optimistic about Boston Scientific (BSX), led by growing demand for WATCHMAN FLX devices and upbeat guidance.",JNJ,0.049221,0.090186,Neutral
Warren Buffett reportedly traded millions of dollars worth of stocks that Berkshire Hathaway was buying and selling,https://markets.businessinsider.com/news/stocks/warren-buffett-berkshire-hathaway-stocks-investors-propublica-finance-wall-street-2023-11,2023-11-09 17:29:00,Warren Buffett Sold Stocks That Berkshire Was Also Trading: Report - Markets Insider ...,JNJ,0.105604,0.118892,Neutral
Warren Buffett reportedly traded stocks that Berkshire Hathaway was trading,https://www.marketwatch.com/story/warren-buffett-reportedly-traded-stocks-that-berkshire-hathaway-was-trading-9d0c8cf5,2023-11-09 17:00:00,"Buffett has said he 'can't be buying' the same stocks as his company Berkshire Hathaway, but a new report calls that into question ...",JNJ,0.294093,-0.084182,Neutral
"Did Warren Buffett Trade Stocks Berkshire Hathaway Owned In His Private Stock Portfolio? - JPMorgan Chase  ( NYSE:JPM ) , Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/news/23/11/35704001/did-warren-buffett-trade-stocks-berkshire-hathaway-owned-in-his-private-stock-portfolio,2023-11-09 15:56:34,"Warren Buffett is one of the most legendary stock traders of the last 50 years. A new report paints a different picture of Buffett, with potential private trades being made that could represent a conflict of interest.",JNJ,0.149038,0.102002,Neutral
"IRS data reportedly shows Buffett traded Berkshire stocks in personal account, according to ProPublica",https://www.cnbc.com/2023/11/09/irs-data-reportedly-shows-buffett-traded-berkshire-stocks-in-personal-account-according-to-propublica.html,2023-11-09 14:50:25,The nonprofit news outlet cited a leak of confidential IRS data.,JNJ,0.169676,0.050728,Neutral
2 Magnificent Dow Stocks to Buy in November and 1 to Avoid Like the Plague,https://www.fool.com/investing/2023/11/09/2-dow-stocks-buy-in-november-1-avoid-like-plague/,2023-11-09 10:21:00,"Two of the Dow's 30 components are historically cheap, while concerns are mounting for another time-tested business.",JNJ,0.230704,0.184974,Somewhat-Bullish
West Pharmaceutical Services Appoints Nilesh Shah as Vice President and General Manager of Emerging Markets ... - PR Newswire,https://www.prnewswire.com/apac/news-releases/west-pharmaceutical-services-appoints-nilesh-shah-as-vice-president-and-general-manager-of-emerging-markets-301982721.html,2023-11-09 05:17:07,West Pharmaceutical Services Appoints Nilesh Shah as Vice President and General Manager of Emerging Markets ... PR ...,JNJ,0.089129,0.115932,Neutral
Voting Rights and Shares Capital of the Company,https://www.globenewswire.com/news-release/2023/11/08/2776737/0/en/Voting-Rights-and-Shares-Capital-of-the-Company.html,2023-11-08 21:15:00,In accordance with Articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority ( AutoritÃ© des MarchÃ©s Financiers ...,JNJ,0.114682,0.165483,Somewhat-Bullish
Pharma ETFs in Focus Post Q3 Earnings,https://www.zacks.com/stock/news/2180987/pharma-etfs-in-focus-post-q3-earnings,2023-11-08 16:10:00,"Many industry bigwigs reported solid results, with some beating on earnings or revenues or both.",JNJ,0.150357,0.070615,Neutral
"Global Precision Medicine Market Size Demonstrates Consistent Growth with a CAGR of 11.12%, with North America Taking a Leading Role - Illumina  ( NASDAQ:ILMN ) , Bristol-Myers Squibb  ( NYSE:BMY ) ",https://www.benzinga.com/pressreleases/23/11/g35674541/global-precision-medicine-market-size-demonstrates-consistent-growth-with-a-cagr-of-11-12-with-nor,2023-11-08 14:50:00,"New York, United States, Nov. 08, 2023 ( GLOBE NEWSWIRE ) -- Precision medicine is a new approach to treating and preventing disease that considers each individual's genetic, environmental, and lifestyle differences. Giving the proper treatment to the right patient at the right time is the goal ...",JNJ,0.039353,0.0,Neutral
3 Brilliant Artificial Intelligence Stocks to Buy and Hold Forever,https://www.fool.com/investing/2023/11/08/3-brilliant-artificial-intelligence-stocks-to-buy/,2023-11-08 14:45:00,Healthcare stocks are widely expected to be a prime beneficiary of the AI revolution. These three names could be the best of the bunch.,JNJ,0.106305,-0.006663,Neutral
"Global Men's Personal Care Market Set to Reach USD 68.89 Billion by 2030, Fueled by Rising Awareness and Fashion Trends",https://www.benzinga.com/pressreleases/23/11/g35672962/global-mens-personal-care-market-set-to-reach-usd-68-89-billion-by-2030-fueled-by-rising-awareness,2023-11-08 14:00:00,"New York, United States, Nov. 08, 2023 ( GLOBE NEWSWIRE ) -- The perception of beauty standards for men is changing. Decades-long gender stereotypes have begun to break down, and men's and women's beauty products are now being created.",JNJ,0.043658,0.177487,Somewhat-Bullish
"Jim Cramer Asks Why The World's Largest Healthcare Products Company Has 'An Ill-Advised Strategy' - AGNC Investment  ( NASDAQ:AGNC ) , Clorox  ( NYSE:CLX ) ",https://www.benzinga.com/trading-ideas/long-ideas/23/11/35666275/jim-cramer-asks-why-the-worlds-largest-healthcare-products-company-has-an-ill-advised-st,2023-11-08 13:35:41,"On CNBC's ""Mad Money Lightning Round,"" Jim Cramer said The Clorox Company's CLX recent quarter was ""ok."" He added, ""I think that the hack is behind them. I think Linda Rendle is doing a very good job."" AGNC Investment Corp. AGNC has ""been a dog so long,"" Cramer said, ""It's just been a value trap.""",JNJ,0.539306,-0.064939,Neutral
Grab these 2 funds with rich 11%-12% yields while you can,https://www.marketwatch.com/story/grab-these-2-funds-with-rich-11-12-yields-while-you-can-f2856fb2,2023-11-08 12:18:00,"If you invest for income, consider taking advantage of these unusual opportunities.",JNJ,0.13459,0.166414,Somewhat-Bullish
NANOBIOTIX Announces Closing of Global Offering,https://www.benzinga.com/pressreleases/23/11/g35657744/nanobiotix-announces-closing-of-global-offering,2023-11-07 21:01:00,"PARIS and CAMBRIDGE, Mass., Nov. 07, 2023 ( GLOBE NEWSWIRE ) -- NANOBIOTIX ( Euronext: NANO - NASDAQ: NBTX - ""Nanobiotix"" or the ""Company"" ) , a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, announces the ...",JNJ,0.022222,0.046698,Neutral
Inside the Dividend Monarchs ETF  ( KNGS ) ,https://www.zacks.com/stock/news/2180335/inside-the-dividend-monarchs-etf-kngs,2023-11-07 19:00:00,The newly-launched KNGS ETF holds 30+ stocks. These stocks have been in a position to consistently raise their dividends over the last 50 years.,JNJ,0.073321,-0.005071,Neutral
Q1 2023/24 - Lower revenue in a challenging market,https://www.globenewswire.com/news-release/2023/11/07/2775449/0/en/Q1-2023-24-Lower-revenue-in-a-challenging-market.html,2023-11-07 19:00:00,ANNOUNCEMENT NO. ...,JNJ,0.029951,0.037699,Neutral
Genmab Announces Financial Results for the First Nine Months of 2023,https://www.globenewswire.com/news-release/2023/11/07/2775338/0/en/Genmab-Announces-Financial-Results-for-the-First-Nine-Months-of-2023.html,2023-11-07 16:01:00,"November 7, 2023 Copenhagen, Denmark. Interim Report for the First Nine Months Ended September ...",JNJ,0.036091,0.0,Neutral
Johnson & Johnson to submit application to start trials for surgical robot,https://www.reuters.com/business/healthcare-pharmaceuticals/johnson-johnson-submit-application-start-trials-its-robotic-surgical-system-2023-11-07/,2023-11-07 13:12:00,Johnson & Johnson to submit application to start trials for its robotic surgical system ...,JNJ,0.282234,0.0,Neutral
2 Magnificent Dividend Stocks Trading Near 52-Week Lows to Buy Now and Hold at Least a Decade,https://www.fool.com/investing/2023/11/07/2-magnificent-dividend-stocks-trading-near-52-week/,2023-11-07 10:37:00,Taking advantage of the discounted prices these stocks have been trading at could do wonders for your passive income stream.,JNJ,0.272788,0.223045,Somewhat-Bullish
Anti-Infective Drugs Market to Hit USD 177.9 billion by 2031 | Transparency Market Research Inc.,https://www.benzinga.com/pressreleases/23/11/g35637643/anti-infective-drugs-market-to-hit-usd-177-9-billion-by-2031-transparency-market-research-inc,2023-11-07 10:30:00,"Wilmington, Delaware, United States, Nov. 07, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global anti-infective drugs market is projected to flourish at a CAGR of 4.0% from 2023 to 2031. As per the report published by TMR, a valuation of US$ 117.9 billion is anticipated for ...",JNJ,0.043658,-0.109878,Neutral
2 Monster Stocks to Buy Without Any Hesitation,https://www.fool.com/investing/2023/11/07/2-monster-stocks-to-buy-without-any-hesitation/,2023-11-07 10:05:00,"Down 33% and 44%, these two stocks look too good to pass up today.",JNJ,0.034831,-0.076883,Neutral
"Mobile health solutions market to grow at a USD 256.69 billion from 2022 to 2027 | Abbott Laboratories, AirStrip ... - PR Newswire",https://www.prnewswire.com/news-releases/mobile-health-solutions-market-to-grow-at-a-usd-256-69-billion-from-2022-to-2027--abbott-laboratories-airstrip-technologies-inc-apple-inc-and-more-among-the-key-companies-in-the-market---technavio-301978707.html,2023-11-07 01:15:00,"Mobile health solutions market to grow at a USD 256.69 billion from 2022 to 2027 | Abbott Laboratories, AirStrip ... PR ...",JNJ,0.058047,0.143994,Neutral
KENVUE ONGOING DEADLINE ALERT: Faruqi & Faruqi Securities Litigation Partner James  ( Josh )  Wilson Encourages Investors Who Suffered Losses In Kenvue To Contact Him Directly To Discuss Their Options - Kenvue  ( NYSE:KVUE ) ,https://www.benzinga.com/pressreleases/23/11/g35951423/kenvue-ongoing-deadline-alert-faruqi-faruqi-securities-litigation-partner-james-josh-wilson-encour,2023-11-26 14:15:00,"If you purchased or acquired securities in Kenvue securities pursuant and/or traceable to the registration statement and related prospectus ( collectively, the ""Registration Statement"" ) issued in connection with the Company's May 2023 initial public offering ( the ""IPO"" or ""Offering"" ) and ...",JNJ,0.064104,0.09307,Neutral
"Got $1,500? You Can Confidently Add These 3 Stocks to Your Portfolio",https://www.fool.com/investing/2023/11/26/got-1500-you-can-confidently-add-these-3-stocks-to/,2023-11-26 12:15:00,These companies offer low-risk growth and income at a value price.,JNJ,0.324292,0.388699,Bullish
Johnson & Johnson and Intuitive Surgical Might Become Ozempic's Next Victims. Are They Still Worth Buying?,https://www.fool.com/investing/2023/11/26/johnson-johnson-and-intuitive-surgical-might-becom/,2023-11-26 11:30:00,"With retailers worrying about Ozempic's impact, healthcare stocks could be next.",JNJ,0.223659,0.065413,Neutral
KENVUE DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered ... - PR Newswire,https://www.prnewswire.com/news-releases/kenvue-deadline-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-in-kenvue-to-contact-him-directly-to-discuss-their-options-301996260.html,2023-11-25 14:00:00,KENVUE DEADLINE ALERT: Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered ... PR ...,JNJ,0.061003,0.093005,Neutral
Warren Buffett-Led Berkshire Hathaway Sells Its Entire Procter & Gamble Stake. Should You?,https://www.fool.com/investing/2023/11/25/buffett-berkshire-sell-procter-gamble-stock/,2023-11-25 10:48:00,Procter & Gamble has proven it can justify repeated price hikes without overly damaging sales volume.,JNJ,0.04882,0.0,Neutral
4 ETFs to Implement Buffett's Investing Philosophy,https://www.zacks.com/stock/news/2189287/4-etfs-to-implement-buffetts-investing-philosophy,2023-11-24 18:42:00,"Warren Buffett is a well-known figure in the global financial world, and it is worthwhile to track his investment portfolio.",JNJ,0.159218,0.233305,Somewhat-Bullish
3 Dividend Stocks You Can Safely Hold for Decades,https://www.fool.com/investing/2023/11/24/3-dividend-stocks-you-can-safely-hold-for-decades/,2023-11-24 13:20:00,Investors can confidently buy these income stocks for the long term.,JNJ,0.154207,0.134131,Neutral
71% of Warren Buffett's $357 Billion Portfolio Is Invested in Just 4 Stocks,https://www.fool.com/investing/2023/11/24/71-warren-buffett-portfolio-invested-in-4-stocks/,2023-11-24 10:06:00,A whopping $252 billion of Berkshire Hathaway's $357 billion of invested assets can be traced to four brand-name businesses.,JNJ,0.030446,0.135671,Neutral
"Underdeveloped nations fighting drugmakers over access to TB, HIV drugs",https://www.business-standard.com/world-news/underdeveloped-nations-fighting-drugmakers-over-access-to-tb-hiv-drugs-123112400284_1.html,2023-11-24 07:25:01,"South Africa, Colombia and other countries that lost out in the global race for coronavirus vaccines are taking a more combative approach towards drugmakers and pushing back on policies that deny cheap treatment to millions of people with tuberculosis and HIV.",JNJ,0.035241,0.008844,Neutral
"South Africa, Colombia and others are fighting drugmakers over access to TB and HIV drugs",https://apnews.com/article/bedaquiline-dolutegravir-tuberculosis-hiv-south-africa-0f6de15ea57279b699c147c015b23c02,2023-11-24 05:07:00,"CAPE TOWN, South Africa ( AP ) - South Africa, Colombia and other countries that lost out in the global race for coronavirus vaccines are taking a more combative approach towards drugmakers and pushing back on policies that deny cheap treatment to millions of people with tuberculosis and HIV.",JNJ,0.035661,0.008854,Neutral
Burn Care Market to grow by USD 843.34 million from 2022 to 2027; North America to account for 35% of market ... - PR Newswire,https://www.prnewswire.com/news-releases/burn-care-market-to-grow-by-usd-843-34-million-from-2022-to-2027-north-america-to-account-for-35-of-market-growth--technavio-301996767.html,2023-11-24 04:15:00,Burn Care Market to grow by USD 843.34 million from 2022 to 2027. North America to account for 35% of market ... PR ...,JNJ,0.064276,0.097542,Neutral
"Cell Surface Markers Market size to grow by USD 14.06 billion from 2023-2028| Abbott Laboratories, Abcam plc ... - PR Newswire",https://www.prnewswire.com/news-releases/cell-surface-markers-market-size-to-grow-by-usd-14-06-billion-from-2023-2028-abbott-laboratories-abcam-plc-agilent-technologies-inc-and-more-among-the-key-companies-in-the-market---technavio-301996069.html,2023-11-23 01:30:00,"Cell Surface Markers Market size to grow by USD 14.06 billion from 2023-2028| Abbott Laboratories, Abcam plc ... PR ...",JNJ,0.064797,0.0,Neutral
"The Evolving Market Dynamics of B-cell Lymphomas: Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Waldenstrom Macroglobulinemia, and Burkitt Lymphoma | DelveInsight",https://www.prnewswire.com/news-releases/the-evolving-market-dynamics-of-b-cell-lymphomas-diffuse-large-b-cell-lymphoma-follicular-lymphoma-chronic-lymphocytic-leukemia-mantle-cell-lymphoma-marginal-zone-lymphoma-waldenstrom-macroglobulinemia-and-burkitt-lymphoma--301995626.html,2023-11-22 22:01:00,"The Evolving Market Dynamics of B-cell Lymphomas: Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Chronic ... PR ...",JNJ,0.013173,0.026023,Neutral
Market Whales and Their Recent Bets on JNJ Options - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/11/35923874/market-whales-and-their-recent-bets-on-jnj-options,2023-11-22 19:46:21,"Financial giants have made a conspicuous bearish move on Johnson & Johnson. Our analysis of options history for Johnson & Johnson JNJ revealed 10 unusual trades. Delving into the details, we found 40% of traders were bullish, while 60% showed bearish tendencies.",JNJ,0.605266,0.313831,Somewhat-Bullish
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Kenvue Inc.  ( KVUE )  - Kenvue  ( NYSE:KVUE ) ,https://www.benzinga.com/pressreleases/23/11/g35921447/glancy-prongay-murray-llp-reminds-investors-of-looming-deadline-in-the-class-action-lawsuit-agains,2023-11-22 17:36:36,"LOS ANGELES, Nov. 22, 2023 ( GLOBE NEWSWIRE ) -- Glancy Prongay & Murray LLP ( ""GPM"" ) reminds investors of the upcoming December 8, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Kenvue Inc. ( ""Kenvue"" or the ...",JNJ,0.062597,0.086023,Neutral
"Skin Care Products Market Estimated to Reach USD 269.2 billion by 2031 Globally, at a CAGR of 5.6 % | Says Transparency Market Research Inc.",https://www.benzinga.com/pressreleases/23/11/g35920040/skin-care-products-market-estimated-to-reach-usd-269-2-billion-by-2031-globally-at-a-cagr-of-5-6-s,2023-11-22 16:30:00,"Wilmington, Delaware, United States, Nov. 22, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The skin care products market stood at US$ 156 billion in 2021 and the global market is projected to reach US$ 269.2 billion in 2031.",JNJ,0.039811,0.084204,Neutral
"Worried About Market Volatility? Invest In These High-Yield Dividend Stocks For Consistent Passive Income - Johnson & Johnson  ( NYSE:JNJ ) , NextEra Energy  ( NYSE:NEE ) ",https://www.benzinga.com/trading-ideas/dividends/23/11/35919184/worried-about-market-volatility-invest-in-these-high-yield-dividend-stocks-for-consistent,2023-11-22 16:01:18,"While the stock market has been recovering since the pullback last year, market volatility remains high as geopolitical tensions persist. The recent crisis in the Middle East has sparked concerns regarding broader regional instability.",JNJ,0.322474,0.321932,Somewhat-Bullish
"The Zacks Analyst Blog Highlights Novo Nordisk Bank of America, Netflix, Johnson & Johnson and TotalEnergies",https://www.zacks.com/stock/news/2187835/the-zacks-analyst-blog-highlights-novo-nordisk-bank-of-america-netflix-johnson-johnson-and-totalenergies,2023-11-22 14:43:00,"Novo Nordisk, Bank of America, Netflix, Johnson & Johnson and TotalEnergies are part of the Zacks top Analyst Blog.",JNJ,0.131643,0.036445,Neutral
Need a path to your dream profession? Rutgers Business School offers a roadmap to success,https://www.prnewswire.com/news-releases/need-a-path-to-your-dream-profession-rutgers-business-school-offers-a-roadmap-to-success-301995139.html,2023-11-22 14:15:00,"NEW BRUNSWICK, N.J., Nov. 22, 2023 /PRNewswire/ -- For Eric Yao, a high school student in Rockville, Maryland, Rutgers Business School offered proximity to New York City ( ""the capital of the world,"" as he put it ) , an extremely large alumni network and the opportunity to study at a tier-one ...",JNJ,0.021013,0.135909,Neutral
AbelZeta Announces Two Abstracts Accepted for Presentation at the 65th ASH Annual Meeting,https://www.prnewswire.com/news-releases/abelzeta-announces-two-abstracts-accepted-for-presentation-at-the-65th-ash-annual-meeting-301995912.html,2023-11-22 14:00:00,"ROCKVILLE, Md. and SHANGHAI, Nov. 22, 2023 /PRNewswire/ -- AbelZeta Pharma, Inc. ( ""AbelZeta"" or the ""Company"" ) , a global clinical-stage biopharmaceutical company focused on discovery and development of innovative and proprietary cell-based therapeutic products, announced today that two ...",JNJ,0.062271,0.199181,Somewhat-Bullish
How Viz.ai Uses Artificial Intelligence To Treat Stroke Patients Faster,https://www.forbes.com/sites/amyfeldman/2023/11/22/how-vizai-uses-artificial-intelligence-to-speed-help-to-stroke-patients/,2023-11-22 11:30:00,"The startup has 12 FDA-approved algorithms to flag problems, agreements with more than 1,500 U.S. hospitals, and big plans to work with drug companies to reduce roadblocks in healthcare. October 26, while visiting New York City for a gala, Jess Allison collapsed on the street.",JNJ,0.016963,0.108781,Neutral
Should You Invest in the Health Care Select Sector SPDR ETF  ( XLV ) ?,https://www.zacks.com/stock/news/2187631/should-you-invest-in-the-health-care-select-sector-spdr-etf-xlv,2023-11-22 11:20:06,Sector ETF report for ...,JNJ,0.126784,0.060142,Neutral
3 Biotech Stocks That Could Be Millionaire Makers,https://www.fool.com/investing/2023/11/22/3-biotech-stocks-that-could-be-millionaire-makers/,2023-11-22 10:30:00,Many biotech stocks offer exciting long-term growth prospects.,JNJ,0.054983,0.257973,Somewhat-Bullish
5 Longtime Holdings Warren Buffett Completely Sold During the Third Quarter,https://www.fool.com/investing/2023/11/22/5-longtime-holdings-warren-buffett-sold-during-q3/,2023-11-22 10:06:00,These brand-name companies had been fixtures in Berkshire Hathaway's portfolio for the past 11 to 18 years.,JNJ,0.112401,-0.043518,Neutral
How Is The Market Feeling About Johnson & Johnson? - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/short-sellers/23/11/35903915/how-is-the-market-feeling-about-johnson-johnson,2023-11-21 19:15:12,"Johnson & Johnson's JNJ short percent of float has fallen 7.69% since its last report. The company recently reported that it has 14.53 million shares sold short, which is 0.6% of all regular shares that are available for trading.",JNJ,0.221819,0.081322,Neutral
J&J  ( JNJ )  Seeks Expanded Use of Lung Cancer Drug Rybrevant,https://www.zacks.com/stock/news/2187470/jj-jnj-seeks-expanded-use-of-lung-cancer-drug-rybrevant,2023-11-21 17:41:00,J&J's (JNJ) sBLA seeks label expansion for Rybrevant plus chemotherapy to treat patients with EGFR-mutated NSCLC whose disease progressed on or after treatment with AstraZeneca's Tagrisso (osimertinib).,JNJ,0.146916,-0.044802,Neutral
4 Best High Yield Dividend Stocks For Retirement Portfolios,https://www.forbes.com/sites/investor-hub/article/best-high-yield-dividend-stocks-for-retirement-portfolios/,2023-11-21 17:03:55,"Dividend stocks are a core part of many retirement portfolios. But dividend investing is at a unique point in market history, with T-bills yielding 5%. That raises the bar for ""high-yield"" stocks, since stocks can fall heavily in price. In this article, I toe the line between yield and stability.",JNJ,0.11995,0.152743,Somewhat-Bullish
"Drexel University BrandVoice: Is College Still Worthwhile? Yes, When It's Tied To Experiences",https://www.forbes.com/sites/drexeluniversity/2023/11/21/is-college-still-worthwhile-yes-when-its-tied-to-experiences/,2023-11-21 14:48:53,"Is College Still Worthwhile? Yes, When It's Tied To Experiences Forbes ...",JNJ,0.024546,0.076643,Neutral
Kenvue Shareholder Action Reminder,https://markets.businessinsider.com/news/stocks/kenvue-shareholder-action-reminder-1032725577,2023-11-21 14:09:00,Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses In Kenvue To Contact Him Directly To Discuss Their Options,JNJ,0.06211,0.093019,Neutral
Should You Invest in the iShares U.S. Healthcare ETF  ( IYH ) ?,https://www.zacks.com/stock/news/2187024/should-you-invest-in-the-ishares-us-healthcare-etf-iyh,2023-11-21 11:20:06,Sector ETF report for ...,JNJ,0.13459,0.070304,Neutral
"Sports medicine market size to grow by USD 2.64 billion from 2022 to 2027|Alimed Inc., Arthrex Inc., Bauerfeind AG ... - PR Newswire",https://www.prnewswire.com/news-releases/sports-medicine-market-size-to-grow-by-usd-2-64-billion-from-2022-to-2027alimed-inc-arthrex-inc-bauerfeind-ag-breg-inc-and-more-among-the-key-companies-in-the-market---technavio-301993965.html,2023-11-21 09:15:00,"Sports medicine market size to grow by USD 2.64 billion from 2022 to 2027|Alimed Inc., Arthrex Inc., Bauerfeind AG ... PR ...",JNJ,0.059049,0.013,Neutral
"Kenvue Inc. Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds KVUE Investors of Securities Fraud Class Action Lawsuit Filed on Their Behalf - Kenvue  ( NYSE:KVUE ) ",https://www.benzinga.com/pressreleases/23/11/g35886105/kenvue-inc-shareholder-reminder-kessler-topaz-meltzer-check-llp-reminds-kvue-investors-of-securiti,2023-11-21 00:52:00,"RADNOR, Pa., Nov. 20, 2023 ( GLOBE NEWSWIRE ) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the District of New Jersey against Kenvue Inc. ( ""Kenvue"" ) KVUE. ...",JNJ,0.056943,0.129956,Neutral
Behind the Scenes of Johnson & Johnson's Latest Options Trends - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/11/35877616/behind-the-scenes-of-johnson-johnsons-latest-options-trends,2023-11-20 17:00:58,"Whales with a lot of money to spend have taken a noticeably bearish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson JNJ we detected 12 trades. If we consider the specifics of each trade, it is accurate to state that 33% of the investors opened trades with bullish ...",JNJ,0.579393,0.305205,Somewhat-Bullish
Janssen Submits Supplemental Biologics License Application to U.S. FDA Seeking Approval of RYBREVANTÂ®  ( amivantamab-vmjw )  Plus Chemotherapy for the Treatment of Patients with EGFR-Mutated Non-Small Cell Lung Cancer Who Progressed on or after Osimertinib,https://www.prnewswire.com/news-releases/janssen-submits-supplemental-biologics-license-application-to-us-fda-seeking-approval-of-rybrevant-amivantamab-vmjw-plus-chemotherapy-for-the-treatment-of-patients-with-egfr-mutated-non-small-cell-lung-cancer-who-progressed-o-301993484.html,2023-11-20 13:01:00,Janssen Submits Supplemental Biologics License Application to U.S. FDA Seeking Approval of RYBREVANT ... PR ...,JNJ,0.082272,0.020891,Neutral
Warren Buffett's Berkshire Hathaway Sold $7 Billion Worth of Stock Last Quarter but Bought 1 Mystery Stock,https://www.fool.com/investing/2023/11/20/buffett-berkshire-hathaway-mystery-stock/,2023-11-20 11:20:00,The SEC let Buffett and his team keep this one a secret.,JNJ,0.046184,0.0,Neutral
"Researchers return to Alzheimer's vaccines, buoyed by recent drug success",https://www.reuters.com/business/healthcare-pharmaceuticals/researchers-return-alzheimers-vaccines-buoyed-by-recent-drug-success-2023-11-20/,2023-11-20 11:15:00,"A doctor points out evidence of Alzheimer's disease on PET scans at the Center for Alzheimer Research and Treatment ( CART ) at Brigham And Women's Hospital in Boston, Massachusetts, U.S., March 30, 2023. REUTERS/Brian Snyder/File photo Acquire Licensing Rights",JNJ,0.041682,-0.290871,Somewhat-Bearish
Meet the Brand-New Value Stock Warren Buffett Is Piling Into,https://www.fool.com/investing/2023/11/20/meet-new-value-stock-warren-buffett-is-piling-into/,2023-11-20 10:06:00,The new apple of the Oracle of Omaha's eye is historically cheap.,JNJ,0.040622,0.0,Neutral
Interventional Spine Devices Market to grow by USD 3.07 billion from 2023 to 2028; North America to account for 47 ... - PR Newswire,https://www.prnewswire.com/news-releases/interventional-spine-devices-market-to-grow-by-usd-3-07-billion-from-2023-to-2028-north-america-to-account-for-47-of-market-growth--technavio-301992857.html,2023-11-20 06:35:00,Interventional Spine Devices Market to grow by USD 3.07 billion from 2023 to 2028. North America to account for 47 ... PR ...,JNJ,0.070517,0.0,Neutral
"SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Kenvue, Inc. of Class Action Lawsuit and Upcoming Deadline - KVUE",https://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-reminds-shareholders-with-losses-on-their-investment-in-kenvue-inc-of-class-action-lawsuit-and-upcoming-deadline--kvue-301992543.html,2023-11-19 19:15:00,"SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Kenvue, Inc ... PR ...",JNJ,0.171363,0.01387,Neutral
KENVUE ONGOING DEADLINE ALERT: Faruqi & Faruqi Securities Litigation Partner James  ( Josh )  Wilson Encourages Investors Who Suffered Losses In Kenvue To Contact Him Directly To Discuss Their Options - Kenvue  ( NYSE:KVUE ) ,https://www.benzinga.com/pressreleases/23/11/g35865247/kenvue-ongoing-deadline-alert-faruqi-faruqi-securities-litigation-partner-james-josh-wilson-encour,2023-11-19 15:00:00,"If you purchased or acquired securities in Kenvue securities pursuant and/or traceable to the registration statement and related prospectus ( collectively, the ""Registration Statement"" ) issued in connection with the Company's May 2023 initial public offering ( the ""IPO"" or ""Offering"" ) and ...",JNJ,0.064104,0.091067,Neutral
Legendary value investor's firm launches new fund targeting 'quality' stocks,https://www.cnbc.com/2023/11/18/legendary-investors-firm-launches-new-fund-targeting-quality-stocks.html,2023-11-18 21:03:52,The money manager behind legendary investor Jeremy Grantham's GMO U.S. Quality ETF delivers his strategy for gains.,JNJ,0.254307,0.14576,Neutral
"KVUE CLASS ACTION NOTICE: Kessler Topaz Meltzer & Check, LLP Reminds Kenvue Inc.  ( KVUE )  Shareholders of Securities Fraud Class Action Lawsuit and Encourages Investors with Substantial Losses to...",https://markets.businessinsider.com/news/stocks/kvue-class-action-notice-kessler-topaz-meltzer-check-llp-reminds-kenvue-inc.-kvue-shareholders-of-securities-fraud-class-action-lawsuit-and-encourages-investors-with-substantial-losses-to-contact-the-firm-1032833108,2023-11-18 14:06:00,"KVUE CLASS ACTION NOTICE: Kessler Topaz Meltzer & Check, LLP Reminds Kenvue Inc. (KVUE) Shareholders of Securities Fraud Class Action Lawsuit and Encourages Investors with Substantial Losses to...",JNJ,0.05833,0.134996,Neutral
KENVUE SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages ... - PR Newswire,https://www.prnewswire.com/news-releases/kenvue-shareholder-action-reminder-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-in-kenvue-to-contact-him-directly-to-discuss-their-options-301992692.html,2023-11-18 14:00:00,KENVUE SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James ( Josh ) Wilson Encourages ... PR ...,JNJ,0.060694,0.093002,Neutral
"Personal Care Industry Poised For Growth: Analyst Initiates Coverage On These 3 Stocks - Kimberly-Clark  ( NYSE:KMB ) , Kenvue  ( NYSE:KVUE ) , Perrigo  ( NYSE:PRGO ) ",https://www.benzinga.com/markets/equities/23/11/35853309/personal-care-industry-poised-for-growth-analyst-initiates-coverage-on-these-3-stocks,2023-11-17 19:54:20,"Piper Sandler analyst Korinne Wolfmeyer initiated coverage on several personal care stocks, noting that amid the present economic conditions, consumers are becoming more discerning in their spending. This positions the personal care category favorably for the near and mid-term, due to its ...",JNJ,0.107978,-0.054832,Neutral
Johnson & Johnson Resolves 2 Major Talc Cases As Legal Battles Continue - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/news/large-cap/23/11/35845493/johnson-johnson-resolves-2-major-talc-cases-as-legal-battles-continue,2023-11-17 14:25:24,"Johnson & Johnson JNJ announced settlements in two talc-related cases, the news follows an appeals court's ruling which overturned a $223.8 million verdict against the company. The company is facing over 50,000 talc-related lawsuits, primarily from women with ovarian cancer, and maintains its ...",JNJ,0.386875,0.23944,Somewhat-Bullish
"13F Rundown: Tepper, Buffett, Druckenmiller",https://www.zacks.com/commentary/2185646/13f-rundown-tepper-buffett-druckenmiller,2023-11-17 13:00:00,Stock Strategist Andrew Rocco divulges valuable insights from the world's best and brightest investors.,JNJ,0.146025,0.206432,Somewhat-Bullish
"Why Warren Buffett, Ray Dalio's Hedge Funds Are Selling Top-Ranking Dividend King - Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/markets/equities/23/11/35846742/why-warren-buffett-ray-dalios-hedge-funds-are-selling-top-ranking-dividend-king,2023-11-17 12:58:37,"One top-ranked dividend king was a popular sell amid hedge fund billionaires in the third quarter this year. This fact came to light in recent 13F filings from the whales of Wall Street. Johnson & Johnson JNJ is among the biggest pharmaceutical companies worldwide, with approximately 130,000 ...",JNJ,0.87799,0.405623,Bullish
Should Vanguard High Dividend Yield ETF  ( VYM )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2185771/should-vanguard-high-dividend-yield-etf-vym-be-on-your-investing-radar,2023-11-17 11:20:07,Style Box ETF report for ...,JNJ,0.125134,0.069019,Neutral
"Johnson & Johnson Is Eyeing Intuitive Surgical's Market, But Can It Win?",https://www.fool.com/investing/2023/11/17/johnson-johnson-eyeing-intuitive-surgicals-market/,2023-11-17 11:03:00,The healthcare company's entry into the market will be a major test for Intuitive Surgical.,JNJ,0.222838,0.08142,Neutral
Senator's Bearish Tesla Bet Under Scrutiny As He Buys Put Options Ahead Of Elon Musk-Led Company's Q3 Results That Set Stock Slide In Motion - Tesla  ( NASDAQ:TSLA ) ,https://www.benzinga.com/markets/equities/23/11/35843401/senators-bearish-tesla-bet-under-scrutiny-as-he-buys-put-options-ahead-of-elon-musk-led-companys,2023-11-17 07:02:36,"Tesla, Inc. TSLA shares have been going through a lean phase and the modest recovery seen has been in fits-and-starts. Against this backdrop, a Congressman has disclosed on Thursday bearish bets on the electric vehicle giant. What Happened: Sen.",JNJ,0.135347,0.134306,Neutral
"Deadline in 2 Days for Kenvue Inc. Investors: Kessler Topaz Meltzer & Check, LLP Reminds Kenvue Inc.  ( KVUE )  Investors of Filing Deadline in Class Action Lawsuit - Kenvue  ( NYSE:KVUE ) ",https://www.benzinga.com/pressreleases/23/12/g36123024/deadline-in-2-days-for-kenvue-inc-investors-kessler-topaz-meltzer-check-llp-reminds-kenvue-inc-kvu,2023-12-06 21:33:24,"RADNOR, Pa., Dec. 06, 2023 ( GLOBE NEWSWIRE ) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the District of New Jersey against Kenvue Inc. ( ""Kenvue"" ) KVUE. ...",JNJ,0.056943,0.129956,Neutral
J&J  ( JNJ )  Announces 2024 and Long-Term Financial Outlook,https://www.zacks.com/stock/news/2194292/jj-jnj-announces-2024-and-long-term-financial-outlook,2023-12-06 16:29:00,"J&J (JNJ) expects operational sales growth in the range of 5-6% in 2024, driven by both its Innovative Medicine and MedTech divisions.",JNJ,0.286864,0.029825,Neutral
"JNJ CEO Signals No Rush Into Weight-Loss Drug Realm, Emphasizes Different Priorities - Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/general/biotech/23/12/36114393/jnj-ceo-signals-no-rush-into-weight-loss-drug-realm-emphasizes-different-priorities,2023-12-06 16:23:36,"Johnson & Johnson JNJ has no immediate plans to venture into weight-loss drugs due to the existing competition saturation, as Chief Executive Officer Joaquin Duato highlighted. During the firm's investor day on Tuesday, Duato emphasized that the company's priorities lie in extensive expansion, ...",JNJ,0.401331,0.0,Neutral
"The Zacks Analyst Blog Highlights Johnson & Johnson, T-Mobile US, Caterpillar, Broadcom and Starbucks",https://www.zacks.com/stock/news/2193912/the-zacks-analyst-blog-highlights-johnson-johnson-t-mobile-us-caterpillar-broadcom-and-starbucks,2023-12-06 09:29:00,"Johnson & Johnson, T-Mobile US, Caterpillar, Broadcom and Starbucks are included in this Analyst Blog.",JNJ,0.259727,0.161487,Somewhat-Bullish
What HR Functions Can Companies Automate With AI?,https://www.forbes.com/sites/bernardmarr/2023/12/06/what-hr-functions-can-companies-automate-with-ai/,2023-12-06 08:09:23,"HR teams have moved beyond administrative and personnel-focused duties and are now leveraging data, analytics, and artificial intelligence ( AI ) to create sweeping changes in the way companies manage people. Automation is a key driver of these changes.",JNJ,0.0864,0.168855,Somewhat-Bullish
"Healthcare education solutions market recorded 8.25% growth between 2021 and 2022 | 3M Corp, B. Braun SE ... - PR Newswire",https://www.prnewswire.com/news-releases/healthcare-education-solutions-market-recorded-8-25-growth-between-2021-and-2022--3m-corp-b-braun-se-becton-dickinson-and-co-and-more-among-the-key-companies-in-the-market--technavio-302006885.html,2023-12-06 02:35:00,"Healthcare education solutions market recorded 8.25% growth between 2021 and 2022 | 3M Corp, B. Braun SE ... PR ...",JNJ,0.066414,0.032078,Neutral
Johnson & Johnson  ( JNJ )  Sees a More Significant Dip Than Broader Market: Some Facts to Know,https://www.zacks.com/stock/news/2193851/johnson-johnson-jnj-sees-a-more-significant-dip-than-broader-market-some-facts-to-know,2023-12-05 22:45:10,"In the latest trading session, Johnson & Johnson (JNJ) closed at $158.55, marking a -0.21% move from the previous day.",JNJ,0.588876,0.275502,Somewhat-Bullish
"Fallopian Tube Cancer Therapeutics Market size to grow by USD 832.01 million from 2023-2028| AbbVie Inc., Amgen ... - PR Newswire",https://www.prnewswire.com/news-releases/fallopian-tube-cancer-therapeutics-market-size-to-grow-by-usd-832-01-million-from-2023-2028-abbvie-inc-amgen-inc-arrien-pharmaceuticals-llc-and-more-among-the-key-companies-in-the-market---technavio-302006567.html,2023-12-05 22:15:00,"Fallopian Tube Cancer Therapeutics Market size to grow by USD 832.01 million from 2023-2028| AbbVie Inc., Amgen ... PR ...",JNJ,0.057628,-0.003,Neutral
"Top Analyst Reports for Johnson & Johnson, T-Mobile & Caterpillar",https://www.zacks.com/research-daily/2193470/top-analyst-reports-for-johnson-johnson-t-mobile-caterpillar,2023-12-05 20:14:00,"Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), T-Mobile US, Inc. (TMUS) and Caterpillar Inc. (CAT).",JNJ,0.088147,0.225055,Somewhat-Bullish
"Bsense Announces the Clinical Candidate Nomination of BSEN760, a Novel Dual Kv7.2/3 and TRPV1 Modulator, to Unlock a New Approach to Dampening Sensory Hyperexcitability for Chronic Pain Treatment",https://www.benzinga.com/pressreleases/23/12/g36099323/bsense-announces-the-clinical-candidate-nomination-of-bsen760-a-novel-dual-kv7-23-and-trpv1-modula,2023-12-05 19:13:08,"NESS ZIONA, Israel, Dec. 05, 2023 ( GLOBE NEWSWIRE ) -- Bsense Bio Therapeutics Ltd., a preclinical-stage biopharmaceutical company developing innovative small molecule drug candidates for sensory hyperexcitability disorders, today announced the clinical candidate nomination of their drug ...",JNJ,0.037155,0.163791,Somewhat-Bullish
Johnson & Johnson's Strategic Forecast: Targets 5%-6% Operational Sales Growth For FY24 - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/equities/23/12/36098586/johnson-johnsons-strategic-forecast-targets-5-6-operational-sales-growth-for-fy24,2023-12-05 19:12:57,Johnson & Johnson JNJ expects operational sales growth in the range of 5%-6% for FY24. The company forecasts adjusted operational earnings per share growth of 7.3% at the midpoint with a range of $10.55-$10.75.,JNJ,0.608634,0.509654,Bullish
Johnson & Johnson sees 2024 sales growth slowing as top drug faces rivals,https://www.business-standard.com/companies/news/johnson-johnson-sees-2024-sales-growth-slowing-as-top-drug-faces-rivals-123120501287_1.html,2023-12-05 16:40:50,"Johnson & Johnson expects operational sales growth to slow in 2024 as its top-selling psoriasis drug starts to face generic competition outside the US. The company forecasts between 5% to 6% operational sales growth next year, compared with its 8.5%-to-9% outlook for this year.",JNJ,0.178459,0.037466,Neutral
"Boston Scientific  ( BSX )  Gains From Global Expansion, FX Woe Ails",https://www.zacks.com/stock/news/2193448/boston-scientific-bsx-gains-from-global-expansion-fx-woe-ails,2023-12-05 13:30:00,Boston Scientific's (BSX) Endoscopy business within MedSurg benefits from strong worldwide demand for its broad range of GI and pulmonary treatment options.,JNJ,0.045139,0.061782,Neutral
J&J's  ( JNJ )  Bladder Cancer Drug Gets FDA's Breakthrough Tag,https://www.zacks.com/stock/news/2193403/jjs-jnj-bladder-cancer-drug-gets-fdas-breakthrough-tag,2023-12-05 12:40:00,FDA grants Breakthrough Therapy Designation to J&J's (JNJ) TAR-200 for high-risk non-muscle-invasive bladder cancer based on data from the phase IIb SunRISe-1 study.,JNJ,0.302243,-0.111678,Neutral
Johnson & Johnson forecasts as much as 6% sales growth in 2024,https://www.reuters.com/business/healthcare-pharmaceuticals/johnson-johnson-forecasts-much-6-sales-growth-2024-2023-12-05/,2023-12-05 12:17:00,Johnson & Johnson forecasts as much as 6% sales growth in ...,JNJ,0.140896,0.191216,Somewhat-Bullish
"Hospital Infection Therapeutics Market to be Worth USD 14.4 billion by 2031| Transparency Market Research, Inc.",https://www.benzinga.com/pressreleases/23/12/g36087772/hospital-infection-therapeutics-market-to-be-worth-usd-14-4-billion-by-2031-transparency-market-re,2023-12-05 12:00:00,"Wilmington, Delaware, United States, Dec. 05, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global hospital infection therapeutics market was estimated to have acquired US$ 11.3 billion in 2022.",JNJ,0.044551,0.0,Neutral
Top legal practitioners who lead in their fields,https://www.ft.com/content/89690990-75f9-4172-97cb-b324407f639f,2023-12-05 05:00:59,"The FT Innovative Lawyers awards seek out those who go beyond sheer prowess to address the nexus of the law, business and wider society ...",JNJ,0.024126,-0.15342,Somewhat-Bearish
"Nanobiotix Announces Closing of the Remaining $4.8 Million Investment From Johnson & Johnson Innovation - JJDC, Inc.",https://www.benzinga.com/pressreleases/23/12/g36080445/nanobiotix-announces-closing-of-the-remaining-4-8-million-investment-from-johnson-johnson-innovati,2023-12-04 21:22:41,Aggregate gross proceeds of approximately â‚¬50.9 million ( equivalent to approximately $53.8 million ) received by NANOBIOTIX has increased to approximately â‚¬55.5 million ( equivalent to approximately $58.7 million ) extending its runway into mid' 2025,JNJ,0.020903,0.034299,Neutral
"Nanobiotix Announces Closing of the Remaining $4.8 Million Investment From Johnson & Johnson Innovation - JJDC, Inc.",https://www.globenewswire.com/news-release/2023/12/04/2790479/0/en/Nanobiotix-Announces-Closing-of-the-Remaining-4-8-Million-Investment-From-Johnson-Johnson-Innovation-JJDC-Inc.html,2023-12-04 21:22:00,"PARIS and CAMBRIDGE, Mass., Dec. 04, 2023 ( GLOBE NEWSWIRE ) -- NANOBIOTIX ( Euronext: NANO - NASDAQ: NBTX - ""Nanobiotix"" or the ""Company"" ) , a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, announces ...",JNJ,0.02105,0.038126,Neutral
"Nanobiotix Announces Closing of the Remaining $4.8 Million Investment From Johnson & Johnson Innovation - JJDC, Inc.",https://www.globenewswire.com/news-release/2023/12/04/2790473/0/en/Nanobiotix-Announces-Closing-of-the-Remaining-4-8-Million-Investment-From-Johnson-Johnson-Innovation-JJDC-Inc.html,2023-12-04 21:16:00,"PARIS and CAMBRIDGE, Mass., Dec. 04, 2023 ( GLOBE NEWSWIRE ) -- NANOBIOTIX ( Euronext: NANO - NASDAQ: NBTX - ""Nanobiotix"" or the ""Company"" ) , a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, announces ...",JNJ,0.01957,0.03778,Neutral
"SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Kenvue, Inc. of Class Action Lawsuit and Upcoming Deadline - KVUE - Kenvue  ( NYSE:KVUE ) ",https://www.benzinga.com/pressreleases/23/12/g36073621/shareholder-alert-pomerantz-law-firm-reminds-shareholders-with-losses-on-their-investment-in-kenvu,2023-12-04 16:56:06,"NEW YORK, Dec. 04, 2023 ( GLOBE NEWSWIRE ) -- Pomerantz LLP announces that a class action lawsuit has been filed against Kenvue, Inc. ( ""Kenvue"" or the ""Company"" ) KVUE and certain officers.",JNJ,0.168021,0.015047,Neutral
"Warren Buffett's Berkshire Hathaway Is Building a Stake in a ""Confidential"" Stock -- Could This Be It?",https://www.fool.com/investing/2023/12/04/warren-buffett-build-stake-in-confidential-stock/,2023-12-04 10:06:00,The Oracle of Omaha's company is requesting secrecy as it builds up its stake in one or more businesses.,JNJ,0.037329,0.0,Neutral
"Disposable Medical Supplies Market to grow by USD 38.36 billion from 2022 to 2027|3M Co., Ambu AS, Ansell Ltd., B ... - PR Newswire",https://www.prnewswire.com/news-releases/disposable-medical-supplies-market-to-grow-by-usd-38-36-billion-from-2022-to-20273m-co-ambu-as-ansell-ltd-bbraun-se-and-more-among-the-key-companies-in-the-market--technavio-302003976.html,2023-12-04 08:15:00,"Disposable Medical Supplies Market to grow by USD 38.36 billion from 2022 to 2027|3M Co., Ambu AS, Ansell Ltd., B ... PR ...",JNJ,0.041682,0.076844,Neutral
"Supreme Court Decision Looms Over Purdue Pharma's $6B Opioid Settlement And Sackler Family Immunity - Johnson & Johnson  ( NYSE:JNJ ) , Teva Pharmaceutical Indus  ( NYSE:TEVA ) ",https://www.benzinga.com/markets/cannabis/23/12/36061732/supreme-court-decision-looms-over-purdue-pharmas-6b-opioid-settlement-and-sackler-family-immunit,2023-12-03 19:33:25,"The fate of a $6 billion bankruptcy settlement involving Purdue Pharma, the maker of the powerful and addictive pain medication OxyContin, hangs in the balance as the U.S. Supreme Court prepares to hear arguments on Monday.",JNJ,0.131643,0.162191,Somewhat-Bullish
Warren Buffett Just Closed His Position in This Dividend Giant. Should You?,https://www.fool.com/investing/2023/12/03/buffett-closed-position-in-this-dividend-giant/,2023-12-03 10:30:00,J&J has a long track record of dividend growth -- something Buffett generally appreciates.,JNJ,0.115232,0.080976,Neutral
"Barron's Weekend Stock Picks: Uber Joins The S&P 500, Schwab Rebounds And What's Next for Johnson & Johnson? - Apple  ( NASDAQ:AAPL ) , Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/news/23/12/36059036/barrons-weekend-stock-picks-uber-joins-the-s-p-500-schwab-rebounds-and-whats-next-for-johnson-johnso,2023-12-02 22:29:29,"Benzinga reviews this weekend's top stories covered by Barron's. Here are the articles investors need to read. In ""Uber Joins the S&P 500.",JNJ,0.375251,0.665314,Bullish
"KENVUE SHAREHOLDER ALERT: Faruqi & Faruqi Securities Litigation Partner James  ( Josh )  Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Kenvue To Contact Him Directly To Discuss Their Options - Kenvue  ( NYSE:KVUE ) ",https://www.benzinga.com/pressreleases/23/12/g36057931/kenvue-shareholder-alert-faruqi-faruqi-securities-litigation-partner-james-josh-wilson-encourages-,2023-12-02 14:15:00,"If you suffered losses exceeding $100,000 investing in Kenvue securities pursuant and/or traceable to the registration statement and related prospectus ( collectively, the ""Registration Statement"" ) issued in connection with the Company's May 2023 initial public offering ( the ""IPO"" or ...",JNJ,0.063933,0.093064,Neutral
"Orthobiologics Market size to grow by USD 2.64 billion from 2022-2027, North America to account for 41% of market ... - PR Newswire",https://www.prnewswire.com/news-releases/orthobiologics-market-size-to-grow-by-usd-2-64-billion-from-2022-2027--north-america-to-account-for-41-of-market-growth---technavio-302002810.html,2023-12-01 23:55:00,"Orthobiologics Market size to grow by USD 2.64 billion from 2022-2027, North America to account for 41% of market ... PR ...",JNJ,0.070517,0.101494,Neutral
"Spinal Implants Market size to grow by USD 3.57 billion from 2023-2028, North America to account for 43% of market ... - PR Newswire",https://www.prnewswire.com/news-releases/spinal-implants-market-size-to-grow-by-usd-3-57-billion-from-2023-2028--north-america-to-account-for-43-of-market-growth---technavio-302002783.html,2023-12-01 23:15:00,"Spinal Implants Market size to grow by USD 3.57 billion from 2023-2028, North America to account for 43% of market ... PR ...",JNJ,0.061631,0.0,Neutral
Dow Jones Bucks Hawkish Powell As Yields Plunge; Tesla Falls On Huge 'Product Problem',https://www.investors.com/market-trend/stock-market-today/dow-jones-bucks-hawkish-powell-yields-plunge-tesla-falls/,2023-12-01 21:30:00,Dow Jones Bucks Hawkish Powell As Yields Plunge. Tesla Falls On ... Investor's Business Daily ...,JNJ,0.108712,0.019997,Neutral
"Phacoemulsification Devices Market size to grow by USD 622.54 million from 2023-2028, North America to account for ... - PR Newswire",https://www.prnewswire.com/news-releases/phacoemulsification-devices-market-size-to-grow-by-usd-622-54-million-from-2023-2028--north-america-to-account-for-40-of-market-growth---technavio-302002779.html,2023-12-01 19:45:00,"Phacoemulsification Devices Market size to grow by USD 622.54 million from 2023-2028, North America to account for ... PR ...",JNJ,0.070935,0.0,Neutral
JNJ: 3 Pharma Stocks Navigating Future Investments - Buy Now,https://stocknews.com/news/jnj-zts-wve-3-pharma-stocks-navigating-future-investments-buy-now/,2023-12-01 19:00:39,"The surge in investment and spending in global medicine is fueling the pharma industry. Therefore, investors could consider investing in quality pharma stocks Zoetis Inc. ( ZTS ) , Wave Life Sciences Ltd. ( WVE ) , and Johnson & Johnson ( JNJ ) .",JNJ,0.257328,0.074989,Neutral
Female Student-Athletes File Title IX Sex Discrimination Class Action Against University of Oregon,https://www.benzinga.com/pressreleases/23/12/n36050597/female-student-athletes-file-title-ix-sex-discrimination-class-action-against-university-of-oregon,2023-12-01 18:57:00,"EUGENE, Ore, Dec. 1, 2023 /PRNewswire/ --Thirty-two female student-athletes filed a detailed sex discrimination class action over 100 pages long against the University of Oregon today for depriving women of equal treatment and benefits, equal athletic aid, and equal opportunities to participate ...",JNJ,0.057628,-0.065191,Neutral
Johnson & Johnson Gets Analyst Upgrade Noting Bullish Pharma & MedTech Projections - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/analyst-ratings/analyst-color/23/12/36045219/johnson-johnson-gets-analyst-upgrade-noting-bullish-pharma-medtech-projections,2023-12-01 18:05:10,"UBS has upgraded Johnson & Johnson JNJ, citing a bullish view of the company's pharmaceutical business and expectations for MedTech growth that align with the market, which is mid-single-digit. This year, Johnson & Johnson spinoff its consumer health company Kenvue Inc KVUE to focus on healthcare ...",JNJ,0.616842,0.527447,Bullish
Texas Attorney General Alleges Pfizer Misled Public on COVID-19 Vaccine Efficacy - Pfizer  ( NYSE:PFE ) ,https://www.benzinga.com/general/biotech/23/12/36041571/texas-attorney-general-alleges-pfizer-misled-public-on-covid-19-vaccine-efficacy,2023-12-01 15:59:03,"Texas Attorney General Ken Paxton has filed a lawsuit against Pfizer Inc PFE, alleging the pharmaceutical giant misrepresented the efficacy of its widely-administered COVID-19 vaccine. Paxton argued that Pfizer's claim of 95% effectiveness was misleading, based on limited clinical trial data ...",JNJ,0.241684,-0.148844,Neutral
"S&P, Nasdaq slip as caution prevails ahead of Powell comments",https://www.reuters.com/markets/us/futures-muted-traders-gear-up-powells-remarks-2023-12-01/,2023-12-01 15:10:00,"Traders work on the floor at the New York Stock Exchange ( NYSE ) in New York City, U.S., October 27, 2023. REUTERS/Brendan McDermid/File Photo Acquire Licensing Rights",JNJ,0.070935,0.099518,Neutral
The Ad Council's 69th Annual Public Service Award Dinner Celebrates Extraordinary Progress of Social Impact Efforts and Inspires the Media and Marketing Industries to Come Together for Tomorrow,https://www.prnewswire.com/news-releases/the-ad-councils-69th-annual-public-service-award-dinner-celebrates-extraordinary-progress-of-social-impact-efforts-and-inspires-the-media-and-marketing-industries-to-come-together-for-tomorrow-302003333.html,2023-12-01 14:32:00,The Ad Council's 69th Annual Public Service Award Dinner Celebrates Extraordinary Progress of Social Impact Efforts ... PR ...,JNJ,0.022181,0.104054,Neutral
The Ad Council's 69th Annual Public Service Award Dinner Celebrates Extraordinary Progress of Social Impact Efforts and Inspires the Media and Marketing Industries to Come Together for Tomorrow,https://www.benzinga.com/pressreleases/23/12/n36044063/the-ad-councils-69th-annual-public-service-award-dinner-celebrates-extraordinary-progress-of-socia,2023-12-01 14:32:00,"NEW YORK, Dec. 1, 2023 /PRNewswire/ -- On Thursday, November 30, the Ad Council, America's leading organization harnessing the power of communications for social change, held its Annual Public Service Award Dinner.",JNJ,0.02214,0.104028,Neutral
"Akari Therapeutics Appoints Experienced Life Sciences Entrepreneur Samir R. Patel, M.D. to Board of Directors - Akari Therapeutics  ( NASDAQ:AKTX ) ",https://www.benzinga.com/pressreleases/23/12/g36041855/akari-therapeutics-appoints-experienced-life-sciences-entrepreneur-samir-r-patel-m-d-to-board-of-d,2023-12-01 13:00:00,"NEW YORK and BOSTON, Dec. 01, 2023 ( GLOBE NEWSWIRE ) -- Akari Therapeutics, Plc AKTX, a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today announced the appointment of experienced life sciences entrepreneur Samir R.",JNJ,0.078226,0.034409,Neutral
Warren Buffett Reduced This Long-Time Berkshire Hathaway Holding by 67%. Should Investors Follow His Lead?,https://www.fool.com/investing/2023/12/01/warren-buffett-reduced-this-long-time-berkshire-ha/,2023-12-01 12:10:00,"Berkshire Hathaway trimmed several longtime holdings in the third quarter, including this stock it has held since 2001.",JNJ,0.054607,0.0,Neutral
Tencent-Backed AI Drug Discovery Startup Xtalpi Files For Hong Kong IPO,https://www.forbes.com/sites/zinnialee/2023/12/01/tencent-backed-ai-drug-discovery-startup-xtalpi-files-for-hong-kong-ipo/,2023-12-01 10:05:07,"Xtalpi, a Shenzhen-based company which uses artificial intelligence to find chemical compounds that could be developed into new drugs, has filed for an initial public offering in Hong Kong. Xtalpi did not disclose details of its IPO in its filing to the Hong Kong stock exchange on Thursday ...",JNJ,0.074692,-0.00707,Neutral
Contact Lens Market Size & Share to Surpass USD 12.6 billion by 2031 | Analysis by Transparency Market Research Inc.,https://www.benzinga.com/pressreleases/23/12/g36038372/contact-lens-market-size-share-to-surpass-usd-12-6-billion-by-2031-analysis-by-transparency-market,2023-12-01 08:08:24,"Wilmington, Delaware, United States, Dec. 01, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. -The global contact lens market was estimated to have acquired US$ 7.9 billion in 2022. It is anticipated to register a 5.5% CAGR from 2023 to 2031 and by 2031.",JNJ,0.132611,0.310652,Somewhat-Bullish
"Cosmetic skin care market size to grow by USD 79.37 billion from 2022 to 2027 | Amorepacific Group Inc., Beiersdorf ... - PR Newswire",https://www.prnewswire.com/news-releases/cosmetic-skin-care-market-size-to-grow-by-usd-79-37-billion-from-2022-to-2027--amorepacific-group-inc-beiersdorf-ag-chanel-ltd-and-more-among-the-key-companies-in-the-market---technavio-302002398.html,2023-12-01 02:15:00,"Cosmetic skin care market size to grow by USD 79.37 billion from 2022 to 2027 | Amorepacific Group Inc., Beiersdorf ... PR ...",JNJ,0.063091,0.04901,Neutral
Jim Cramer explains why it's hard to be bullish on the healthcare sector,https://www.cnbc.com/2023/11/30/jim-cramer-explains-why-its-hard-to-be-bullish-on-healthcare.html,2023-12-01 01:32:24,CNBC's Jim Cramer on Thursday detailed what may be hurting healthcare stocks.,JNJ,0.089797,-0.120177,Neutral
Texas AG Sues Pfizer Over Covid Vaccine Effectiveness,https://www.forbes.com/sites/mollybohannon/2023/11/30/texas-ag-sues-pfizer-over-covid-vaccine-effectiveness/,2023-11-30 22:39:33,"Texas Attorney General Ken Paxton announced Thursday he sued pharmaceutical company Pfizer for misleading Texans about the efficacy of its Covid-19 vaccine and ""attempting to censor public discussion""-despite the vaccine continuing to be effective and recommended by leading health agencies.",JNJ,0.130217,0.054082,Neutral
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Kenvue Inc.  ( KVUE )  - Kenvue  ( NYSE:KVUE ) ,https://www.benzinga.com/pressreleases/23/11/g36030004/glancy-prongay-murray-llp-reminds-investors-of-looming-deadline-in-the-class-action-lawsuit-agains,2023-11-30 18:18:57,"LOS ANGELES, Nov. 30, 2023 ( GLOBE NEWSWIRE ) -- Glancy Prongay & Murray LLP ( ""GPM"" ) reminds investors of the upcoming December 8, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Kenvue Inc. ( ""Kenvue"" or the ...",JNJ,0.062597,0.086023,Neutral
Turkey launches investigation into 19 pharma companies,https://www.reuters.com/business/healthcare-pharmaceuticals/turkey-launches-investigation-into-19-pharma-companies-2023-11-30/,2023-11-30 16:19:00,"ANKARA, Nov 30 ( Reuters ) - Turkey's competition authority said on Thursday it had launched an investigation into 19 pharmaceutical companies to determine whether they had violated competition law.",JNJ,0.407844,-0.090206,Neutral
"When it Comes to Treating Ulcerative Colitis, US Gastroenterologists May be Betting it All on JAKâ€¦",https://www.benzinga.com/pressreleases/23/11/g36026546/when-it-comes-to-treating-ulcerative-colitis-us-gastroenterologists-may-be-betting-it-all-on-jak,2023-11-30 15:59:35,"Exton, Pennsylvania, Nov. 30, 2023 ( GLOBE NEWSWIRE ) -- With the Ulcerative Colitis ( UC ) market set to heat up in the coming months, the JAK class seems poised to become a dominant treatment, challenging established alternative mechanism of action ( AMOA ) favorites: Takeda's Entyvio ( ...",JNJ,0.036587,0.139865,Neutral
Johnson & Johnson  ( JNJ )  Ascends While Market Falls: Some Facts to Note,https://www.zacks.com/stock/news/2191136/johnson-johnson-jnj-ascends-while-market-falls-some-facts-to-note,2023-11-29 22:45:08,"In the closing of the recent trading day, Johnson & Johnson (JNJ) stood at $152.11, denoting a +0.32% change from the preceding trading day.",JNJ,0.511734,0.202836,Somewhat-Bullish
Occupational Medicines Global Market Report 2023 Highlights Robust Growth: Market Size To Reach $6.2 Billion By 2027 As Per The Business Research Company's Occupational Medicines Global Market Report 2023,https://www.benzinga.com/pressreleases/23/11/g36005663/occupational-medicines-global-market-report-2023-highlights-robust-growth-market-size-to-reach-6-2,2023-11-29 16:30:00,"LONDON, Nov. 29, 2023 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Occupational Medicines Global Market Report 2023, the global occupational medicines market is poised for significant expansion, projecting a rise from $4.52 billion in 2022 to $4.86 billion in 2023, demonstrating ...",JNJ,0.064623,0.242625,Somewhat-Bullish
Johnson & Johnson  ( JNJ )  Is a Trending Stock: Facts to Know Before Betting on It,https://www.zacks.com/stock/news/2190784/johnson-johnson-jnj-is-a-trending-stock-facts-to-know-before-betting-on-it,2023-11-29 14:00:10,"Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",JNJ,0.47147,0.138208,Neutral
"The Largest Holding in Warren Buffett's ""Secret"" Portfolio Has Been a Guaranteed Moneymaker  ( With 1 Big Condition ) ",https://www.fool.com/investing/2023/11/29/warren-buffett-secret-portfolio-certain-moneymaker/,2023-11-29 10:06:00,This security has a flawless track record of making investors with a long-term mindset richer.,JNJ,0.033751,0.0,Neutral
"Alvotech Announces Positive Top-Line Results from a Pharmacokinetic Study for AVT05, a Proposed Biosimilar for SimponiÂ® and Simponi AriaÂ®",https://www.globenewswire.com/news-release/2023/11/29/2787527/0/en/Alvotech-Announces-Positive-Top-Line-Results-from-a-Pharmacokinetic-Study-for-AVT05-a-Proposed-Biosimilar-for-Simponi-and-Simponi-Aria.html,2023-11-29 09:00:00,"The study, assessing pharmacokinetics, safety, and tolerability of AVT05 compared to SimponiÂ® ( golimumab ) in healthy adult subjects, met its primary endpoint The study, assessing pharmacokinetics, safety, and tolerability of AVT05 compared to SimponiÂ® ( golimumab ) in healthy adult subjects, ...",JNJ,0.025873,0.0,Neutral
"Alvotech Announces Positive Top-Line Results from a Pharmacokinetic Study for AVT05, a Proposed Biosimilar for SimponiÂ® and Simponi AriaÂ®",https://www.globenewswire.com/news-release/2023/11/29/2787524/0/en/Alvotech-Announces-Positive-Top-Line-Results-from-a-Pharmacokinetic-Study-for-AVT05-a-Proposed-Biosimilar-for-Simponi-and-Simponi-Aria.html,2023-11-29 09:00:00,"Alvotech ( NASDAQ: ALVO ) , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today positive top-line results from a pharmacokinetic study for AVT05, a biosimilar candidate to SimponiÂ® and Simponi AriaÂ® ( golimumab ...",JNJ,0.025596,0.0,Neutral
"Final Deadline Approaching for Kenvue Inc. Investors: Kessler Topaz Meltzer & Check, LLP Reminds Kenvue Inc.  ( KVUE )  Investors of December 8, 2023 Lead Plaintiff Deadline - Kenvue  ( NYSE:KVUE ) ",https://www.benzinga.com/pressreleases/23/11/g35990408/final-deadline-approaching-for-kenvue-inc-investors-kessler-topaz-meltzer-check-llp-reminds-kenvue,2023-11-28 21:32:00,"RADNOR, Pa., Nov. 28, 2023 ( GLOBE NEWSWIRE ) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the District of New Jersey against Kenvue Inc. ( ""Kenvue"" ) KVUE. ...",JNJ,0.057079,0.129961,Neutral
Alvotech Reports Financial Results for First Nine Months of 2023 and Provides Business Update,https://www.globenewswire.com/news-release/2023/11/28/2787373/0/en/Alvotech-Reports-Financial-Results-for-First-Nine-Months-of-2023-and-Provides-Business-Update.html,2023-11-28 21:15:00,"Alvotech ( NASDAQ: ALVO, or the ""Company"" ) , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today reported unaudited financial results for the first nine months of 2023 and provided a summary of recent corporate ...",JNJ,0.02746,0.125229,Neutral
Alvotech Reports Financial Results for First Nine Months of 2023 and Provides a Business Update,https://www.globenewswire.com/news-release/2023/11/28/2787372/0/en/Alvotech-Reports-Financial-Results-for-First-Nine-Months-of-2023-and-Provides-a-Business-Update.html,2023-11-28 21:15:00,"REYKJAVIK, Iceland, Nov. 28, 2023 ( GLOBE NEWSWIRE ) -- Alvotech ( NASDAQ: ALVO, or the ""Company"" ) , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today reported unaudited financial results for the first nine months of ...",JNJ,0.027366,0.125172,Neutral
5 Best Blue-Chip Stocks For 2024,https://www.forbes.com/sites/investor-hub/article/best-blue-chip-stocks/,2023-11-28 21:03:08,"Blue chip stocks have long been popular for investors of all wealth and ages. This article will explain blue-chip stocks and list five top picks for the upcoming year. Blue chip stocks refer to shares of well-established, financially robust companies with a long history of stable earnings, a ...",JNJ,0.079788,0.294124,Somewhat-Bullish
US FDA investigating safety risk of CAR-T cancer therapies,https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-investigating-safety-risk-car-t-cancer-therapies-2023-11-28/,2023-11-28 18:42:00,"Signage is seen outside of the Food and Drug Administration ( FDA ) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo Acquire Licensing Rights Nov 28 ( Reuters ) - The U.S.",JNJ,0.113062,-0.247011,Somewhat-Bearish
"Shein, Skims, Starlink: Billionaire-Linked Brands Could Go Public In 2024",https://www.forbes.com/sites/dereksaul/2023/11/28/shein-skims-starlink-billionaire-linked-brands-could-go-public-in-2024/,2023-11-28 15:54:54,"Shein, the Chinese fast fashion behemoth, reportedly filed confidential paperwork Monday to go public in the U.S., setting the clothing company up to potentially headline a deep roster of high-profile upcoming initial public offerings.",JNJ,0.082677,0.04532,Neutral
Executives From Leading Retail and Healthcare Companies Join GS1 US Board of Governors - PR Newswire,https://www.prnewswire.com/news-releases/executives-from-leading-retail-and-healthcare-companies-join-gs1-us-board-of-governors-301999185.html,2023-11-28 14:15:00,Executives From Leading Retail and Healthcare Companies Join GS1 US Board of Governors PR ...,JNJ,0.103778,0.031633,Neutral
Why Is Warren Buffett Selling Amazon Stock Instead of Buying It Hand Over Fist?,https://www.fool.com/investing/2023/11/28/why-is-warren-buffett-selling-amazon-stock-instead/,2023-11-28 10:50:00,The Oracle of Omaha isn't fully on the Amazon bandwagon for one likely reason.,JNJ,0.064104,0.0,Neutral
2 Unstoppable Dividend Stocks Trading Near 52-Week Lows to Buy Now,https://www.fool.com/investing/2023/11/28/2-top-dividend-stocks-trading-near-52-week-lows-to/,2023-11-28 10:41:00,"With clear advantages over the competition, these divided payers could deliver market-beating gains to patient investors.",JNJ,0.263373,0.160978,Somewhat-Bullish
"Google Alum's Biotech Startup Cradle Raises $24M To Boost AI-Powered Protein Design And Engineering - Alphabet  ( NASDAQ:GOOG ) , Alphabet  ( NASDAQ:GOOGL ) ",https://www.benzinga.com/general/biotech/23/11/35973584/google-alums-biotech-startup-cradle-raises-24m-to-boost-ai-powered-protein-design-and-engineering,2023-11-28 10:10:08,"Netherlands-based biotech startup Cradle has raised $24 million in Series A funding as it looks to boost its protein design and engineering process. What Happened: Cradle's $24 million Series A funding was led by Index Ventures, with Kindred Capital also participating in the round.",JNJ,0.230235,0.277341,Somewhat-Bullish
This Is What Whales Are Betting On Johnson & Johnson - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/11/35966772/this-is-what-whales-are-betting-on-johnson-johnson,2023-11-27 19:46:09,"Financial giants have made a conspicuous bullish move on Johnson & Johnson. Our analysis of options history for Johnson & Johnson JNJ revealed 10 unusual trades. Delving into the details, we found 70% of traders were bullish, while 30% showed bearish tendencies.",JNJ,0.554916,0.335578,Somewhat-Bullish
Global Advanced Drug Delivery Systems Market To Witness Significant Growth In The Forecast Period - Projected CAGR Of 6% From 2023 To 2027 As Per The Business Research Company's Advanced Drug Delivery Systems Global Market Report 2023,https://www.benzinga.com/pressreleases/23/11/g35962849/global-advanced-drug-delivery-systems-market-to-witness-significant-growth-in-the-forecast-period-,2023-11-27 16:30:00,"LONDON, Nov. 27, 2023 ( GLOBE NEWSWIRE ) -- The latest market report from The Business Research Company reveals promising prospects for the global advanced drug delivery systems market.",JNJ,0.051999,0.178561,Somewhat-Bullish
3 Biotech Stocks To Watch Before December 2023,https://stockmarket.com/featured/3-biotech-stocks-to-watch-before-december-2023-2023-11-27,2023-11-27 15:38:43,"The biotechnology sector is a dynamic and innovative field that combines biological sciences with technology. It encompasses a range of companies focusing on medical research, pharmaceuticals, and genetic engineering. These companies work on groundbreaking treatments, vaccines, and technologies.",JNJ,0.296582,0.136713,Neutral
Should Vanguard Russell 1000 Value ETF  ( VONV )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2189497/should-vanguard-russell-1000-value-etf-vonv-be-on-your-investing-radar,2023-11-27 11:20:05,Style Box ETF report for ...,JNJ,0.125789,0.069184,Neutral
5 Stocks You Can Confidently Invest $500 In Right Now,https://www.fool.com/investing/2023/11/27/5-stocks-you-can-confidently-invest-500-in-now/,2023-11-27 10:30:00,These companies could significantly grow your investment over the long haul.,JNJ,0.089629,0.137094,Neutral
"Virtualware Appoints John A. Cunningham, COO of VRARA and Former Unity Executive, to International Advisory Board for U.S. Expansion Drive",https://www.globenewswire.com/news-release/2023/11/27/2785842/0/en/Virtualware-Appoints-John-A-Cunningham-COO-of-VRARA-and-Former-Unity-Executive-to-International-Advisory-Board-for-U-S-Expansion-Drive.html,2023-11-27 06:45:00,"BILBAO, Spain and MIAMI, November 27, 2023.- Virtualware, a European leader in Virtual Reality solutions, has appointed VR and AR industry leader John A. Cunningham to its International Advisory Board in a move that marks a significant step in Virtualware's U.S. market expansion.",JNJ,0.042122,0.103523,Neutral
Viatris Continues its Preparations for Phase 2 of its Strategic Plan by Announcing the Appointment of Theodora ... - PR Newswire,https://www.prnewswire.com/news-releases/viatris-continues-its-preparations-for-phase-2-of-its-strategic-plan-by-announcing-the-appointment-of-theodora-doretta-mistras-as-chief-financial-officer-effective-march-1-2024-and-philippe-martin-as-chief-rd-officer-302017098.html,2023-12-15 21:45:00,Viatris Continues its Preparations for Phase 2 of its Strategic Plan by Announcing the Appointment of Theodora ... PR ...,JNJ,0.024852,0.07612,Neutral
Boycotts and protests - how are people around the world defying Israel?,https://www.aljazeera.com/news/2023/12/15/boycotts-and-protests-how-are-people-around-the-world-defying-israel,2023-12-15 20:17:05,"Al Jazeera takes a look at the movements against Israel and illegal settlements in Palestine. From Jakarta to San Francisco, hundreds of thousands of people have taken to the streets over the past two months to protest Israel's ongoing assault on Gaza, which has killed more than 18,700 people, ...",JNJ,0.018496,0.0,Neutral
Dow Jones Holds Near Highs As Boeing Stock Jumps; DocuSign Surges On Takeover Chatter,https://www.investors.com/market-trend/stock-market-today/dow-jones-holds-near-highs-boeing-stock-jumps-docusign-surges-takeover-chatter/,2023-12-15 20:14:00,Dow Jones Holds Near Highs As Boeing Stock Jumps. DocuSign Surges On Takeover Chatter Investor's Business Daily ...,JNJ,0.143843,0.15783,Somewhat-Bullish
"AC Immune Raises $50M, Its Alzheimer's Targeting Immunotherapy Advances Into Phase 2b Trial",https://www.benzinga.com/node/36256704,2023-12-15 15:58:43,"AC Immune SA's ( NASDAQ: ACIU ) development partner has programmed the launch of a Phase 2b clinical study to evaluate ACI-35.030 ( JNJ-64042056 ) in patients with preclinical Alzheimer's disease ( AD ) , those individuals not yet showing symptoms.",JNJ,0.401331,0.165157,Somewhat-Bullish
Cartilage Repair / Cartilage Regeneration Market Worth $2.8 billion | MarketsandMarkets,https://www.prnewswire.com/news-releases/cartilage-repair--cartilage-regeneration-market-worth-2-8-billion--marketsandmarkets-302016408.html,2023-12-15 15:30:00,"CHICAGO, Dec. 15, 2023 /PRNewswire/ -- Cartilage Repair / Cartilage Regeneration Market in terms of revenue was estimated to be worth $1.3 billion in 2023 and is poised to reach $2.8 billion by 2028, growing at a CAGR of 17.2% from 2023 to 2028 according to a new report by MarketsandMarkets.",JNJ,0.033098,-0.011354,Neutral
AC Immune's Targeted Anti-pTau Active Immunotherapy for Alzheimer's Disease Advances into Phase 2b Trial - AC Immune  ( NASDAQ:ACIU ) ,https://www.benzinga.com/pressreleases/23/12/g36255065/ac-immunes-targeted-anti-ptau-active-immunotherapy-for-alzheimers-disease-advances-into-phase-2b-t,2023-12-15 12:22:47,Potentially registration-enabling Phase 2b study ( ReTain ) will evaluate the effect of ACI-35.030 on cognition and Tau pathology in approximately 500 participants with preclinical Alzheimer's disease ( AD ),JNJ,0.10607,0.050182,Neutral
AC Immune's Targeted Anti-pTau Active Immunotherapy for Alzheimer's Disease Advances into Phase 2b Trial,https://www.globenewswire.com/news-release/2023/12/15/2796982/0/en/AC-Immune-s-Targeted-Anti-pTau-Active-Immunotherapy-for-Alzheimer-s-Disease-Advances-into-Phase-2b-Trial.html,2023-12-15 12:22:00,â€¢ Potentially registration-enabling Phase 2b study ( ReTain ) will evaluate the effect of ACI-35.030 on cognition and Tau pathology in approximately 500 participants with preclinical Alzheimer's disease ( AD ) â€¢ Anti-pTau active immunotherapy being designed to potentially prevent or reduce ...,JNJ,0.081276,0.050176,Neutral
Is SPDR S&P Pharmaceuticals ETF  ( XPH )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2198396/is-spdr-sp-pharmaceuticals-etf-xph-a-strong-etf-right-now,2023-12-15 11:20:03,Smart Beta ETF report for ...,JNJ,0.112797,0.053966,Neutral
Decade of Excellence: HR Asia Best Companies to Work for in Asia Celebrates 10th Anniversary with Recognition of 78 Outstanding Workplaces,https://www.prnewswire.com/apac/news-releases/decade-of-excellence-hr-asia-best-companies-to-work-for-in-asia-celebrates-10th-anniversary-with-recognition-of-78-outstanding-workplaces-302016279.html,2023-12-15 03:52:00,Decade of Excellence: HR Asia Best Companies to Work for in Asia Celebrates 10th Anniversary with Recognition of ... PR ...,JNJ,0.059488,0.24308,Somewhat-Bullish
"Neuropathy Pain Treatment Market size to grow by USD 5.84 billion from 2023 to 2028, North America accounts for 33 ... - PR Newswire",https://www.prnewswire.com/news-releases/neuropathy-pain-treatment-market-size-to-grow-by-usd-5-84-billion-from-2023-to-2028--north-america-accounts-for-33-of-market-growth--technavio-302015282.html,2023-12-14 22:15:00,"Neuropathy Pain Treatment Market size to grow by USD 5.84 billion from 2023 to 2028, North America accounts for 33 ... PR ...",JNJ,0.078099,0.0,Neutral
Integra  ( IART )  to Advance ENT Division With New Buyout Deal,https://www.zacks.com/stock/news/2198095/integra-iart-to-advance-ent-division-with-new-buyout-deal,2023-12-14 16:14:00,Integra (IART) will be among the top suppliers of ENT products and technologies following the Acclarent acquisition.,JNJ,0.053153,0.064716,Neutral
Beam Therapeutics Appoints Biotech Executive Christi Shaw to its Board of Directors,https://www.globenewswire.com/news-release/2023/12/14/2796105/0/en/Beam-Therapeutics-Appoints-Biotech-Executive-Christi-Shaw-to-its-Board-of-Directors.html,2023-12-14 11:30:00,"CAMBRIDGE, Mass., Dec. 14, 2023 ( GLOBE NEWSWIRE ) -- ( Nasdaq: BEAM ) , a biotechnology company developing precision genetic medicines through base editing, today announced the appointment of Christi Shaw to the company's board of directors.",JNJ,0.040348,0.015373,Neutral
Beam Therapeutics Appoints Biotech Executive Christi Shaw to its Board of Directors - Beam Therapeutics  ( NASDAQ:BEAM ) ,https://www.benzinga.com/pressreleases/23/12/g36232869/beam-therapeutics-appoints-biotech-executive-christi-shaw-to-its-board-of-directors,2023-12-14 11:30:00,"CAMBRIDGE, Mass., Dec. 14, 2023 ( GLOBE NEWSWIRE ) -- Beam Therapeutics Inc. BEAM, a biotechnology company developing precision genetic medicines through base editing, today announced the appointment of Christi Shaw to the company's board of directors.",JNJ,0.039614,0.014369,Neutral
Should You Invest in the SPDR S&P Pharmaceuticals ETF  ( XPH ) ?,https://www.zacks.com/stock/news/2197719/should-you-invest-in-the-spdr-sp-pharmaceuticals-etf-xph,2023-12-14 11:20:02,Sector ETF report for ...,JNJ,0.125789,0.059923,Neutral
Voting Rights and Shares Capital of the Company,https://www.globenewswire.com/news-release/2023/12/13/2795880/0/en/Voting-Rights-and-Shares-Capital-of-the-Company.html,2023-12-13 21:15:00,In accordance with Articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority ( AutoritÃ© des MarchÃ©s Financiers ...,JNJ,0.114682,0.165483,Somewhat-Bullish
"Eli Lilly will be the first trillion-dollar drug company in history, billionaire investor Ken Langone says",https://markets.businessinsider.com/news/stocks/eli-lilly-stock-diabetes-ozempic-wegovy-weight-loss-drug-pharma-2023-12,2023-12-13 17:40:00,Eli Lilly Will Be the First Trillion-Dollar Drug Company: Ken Langone - Markets Insider ...,JNJ,0.124809,0.100148,Neutral
Neurosurgery Focused Integra LifeSciences Bolsters Its ENT Portfolio With $275M Acquisition Deal - Integra Lifesciences  ( NASDAQ:IART ) ,https://www.benzinga.com/m-a/23/12/36216015/neurosurgery-focused-integra-lifesciences-bolsters-its-ent-portfolio-with-275m-acquisition-deal,2023-12-13 16:20:41,"Integra LifeSciences Holdings Corporation IART agreed to acquire Acclarent Inc. from Ethicon Inc, a Johnson & Johnson JNJ MedTech company, for $275 million in cash, and an additional $5 million upon the achievement of certain regulatory milestones. Acclarent offers medical devices for ENT ...",JNJ,0.252987,0.322612,Somewhat-Bullish
Pfizer Stock Sinks To 10-Year Low-Why Investors Have Soured On Covid-Era Giant,https://www.forbes.com/sites/dereksaul/2023/12/13/pfizer-stock-sinks-to-10-year-low-why-investors-have-soured-on-covid-era-giant/,2023-12-13 14:38:23,"Pfizer stock's struggles continued Wednesday, as shares of the healthcare titan dropped to their lowest level since before the Covid-19 pandemic, the latest dubious milestone for the battered stock that has failed to convert its vaccine boom into long-term sales growth.",JNJ,0.110462,0.033284,Neutral
Johnson & Johnson  ( JNJ )  is Attracting Investor Attention: Here is What You Should Know,https://www.zacks.com/stock/news/2197256/johnson-johnson-jnj-is-attracting-investor-attention-here-is-what-you-should-know,2023-12-13 14:00:11,"Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",JNJ,0.474082,0.168058,Somewhat-Bullish
"D.R. Horton To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Wednesday - Coherent  ( NYSE:COHR ) , C4 Therapeutics  ( NASDAQ:CCCC ) ",https://www.benzinga.com/news/23/12/36213882/d-r-horton-to-rally-around-19-here-are-10-top-analyst-forecasts-for-wednesday,2023-12-13 12:44:22,"Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Raymond James cut Nokia Oyj NOK price target from $4.5 to $4.",JNJ,0.24289,-0.106392,Neutral
Integra LifeSciences Announces Definitive Agreement to Acquire AcclarentÂ®,https://www.globenewswire.com/news-release/2023/12/13/2795373/1063/en/Integra-LifeSciences-Announces-Definitive-Agreement-to-Acquire-Acclarent.html,2023-12-13 11:15:00,"PRINCETON, N.J., Dec. 13, 2023 ( GLOBE NEWSWIRE ) -- Integra LifeSciences Holdings Corporation ( Nasdaq: IART ) , a global leader in medical technology, today announced that it has entered into a definitive agreement to acquire Acclarent, Inc. from Ethicon, Inc., a Johnson & Johnson MedTech ...",JNJ,0.049835,0.099247,Neutral
Integra LifeSciences Announces Definitive Agreement to Acquire AcclarentÂ® - Integra Lifesciences  ( NASDAQ:IART ) ,https://www.benzinga.com/pressreleases/23/12/g36212513/integra-lifesciences-announces-definitive-agreement-to-acquire-acclarent,2023-12-13 11:15:00,"The acquisition will become part of Integra's Codman Specialty Surgical ( CSS ) division. The ear, nose and throat ( ENT ) category is a key area of strategic interest and highly complementary to the neurosurgery segment.",JNJ,0.028833,0.090773,Neutral
"Got $4,000? These 4 Dividend Stocks Could Turn It Into Nearly $200 of Annual Income in 2024.",https://www.fool.com/investing/2023/12/13/got-4000-these-4-dividend-stocks-could-turn-it-int/,2023-12-13 10:42:00,These companies can boost your investment income next year.,JNJ,0.046095,0.128388,Neutral
"Chronic Inflammatory Demyelinating Polyneuropathy Market to Register Positive Growth During the Study Period  ( 2019-2032 ) , Evaluates DelveInsight | Key Companies to Watch Out - Octapharma, argenx, Immunovant Sciences, Sanofi, Janssen, Takeda",https://www.prnewswire.com/news-releases/chronic-inflammatory-demyelinating-polyneuropathy-market-to-register-positive-growth-during-the-study-period-20192032-evaluates-delveinsight--key-companies-to-watch-out---octapharma-argenx-immunovant-sciences-sanofi-janss-302013061.html,2023-12-12 22:01:00,Chronic Inflammatory Demyelinating Polyneuropathy Market to Register Positive Growth During the Study Period ( 2019 ... PR ...,JNJ,0.026241,-0.057694,Neutral
Innocan Pharma Announces Expert Team for LPT CBD Application to United States Food and Drug Administration,https://www.newswire.ca/news-releases/innocan-pharma-announces-expert-team-for-lpt-cbd-application-to-united-states-food-and-drug-administration-847008069.html,2023-12-12 21:00:00,"HERZLIYA, Israel and CALGARY, Alberta, Dec. 12, 2023 /CNW/ -- Innocan Pharma Corporation ( CSE: INNO ) ( FSE: IP4 ) ( OTCQB: INNPF ) ( the ""Company"" or ""Innocan"" ) a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce establishment of a specialized team to prepare ...",JNJ,0.034087,-0.000951,Neutral
Johnson & Johnson Unusual Options Activity - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/12/36202302/johnson-johnson-unusual-options-activity,2023-12-12 17:16:17,"Investors with a lot of money to spend have taken a bullish stance on Johnson & Johnson JNJ. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.",JNJ,0.574235,0.403269,Bullish
"LAZA MEDICAL, INC., A SHIFAMED PORTFOLIO COMPANY, CLOSES $36M IN SERIES A FINANCING",https://www.prnewswire.com/news-releases/laza-medical-inc-a-shifamed-portfolio-company-closes-36m-in-series-a-financing-302012751.html,2023-12-12 14:10:00,"Company accelerates development of its AI-powered robotically-assisted imaging solution for cardiovascular interventions and appoints seasoned medtech executive as General Manager LOS GATOS, Calif., Dec. 12, 2023 /PRNewswire/ -- , the latest portfolio company, announced today that it has closed ...",JNJ,0.213674,-0.029686,Neutral
Should iShares Core High Dividend ETF  ( HDV )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2196537/should-ishares-core-high-dividend-etf-hdv-be-on-your-investing-radar,2023-12-12 11:20:07,Style Box ETF report for ...,JNJ,0.122269,0.068311,Neutral
Is Vanguard High Dividend Yield ETF  ( VYM )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2196547/is-vanguard-high-dividend-yield-etf-vym-a-strong-etf-right-now,2023-12-12 11:20:06,Smart Beta ETF report for ...,JNJ,0.1172,0.060376,Neutral
Johnson & Johnson  ( JNJ )  Outpaces Stock Market Gains: What You Should Know,https://www.zacks.com/stock/news/2196431/johnson-johnson-jnj-outpaces-stock-market-gains-what-you-should-know,2023-12-11 22:45:18,"Johnson & Johnson (JNJ) closed at $155.06 in the latest trading session, marking a +0.41% move from the prior day.",JNJ,0.462395,0.34181,Somewhat-Bullish
"Blood Cancer Player Arcellx's Lead Product Exceeds Expectations, Analysts Say - Arcellx  ( NASDAQ:ACLX ) ",https://www.benzinga.com/analyst-ratings/analyst-color/23/12/36181675/blood-cancer-player-arcellxs-lead-product-exceeds-expectations-analysts-say,2023-12-11 19:33:58,"Friday, Arcellx Inc ACLX announced new data from its Phase 1 expansion study of CART-ddBCMA, now known as anitocabtagene autoleucel ( anito-cel ) for relapsed and/or refractory multiple myeloma. The interim anito-cel Phase 1 clinical results ( October 15, 2023 cutoff date ) demonstrate deep ...",JNJ,0.244109,0.103098,Neutral
"Gilead Sciences Battles Rising Threat of Drug Counterfeiting, Initiates Legal Actions - Gilead Sciences  ( NASDAQ:GILD ) ",https://www.benzinga.com/general/biotech/23/12/36179349/gilead-sciences-battles-rising-threat-of-drug-counterfeiting-initiates-legal-actions,2023-12-11 17:11:51,"Gilead Sciences Inc GILD faces a severe threat from the rise in drug counterfeiting, a global issue highlighted by the World Health Organization's staggering estimate of up to $431 billion in counterfeit drugs annually.",JNJ,0.375251,0.36812,Bullish
Fraud in a bottle: How Big Pharma takes on criminals who make millions off counterfeit drugs,https://www.cnbc.com/2023/12/11/fraud-in-a-bottle-big-pharma-takes-on-counterfeit-drugs.html,2023-12-11 14:00:01,A CNBC investigation found criminal networks altering pill bottles of lifesaving drugs and then selling them back to pharmacies at large discounts.,JNJ,0.05469,-0.068818,Neutral
"The Honest Company Announces Appointment of Michael Barkley, Alissa Hsu Lynch, and Andrea Turner to the Board of Directors",https://www.globenewswire.com/news-release/2023/12/11/2793894/0/en/The-Honest-Company-Announces-Appointment-of-Michael-Barkley-Alissa-Hsu-Lynch-and-Andrea-Turner-to-the-Board-of-Directors.html,2023-12-11 14:00:00,"LOS ANGELES, Dec. 11, 2023 ( GLOBE NEWSWIRE ) -- The Honest Company ( NASDAQ: HNST ) , a digitally-native consumer products company dedicated to creating clean- and sustainably-designed products spanning baby care, beauty, personal care, wellness and household care, today announced that Michael ...",JNJ,0.082677,0.21644,Somewhat-Bullish
"The Honest Company Announces Appointment of Michael Barkley, Alissa Hsu Lynch, and Andrea Turner to the Board of Directors - Pulmonx  ( NASDAQ:LUNG ) , Honest Co  ( NASDAQ:HNST ) ",https://www.benzinga.com/pressreleases/23/12/g36176162/the-honest-company-announces-appointment-of-michael-barkley-alissa-hsu-lynch-and-andrea-turner-to-,2023-12-11 14:00:00,"LOS ANGELES, Dec. 11, 2023 ( GLOBE NEWSWIRE ) -- The Honest Company HNST, a digitally-native consumer products company dedicated to creating clean- and sustainably-designed products spanning baby care, beauty, personal care, wellness and household care, today announced that Michael Barkley, ...",JNJ,0.08183,0.216068,Somewhat-Bullish
Should You Invest in the iShares U.S. Pharmaceuticals ETF  ( IHE ) ?,https://www.zacks.com/stock/news/2195941/should-you-invest-in-the-ishares-us-pharmaceuticals-etf-ihe,2023-12-11 11:20:07,Sector ETF report for ...,JNJ,0.133841,0.061752,Neutral
Should You Invest in the Fidelity MSCI Health Care Index ETF  ( FHLC ) ?,https://www.zacks.com/stock/news/2195947/should-you-invest-in-the-fidelity-msci-health-care-index-etf-fhlc,2023-12-11 11:20:06,Sector ETF report for ...,JNJ,0.128135,0.049945,Neutral
2 Top Dividend Stocks to Buy Now,https://www.fool.com/investing/2023/12/11/2-top-dividend-stocks-to-buy-now/,2023-12-11 10:30:00,You can snap up these particular dividend stocks for a bargain today.,JNJ,0.114137,0.163578,Somewhat-Bullish
"5 Phenomenal Stocks in Warren Buffett's ""Secret"" Portfolio That Are Screaming Buys in 2024",https://www.fool.com/investing/2023/12/11/5-stocks-warren-buffett-secret-portfolio-buy-2024/,2023-12-11 10:06:00,The Oracle of Omaha's $610 million hidden portfolio has five amazing bargains hiding in plain sight.,JNJ,0.134741,0.132546,Neutral
3 Dividend Stocks You Can Safely Hold for Decades,https://www.fool.com/investing/2023/12/09/3-dividend-stocks-you-can-safely-hold-for-decades/,2023-12-09 10:51:00,These companies and their dividends are built to last.,JNJ,0.125789,0.040278,Neutral
"'s 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet - Johnson & Johnson  ( NYSE:JNJ ) , Altimmune  ( NASDAQ:ALT ) ",https://www.benzinga.com/top-stories/23/12/36157420/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet,2023-12-08 17:50:15,"Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and warrant attention. Investors are constantly on the hunt for undervalued, under-followed and emerging stocks.",JNJ,0.193723,0.092631,Neutral
UPenn President Liz Magill under fire over antisemitism on campus: Jon Huntsman calls her resignation 'not even debatable' | Business,https://www.cnn.com/2023/12/08/business/upenn-president-liz-magill-resign/index.html,2023-12-08 13:12:00,UPenn President Liz Magill under fire over antisemitism on campus: Jon Huntsman calls her resignation 'not even debatable' ...,JNJ,0.054114,0.06179,Neutral
Transdermal Patches Market is Expected to Reach $8.0 Billion | MarketsandMarkets.,https://www.benzinga.com/pressreleases/23/12/g36151396/transdermal-patches-market-is-expected-to-reach-8-0-billion-marketsandmarkets,2023-12-08 12:30:00,"Chicago, Dec. 08, 2023 ( GLOBE NEWSWIRE ) -- Transdermal Patches market in terms of revenue was estimated to be worth $6.2 billion in 2023 and is poised to reach $8.0 billion by 2029, growing at a CAGR of 4.5% from 2023 to 2029 according to a latest report published by MarketsandMarketsâ„¢.",JNJ,0.031529,0.006513,Neutral
Global Bispecific Antibody Therapeutics Contract Manufacturing Market Size to Expand Lucratively and Reach $82.85 Bn to 2031 - Explained Details | Updated InsightAce Study,https://www.prnewswire.com/news-releases/global-bispecific-antibody-therapeutics-contract-manufacturing-market-size-to-expand-lucratively-and-reach-82-85-bn-to-2031---explained-details--updated-insightace-study-302009968.html,2023-12-08 10:20:00,Global Bispecific Antibody Therapeutics Contract Manufacturing Market Size to Expand Lucratively and Reach $82.85 ... PR ...,JNJ,0.041323,0.07774,Neutral
"Red Biotechnology Market to Reach $1,513.22 Billion, Globally, by 2030 at 10.7% CAGR: Coherent Market Insights",https://www.prnewswire.com/news-releases/red-biotechnology-market-to-reach-1-513-22-billion-globally-by-2030-at-10-7-cagr-coherent-market-insights-302009313.html,2023-12-08 07:14:00,"BURLINGAME, Calif., Dec. 8, 2023 /PRNewswire/ -- According to Coherent Market Insights, The global red biotechnology market was valued at US$ 742.80 Billion in 2023 and is forecast to reach a value of US$ 1,513.22 Billion by 2030 at a CAGR of 10.7% between 2023 and 2030.",JNJ,0.028833,0.001897,Neutral
Walgreens' stock soars 8% to lead Dow gainers but is still on track for worst year since 1972,https://www.marketwatch.com/story/walgreens-stock-soars-8-to-lead-djia-and-s-p-500-gainers-but-is-still-on-track-for-worst-year-since-1972-dee951b5,2023-12-07 20:41:00,Walgreens' stock rose ahead of a ruling on what scientific evidence can be cited in lawsuits alleging that use of Tylenol by pregnant women can lead to autism and ADHD in their children.,JNJ,0.218817,-0.079486,Neutral
Here's Why You Should Retain Boston Scientific  ( BSX )  Now,https://www.zacks.com/stock/news/2195111/heres-why-you-should-retain-boston-scientific-bsx-now,2023-12-07 20:14:00,Investors are optimistic about Boston Scientific (BSX) on strong worldwide demand for its GI and pulmonary treatment options and traction in Europe for its next-generation WATCHMAN FLX.,JNJ,0.049835,0.090277,Neutral
"Major donor calls on UPenn president to resign, threatens to rescind $100 million in stock | Business",https://www.cnn.com/2023/12/07/business/penn-emergency-meeting-liz-magill,2023-12-07 17:55:00,University of Pennsylvania board of trustees holds emergency meeting after president Liz Magill's disastrous testimony ...,JNJ,0.021331,0.057627,Neutral
Vanda Pharmaceuticals Acquires Rights To Multiple Sclerosis Drug From Johnson & Johnson's Company - Vanda Pharma  ( NASDAQ:VNDA ) ,https://www.benzinga.com/general/biotech/23/12/36135531/vanda-pharmaceuticals-acquires-rights-to-multiple-sclerosis-drug-from-johnson-johnsons-company,2023-12-07 17:32:29,"Vanda Pharmaceuticals Inc VNDA has acquired U.S. and Canadian rights to Ponvory ( ponesimod ) from Actelion Pharmaceuticals Ltd, a Johnson & Johnson company JNJ.",JNJ,0.323078,0.0,Neutral
"BMS Attributes Sotyktu Falling Short of Growth Expectations to Access, but Recent Spherix Global Insights' Data Suggest Safety Concerns Are More of a Barrier to Increased Uptake",https://www.benzinga.com/pressreleases/23/12/g36138279/bms-attributes-sotyktu-falling-short-of-growth-expectations-to-access-but-recent-spherix-global-in,2023-12-07 17:01:24,"Exton, PA, Dec. 07, 2023 ( GLOBE NEWSWIRE ) -- While access took the forefront of BMS' response to Sotyktu ( deucravacitinib ) not meeting growth expectations during the company's Q3 earnings call, practicing dermatologists in Spherix research highlight safety as the leading, and growing, ...",JNJ,0.068995,0.236412,Somewhat-Bullish
 ( JNJ )  - Analyzing Johnson & Johnson's Short Interest - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/short-sellers/23/12/36134013/jnj-analyzing-johnson-johnsons-short-interest,2023-12-07 14:15:17,"Johnson & Johnson's JNJ short percent of float has fallen 8.33% since its last report. The company recently reported that it has 13.19 million shares sold short, which is 0.55% of all regular shares that are available for trading.",JNJ,0.221819,0.081322,Neutral
Biden administration asserts power to seize drug patents in move to slash high prices,https://www.cnbc.com/2023/12/07/biden-administration-asserts-power-to-seize-drug-patents.html,2023-12-07 14:00:03,The Biden administration unveiled a new framework outlining the factors federal agencies should consider in determining whether to use march-in rights.,JNJ,0.054114,-0.075771,Neutral
"Vanda Pharmaceuticals Acquires U.S. and Canadian Rights to PONVORYÂ®  ( ponesimod ) , a Selective S1P1R Modulator Approved for Patients with Relapsing Multiple Sclerosis - Vanda Pharma  ( NASDAQ:VNDA ) ",https://www.benzinga.com/pressreleases/23/12/n36130427/vanda-pharmaceuticals-acquires-u-s-and-canadian-rights-to-ponvory-ponesimod-a-selective-s1p1r-modu,2023-12-07 12:00:00,"WASHINGTON, Dec. 7, 2023 /PRNewswire/ -- Vanda Pharmaceuticals Inc. ( Vanda ) VNDA today announced that it has acquired U.S. and Canadian rights to PONVORYÂ® ( ponesimod ) from Actelion Pharmaceuticals Ltd. ( Janssen ) , a Johnson & Johnson Company. PONVORYÂ® is approved by the U.S.",JNJ,0.028155,0.106145,Neutral
"Vanda Pharmaceuticals Acquires U.S. and Canadian Rights to PONVORYÂ®  ( ponesimod ) , a Selective S1P1R Modulator Approved for Patients with Relapsing Multiple Sclerosis",https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-acquires-us-and-canadian-rights-to-ponvory-ponesimod-a-selective-s1p1r-modulator-approved-for-patients-with-relapsing-multiple-sclerosis-302008402.html,2023-12-07 12:00:00,"Vanda Pharmaceuticals Acquires U.S. and Canadian Rights to PONVORYÂ® ( ponesimod ) , a Selective S1P1R ... PR ...",JNJ,0.027195,0.11855,Neutral
Santhera Appoints Executive Committee Members as it Transitions into Commercial Stage,https://www.globenewswire.com/news-release/2023/12/07/2792212/0/en/Santhera-Appoints-Executive-Committee-Members-as-it-Transitions-into-Commercial-Stage.html,2023-12-07 06:00:00,"Pratteln, Switzerland, December 7, 2023 - Santhera Pharmaceuticals ( SIX: SANN ) announces the promotion of Geert Jan van Daal, MD, PhD, to Chief Commercial Officer ( CCO ) and of Marc Schrader to Chief Technology Officer ( CTO ) . Both will join the six-member Executive Committee effective ...",JNJ,0.050254,0.0,Neutral
"Nasdaq Leads Over NYSE in IPO Listings, Drawing Major Tech and Global Firms in 2023 - Nasdaq  ( NASDAQ:NDAQ ) ",https://www.benzinga.com/markets/equities/23/12/36387988/nasdaq-leads-over-nyse-in-ipo-listings-drawing-major-tech-and-global-firms-in-2023,2023-12-26 18:55:22,"Nasdaq, Inc. NDAQ is reportedly poised to outpace the New York Stock Exchange in securing initial public offerings in 2023. This marks the fifth consecutive year where the once-leading NYSE has trailed its competitor, the Wall Street Journal said in a news report.",JNJ,0.207571,0.406106,Bullish
Shares Of Chip Designer Arm Hit New All-Time High-Outclassing 2023 IPO Peers,https://www.forbes.com/sites/dereksaul/2023/12/26/shares-of-chip-designer-arm-hit-new-all-time-high-outclassing-2023-ipo-peers/,2023-12-26 18:10:04,"British chip designer Arm's stock rallied Tuesday to its highest level since it began trading in September, riding the wave of optimism surrounding generative artificial intelligence to a rare win for recent initial public offerings on the stock market.",JNJ,0.099066,0.068778,Neutral
Best Stocks To Buy In 2024? 2 Blue Chip Stocks In Focus,https://stockmarket.com/featured/best-stocks-to-buy-in-2024-2-blue-chip-stocks-in-focus-2023-12-26,2023-12-26 15:39:38,"Blue chip stocks refer to shares of large, well-established companies that have a history of steady earnings and dividend payments. These companies typically have ample cash reserves and operate in mature industries.",JNJ,0.153961,0.273587,Somewhat-Bullish
Investors Lose $426 Billion On These 8 Giant Losers This Year,https://www.investors.com/etfs-and-funds/sectors/sp500-investors-lose-billions-on-these-giant-losers-this-year-2023/,2023-12-26 13:00:00,"Investors scored big-time on the biggest S&P 500 stocks this year. But those who picked the wrong stocks suffered mightily. Investors lost $462 billion holding just eight stocks dropping the most market value this year, including ailing vaccine maker Pfizer ( PFE ) , struggling oil giant Chevron ...",JNJ,0.142565,-0.041371,Neutral
LianBio Enters into Agreement Assigning its Rights for NBTXR3 in China and Other Asian Markets,https://www.globenewswire.com/news-release/2023/12/26/2801027/0/en/LianBio-Enters-into-Agreement-Assigning-its-Rights-for-NBTXR3-in-China-and-Other-Asian-Markets.html,2023-12-26 07:00:00,"SHANGHAI, China and PRINCETON, N.J., Dec. 26, 2023 ( GLOBE NEWSWIRE ) -- LianBio ( Nasdaq: LIAN ) , a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, today announced that the company has entered into an agreement with Janssen ...",JNJ,0.039745,0.170952,Somewhat-Bullish
LianBio Enters into Agreement Assigning its Rights for NBTXR3 in China and Other Asian Markets - LianBio  ( NASDAQ:LIAN ) ,https://www.benzinga.com/pressreleases/23/12/g36380995/lianbio-enters-into-agreement-assigning-its-rights-for-nbtxr3-in-china-and-other-asian-markets,2023-12-26 07:00:00,"SHANGHAI, China and PRINCETON, N.J., Dec. 26, 2023 ( GLOBE NEWSWIRE ) -- LianBio LIAN, a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, today announced that the company has entered into an agreement with Janssen Pharmaceutica ...",JNJ,0.038284,0.160376,Somewhat-Bullish
Nanobiotix Partner LianBio Assigns Its Development and Commercialization Rights for NBTXR3 in China and Other Asian Markets,https://www.globenewswire.com/news-release/2023/12/26/2801026/0/en/Nanobiotix-Partner-LianBio-Assigns-Its-Development-and-Commercialization-Rights-for-NBTXR3-in-China-and-Other-Asian-Markets.html,2023-12-26 07:00:00,"PARIS and CAMBRIDGE, Mass., Dec. 26, 2023 ( GLOBE NEWSWIRE ) -- NANOBIOTIX ( Euronext : NANO -- NASDAQ: NBTX - the ''Company'' ) , a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced that ...",JNJ,0.03399,0.074574,Neutral
Nanobiotix Partner LianBio Assigns Its Development and Commercialization Rights for NBTXR3 in China and Other Asian Markets - Nanobiotix  ( NASDAQ:NBTX ) ,https://www.benzinga.com/pressreleases/23/12/g36380993/nanobiotix-partner-lianbio-assigns-its-development-and-commercialization-rights-for-nbtxr3-in-chin,2023-12-26 07:00:00,"PARIS and CAMBRIDGE, Mass., Dec. 26, 2023 ( GLOBE NEWSWIRE ) -- NANOBIOTIX NBTX, a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced that partner LianBio has entered into an agreement with ...",JNJ,0.033703,0.074503,Neutral
How Is The Market Feeling About Johnson & Johnson? - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/short-sellers/23/12/36379602/how-is-the-market-feeling-about-johnson-johnson,2023-12-25 17:30:24,"Johnson & Johnson's JNJ short percent of float has risen 12.73% since its last report. The company recently reported that it has 15.00 million shares sold short, which is 0.62% of all regular shares that are available for trading.",JNJ,0.221819,0.15378,Somewhat-Bullish
2 Top Dividend Stocks You Can Buy and Hold Forever,https://www.fool.com/investing/2023/12/24/2-top-dividend-stocks-you-can-buy-and-hold-forever/,2023-12-24 10:12:00,These companies pay very durable dividends.,JNJ,0.364529,0.494193,Bullish
5 Top Stocks to Buy With Your End-of-the-Year Bonus,https://www.fool.com/investing/2023/12/23/5-top-stocks-to-buy-with-your-bonus/,2023-12-23 10:00:00,Your bonus could become the gift that keeps on giving.,JNJ,0.077593,0.150159,Somewhat-Bullish
Check Out What Whales Are Doing With JNJ - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/12/36363065/check-out-what-whales-are-doing-with-jnj,2023-12-22 15:02:40,"Financial giants have made a conspicuous bullish move on Johnson & Johnson. Our analysis of options history for Johnson & Johnson JNJ revealed 10 unusual trades. Delving into the details, we found 70% of traders were bullish, while 30% showed bearish tendencies.",JNJ,0.677874,0.370294,Bullish
"Cosmetic Skin Care Market is Anticipated to Reach USD 154.7 billion at a CAGR of 4.8% CAGR by 2031 - Report by Transparency Market Research, Inc.",https://www.benzinga.com/pressreleases/23/12/g36362289/cosmetic-skin-care-market-is-anticipated-to-reach-usd-154-7-billion-at-a-cagr-of-4-8-cagr-by-2031-,2023-12-22 14:30:00,"Wilmington, Delaware, United States, Dec. 22, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global cosmetic skin care market is estimated to flourish at a CAGR of 4.8% from 2022 to 2031.",JNJ,0.035661,0.0,Neutral
Surgical Sutures Market is Expected to Reach $5.5 Billion | MarketsandMarkets.,https://www.benzinga.com/pressreleases/23/12/g36359974/surgical-sutures-market-is-expected-to-reach-5-5-billion-marketsandmarkets,2023-12-22 12:30:00,"Chicago, Dec. 22, 2023 ( GLOBE NEWSWIRE ) -- Surgical Sutures market in terms of revenue was estimated to be worth $4.0 Billion in 2023 and is poised to reach $5.5 billion by 2028, growing at a CAGR of 6.4% from 2023 to 2028 according to a latest report published by MarketsandMarketsâ„¢.",JNJ,0.046452,0.0,Neutral
"Feminine Hygiene Market size to worth $63.5 billion by 2030, globally at a CAGR of 7.4%, says Coherent Market Insights",https://www.prnewswire.com/news-releases/feminine-hygiene-market-size-to-worth-63-5-billion-by-2030--globally-at-a-cagr-of-7-4-says-coherent-market-insights-302021679.html,2023-12-22 09:14:00,"SEATTLE, Dec. 22, 2023 /PRNewswire/ -- As per the recent analysis by Coherent Market Insights, the global feminine hygiene market size was valued at US$ 33.3 billion in 2023 and is predicted to reach US$ 63.5 billion by 2030.",JNJ,0.029399,0.044076,Neutral
"Pharma industry optimistic, expects more collaborative efforts in New Year",https://www.business-standard.com/industry/news/pharma-industry-optimistic-expects-more-collaborative-efforts-in-new-year-123122200253_1.html,2023-12-22 06:02:49,"The domestic pharmaceutical industry expects another year of sustained growth in 2024 amid various challenges, including maintaining quality standards, while moving from volume to value leadership.",JNJ,0.055751,0.0,Neutral
Monthly Meeting Q&A with Jim Cramer: Stock buying and selling strategies into year end,https://www.cnbc.com/2023/12/21/monthly-meeting-qa-with-jim-cramer-stock-buying-and-selling-strategies-into-year-end.html,2023-12-21 18:07:06,"During the December Monthly Meeting, we took questions directly from Investing Club members.",JNJ,0.019618,0.039266,Neutral
Why Is Eye Disease Related Gene Therapy Focused MeiraGTx Stock Soaring Today? - MeiraGTx Hldgs  ( NASDAQ:MGTX ) ,https://www.benzinga.com/general/biotech/23/12/36343217/why-is-eye-disease-related-gene-therapy-focused-meiragtx-stock-soaring-today,2023-12-21 16:11:13,"MeiraGTx Holdings plc MGTX on Thursday announced an asset purchase agreement with Janssen Pharmaceuticals Inc, a Johnson & Johnson JNJ company, for the remaining interests in botaretigene sparoparvovec ( bota-vec, formerly AAV-RPGR ) for X-linked retinitis pigmentosa ( XLRP ) .",JNJ,0.271274,0.327064,Somewhat-Bullish
Medical Aesthetics Market is Expected to Reach $25.9 Billion | MarketsandMarkets.,https://www.benzinga.com/pressreleases/23/12/g36341317/medical-aesthetics-market-is-expected-to-reach-25-9-billion-marketsandmarkets,2023-12-21 12:30:00,"Chicago, Dec. 21, 2023 ( GLOBE NEWSWIRE ) -- Medical Aesthetics market in terms of revenue was estimated to be worth $15.4 Billion in 2023 and is poised to reach $25.9 billion by 2028, growing at a CAGR of 11.0% from 2023 to 2028 according to a latest report published by MarketsandMarketsâ„¢.",JNJ,0.041901,0.0,Neutral
MeiraGTx Announces Asset Purchase Agreement Involving its AAV-RPGR Collaboration for up to $415 million - MeiraGTx Hldgs  ( NASDAQ:MGTX ) ,https://www.benzinga.com/pressreleases/23/12/g36340683/meiragtx-announces-asset-purchase-agreement-involving-its-aav-rpgr-collaboration-for-up-to-415-mil,2023-12-21 12:00:00,"- MeiraGTx enters into an Asset Purchase Agreement related to botaretigene sparoparvovec ( bota-vec, formerly AAV-RPGR ) for the treatment of X-linked retinitis pigmentosa ( XLRP ) for a total of up to $415 million - MeiraGTx to receive $130 million in upfront and near-term milestone ...",JNJ,0.030292,0.218785,Somewhat-Bullish
2 No-Brainer Buys During a Stock Market Crash,https://www.fool.com/investing/2023/12/21/2-no-brainer-buys-during-a-stock-market-crash/,2023-12-21 11:55:00,"If the stock market pulls back, JPMorgan Chase and Microsoft should be at the top of your buy list.",JNJ,0.061315,-0.06417,Neutral
"Got $1,000? 5 of the Safest Stocks to Buy for 2024",https://www.fool.com/investing/2023/12/21/got-1000-5-of-the-safest-stocks-to-buy-for-2024/,2023-12-21 10:21:00,"Regardless of what's thrown Wall Street's way in the new year, these tried-and-true companies can deliver for their shareholders.",JNJ,0.15078,0.264171,Somewhat-Bullish
Judge Bars Testimony Linking Kenvue's Pain Killer Tylenol to Autism in Pregnancy - Kenvue  ( NYSE:KVUE ) ,https://www.benzinga.com/news/23/12/36321800/judge-bars-testimony-linking-kenvues-pain-killer-tylenol-to-autism-in-pregnancy,2023-12-20 15:51:18,U.S. District Judge Denise Cote ruled against allowing expert witnesses to testify that Johnson & Johnson JNJ spin-off Kenvue Inc's KVUE painkiller Tylenol could cause autism in babies if taken during pregnancy.,JNJ,0.348919,-0.069203,Neutral
"Global Oral Care Market Size is Estimated to Reach USD 56.91 billion by 2030, Growing at a CAGR of 6.1%: Straits Research",https://www.benzinga.com/pressreleases/23/12/g36324134/global-oral-care-market-size-is-estimated-to-reach-usd-56-91-billion-by-2030-growing-at-a-cagr-of-,2023-12-20 13:50:00,"New York, United States, Dec. 20, 2023 ( GLOBE NEWSWIRE ) -- Oral hygiene is the process of maintaining a healthy, disease-free mouth. Regular dental exams that include cleanings, exams, X-rays, tooth brushing, and flossing are required for excellent oral hygiene.",JNJ,0.097259,0.120816,Neutral
Martin Glensbjerg takes up new position at ChemoMetec,https://www.globenewswire.com/news-release/2023/12/20/2799277/0/en/Martin-Glensbjerg-takes-up-new-position-at-ChemoMetec.html,2023-12-20 13:35:00,ANNOUNCEMENT NO. ...,JNJ,0.090474,0.042426,Neutral
"Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma",https://www.cnbc.com/2023/12/20/weight-loss-drugs-covid-downturn-pharma-had-a-year-full-of-firsts.html,2023-12-20 12:00:01,"Wall Street turned its focus to a handful of newer treatments in different disease areas in 2023, including weight loss medications and a new Alzheimer's drug.",JNJ,0.053992,-0.015961,Neutral
Is American Century U.S. Quality Value ETF  ( VALQ )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2200357/is-american-century-us-quality-value-etf-valq-a-strong-etf-right-now,2023-12-20 11:20:06,Smart Beta ETF report for ...,JNJ,0.115787,0.044463,Neutral
Goldman Sachs is considering a sweeping overhaul of its management committee. Here's what executives are thinking.,https://www.businessinsider.com/goldman-sachs-management-committee-david-solomon-and-john-waldron-2023-12,2023-12-19 21:39:00,What a Goldman Sachs Overhaul Could Mean for David Solomon and John Waldron. - Business Insider ...,JNJ,0.035345,0.0,Neutral
Bioventus Names Robert Claypoole as President and Chief Executive Officer,https://www.globenewswire.com/news-release/2023/12/19/2798909/0/en/Bioventus-Names-Robert-Claypoole-as-President-and-Chief-Executive-Officer.html,2023-12-19 21:30:00,Seasoned Leader Brings More than Two Decades of Medical Device Experience and Proven Track Record of Driving Revenue and Operating Margin Growth Seasoned Leader Brings More than Two Decades of Medical Device Experience and Proven Track Record of Driving Revenue and Operating Margin Growth ...,JNJ,0.029581,0.202708,Somewhat-Bullish
Bioventus Names Robert Claypoole as President and Chief Executive Officer - Bioventus  ( NASDAQ:BVS ) ,https://www.benzinga.com/pressreleases/23/12/g36315192/bioventus-names-robert-claypoole-as-president-and-chief-executive-officer,2023-12-19 21:30:00,"DURHAM, N.C., Dec. 19, 2023 ( GLOBE NEWSWIRE ) -- Bioventus Inc. BVS ( ""Bioventus"" or the ""Company"" ) , a global leader in innovations for active healing, today announced that its Board of Directors has appointed Robert ( Rob ) Claypoole as Bioventus' President and Chief Executive Officer and a ...",JNJ,0.029149,0.202448,Somewhat-Bullish
3 Penny Stocks Under $3 To Watch Right Now,https://pennystocks.com/featured/2023/12/19/3-penny-stocks-under-3-to-watch-right-now-december-2023/,2023-12-19 19:22:11,"As an aggressive subset of equities, penny stocks offer patient investors occasional lottery ticket-like returns. However, the market gyrations around news and events also invite risk. This guide explores the fundamentals of penny stocks, how announcements drive explosive moves, and resources to ...",JNJ,0.063091,0.122282,Neutral
Kenvue's stock rises after favorable court ruling in Tylenol litigation,https://www.marketwatch.com/story/kenvue-shares-rise-after-favorable-court-ruling-in-tylenol-litigation-3daa0865,2023-12-19 16:43:00,Kenvue shares gained nearly 5% Tuesday morning after a federal court's ruling in a product-liability case appeared to work in the Tylenol maker's favor.,JNJ,0.176502,-0.122694,Neutral
The Migraine Market Size Is Expected To Reach $2.15 Billion By 2028 At A CAGR Of 2.8% As Per The Business Research Company's Migraine Global Market Report 2024,https://www.benzinga.com/pressreleases/23/12/g36308373/the-migraine-market-size-is-expected-to-reach-2-15-billion-by-2028-at-a-cagr-of-2-8-as-per-the-bus,2023-12-19 16:30:00,"LONDON, Dec. 19, 2023 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Migraine Global Market Report 2024, the migraine market has demonstrated a steady growth trajectory, marking an increase from $1.87 billion in 2023 to an estimated $1.93 billion in 2024.",JNJ,0.063763,-0.006038,Neutral
3 Healthcare Stocks That Could Help Make You a Millionaire,https://www.fool.com/investing/2023/12/19/3-healthcare-stocks-could-help-make-you-rich/,2023-12-19 10:00:00,These stocks each have reached an important turning point that could signal growth ahead.,JNJ,0.159218,0.23199,Somewhat-Bullish
Face Wash Market to grow by USD 8.38 billion from 2023 to 2028 | Market is fragmented due to the presence of ... - PR Newswire,https://www.prnewswire.com/news-releases/face-wash-market-to-grow-by-usd-8-38-billion-from-2023-to-2028--market-is-fragmented-due-to-the-presence-of-prominent-companies-like-alchemee-llc-amway-corp-and-beiersdorf-ag-and-many-more---technavio-302018052.html,2023-12-19 07:15:00,Face Wash Market to grow by USD 8.38 billion from 2023 to 2028 | Market is fragmented due to the presence of ... PR ...,JNJ,0.048919,0.060598,Neutral
Johnson & Johnson  ( JNJ )  Increases Yet Falls Behind Market: What Investors Need to Know,https://www.zacks.com/stock/news/2199619/johnson-johnson-jnj-increases-yet-falls-behind-market-what-investors-need-to-know,2023-12-18 22:45:19,"In the latest trading session, Johnson & Johnson (JNJ) closed at $155.44, marking a +0.18% move from the previous day.",JNJ,0.554916,0.208639,Somewhat-Bullish
"Schizophrenia Future Outlook 2024-2028: Forecasted Market Rate, Growth Factors, And Leading Segments As Per The Business Research Company's Schizophrenia Global Market Report 2024",https://www.benzinga.com/pressreleases/23/12/g36286286/schizophrenia-future-outlook-2024-2028-forecasted-market-rate-growth-factors-and-leading-segments-,2023-12-18 16:30:00,"LONDON, Dec. 18, 2023 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Schizophrenia Global Market Report 2024, the schizophrenia market has exhibited robust growth, surging from $5.48 billion in 2023 to $5.82 billion in 2024, reflecting a notable compound annual growth rate ( CAGR ) ...",JNJ,0.059488,0.153093,Somewhat-Bullish
UNICEF USA BrandVoice: Closing The Health Inequity Gap By Investing In Data And Technology,https://www.forbes.com/sites/unicefusa/2023/12/18/closing-the-health-inequity-gap-by-investing-in-data-and-technology/,2023-12-18 15:38:00,Closing The Health Inequity Gap By Investing In Data And Technology Forbes ...,JNJ,0.031322,0.22609,Somewhat-Bullish
"Makeup Remover Market Size to be Worth USD 4.3 billion by 2031, with Grow at CAGR of 6.5%| Transparency Market Research, Inc.",https://www.benzinga.com/pressreleases/23/12/g36279593/makeup-remover-market-size-to-be-worth-usd-4-3-billion-by-2031-with-grow-at-cagr-of-6-5-transparen,2023-12-18 12:30:00,"Wilmington, Delaware, United States, Dec. 18, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The makeup remover market was valued at over US$ 2.3 billion in 2021. A CAGR of 6.5% is expected between 2022 and 2031. The makeup remover sales are expected to exceed US$ 4.3 billion by ...",JNJ,0.033421,-0.095627,Neutral
"Muckle Wells Syndrome Market to Reach US$ 335.9 Million by 2030, Rising at a CAGR of 12.6% | Report by CoherentMI",https://www.prnewswire.com/news-releases/muckle-wells-syndrome-market-to-reach-us-335-9-million-by-2030--rising-at-a-cagr-of-12-6--report-by-coherentmi-302017763.html,2023-12-18 11:54:00,"BURLINGAME, Calif., Dec. 18, 2023 /PRNewswire/ -- CoherentMI published a report, titled, Muckle Wells Syndrome Market is estimated to value at US$ 146.4 Million in the year 2023 and is anticipated to reach US$ 335.9 Million by 2030, at a CAGR of 12.6% during forecast period 2023-2030.",JNJ,0.030331,0.083206,Neutral
"The Zacks Analyst Blog Highlights JPMorgan Chase, Abbott Laboratories, Qualcomm, Johnson & Johnson and BHP",https://www.zacks.com/stock/news/2199138/the-zacks-analyst-blog-highlights-jpmorgan-chase-abbott-laboratories-qualcomm-johnson-johnson-and-bhp,2023-12-18 10:09:00,"JPMorgan Chase, Abbott Laboratories, Qualcomm, Johnson & Johnson and BHP are included in this Analyst Blog.",JNJ,0.124809,0.037836,Neutral
"Advanced Wound Care Market size to grow by USD 4.02 billion from 2022 to 2027, North America to account for 41 ... - PR Newswire",https://www.prnewswire.com/news-releases/advanced-wound-care-market-size-to-grow-by-usd-4-02-billion-from-2022-to-2027--north-america-to-account-for-41-of-market-growth--technavio-302026301.html,2024-01-05 19:00:00,"Advanced Wound Care Market size to grow by USD 4.02 billion from 2022 to 2027, North America to account for 41 ... PR ...",JNJ,0.065327,0.068069,Neutral
"Illumina's MRD Technology For Cancer Testing Collaborates With Johnson & Johnson Unit - Illumina  ( NASDAQ:ILMN ) , Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/markets/equities/24/01/36513008/illuminas-mrd-technology-for-cancer-testing-collaborates-with-johnson-johnson-unit,2024-01-05 17:01:10,"Illumina, Inc. ILMN announced it has signed an agreement with Janssen Research & Development, a unit of Johnson & Johnson JNJ.",JNJ,0.29234,0.324453,Somewhat-Bullish
Blood Cancer Player Arcellx Finds Place On Analyst Conviction List - Potential Room For Growth In 2024 - Arcellx  ( NASDAQ:ACLX ) ,https://www.benzinga.com/analyst-ratings/analyst-color/24/01/36497306/blood-cancer-player-arcellx-finds-place-on-analyst-conviction-list-potential-room-f,2024-01-04 19:08:32,"Needham analyst forecasts a positive outlook for Arcellx Inc ACLX in 2024, citing strong potential stemming from the anticipated pivotal interim readout from the iMMagine-1 study, expected in the second half of 2024. This development is poised to bolster filing prospects for the company in 2025.",JNJ,0.288893,0.629575,Bullish
Check Out What Whales Are Doing With JNJ - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/24/01/36494464/check-out-what-whales-are-doing-with-jnj,2024-01-04 16:45:49,"High-rolling investors have positioned themselves bearish on Johnson & Johnson JNJ, and it's important for retail traders to take note. \This activity came to our attention today through Benzinga's tracking of publicly available options data.",JNJ,0.681225,0.347717,Somewhat-Bullish
Pharmaceutical First: Eli Lilly Website Will Prescribe Weight Loss Drugs Through Service,https://www.forbes.com/sites/maryroeloffs/2024/01/04/pharmaceutical-first-eli-lilly-website-will-prescribe-weight-loss-drugs-through-service/,2024-01-04 14:51:12,"Drugmaker Eli Lilly has launched a new website specifically for prescribing weight loss drugs through a telehealth service less than a month after the company's new injectable, Zepbound, became available in U.S. pharmacies for overweight or obese adults.",JNJ,0.065866,0.15594,Somewhat-Bullish
"Accord BioPharma, Inc. Announces U.S. FDA Acceptance of Biologics License Application for Proposed STELARAÂ® Biosimilar DMB-3115",https://www.prnewswire.com/news-releases/accord-biopharma-inc-announces-us-fda-acceptance-of-biologics-license-application-for-proposed-stelara-biosimilar-dmb-3115-302025983.html,2024-01-04 13:22:00,"Accord BioPharma, Inc. Announces U.S. FDA Acceptance of Biologics License Application for Proposed STELARA ... PR ...",JNJ,0.062597,0.090301,Neutral
Antibody Therapeutics Market is Expected to Reach $479.0 Billion | MarketsandMarkets.,https://www.benzinga.com/pressreleases/24/01/g36487416/antibody-therapeutics-market-is-expected-to-reach-479-0-billion-marketsandmarkets,2024-01-04 12:30:00,"Chicago, Jan. 04, 2024 ( GLOBE NEWSWIRE ) -- Antibody Therapeutics market in terms of revenue was estimated to be worth $247.3 Billion in 2023 and is poised to reach $479.0 billion by 2028, growing at a CAGR of 14.1% from 2023 to 2028 according to a latest report published by MarketsandMarketsâ„¢.",JNJ,0.079392,0.0,Neutral
Sharing COVID therapy secrets is a Trojan horse that would gut U.S. biotech,https://www.marketwatch.com/story/sharing-covid-therapy-secrets-is-a-trojan-horse-that-would-gut-u-s-biotech-734c680c,2024-01-04 12:20:00,IP waiver would allow developing countries access to formulas and manufacturing details.,JNJ,0.042723,0.02678,Neutral
3 Delaware Mutual Funds to Build a Strong Portfolio,https://www.zacks.com/stock/news/2205443/3-delaware-mutual-funds-to-build-a-strong-portfolio,2024-01-04 11:40:00,"Invest in Delaware mutual funds like WLGYX, IDAAX and DDFAX for positive returns.",JNJ,0.069294,0.053163,Neutral
Johnson & Johnson  ( JNJ )  Rises As Market Takes a Dip: Key Facts,https://www.zacks.com/stock/news/2205270/johnson-johnson-jnj-rises-as-market-takes-a-dip-key-facts,2024-01-03 22:45:20,"In the closing of the recent trading day, Johnson & Johnson (JNJ) stood at $160.97, denoting a +0.63% change from the preceding trading day.",JNJ,0.605266,0.126404,Neutral
Stock Market Trims Losses After Fed Minutes; What The Bad Santa Rally Means For Indexes,https://www.investors.com/market-trend/stock-market-today/stock-market-trims-losses-after-fed-minutes-what-the-bad-santa-rally-means-for-indexes/,2024-01-03 20:17:00,Stock Market Trims Losses After Fed Minutes. What The Bad Santa Rally Means For Indexes Investor's Business Daily ...,JNJ,0.12013,0.112157,Neutral
Will 2024 Be The Year Of The Other 493?,https://www.benzinga.com/markets/24/01/36476280/will-2024-be-the-year-of-the-other-493,2024-01-03 19:08:42,"As we welcome in 2024, one of the most critical questions facing investors is which stocks and sectors will beat the market. Can the Magnificent 7 retain its crown? Or will some subset of the 493 other S&P 500 stocks and their neglected sectors take the throne in 2024? The Magnificent 7 stole the ...",JNJ,0.035661,0.093705,Neutral
"This Analyst Downgrades Bristol-Myers Squibb, Cautions Amid Product Launch And Revenue Concerns - Bristol-Myers Squibb  ( NYSE:BMY ) ",https://www.benzinga.com/analyst-ratings/analyst-color/24/01/36473452/this-analyst-downgrades-bristol-myers-squibb-cautions-amid-product-launch-and-reven,2024-01-03 17:29:30,"BofA Securities downgraded Bristol-Myers Squibb & Co BMY, noting that initially, the analyst believed that Bristol's loss of exclusivity ( LOEs ) for drugs like Eliquis and Opdivo was widely understood and it was anticipated that new product lineup would compensate for these losses and boost ...",JNJ,0.303175,0.282842,Somewhat-Bullish
Pharmaceutical Drug Delivery Market Set For Robust Growth: Market Size To Reach $2337 Billion By 2028 As Per The Business Research Company's Pharmaceutical Drug Delivery Global Market Report 2024,https://www.benzinga.com/pressreleases/24/01/g36473207/pharmaceutical-drug-delivery-market-set-for-robust-growth-market-size-to-reach-2337-billion-by-202,2024-01-03 16:30:00,"LONDON, Jan. 03, 2024 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's pharmaceutical drug delivery global market report 2024, the global pharmaceutical drug delivery market has exhibited robust growth, expanding from $1711.47 billion in 2023 to an estimated $1816.05 billion in 2024, ...",JNJ,0.04882,0.091119,Neutral
"Medytox, Inc. Announces the Formation of Luvantas Subsidiary and Appointment of Key Executives",https://www.prnewswire.com/news-releases/medytox-inc-announces-the-formation-of-luvantas-subsidiary-and-appointment-of-key-executives-302025050.html,2024-01-03 13:45:00,"IRVINE, Calif., Jan. 3, 2024 /PRNewswire/ -- Medytox, Inc. is pleased to announce the formation of Luvantas, Inc. ( www.luvantas.com ) as its wholly-owned North American subsidiary.",JNJ,0.064973,0.092192,Neutral
"Why Is TikTok Parent ByteDance Moving Into Biology, Chemistry And Drug Discovery?",https://www.forbes.com/sites/alexandralevine/2024/01/02/tiktok-bytedance-pharmaceuticals-drug-discovery-science-biology-chemistry-ai-china/,2024-01-03 11:30:00,TikTok's Chinese parent is beginning to recruit across the U.S. for experts in science and healthcare disciplines far afield from social media. Its motives are unclear.,JNJ,0.026042,0.108238,Neutral
"3 No-Brainer Stocks to Buy With $1,000 Right Now for the New Year",https://www.fool.com/investing/2024/01/03/3-no-brainer-stocks-to-buy-with-1000-right-now/,2024-01-03 10:21:00,"A modest amount of money can go a long way when it's put to work in industry-leading, time-tested businesses with well-defined catalysts.",JNJ,0.146916,-0.051886,Neutral
"10 things turning 100 in 2024, from Band-Aids to Popsicles",https://www.businessinsider.com/inventions-brands-events-100-years-ago-2024-1,2024-01-02 21:26:00,"Things invented 100 years ago, turning 100 in 2024 - Business Insider ...",JNJ,0.096283,-0.045114,Neutral
Johnson & Johnson Shareholders' Class Action Lawsuit Gets Nod from Federal Judge - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/general/biotech/24/01/36455727/johnson-johnson-shareholders-class-action-lawsuit-gets-nod-from-federal-judge,2024-01-02 19:01:30,"A federal judge's ruling in Trenton, New Jersey, has paved the way for Johnson & Johnson JNJ shareholders to collectively proceed with a lawsuit alleging the company concealed information about asbestos contamination in its talc products. U.S.",JNJ,0.386875,-0.138228,Neutral
Travel Updates: Gatwick Hikes Drop-Off Fee,https://www.forbes.com/uk/advisor/travel-insurance/2024/01/02/travel-latest-news/,2024-01-02 18:01:48,"2 January: Minimum Charge To Rise 20% To Â£6 For 10 Minutes Gatwick Airport is increasing its minimum drop-off charge by 20% from 5 January, when it will increase from Â£5 to Â£6. The minimum charge covers the first 10 minutes and must be paid by midnight the day after the visit.",JNJ,0.000901,0.0,Neutral
MeiraGTx  ( MGTX )  Stock Surges 35% in a Month: Here's Why,https://www.zacks.com/stock/news/2204585/meiragtx-mgtx-stock-surges-35-in-a-month-heres-why,2024-01-02 17:17:00,MeiraGTx's (MGTX) shares surge on the sale of rights for a rare ocular disease gene therapy for up to $ 415 million. This funding helps MGTX extend its cash runway into mid-2026.,JNJ,0.118064,0.110221,Neutral
Here's Why You Should Retain Medtronic  ( MDT )  Stock for Now,https://www.zacks.com/stock/news/2204570/heres-why-you-should-retain-medtronic-mdt-stock-for-now,2024-01-02 17:10:00,Investors are optimistic about Medtronic's (MDT) expansion in global markets and stable solvency position.,JNJ,0.04823,0.097986,Neutral
Perspective Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference,https://www.globenewswire.com/news-release/2024/01/02/2802628/0/en/Perspective-Therapeutics-to-Present-at-the-42nd-Annual-J-P-Morgan-Healthcare-Conference.html,2024-01-02 13:00:00,"SEATTLE, Jan. 02, 2024 ( GLOBE NEWSWIRE ) -- Perspective Therapeutics, Inc. ( ""Perspective"" or ""the Company"" ) ( NYSE AMERICAN: CATX ) , today announced that Thijs Spoor, the Company's Chief Executive Officer, will present at the 42nd Annual J.P.",JNJ,0.038407,0.204125,Somewhat-Bullish
XORTX Welcomes New Member to the Board of Directors,https://www.globenewswire.com/news-release/2024/01/02/2802570/0/en/XORTX-Welcomes-New-Member-to-the-Board-of-Directors.html,2024-01-02 12:00:00,"CALGARY, Alberta, Jan. 02, 2024 ( GLOBE NEWSWIRE ) -- XORTX Therapeutics Inc. ( ""XORTX"" or the ""Company"" ) ( NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU ) , a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, welcomes Mr. ...",JNJ,0.052918,0.052981,Neutral
"Johnson & Johnson  ( NYSE:JNJ )  Downgraded by StockNews.com to ""Buy""",https://www.defenseworld.net/2024/01/02/johnson-johnson-nysejnj-downgraded-by-stocknews-com-to-buy.html,2024-01-02 07:22:46,StockNews.com cut shares of Johnson & Johnson ( NYSE:JNJ - Free Report ) from a strong-buy rating to a buy rating in a report released on Monday morning. Other equities analysts also recently issued research reports about the stock.,JNJ,0.82927,0.414319,Bullish
PLATINUM EQUITY TO ACQUIRE HORIZON ORGANIC AND WALLABY FROM DANONE,https://www.prnewswire.com/news-releases/platinum-equity-to-acquire-horizon-organic-and-wallaby-from-danone-302024315.html,2024-01-02 04:35:00,"Leading dairy products brands projected to benefit from Platinum Equity's carve-out experience and operational expertise LOS ANGELES, Jan. 1, 2024 /PRNewswire/ -- Platinum Equity today announced the signing of a definitive agreement to acquire Horizon Organic and Wallaby from Danone.",JNJ,0.043898,0.037051,Neutral
Johnson & Johnson  ( JNJ )  Is a Trending Stock: Facts to Know Before Betting on It,https://www.zacks.com/stock/news/2204062/johnson-johnson-jnj-is-a-trending-stock-facts-to-know-before-betting-on-it,2024-01-01 14:00:12,"Recently, Zacks.com users have been paying close attention to Johnson & Johnson (JNJ). This makes it worthwhile to examine what the stock has in store.",JNJ,0.474958,0.13886,Neutral
Meet the 2024 Dogs of the Dow,https://www.fool.com/investing/2024/01/01/meet-the-2024-dogs-of-the-dow/,2024-01-01 09:46:00,"2023 was another tough year for this popular investing strategy, but fans are hoping for better results in the coming year.",JNJ,0.060085,-0.081217,Neutral
3 Beaten-Down Dow Jones Stocks That Dividend Investors Should Scoop Up in 2024,https://www.fool.com/investing/2023/12/31/3-beaten-down-dow-jones-stocks-dividend-investors/,2023-12-31 12:44:00,"These ""Dogs of the Dow"" offer attractive dividend yields and upside potential.",JNJ,0.277433,0.171156,Somewhat-Bullish
"Jimmy Buffett, Gordon Moore And The Other Billionaires Who Died In 2023",https://www.forbes.com/sites/jemimadenham/2023/12/31/jimmy-buffett-gordon-moore-and-the-other-billionaires-who-died-in-2023/,2023-12-31 11:30:00,"Some larger than life personalities among the billionaire ranks died in 2023, including Jimmy Buffett, who turned his Margaritaville song into a lifestyle empire. cruise-ship-singer-turned-media mogul and Italian prime minister Silvio Berlusconi.",JNJ,0.014367,0.054896,Neutral
2 Best Warren Buffett Stocks to Buy for the Long Haul,https://www.fool.com/investing/2023/12/30/2-best-warren-buffett-stocks-to-buy-for-the-long/,2023-12-30 13:15:00,These companies need no introduction.,JNJ,0.304787,0.288497,Somewhat-Bullish
Judge certifies Johnson & Johnson shareholder class action over talc disclosures,https://www.foxbusiness.com/markets/judge-certifies-johnson-johnson-shareholder-class-action-talc-disclosures,2023-12-29 23:10:00,A federal judge said Johnson & Johnson shareholders may pursue as a class action their lawsuit accusing the company of fraudulently concealing how its talc products were contaminated by cancer-causing asbestos. U.S.,JNJ,0.226301,-0.050515,Neutral
Unpacking the Latest Options Trading Trends in Johnson & Johnson - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/12/36431124/unpacking-the-latest-options-trading-trends-in-johnson-johnson,2023-12-29 17:45:58,"Investors with a lot of money to spend have taken a bearish stance on Johnson & Johnson JNJ. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.",JNJ,0.568819,0.319038,Somewhat-Bullish
There Are Only 5 Dow Stocks I Wouldn't Buy in 2024,https://www.fool.com/investing/2023/12/29/there-are-only-5-dow-stocks-i-wouldnt-buy-in-2024/,2023-12-29 15:00:00,"There's a lot to like about Apple, Microsoft, and most of the Dow Jones Industrial Average components in 2024.",JNJ,0.144853,-0.064554,Neutral
3 Top Dividend Stocks I Can't Wait to Buy in 2024,https://www.fool.com/investing/2023/12/29/3-top-dividend-stocks-i-cant-wait-to-buy-in-2024/,2023-12-29 12:40:00,These companies will help me reach my income goals in 2024.,JNJ,0.057767,0.173998,Somewhat-Bullish
Is iShares Core High Dividend ETF  ( HDV )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2203479/is-ishares-core-high-dividend-etf-hdv-a-strong-etf-right-now,2023-12-29 11:20:07,Smart Beta ETF report for ...,JNJ,0.115787,0.066792,Neutral
Johnson & Johnson  ( JNJ )  Laps the Stock Market: Here's Why,https://www.zacks.com/stock/news/2203354/johnson-johnson-jnj-laps-the-stock-market-heres-why,2023-12-28 22:45:17,"In the most recent trading session, Johnson & Johnson (JNJ) closed at $156.58, indicating a +0.15% shift from the previous trading day.",JNJ,0.519002,0.179476,Somewhat-Bullish
"Contagious Opportunities: Norovirus Cases Are On The Rise, These Are The Stocks That May Be Impacted - Johnson & Johnson  ( NYSE:JNJ ) , Darden Restaurants  ( NYSE:DRI ) , Clorox  ( NYSE:CLX ) ",https://www.benzinga.com/general/health-care/23/12/36414917/contagious-opportunities-norovirus-cases-are-on-the-rise-these-are-the-stocks-that-may-be-imp,2023-12-28 19:42:06,"Cases of norovirus, sometimes called the ""winter vomiting disease,"" are on the rise in multiple states throughout the U.S. The virus causes stomach pain, vomiting and diarrhea and has been linked to outbreaks at restaurants such as the one at a sushi restaurant in North Carolina that infected ...",JNJ,0.499789,-0.210934,Somewhat-Bearish
"Investor Michael Farr is back with his top 10 stocks he's buying for 2024, and the tilt is defensive",https://www.cnbc.com/2023/12/28/investor-michael-farr-is-back-with-his-top-10-stocks-hes-buying-for-2024-and-the-tilt-is-defensive.html,2023-12-28 19:02:55,This year's list is a bit more defensive than in years past and has a focus on earnings growth.,JNJ,0.046724,0.034382,Neutral
"Pharmaceutical Giants Brace for Showdown as Medicare Drug Price Negotiations Are Poised For 2024 - AstraZeneca  ( NASDAQ:AZN ) , Bristol-Myers Squibb  ( NYSE:BMY ) ",https://www.benzinga.com/general/biotech/23/12/36410940/pharmaceutical-giants-brace-for-showdown-as-medicare-drug-price-negotiations-are-poised-for-2024,2023-12-28 14:21:24,"2024 will mark a pivotal moment for the healthcare industry, particularly in drug pricing negotiations. The forthcoming year will provide the first glimpse into how much Medicare can leverage its newfound power to negotiate down drug prices.",JNJ,0.239305,0.028897,Neutral
"Eli Lilly, Johnson & Johnson And Other Health Care Stocks From Wall Street's Most Accurate Analysts - Abbott Laboratories  ( NYSE:ABT ) , Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/news/23/12/36409451/eli-lilly-johnson-johnson-and-other-health-care-stocks-from-wall-streets-most-accurate-analysts,2023-12-28 12:33:13,"Wall Street analysts make new stock picks on a daily basis. Unfortunately for investors, not all analysts have particularly impressive track records at predicting market movements. Even when it comes to one single stock, analyst ratings and price targets can vary widely, leaving investors ...",JNJ,0.077845,0.17572,Somewhat-Bullish
Biden administration's Medicare drug price negotiations will face major tests in 2024,https://www.cnbc.com/2023/12/28/medicare-drug-price-negotiations-whats-ahead-in-2024.html,2023-12-28 12:00:01,"Next year could set the precedent for the Inflation Reduction Act's controversial talks, which could affect dozens of medications by the end of the decade.",JNJ,0.1172,-0.026135,Neutral
Warren Buffett Dumped These 2 Top Dividend Stocks. Should You Follow His Lead?,https://www.fool.com/investing/2023/12/28/warren-buffett-dumped-these-2-top-dividend-stocks/,2023-12-28 10:39:00,Buffett didn't say why he closed positions in two stocks with underlying businesses that are doing well at the moment.,JNJ,0.138464,0.17944,Somewhat-Bullish
THE SKIN OF COLOR SOCIETY  ( SOCS )  REPORTS A BANNER YEAR OF PROGRESS TOWARD GREATER DIVERSITY & INCLUSION IN DERMATOLOGY AND HEALTH EQUITY FOR PATIENTS OF COLOR,https://markets.businessinsider.com/news/stocks/the-skin-of-color-society-socs-reports-a-banner-year-of-progress-toward-greater-diversity-inclusion-in-dermatology-and-health-equity-for-patients-of-color-1032928334,2023-12-27 15:10:00,THE SKIN OF COLOR SOCIETY (SOCS) REPORTS A BANNER YEAR OF PROGRESS TOWARD GREATER DIVERSITY & INCLUSION IN DERMATOLOGY AND HEALTH EQUITY FOR PATIENTS OF COLOR ...,JNJ,0.078269,0.264914,Somewhat-Bullish
Avalo Therapeutics Announces 1-for-240 Reverse Stock Split,https://www.globenewswire.com/news-release/2023/12/27/2801310/0/en/Avalo-Therapeutics-Announces-1-for-240-Reverse-Stock-Split.html,2023-12-27 12:00:00,"WAYNE, Pa. and ROCKVILLE, Md., Dec. 27, 2023 ( GLOBE NEWSWIRE ) -- Avalo Therapeutics, Inc. ( Nasdaq: AVTX ) today announced a 1-for-240 reverse stock split of the Company's common stock, par value $0.001, which will be effective at 5:00 pm Eastern Time on December 28, 2023.",JNJ,0.039811,0.120526,Neutral
Is It Time to Buy the Dow Jones' 3 Worst Performing Stocks This Year?,https://www.fool.com/investing/2023/12/27/is-it-time-to-buy-the-dow-jones-3-worst-performing/,2023-12-27 11:12:00,"These stocks have significantly underperformed the market. But are they really ""cheap""?",JNJ,0.149656,0.058937,Neutral
3 No-Brainer Stocks to Buy With $200 Right Now,https://www.fool.com/investing/2023/12/27/3-no-brainer-stocks-to-buy-with-200-right-now/,2023-12-27 10:21:00,A reasonably modest amount of money can go a long way when it's invested in innovation-driven businesses.,JNJ,0.063258,0.28464,Somewhat-Bullish
"Bioplastics Packaging Market Projected to Hit US$ 8,913.1 Million by 2033 with a CAGR of 12.5% | Persistence Market Research",https://www.benzinga.com/pressreleases/24/01/g36632333/bioplastics-packaging-market-projected-to-hit-us-8-913-1-million-by-2033-with-a-cagr-of-12-5-persi,2024-01-15 18:30:00,"New York, Jan. 16, 2024 ( GLOBE NEWSWIRE ) -- In this section, we delve into a comprehensive analysis of the Bioplastics Packaging Market, offering insights into its current dynamics and future prospects.",JNJ,0.03545,0.265317,Somewhat-Bullish
Forget Meme Stocks and Bitcoin. These Investors Are Hunting Quality.,https://www.wsj.com/finance/stocks/forget-meme-stocks-and-bitcoin-these-investors-are-hunting-quality-1576454e,2024-01-15 10:30:00,"The targets are shares of companies with some combination of growth, reliable profits and strong balance sheets.",JNJ,0.535653,0.741737,Bullish
"Eye Health Products Market: Projected to Attain US$ 4.7 Billion by 2033, Propelled by a Resilient 7.3% CAGR | Persistence Market Research",https://www.benzinga.com/pressreleases/24/01/g36627196/eye-health-products-market-projected-to-attain-us-4-7-billion-by-2033-propelled-by-a-resilient-7-3,2024-01-15 08:10:00,"New York, Jan. 15, 2024 ( GLOBE NEWSWIRE ) -- Market Overview: The eye health products market is experiencing a surge in demand, fueled by a growing awareness of eye health, rising prevalence of eye diseases, and an aging global population.",JNJ,0.018482,0.233091,Somewhat-Bullish
Biotech and pharma companies are betting on a promising class of cancer drugs to drive growth,https://www.cnbc.com/2024/01/14/cancer-drugs-renewed-interest-in-adcs-will-continue-in-2024.html,2024-01-14 13:12:40,The JPMorgan Healthcare Conference was likely just the beginning of another year of heightened interest and investments in ADC cancer drugs.,JNJ,0.032691,-0.024714,Neutral
Virpax: A Promising Stock In A Sickly Biotech Market,https://www.forbes.com/sites/lawrencelight/2024/01/14/virpax-a-promising-stock-in-a-sickly-biotech-market/,2024-01-14 13:00:00,"Biotech always is a tough line of work, with a high failure rate because the research folks' ideas don't pan out, or even if they do, the Food and Drug Administration fails to approve their applications. Of the three FDA stages needed to greenlight a drug, the first has a mere 9% approval rate.",JNJ,0.061949,-0.145062,Neutral
3 Super-Safe High-Yield Dividend Stocks You Can Buy Right Now,https://www.fool.com/investing/2024/01/14/super-safe-high-yield-dividend-stocks-buy-now/,2024-01-14 10:50:00,You shouldn't lose any sleep worrying about these great dividends.,JNJ,0.127119,0.042741,Neutral
2 Former Warren Buffett Stocks That Stand Out as Stong Buys in 2024,https://www.fool.com/investing/2024/01/14/2-former-warren-buffett-stocks-that-stand-out-as-s/,2024-01-14 10:30:00,"Berkshire Hathaway exited its positions in these two blue chip dividend stocks last year, but they are still superb buys for certain types of investors.",JNJ,0.449219,0.134039,Neutral
2 Average Stocks That Could Make You Rich,https://www.fool.com/investing/2024/01/13/2-average-stocks-that-could-make-you-rich/,2024-01-13 14:10:00,You don't always have to pick a game-changing company to win in the stock market.,JNJ,0.100729,0.052034,Neutral
"STOCKHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger - RYZB, FGH, AMAM, CSTR",https://www.prnewswire.com/news-releases/stockholder-alert-the-ma-class-action-firm-continues-investigating-the-merger--ryzb-fgh-amam-cstr-302033994.html,2024-01-13 01:30:00,"NEW YORK, Jan. 12, 2024 /PRNewswire/ -- , founder and managing partner of the class action firm ( the ""M&A Class Action Firm"" ) , a national securities firm rated Top 50 in the 2018-2022 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, ...",JNJ,0.075635,0.137439,Neutral
"Gene Therapy Global Market is Projected to Grow at a CAGR of ~19% by 2028, Predicts DelveInsight",https://www.prnewswire.com/news-releases/gene-therapy-global-market-is-projected-to-grow-at-a-cagr-of-19-by-2028-predicts-delveinsight-302033381.html,2024-01-12 22:01:00,"LAS VEGAS, Jan. 12, 2024 /PRNewswire/ -- DelveInsight's Gene Therapy Market Insights report provides the current and forecast market analysis, individual leading gene therapy companies' market shares, challenges, gene therapy market drivers, barriers, trends, and key market gene therapy ...",JNJ,0.030369,0.096229,Neutral
Cytokinetics  ( CYTK )  Down on Report of Novartis Not Interested,https://www.zacks.com/stock/news/2209728/cytokinetics-cytk-down-on-report-of-novartis-not-interested,2024-01-12 19:47:00,Cytokinetics (CYTK) slumps after a report stating Novartis not interested in acquiring the company surface.,JNJ,0.075161,0.04437,Neutral
"Market Rebounds As Nvidia Leads; Bitcoin ETFs, Tesla Fall: Weekly Review",https://www.investors.com/news/stock-market-rally-rebounds-nvidia-tesla-jpmorgan-bitcoin-etfs-in-focus/,2024-01-12 19:13:00,"Market Rebounds As Nvidia Leads. Bitcoin ETFs, Tesla Fall: Weekly Review Investor's Business Daily ...",JNJ,0.045612,-0.022883,Neutral
Lung Cancer Surgery Market Projected to Reach USD 20.2 billion with Registering at a CAGR of 5.6% by 2031| Transparency Market Research Inc.,https://www.benzinga.com/pressreleases/24/01/g36613349/lung-cancer-surgery-market-projected-to-reach-usd-20-2-billion-with-registering-at-a-cagr-of-5-6-b,2024-01-12 16:19:47,"Wilmington, Delaware, United States, Jan. 12, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global lung cancer surgery market is estimated to flourish at a CAGR of 5.6% from 2023 to 2031.",JNJ,0.034233,0.0,Neutral
Johnson & Johnson  ( JNJ )  is Attracting Investor Attention: Here is What You Should Know,https://www.zacks.com/stock/news/2209423/johnson-johnson-jnj-is-attracting-investor-attention-here-is-what-you-should-know,2024-01-12 14:00:11,"Recently, Zacks.com users have been paying close attention to Johnson & Johnson (JNJ). This makes it worthwhile to examine what the stock has in store.",JNJ,0.473208,0.173211,Somewhat-Bullish
There's A Paradigm Shift In Immunology; And Big Pharma Is Paying Richly For It,https://www.investors.com/news/technology/biotech-stocks-forge-a-paradigm-shift-in-immunology-and-big-pharma-pays-handsomely-for-it/,2024-01-12 14:00:00,There's A Paradigm Shift In Immunology. And Big Pharma Is Paying Richly For It Investor's Business Daily ...,JNJ,0.047654,-0.155656,Somewhat-Bearish
Antibiotic Resistance Market Projected to Hit US$ 17.8 Billion by 2033 with a CAGR of 5.3% | Persistence Market Research,https://www.benzinga.com/pressreleases/24/01/g36606656/antibiotic-resistance-market-projected-to-hit-us-17-8-billion-by-2033-with-a-cagr-of-5-3-persisten,2024-01-12 09:08:35,"New York, Jan. 12, 2024 ( GLOBE NEWSWIRE ) -- The growing demand for new antibiotic therapies to combat antibiotic resistance is a prominent driver in the global market. In a July 2023 Science Daily article, the World Health Organization ( WHO ) recognized antibiotic-resistant bacteria as a major ...",JNJ,0.018187,-0.131837,Neutral
"The Zacks Analyst Blog Highlights Johnson & Johnson, Micron Technology, The Southern Company, TotalEnergies and PACCAR",https://www.zacks.com/stock/news/2208844/the-zacks-analyst-blog-highlights-johnson-johnson-micron-technology-the-southern-company-totalenergies-and-paccar,2024-01-11 14:22:00,"Johnson & Johnson, Micron Technology, The Southern Company, TotalEnergies and PACCAR are part of the Zacks top Analyst Blog.",JNJ,0.278222,0.188508,Somewhat-Bullish
Walgreens Cut Its Dividend by 48%: Here Are 5 Better Dow Dividend Stocks to Buy in January,https://www.fool.com/investing/2024/01/11/walgreens-cuts-dividend-better-dow-stocks-buy-now/,2024-01-11 11:08:00,Businesses with efficient operations and growth potential open the door to dividend raises for years to come.,JNJ,0.180595,0.107463,Neutral
"Baby Wipes Market Is Estimated to Translate to a Revenue of US$ 9.9 Billion by 2032, According to Persistence Market Research",https://www.benzinga.com/pressreleases/24/01/g36589950/baby-wipes-market-is-estimated-to-translate-to-a-revenue-of-us-9-9-billion-by-2032-according-to-pe,2024-01-11 11:00:00,"New York, Jan. 11, 2024 ( GLOBE NEWSWIRE ) -- The Wriggling World of Baby Wipes: A Market Deep Dive Baby wipes are moistened, disposable cloths used for cleaning infants during diaper changes and for general hygiene purposes. They are typically formulated to be gentle on a baby's delicate ...",JNJ,0.040484,0.244139,Somewhat-Bullish
Why Eli Lilly Stock Skyrocketed 59% in 2023,https://www.fool.com/investing/2024/01/11/why-eli-lilly-stock-skyrocketed-59-in-2023/,2024-01-11 10:49:00,Lilly's pipeline success in 2023 allowed it to to claim the crown as the biggest drugmaker on the planet by market cap.,JNJ,0.078611,0.155496,Somewhat-Bullish
2 Dow Stocks to Buy Hand Over Fist in 2024 and 1 to Avoid Like the Plague,https://www.fool.com/investing/2024/01/11/2-dow-stocks-to-buy-2024-and-1-avoid-like-plague/,2024-01-11 10:21:00,"Among the Dow Jones Industrial Average's 30 time-tested components, there are two that are historically cheap and ripe for the picking, while another outperformer is riddled with issues.",JNJ,0.201884,0.130795,Neutral
"Traditional Wound Dressings Market Regain Ground in Evolving Healthcare Landscape: Market Projected to Reach US$ 6.93 Billion by 2032, Report by Persistence Market Research",https://www.benzinga.com/pressreleases/24/01/g36588271/traditional-wound-dressings-market-regain-ground-in-evolving-healthcare-landscape-market-projected,2024-01-11 05:30:00,"New York, Jan. 11, 2024 ( GLOBE NEWSWIRE ) -- Market Overview: The global traditional wound dressing market recorded a valuation of US$ 5.1 Billion in 2022 and is expected to reach US$ 6.93 billion by the end of 2032, expanding at a CAGR of 3.2% from 2022 to 2032.",JNJ,0.012651,-0.007008,Neutral
"Top Analyst Reports for Johnson & Johnson, Micron Technology & Southern Company",https://www.zacks.com/research-daily/2208227/top-analyst-reports-for-johnson-johnson-micron-technology-southern-company,2024-01-10 22:16:00,"Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), Micron Technology, Inc. (MU) and The Southern Company (SO).",JNJ,0.098255,0.266129,Somewhat-Bullish
Mastercard crosses $400 billion market-cap level in a sign of spending resilience,https://www.marketwatch.com/story/mastercard-crosses-400-billion-market-cap-level-in-a-sign-of-spending-resilience-59fe2392,2024-01-10 21:46:00,Mastercard vaulted into $400 billion territory for the first time Wednesday in a testament to confidence about consumer spending.,JNJ,0.271274,0.094822,Neutral
"In An Age Of 'Cancel Culture,' Some Voices Persist-On Smaller Platforms",https://www.forbes.com/sites/cmo/2024/01/10/in-an-age-of-cancel-culture-some-voices-persist-on-smaller-platforms/,2024-01-10 19:15:47,"This is the published version of Forbes' CMO newsletter, which offers the latest news for chief marketing officers and other messaging-focused leaders. Click here to get it delivered to your inbox every Wednesday.",JNJ,0.059835,0.049758,Neutral
A Closer Look at Johnson & Johnson's Options Market Dynamics - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/24/01/36579369/a-closer-look-at-johnson-johnsons-options-market-dynamics,2024-01-10 16:17:01,"Deep-pocketed investors have adopted a bearish approach towards Johnson & Johnson JNJ, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.",JNJ,0.629492,0.35671,Bullish
Will Q4 Earnings Push Dow ETF Higher?,https://www.zacks.com/stock/news/2208372/will-q4-earnings-push-dow-etf-higher,2024-01-10 16:10:00,Let's delve deeper into the probable fourth-quarter earnings picture that will likely aid Dow ETF in the coming days.,JNJ,0.131164,0.017822,Neutral
"Mens Grooming Products Market Projected to Reach $139,588.4 Million Globally by 2033, with a CAGR of 7.5%, According to Persistence Market Research",https://www.benzinga.com/pressreleases/24/01/g36575377/mens-grooming-products-market-projected-to-reach-139-588-4-million-globally-by-2033-with-a-cagr-of,2024-01-10 13:34:33,"New York, Jan. 10, 2024 ( GLOBE NEWSWIRE ) -- Snapshot of the Men's Grooming Products Market: In 2022, the men's grooming products market raked in a revenue of $63,140.3 million, as reported by Persistence Market Research. The demand for these products is set to rise, with key players ...",JNJ,0.027603,-0.309225,Somewhat-Bearish
Wall Street Doesn't Expect Eli Lilly Stock to Move Much Higher in 2024. Here's Why Analysts Could Be Wrong.,https://www.fool.com/investing/2024/01/10/wall-street-doesnt-expect-eli-lilly-stock-to-move/,2024-01-10 10:51:00,Lilly's sizzle might not fizzle in the new year.,JNJ,0.062434,0.020019,Neutral
Is Johnson & Johnson Stock a Buy Now?,https://www.fool.com/investing/2024/01/10/is-johnson-johnson-stock-a-buy-now/,2024-01-10 10:25:00,The pharmaceutical giant recently announced another acquisition.,JNJ,0.509589,0.197609,Somewhat-Bullish
"Bone Wax Market to Reach USD 107.8 billion by 2031, Rising at a CAGR of 3.3% | Transparency Market Research, Inc.",https://www.benzinga.com/pressreleases/24/01/g36571219/bone-wax-market-to-reach-usd-107-8-billion-by-2031-rising-at-a-cagr-of-3-3-transparency-market-res,2024-01-10 07:56:18,"Wilmington, Delaware, United States, Jan. 10, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global bone wax market is estimated to rise at a CAGR of 3.3% from 2023 to 2031. Transparency Market Research projects that the overall sales revenue for bone wax is estimated to reach ...",JNJ,0.06471,-0.016098,Neutral
Johnson & Johnson  ( JNJ )  Ascends While Market Falls: Some Facts to Note,https://www.zacks.com/stock/news/2207775/johnson-johnson-jnj-ascends-while-market-falls-some-facts-to-note,2024-01-09 22:45:20,"The latest trading day saw Johnson & Johnson (JNJ) settling at $161.63, representing a +0.06% change from its previous close.",JNJ,0.601928,0.258805,Somewhat-Bullish
"SHAREHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger - AMAM, CSTR, PGTI, WAVD",https://www.benzinga.com/pressreleases/24/01/g36567500/shareholder-alert-the-m-a-class-action-firm-continues-investigating-the-merger-amam-cstr-pgti-wavd,2024-01-09 22:27:50,"NEW YORK, Jan. 09, 2024 ( GLOBE NEWSWIRE ) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC ( the ""M&A Class Action Firm"" ) , a national securities firm rated Top 50 in the 2018-2022 ISS Securities Class Action Services Report and ...",JNJ,0.068698,0.127207,Neutral
Ambrx  ( AMAM )  Skyrockets 102% on $2B Buyout Offer From J&J,https://www.zacks.com/stock/news/2207649/ambrx-amam-skyrockets-102-on-2b-buyout-offer-from-jj,2024-01-09 18:04:00,J&J (JNJ) is set to acquire Ambrx Biopharma (AMAM) in an all-cash transaction for $2.0 billion. The transaction will likely close in first-half 2024.,JNJ,0.118647,0.213928,Somewhat-Bullish
"Breast Biopsy Market Set to Achieve US$ 3.8 Billion in Revenue by 2033, Report by Persistence Market Research",https://www.benzinga.com/pressreleases/24/01/g36561357/breast-biopsy-market-set-to-achieve-us-3-8-billion-in-revenue-by-2033-report-by-persistence-market,2024-01-09 17:10:00,"New York, Jan. 09, 2024 ( GLOBE NEWSWIRE ) -- Breast biopsy is a medical procedure involving the removal of a sample of breast tissue for diagnostic examination. It is a crucial step in the early detection and diagnosis of breast cancer, enabling healthcare professionals to determine the presence ...",JNJ,0.020491,0.069883,Neutral
Illumina Shares Trading Higher After Confirming Partnership With Johnson & Johnson Unit - Illumina  ( NASDAQ:ILMN ) ,https://www.benzinga.com/news/earnings/24/01/36559887/illumina-shares-trading-higher-after-confirming-partnership-with-johnson-johnson-unit,2024-01-09 16:50:59,"Illumina, Inc. ILMN shares are trading higher after announcing preliminary financial results for the fourth quarter ( Q4 ) and fiscal year 2023. For Q4, the company reported preliminary consolidated revenue of approximately $1.115 billion, up 3% from Q4 2022. The analyst consensus stands at ...",JNJ,0.366061,0.365218,Bullish
Biotech ETFs Stage Solid Comeback at the Start of 2024,https://www.zacks.com/stock/news/2207551/biotech-etfs-stage-solid-comeback-at-the-start-of-2024,2024-01-09 16:05:00,"The biotech space staged a strong comeback at the start of 2024, driven by multi-billion dollar deals, upbeat clinical results and cutting-edge medical advances like CRISPR gene-editing hitting prime-time.",JNJ,0.089129,0.084886,Neutral
"Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030 - Ambrx Biopharma  ( NASDAQ:AMAM ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/pressreleases/24/01/g36558906/global-oncology-cancer-drugs-market-revenue-projected-to-surpass-289-billion-by-2030,2024-01-09 15:25:00,"PALM BEACH, Fla., Jan. 09, 2024 ( GLOBE NEWSWIRE ) -- FN Media Group News Commentary - According to the report titled ""Aging in the United States,"" published by the Population Reference Bureau, ""the number of Americans aged 65 and older is projected to increase more than double over 95 million ...",JNJ,0.058377,0.166162,Somewhat-Bullish
Dr. Rama Kondru Named Chief Executive Officer of Veridix AI - PR Newswire,https://www.prnewswire.com/news-releases/dr-rama-kondru-named-chief-executive-officer-of-veridix-ai-302029873.html,2024-01-09 14:00:00,Dr. Rama Kondru Named Chief Executive Officer of Veridix AI PR ...,JNJ,0.059488,0.046009,Neutral
"NeuroTrauma Sciences Appoints William Fricker, CPA, MBA, as Chief Financial Officer",https://www.prnewswire.com/news-releases/neurotrauma-sciences-appoints-william-fricker-cpa-mba-as-chief-financial-officer-302029049.html,2024-01-09 13:30:00,David Lawrence Departs as CFO; Appointed to Board of Directors,JNJ,0.082677,0.026635,Neutral
Daily: One Of Nike's Most Famous Partnerships Comes To An End,https://www.forbes.com/sites/forbesdaily/2024/01/09/forbes-daily-one-of-nikes-most-famous-partnerships-comes-to-an-end/,2024-01-09 13:09:22,Forbes Daily: Nike and Tiger Woods End Endorsement Deal After 27 Years Forbes ...,JNJ,0.023838,-0.232573,Somewhat-Bearish
Want to Win in the Stock Market? Be Average.,https://www.fool.com/investing/2024/01/09/want-to-win-in-the-stock-market-be-average/,2024-01-09 10:30:00,Start with companies that have proven themselves.,JNJ,0.122269,0.187826,Somewhat-Bullish
This Dividend Stock Has a $13 Billion Secret Weapon,https://www.fool.com/investing/2024/01/09/this-dividend-stock-has-a-13-billion-secret-weapon/,2024-01-09 10:00:00,Johnson & Johnson made a key decision last year.,JNJ,0.119532,0.320641,Somewhat-Bullish
Johnson & Johnson  ( NYSE:JNJ )  Upgraded at StockNews.com,https://www.defenseworld.net/2024/01/09/johnson-johnson-nysejnj-upgraded-at-stocknews-com.html,2024-01-09 06:14:46,"Johnson & Johnson ( NYSE:JNJ - Get Free Report ) was upgraded by stock analysts at StockNews.com from a ""buy"" rating to a ""strong-buy"" rating in a research note issued on Tuesday. Other equities research analysts also recently issued research reports about the stock.",JNJ,0.851762,0.430073,Bullish
"SHAREHOLDER RIGHTS INVESTIGATION: Halper Sadeh LLC Investigates HARP, AMAM, AXNX, EAR - Ambrx Biopharma  ( NASDAQ:AMAM ) , Axonics  ( NASDAQ:AXNX ) ",https://www.benzinga.com/pressreleases/24/01/g36548462/shareholder-rights-investigation-halper-sadeh-llc-investigates-harp-amam-axnx-ear,2024-01-09 01:21:35,"NEW YORK, Jan. 08, 2024 ( GLOBE NEWSWIRE ) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Harpoon Therapeutics, Inc.",JNJ,0.141726,0.095681,Neutral
"BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc.  ( Nasdaq - AMAM ) , Gracell Biotechnologies Inc.  ( Nasdaq - GRCL ) , Axonics, Inc.  ( Nasdaq - AXNX ) , Harpoon Therapeutics, Inc.  ( Nasdaq - HARP ) ",https://www.benzinga.com/pressreleases/24/01/g36547175/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-ambrx-biophar,2024-01-08 22:31:37,"BALA CYNWYD, Pa., Jan. 08, 2024 ( GLOBE NEWSWIRE ) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ( jbrodsky@brodskysmith.com ) or Marc Ackerman ( mackerman@brodskysmith.com ) at 855-576-4847.",JNJ,0.15697,0.156505,Somewhat-Bullish
Tech sector powers stock market higher with the Nasdaq jumping 2%,https://markets.businessinsider.com/news/stocks/stock-market-news-today-tech-sector-nasdaq-surge-ces-conference-2024-1,2024-01-08 21:05:00,Stock Market News Today: Tech Sector Powers Markets Higher With 2% Gain - Markets Insider ...,JNJ,0.100308,0.057295,Neutral
ALLENTOWN ANNOUNCES STRATEGIC ACQUISITION OF CLORDISYS - PR Newswire,https://www.prnewswire.com/news-releases/allentown-announces-strategic-acquisition-of-clordisys-302028906.html,2024-01-08 20:04:00,ALLENTOWN ANNOUNCES STRATEGIC ACQUISITION OF CLORDISYS PR ...,JNJ,0.041181,0.125941,Neutral
"Dow Surges Over 100 Points; Commercial Metals Posts Upbeat Q1 Results - Ambrx Biopharma  ( NASDAQ:AMAM ) , Commercial Metals  ( NYSE:CMC ) ",https://www.benzinga.com/news/earnings/24/01/36542311/dow-surges-over-100-points-commercial-metals-posts-upbeat-q1-results,2024-01-08 19:33:00,"U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 100 points on Monday. The Dow traded up 0.35% to 37,596.43 while the NASDAQ rose 1.89% to 14,799.21. The S&P 500 also rose, gaining, 1.11% to 4,749.41. Information technology shares jumped by 2.1% on ...",JNJ,0.073321,0.209122,Somewhat-Bullish
How To Buy Hot And Promising - But Uncertain - Biotech Stocks,https://www.investors.com/research/how-to-find-the-best-stocks-to-buy/xbi-etf-how-to-buy-hot-and-promising-but-uncertain-biotech-stocks/,2024-01-08 17:34:00,"A mix of choppy or nonexistent earnings alongside the promise of game-changing breakthroughs make biotech stocks a challenge for investors. The SPDR S&P Biotech ETF ( XBI ) , now on the IBD Leaderboard watchlist, offers an alternative to betting on a single biotech name.",JNJ,0.166169,0.200529,Somewhat-Bullish
"Crude Oil Falls Sharply; Ambrx Biopharma Shares Spike Higher - Ambrx Biopharma  ( NASDAQ:AMAM ) , Commercial Metals  ( NYSE:CMC ) ",https://www.benzinga.com/news/earnings/24/01/36539499/crude-oil-falls-sharply-ambrx-biopharma-shares-spike-higher,2024-01-08 17:22:01,"U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining more than 1% on Monday. The Dow traded down 0.19% to 37,396.28 while the NASDAQ rose 1.20% to 14,698.88. The S&P 500 also rose, gaining, 0.55% to 4,722.93. Information technology shares jumped by 2% on Monday.",JNJ,0.076358,0.209987,Somewhat-Bullish
Predicine Announces Collaboration with Janssen to Develop PredicineCAREâ„¢ as a Companion Diagnostic Assay in Localized Bladder Cancer,https://www.benzinga.com/pressreleases/24/01/g36538805/predicine-announces-collaboration-with-janssen-to-develop-predicinecare-as-a-companion-diagnostic-,2024-01-08 17:01:13,"HAYWARD, Calif., Jan. 08, 2024 ( GLOBE NEWSWIRE ) -- Predicine, Inc., a leading molecular insights company, today announced a collaboration with Janssen Pharmaceutica NV ( Janssen ) , a Johnson & Johnson company.",JNJ,0.095899,0.073478,Neutral
J&J's Tentative $700M Agreement To Resolve Talc Powder-Related Lawsuits Across US States - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/news/large-cap/24/01/36537800/j-js-tentative-700m-agreement-to-resolve-talc-powder-related-lawsuits-across-us-states,2024-01-08 16:19:50,Healthcare giant Johnson & Johnson JNJ has reached a tentative agreement to pay approximately $700 million to settle an investigation involving over 40 US states. The settlement seeks to resolve claims that J&J failed to disclose connections between its talc powder and various cancers.,JNJ,0.375251,0.211091,Somewhat-Bullish
"Johnson & Johnson Will Pay $700 Million To Resolve Baby Powder Marketing Probe, Report Says",https://www.forbes.com/sites/tylerroush/2024/01/08/johnson--johnson-will-pay-700-million-to-resolve-baby-powder-marketing-probe-report-says/,2024-01-08 16:02:56,"Johnson & Johnson will pay an estimated $700 million to resolve an investigation by more than 40 states into the pharmaceutical firm's marketing of its talcum powder, according to Bloomberg, following thousands of lawsuits alleging it failed to warn customers about cancer risks.",JNJ,0.769861,-0.286231,Somewhat-Bearish
"Today Is Cancer-Focused Deals Day: Johnson & Johnson Scoops Up Ambrx Biopharma As Merck Boosts Cancer Portfolio With Harpoon Deal - Ambrx Biopharma  ( NASDAQ:AMAM ) , Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/general/biotech/24/01/36535176/today-is-cancer-focused-deals-day-johnson-johnson-scoops-up-ambrx-biopharma-as-merck-boosts-cance,2024-01-08 15:18:52,"Monday, Johnson & Johnson JNJ has agreed to acquire Ambrx Biopharma Inc AMAM in an all-cash merger transaction for a total equity value of approximately $2.0 billion, or $1.9 billion net of estimated cash acquired. Johnson & Johnson will acquire Ambrx for $28.00/share.",JNJ,0.465901,0.368504,Bullish
"Health Care Company Johnson & Johnson Announces Merger With Ambrx Biopharma - Ambrx Biopharma  ( NASDAQ:AMAM ) , Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/m-a/24/01/36535899/health-care-company-johnson-johnson-announces-merger-with-ambrx-biopharma,2024-01-08 15:10:10,"Johnson & Johnson JNJ has announced a merger with Ambrx Biopharma AMAM that is expected to be completed 2024-H1. Under the terms of the agreement, Johnson & Johnson has agreed to give Ambrx Biopharma $2.00 billion in cash in exchange for AMAM stock.",JNJ,0.524949,0.263951,Somewhat-Bullish
"US Stocks Mixed; Nasdaq Jumps Over 100 Points - Ambrx Biopharma  ( NASDAQ:AMAM ) , Commercial Metals  ( NYSE:CMC ) ",https://www.benzinga.com/news/earnings/24/01/36535602/us-stocks-mixed-nasdaq-jumps-over-100-points,2024-01-08 15:00:54,"U.S. stocks traded mixed this morning, with the Nasdaq Composite gaining around 100 points on Monday. Following the market opening Monday, the Dow traded down 0.45% to 37,296.85 while the NASDAQ rose 0.75% to 14,632.70. The S&P 500 also rose, gaining, 0.26% to 4,709.31.",JNJ,0.075635,0.209768,Somewhat-Bullish
"AAMI and FDA Co-Sponsor Medtech Conference, 'AAMI and FDA neXus'",https://www.benzinga.com/pressreleases/24/01/g36535042/aami-and-fda-co-sponsor-medtech-conference-aami-and-fda-nexus,2024-01-08 14:37:00,"Arlington, VA, Jan. 08, 2024 ( GLOBE NEWSWIRE ) -- The Association for the Advancement of Medical Instrumentation ( AAMI ) is delighted to welcome the U.S. Food and Drug Administration as an official co-sponsor of its upcoming medical device standards conference, AAMI and FDA neXus 2024.",JNJ,0.075397,0.0,Neutral
Two Biotechs Roughly Double After Snagging Splashy Takeover Deals,https://www.investors.com/news/technology/amam-stock-harp-stock-catapult-after-snagging-jnj-merck-buyouts/,2024-01-08 14:19:00,"AMAM Stock, HARP Stock Catapult After Snagging J&J, Merck Buyouts Investor's Business Daily ...",JNJ,0.227007,0.160288,Somewhat-Bullish
J&J to acquire cancer drug developer Ambrx Biopharma for $2 billion,https://www.cnbc.com/2024/01/08/jj-to-acquire-ambrx-biopharma-a-cancer-drug-developer.html,2024-01-08 14:09:31,"The deal, which was announced on the first day of the annual JPMorgan Healthcare Conference, makes J&J the latest drugmaker to bet on ADCs.",JNJ,0.154455,-0.076968,Neutral
Health In Her HUE Announces $3 Million In Funding,https://www.prnewswire.com/news-releases/health-in-her-hue-announces-3-million-in-funding-302028034.html,2024-01-08 14:00:00,Health tech startup connects Black women and women of color with culturally sensitive and responsive healthcare providers and content.,JNJ,0.111747,0.152291,Somewhat-Bullish
Johnson & Johnson to Acquire Cancer-Treatment Developer Ambrx for $2 Billion,https://www.wsj.com/health/pharma/johnson-johnson-to-acquire-cancer-treatment-developer-amrbx-for-2b-f7fbafea,2024-01-08 13:08:00,Johnson & Johnson will acquire cancer-treatment developer Ambrx Biopharma in a $2 billion cash deal.,JNJ,0.716023,0.562146,Bullish
Ambrx Announces Sale to Johnson & Johnson,https://www.globenewswire.com/news-release/2024/01/08/2805344/0/en/Ambrx-Announces-Sale-to-Johnson-Johnson.html,2024-01-08 12:35:00,"SAN DIEGO, Jan. 08, 2024 ( GLOBE NEWSWIRE ) -- Ambrx Biopharma, Inc., or Ambrx ( NASDAQ: AMAM ) , today announced that it has entered into a definitive agreement pursuant to which Johnson & Johnson will acquire all of the outstanding shares of Ambrx for $28.00 per share in cash, representing an ...",JNJ,0.187827,0.16424,Somewhat-Bullish
Ambrx Announces Sale to Johnson & Johnson - Ambrx Biopharma  ( NASDAQ:AMAM ) ,https://www.benzinga.com/pressreleases/24/01/g36531191/ambrx-announces-sale-to-johnson-johnson,2024-01-08 12:35:00,"SAN DIEGO, Jan. 08, 2024 ( GLOBE NEWSWIRE ) -- Ambrx Biopharma, Inc., or Ambrx AMAM, today announced that it has entered into a definitive agreement pursuant to which Johnson & Johnson will acquire all of the outstanding shares of Ambrx for $28.00 per share in cash, representing an approximately ...",JNJ,0.184422,0.159037,Somewhat-Bullish
"Human Microbiome Therapeutics Market size to grow by USD 732.95 million from 2022 to 2027, North America to ... - PR Newswire",https://www.prnewswire.com/news-releases/human-microbiome-therapeutics-market-size-to-grow-by-usd-732-95-million-from-2022-to-2027--north-america-to-account-for-41-of-market-growth---technavio-302027860.html,2024-01-08 09:15:00,"Human Microbiome Therapeutics Market size to grow by USD 732.95 million from 2022 to 2027, North America to ... PR ...",JNJ,0.050679,0.0,Neutral
Dogs Of The Dow 2024: 10 Blue-Chip Dividend Payers,https://www.forbes.com/sites/brettowens/2024/01/07/dogs-of-the-dow-2024-10-blue-chip-dividend-payers/,2024-01-07 12:15:00,"The 2024 Dogs of the Dow are particularly homely hounds-which means we're talking big dividends. This year's Dogs yield more than three-times the broader market's paltry payout. So, should we hold our noses and buy? Let's grab some peanut butter treats and investigate.",JNJ,0.115509,0.087575,Neutral
5 Top Investing Resolutions for 2024,https://www.fool.com/investing/2024/01/07/5-top-investing-resolutions-for-2024/,2024-01-07 10:00:00,You don't need a fortune to start investing today.,JNJ,0.09186,0.096983,Neutral
"Kuehn Law Encourages CPE, ROVR, AMAM, and JNPR Investors to Contact Law Firm - Ambrx Biopharma  ( NASDAQ:AMAM ) , Callon Petroleum  ( NYSE:CPE ) ",https://www.benzinga.com/pressreleases/24/01/g36789166/kuehn-law-encourages-cpe-rovr-amam-and-jnpr-investors-to-contact-law-firm,2024-01-25 20:23:04,"NEW YORK, Jan. 25, 2024 ( GLOBE NEWSWIRE ) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek additional disclosures or other relief on behalf of the shareholders of these companies.",JNJ,0.10607,0.336739,Somewhat-Bullish
"SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates AMAM, HARP, JNPR, TARO - Ambrx Biopharma  ( NASDAQ:AMAM ) , Harpoon Therapeutics  ( NASDAQ:HARP ) ",https://www.benzinga.com/pressreleases/24/01/g36778188/shareholder-notice-halper-sadeh-llc-investigates-amam-harp-jnpr-taro,2024-01-25 13:03:47,"NEW YORK, Jan. 25, 2024 ( GLOBE NEWSWIRE ) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Ambrx Biopharma, Inc.",JNJ,0.140896,0.095371,Neutral
Better Dividend Stock to Buy Now: Johnson & Johnson vs. Verizon,https://www.fool.com/investing/2024/01/25/better-dividend-stock-to-buy-now-johnson-johnson-v/,2024-01-25 12:19:00,Both recently reported results from the fourth quarter of 2023 and their performances could hardly look more different.,JNJ,0.203643,0.175527,Somewhat-Bullish
UAW endorses Joe Biden; Ohio bans gender-affirming care for minors,https://www.economist.com/in-brief/2024/01/25/uaw-endorses-joe-biden-ohio-bans-gender-affirming-care-for-minors,2024-01-25 05:54:05,UAW endorses Joe Biden. Ohio bans gender-affirming care for minors The Economist ...,JNJ,0.068112,-0.055308,Neutral
UAW endorses Joe Biden; Ohio bans gender-affirming care for minors,https://www.economist.com/news/2024/01/25/uaw-endorses-joe-biden-ohio-bans-gender-affirming-care-for-minors,2024-01-25 05:54:05,UAW endorses Joe Biden. Ohio bans gender-affirming care for minors The Economist ...,JNJ,0.067536,-0.055246,Neutral
UAW endorses Joe Biden; Trump on the attack,https://www.economist.com/in-brief/2024/01/25/uaw-endorses-joe-biden-trump-on-the-attack,2024-01-25 05:54:05,UAW endorses Joe Biden. Ohio bans gender-affirming care for minors The Economist ...,JNJ,0.06623,-0.055112,Neutral
"STOCKHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger - AMAM, CSTR, RYZB, THRX",https://www.benzinga.com/pressreleases/24/01/g36769662/stockholder-alert-the-m-a-class-action-firm-continues-investigating-the-merger-amam-cstr-ryzb-thrx,2024-01-24 22:16:58,"NEW YORK, Jan. 24, 2024 ( GLOBE NEWSWIRE ) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC ( the ""M&A Class Action Firm"" ) , a national securities firm rated Top 50 in the 2018-2022 ISS Securities Class Action Services Report and ...",JNJ,0.068502,0.127176,Neutral
Washington state reaches a nearly $150 million settlement with Johnson & Johnson over opioid crisis,https://apnews.com/article/washington-opioids-johnson-johnson-settlement-58038e4877ca7b9bf458c54e110b12d8,2024-01-24 21:00:00,"OLYMPIA, Wash. ( AP ) - The Washington state attorney general announced a $149.5 million settlement Wednesday with drugmaker Johnson & Johnson, more than four years after the state sued the company over its role fueling the opioid addiction crisis. ""They knew what the harm was.",JNJ,0.188193,-0.023132,Neutral
"Gilead's Tecartus Dropped From FDA List Of CAR-T Therapy With Updated Label Warning Of ""Risks Of Secondary Cancer' - Gilead Sciences  ( NASDAQ:GILD ) ",https://www.benzinga.com/general/biotech/24/01/36760938/gileads-tecartus-dropped-from-fda-list-of-car-t-therapy-with-updated-label-warning-of-risks-of-se,2024-01-24 15:36:09,"Tuesday, the FDA announced to impose a classwide black box warning following its investigation into secondary T-cell cancers arising from the use of existing CAR-T therapies.",JNJ,0.240489,0.0,Neutral
"Stock Market News for Jan 24, 2024",https://www.zacks.com/stock/news/2214906/stock-market-news-for-jan-24-2024,2024-01-24 14:21:00,Wall Street closed mixed on Tuesday on strong to mixed quarterly earnings.,JNJ,0.188928,0.069195,Neutral
What's Going On Johnson & Johnson Stock Today? - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/general/biotech/24/01/36755938/whats-going-on-johnson-johnson-stock-today,2024-01-24 12:54:16,"Tuesday, Johnson & Johnson JNJ released better-than-expected earnings for its fourth quarter of 2023. It reported quarterly adjusted earnings of $2.29 per share, up 11.7% year-over-year, beating the consensus of $2.28. Sales increased 7.3% Y/Y to $21.4 billion, beating the consensus of $20.99 ...",JNJ,0.671304,-0.079756,Neutral
"Nasdaq, S&P 500 Futures Jump As Wall Street Eagerly Awaits Tesla's Q4 Earnings: Analyst Says Rally Broadening But Favors These Stocks - Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , SPDR S&P 500  ( ARCA:SPY ) ",https://www.benzinga.com/news/earnings/24/01/36755805/nasdaq-s-p-500-futures-jump-as-wall-street-eagerly-awaits-teslas-q4-earnings-analyst-says-rally-bro,2024-01-24 12:41:45,"U.S. stock futures indicate a positive opening on Wednesday, buoyed by strong earnings reports from Netflix, Inc. NFLX and semiconductor equipment maker ASML Holding N.V. ASML. Investors are eagerly awaiting Tesla, Inc.'s TSLA fourth-quarter results, which are expected to take center stage.",JNJ,0.115787,-0.100818,Neutral
"Investor Optimism Improves Following Earnings Reports; S&P 500 Reaches Another High - Abbott Laboratories  ( NYSE:ABT ) , IBM  ( NYSE:IBM ) ",https://www.benzinga.com/news/earnings/24/01/36752497/investor-optimism-improves-following-earnings-reports-s-p-500-reaches-another-high,2024-01-24 08:49:59,"The CNN Money Fear and Greed index showed a further increase in overall market sentiment, while the index remained in the ""Greed"" zone on Tuesday. U.S. stocks closed mixed on Tuesday, with the Dow Jones index snapping a three-day winning streak. However, the S&P 500 hit a new all-time closing ...",JNJ,0.231332,0.525561,Bullish
"Virtualware Reports  ( MLVIR.PA )  Record â‚¬4.52 Million Revenue in 2023, a 40% Surge from Previous Year",https://www.globenewswire.com/news-release/2024/01/24/2814776/0/en/Virtualware-Reports-MLVIR-PA-Record-4-52-Million-Revenue-in-2023-a-40-Surge-from-Previous-Year.html,2024-01-24 07:10:00,"Bilbao, January 24 - European Virtual Reality company Virtualware ( MLVIR.PA ) ( EPA:MLVIR ) , reported record total revenues of â‚¬4.52 million in 2023, 40% more than in the previous year, just nine months after its IPO on Euronext Access Paris.",JNJ,0.039033,0.074235,Neutral
S&P 500 notches third straight record high close,https://www.moneycontrol.com/news/business/markets/sp-500-notches-third-straight-record-high-close-12112521.html,2024-01-24 00:52:18,"It was the third straight all-time high for the benchmark stock index, and many investors view upcoming quarterly reports from the heavily weighted ""Magnificent 7"" group of megacap companies as key to whether Wall Street's recent rally continues or loses steam.",JNJ,0.072,0.0,Neutral
"Implantable Drug Delivery Devices Global Market to Exhibit Growth at a Considerable CAGR of ~6% by 2028, Assesses DelveInsight",https://www.prnewswire.com/news-releases/implantable-drug-delivery-devices-global-market-to-exhibit-growth-at-a-considerable-cagr-of-6-by-2028-assesses-delveinsight-302041477.html,2024-01-23 22:31:00,Implantable Drug Delivery Devices Global Market to Exhibit Growth at a Considerable CAGR of ~6% by 2028 ... PR ...,JNJ,0.054175,0.028936,Neutral
3 Stocks to Consider After Beating Earnings Estimates,https://www.zacks.com/commentary/2214526/3-stocks-to-consider-after-beating-earnings-estimates,2024-01-23 20:15:00,"Q4 earnings results are rolling in, and these stocks showed strong performance ...",JNJ,0.199859,0.247982,Somewhat-Bullish
Johnson & Johnson  ( JNJ )  Q4 2023 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2024/01/23/johnson-johnson-jnj-q4-2023-earnings-call-transcri/,2024-01-23 19:30:16,"JNJ earnings call for the period ending December 31, 2023.",JNJ,0.055503,0.102029,Neutral
"US Stocks Pause As Treasury Yields, Dollar Surge On Trimmed Fed Rate Cut Bets: What's Driving Markets Tuesday? - Alibaba Gr Holding  ( NYSE:BABA ) ",https://www.benzinga.com/markets/cryptocurrency/24/01/36744784/us-stocks-pause-as-treasury-yields-dollar-surge-on-trimmed-fed-rate-cut-bets-whats-driving,2024-01-23 19:07:43,"Wall Street took a breather on Tuesday, with the major U.S. stock indices trading near the flatline or showing slight declines during midday trading in New York as investors closely await a series of relevant earnings reports and crucial economic data slated for the remainder of the week.",JNJ,0.151064,-0.239315,Somewhat-Bearish
"Johnson & Johnson to settle talc baby powder investigation, will reportedly pay $700 million",https://www.cnbc.com/2024/01/23/johnson-johnson-to-settle-talc-baby-powder-probe.html,2024-01-23 18:59:18,The settlement does not resolve the tens of thousands of lawsuits alleging that J&J's talc-based products caused cancer.,JNJ,0.097854,0.105276,Neutral
Global Process Mining Market Research Report 2023-2028: Opportunities in Artificial Intelligence and Machine Learning Integration and Rising Demand for Cloud-Based Solutions,https://www.prnewswire.com/news-releases/global-process-mining-market-research-report-2023-2028-opportunities-in-artificial-intelligence-and-machine-learning-integration-and-rising-demand-for-cloud-based-solutions-302042109.html,2024-01-23 18:45:00,Global Process Mining Market Research Report 2023-2028: Opportunities in Artificial Intelligence and Machine ... PR ...,JNJ,0.063763,0.158545,Somewhat-Bullish
Johnson & Johnson's Settlement For Talc Cancer Lawsuits Reaches $700M Settlement With US States - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/general/biotech/24/01/36743981/johnson-johnsons-settlement-for-talc-cancer-lawsuits-reaches-700m-settlement-with-us-states,2024-01-23 18:18:25,"Johnson & Johnson JNJ announced on Tuesday a tentative settlement to address investigations by 42 U.S. states and Washington, D.C., regarding alleged misleading information about the safety of its talc products linked to cancer cases.",JNJ,0.428632,-0.289603,Somewhat-Bearish
Why Johnson & Johnson Stock Was Pulling Back Today,https://www.fool.com/investing/2024/01/23/why-johnson-johnson-stock-was-pulling-back-today/,2024-01-23 17:41:11,"The healthcare giant matched estimates, but it wasn't enough to please investors.",JNJ,0.355588,0.067453,Neutral
Is Medtronic Stock a Buy Now?,https://www.fool.com/investing/2024/01/23/is-medtronic-stock-a-buy-now/,2024-01-23 16:45:00,This longtime healthcare leader still has tricks up its sleeve.,JNJ,0.061631,0.173458,Somewhat-Bullish
Here's the message yet another bullish Wall Street call sends on this Big Tech stock,https://www.cnbc.com/2024/01/23/wall-street-issues-bullish-call-on-this-big-tech-name-heres-our-take.html,2024-01-23 16:43:01,"The Investing Club holds its ""Morning Meeting"" every weekday at 10:20 a.m. ET.",JNJ,0.076358,0.089127,Neutral
"Lice Treatment Market Analysis 2024-2028: Expected Market Size, Major Drivers And Leading Segments As Per The Business Research Company's Lice Treatment Global Market Report 2024",https://www.benzinga.com/pressreleases/24/01/g36741497/lice-treatment-market-analysis-2024-2028-expected-market-size-major-drivers-and-leading-segments-a,2024-01-23 16:30:00,"LONDON, Jan. 23, 2024 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Lice Treatment Global Market Report 2024, the global lice treatment market has demonstrated robust growth, reaching $1.05 billion in 2024 with an impressive compound annual growth rate ( CAGR ) of 7.7%.",JNJ,0.064623,0.175309,Somewhat-Bullish
"J&J's  ( JNJ )  Q4 Earnings Beat, Darzalex, Stelara Drive Sales",https://www.zacks.com/stock/news/2214342/jjs-jnj-q4-earnings-beat-darzalex-stelara-drive-sales,2024-01-23 16:03:00,"J&J (JNJ) beats estimates for fourth-quarter earnings and sales. Sales of several key drugs like Darzalex, Stelara and Tremfya beat estimates.",JNJ,0.099202,0.059246,Neutral
Mixed Q4 Earnings Report,https://www.zacks.com/stock/news/2214340/mixed-q4-earnings-report,2024-01-23 16:00:00,"Pre-market futures are mixed at this hour, coming off two strong trading days as Q4 earnings season begins to hit its stride. The Dow is -0.55% currently, while the S&P 500 and Nasdaq are +0.21% and +0.36%, respectively.",JNJ,0.171485,0.084771,Neutral
"Q4 Earnings for J&J, Procter, GE & More",https://www.zacks.com/stock/news/2214313/q4-earnings-for-jj-procter-ge-more,2024-01-23 15:25:00,"Pre-market trading fortunes are mixed for this morning's reportees, including JNJ, PG, GE, MMM and DHI.",JNJ,0.16117,0.081282,Neutral
"US Stocks Mixed; Johnson & Johnson Posts Upbeat Earnings - FaZe Hldgs  ( NASDAQ:FAZE ) , Etao International Co  ( NASDAQ:ETAO ) ",https://www.benzinga.com/news/earnings/24/01/36739183/us-stocks-mixed-johnson-johnson-posts-upbeat-earnings,2024-01-23 15:04:38,"U.S. stocks traded mixed this morning, with the Dow Jones index falling around 90 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.23% to 37,915.41 while the NASDAQ rose 0.12% to 15,378.87. The S&P 500 also rose, gaining, 0.07% to 4,853.64.",JNJ,0.241284,0.093444,Neutral
"Johnson & Johnson's Clock 12% Q4 Revenue Growth, Cancer and Crohn's Disease Drugs Account as Largest Sellers - Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/general/biotech/24/01/36738885/johnson-johnsons-clock-12-q4-revenue-growth-cancer-and-crohns-disease-drugs-account-as-largest-se,2024-01-23 14:49:32,"On Tuesday, Johnson & Johnson JNJ reported fourth-quarter 2023 adjusted earnings of $2.29 per share, up 11.7% year-over-year, beating the consensus of $2.28. Sales increased 7.3% Y/Y to $21.4 billion, beating the consensus of $20.99 billion, with operational growth of 7.2% and adjusted ...",JNJ,0.674691,0.299757,Somewhat-Bullish
Why J&J's Narrow Beat Is A Blessing For Medtech Stocks,https://www.investors.com/news/technology/jnj-stock-johnson-johnson-earnings-q4-2023/,2024-01-23 13:51:00,JNJ Stock Inches Higher As Medtech Strength Drives Fourth-Quarter Beat Investor's Business Daily ...,JNJ,0.843611,0.454772,Bullish
"Focus On Bristol Myers, Gilead Sciences, Johnson & Johnson, Novartis: FDA To Issue Classwide Black Box Warning on CAR-T Therapies For Blood Cancer Treatment - Johnson & Johnson  ( NYSE:JNJ ) , Novartis  ( NYSE:NVS ) , Gilead Sciences  ( NASDAQ:GILD ) , Bristol-Myers Squibb  ( NYSE:BMY ) ",https://www.benzinga.com/general/biotech/24/01/36736043/focus-on-bristol-myers-gilead-sciences-johnson-johnson-novartis-fda-to-issue-classwide-black-box-,2024-01-23 13:19:18,"In a significant development, the FDA is set to impose a classwide black box warning following its investigation into secondary T-cell cancers arising from the use of existing CAR-T therapies. In its January 19 notification letters, the agency stressed that the potential risk applies to all ...",JNJ,0.175859,0.007437,Neutral
Futures Mixed After Earnings Reports,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-big-earnings-reports-magnificent-seven-stock-netflix-to-report-next/,2024-01-23 13:12:00,Dow Jones Futures Fall On Big Earnings Reports. Magnificent Seven Stock Netflix To Report Next Investor's Business Daily ...,JNJ,0.085782,0.0,Neutral
"FDA Demands ""Boxed Warning"" to CAR T-Cell Therapy Labels",https://www.zacks.com/stock/news/2214008/fda-demands-boxed-warning-to-car-t-cell-therapy-labels,2024-01-23 13:08:00,"The FDA directs companies like NVS, BMY, GILD and others to add ""boxed warning"" to the labels of their CAR T-cell immunotherapies after it identified adverse events.",JNJ,0.112008,-0.058239,Neutral
"US Stocks Prepare For Nervy Start Ahead of Netflix, TI Earnings: Analyst Says Cash Waiting On Sidelines Could Flood Street If This Happens - Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , SPDR S&P 500  ( ARCA:SPY ) ",https://www.benzinga.com/news/earnings/24/01/36734767/us-stocks-prepare-for-nervy-start-ahead-of-netflix-ti-earnings-analyst-says-cash-waiting-on-sidelin,2024-01-23 12:32:03,The mood turned circumspect on Tuesday as traders digested a deluge of earnings reports and anticipated market-moving economic data for the week. Earnings releases from 3M Company MMM and General Electric Co. GE led to a pullback in their stocks during premarket trading.,JNJ,0.10607,0.048514,Neutral
"Cough Suppressant Market to Hit US$ 39,216.3 Million by 2030 | Updated Insights Report by Persistence Market Research",https://www.benzinga.com/pressreleases/24/01/g36734013/cough-suppressant-market-to-hit-us-39-216-3-million-by-2030-updated-insights-report-by-persistence,2024-01-23 12:00:00,"New York, Jan. 23, 2024 ( GLOBE NEWSWIRE ) -- Cough suppressants, also known as antitussives, are pharmaceutical substances engineered to alleviate cough symptoms.",JNJ,0.062488,0.179295,Somewhat-Bullish
Johnson & Johnson earnings beat estimates with boost from medtech sales,https://www.marketwatch.com/story/johnson-johnson-q4-earnings-beat-estimates-amid-strength-in-medtech-1803820f,2024-01-23 11:35:00,Medtech sales were up more than 13% in the latest quarter.,JNJ,0.371523,0.206173,Somewhat-Bullish
Genmab Announces Net Sales of DARZALEXÂ®  ( daratumumab )  for 2023,https://www.globenewswire.com/news-release/2024/01/23/2813898/0/en/Genmab-Announces-Net-Sales-of-DARZALEX-daratumumab-for-2023.html,2024-01-23 11:24:00,Company Announcement ...,JNJ,0.133841,0.011832,Neutral
"Johnson & Johnson narrowly tops quarterly estimates as pharmaceutical, medtech sales jump",https://www.cnbc.com/2024/01/23/johnson-johnson-jnj-earnings-q4-2023.html,2024-01-23 11:22:37,"The results come six months after J&J completed its spinoff of consumer health unit Kenvue, the company's biggest shake-up in its nearly 140-year history.",JNJ,0.087185,0.0,Neutral
Should You Invest in the iShares U.S. Healthcare ETF  ( IYH ) ?,https://www.zacks.com/stock/news/2213920/should-you-invest-in-the-ishares-us-healthcare-etf-iyh,2024-01-23 11:20:06,Sector ETF report for ...,JNJ,0.1331,0.069906,Neutral
Should You Invest in the Health Care Select Sector SPDR ETF  ( XLV ) ?,https://www.zacks.com/stock/news/2213924/should-you-invest-in-the-health-care-select-sector-spdr-etf-xlv,2024-01-23 11:20:05,Sector ETF report for ...,JNJ,0.127456,0.063784,Neutral
Accent Therapeutics Announces $75 Million Series C Financing to Advance Small Molecule Precision Cancer Therapies,https://www.prnewswire.com/news-releases/accent-therapeutics-announces-75-million-series-c-financing-to-advance-small-molecule-precision-cancer-therapies-302041338.html,2024-01-23 11:00:00,"Financing led by Mirae Asset Capital Life Science with participation from additional new and existing investors Funds will support advancement of lead programs through early clinical development, including Accent's first-in-class DHX9 inhibitor and newly unveiled, potentially best-in-class KIF18A ...",JNJ,0.039418,0.045323,Neutral
S&P 500 futures hold at record highs as earnings season ramps up,https://www.marketwatch.com/story/s-p-500-futures-hold-at-record-highs-as-earnings-season-ramps-up-netflix-eyed-after-the-close-de2923e4,2024-01-23 10:31:00,U.S. stock index futures showed benchmarks holding at record levels as bond markets stabilized and traders eyed an accelerating flow of corporate earnings reports.,JNJ,0.202366,0.0,Neutral
2 Genius Safe Stocks to Buy for 2024 and Beyond,https://www.fool.com/investing/2024/01/23/2-genius-safe-stocks-to-buy-for-2024-and-beyond/,2024-01-23 10:15:00,These companies have considerable profits and tried-and-true dividends in common.,JNJ,0.279015,0.002106,Neutral
Expectorant Drugs Market Poised to Reach US$22.9 Billion by 2030 with a Steady 4.5% CAGR | Persistence Market Research,https://www.benzinga.com/pressreleases/24/01/g36732382/expectorant-drugs-market-poised-to-reach-us-22-9-billion-by-2030-with-a-steady-4-5-cagr-persistenc,2024-01-23 09:30:00,"New York, Jan. 23, 2024 ( GLOBE NEWSWIRE ) -- Market Size & Overview: The global expectorant drugs market is projected to grow at a robust CAGR of 4.5%, surging from US$16.8 billion in 2023 to reach US$22.9 billion by the conclusion of 2030.",JNJ,0.015226,0.066705,Neutral
"Surgical Staplers Market Soars, Forecasting an 4.7% CAGR Surge to Reach US$5.5 Billion by 2030 | Persistence Market Research",https://www.benzinga.com/pressreleases/24/01/g36732339/surgical-staplers-market-soars-forecasting-an-4-7-cagr-surge-to-reach-us-5-5-billion-by-2030-persi,2024-01-23 09:15:00,"New York, Jan. 23, 2024 ( GLOBE NEWSWIRE ) -- Market Overview: The Surgical Staplers Market is a vital segment within the broader medical device industry, dedicated to simplifying and enhancing surgical procedures.",JNJ,0.043499,0.189608,Somewhat-Bullish
"Surgical Dressing Market Valuation to Reach US$1.9 Billion by 2030, Driven by 6.1% CAGR | Persistence Market Research",https://www.benzinga.com/pressreleases/24/01/g36732234/surgical-dressing-market-valuation-to-reach-us-1-9-billion-by-2030-driven-by-6-1-cagr-persistence-,2024-01-23 08:50:00,"New York, Jan. 23, 2024 ( GLOBE NEWSWIRE ) -- Market Overview: The surgical dressing market plays a vital role in the healthcare industry, providing essential products that aid in the post-operative care of patients and promote wound healing.",JNJ,0.04425,0.014969,Neutral
"Fear & Greed Index Remains In 'Greed' Zone; Dow Settles Above 38,000 - Johnson & Johnson  ( NYSE:JNJ ) , Archer-Daniels Midland  ( NYSE:ADM ) ",https://www.benzinga.com/news/earnings/24/01/36731525/fear-greed-index-remains-in-greed-zone-dow-settles-above-38-000,2024-01-23 07:33:46,"The CNN Money Fear and Greed index remained in the ""Greed"" zone on Monday. U.S. stocks closed higher on Monday, with the Dow Jones index settling above the 38,000 mark for the first time.",JNJ,0.263942,0.0,Neutral
"Verizon, Netflix And 3 Stocks To Watch Heading Into Tuesday - Netflix  ( NASDAQ:NFLX ) , Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/news/earnings/24/01/36731409/verizon-netflix-and-3-stocks-to-watch-heading-into-tuesday,2024-01-23 06:53:00,"With U.S. stock futures trading mixed this morning on Tuesday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Verizon Communications Inc. VZ to report quarterly earnings at $1.08 per share on revenue of $34.58 billion before the opening bell.",JNJ,0.504646,0.404618,Bullish
"Medical Adhesive Tape Market Is Projected to Reach a Value of US$13.1 Billion by The End 2030, According to Persistence Market Research",https://www.benzinga.com/pressreleases/24/01/g36731378/medical-adhesive-tape-market-is-projected-to-reach-a-value-of-us-13-1-billion-by-the-end-2030-acco,2024-01-23 06:30:00,"New York, Jan. 23, 2024 ( GLOBE NEWSWIRE ) -- Medical Adhesive Tape Market Booming with Growing Demand and Technological Advancements Medical adhesive tapes are essential in wound care, surgeries, and medical applications.",JNJ,0.017795,0.149182,Neutral
S&P 500 ends with record high for 2nd session in row,https://www.moneycontrol.com/news/business/markets/sp-500-ends-with-record-high-for-2nd-session-in-row-12105241.html,2024-01-23 01:01:43,"Friday's finish confirmed that the SP 500 has been in a bull market since it closed at its low on Oct. 12, 2022, according to one commonly used measure.",JNJ,0.087824,0.0,Neutral
Genmab Announces Decision in Arbitration Appeal under License Agreement with Janssen,https://www.globenewswire.com/news-release/2024/01/22/2813563/0/en/Genmab-Announces-Decision-in-Arbitration-Appeal-under-License-Agreement-with-Janssen.html,2024-01-22 23:40:00,Company Announcement ...,JNJ,0.062597,0.0,Neutral
"Rehabilitation Equipment Global Market to Showcase Growth at a CAGR of ~5% by 2028, Examines DelveInsight",https://www.prnewswire.com/news-releases/rehabilitation-equipment-global-market-to-showcase-growth-at-a-cagr-of-5-by-2028-examines-delveinsight-302040512.html,2024-01-22 22:31:00,"The increasing demand for rehabilitation equipment is driven by several factors, including a growing number of accidents, injuries, and falls.",JNJ,0.079921,-0.002038,Neutral
"From 3M To Intel, A Big Earnings Week For Dow Jones Stocks",https://www.investors.com/news/dow-jones-stocks-from-3m-to-intel-a-big-earnings-week-for-blue-chips/,2024-01-22 21:02:00,"The biggest reporting week of the season for Dow Jones Industrials stocks begins Tuesday, when Verizon ( VZ ) , Johnson & Johnson ( JNJ ) , Procter & Gamble ( PG ) and 3M ( MMM ) all deliver results. It is one of the season's biggest reporting days for Dow Jones stocks.",JNJ,0.223522,-0.070824,Neutral
JNJ: Johnson & Johnson  ( JNJ ) : Analyzing Signals Before Quarterly Earnings,https://stocknews.com/news/jnj-nvs-nvo-snphy-amam-johnson-johnson-jnj-analyzing-signals-before-quarterly-earnings/,2024-01-22 18:11:28,"Boasting a market cap of $389.21 billion, leading pharma giant Johnson & Johnson ( JNJ ) is all set to lift the curtains on its fourth-quarter results ( ended December 2023 ) on January 23, 2024. Thus, this article sheds light on the fundamentals of JNJ to determine the stock's worthiness as an ...",JNJ,0.55206,0.312855,Somewhat-Bullish
Talc lawsuit: J&J sets up 3rd bankruptcy bid by moving unit to Texas,https://www.business-standard.com/world-news/talc-lawsuit-j-j-sets-up-3rd-bankruptcy-bid-by-moving-unit-to-texas-124012201028_1.html,2024-01-22 17:12:55,"Johnson & Johnson is seeking to move a unit to Texas as it prepares for a potential third bankruptcy court filing to resolve more than 50,000 lawsuits alleging tainted talc in its baby powder caused cancer.",JNJ,0.110209,-0.213977,Somewhat-Bearish
"Johnson & Johnson Secures Complete FDA Approval For Bladder Cancer Drug Balversa, After Almost Five Years Of Accelerated Approval - Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/general/biotech/24/01/36719728/johnson-johnson-secures-complete-fda-approval-for-bladder-cancer-drug-balversa-after-almost-five-,2024-01-22 16:59:59,"Friday afternoon, the FDA approved Johnson & Johnson's JNJ supplemental New Drug Application ( sNDA ) for Balversa ( erdafitinib ) for adult patients with locally advanced or metastatic urothelial carcinoma ( mUC ) with susceptible fibroblast growth factor receptor 3 ( FGFR3 ) genetic ...",JNJ,0.597963,0.363424,Bullish
Earnings Season Heats Up This Week Along With Inflation Data,https://www.forbes.com/sites/jjkinahan/2024/01/22/earnings-season-heats-up-this-week-along-with-inflation-data/,2024-01-22 15:38:16,"â€¢ Netflix And Tesla Among Companies Reporting This Week â€¢ Market Unconcerned With Much Of Anything Equity markets are picking up steam and setting records. Last week, the S&P 500 closed at an all-time high with a gain of 1.17%. Meanwhile, the Nasdaq Composite is coming up on its all-time highs ...",JNJ,0.06515,-0.017046,Neutral
Tissue Engineering Market is Expected to Reach $8.9 Billion | MarketsandMarketsâ„¢,https://www.benzinga.com/pressreleases/24/01/g36713761/tissue-engineering-market-is-expected-to-reach-8-9-billion-marketsandmarkets,2024-01-22 12:30:00,"Chicago, Jan. 22, 2024 ( GLOBE NEWSWIRE ) -- Tissue Engineering market in terms of revenue was estimated to be worth $4.4 Billion in 2023 and is poised to reach $8.9 Billion by 2028, growing at a CAGR of 15.3% from 2023 to 2028 according to a latest report published by MarketsandMarketsâ„¢.",JNJ,0.03792,-0.040123,Neutral
Tim Czartoski Appointed as CEO of Genesis Innovation Group,https://www.prnewswire.com/news-releases/tim-czartoski-appointed-as-ceo-of-genesis-innovation-group-302040014.html,2024-01-22 11:45:00,"GRAND RAPIDS, Mich., Jan. 22, 2024 /PRNewswire/ -- Genesis Innovation Group ( GIG ) , a leader in medical device innovation, is excited to announce the appointment of Tim Czartoski as Chief Executive Officer effective April 1, 2024, and serving in an advisory role until that time.",JNJ,0.066047,0.087133,Neutral
Orthopedic Implants Market Size to Worth USD 61 Million by 2030| According to Persistence Market Research,https://www.benzinga.com/pressreleases/24/01/g36712657/orthopedic-implants-market-size-to-worth-usd-61-million-by-2030-according-to-persistence-market-re,2024-01-22 11:30:00,"New York, Jan. 22, 2024 ( GLOBE NEWSWIRE ) -- The projected rise in the number of patients in need of orthopedic implant surgery is anticipated to propel the global orthopedic implants market in the coming years.",JNJ,0.020197,0.145597,Neutral
Legal-Bay Pre-Settlement Funding Reports Johnson & Johnson Talc Powder Settlement of $700MM with 40 States Nationwide,https://www.prnewswire.com/news-releases/legal-bay-pre-settlement-funding-reports-johnson--johnson-talc-powder-settlement-of-700mm-with-40-states-nationwide-302039711.html,2024-01-22 11:30:00,Legal-Bay Pre-Settlement Funding Reports Johnson & Johnson Talc Powder Settlement of $700MM with 40 States ... PR ...,JNJ,0.145583,-0.157113,Somewhat-Bearish
"Tesla, Netflix, Intel Take Center Stage In Pivotal Q4 Earnings Week As S&P 500 Eyes Breaking New Highs - SPDR S&P 500  ( ARCA:SPY ) ",https://www.benzinga.com/news/earnings/24/01/36711792/tesla-netflix-intel-take-center-stage-in-pivotal-q4-earnings-week-as-s-p-500-eyes-breaking-new-high,2024-01-22 10:00:45,"The earnings season is gaining momentum as the tech reporting season kicks off this week. With the S&P 500 Index reaching a new high on Friday, investors are keenly watching earnings reports to sustain the market's upward momentum.",JNJ,0.107255,0.049774,Neutral
"Chronic Wound Care Market is expected to see an expansion to US$16.7 billion, as per the projections, By the end of 2030 | Persistence Market Research",https://www.benzinga.com/pressreleases/24/01/g36710946/chronic-wound-care-market-is-expected-to-see-an-expansion-to-us-16-7-billion-as-per-the-projection,2024-01-22 06:15:00,"New York, Jan. 22, 2024 ( GLOBE NEWSWIRE ) -- Chronic Wound Care Market Booms as Advanced Solutions Emerge to Combat Rising Burden Chronic wound care involves the management and treatment of wounds that fail to progress through normal stages of healing within an expected timeframe.",JNJ,0.014384,0.215192,Somewhat-Bullish
Little-Known Biotech Company Shows How Hard It Is To Ride The Ozempic Wave,https://www.forbes.com/sites/johnkang/2024/01/21/little-known-biotech-company-shows-how-hard-it-is-to-ride-the-ozempic-wave/,2024-01-22 03:00:41,Shares of Korea-listed Caregen surged on hope its diabetes-weight loss supplement could give the little-known biotech company an Ozempic-like boost. But then the stock crashed.,JNJ,0.024126,0.187772,Somewhat-Bullish
I'm Putting My Cash Stockpile to Work on These 3 Stocks,https://www.fool.com/investing/2024/01/21/im-putting-my-cash-stockpile-to-work-on-these-3-st/,2024-01-21 17:47:00,"With the market selling off to start the year, this Fool plans to put some of his growing cash pile to work.",JNJ,0.050465,-0.019973,Neutral
Nearing Retirement? These Stocks Are as Safe as They Come,https://www.fool.com/investing/2024/01/21/nearing-retirement-these-stocks-are-as-safe-as-the/,2024-01-21 16:51:00,These stocks should provide solid income with little drama.,JNJ,0.401331,0.348195,Somewhat-Bullish
March Rate Cut Odds Plummet As Magnificent 7 Surge,https://www.forbes.com/sites/bill_stone/2024/01/21/march-rate-cut-odds-plummet-as-magnificent-7-surge/,2024-01-21 16:39:56,"The earnings season continued its slow start last week, with only 23 S&P 500 companies reporting. Banks were a large contingent of the reporters, which weighed on earnings again. The S&P 500 rose 1.2% for the week, finally eclipsing its all-time high from 2022. The 10-year Treasury yield rose ...",JNJ,0.11983,0.066592,Neutral
Prediction: This Will Be the First Trillion-Dollar Healthcare Stock,https://www.fool.com/investing/2024/01/21/prediction-this-will-be-the-first-trillion-dollar/,2024-01-21 16:02:00,This company is currently firing on all cylinders.,JNJ,0.166551,0.132619,Neutral
Walgreens Boots Alliance Just Cut Its Dividend: Here Are 2 Companies That Won't,https://www.fool.com/investing/2024/01/21/walgreens-boots-alliance-just-cut-its-dividend-her/,2024-01-21 15:45:00,"Not every dividend stock is created equal, and these two far exceed Walgreens Boots Alliance.",JNJ,0.340915,0.071285,Neutral
Markets tried to fight the Fed on rate cuts. It didn't work | Business,https://www.cnn.com/2024/01/21/markets/stocks-week-ahead-markets-fight-the-fed/index.html,2024-01-21 12:30:00,Markets are trying to fight the Fed on rate cuts. It's not working ...,JNJ,0.029292,0.0,Neutral
My 5 Top Dividend Stocks to Buy Hand Over Fist in 2024,https://www.fool.com/investing/2024/01/21/my-5-top-dividend-stocks-to-buy-in-2024/,2024-01-21 11:17:00,These stocks may help you win in 2024 -- no matter what the market does.,JNJ,0.078099,0.188048,Somewhat-Bullish
24 Dividend Growth Stocks to Buy and Hold in 2024,https://www.fool.com/investing/2024/01/21/24-dividend-growth-stocks-to-buy-and-hold-in-2024/,2024-01-21 10:51:00,Dividends are good. Growing dividends are even better.,JNJ,0.030958,0.141351,Neutral
The 4 most important things we're watching in the stock market this coming week,https://www.cnbc.com/2024/01/20/4-most-important-things-were-watching-in-the-stock-market-this-week.html,2024-01-20 15:13:48,On tap: A handful of key economic updates and a ramp up of quarterly earnings reports.,JNJ,0.042234,-0.028099,Neutral
3 High-Flying Stocks That Could Soar Even More in 2024,https://www.fool.com/investing/2024/01/20/3-high-flying-stocks-that-could-soar-even-more-in/,2024-01-20 11:50:00,These big winners could keep the momentum going.,JNJ,0.044222,-0.005924,Neutral
The 2024 Dogs of the Dow: Which Ones Are Buys Right Now?,https://www.fool.com/investing/2024/01/20/the-2024-dogs-of-the-dow-which-ones-are-buys/,2024-01-20 10:50:00,A few of these Dogs of the Dow can probably hunt in the new year.,JNJ,0.13459,0.198925,Somewhat-Bullish
"SHAREHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger - RYZB, THRX, AMAM, CSTR",https://www.benzinga.com/pressreleases/24/01/g36704959/shareholder-alert-the-m-a-class-action-firm-continues-investigating-the-merger-ryzb-thrx-amam-cstr,2024-01-20 01:00:00,"NEW YORK, Jan. 19, 2024 ( GLOBE NEWSWIRE ) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC ( the ""M&A Class Action Firm"" ) , a national securities firm rated Top 50 in the 2018-2022 ISS Securities Class Action Services Report and ...",JNJ,0.068502,0.127176,Neutral
"Cramer's week ahead: Earnings from Procter & Gamble, Tesla, Lockheed Martin",https://www.cnbc.com/2024/01/19/cramers-week-ahead-earnings-from-procter-gamble-tesla-lockheed-martin.html,2024-01-19 23:36:25,"CNBC's Jim Cramer guided investors through next week's Wall Street action, telling them to gear up for a slew of earnings reports.",JNJ,0.07913,0.195526,Somewhat-Bullish
"Tesla, Netflix, GE Earnings: Investing Action Plan",https://www.investors.com/research/investing-action-plan/tesla-netflix-ge-earnings-investing-action-plan/,2024-01-19 22:00:00,"The Nasdaq set a hot pace as the market's rally hammered out yet another weekly gain. The S&P 500 turned early-week losses into a 1.5% advance, taking a record high. The Dow rose 0.7% to test resistance just below 38,000. IBD continues to hold its exposure recommendation to between 80% and 100%.",JNJ,0.069596,0.042131,Neutral
Q4 Earnings Results Reflect Stability,https://www.zacks.com/commentary/2213047/q4-earnings-results-reflect-stability,2024-01-19 21:48:00,"The picture emerging from the Q4 earnings season thus far has been good enough - not great, but definitely not bad either. Next week, we shift into a much higher gear, with 71 S&P 500 members scheduled to report.",JNJ,0.098862,0.0,Neutral
How Is The Market Feeling About Johnson & Johnson? - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/insights/short-sellers/24/01/36700113/how-is-the-market-feeling-about-johnson-johnson,2024-01-19 19:00:26,"Johnson & Johnson's JNJ short percent of float has fallen 18.75% since its last report. The company recently reported that it has 12.47 million shares sold short, which is 0.52% of all regular shares that are available for trading.",JNJ,0.221819,0.081322,Neutral
"Global Transdermal Skin Patches Market Forecast Report, 2024-2030: A $9.9B Projected Industry, Dominated by Teva Pharma, 3M Company, Nitto Denko Corporation, and Johnson & Johnson",https://www.prnewswire.com/news-releases/global-transdermal-skin-patches-market-forecast-report-2024-2030-a-9-9b-projected-industry-dominated-by-teva-pharma-3m-company-nitto-denko-corporation-and-johnson--johnson-302039341.html,2024-01-19 17:15:00,"Global Transdermal Skin Patches Market Forecast Report, 2024-2030: A $9.9B Projected Industry, Dominated by Teva ... PR ...",JNJ,0.063425,0.143639,Neutral
"Hyaluronic Acid Serums Market Targets US$ 506.4 Million by 2033 at 5.9% CAGR, Persistence Market Research",https://www.benzinga.com/pressreleases/24/01/g36697064/hyaluronic-acid-serums-market-targets-us-506-4-million-by-2033-at-5-9-cagr-persistence-market-rese,2024-01-19 15:45:00,"New York, Jan. 19, 2024 ( GLOBE NEWSWIRE ) -- Hyaluronic Acid Serums have witnessed significant growth in recent years, driven by increasing consumer awareness of skincare and anti-aging products.",JNJ,0.022389,-0.0018,Neutral
J&J  ( JNJ )  Gears Up to Report Q4 Earnings: What's in Store?,https://www.zacks.com/stock/news/2212628/jj-jnj-gears-up-to-report-q4-earnings-whats-in-store,2024-01-19 12:39:00,J&J's (JNJ) Innovative Medicines unit sales are expected to have been driven by drugs like Darzalex and Stelara. Surgical procedure recovery and new products are likely to have driven MedTech sales.,JNJ,0.224903,0.093117,Neutral
"Shampoo Market to Surge with 5.57% CAGR, Anticipated Valuation Exceeds US$ 50.37 Billion by 2034 | Persistence Market Research",https://www.benzinga.com/pressreleases/24/01/g36691119/shampoo-market-to-surge-with-5-57-cagr-anticipated-valuation-exceeds-us-50-37-billion-by-2034-pers,2024-01-19 08:50:00,"New York, Jan. 19, 2024 ( GLOBE NEWSWIRE ) -- Market Overview: The shampoo market is a vital segment within the broader personal care and grooming industry, catering to the basic hygiene and aesthetic needs of consumers worldwide.",JNJ,0.02866,0.107706,Neutral
"Hepatitis C Virus Testing Market Poised to Expand at a 5.8% CAGR, Surpassing US$1,185.2 Million by 2030 | Persistence Market Research",https://www.benzinga.com/pressreleases/24/01/g36691001/hepatitis-c-virus-testing-market-poised-to-expand-at-a-5-8-cagr-surpassing-us-1-185-2-million-by-2,2024-01-19 08:30:00,"New York, Jan. 19, 2024 ( GLOBE NEWSWIRE ) -- Market Overview: The Hepatitis C Virus ( HCV ) Testing Market is a dynamic and evolving sector within the healthcare industry, driven by the persistent threat posed by the Hepatitis C Virus.",JNJ,0.012889,0.0,Neutral
List Price Of Ozempic And Other Drugs Reportedly Rise: Here's What That Means For Consumers,https://www.forbes.com/sites/ariannajohnson/2024/01/18/list-price-of-ozempic-and-other-drugs-reportedly-rise-heres-what-that-means-for-consumers/,2024-01-18 19:49:30,"Almost 800 medications-including Ozempic and Mounjaro-had a median list price increase of 4.5% this month, according to a Wall Street Journal report, meaning copays may increase for consumers.",JNJ,0.056808,0.0,Neutral
Wall Street's Insights Into Key Metrics Ahead of Johnson & Johnson  ( JNJ )  Q4 Earnings,https://www.zacks.com/stock/news/2212378/wall-streets-insights-into-key-metrics-ahead-of-johnson-johnson-jnj-q4-earnings,2024-01-18 17:56:00,Get a deeper insight into the potential performance of Johnson & Johnson (JNJ) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.,JNJ,0.345674,0.079971,Neutral
Nivolumab Market Overview 2024-2028: Global Expansion Driven By Immunotherapy Advancements And Rising Cancer Incidence As Per The Business Research Company's Nivolumab Global Market Report 2024,https://www.benzinga.com/pressreleases/24/01/g36681451/nivolumab-market-overview-2024-2028-global-expansion-driven-by-immunotherapy-advancements-and-risi,2024-01-18 16:30:00,"LONDON, Jan. 18, 2024 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Nivolumab Global Market Report 2024, nivolumab market has experienced remarkable growth in recent years and is set to continue its upward trajectory, with the market size projected to reach $1.69 billion in 2024, ...",JNJ,0.061315,0.115659,Neutral
Otic Drugs Market To Surge At A CAGR Of 7.0%: Global Growth Driven By Rising Prevalence Of Ear Infections And Innovations In Drug Formulations As Per The Business Research Company's Otic Drugs Global Market Report 2024,https://www.benzinga.com/pressreleases/24/01/g36681448/otic-drugs-market-to-surge-at-a-cagr-of-7-0-global-growth-driven-by-rising-prevalence-of-ear-infec,2024-01-18 16:30:00,"LONDON, Jan. 18, 2024 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Otic Drugs Global Market Report 2024, the otic drugs market has witnessed robust growth in recent years and is poised to continue its upward trajectory, with the market size projected to reach $1.71 billion in ...",JNJ,0.057079,0.097064,Neutral
Inactivated Vaccines Market Set to Reach $7.3 Billion in 2028 - Global Growth Driven by Immunization Initiatives and Advancements in Biomanufacturing As Per The Business Research Company's Inactivated Vaccines Global Market Report 2024,https://www.benzinga.com/pressreleases/24/01/g36681454/inactivated-vaccines-market-set-to-reach-7-3-billion-in-2028-global-growth-driven-by-immunization-,2024-01-18 16:30:00,"LONDON, Jan. 18, 2024 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Inactivated Vaccines Global Market Report 2024, the inactivated vaccines market has exhibited consistent growth, with the market size reaching $5.95 billion in 2023 and expected to climb to $6.19 billion in 2024, ...",JNJ,0.056808,0.180983,Somewhat-Bullish
"Feminine Hygiene Market is poised to reach US$ 56.5 billion by 2033, with a projected CAGR of 6.0%, Persistence Market Research",https://www.benzinga.com/pressreleases/24/01/g36681181/feminine-hygiene-market-is-poised-to-reach-us-56-5-billion-by-2033-with-a-projected-cagr-of-6-0-pe,2024-01-18 16:15:00,"New York, Jan. 18, 2024 ( GLOBE NEWSWIRE ) -- The global market for feminine hygiene products has experienced notable growth and transformation due to evolving societal attitudes, increased awareness of women's health, and advancements in product innovation.",JNJ,0.038499,0.171373,Somewhat-Bullish
"Cardiac Sutures Market Estimated to Reach USD 2.3 billion, Advancing at a CAGR of 6.8% by 2031: Transparency Market Research, Inc.",https://www.benzinga.com/pressreleases/24/01/g36680030/cardiac-sutures-market-estimated-to-reach-usd-2-3-billion-advancing-at-a-cagr-of-6-8-by-2031-trans,2024-01-18 15:30:00,"Wilmington, Delaware, United States, Jan. 18, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global cardiac sutures market is estimated to flourish at a CAGR of 6.8% from 2023 to 2031.",JNJ,0.109289,0.118142,Neutral
"Fibromyalgia Treatment Market Projected to Surpass US$ 2.7 Billion in Revenue by 2033, According to Persistence Market Research",https://www.benzinga.com/pressreleases/24/01/g36679018/fibromyalgia-treatment-market-projected-to-surpass-us-2-7-billion-in-revenue-by-2033-according-to-,2024-01-18 14:45:00,"New York, Jan. 18, 2024 ( GLOBE NEWSWIRE ) -- Market Overview: The global revenue from the fibromyalgia treatment market stands at US$ 1.3 billion in 2022, with the global market expected to grow at a CAGR of 7.0% to reach a valuation of approximately US$ 2.7 billion by the end of 2033.",JNJ,0.014775,0.0,Neutral
2024 Will Be a Good Year for the Pharma Industry: The Kiplinger Letter,https://www.kiplinger.com/business/a-good-year-for-the-pharma-industry-the-kiplinger-letter,2024-01-18 13:30:15,2024: The Pharma Industry's Good Year Kiplinger's Personal Finance ...,JNJ,0.19661,-0.0803,Neutral
"Active Wound Care Market Size to be Worth USD 451.9 million by 2031, with Notable CAGR of 7.3%| Transparency Market Research, Inc.",https://www.benzinga.com/pressreleases/24/01/g36676060/active-wound-care-market-size-to-be-worth-usd-451-9-million-by-2031-with-notable-cagr-of-7-3-trans,2024-01-18 13:00:00,"Wilmington, Delaware, United States, Jan. 18, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global active wound care market was projected to attain US$ 242.2 million in 2022. It is anticipated to garner a 7.3% CAGR from 2023 to 2031 and by 2031.",JNJ,0.037155,0.385239,Bullish
Oral Hygiene Products Market Size & Share to Surpass US$ 34.1 Billion by 2033 | Persistence Market Research,https://www.benzinga.com/pressreleases/24/01/g36673864/oral-hygiene-products-market-size-share-to-surpass-us-34-1-billion-by-2033-persistence-market-rese,2024-01-18 10:45:00,"New York, Jan. 18, 2024 ( GLOBE NEWSWIRE ) -- Market Size & Overview: In 2022, the global revenue from oral hygiene products reached US$ 22.3 billion, and it is projected to experience a Compound Annual Growth Rate ( CAGR ) of 3.9%, reaching a valuation of US$ 34.1 billion by 2033.",JNJ,0.017219,0.388599,Bullish
Catheter Associated Urinary Tract Infections Treatment Market Surges with a Promising CAGR of 4.0% through 2033 | Persistence Market Research,https://www.benzinga.com/pressreleases/24/01/g36673659/catheter-associated-urinary-tract-infections-treatment-market-surges-with-a-promising-cagr-of-4-0-,2024-01-18 10:15:00,"New York, Jan. 18, 2024 ( GLOBE NEWSWIRE ) -- Market Size & Overview: The global market for treating catheter-associated urinary tract infections ( CAUTIs ) is projected to grow at a compound annual growth rate ( CAGR ) of 4.0%.",JNJ,0.029581,0.063368,Neutral
Johnson & Johnson  ( JNJ )  Stock Moves -0.06%: What You Should Know,https://www.zacks.com/stock/news/2211717/johnson-johnson-jnj-stock-moves--006-what-you-should-know,2024-01-17 22:45:19,"Johnson & Johnson (JNJ) concluded the recent trading session at $160.43, signifying a -0.06% move from its prior day's close.",JNJ,0.556576,0.16099,Somewhat-Bullish
"Dry Skin Cream, Lotion, And Ointment Market Set to Soar 8.5% to $59.4 Billion by 2030, Insights by Persistence Market Research",https://www.benzinga.com/pressreleases/24/01/g36662794/dry-skin-cream-lotion-and-ointment-market-set-to-soar-8-5-to-59-4-billion-by-2030-insights-by-pers,2024-01-17 16:00:00,"New York, Jan. 17, 2024 ( GLOBE NEWSWIRE ) -- Dry skin cream, lotion, and ointment form an essential category dedicated to fulfilling the needs of individuals dealing with dry skin conditions. These formulations are intricately designed to provide hydration, nourishment, and relief to dry and ...",JNJ,0.035821,0.234516,Somewhat-Bullish
"Tr1X, Inc. Announces $75 Million Series A Financing to Develop Best-in-Class Universal Allogeneic Regulatory T  ( Treg )  and CAR-Treg Cell Therapies to Treat and Potentially Cure Autoimmune and Inflammatory Diseases",https://www.prnewswire.com/news-releases/tr1x-inc-announces-75-million-series-a-financing-to-develop-best-in-class-universal-allogeneic-regulatory-t-treg-and-car-treg-cell-therapies-to-treat-and-potentially-cure-autoimmune-and-inflammatory-diseases-302036679.html,2024-01-17 13:30:00,"Tr1X, Inc. Announces $75 Million Series A Financing to Develop Best-in-Class Universal Allogeneic Regulatory T ( Treg ... PR ...",JNJ,0.044386,0.048031,Neutral
"Cell Therapy Market Global Surge to Over USD 26.8 Billion by 2033, Fueled by Growing Demand in United States",https://www.benzinga.com/pressreleases/24/01/g36658512/cell-therapy-market-global-surge-to-over-usd-26-8-billion-by-2033-fueled-by-growing-demand-in-unit,2024-01-17 13:21:47,"New York, Jan. 17, 2024 ( GLOBE NEWSWIRE ) -- According to Market.us, the global Cell Therapy Market size is forecasted to exceed USD 26.8 Billion by 2033, with a promising CAGR of 16.9% from 2024 to 2033.",JNJ,0.018802,-0.142541,Neutral
"INVO Bioscience Files S-4 Registration and Preliminary Joint Proxy Statements in Connection with Merger with NAYA Biosciences, NAYA Announces New Board Directors - Kymera Therapeutics  ( NASDAQ:KYMR ) , Nanobiotix  ( NASDAQ:NBTX ) ",https://www.benzinga.com/pressreleases/24/01/g36657953/invo-bioscience-files-s-4-registration-and-preliminary-joint-proxy-statements-in-connection-with-m,2024-01-17 13:00:00,"INVO INVO and NAYA Biosciences expect to close their previously announced merger in the first quarter of 2024 Experienced, entrepreneurial leadership team to help structure merged public company and accelerate growth",JNJ,0.019928,0.03272,Neutral
Should You Invest in the Vanguard Health Care ETF  ( VHT ) ?,https://www.zacks.com/stock/news/2211196/should-you-invest-in-the-vanguard-health-care-etf-vht,2024-01-17 11:20:07,Sector ETF report for ...,JNJ,0.136113,0.064698,Neutral
Skin Toner Market Set to Surge to US$ 2.0 Billion by 2030 Driven by Soaring Worldwide Demand for Full Ingredient Transparency | Persistence Market Research,https://www.benzinga.com/pressreleases/24/01/g36655653/skin-toner-market-set-to-surge-to-us-2-0-billion-by-2030-driven-by-soaring-worldwide-demand-for-fu,2024-01-17 10:15:00,"New York, Jan. 17, 2024 ( GLOBE NEWSWIRE ) -- Market Size & Overview: The skin toner market is expected to witness a compound annual growth rate ( CAGR ) of 5.3%, leading to an increase from US$1.3 billion in 2023 to US$2.0 billion by the end of 2030.",JNJ,0.039966,0.104837,Neutral
"Alzheimer's Disease Diagnostics & Treatment Market Revenues to Reach US$11.9 Billion by 2030 - Market Size, Share, Forecasts, & Trends Analysis Report by Persistence Market Research",https://www.benzinga.com/pressreleases/24/01/g36655498/alzheimers-disease-diagnostics-treatment-market-revenues-to-reach-us-11-9-billion-by-2030-market-s,2024-01-17 10:00:00,"New York, Jan. 17, 2024 ( GLOBE NEWSWIRE ) -- Market Size & Overview: The global market for Alzheimer's disease diagnostics and treatment is projected to experience a compound annual growth rate ( CAGR ) of 8.9%, reaching a value of US$11.9 billion by the end of 2030, up from US$6.5 billion ...",JNJ,0.01403,0.0,Neutral
"SHAREHOLDER RIGHTS INVESTIGATION: Halper Sadeh LLC Investigates FGH, AXNX, AMAM, HARP - Ambrx Biopharma  ( NASDAQ:AMAM ) , Axonics  ( NASDAQ:AXNX ) ",https://www.benzinga.com/pressreleases/24/01/g36653978/shareholder-rights-investigation-halper-sadeh-llc-investigates-fgh-axnx-amam-harp,2024-01-17 05:00:00,"NEW YORK, Jan. 17, 2024 ( GLOBE NEWSWIRE ) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: FG Group Holdings Inc.",JNJ,0.12546,0.089947,Neutral
Top 5 Life Science ETFs,https://investingnews.com/daily/life-science-investing/biotech-investing/top-performing-life-science-etfs/,2024-01-16 21:15:00,"Taking a position in a life science exchange-traded fund ( ETF ) provides exposure to a basket of stocks focused on the healthcare sector, while mitigating the risks of holding shares in a single company.",JNJ,0.1789,0.109406,Neutral
Johnson & Johnson Options Trading: A Deep Dive into Market Sentiment - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/24/01/36648551/johnson-johnson-options-trading-a-deep-dive-into-market-sentiment,2024-01-16 19:30:52,"Whales with a lot of money to spend have taken a noticeably bearish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson JNJ we detected 11 trades. If we consider the specifics of each trade, it is accurate to state that 18% of the investors opened trades with bullish ...",JNJ,0.535653,0.313788,Somewhat-Bullish
"Molecular Diagnostics Market Hits US$ 39.5 Billion in 2022, Expected to Reach US$ 59.4 Billion by 2033 with a 4.2% CAGR, Persistence Market Research",https://www.benzinga.com/pressreleases/24/01/g36643857/molecular-diagnostics-market-hits-us-39-5-billion-in-2022-expected-to-reach-us-59-4-billion-by-203,2024-01-16 15:30:00,"New York, Jan. 16, 2024 ( GLOBE NEWSWIRE ) -- The Molecular Diagnostics Market is experiencing robust growth due to technological advancements and increasing demand for personalized medicine. Key applications include oncology, infectious diseases, genetic testing, and cardiovascular diseases.",JNJ,0.019797,0.0,Neutral
"Liquid Soap Market Bubbles Up to USD 35.70 Billion by 2030, Report by Persistence Market Research",https://www.benzinga.com/pressreleases/24/01/g36642766/liquid-soap-market-bubbles-up-to-usd-35-70-billion-by-2030-report-by-persistence-market-research,2024-01-16 14:45:00,"New York, Jan. 16, 2024 ( GLOBE NEWSWIRE ) -- Market Overview: The global liquid soap market size was valued at USD 21.18 billion in 2022 and is projected to grow from USD 22.46 billion in 2023 to USD 35.70 billion by 2030, exhibiting a CAGR of 6.84% during the forecast period.",JNJ,0.032758,0.085756,Neutral
"After-sun Products Market is Anticipated to Reach USD 3.3 billion at a CAGR of 3.7 % CAGR by 2031 - Report by Transparency Market Research, Inc.",https://www.benzinga.com/pressreleases/24/01/g36642400/after-sun-products-market-is-anticipated-to-reach-usd-3-3-billion-at-a-cagr-of-3-7-cagr-by-2031-re,2024-01-16 14:30:00,"Wilmington, Delaware, United States, Jan. 16, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - After-sun products accounted for a global market value of US$ 2.4 billion in 2022. From 2023 to 2031, it is expected to expand at a CAGR of 3.7%, reaching US$ 3.3 billion by 2031.",JNJ,0.038407,0.0,Neutral
"BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc.  ( Nasdaq - AMAM ) , Gracell Biotechnologies Inc.  ( Nasdaq - GRCL ) , Axonics, Inc.  ( Nasdaq - AXNX ) , Harpoon Therapeutics, Inc.  ( Nasdaq - HARP ) ",https://www.benzinga.com/pressreleases/24/01/g36638641/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-ambrx-biophar,2024-01-16 13:05:00,"BALA CYNWYD, Pa., Jan. 16, 2024 ( GLOBE NEWSWIRE ) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ( jbrodsky@brodskysmith.com ) or Marc Ackerman ( mackerman@brodskysmith.com ) at 855-576-4847.",JNJ,0.15697,0.156505,Somewhat-Bullish
Ecovyst Names Kara L. Thornton Vice President and Chief Human Resources Officer,https://www.prnewswire.com/news-releases/ecovyst-names-kara-l-thornton-vice-president-and-chief-human-resources-officer-302033970.html,2024-01-16 12:00:00,"MALVERN, Pa., Jan. 16, 2024 /PRNewswire/ -- Ecovyst Inc. ( NYSE: ECVT ) ( ""Ecovyst"" or the ""Company"" ) , a leading integrated and innovative global provider of advanced materials,specialty catalysts and services, today announced that Kara L. Thornton has been appointed Vice President and Chief ...",JNJ,0.102013,-0.057567,Neutral
"Asia Pacific Facial Care Market Projected to Reach USD 88.4 billion, Growing at a CAGR of 6.9% by 2031: Transparency Market Research, Inc.",https://www.benzinga.com/pressreleases/24/01/g36634032/asia-pacific-facial-care-market-projected-to-reach-usd-88-4-billion-growing-at-a-cagr-of-6-9-by-20,2024-01-16 02:30:00,"Wilmington, Delaware, United States, Jan. 15, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The Asia Pacific facial care market is estimated to flourish at a CAGR of 6.9% from 2021 to 2031.",JNJ,0.03448,-0.185059,Somewhat-Bearish
Hold That Spinoff Stock: Selling Could Cost You Big,https://www.forbes.com/sites/jimosman/2024/02/04/hold-that-spinoff-stock-selling-could-cost-you-big/,2024-02-04 16:00:00,"The legendary investor Peter Lynch once said, ""Invest in what you know."" Lynch emphasized the importance of understanding the companies or investments you're involved in, suggesting that investors will make better decisions if they invest in industries or companies they're familiar with or have ...",JNJ,0.01978,0.054423,Neutral
2 Healthcare Dividend Kings to Buy and Hold Forever,https://www.fool.com/investing/2024/02/04/2-healthcare-dividend-kings-to-buy-and-hold-foreve/,2024-02-04 13:20:00,It's going to take a lot to interrupt these companies' streaks.,JNJ,0.254573,-0.096638,Neutral
"AbbVie  ( ABBV )  Q4 Earnings Beat, Raises Sales View for Key Drugs",https://www.zacks.com/stock/news/2220511/abbvie-abbv-q4-earnings-beat-raises-sales-view-for-key-drugs,2024-02-02 18:04:00,AbbVie???s (ABBV) fourth-quarter earnings and sales beat estimates. Management hikes the 2027 forecast for new immunology drugs to more than $27 billion.,JNJ,0.073773,0.131161,Neutral
"North America Cosmetic Surgery Market is Expected to Reach USD 29.2 billion, Advancing at a CAGR of 6.8% by 2031: Transparency Market Research, Inc.",https://www.benzinga.com/pressreleases/24/02/g36909586/north-america-cosmetic-surgery-market-is-expected-to-reach-usd-29-2-billion-advancing-at-a-cagr-of,2024-02-02 14:08:11,"Wilmington, Delaware, United States, Feb. 02, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The North America cosmetic surgery market is estimated to flourish at a CAGR of 6.8% from 2023 to 2031.",JNJ,0.035502,0.162941,Somewhat-Bullish
Dividend Aristocrat List 2024: 10 Highest-Yielding Stocks,https://www.forbes.com/sites/investor-hub/article/dividend-aristocrats-list/,2024-02-01 17:11:28,Dividend Aristocrats List 2024: 10 Highest-Yielding Stocks Forbes ...,JNJ,0.102013,0.153193,Somewhat-Bullish
Biden Administration Starts Negotiations Over Medicare Drug Prices-Here's How Prices May Be Affected,https://www.forbes.com/sites/tylerroush/2024/02/01/biden-administration-starts-negotiations-over-medicare-drug-prices-heres-how-prices-may-be-affected/,2024-02-01 15:59:16,"The Biden Administration started negotiations on Thursday with the manufacturers of 10 drugs widely used by older Americans, as part of an effort to cut prescription prices for the costliest medications covered by Medicare, which federal officials estimate could save the health program an ...",JNJ,0.068896,-0.025316,Neutral
"Why ETF Yields Could Crash, And These 8%+ Payers Will Soar",https://www.forbes.com/sites/brettowens/2024/01/31/why-etf-yields-could-crash-and-these-8-payers-will-soar/,2024-01-31 12:45:00,"This market bounce is strangling the payouts on everybody's favorite ETFs. But it's also given us a sweet setup to grab another group of funds kicking out big dividends, to the tune of 9%+ yields. Even better, many of these funds-wallflowers to ""popular-kid"" ETFs-were left off the invite list for ...",JNJ,0.065061,0.149255,Neutral
"Healthy Returns: J&J, Merck and Bristol Myers Squibb are in the hot seat",https://www.cnbc.com/2024/01/30/healthy-returns-jj-merck-and-bristol-myers-squibb-in-the-hot-seat.html,2024-01-30 18:52:54,"J&J, Merck and Bristol Myers Squibb face a pivotal few weeks ahead. Meanwhile, Apple will reportedly explore health applications for the Vision Pro headset.",JNJ,0.038592,0.0,Neutral
3 Blue Chip Stocks To Watch Ahead Of February 2024,https://stockmarket.com/featured/3-blue-chip-stocks-to-watch-ahead-of-february-2024-2024-01-30,2024-01-30 15:54:12,"Investing in the stock market offers individuals the opportunity to own a share of a company's assets and earnings. It's a way to grow wealth over time, though it comes with varying levels of risk.",JNJ,0.300946,0.227503,Somewhat-Bullish
"Drug, Biotech Stocks' Q4 Earnings Due on Jan 31: NVO, NVS & GSK",https://www.zacks.com/stock/news/2217797/drug-biotech-stocks-q4-earnings-due-on-jan-31-nvo-nvs-gsk,2024-01-30 14:09:00,"Let's look at three biotech/drug companies, NVO, NVS and GSK, slated to release quarterly results on Jan 31.",JNJ,0.110973,0.255206,Somewhat-Bullish
"1 Mental Trick You Can Use If You Want to Invest in the S&P 500 but Don't Like the ""Magnificent Seven""",https://www.fool.com/investing/2024/01/30/mental-trick-buy-market-magnificent-seven-stocks/,2024-01-30 14:03:00,These seven companies alone make up more than $12 trillion in value.,JNJ,0.037504,0.136778,Neutral
Will Novo Nordisk Be a $1 Trillion Company by 2030?,https://www.fool.com/investing/2024/01/30/will-novo-nordisk-be-a-1-trillion-company-by-2030/,2024-01-30 12:15:00,"Novo Nordisk's market cap has ballooned thanks to the overwhelming success of its Ozempic, Wegovy, and Rybelsus medications.",JNJ,0.047749,0.0,Neutral
"Wall Street's Greatest Dividend Stock Just Made History Again, and 99% of Investors Probably Don't Realize It Exists",https://www.fool.com/investing/2024/01/30/wall-street-greatest-dividend-stock-made-history/,2024-01-30 10:21:00,This virtually unknown company has been paying a consecutive dividend to its investors for more than 200 years.,JNJ,0.152741,0.231478,Somewhat-Bullish
3 Perfect Stocks for Retirees to Buy Hand Over Fist in the New Bull Market,https://www.fool.com/investing/2024/01/30/3-perfect-stocks-for-retirees-buy-new-bull-market/,2024-01-30 10:06:00,"These industry-leading, time-tested companies are ideal for retired investors.",JNJ,0.137987,0.068015,Neutral
"Johnson & Johnson  ( NYSE:JNJ )  Downgraded to ""Buy"" at StockNews.com",https://www.defenseworld.net/2024/01/30/johnson-johnson-nysejnj-downgraded-to-buy-at-stocknews-com.html,2024-01-30 08:44:45,StockNews.com lowered shares of Johnson & Johnson ( NYSE:JNJ - Free Report ) from a strong-buy rating to a buy rating in a research note published on Monday. Other analysts also recently issued research reports about the stock.,JNJ,0.75914,0.398076,Bullish
"Antibody drug conjugates focus draws global pharma giants attention to China, says GlobalData",https://www.financialexpress.com/healthcare/pharma-healthcare/antibody-drug-conjugates-focus-draws-global-pharma-giants-attention-to-china-says-globaldata/3377889/,2024-01-30 02:30:00,"Antibody-drug conjugates ( ADCs ) represent a significant breakthrough in targeted cancer therapy. By blending the specificity of monoclonal antibodies with the potency of cytotoxic drugs, ADCs offer a targeted approach to cancer treatment, minimizing the damage to healthy cells.",JNJ,0.097854,0.031578,Neutral
Nanobiotix Announces Achievement of $20M Development Milestone Payment Related to Ongoing Global Phase 3 Head and Neck Cancer Study,https://www.globenewswire.com/news-release/2024/01/29/2819438/0/en/Nanobiotix-Announces-Achievement-of-20M-Development-Milestone-Payment-Related-to-Ongoing-Global-Phase-3-Head-and-Neck-Cancer-Study.html,2024-01-29 21:15:00,"PARIS and CAMBRIDGE, Mass., Jan. 29, 2024 ( GLOBE NEWSWIRE ) -- NANOBIOTIX ( Euronext : NANO -- NASDAQ: NBTX - the ''Company'' ) , a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced ...",JNJ,0.038843,-0.005935,Neutral
Nanobiotix Announces Achievement of $20M Development Milestone Payment Related to Ongoing Global Phase 3 Head and Neck Cancer Study - Nanobiotix  ( NASDAQ:NBTX ) ,https://www.benzinga.com/pressreleases/24/01/g36833599/nanobiotix-announces-achievement-of-20m-development-milestone-payment-related-to-ongoing-global-ph,2024-01-29 21:15:00,"PARIS and CAMBRIDGE, Mass., Jan. 29, 2024 ( GLOBE NEWSWIRE ) -- NANOBIOTIX NBTX, a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced achievement of operational requirements in NANORAY-312, an ...",JNJ,0.038407,-0.00593,Neutral
Cartilage Degeneration Market Size Is Expected To Reach A Value Of More Than $15 Billion By 2028 As Per The Business Research Company's Cartilage Degeneration Global Market Report 2024,https://www.benzinga.com/pressreleases/24/01/g36828226/cartilage-degeneration-market-size-is-expected-to-reach-a-value-of-more-than-15-billion-by-2028-as,2024-01-29 16:30:00,"LONDON, Jan. 29, 2024 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Cartilage Degeneration Global Market Report 2024, the global cartilage degeneration market has witnessed a substantial upswing, with the market size surging from $11.88 billion in 2023 to $12.63 billion in 2024, ...",JNJ,0.058472,0.047017,Neutral
"Johnson & Johnson To Pay $149M In Opioid Settlement, Washington State AG Says 'We Are Not Done' - Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/markets/cannabis/24/01/36828018/johnson-johnson-to-pay-149m-in-opioid-settlement-washington-state-ag-says-we-are-not-done,2024-01-29 16:19:42,Opioid producer and raw material supplier Johnson & Johnson JNJ reached a settlement last week in an opioid lawsuit with Washington state.,JNJ,0.331765,-0.067945,Neutral
Johnson & Johnson  ( JNJ )  Is a Trending Stock: Facts to Know Before Betting on It,https://www.zacks.com/stock/news/2216975/johnson-johnson-jnj-is-a-trending-stock-facts-to-know-before-betting-on-it,2024-01-29 14:00:09,"Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",JNJ,0.474082,0.150631,Somewhat-Bullish
"Better Buy in 2024: The ""Magnificent Seven"" or the ""Terrific 10""?",https://www.fool.com/investing/2024/01/29/better-buy-the-magnificent-seven-or-terrific-ten/,2024-01-29 11:26:00,The financial and healthcare sectors make up a massive amount of the market.,JNJ,0.068995,0.111863,Neutral
"Dementia and Movement Disorder Treatment Market to Grow by USD 8.55 billion, Market Share, Trends, and Growth ... - PR Newswire",https://www.prnewswire.com/news-releases/dementia-and-movement-disorder-treatment-market-to-grow-by-usd-8-55-billion-market-share-trends-and-growth-analysis----technavio-302045378.html,2024-01-29 10:15:00,"Dementia and Movement Disorder Treatment Market to Grow by USD 8.55 billion, Market Share, Trends, and Growth ... PR ...",JNJ,0.053509,0.125702,Neutral
Why It Matters That Consumers Are So Enraged By The Kyte Baby Debacle,https://www.forbes.com/sites/soniathompson/2024/01/28/why-it-matters-that-consumers-are-so-enraged-by-the-kyte-baby-debacle/,2024-01-28 16:49:03,"Data shows that 71% of consumers want to know the brands they buy from are aligned with their values. And increasingly, real life examples continue to pop up that showcase consumers exercising their credit card activism by refusing to support brands that they feel are either not aligned with ...",JNJ,0.043342,0.081831,Neutral
"20 ""Tech"" Stocks Make Up Over 35% of the S&P 500. Here's What That Means for Your Portfolio.",https://www.fool.com/investing/2024/01/28/20-tech-stocks-sp-500-buy-2024-invest/,2024-01-28 15:20:00,The stock market isn't what it used to be.,JNJ,0.130217,-0.007077,Neutral
"Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs",https://www.cnbc.com/2024/01/28/big-pharma-merck-bristol-myers-jj-prepare-to-lose-revenue.html,2024-01-28 13:00:01,Fast-approaching patent expirations will take a bite out of revenues and put the industry's top players in the hot seat over the next few years.,JNJ,0.021427,-0.120651,Neutral
"Want to Invest $1,000 in the ""Magnificent Seven?"" Invest This Amount in an S&P 500 Index Fund",https://www.fool.com/investing/2024/01/28/invest-magnificent-seven-stock-sp-500-fund/,2024-01-28 12:55:00,The stock market has become more concentrated than ever before.,JNJ,0.050786,0.096735,Neutral
Investing Has Its Own Lingo. We'll Help You Understand It.,https://www.fool.com/investing/2024/01/28/investing-has-its-own-lingo-well-help-you-understa/,2024-01-28 09:25:00,"We're here to make you smarter, happier, and richer, and today we're focusing on the smarter part.",JNJ,0.008497,0.14092,Neutral
Better Growth Stock: UnitedHealth Group vs. Johnson & Johnson,https://www.fool.com/investing/2024/01/27/better-growth-stock-unitedhealth-group-vs-johnson/,2024-01-27 15:15:00,"These companies have been focusing on growing their operations, but which stock is likely to provide investors with better returns?",JNJ,0.365166,0.24848,Somewhat-Bullish
Should You Buy the Dogs of the Dow in 2024?,https://www.fool.com/investing/2024/01/27/should-you-buy-the-dogs-of-the-dow-in-2024/,2024-01-27 11:59:00,The popular dividend-investing strategy has been around for years. Is it right for you?,JNJ,0.064797,0.134527,Neutral
"AMBRX INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Ambrx Biopharma, Inc. - AMAM",https://www.prnewswire.com/news-releases/ambrx-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick--foti-llc-investigates-adequacy-of-price-and-process-in-proposed-sale-of-ambrx-biopharma-inc---amam-302046072.html,2024-01-27 04:17:00,"AMBRX INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC ... PR ...",JNJ,0.451494,0.195991,Somewhat-Bullish
Global Pompe Disease Drugs Market: USD 294.7 Million Growth Forecasted at a CAGR of 4.16% between 2024 to ... - PR Newswire,https://www.prnewswire.com/news-releases/global-pompe-disease-drugs-market-usd-294-7-million-growth-forecasted-at-a-cagr-of-4-16-between-2024-to-2028--technavio-302045515.html,2024-01-26 23:31:00,Global Pompe Disease Drugs Market: USD 294.7 Million Growth Forecasted at a CAGR of 4.16% between 2024 to ... PR ...,JNJ,0.051774,0.080886,Neutral
"Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices",https://www.cnbc.com/2024/01/26/merck-jj-ceos-agree-to-testify-in-senate-hearing-on-drug-prices-.html,2024-01-26 21:17:09,"The CEOs of Merck, Johnson & Johnson and Bristol Myers Squibb will testify at the hearing on drug prices, Sen. Bernie Sanders said.",JNJ,0.085022,0.052216,Neutral
"S&P 500 Dividend Aristocrats: Who's Out, Who's In",https://www.kiplinger.com/investing/sandp-500-dividend-aristocrats-whos-out-whos-in,2024-01-26 19:55:30,"The S&P 500 Dividend Aristocrats index looks only a little different as we head into the new year. Widely regarded as some of the best dividend stocks for dependable dividend growth, the S&P 500 Dividend Aristocrats is an index of S&P 500 companies that have raised their dividends for at least 25 ...",JNJ,0.178459,0.0,Neutral
"Stocks Rally Amid Big Earnings, Economic Data: Weekly Review",https://www.investors.com/news/stock-market-continues-to-rally-asml-netflix-tesla-intel-are-big-earnings-movers-weekly-review/,2024-01-26 17:29:00,"Stock Market Continues To Rally. ASML, Netflix, Tesla, Intel Are Big Earnings Movers: Weekly Review Investor's Business Daily ...",JNJ,0.060287,0.075292,Neutral
The U.S. has no federal bereavement leave. What to know about options at work when someone you love dies,https://www.cnbc.com/2024/01/26/what-to-know-about-bereavement-leave-at-work-when-someone-you-love-dies.html,2024-01-26 14:45:40,"The U.S. has no federal bereavement leave policy, but workers in mourning still have options. Here's what they should know.",JNJ,0.057767,0.092237,Neutral
Key Takeaways From JNJ's  ( JNJ )  Q4 Earnings Presentation,https://www.zacks.com/stock/news/2216453/key-takeaways-from-jnjs-jnj-q4-earnings-presentation,2024-01-26 14:30:00,J&J's (JNJ) Innovative Medicines as well as MedTech units outperform expectations in the fourth quarter. Here we discuss some highlights of its performance in the fourth quarter.,JNJ,0.114137,0.060868,Neutral
When You Make A Mistake Take Responsibility,https://www.forbes.com/sites/jerryweissman/2024/01/26/when-you-make-a-mistake-take-responsibility/,2024-01-26 14:00:00,Boeing CEO David Calhoun and San Francisco Forty-Niner quarterback Brock Purdy have something in common: each of them took responsibility for their mistakes.,JNJ,0.090816,0.0,Neutral
"Men's Skincare Products Market to Acquire a Size of USD 24,824.0 Million By 2030, According to Persistence Market Research",https://www.benzinga.com/pressreleases/24/01/g36796496/mens-skincare-products-market-to-acquire-a-size-of-usd-24-824-0-million-by-2030-according-to-persi,2024-01-26 08:44:04,"New York, Jan. 26, 2024 ( GLOBE NEWSWIRE ) -- Men's skincare products industry is a rapidly expanding and continually evolving sector that specializes in creating and distributing personal care products tailored for men's skin.",JNJ,0.028456,0.0,Neutral
